Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5152080752706033,-2.0976646162752344,0.0,0.054186176248031244,0.044,51/87,25.05%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;SEC61B;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPLP2;RPS6;RPS15A;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;RPL22;RPS9;RPS14;RPS25
prerank,cellular response to zinc ion (GO:0071294),-0.7692293791533743,-2.0666686929546367,0.0,0.0496706615606953,0.082,11/15,16.01%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;GLRA2;P2RX4;MT2A
prerank,blood vessel diameter maintenance (GO:0097746),-0.6010315430679962,-2.032123880634506,0.0,0.05719651937292187,0.129,17/34,19.18%,ROCK2;ECE1;NOS3;GCLM;NPR1;ACE;BDKRB2;AGTR1;KLF2;EDNRA;EDN1;EDN3;ACE2;NOS1;PER2;GCLC;AGT
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6828256513952492,-2.0238472209138596,0.0,0.049388441892736806,0.147,7/20,4.89%,IGF1;PDGFRB;LRP1;SLIT2;IGFBP3;IGFBP5;ACE
prerank,protein targeting to ER (GO:0045047),-0.4869824844920958,-2.020248074299423,0.0,0.042220062326591014,0.154,53/99,22.61%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;SGTA;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;SEC62;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;ZFAND2A;RPS12;RPL18A;RPS21;SPCS1;RPS18;RPLP2;RPS6;SGTB;RPS15A;RPL14;RPS2;RPL10A;GET3;RPL39;RPL34;RPL5;RPL22
prerank,dorsal/ventral pattern formation (GO:0009953),0.8071742465075165,2.015572021284107,0.0,0.2993294057109207,0.226,5/20,4.27%,PTCH1;FBXL15;GLI2;BMPR1B;NBL1
prerank,smoothened signaling pathway (GO:0007224),0.744302371204715,1.9979486232385018,0.0,0.21769411324430601,0.305,6/32,5.28%,PTCH1;PTCH2;GLI1;GLI2;STIL;HIPK1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.4839756847061099,-1.9925363549256623,0.0,0.05399802980272558,0.23,42/91,16.50%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;SSR1;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;SEC62;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPLP2;RPS6;RPS15A
prerank,dopamine metabolic process (GO:0042417),-0.703937923516334,-1.9880457700356404,0.0,0.04870305127055189,0.241,8/18,12.75%,SNCAIP;MOXD1;MAOA;COMT;ATP7A;GCH1;MAOB;TGFB2
prerank,negative regulation of cell activation (GO:0050866),-0.735948597166,-1.9787331393002683,0.0,0.05108175990048778,0.283,6/14,6.95%,PDGFRA;NOS3;THBD;LDLR;APOE;CD200
prerank,regulation of cell morphogenesis (GO:0022604),0.7441960525739084,1.9773387253359114,0.0,0.2236369123127569,0.418,5/30,2.67%,NTNG2;NTNG1;EFNA5;FMNL2;CAPZB
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5984067287341763,-1.9652474913994207,0.0,0.05581677877401366,0.349,15/31,17.56%,OSR1;PDGFRA;HOXA3;TGFBR1;FGFR2;HOXB4;DSCAML1;HOXB9;TBX1;HOXC4;HOXA9;FUZ;MEGF8;HOXD4;HOXD3
prerank,smooth muscle contraction (GO:0006939),-0.7185313224280816,-1.9635581979305088,0.0,0.05136397956844628,0.355,8/14,11.69%,ROCK2;MYLK;SLC8A1;BDKRB2;MYH11;PIK3C2A;ACTA2;EDNRA
prerank,somite development (GO:0061053),0.9053803841094517,1.9621987877340261,0.0,0.22520080680445448,0.498,2/11,0.06%,PTCH1;MEOX2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.7575027837349838,-1.956731294981882,0.0,0.05244154557337872,0.385,6/14,2.58%,PRKG1;LRP1;SLIT2;TPM1;IGFBP3;IGFBP5
prerank,basement membrane organization (GO:0071711),0.8527618048841829,1.9562991635484293,0.0,0.20042871805596452,0.533,5/14,1.47%,NTNG2;NTNG1;PXDN;NID1;LAMB2
prerank,positive regulation of embryonic development (GO:0040019),-0.669616832150684,-1.9482338164256048,0.0025575447570332483,0.05277507790823876,0.412,5/19,6.20%,PLCB1;OSR1;WNT4;CFL1;ZBED3
prerank,heart trabecula morphogenesis (GO:0061384),-0.7122874616235211,-1.9432917143467723,0.0,0.051841582083452964,0.432,8/18,2.84%,ENG;TEK;ADGRG6;TGFBR3;RBPJ;FKBP1A;RBP4;TGFBR1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6789749693832536,1.9388765519486522,0.0,0.23004887972871707,0.637,10/50,7.03%,PTCH1;RORA;GPC3;PTCH2;GLI1;GLIS2;INTU;KIF7;IFT81;PDCL
prerank,hemidesmosome assembly (GO:0031581),0.8812140829131347,1.9334663661254823,0.0,0.21742601704572928,0.667,3/11,1.47%,ITGB4;ITGA6;LAMC1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6172577294534727,-1.9279536894340485,0.0,0.06039500894311816,0.489,12/26,6.86%,SLC30A10;SLC39A10;SLC39A8;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;SLC39A14
prerank,response to zinc ion (GO:0010043),-0.6238045158427008,-1.9199248710694647,0.0,0.06329246420082538,0.532,13/25,17.57%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;GLRA2;P2RX4;MT2A;SLC30A4;D2HGDH
prerank,cellular response to copper ion (GO:0071280),-0.7062377850206631,-1.9109405565644466,0.0,0.06723883589111168,0.581,8/16,3.81%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6573167316927426,-1.9090215259358114,0.0,0.06461170280555685,0.588,9/21,9.69%,RBPMS;BMP6;DAB2;BMP4;TGFBR1;CCN3;JAK2;TGFB3;SLC2A10
prerank,cell-substrate junction assembly (GO:0007044),0.7159970059439994,1.9084500295890499,0.0,0.2873656128494341,0.789,8/33,5.16%,ITGB4;ITGA6;DLC1;SORBS1;LAMC1;PEAK1;SRC;FN1
prerank,cellular response to sterol (GO:0036315),0.8651102860223988,1.9076408701382521,0.0,0.2574170333334251,0.794,4/13,4.10%,PTCH1;RORA;GPLD1;GRAMD1B
prerank,manganese ion transport (GO:0006828),-0.7174325674357512,-1.898328905770906,0.0,0.07024133958078124,0.627,7/14,6.86%,SLC30A10;TRPC3;SLC39A8;TRPC1;SLC11A2;ATP2C1;SLC39A14
prerank,regulation of Golgi organization (GO:1903358),-0.6760123132246081,-1.8975773923606445,0.0,0.06737623230840727,0.631,7/17,7.55%,PDE4DIP;MYO5A;STX18;USP6NL;PDCD10;RBSN;MAP2K2
prerank,extracellular matrix assembly (GO:0085029),0.7519224895739718,1.8917863808195583,0.0047694753577106515,0.2966082292953669,0.858,5/23,1.47%,NTNG2;NTNG1;TNXB;PXDN;LAMB2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.7536874334985681,1.8890928650197223,0.0015128593040847202,0.28124509849783574,0.87,6/23,5.68%,PTCH1;GPC3;PTCH2;GPR161;GLIS2;KIF7
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.8043853837336434,1.887744702107756,0.0,0.2628906640543667,0.871,3/16,1.37%,CLDN1;CLDN11;CLDN19
prerank,embryonic axis specification (GO:0000578),0.8006256861264449,1.8806126570925032,0.004975124378109453,0.2752213706235208,0.893,3/15,3.46%,PTCH1;COBL;STIL
prerank,regulation of glucose import (GO:0046324),-0.5908023755309727,-1.8772836269419935,0.006472491909385114,0.08212592337592234,0.714,10/30,2.90%,PRKAG2;IGF1;OSBPL8;INSR;PID1;ENPP1;GRB10;PIK3R1;CREBL2;APPL2
prerank,zinc ion homeostasis (GO:0055069),-0.5955824740063539,-1.876125090490208,0.003246753246753247,0.07934404379176004,0.715,12/28,6.86%,SLC30A10;SLC39A10;SLC39A8;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;SLC39A14
prerank,regulation of histone modification (GO:0031056),-0.7170330320230475,-1.8755440416983988,0.0,0.07635324834949855,0.718,8/13,16.53%,SETD5;IGF2;PARG;UBE2N;CDK9;MTHFR;MYOCD;AKAP8L
prerank,regulation of cell projection organization (GO:0031344),0.825355767954312,1.8754911941104258,0.0,0.2780827819737148,0.909,2/13,0.08%,NTNG2;NTNG1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7797081268719019,-1.8717728102458866,0.0024154589371980675,0.07715640313578362,0.734,7/11,9.15%,ADIPOR2;NDNF;PRCP;KDR;CD34;GATA2;MCAM
prerank,synaptic membrane adhesion (GO:0099560),0.7969741337082976,1.8446341734077976,0.0033613445378151263,0.40367244619698467,0.973,3/14,2.28%,NTNG1;PTPRF;GPC6
prerank,erythrocyte differentiation (GO:0030218),-0.5229838290360624,-1.8441358887403216,0.0036363636363636364,0.10385683780872655,0.831,21/44,28.47%,TGFBR3;LYN;MFHAS1;KIT;CEBPG;UBA5;JAK2;RPS19;CASP3;SLC25A38;TAL1;ID2;CDK5RAP3;ABCB10;INHBA;ALAS1;NCKAP1L;RPS14;JAK3;KMT2E;ALAS2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.6373204098647842,-1.8427772776485398,0.007731958762886598,0.10105721870257826,0.834,7/19,7.37%,IGF1;NUPR1;IL18;TNFRSF1B;IL33;CD200;DAGLA
prerank,metanephros development (GO:0001656),0.7235196642094129,1.841596579685144,0.0030349013657056147,0.3924593226915129,0.979,3/26,3.23%,PTCH1;FOXD1;NF1
prerank,regulation of cholesterol efflux (GO:0010874),0.7067334538780707,1.8392440272845418,0.0014771048744460858,0.3790880247874984,0.981,2/30,0.24%,PTCH1;CAV1
prerank,skin development (GO:0043588),0.608645824288046,1.8379023636023042,0.0025380710659898475,0.3651172339949998,0.983,12/65,6.66%,ITGB4;CLDN1;ITGA6;WNT10A;JAG1;COL5A3;WNT16;ALOXE3;LSR;WNT5A;TMEM79;COL3A1
prerank,regulation of wound healing (GO:0061041),0.649080588488338,1.8322654620132879,0.0055248618784530384,0.3737543214684455,0.986,10/42,8.23%,CLDN1;CAV1;PRKCE;CLDN19;AJAP1;CASK;TNFAIP3;EPHB2;KANK1;OCLN
prerank,positive regulation of cholesterol transport (GO:0032376),0.7131065906109777,1.8318338820400408,0.0,0.3568963619503094,0.986,2/27,0.24%,PTCH1;CAV1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.45403983075412074,-1.82859967907772,0.0,0.11379965380295663,0.879,23/91,7.18%,BMP6;SLC30A10;ABCG2;SLC39A10;FTH1;TFRC;SCARA5;SLC39A8;ATP7A;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;SLC31A1;FTL;SLC31A2;SLC11A2;SLC39A14;NEDD8
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.6331050841818194,1.8212318467748327,0.002770083102493075,0.3872649588440887,0.992,14/46,10.07%,NTNG2;NTNG1;PARVA;PXN;LAMB2;LAMC1;PEAK1;FN1;FER;LAMA5;ITGB7;SRCIN1;NTN4;FERMT2
prerank,melanocyte differentiation (GO:0030318),-0.7233349477483306,-1.8203543185790554,0.002277904328018223,0.12099906949213148,0.896,4/11,3.98%,ENPP1;LRMDA;KIT;MITF
prerank,positive regulation of cholesterol efflux (GO:0010875),0.7476752327847758,1.8196078739074757,0.0031645569620253164,0.3785335531040783,0.992,2/21,0.24%,PTCH1;CAV1
prerank,regulation of neuron projection arborization (GO:0150011),0.7853145352243365,1.8158363156667299,0.003355704697986577,0.37810889084487026,0.996,3/15,4.96%,NTNG2;NTNG1;WNT5A
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.712105482493034,-1.8145442475479374,0.0023923444976076554,0.12550711805068546,0.914,7/13,8.02%,RBPMS;BMP6;DAB2;BMP4;TGFBR1;JAK2;TGFB3
prerank,cytoplasmic translation (GO:0002181),-0.44081943320415684,-1.8101702280473269,0.0,0.12740758251422862,0.926,47/91,22.61%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPS6;RPS15A;GSPT2;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;RPL22
prerank,embryonic appendage morphogenesis (GO:0035113),0.8374946458462458,1.8091518857229363,0.005272407732864675,0.39265480950297504,0.999,1/12,0.01%,PTCH1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5909050525902436,1.8057105634540445,0.0,0.3927502070669686,1.0,18/70,10.52%,NTNG2;NTNG1;PARVA;PXN;LAMB2;LAMC1;SPI1;OPHN1;PEAK1;FN1;FER;POF1B;LAMA5;ITGB7;SRCIN1;NTN4;FERMT2;RELN
prerank,actin filament-based transport (GO:0099515),-0.6152329386147631,-1.8035800304444138,0.008130081300813009,0.13275613180767656,0.936,5/21,2.67%,MYO1D;SYNE2;MYO1B;MYO5A;MYO6
prerank,limb morphogenesis (GO:0035108),0.7361485895051696,1.7992971384621994,0.0060882800608828,0.4072020357651699,1.0,3/20,4.10%,PTCH1;PCSK5;BMPR1B
prerank,copper ion transport (GO:0006825),-0.7286570768790228,-1.7973873100305848,0.0049382716049382715,0.1381965986970958,0.946,5/11,6.14%,STEAP3;ATP7A;SLC31A1;SLC31A2;SLC11A2
prerank,cellular response to amyloid-beta (GO:1904646),-0.521635681357274,-1.795183077830883,0.003355704697986577,0.1369470938768602,0.951,8/35,9.43%,IGF1R;IGF1;LRP1;GJA1;EPHA4;VCAM1;GRIN1;LGMN
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.7471101426448461,1.787722047613261,0.008169934640522876,0.4487682126953581,1.0,4/18,5.19%,CAV1;NEDD4L;CAMK2D;ATP1A2
prerank,transition metal ion transport (GO:0000041),-0.535825206074213,-1.787228771021607,0.0,0.1446333037731541,0.964,11/35,6.32%,SLC30A10;TRPC3;FTH1;TFRC;SLC39A8;ATP7A;TRPC1;SLC31A1;SLC31A2;SLC11A2;ATP2C1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7631863510307462,1.7841152415942554,0.009302325581395349,0.45120590220463913,1.0,5/16,8.29%,RORA;FOXK1;PDK4;BCKDK;FOXK2
prerank,response to cholesterol (GO:0070723),0.7623756905768592,1.7830594124090158,0.00641025641025641,0.44069468228113073,1.0,3/17,4.10%,PTCH1;GPLD1;GRAMD1B
prerank,mesoderm formation (GO:0001707),0.7425664517192544,1.7810277347054808,0.003436426116838488,0.4361076179547929,1.0,1/17,0.03%,ITGB4
prerank,digestive tract development (GO:0048565),0.6678985859191143,1.7791586309645062,0.004201680672268907,0.4313019215264344,1.0,10/32,8.48%,STRA6;PKDCC;GLI1;RARB;COBL;PCSK5;GLI2;CHD8;CCDC39;CLMP
prerank,inositol phosphate-mediated signaling (GO:0048016),0.7507229585948368,1.776836482484878,0.0046439628482972135,0.4300221135139746,1.0,4/19,1.39%,HRH1;NFATC2;PLCE1;NFATC1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7231391497283994,1.7706296716994037,0.004893964110929853,0.44642079126640594,1.0,3/19,4.67%,THBS4;RIPOR2;RAC2
prerank,neural tube development (GO:0021915),0.7770724033432787,1.7665234493356554,0.008375209380234505,0.45285784789881045,1.0,3/15,4.94%,PTCH1;STIL;DACT1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7293471241188001,1.7595999383168859,0.007987220447284345,0.47345788668650785,1.0,6/20,5.62%,SMOC2;SULF1;SPRY1;SPRY4;CREB3L1;APLN
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7311290039235733,1.759042327166801,0.001644736842105263,0.46301702917526966,1.0,3/17,4.67%,THBS4;RIPOR2;RAC2
prerank,integrin-mediated signaling pathway (GO:0007229),0.574985094138072,1.7525320447167876,0.0025412960609911056,0.4828883516175245,1.0,20/73,10.56%,ITGB4;TEC;ITGBL1;CEACAM1;ADAMTS1;DOCK1;CDH17;TXK;PLPP3;SRC;FN1;ADAM10;LAMA5;COL3A1;ITGB7;CUL3;PLEK;FERMT2;LAT;ZYX
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5704502510211773,-1.7497055037536258,0.0079155672823219,0.20854373346438984,0.994,7/25,10.37%,ANK2;ACTN2;DMD;SLC6A9;ATP1B1;ANK3;ATP1B2
prerank,positive regulation of neutrophil migration (GO:1902624),0.7148361845839776,1.749211255661362,0.006472491909385114,0.4872436754238482,1.0,3/18,4.67%,THBS4;RIPOR2;RAC2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6697537147070526,1.7472588502329307,0.011976047904191617,0.48545691013819203,1.0,6/27,9.35%,NTNG2;NTNG1;BRSK1;ULK4;FRMD7;GSK3B
prerank,regulation of glucose metabolic process (GO:0010906),0.6502582421557972,1.7459348533353172,0.0070921985815602835,0.48042838784950287,1.0,9/34,9.58%,RORA;OGT;GPLD1;FOXK1;PDK4;BCKDK;SELENOS;FOXK2;SIRT7
prerank,regulation of water loss via skin (GO:0033561),0.7611281781125214,1.7456176688446932,0.004746835443037975,0.4589360092636015,1.0,5/15,9.28%,CLDN1;ALOXE3;LSR;TMEM79;SFN
prerank,establishment of skin barrier (GO:0061436),0.7611281781125214,1.7456176688446932,0.004746835443037975,0.4589360092636015,1.0,5/15,9.28%,CLDN1;ALOXE3;LSR;TMEM79;SFN
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.712717350504946,1.74273154099004,0.01393188854489164,0.4616180103819215,1.0,6/21,9.63%,CNKSR3;CAV1;PDE4D;NCK2;NLRP2B;RASSF2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.7058039751795475,1.739527502406946,0.009077155824508321,0.4655642815670498,1.0,7/21,11.20%,CAV1;FZD2;AXIN1;GSK3B;CSNK1A1;APC;DVL3
prerank,muscle tissue development (GO:0060537),0.7745364771221039,1.7391080231107046,0.0071301247771836,0.45751212056449414,1.0,4/13,4.33%,PTCH1;STRA6;NF1;CSRP3
prerank,positive regulation of vasoconstriction (GO:0045907),0.7700439765890619,1.7379449460039682,0.025380710659898477,0.45244147598938406,1.0,3/13,3.83%,CAV1;SMTNL1;SMTNL2
prerank,vascular process in circulatory system (GO:0003018),-0.6535028795319752,-1.7374537389408036,0.014527845036319613,0.22370612346843455,0.995,6/13,5.71%,ROCK2;NOS3;GCLM;NPR1;ACE;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.6535028795319752,-1.7374537389408036,0.014527845036319613,0.22370612346843455,0.995,6/13,5.71%,ROCK2;NOS3;GCLM;NPR1;ACE;AGTR1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5523010055911146,-1.7366545198565209,0.0,0.2194601158514013,0.995,8/27,11.17%,FLT1;TEK;PDGFRB;PDGFRA;KIT;EPHA8;TNFAIP8L3;AMBRA1
prerank,pharyngeal system development (GO:0060037),0.7461736950365623,1.7363737906818875,0.01309328968903437,0.44980267529293966,1.0,3/15,4.65%,PTCH1;FOLR1;BMP5
prerank,actin cytoskeleton reorganization (GO:0031532),0.5834216722043657,1.7345262347998507,0.001310615989515072,0.4486031349434567,1.0,11/63,5.71%,GAB1;FGF7;CXADR;SIPA1L1;PARVA;CLDN19;PDLIM4;MINK1;TRPV4;THSD7A;FER
prerank,camera-type eye development (GO:0043010),0.6728462313362957,1.732858208562025,0.0074962518740629685,0.44651421872954633,1.0,5/25,6.15%,ALDH1A3;STRA6;EFEMP1;NF1;SHROOM2
prerank,positive regulation of wound healing (GO:0090303),0.6284052445052529,1.7300312886129912,0.008450704225352112,0.44927560957488666,1.0,10/36,10.37%,CLDN1;SMOC2;ST3GAL4;PRKCE;PLPP3;RREB1;KANK1;OCLN;FERMT2;ADRA2A
prerank,embryonic organ development (GO:0048568),0.587278314336837,1.7299357755406979,0.00641025641025641,0.4409446516238199,1.0,10/61,3.53%,ALDH1A3;STRA6;PKDCC;RARB;COBL;PBX1;PCSK5;GLI2;STIL;KMT2A
prerank,ventricular septum morphogenesis (GO:0060412),-0.5518331636470656,-1.727437916858197,0.006289308176100629,0.23453939774024488,1.0,9/27,12.75%,ROBO1;TGFBR3;SLIT2;BMP4;TGFBR1;BMPR2;CITED2;PROX1;TGFB2
prerank,regulation of store-operated calcium entry (GO:2001256),0.8125690056707661,1.7272925655215496,0.010471204188481676,0.4447355035659123,1.0,3/10,1.76%,HOMER2;EFHB;SLC8B1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.7126515019741658,-1.7263357440465172,0.01152073732718894,0.2307543787656544,1.0,4/11,15.22%,RAPGEF2;LYN;ANXA1;LGALS9
prerank,response to interleukin-6 (GO:0070741),-0.7129700191462272,-1.7234176252944364,0.01098901098901099,0.231561237559946,1.0,3/10,0.98%,ST3GAL6;PTGIS;PID1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.6825435765401365,1.719397319130429,0.01676829268292683,0.47051388692100493,1.0,3/22,1.89%,NGF;NTRK3;RAP1A
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.6958146152837327,-1.7193377276460113,0.004357298474945534,0.23513716725517622,1.0,5/11,2.18%,IGF1R;PLCB1;IGF1;GHR;PIK3R1
prerank,chordate embryonic development (GO:0043009),0.5924474956932532,1.7184758050212599,0.002652519893899204,0.46611006494773816,1.0,10/55,6.14%,PTCH1;FGFR1;SULF1;KIAA1217;PCSK5;STIL;BMP5;DACT1;WNT5A;ADAM10
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7206088826845197,1.7153590246981032,0.009569377990430622,0.47232457093797897,1.0,4/19,2.50%,LBP;PRKCE;PIK3AP1;TNIP3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.7735937637662599,1.7127834253742797,0.017152658662092625,0.4755859002627107,1.0,3/12,4.74%,DCN;ADAMTS12;ATP2B4
prerank,vasoconstriction (GO:0042310),-0.6893311187836187,-1.7092268831603248,0.016355140186915886,0.2538095547173408,1.0,6/11,15.95%,SLC8A1;PIK3C2A;ACTA2;EDNRA;EDN1;EDN3
prerank,negative regulation of locomotion (GO:0040013),-0.6942098990862418,-1.7088078205325796,0.007371007371007371,0.24872084969663177,1.0,6/12,13.86%,FBLN1;FRMD5;DUSP3;CCDC125;CRK;SPOCK3
prerank,embryonic digestive tract development (GO:0048566),0.7252859615183134,1.7046356094245538,0.017027863777089782,0.5038374190831238,1.0,5/18,2.92%,STRA6;PKDCC;RARB;PCSK5;GLI2
prerank,response to alcohol (GO:0097305),-0.5367356261764833,-1.7038710613735304,0.011799410029498525,0.2557679881707497,1.0,8/27,12.93%,TGFBR3;SLIT2;TGFBR1;GRIN3A;GRIN2B;GRIN1;PMVK;ABCA2
prerank,external encapsulating structure organization (GO:0045229),0.5033104992777839,1.7038002704897326,0.0,0.49900098312331853,1.0,35/205,7.33%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMB2;LAMC1;ADAMTSL5;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;FN1;NCAN;LAMA5;COL3A1;DAG1;ITGB7
prerank,regulation of tissue remodeling (GO:0034103),0.6933319350625555,1.7032023529918825,0.020602218700475437,0.4932152133206033,1.0,3/18,1.54%,THBS4;CEACAM1;LEPR
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.7220071857955266,-1.6983732210546416,0.011627906976744186,0.2635555405841742,1.0,4/10,10.34%,ZEB2;RAPGEF2;ATP7A;CTNS
prerank,GPI anchor metabolic process (GO:0006505),0.6560491284093198,1.697556307258822,0.010130246020260492,0.5100172716324215,1.0,5/26,9.37%,PIGU;GPLD1;PGAP3;PIGB;PIGA
prerank,smooth muscle tissue development (GO:0048745),0.7867291845933605,1.6953148918726488,0.007054673721340388,0.51225492263628,1.0,3/10,3.23%,PTCH1;STRA6;NF1
prerank,macrophage differentiation (GO:0030225),-0.6517777628867292,-1.6945021409358485,0.01278772378516624,0.2674951635432702,1.0,6/13,19.29%,IL31RA;CDC42;BMP4;CSF1;CASP8;PARP1
prerank,extracellular structure organization (GO:0043062),0.5001181603443438,1.6919420845841013,0.0,0.5200050081313341,1.0,38/204,8.54%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMB2;LAMC1;ADAMTSL5;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;FN1;NCAN;LAMA5;COL3A1;DAG1;ITGB7;ADAMTS2;TEX14;TNR
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4651869401647451,-1.6898923291042238,0.003937007874015748,0.27299648902266094,1.0,8/49,6.94%,IGF1;IL31RA;GHR;IL6R;LYN;KIT;IL18;JAK2
prerank,response to amyloid-beta (GO:1904645),-0.4657408108802509,-1.6891756900129304,0.0034482758620689655,0.26926108153806844,1.0,9/44,9.43%,IGF1R;IGF1;LRP1;GJA1;EPHA4;VCAM1;MMP2;GRIN1;LGMN
prerank,muscle tissue morphogenesis (GO:0060415),-0.6200186241842094,-1.685769520143512,0.01288659793814433,0.2723131816546468,1.0,6/16,10.53%,MYLK;TGFBR3;BMP4;TBX1;PROX1;BMP2
prerank,cardiac conduction system development (GO:0003161),-0.5346259155351413,-1.6853113435780618,0.014367816091954023,0.26824415000119134,1.0,7/24,12.69%,NOTCH2;GJB6;BMP4;GJA1;SMAD5;CACNA1G;GATA6
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7700697961816926,1.6835736066018951,0.018272425249169437,0.5510121592414545,1.0,4/12,5.76%,DCN;CSPG4;UST;NCAN
prerank,negative regulation of T cell activation (GO:0050868),0.6207332203685434,1.6826909007424682,0.012747875354107648,0.5466251093808904,1.0,6/35,4.23%,RIPOR2;CEACAM1;ARG1;GLMN;IL4I1;PTPN22
prerank,limb development (GO:0060173),0.65070142095002,1.6801978496829362,0.01680672268907563,0.5496776359418727,1.0,5/28,5.12%,PTCH1;LRP4;PCSK5;BMPR1B;INTU
prerank,dermatan sulfate metabolic process (GO:0030205),0.7559924245827832,1.6782739278500276,0.02152317880794702,0.5499932582847425,1.0,4/13,5.76%,DCN;CSPG4;UST;NCAN
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.6342123259814261,-1.6781256377824112,0.013368983957219251,0.28159989143278324,1.0,11/15,28.27%,MKNK2;CPEB2;VCP;ZC3H12A;HSF1;DHX36;GSTO1;HNRNPA1;GSTO2;ATF3;DDX3X
prerank,regulation of multicellular organism growth (GO:0040014),0.7307712805922292,1.6777562653846385,0.023333333333333334,0.5442072730601674,1.0,1/15,0.01%,PTCH1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5047766766185642,1.6755223840571427,0.0022123893805309734,0.547947232683706,1.0,18/159,4.59%,NTNG1;TENM2;CLDN1;CXADR;CDH13;CLDN11;CEACAM1;CLDN19;CDH11;PTPRF;MPZL2;GPC6;CDH5;CDH17;HMCN1;CDH9;TRO;DSCAM
prerank,nerve growth factor signaling pathway (GO:0038180),0.795102096514102,1.6753992070186299,0.01773049645390071,0.5406043280735193,1.0,2/10,1.89%,NGF;RAP1A
prerank,cellular response to alcohol (GO:0097306),0.6035453040954917,1.673852717430847,0.010189228529839884,0.5399055295037508,1.0,5/42,5.35%,PTCH1;PTGFR;GPLD1;GRAMD1B;ADCY5
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.682537826390968,1.671976581589338,0.022116903633491312,0.5409312806635165,1.0,2/21,1.22%,NGF;USP50
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.5228277316070244,-1.6717632655483166,0.005797101449275362,0.2912724065383955,1.0,7/31,3.93%,ENG;TGFBR3;RBPJ;TPM1;FKBP1A;TGFBR1;FGFR2
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.5484393090164227,-1.6715239548941152,0.018518518518518517,0.2863091906941965,1.0,4/24,1.71%,PICALM;NUMB;PID1;DAB2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7579812580618198,1.6704134125741537,0.020689655172413793,0.5324996474593685,1.0,7/12,17.54%,HOMER2;ATP2B4;RCAN1;GSK3B;HOMER3;CHP1;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7579812580618198,1.6704134125741537,0.020689655172413793,0.5324996474593685,1.0,7/12,17.54%,HOMER2;ATP2B4;RCAN1;GSK3B;HOMER3;CHP1;DYRK2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.7206300680480693,1.6702046286198784,0.026578073089700997,0.5263561650029789,1.0,10/15,21.77%,GTSE1;RAPGEF3;BAG3;RBM22;GSK3B;TPR;EMD;YWHAE;TCF7L2;XPO4
prerank,maintenance of blood-brain barrier (GO:0035633),0.6241797841488347,1.6688871302309036,0.01884057971014493,0.5252308372476557,1.0,8/30,4.56%,CLDN1;F11R;LAMA2;LAMC1;SLC12A2;CDH5;TJP2;LSR
prerank,regulation of neuron projection development (GO:0010975),0.5013258433014047,1.668192136941482,0.0011001100110011,0.5210731825863595,1.0,29/163,10.75%,ROR2;NTNG2;NTNG1;ITGA6;ROR1;SIPA1L1;NTRK3;LPAR1;RAP1A;PPFIA2;RAB29;RTN4R;TRPV4;LZTS3;WNT5A;BRSK1;ULK4;ABL2;EFNB2;SEMA3A;SRCIN1;KANK1;CDH2;FRMD7;GSK3B;HDAC2;RELN;RTN4RL1;S100A9
prerank,atrial septum development (GO:0003283),-0.6538941099981457,-1.6675525155181328,0.009708737864077669,0.29141793861788406,1.0,6/13,12.75%,NOTCH2;ANK2;NPHP3;BMPR2;DAND5;TGFB2
prerank,actin filament organization (GO:0007015),-0.380314221061701,-1.6591014607847072,0.0,0.3103800595540638,1.0,39/151,11.56%,MYO1D;HIP1;RHOBTB1;EPS8;SVIL;NEDD9;MYO1B;ARHGEF2;RUFY3;MYO5A;TPM1;ELMO1;CDC42;DSTN;MYO6;SHROOM3;RHOBTB3;TRIOBP;TMOD3;PLS3;HIP1R;ERMN;ZBED3;RHOC;MARCKS;ARHGAP17;CAPG;ABI1;FLNA;EVL;RHOH;RHOB;PROX1;TPM3;NEBL;AVIL;LMOD1;TPM2;BAIAP2L1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.6321253193485661,-1.6574507603600455,0.022222222222222223,0.3096352928458928,1.0,6/13,12.93%,PLCB1;IGF1;IL33;SLC2A10;GOLGA2;ABCA2
prerank,melanosome transport (GO:0032402),-0.5680211849393021,-1.656938908003011,0.010723860589812333,0.3000676290286989,1.0,9/18,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,pigment granule transport (GO:0051904),-0.5680211849393021,-1.656938908003011,0.010723860589812333,0.3000676290286989,1.0,9/18,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.5307130329632744,1.6566628994670451,0.010962241169305725,0.5674377904784966,1.0,15/93,11.27%,NGF;CNKSR3;CAV1;NTRK3;EGFR;RAPGEF3;AXIN1;PDE4D;ATP2B4;NCK2;IRGM;NLRP2B;RASSF2;DOCK7;HDAC6
prerank,cellular response to superoxide (GO:0071451),-0.6978783169331809,-1.655927420372094,0.01643192488262911,0.2973925626494172,1.0,4/10,6.10%,NOS3;ATP7A;SOD3;PRDX2
prerank,iron ion homeostasis (GO:0055072),-0.4334603276836322,-1.6538039569755443,0.0,0.297365456805602,1.0,22/58,23.51%,PICALM;BMP6;ABCG2;FTH1;TFRC;SCARA5;NEO1;B2M;FTL;SLC11A2;NEDD8;BDH2;FXN;SLC40A1;HFE;SMAD4;CUL1;SKP1;CYBRD1;BOLA2;CCDC115;ISCU
prerank,catecholamine metabolic process (GO:0006584),-0.6295928716174751,-1.6528653291761368,0.004807692307692308,0.2949519388801646,1.0,3/14,3.31%,SNCAIP;COMT;ATP7A
prerank,vesicle transport along actin filament (GO:0030050),-0.5758657959322024,-1.6509788642769068,0.02806122448979592,0.29547488849228865,1.0,4/19,2.67%,MYO1D;MYO1B;MYO5A;MYO6
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6645906505124775,1.6491109708548117,0.024615384615384615,0.5962768798114098,1.0,4/22,10.37%,APOD;CEACAM1;NCOR1;ADRA2A
prerank,ganglioside biosynthetic process (GO:0001574),-0.6001358024086383,-1.6485420648595646,0.02512562814070352,0.2970026029467982,1.0,4/15,2.25%,ST3GAL5;ST3GAL1;ST8SIA4;ST6GALNAC3
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6527349355919437,1.6483687247496477,0.015625,0.5923280081503872,1.0,5/23,7.89%,THBS4;RIPOR2;MPP1;RAC2;DPP4
prerank,regulation of coagulation (GO:0050818),0.7487917516064797,1.6468883912799046,0.03198653198653199,0.5921021837653994,1.0,4/11,11.69%,CAV1;EPHB2;PROC;HS3ST5
prerank,positive regulation of behavior (GO:0048520),0.7603970768492392,1.642901135186375,0.028469750889679714,0.6040108059045399,1.0,4/10,11.65%,STRA6;NPAS2;SGIP1;CFAP20
prerank,peptide biosynthetic process (GO:0043043),-0.3704758320703164,-1.64290054715136,0.0,0.30634944956894744,1.0,69/153,22.69%,DMD;RPL37A;RRBP1;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RPS24;RPLP0;HARS1;RPS19;HBS1L;RPL31;RPL41;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;FURIN;RPL38;DHPS;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;MRPL32;MRPL18;CARNS1;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;MRPL9;MRPL28;GSPT2;MRPS11;MRPS16;RPL14;MRPS18B;RPS2;MRPL42;RPL10A;RPL39;RPL34;RPL5;MRPS12;RPL22;MRPL55
prerank,regulation of developmental growth (GO:0048638),-0.5171026592071559,-1.642513966864689,0.013029315960912053,0.3024700145947795,1.0,7/29,6.29%,PLCB1;IGF1;INSR;GHR;LATS2;MBD5;APOE
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.7500958752930109,1.64159765924897,0.029411764705882353,0.6031101891579662,1.0,3/11,2.13%,CAV1;LEPROT;BCL3
prerank,aorta morphogenesis (GO:0035909),-0.5735311035206296,-1.6411460641886615,0.02763819095477387,0.3014106053796738,1.0,8/17,10.38%,ENG;PDGFRB;LRP1;MYLK;RBPJ;ACVRL1;TBX1;PROX1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5683070210794263,1.637694123560681,0.013280212483399735,0.6143731247480559,1.0,18/55,17.78%,DCN;GPC3;CSPG4;PRELP;GPC6;NCAN;SDC1;HEXA;GPC2;SDC3;CEMIP2;HSPG2;HEXB;HGSNAT;CHP1;GPC5;VCAN;SDC4
prerank,negative regulation of developmental growth (GO:0048640),0.6228750385590099,1.6376580274476038,0.034074074074074076,0.6072043777514747,1.0,3/30,4.30%,PTCH1;RTN4R;CDKL3
prerank,negative regulation of signal transduction (GO:0009968),0.4781564586116243,1.6375554805174384,0.0,0.6004692492804655,1.0,39/249,9.71%,PTCH1;DCN;APOD;GPC3;PTCH2;UBASH3B;VGLL4;NTN1;RGS14;ADAMTS12;SULF1;NFATC1;NRARP;LEPROT;EGFR;SOCS5;SPRY1;GLIS2;SPRY4;BMP5;IRAK3;PIP4K2B;DACT1;PTPRC;CREB3L1;KANK2;APLN;KIF7;TNFAIP3;HIC1;EGFL7;SIAH1;KANK1;PALM;PTPRJ;PLEK;NLRP2B;SLC27A4;PTPRT
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.5494778292961766,-1.6371082165830564,0.01466275659824047,0.30734143064065234,1.0,11/22,17.26%,KDM2B;APPL2;NES;GATA2;PROX1;SLC16A2;LRRK2;KDM1A;TOX;ID2;TAFA1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.47256562190331597,-1.6362611149548583,0.021505376344086023,0.3049300506506856,1.0,19/40,25.83%,HIP1;INSR;ANGPT1;DAB2;B2M;HNRNPK;ANXA2;LDLRAP1;HFE;AHI1;EGF;PICK1;CLU;CCL19;C3;NTF3;GREM1;ARRB2;VTN
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5808379421903492,1.6348553440647233,0.019471488178025034,0.6055544950410476,1.0,10/45,6.40%,GAB1;PLCE1;EFEMP1;EGFR;FAM83A;REPS2;SOX9;SRC;KIF16B;NCK2
prerank,regulation of small molecule metabolic process (GO:0062012),0.6201068784108573,1.6344391436493824,0.023743016759776536,0.600449200977854,1.0,6/28,10.99%,RORA;FOXK1;PDK4;BCKDK;FOXK2;NCOR2
prerank,regulation of axon guidance (GO:1902667),-0.6839693065143131,-1.6324284722280291,0.015909090909090907,0.310457995314807,1.0,8/10,30.44%,ZSWIM6;YTHDF1;ZSWIM4;NRP1;TUBB2B;ZSWIM8;MYCBP2;ZSWIM5
prerank,action potential (GO:0001508),0.5770530071760563,1.6318843678959638,0.013927576601671309,0.6061335162310234,1.0,5/44,4.79%,GNA14;SCN10A;SLC4A3;GNAQ;CACNA1H
prerank,glycolipid biosynthetic process (GO:0009247),0.5914543931032669,1.6295737381358113,0.019390581717451522,0.6101718863764513,1.0,9/38,12.82%,PIGU;ST3GAL4;A4GALT;PGAP3;PIGB;PIGA;ST8SIA5;ST8SIA3;SCCPDH
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.3878436621662623,-1.6291186000468056,0.0,0.3146829931928076,1.0,58/110,22.82%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;PABPC1;RPLP1;RPS17;RPS3;RPL23;RPL17;PNRC2;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;MAGOH;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;NCBP1;CTIF;MAGOHB;RNPS1;GSPT2;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;EIF3E;RPL22;PPP2R1A
prerank,aortic valve development (GO:0003176),-0.48676519714770733,-1.628822360498728,0.006230529595015576,0.31110942213768406,1.0,10/34,5.38%,ROBO1;ROCK2;ELN;SMAD6;SLIT2;NOS3;BMP4;TIE1;BMPR2;TNFRSF1B
prerank,amino acid import across plasma membrane (GO:0089718),-0.5253751037322367,-1.6282699825198126,0.0026954177897574125,0.30829362950377265,1.0,11/24,17.11%,SLC6A6;SLC47A1;SLC6A9;SLC7A5;SLC22A4;SLC7A1;SLC16A2;SLC1A3;SLC1A1;SLC3A2;SLC22A2
prerank,tube closure (GO:0060606),0.6088905458580368,1.6279211780943306,0.03422619047619048,0.6112638010249243,1.0,7/31,5.28%,DLC1;PRICKLE1;COBL;FOLR1;STIL;LMO4;MTHFD1
prerank,eye morphogenesis (GO:0048592),0.6707556299451153,1.6273255164771865,0.02857142857142857,0.6074338062291029,1.0,5/19,6.15%,ALDH1A3;EFEMP1;MFAP5;NF1;SHROOM2
prerank,long-term synaptic potentiation (GO:0060291),0.6797419101537364,1.6264949916702873,0.028616852146263912,0.6049313882418025,1.0,4/21,2.75%,PLK2;TSHZ3;RGS14;SLC24A1
prerank,skeletal muscle organ development (GO:0060538),0.6260205783724911,1.625988061411945,0.0286144578313253,0.6006969190819893,1.0,3/26,4.33%,STRA6;CAV1;CSRP3
prerank,response to copper ion (GO:0046688),-0.5624114808976655,-1.6251271860267065,0.03125,0.3117251543401295,1.0,8/20,3.81%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5000695724289927,-1.6220721725079563,0.02364864864864865,0.31562837459790716,1.0,11/34,11.17%,FLT1;TEK;PDGFRB;PDGFRA;PIK3R1;KIT;PIK3R3;EPHA8;TNFAIP8L3;RUBCN;AMBRA1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5433840317743681,-1.6217131711509547,0.011428571428571429,0.31260908180426683,1.0,11/22,21.13%,ANK2;AKAP6;VMP1;CALM1;ATP1B1;SLC9A1;CALM3;JPH2;P2RY6;STAC3;GSTO1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.5571518230628492,-1.621477820316387,0.028720626631853787,0.3090750974147571,1.0,7/20,3.53%,ENG;TGFBR3;RBPJ;BMP4;TBX3;TGFBR1;ACVRL1
prerank,icosanoid secretion (GO:0032309),-0.6311245662376452,-1.6203471861854641,0.03309692671394799,0.3078760014092684,1.0,4/12,7.39%,ABCC4;ACE;BDKRB2;ANXA1
prerank,SNARE complex assembly (GO:0035493),0.7626585148924101,1.6199951407209643,0.03327495621716287,0.6222070695447008,1.0,1/10,0.06%,STXBP6
prerank,spinal cord development (GO:0021510),0.7265581161656455,1.6197049565664454,0.04035087719298246,0.616981070045625,1.0,6/12,13.45%,VIT;GLI2;NF1;RELN;PKD1;SOX4
prerank,amino acid import (GO:0043090),-0.5454459083198061,-1.6150329505067098,0.020887728459530026,0.31772145490732634,1.0,11/21,17.11%,SLC6A6;SLC47A1;SLC7A5;SLC22A4;SLC7A1;SLC25A38;SLC16A2;SLC1A3;SLC6A1;SLC1A1;SLC22A2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6170386542756486,1.6140817222386377,0.03522205206738132,0.636377991693473,1.0,7/24,4.10%,PKDCC;MBOAT2;ADAMTS12;EFEMP1;PTHLH;SOX9;BMPR1B
prerank,cell-matrix adhesion (GO:0007160),0.5130366039823003,1.6136129548488172,0.007352941176470588,0.6323712174232815,1.0,13/95,7.33%,ITGB4;ITGBL1;DLC1;SORBS1;ECM2;ADAMTS12;PPFIA2;ITGA7;PEAK1;SRC;FN1;COL3A1;ITGB7
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7394449933172533,1.613169993506109,0.037037037037037035,0.6280344948944634,1.0,2/11,0.82%,CAV1;NEDD4L
prerank,respiratory tube development (GO:0030323),0.6146111411111332,1.6129602523322795,0.015151515151515152,0.6228849588205025,1.0,5/28,2.92%,STRA6;FGF7;FGF1;PCSK5;GLI2
prerank,response to ethanol (GO:0045471),-0.6100232355590318,-1.6126105108956428,0.0405727923627685,0.3199156418356866,1.0,5/14,11.74%,ADCY7;GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5202239764925672,1.6116667874970712,0.005952380952380952,0.6225582470439642,1.0,16/100,5.16%,ROR2;GAB1;DCN;ROR1;NTRK3;FGFR1;HCST;PTPN13;CEACAM1;PIK3AP1;EGFR;WNT16;SOX9;SRC;PIP4K2B;FN1
prerank,positive regulation of neuron differentiation (GO:0045666),0.5849024498593065,1.6112723751812281,0.023066485753052916,0.6182431060069814,1.0,7/40,5.24%,NGF;FGFR1;DLX1;ZC4H2;MMD2;NBL1;HEYL
prerank,electron transport chain (GO:0022900),0.6865799807354014,1.6109781676204116,0.04355400696864112,0.613469812196154,1.0,2/15,0.66%,PPARGC1A;POR
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6290998088673095,1.6109505370833948,0.03609022556390978,0.6076868858370201,1.0,5/25,4.59%,ITGA6;GLMN;EGFR;SRC;DSCAM
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.515460051940608,-1.6107921303061405,0.01834862385321101,0.3204039890332806,1.0,7/29,10.53%,ENG;TGFBR3;TPM1;FKBP1A;FGFR2;PROX1;BMP2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.6706947470930382,-1.6083084587407794,0.026066350710900472,0.3229150472394249,1.0,4/10,2.90%,PID1;ENPP1;GRB10;APPL2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5775967189062091,1.605979402959275,0.034722222222222224,0.6246976547086066,1.0,5/37,7.34%,TENM2;CXADR;HMCN1;AMIGO2;CRTAM
prerank,retinal metabolic process (GO:0042574),0.721139111113971,1.6059429740800462,0.03571428571428571,0.6189268840342423,1.0,3/12,5.83%,ALDH1A3;RDH10;BCO1
prerank,cell cycle checkpoint signaling (GO:0000075),0.7297873837507695,1.6057816604674635,0.047933884297520664,0.6137607208718573,1.0,5/12,14.75%,PLK2;WEE1;CHFR;ZWILCH;ZW10
prerank,monoacylglycerol metabolic process (GO:0046462),0.7148221356515644,1.6057424219635943,0.039735099337748346,0.608243876913947,1.0,4/13,8.31%,MOGAT2;MOGAT3;AWAT2;ABHD12
prerank,regulation of signal transduction (GO:0009966),0.4775837337907119,1.6045613697259855,0.0010857763300760044,0.6078510357119308,1.0,22/190,6.40%,PTCH1;RORA;IGFBP6;MDFIC;UBASH3B;RGS6;GLI1;PXN;RGS14;PLCE1;SULF1;DTX1;AXIN1;SOCS5;CDC42SE2;OGT;CD55;SRC;NUP62;INTU;IFT81;NCK2
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6307589773321377,-1.6035752977897328,0.019704433497536946,0.3320830649021874,1.0,5/12,15.73%,LYN;BST2;IL34;PTK2;CSF1
prerank,negative regulation of anoikis (GO:2000811),0.7068213757190548,1.6023902761726134,0.04215851602023609,0.6124669954476192,1.0,4/14,6.98%,CAV1;SRC;PDK4;MCL1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5570950022547536,1.6006719380550862,0.023224043715846996,0.6148152632433429,1.0,16/51,14.73%,NGF;EPB41L3;MINK1;KIF20B;GAS7;NBL1;CNTNAP1;TRIO;GPM6A;SLC9A6;PLXNB1;SNX2;SGK1;CTTN;DICER1;CNTNAP2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5312284126871964,1.6003374825241203,0.02544529262086514,0.6108740954245606,1.0,6/73,2.19%,NGF;CAV1;NTRK3;EGFR;RAPGEF3;AXIN1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.7510297611819062,1.5999741640550091,0.0313588850174216,0.606902769528076,1.0,2/10,1.06%,APOD;RIPOR2
prerank,aortic valve morphogenesis (GO:0003180),-0.49249249299886955,-1.5998644056747635,0.017857142857142856,0.33826917406244605,1.0,8/30,2.87%,ROBO1;ROCK2;ELN;SMAD6;SLIT2;NOS3;BMP4;TIE1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5873745254530718,-1.5984491268743688,0.03233830845771144,0.3376556741646292,1.0,6/16,12.75%,NOTCH2;ENG;BMPR2;PROX1;BMP2;TGFB2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7091724245437082,1.595427770507086,0.04697986577181208,0.6220840133390748,1.0,3/12,2.99%,CAV1;CAMK2D;PDE4D
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7517433769033244,1.5946043585633987,0.04537521815008726,0.6203722517855166,1.0,1/10,0.15%,DCN
prerank,activation of phospholipase C activity (GO:0007202),0.5989768561019877,1.594518757899982,0.036603221083455345,0.6153367262446062,1.0,5/29,4.47%,LPAR1;EGFR;ITK;TXK;GNAQ
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5846467423529174,1.5941906948877191,0.03125,0.6113587132423512,1.0,5/35,4.99%,PIGU;CAV1;LEPROT;BCL3;PTPRC
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5345185163156898,1.592104533928002,0.020151133501259445,0.6156771914802123,1.0,12/72,5.16%,ROR2;GAB1;DCN;ROR1;NTRK3;FGFR1;HCST;PIK3AP1;WNT16;SOX9;SRC;FN1
prerank,transepithelial transport (GO:0070633),0.6812381852042808,1.59177645251615,0.05650684931506849,0.6118750452110012,1.0,5/15,9.81%,CXADR;SLC12A2;GPLD1;ABCC1;BEST1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.613500625976269,1.5915514904569013,0.029154518950437316,0.6077110007149618,1.0,7/26,7.28%,ITPR2;ITPR3;SLC8B1;ERO1A;PTPRC;IBTK;CHERP
prerank,sodium-independent organic anion transport (GO:0043252),-0.6691967850152846,-1.5910090051258192,0.03837471783295711,0.3540030705615864,1.0,4/10,10.86%,SLCO3A1;SLCO1C1;SLCO2A1;SLC16A2
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4772709196028819,-1.5906701867674242,0.02666666666666667,0.3506480925662932,1.0,12/34,15.47%,IGF1;PICALM;ROCK2;EPHA4;APOE;CASP3;RTN1;GSK3A;SP1;ABCA2;ABCG1;GGA3
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6781399520726006,1.5903982717019314,0.028380634390651086,0.6076277463317272,1.0,5/17,7.53%,CAV1;CEACAM1;AJAP1;SOX9;MAFG
prerank,response to sterol (GO:0036314),0.7291575688498144,1.5897060919837023,0.05759162303664921,0.6056226655716487,1.0,1/11,0.04%,RORA
prerank,tight junction assembly (GO:0120192),0.5499139387388986,1.5885579246532409,0.02656042496679947,0.6059270751660426,1.0,13/49,11.15%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;LSR;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6113296390253936,1.5882998116455205,0.028125,0.6021375230716665,1.0,5/26,3.90%,RORA;SULF1;CXCL17;IL1A;EIF2AK3
prerank,negative regulation of potassium ion transport (GO:0043267),0.7054660540042241,1.5870755338564737,0.0411663807890223,0.6024651288217957,1.0,2/13,0.82%,CAV1;NEDD4L
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5626814465477707,-1.5849148440598493,0.02077922077922078,0.36151366294214526,1.0,4/18,4.03%,IGF1;IGFBP2;IGF2;IL18
prerank,lymphocyte mediated immunity (GO:0002449),0.7157029380343771,1.583987061347002,0.04276315789473684,0.6103992801499137,1.0,3/12,7.45%,JAG1;CD55;MSH2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.685007275817625,1.5832079813125262,0.048576214405360134,0.6086900775185875,1.0,4/15,6.93%,RIPOR2;RAPGEF3;CD53;EHD2
prerank,intestinal absorption (GO:0050892),0.70777220767227,1.5814121938472019,0.03826955074875208,0.6115443169030413,1.0,5/13,14.92%,F11R;TJP2;SLC2A2;ADRA2A;SLC46A1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6865582974637836,1.5804707472160127,0.044444444444444446,0.6110477880982584,1.0,1/15,0.03%,NGF
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.5173919762456903,1.5801846859719442,0.01913265306122449,0.6074311684310847,1.0,11/75,8.17%,NTNG2;NTNG1;LRP4;PARD6B;MINK1;OPHN1;S100A6;BRSK1;RAB3A;S100B;ISL1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6985972914474075,1.5785165825245064,0.06017699115044248,0.6100343393552973,1.0,3/12,10.34%,APOD;PTPRJ;CBLB
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6160297113926988,-1.5772989551692043,0.015665796344647518,0.37989332940558646,1.0,3/12,5.50%,IGF1R;INSR;UVRAG
prerank,neuron projection morphogenesis (GO:0048812),0.47972815359082516,1.5771169728162375,0.0033975084937712344,0.6113514268689627,1.0,27/137,13.06%,NGF;NTNG2;NTNG1;LRP4;EPB41L3;PARD6B;MINK1;KIF20B;GAS7;S100A6;NBL1;DIP2A;CNTNAP1;TRIO;BRSK1;EPHB2;RAB3A;S100B;ISL1;GPM6A;POU4F1;DOCK7;SLC9A6;PLXNB1;SGK1;PTEN;CTTN
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7047805109585085,1.5762980644041102,0.03885135135135135,0.610281390939685,1.0,5/14,5.62%,SULF1;SPRY1;SPRY4;CREB3L1;APLN
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5181688678299139,1.5746422264026452,0.018891687657430732,0.6127903031520835,1.0,4/76,1.21%,GNA14;HRH1;LPAR1;PLCE1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5706716059004407,1.5725182083410993,0.03910614525139665,0.617306502607173,1.0,13/37,17.15%,DYNLL1;DYNC2I1;CEP131;IFT81;KIF3C;CLUAP1;DYNLL2;IFT74;TTC21B;TRIP11;PCM1;DYNC2LI1;DYNC2H1
prerank,regulation of keratinocyte migration (GO:0051547),0.6938781920605711,1.5718061455316563,0.06349206349206349,0.6154793655103223,1.0,4/12,12.83%,FGF7;ARF6;PTEN;MAPRE2
prerank,negative regulation of cellular component movement (GO:0051271),-0.5913761251161057,-1.5715106122637914,0.045454545454545456,0.3922282603272168,1.0,6/15,7.14%,FBLN1;TGFBR3;FRMD5;SP100;CCDC125;CRK
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6905490031581946,1.5701828959613409,0.033112582781456956,0.6178395173935445,1.0,7/16,16.06%,CAV1;LEPROT;BCL3;INPP5F;NF2;PIBF1;SOCS1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6186746747002811,1.5700778433120464,0.03685897435897436,0.6138365786930906,1.0,5/24,3.90%,RORA;SULF1;CXCL17;IL1A;EIF2AK3
prerank,negative regulation of cell migration (GO:0030336),-0.3561344565335984,-1.570032309506027,0.0,0.3922853384623095,1.0,36/137,11.62%,ROBO1;PHLDB2;PTPRG;MCC;ENG;AFDN;CLDN5;LIMCH1;LRP1;SLIT2;TPM1;RECK;DACH1;CLIC4;IGFBP3;IGFBP5;GJA1;EPHA4;PTPRK;ACVRL1;CYP1B1;MITF;PODN;SRGAP1;DUSP10;DUSP3;BST2;TMEFF2;CITED2;EVL;RHOB;SINHCAF;ATP1B2;TRIB1;ARID2;FUZ
prerank,bicellular tight junction assembly (GO:0070830),0.5506426593429461,1.5690284012922402,0.02857142857142857,0.6136789980834066,1.0,12/46,11.15%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC
prerank,protein localization to centrosome (GO:0071539),0.6594115766317833,1.568707399605762,0.03858520900321544,0.6106479191222226,1.0,10/17,19.16%,STIL;CEP131;NEDD1;SNX10;GOLGB1;C2CD3;HOOK3;PCM1;PIBF1;DCTN2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.550809239168917,-1.5682308949915573,0.03903903903903904,0.393569282885769,1.0,4/20,1.71%,PICALM;NUMB;PID1;DAB2
prerank,negative regulation of complement activation (GO:0045916),0.7381560548247519,1.5673471677657707,0.03880070546737213,0.6121507526152156,1.0,3/10,8.44%,SERPING1;CD55;SUSD4
prerank,epithelium development (GO:0060429),0.49784088051030356,1.567265550079735,0.015606242496998799,0.6081952403861082,1.0,12/107,7.23%,PTCH1;MEOX2;CDHR2;RIPK4;STIL;SOX9;DACT1;MTHFD1;KANK2;ANXA4;DAG1;TBX2
prerank,response to cadmium ion (GO:0046686),-0.4894974343894906,-1.5668149450819107,0.030211480362537766,0.393708707222448,1.0,9/26,8.19%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;AKT1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6897823356704089,1.5651464082063775,0.04895104895104895,0.612482757661129,1.0,2/13,0.33%,APOD;MDFIC
prerank,positive regulation of mitochondrial fission (GO:0090141),0.6489467353933117,1.5646927186333803,0.06472491909385113,0.6100697730486757,1.0,10/18,20.63%,DCN;DDHD1;FIS1;MIEF1;BNIP3;RALBP1;PINK1;RALA;PRKN;MUL1
prerank,positive regulation of DNA replication (GO:0045740),0.6697057369118373,1.5640344871834755,0.0532258064516129,0.6085765089900238,1.0,4/16,5.81%,GLI1;EGFR;GLI2;STN1
prerank,Rap protein signal transduction (GO:0032486),0.7366271623556464,1.562009614540721,0.055267702936096716,0.6123714697442161,1.0,3/10,1.89%,PLK2;RAPGEF3;RAP1A
prerank,protein localization to microtubule organizing center (GO:1905508),0.6791178795816406,1.5618025948797873,0.035830618892508145,0.6090833464856779,1.0,9/15,19.16%,STIL;CEP131;NEDD1;SNX10;C2CD3;HOOK3;PCM1;PIBF1;DCTN2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6114055774622823,-1.561622160796382,0.027093596059113302,0.40493970421915815,1.0,4/12,12.26%,NUPR1;IL18;IL33;TTBK1
prerank,response to organic cyclic compound (GO:0014070),-0.4257624774685718,-1.5614983899181358,0.011811023622047244,0.4009560874098004,1.0,23/52,28.88%,PAQR7;IGFBP5;CYP1B1;IL18;ALPL;ARL6IP5;ANXA1;HLCS;LRRK2;ESR1;FGFR4;ABCA2;SLC1A1;DHFR;TRPM2;TLR3;ABCB4;KYNU;GGT5;STAT3;STRN3;CDKN2D;SFRP1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6913961644843999,1.5613621062684098,0.04974271012006861,0.606791062778669,1.0,3/13,9.71%,PIGU;PTPRC;PTPRT
prerank,response to axon injury (GO:0048678),0.6524791485943064,1.5606993853961755,0.05,0.6052461886253839,1.0,4/18,10.73%,APOD;FOLR1;SARM1;RTN4RL1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6038398273538883,1.5606062658526068,0.03680981595092025,0.6015116068771664,1.0,3/25,1.42%,CAV1;CXADR;CAMK2D
prerank,cell junction maintenance (GO:0034331),0.6841809824948636,1.5592350826727408,0.05081967213114754,0.6031815942918309,1.0,1/14,0.18%,CLDN1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6151852212571638,-1.5576458957488322,0.03818615751789976,0.4081668789350055,1.0,6/13,14.20%,NOS3;CALM1;GCH1;AKT1;QDPR;MTHFD1L
prerank,catecholamine biosynthetic process (GO:0042423),-0.6338450919688707,-1.5545056021443044,0.0430622009569378,0.41341653610070195,1.0,3/11,12.75%,MOXD1;GCH1;TGFB2
prerank,positive regulation of lipid transport (GO:0032370),-0.6205016051900442,-1.5544316461011012,0.04050632911392405,0.4093174408976604,1.0,3/12,6.29%,LRP1;DBI;APOE
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6808826575548249,1.5540453467550448,0.045454545454545456,0.6206506893269454,1.0,4/15,5.76%,DCN;CSPG4;UST;NCAN
prerank,glucan catabolic process (GO:0009251),-0.5792322861878884,-1.5519419718814567,0.03282828282828283,0.4123056561321816,1.0,10/15,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,cellular response to cadmium ion (GO:0071276),-0.4984769031553741,-1.5519145563901007,0.04451038575667656,0.40818656379435486,1.0,9/24,8.19%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;AKT1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4870834279192945,-1.5502051702210866,0.022792022792022793,0.40941042791403104,1.0,9/28,17.34%,STMN2;STMN4;CAMSAP1;GBA2;STMN1;MAP1B;MAPT;SKA2;ARL2
prerank,regulation of cell-cell adhesion (GO:0022407),0.5666416332818662,1.549722954500089,0.04129793510324484,0.6344390711871544,1.0,7/39,4.48%,MAGI1;EFNA5;CEACAM1;JAG1;MINK1;FLOT2;SRC
prerank,embryonic eye morphogenesis (GO:0048048),0.7241545252825331,1.5477214472453655,0.055357142857142855,0.6389336942727362,1.0,5/11,11.10%,ALDH1A3;EFEMP1;MFAP5;TBX2;RARG
prerank,monocyte differentiation (GO:0030224),-0.6361209069531498,-1.546025246669722,0.042986425339366516,0.4171374347674864,1.0,6/10,18.52%,IL31RA;BMP4;MT1G;PIR;PDE1B;MYH9
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6091019596586085,1.5459019346157985,0.05069124423963134,0.6420782094004276,1.0,6/25,9.01%,CXADR;PARVA;ITGAX;ITGA7;ITGB7;CD200R1
prerank,acylglycerol homeostasis (GO:0055090),0.6435204335714799,1.5453496616825342,0.054140127388535034,0.6402483152591159,1.0,1/20,0.04%,RORA
prerank,mesoderm development (GO:0007498),-0.5510616775971507,-1.5442464597269636,0.029891304347826088,0.4184819641116334,1.0,7/18,13.61%,TBX3;TIE1;TBX1;BMX;JAK2;MEST;MESD
prerank,cardiac myofibril assembly (GO:0055003),-0.5647149790876391,-1.543177253718948,0.03314917127071823,0.4173563089654186,1.0,6/15,11.13%,PDGFRB;PDGFRA;OBSL1;MEF2A;PROX1;NEBL
prerank,regulation of trans-synaptic signaling (GO:0099177),0.565658577584927,1.542206581172151,0.050221565731166914,0.6490823788214606,1.0,2/33,1.67%,NGF;CEL
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6963421173179811,1.5410754526764772,0.06394316163410302,0.649574036293581,1.0,3/13,5.76%,DCN;CSPG4;NCAN
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6725475389065759,1.540418353406346,0.059322033898305086,0.6479868151485767,1.0,1/14,0.10%,GAB1
prerank,regulation of anoikis (GO:2000209),0.6444445994111958,1.5402486400015432,0.05546492659053834,0.6445900975685676,1.0,5/19,6.98%,CAV1;MYBBP1A;SRC;PDK4;MCL1
prerank,regulation of monooxygenase activity (GO:0032768),0.60783984236216,1.5395584306008885,0.05901116427432217,0.6435113054437287,1.0,6/23,8.37%,CAV1;POR;EGFR;IL1A;DDAH2;NOS1AP
prerank,regulation of steroid metabolic process (GO:0019218),0.6090075994032108,1.5381401702564788,0.0487062404870624,0.6456688970244484,1.0,1/23,0.04%,RORA
prerank,extracellular matrix organization (GO:0030198),0.4471375530476173,1.5365796338573647,0.0010362694300518134,0.6480083709376324,1.0,40/276,7.33%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMB2;LAMC1;ADAMTSL5;KLK2;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;SERPINH1;CREB3L1;FN1;NCAN;SH3PXD2B;ADAM10;LAMA5;COL3A1;DAG1;ITGB7
prerank,regulation of neuron migration (GO:2001222),0.5967922033694697,1.5365492936099694,0.054252199413489736,0.6441307227957778,1.0,6/26,7.12%,NTNG2;NTNG1;KIF20B;ULK4;COL3A1;SEMA3A
prerank,ERBB signaling pathway (GO:0038127),0.5139651383618065,1.5359310759898337,0.027237354085603113,0.6426118753921622,1.0,11/64,6.40%,GAB1;PLCE1;EFEMP1;EGFR;FAM83A;REPS2;SOX9;PRKCA;SRC;KIF16B;NCK2
prerank,regulation of membrane repolarization (GO:0060306),0.6812219347781934,1.5358960806428916,0.06462585034013606,0.638836682635818,1.0,2/13,0.82%,CAV1;NEDD4L
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5823927722942476,-1.535551948137082,0.04428904428904429,0.4368760459997519,1.0,3/13,4.50%,ENPP1;ENTPD1;ENPP3
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.71624353614071,1.533300596469525,0.04340567612687813,0.6458017514004848,1.0,3/11,4.99%,CEACAM1;IL4I1;PTPRC
prerank,cellular glucan metabolic process (GO:0006073),-0.6357521860522242,-1.5326778773601069,0.03755868544600939,0.44153132661788635,1.0,4/11,12.73%,PRKAG2;GBE1;UGP2;PPP1R3C
prerank,primary neural tube formation (GO:0014020),0.5769597605112038,1.532222074468749,0.059790732436472344,0.6461656183462842,1.0,6/30,5.28%,DLC1;PRICKLE1;COBL;STIL;LMO4;MTHFD1
prerank,cell-cell junction organization (GO:0045216),0.5000311220060571,1.53176531300495,0.03078817733990148,0.6443077745670004,1.0,11/79,3.53%,CLDN1;CXADR;CDH13;TLN2;CDH11;PARD6B;CDH5;CDH17;CDH9;TRPV4;TJP2
prerank,neural tube closure (GO:0001843),0.564135526324166,1.5294104261451946,0.05967976710334789,0.6498620126139194,1.0,7/34,5.28%,DLC1;PRICKLE1;COBL;FOLR1;STIL;LMO4;MTHFD1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5914502152530668,1.5275115076935015,0.06838905775075987,0.654125549352674,1.0,4/28,7.49%,NGF;SPI1;TRADD;BAG3
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5991946739114216,-1.5265089248482235,0.04207920792079208,0.4566207729580557,1.0,4/14,10.37%,ANK2;ACTN2;ATP1B1;ATP1B2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6415388656812611,-1.525885111455052,0.041666666666666664,0.4543156389393928,1.0,4/10,7.55%,LYN;FAS;NBR1;MAP2K2
prerank,peripheral nervous system development (GO:0007422),0.6136013215220535,1.5255859395141236,0.05692307692307692,0.658602612921156,1.0,3/23,6.12%,NGF;NF1;ARTN
prerank,ear morphogenesis (GO:0042471),-0.5138603599030991,-1.5243811759621817,0.03561643835616438,0.45516806151558037,1.0,6/20,11.87%,OSR1;CHD7;MYO6;FGFR2;TBX1;ZIC1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.558742422828656,1.5232913485076218,0.040446304044630406,0.6645824196927966,1.0,5/35,3.26%,CDH13;CDH11;CDH5;CDH17;CDH9
prerank,regulation of T cell migration (GO:2000404),0.6353052307222045,1.5221686404598331,0.06472491909385113,0.6654922493179034,1.0,2/18,1.06%,APOD;RIPOR2
prerank,negative regulation of hemostasis (GO:1900047),-0.6100973562542122,-1.5215735737876153,0.052083333333333336,0.46036500772194894,1.0,5/12,6.50%,TFPI;THBD;SERPINE2;APOE;CD34
prerank,positive regulation of nuclear division (GO:0051785),-0.5018566815795076,-1.521489232687175,0.039634146341463415,0.4564364346226208,1.0,5/25,3.56%,IGF1;INSR;TGFA;PDGFRB;IGF2
prerank,presynapse assembly (GO:0099054),0.6331188441133097,1.5212230764330716,0.06430868167202572,0.6655287827909803,1.0,3/16,4.96%,LRP4;CEL;WNT5A
prerank,negative regulation of intracellular protein transport (GO:0090317),0.612451919223878,1.5201363945212523,0.048,0.6662833965508362,1.0,4/22,9.05%,APOD;MDFIC;GDI1;SIAH3
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.36813301578343355,-1.5193399529123999,0.011627906976744186,0.45903664623332174,1.0,34/98,24.33%,INSR;PDGFRB;ECE1;PID1;ANGPT1;PPARD;SLCO1C1;IL10RB;NR1H3;XDH;ANXA2;AGTR1;KLF4;APOE;NR1H2;AKT1;ZC3H12A;ACLY;THBS1;GHITM;CSF1;EIF4G1;AHI1;EGF;ACE2;IFNAR1;AGT;ROMO1;PICK1;INHBA;GRB2;RIPK1;NTF3;GREM1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4786377009830783,-1.5189139981117303,0.054878048780487805,0.4562988067196098,1.0,7/29,7.83%,FLT1;TEK;PDGFRB;PDGFRA;KIT;EPHA8;TNFAIP8L3
prerank,neurotrophin signaling pathway (GO:0038179),0.6222098543126745,1.5188065123501528,0.06840390879478828,0.6683516368609473,1.0,2/21,1.89%,NGF;RAP1A
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5928248981666691,-1.5183061773324216,0.04954954954954955,0.4541588787632279,1.0,5/12,11.39%,CYP26B1;TRIM16;SNW1;KLF2;CTBP2
prerank,regulation of metal ion transport (GO:0010959),-0.5493734567711575,-1.5167740339608036,0.057692307692307696,0.4552846903062377,1.0,5/16,15.44%,ANK2;SLC30A10;ORAI1;EPB41;SRI
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6291454236936405,1.5144987432577883,0.05853658536585366,0.6832151407187118,1.0,2/18,0.33%,APOD;MDFIC
prerank,epidermis development (GO:0008544),0.5163325116057861,1.5142100574722221,0.044386422976501305,0.6806525695921711,1.0,6/56,4.00%,FGF7;GLI1;WNT10A;EMP1;FLOT2;PTHLH
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5614719019177464,1.5138159220619467,0.04822695035460993,0.6783597673495632,1.0,6/38,8.41%,RORA;PPM1N;TNIP3;PPM1A;TNFAIP3;TNIP1
prerank,negative regulation of proteolysis (GO:0045861),-0.45070656977252854,-1.5129408756367995,0.03618421052631579,0.4632034598941757,1.0,9/34,12.02%,TIMP3;PTPN3;DNAJC1;EPHA4;GAS1;SERPINE2;AKT1;LRRK2;CAMK2N1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6925472309514189,1.5123798366384853,0.08188153310104529,0.6811594588405289,1.0,3/10,12.83%,FGF7;ARF6;MAPRE2
prerank,phosphate ion homeostasis (GO:0055062),-0.6406005481452567,-1.5117791345430431,0.06481481481481481,0.4628207920265571,1.0,2/10,12.13%,ENPP1;FGFR4
prerank,GPI anchor biosynthetic process (GO:0006506),0.571846105961241,1.511494802660635,0.054285714285714284,0.6810976518869528,1.0,4/30,9.37%,PIGU;PGAP3;PIGB;PIGA
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.689853029459262,1.5105317536288023,0.07155322862129145,0.6779559534352952,1.0,3/12,7.57%,EFNA5;SPRY4;KANK1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.689853029459262,1.5105317536288023,0.07155322862129145,0.6779559534352952,1.0,3/12,7.57%,EFNA5;SPRY4;KANK1
prerank,regulation of peptide hormone secretion (GO:0090276),0.5020925415989111,1.51010742359345,0.029262086513994912,0.6760154925454096,1.0,17/67,13.40%,ITPR2;ITPR3;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;TFR2;PRKCA;RAPGEF4;SLC2A2;DPP4;RASL10B;KCNS3;ADRA2A;ENSA;GCK
prerank,digestive tract morphogenesis (GO:0048546),0.6794410669414415,1.5097957368619266,0.07961783439490445,0.6735989447672427,1.0,2/14,0.56%,STRA6;GLI1
prerank,epithelial structure maintenance (GO:0010669),0.6875964902993609,1.5094894684044946,0.06756756756756757,0.6712487399413151,1.0,1/11,0.29%,CXADR
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.631060091620242,-1.507112335876338,0.05787037037037037,0.4736273183161249,1.0,6/11,13.98%,NOS3;CALM1;GCH1;AKT1;QDPR;DHFR
prerank,calcineurin-mediated signaling (GO:0097720),0.7149234223452894,1.5053599578086638,0.07194244604316546,0.6813172901782372,1.0,2/10,1.39%,NFATC2;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.7149234223452894,1.5053599578086638,0.07194244604316546,0.6813172901782372,1.0,2/10,1.39%,NFATC2;NFATC1
prerank,retinoid metabolic process (GO:0001523),0.5000076293389935,1.5045184975918617,0.02681992337164751,0.681247334816729,1.0,16/71,12.14%,ALDH1A3;STRA6;GPC3;RDH10;GPC6;RDH5;AWAT2;CYP2S1;BCO1;OPN1MW;SDC1;SCPEP1;AKR1B10;RDH13;GPC2;SDC3
prerank,regulation of protein export from nucleus (GO:0046825),0.5861257836996804,1.5036631383257997,0.07261724659606657,0.6812176247409218,1.0,9/23,12.96%,GTSE1;RAPGEF3;PTPN14;BAG3;RBM22;GSK3B;SIRT7;TPR;EMD
prerank,mesonephric tubule development (GO:0072164),-0.555382414055688,-1.5033740664302493,0.06806282722513089,0.48201205933630054,1.0,4/15,3.93%,OSR1;SLIT2;BMP4;FGFR2
prerank,muscle cell development (GO:0055001),-0.46902015535149166,-1.5012063020099002,0.039634146341463415,0.4851332376268063,1.0,11/30,12.01%,MYOF;IGF1;ENG;ANK2;DMD;SLC8A1;DYSF;MYH11;RAMP2;NEBL;KDM1A
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6752353732798206,1.5009755099716218,0.06756756756756757,0.6817234872477074,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6752353732798206,1.5009755099716218,0.06756756756756757,0.6817234872477074,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6752353732798206,1.5009755099716218,0.06756756756756757,0.6817234872477074,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,lipid translocation (GO:0034204),0.5921674118974667,1.4996283267353674,0.06748466257668712,0.6841296760490219,1.0,12/21,15.78%,ATP8B3;ATP8B1;ABCC1;RFT1;ATP9B;ATP11C;ATP9A;ATP8B2;ABCA1;ATP10B;TMEM30A;ATP8B4
prerank,regulation of RNA splicing (GO:0043484),0.4882394952977743,1.49746869660383,0.03875,0.6894272477199702,1.0,21/69,15.02%,AHNAK;AHNAK2;CLK1;QKI;SLC38A2;CELF1;ZNF326;SON;CLK4;RBM22;SRPK1;DYRK1A;RPS13;PTBP3;KHDRBS2;SRPK2;PTBP2;ERN1;RBM38;TRA2B;SF1
prerank,regulation of urine volume (GO:0035809),-0.6332143905821698,-1.4963485499802005,0.0547945205479452,0.49711113046436023,1.0,5/10,28.03%,NPR3;NPR1;ADM;ADCY6;HAS2
prerank,vesicle organization (GO:0016050),0.5267804964858203,1.4960595349861803,0.054775280898876406,0.691803090698786,1.0,10/46,6.96%,CAV1;USP50;HOOK2;PI4K2B;CAV2;PHETA2;DNM1;ZFYVE16;USP8;SNX10
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6095660701206527,-1.4956727635925318,0.04589371980676329,0.49532583838851146,1.0,3/11,3.02%,PID1;OMA1;TFRC
prerank,regulation of chemotaxis (GO:0050920),-0.4544791119496337,-1.4955818528697822,0.040498442367601244,0.49162666158370016,1.0,19/30,32.88%,PDGFRB;PDGFRA;DUSP3;CYRIB;ZSWIM6;YTHDF1;THBS1;ZSWIM4;P2RX4;RARRES2;ZSWIM8;CCL19;MYCBP2;P2RY12;PPM1F;CXCR4;ZSWIM5;AIF1;TREM2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.6990590370568461,1.494955331073416,0.08,0.6924353233585188,1.0,2/10,3.18%,HK2;PFKP
prerank,regulation of centriole replication (GO:0046599),0.6209995899744429,1.4939177851000447,0.08112582781456953,0.693321818911719,1.0,3/17,4.94%,PLK2;STIL;NUP62
prerank,cardiac cell development (GO:0055006),0.6820693967013751,1.4936094431165412,0.08247422680412371,0.6911863539663099,1.0,2/11,2.29%,CXADR;JAG1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6579748736389711,1.4936071410555938,0.06563039723661486,0.6877398055634284,1.0,3/14,3.49%,CAV1;SPRED1;SPRY1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.569454188941469,1.4924928247555624,0.05597579425113464,0.6887718125359872,1.0,6/32,4.48%,APOD;DLC1;JAG1;AJAP1;CASK;SRC
prerank,sulfur compound catabolic process (GO:0044273),0.5440457282939984,1.4922491740713992,0.05172413793103448,0.686332904400952,1.0,9/38,15.30%,DCN;CSPG4;PRELP;NCAN;ACAT1;HEXA;HEXB;TXN2;GGT1
prerank,axon development (GO:0061564),0.4878914340943631,1.4921817590412847,0.03694267515923567,0.6832755185105596,1.0,13/78,10.91%,NTNG2;NTNG1;FOLR1;PARD6B;S100A6;BRSK1;EPHB2;RAB3A;S100B;ISL1;POU4F1;RTN4RL1;DOCK7
prerank,sulfation (GO:0051923),0.6751172027670906,1.4908563527248744,0.07419898819561552,0.6854687547801027,1.0,3/11,11.69%,UST;SULT1A1;HS3ST5
prerank,negative regulation of cartilage development (GO:0061037),0.661383212677645,1.4908213775531642,0.0690846286701209,0.6822943630871057,1.0,6/13,12.74%,ADAMTS12;EFEMP1;PTHLH;SOX9;CHADL;WNT9A
prerank,secondary palate development (GO:0062009),-0.5666137397354408,-1.49063572848863,0.07125890736342043,0.5034431761364339,1.0,7/14,17.78%,LEF1;TGFBR3;CHD7;TGFB3;TGFB2;SMAD4;WNT11
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6007076252089906,-1.4906007269441233,0.06855791962174941,0.49941956596345727,1.0,5/11,15.22%,CD34;CD200;GATA6;THBS1;LGALS9
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5866257612113068,1.4905848130757686,0.06289308176100629,0.6800299120034511,1.0,5/23,9.04%,UBASH3B;CAMK2D;ATP1A2;NOS1AP;CASQ2
prerank,diacylglycerol metabolic process (GO:0046339),0.5937308785495866,1.4903434608888528,0.07476635514018691,0.6777102782065211,1.0,4/23,3.58%,DGKA;PLCE1;MOGAT2;DGKZ
prerank,positive regulation of neuron projection development (GO:0010976),0.4800375744360308,1.489555107280804,0.02567237163814181,0.6774610488669579,1.0,9/85,6.49%,ROR2;ITGA6;ROR1;NTRK3;COBL;RAP1A;BMP5;WNT5A;ABL2
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4410517933655729,-1.488684144415708,0.04081632653061224,0.5014569370580304,1.0,15/36,21.66%,SGMS1;TGFBR1;MADD;FAS;MAZ;NR4A2;BCL2L12;RPS3;BDNF;CSNK2A1;DEPTOR;TPD52L1;STYXL1;QARS1;TMBIM6
prerank,apical junction assembly (GO:0043297),0.5128474607614014,1.4877516417208487,0.05695364238410596,0.6813446818149365,1.0,15/53,14.75%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC;PATJ;FBF1;CTNNA1
prerank,neutral amino acid transport (GO:0015804),-0.47624098444842095,-1.4869090716822613,0.04507042253521127,0.5034171721561883,1.0,14/28,24.62%,SLC6A6;SLC6A9;SLC7A5;CTNS;SLC43A2;SLC1A1;LLGL2;SLC3A2;SLC38A5;SLC1A4;SLC6A17;SLC38A1;SLC7A10;SLC1A5
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6291769858440519,-1.4859780664123545,0.07045454545454545,0.5023598977745626,1.0,6/10,27.51%,LYN;KIT;CD40;CD24;BTLA;FGR
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6554932152933507,1.4849451783727163,0.07413793103448275,0.6893200092405395,1.0,3/14,8.07%,MEOX2;CARD10;STARD13
prerank,response to histamine (GO:0034776),0.694255109487423,1.482513274406264,0.06713780918727916,0.6959834491966339,1.0,3/10,12.26%,HRH1;GABRG2;GABRB3
prerank,type I interferon signaling pathway (GO:0060337),-0.4286429606818241,-1.482053267108437,0.03985507246376811,0.5077678763914348,1.0,19/41,26.32%,SP100;IFNAR2;ADAR;SAMHD1;IRF2;IFIT2;IFIT3;BST2;IRF1;GBP2;ISG15;IFIT1;IFNAR1;RSAD2;PSMB8;XAF1;IRF5;MYD88;IRF8
prerank,cellular response to type I interferon (GO:0071357),-0.4286429606818241,-1.482053267108437,0.03985507246376811,0.5077678763914348,1.0,19/41,26.32%,SP100;IFNAR2;ADAR;SAMHD1;IRF2;IFIT2;IFIT3;BST2;IRF1;GBP2;ISG15;IFIT1;IFNAR1;RSAD2;PSMB8;XAF1;IRF5;MYD88;IRF8
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.41068706185958326,-1.4817270134328544,0.03676470588235294,0.504930062547159,1.0,18/47,18.82%,SOX13;TMEM64;PPARD;CREBL2;NAPEPLD;AKT1;CMKLR1;CREB1;ASXL2;ZC3H12A;BMP2;NOCT;ID2;CEBPB;ZFP36;LRP5;RARRES2;PIM1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6376707582633749,1.481017069724285,0.08431703204047218,0.6990608377888275,1.0,2/15,0.50%,NTRK3;CDH13
prerank,embryonic limb morphogenesis (GO:0030326),0.5459170589402604,1.4801838505930573,0.05397727272727273,0.6992370512526807,1.0,2/34,1.15%,PTCH1;AFF3
prerank,positive regulation of growth (GO:0045927),-0.3813573318447282,-1.4792355399676786,0.017777777777777778,0.5090467244471536,1.0,23/64,17.06%,PLCB1;INSR;ADNP2;CDC42;TGFBR1;CXCL16;RFTN1;AKAP6;AKT1;SLC25A33;TGFB2;CSNK2A1;MFSD2A;SPHK1;CDKN2AIP;FXN;LGI1;PABIR1;ZPR1;HDGFL2;EIF4G1;NCBP1;DERL2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5212458780578744,-1.4781984700047308,0.0425531914893617,0.5087565402176658,1.0,7/18,17.04%,SMAD3;HIF1A;CD34;CD200;TGFB2;LGALS9;SMAD4
prerank,positive regulation of sodium ion transport (GO:0010765),0.658184111894909,1.4774509701842025,0.0912280701754386,0.7071156252128886,1.0,1/12,0.20%,CNKSR3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.49536288969661324,1.4767087741758598,0.0532994923857868,0.7070476105882878,1.0,9/64,4.40%,EFNA5;CDH13;UTRN;JAG1;MINK1;AJAP1;CASK;NF1;PEAK1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.642252533639805,1.4747433745540168,0.07491289198606271,0.7117935454420654,1.0,6/14,12.74%,ADAMTS12;EFEMP1;PTHLH;SOX9;CHADL;WNT9A
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4463459170423764,1.4745185677091546,0.02252252252252252,0.7094906447399093,1.0,20/142,9.49%,CAV1;LPAR1;ACKR3;PLCE1;ITPR3;PTGFR;SLC8B1;CD55;TRPV4;FKBP1B;CAV2;ATP2B4;FIS1;WNT5A;ATP1A2;ADCY5;ABL2;PTGER4;HCRTR2;HMGB1
prerank,cellular response to estradiol stimulus (GO:0071392),0.6213703937206431,1.4740537243578735,0.09075907590759076,0.708259119978069,1.0,9/18,18.67%,EGFR;SSTR1;NRIP1;POU4F1;NCOA3;LCOR;GPER1;CCDC62;RUVBL2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5852882114328862,1.4738977852536819,0.07751937984496124,0.7056634717935014,1.0,8/23,12.70%,CAV1;SOCS5;PTPRC;TSG101;SRCIN1;CBLB;SOCS4;MVP
prerank,modulation of chemical synaptic transmission (GO:0050804),0.4646923403877796,1.4726956111674994,0.024734982332155476,0.7073864433737195,1.0,13/107,8.60%,NGF;CLSTN2;CEL;SLC12A2;DGKZ;OPHN1;CLSTN3;NPTX2;ATP1A2;RIMS2;CPLX1;CDH2;GRID1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5991713720672381,1.4723660076815046,0.09494640122511486,0.7056249487865591,1.0,8/21,10.01%,ARHGAP12;LZTR1;SPRY1;MFN2;SPRY4;EPHB2;CGNL1;MAPKAP1
prerank,protein maturation (GO:0051604),0.46772920806506385,1.4720362681294936,0.03588516746411483,0.7039004572293511,1.0,16/95,12.32%,PTCH1;PCSK5;ADAM19;OGT;APH1B;CPE;NCSTN;ADAM10;NAA35;PCSK7;LMF1;MME;TASP1;XPNPEP3;TSPAN14;MMP16
prerank,regulation of filopodium assembly (GO:0051489),0.5312650602223236,1.47003956253997,0.05285118219749652,0.7090122561014682,1.0,8/38,9.20%,TENM2;RIPOR2;ARAP1;CAPZB;FXR2;ARF6;PALM;GPM6A
prerank,regulation of cholesterol esterification (GO:0010872),-0.6105581782009852,-1.4699646728717155,0.08674698795180723,0.5329750258682058,1.0,5/10,19.18%,AGTR1;APOE;ABCA2;ABCG1;AGT
prerank,negative regulation of cell differentiation (GO:0045596),0.43479443622119135,1.4698952048996123,0.01644736842105263,0.7064921292931262,1.0,33/181,13.50%,PTCH1;RORA;CAV1;TRIB2;ADAMTS12;EFEMP1;EGFR;DTX1;JAG1;SPRED1;SPRY1;PTHLH;SOX9;BMP5;LEO1;WNT5A;TRIO;ANKRD2;PAF1;LDLRAD4;NELFB;RORB;ABCA1;SDHAF2;FERMT2;MEN1;CHADL;SEMA4D;HOPX;WNT9A;PTEN;ZFP36L2;SPRED2
prerank,sprouting angiogenesis (GO:0002040),-0.4050264814456724,-1.467584753914289,0.024193548387096774,0.5372872765190747,1.0,22/51,14.97%,ROBO1;ENG;TEK;CCBE1;RSPO3;ANGPT1;RNF213;SLIT2;RECK;BMP4;PIK3R3;ACVRL1;KDR;AKT1;VEGFC;RAMP2;FLT4;VEGFD;THBS1;ESM1;BMPER;NRP1
prerank,regulation of establishment of protein localization (GO:0070201),-0.5629847765713702,-1.4666555130052628,0.06870229007633588,0.53650167930516,1.0,7/13,17.39%,DNAJA1;CORO2B;CEP135;CTSD;CEP120;SCFD1;GAPVD1
prerank,ERBB2 signaling pathway (GO:0038128),0.5487712340400326,1.4638353291839357,0.076163610719323,0.7282743868937386,1.0,4/31,4.48%,GAB1;EGFR;PRKCA;SRC
prerank,protein localization to cell-cell junction (GO:0150105),0.634232048902734,1.4637420724458736,0.08848080133555926,0.7254588232177125,1.0,5/15,7.94%,F11R;CDH5;TJP2;LSR;CGNL1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.558472340994346,1.463693576238045,0.07668711656441718,0.7224779187460086,1.0,5/27,4.74%,UTRN;SLMAP;NEDD4L;CAMK2D;ATP2B4
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6060615411297774,1.4636264689081753,0.0727580372250423,0.7195890107482686,1.0,2/19,0.38%,DCN;SMOC2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.47400589576376306,1.4634054907938856,0.035,0.7172866963890132,1.0,20/86,8.07%,NGF;DLC1;ARHGEF28;PLCE1;OGT;AKAP13;LZTR1;SPRY1;OPHN1;MMD2;MFN2;SPRY4;NUP62;KANK2;LRRC59;EPHB2;RDX;KANK1;ARF6;STARD13
prerank,lipid modification (GO:0030258),0.544573390812022,1.4632186255206743,0.06811594202898551,0.7147677781184859,1.0,5/37,4.15%,DGKA;MBOAT2;PLPP2;DGKZ;PLPP3
prerank,negative regulation of cellular senescence (GO:2000773),-0.5612521277279818,-1.4606736574487529,0.07920792079207921,0.5532418555618153,1.0,5/13,7.77%,SLC30A10;AKT3;ZKSCAN3;RBL1;CDK6
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5328951724334531,-1.4601573495327569,0.06201550387596899,0.5511564715447557,1.0,10/16,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.4329860649815195,-1.4601134581583324,0.05688622754491018,0.5473589107953301,1.0,11/32,13.12%,CHKA;GPAT4;CHPT1;LPIN2;PCYT1A;SLC44A5;ABHD3;CEPT1;LPIN3;CSNK2A1;MFSD2A
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6442131419220031,1.4600909200506818,0.09803921568627451,0.7243796802998694,1.0,3/13,2.99%,CAV1;CAMK2D;PDE4D
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.40111515698278377,-1.4596280827738302,0.029411764705882353,0.5450616056220576,1.0,19/47,26.51%,PDGFRB;PID1;XDH;AGTR1;PLCG2;CYBA;GRIN1;ZC3H12A;THBS1;MAPT;ACE2;ADGRB1;AGT;ROMO1;GRB2;RAB27A;RIPK1;ITGB2;ITGAM
prerank,"wound healing, spreading of cells (GO:0044319)",-0.47984392014636285,-1.4586374862137275,0.043596730245231606,0.5444098029110235,1.0,10/24,10.23%,ARHGAP24;COL5A1;DDR1;ACVRL1;PDCD10;ARHGAP35;RHOC;TMEFF2;FLNA;CCN1
prerank,negative regulation of synaptic transmission (GO:0050805),0.5870708946881342,1.4584731988812485,0.0791476407914764,0.7277367307529722,1.0,2/23,2.75%,PLK2;SLC24A1
prerank,negative regulation of cell motility (GO:2000146),-0.3460909649289386,-1.4583093516637422,0.005917159763313609,0.5417496752363005,1.0,31/108,11.62%,ROBO1;ENG;AFDN;CLDN5;FBLN1;LIMCH1;SLIT2;FRMD5;TPM1;RECK;DACH1;CLIC4;IGFBP5;EPHA4;PTPRK;ACVRL1;CYP1B1;MITF;PODN;SRGAP1;DUSP10;DUSP3;CCDC125;CRK;BST2;TMEFF2;CITED2;RHOB;SINHCAF;ARID2;FUZ
prerank,protein processing (GO:0016485),0.46275162414569426,1.4575310137932647,0.02832512315270936,0.7285882397110424,1.0,10/102,6.14%,PTCH1;KLK2;PCSK5;ADAM19;OGT;APH1B;CD5L;CPE;NCSTN;ADAM10
prerank,negative regulation of neuron differentiation (GO:0045665),0.5756485194007225,1.4572324785103434,0.09327217125382263,0.7266455306308475,1.0,4/22,9.35%,DLX1;DTX1;SOX9;GSK3B
prerank,acylglycerol biosynthetic process (GO:0046463),0.5778196187649899,1.4549372326193437,0.0783132530120482,0.7329447747842637,1.0,6/23,3.74%,PLCE1;MOGAT2;MOGAT3;GPAT3;AWAT2;AGMO
prerank,regulation of activated T cell proliferation (GO:0046006),-0.44959471153373853,-1.454813261441566,0.045180722891566265,0.549366420693068,1.0,9/30,18.95%,IGF1;IGFBP2;IGF2;IL18;RPS3;LGALS9;RC3H1;CD24;ICOSLG
prerank,negative regulation of lipid storage (GO:0010888),-0.5052358891619627,-1.4540442795500763,0.054285714285714284,0.5484297838437101,1.0,5/19,8.19%,OSBPL8;PPARD;NR1H3;ABHD5;NR1H2
prerank,positive regulation of cell projection organization (GO:0031346),0.4548055511406643,1.453947214904564,0.021251475796930343,0.7339542396340939,1.0,10/115,4.96%,NGF;ROR2;ITGA6;ROR1;NTRK3;TIAM2;RAP1A;CDKL3;PLXNA3;WNT5A
prerank,carboxylic acid transport (GO:0046942),-0.3975794972408252,-1.452040056049284,0.015209125475285171,0.5515669832839963,1.0,21/55,23.04%,SLC16A12;SLC13A3;SLC6A6;SLC6A9;SLC7A5;SLC17A5;SLC7A1;SLC7A6;SLC16A6;SLC16A4;SLC15A4;SLC16A2;SLC16A7;SLC1A1;LLGL2;SLC3A2;SLC38A5;SLC25A29;SLC1A4;SLC6A17;SLC38A1
prerank,superoxide anion generation (GO:0042554),-0.5625870458039677,-1.4510413886725835,0.0821256038647343,0.5510718553684476,1.0,4/13,11.33%,NOX4;CYBA;NOX1;NCF2
prerank,mitotic chromosome condensation (GO:0007076),-0.4623697192856441,-1.4508423828804309,0.049689440993788817,0.5478386338044746,1.0,13/26,30.76%,PHF8;SMC4;NCAPD3;MCPH1;CSNK2A1;AKAP8L;CSNK2B;NCAPG2;NCAPD2;NUSAP1;NCAPH;TTN;NCAPG
prerank,aminoglycan catabolic process (GO:0006026),0.5574803050274106,1.4495875164834577,0.08383233532934131,0.7494538734605416,1.0,9/28,17.78%,GPC3;GPC6;SDC1;GPC2;SDC3;HSPG2;HGSNAT;GPC5;SDC4
prerank,protein kinase B signaling (GO:0043491),-0.48370479084938456,-1.4478523684771811,0.061764705882352944,0.5542947867639806,1.0,4/23,8.19%,IGF1;PIK3R3;KDR;AKT1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.4584334899344793,-1.44773458747558,0.07051282051282051,0.5510377154682602,1.0,11/28,15.04%,SHANK3;EPHA4;ADCY1;SQSTM1;APOE;LGMN;EIF2AK4;NSG1;YTHDF1;CALB1;ZDHHC2
prerank,gland development (GO:0048732),0.4863678503733269,1.4461842033072463,0.057441253263707574,0.7604588098540545,1.0,10/59,6.10%,STRA6;CAV1;COBL;WNT10A;GLI2;NF1;SOX9;LSR;IGSF3;GFER
prerank,metanephric mesenchyme development (GO:0072075),-0.6201185906722706,-1.446105764491747,0.08,0.552999021860151,1.0,2/10,3.04%,OSR1;WNT4
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5822625794624607,-1.4460971172277868,0.06940874035989718,0.5493424651456655,1.0,10/13,38.40%,EPS8;EPS8L2;PFN1;HRAS;P2RY12;DEF8;PLEKHM1;FAM98A;CARMIL2;NLGN1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4606580397252262,1.4441354650263427,0.0392156862745098,0.7658711956931405,1.0,13/88,6.83%,THBS4;CAV1;CDH13;NR2F2;SULF1;NRARP;NRP2;NF1;CAV2;PRKCA;WNT5A;NRAS;EGFL7
prerank,regulation of ion transmembrane transport (GO:0034765),0.5430954192667159,1.4438201689257923,0.07917888563049853,0.7640054662927996,1.0,11/33,16.76%,NEDD4L;KCNJ4;SCN10A;KCNJ16;ANO6;KCNJ13;CASQ2;NEDD4;CHRM3;WWP2;YWHAE
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.44421297137542737,1.443396303041076,0.02699530516431925,0.7626068676618479,1.0,16/113,7.32%,THBS4;CLDN1;FGF7;CDH13;LAMC1;NRARP;EGFR;FGF1;NRP2;SOX9;PRKCA;BMP5;WNT5A;NRAS;EGFL7;RREB1
prerank,regulation of insulin secretion (GO:0050796),0.45557661697416646,1.4427699787753914,0.0380952380952381,0.7620689836320158,1.0,17/101,10.37%,EFNA5;INHBB;ITPR2;ITPR3;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;PRKCA;ADCY5;RAPGEF4;SLC2A2;DPP4;ISL1;KCNS3;ADRA2A
prerank,amide biosynthetic process (GO:0043604),0.5106149213618515,1.4425345786981663,0.06334231805929919,0.7600295541577494,1.0,7/47,5.64%,SGMS2;CERS6;ARG1;ASS1;PCSK5;ALOXE3;CLN8
prerank,clathrin coat assembly (GO:0048268),-0.53652820923656,-1.4423569617472636,0.08312958435207823,0.557972580611453,1.0,6/15,10.53%,PICALM;HIP1;HIP1R;EPS15;PIK3C2A;NSG1
prerank,aminoglycan biosynthetic process (GO:0006023),0.5108769988759326,1.4419736935874785,0.07422402159244265,0.7591797621872912,1.0,19/49,17.78%,GPC3;XYLT2;GPC6;B3GALT1;B4GAT1;NDST1;SDC1;SLC35D2;GCNT2;HEXA;HS3ST6;HS3ST5;GPC2;SDC3;HSPG2;EXT1;EXT2;GPC5;SDC4
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6256356435200253,1.4419600159245354,0.09797297297297297,0.7561270286287317,1.0,7/15,15.81%,MGAT3;CHST7;EXTL2;CHST2;NAGK;GNPDA2;OGA
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5286753408297957,1.4415901512106633,0.07913669064748201,0.7546096072585645,1.0,12/35,10.01%,DLC1;RIPOR2;SCAI;LZTR1;SPRY1;MFN2;SPRY4;EPHB2;ABL2;KANK1;CUL3;MAPKAP1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.48674827547456345,-1.4410711056785426,0.07961783439490445,0.558364186222517,1.0,9/22,14.28%,PICALM;ROCK2;LYN;EPHA4;CASP3;GSK3A;SP1;ABCA2;ABCG1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5809309555768956,-1.4408561294888205,0.09047619047619047,0.5554894677540207,1.0,6/10,32.00%,KDR;IL33;JAK2;NOD2;NAMPT;CCL2
prerank,regulation of embryonic development (GO:0045995),-0.4342929298664604,-1.4406925857083164,0.04126984126984127,0.552388189576115,1.0,8/34,9.26%,PLCB1;PHLDB2;INSR;NPHP3;CFL1;ZBED3;SOX17;WDPCP
prerank,regulation of calcium ion import (GO:0090279),-0.4861257383367211,-1.440200388743168,0.05405405405405406,0.5505432036211261,1.0,9/21,32.00%,PDGFRB;CXCL12;EGF;PLPP4;PLN;TRIM27;PSEN2;STC1;CCL2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5840058737126388,1.439922853699833,0.09034267912772585,0.7587116992672948,1.0,2/19,2.89%,CHRNB3;RIC3
prerank,positive regulation of synaptic transmission (GO:0050806),0.48147883922520807,1.4392468516090373,0.06592039800995025,0.7584333354429857,1.0,8/72,6.58%,CLSTN2;PLK2;TSHZ3;RGS14;SLC24A1;CLSTN3;EPHB2;RIMS2
prerank,negative regulation of MAPK cascade (GO:0043409),0.4653877685038144,1.439195491176887,0.04584882280049566,0.7556022183995041,1.0,15/87,8.41%,CNKSR3;CAV1;RGS14;STK38;SPRED1;NF1;SPRY1;SPRY4;IRAK3;PTPRC;EPHB2;DAG1;PIK3R2;PTPRJ;TNIP1
prerank,regulation of axonogenesis (GO:0050770),0.4995928098605647,1.4388378508421291,0.06657420249653259,0.7541862419477778,1.0,8/51,5.95%,NGF;SIPA1L1;LRP4;TIAM2;RTN4R;PLXNA3;BRSK1;GDI1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6771802570083453,1.4384102681639865,0.1213768115942029,0.7529011767595738,1.0,2/10,8.21%,APOD;PTPRJ
prerank,regulation of DNA replication (GO:0006275),0.5002600987354501,1.43792478681241,0.06403269754768393,0.7519167480498928,1.0,20/49,20.51%,GLI1;EGFR;GLI2;CDAN1;SMC3;STN1;ORC5;FBXO5;ORC3;OBI1;FAF1;CDC6;NUCKS1;BRPF3;GMNN;USP37;DSCC1;DHX9;PPP2CA;ATR
prerank,endocrine system development (GO:0035270),0.5845877181097787,1.4377466576872968,0.08620689655172414,0.7496382983025354,1.0,3/21,3.23%,STRA6;GLI2;NF1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.5230321149269278,-1.4359424803005554,0.04736842105263158,0.5608645534561845,1.0,7/16,21.08%,SNCAIP;MCTP2;SYN1;CAMK2A;CPLX2;FLOT1;RIMS1
prerank,positive regulation of filopodium assembly (GO:0051491),0.5709555692848036,1.4357104645087055,0.08282208588957055,0.7549583674436536,1.0,3/24,2.02%,TENM2;RIPOR2;ARAP1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5925765244803394,-1.4345744959365998,0.07221006564551423,0.562253481673441,1.0,2/10,4.03%,ROCK2;IL18
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6853497830402498,1.434435317142894,0.11310592459605028,0.7572929091561558,1.0,3/10,13.05%,CAV1;KCNAB1;KCNRG
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.46623138080472126,1.4341405066635937,0.043683589138134596,0.7555736313974062,1.0,23/95,12.14%,DCN;GPC3;CSPG4;ST3GAL4;PRELP;UST;XYLT2;GPC6;GLCE;B4GAT1;CHST7;NCAN;NDST1;SDC1;SLC35D2;GCNT2;CHST2;HEXA;CHST12;HS3ST6;HS3ST5;GPC2;SDC3
prerank,B cell receptor signaling pathway (GO:0050853),0.5406225471881912,1.433805364922575,0.09156976744186046,0.7539224999652823,1.0,4/32,4.99%,TEC;NFATC2;ITK;PTPRC
prerank,miRNA metabolic process (GO:0010586),0.5926342082770168,1.4327866437219043,0.08108108108108109,0.7550046170243914,1.0,8/20,17.20%,DDX17;DIS3L2;LIN28B;DGCR8;DICER1;RAN;PRKRA;XPO5
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6134182922411742,-1.4324349595537573,0.09255079006772009,0.565825427450763,1.0,9/10,34.40%,ACER2;CYP1B1;NEXMIF;WNK1;PDE3B;JAM3;SNAI2;HRG;SERPINE1
prerank,cholesterol homeostasis (GO:0042632),0.48557847373808466,1.4321300602844176,0.06623376623376623,0.7548538304656067,1.0,4/64,4.10%,RORA;CAV1;CYP7B1;GRAMD1B
prerank,acylglycerol metabolic process (GO:0006639),0.5242599516674963,1.432062592163828,0.08737864077669903,0.7522284385234945,1.0,6/37,10.46%,CAV1;DGKA;AWAT2;DGKZ;ABHD12;LMF1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6122270318891891,1.4320125135092205,0.10481099656357389,0.749526095214021,1.0,3/15,8.31%,PRODH;HOGA1;ABHD12
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4293932893864821,-1.4312204027016056,0.04113924050632911,0.5665408962117271,1.0,5/36,1.08%,PDGFD;ENG;EPHA7;ERRFI1;ENPP1
prerank,regulation of muscle contraction (GO:0006937),0.5638983520624825,1.4308568440887706,0.1,0.7513390848773234,1.0,4/26,5.19%,CAV1;MYBPH;PLCE1;ATP1A2
prerank,regulation of stem cell proliferation (GO:0072091),-0.5072277484624528,-1.4305165762764556,0.09171597633136094,0.5654412157382448,1.0,5/17,12.01%,FBLN1;GJA1;ACE;AGO3;KDM1A
prerank,canonical Wnt signaling pathway (GO:0060070),0.470208835782796,1.4304146338062065,0.059569074778200254,0.7502233784982045,1.0,25/68,19.41%,CAV1;WNT10A;FZD2;AXIN1;WNT2B;WNT16;PLPP3;WNT5A;GSK3B;CSNK1A1;RARG;APC;DVL3;WNT9A;PTEN;BCL9;FZD7;FZD9;FZD3;PPP1CA;WNT6;CDH3;RAB5A;TCF7L1;SCYL2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.6327247159984021,1.429539372236545,0.10696095076400679,0.7509359289395694,1.0,5/14,8.36%,ADAM19;APH1B;NCSTN;ADAM10;DYRK1A
prerank,sympathetic nervous system development (GO:0048485),0.6246538630666836,1.429418064846799,0.10391822827938671,0.7486014743926186,1.0,5/15,14.91%,NRP2;NF1;SEMA3A;SOX4;FZD3
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5056339127411785,-1.4292850602483715,0.07868020304568528,0.5664797315288163,1.0,8/18,13.39%,AKT3;HDAC7;HDAC9;KDR;ANXA1;PIK3C2A;GATA2;SRPX2
prerank,fatty acid elongation (GO:0030497),0.641865331726192,1.4285399855504741,0.10067114093959731,0.749381788745368,1.0,7/13,13.29%,ELOVL5;HACD4;ELOVL1;ELOVL2;HACD2;ABCD1;ELOVL6
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6661049448045977,1.4281902566487863,0.10033444816053512,0.7480406075209387,1.0,4/10,5.19%,NEDD4L;PRKCE;CAMK2D;ATP1A2
prerank,negative regulation of response to external stimulus (GO:0032102),0.4487021863850424,1.427858265350635,0.04693140794223827,0.74661490119085,1.0,22/105,11.15%,RORA;CLDN19;CDH5;CXCL17;AJAP1;CASK;RTN4R;PCBP2;FNDC4;IRAK3;TNFAIP3;TRIM21;SELENOS;MAPK7;PTGER4;ISL1;ACOD1;INPP5F;TRAFD1;SHARPIN;RTN4RL1;PROC
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4030753794505195,-1.427781915014789,0.05405405405405406,0.5679304977354417,1.0,13/43,8.52%,IGF1;PDGFRB;IL6R;FOXP1;MEF2D;IGFBP5;BMP4;GJA1;IL18;AKT1;MMP2;LDLRAP1;NOX1
prerank,regulation of mitochondrial fission (GO:0090140),0.5595025489139621,1.4276087946082356,0.09472049689440994,0.7448300414146212,1.0,11/24,20.63%,DCN;DDHD1;FIS1;MIEF1;STAT2;BNIP3;RALBP1;PINK1;RALA;PRKN;MUL1
prerank,regulation of platelet aggregation (GO:0090330),0.6011222586189472,1.4265724127991544,0.10638297872340426,0.74650592134584,1.0,4/17,4.28%,F11R;CEACAM1;CD9;PRKCA
prerank,aspartate family amino acid metabolic process (GO:0009066),0.5876961194116188,1.4260939282454368,0.09470304975922954,0.7455344729199681,1.0,8/18,14.34%,ASS1;NAALAD2;SLC25A12;NIT2;MTHFD1;SLC25A13;GOT1;SMS
prerank,muscle cell migration (GO:0014812),0.6579446195198256,1.4257473982701818,0.11702127659574468,0.7441285972878071,1.0,1/10,0.16%,THBS4
prerank,skeletal system morphogenesis (GO:0048705),-0.4043412048091072,-1.4257105110548678,0.04669260700389105,0.5713926744846075,1.0,20/42,19.28%,PDGFRA;CYP26B1;HOXA3;TGFBR1;FGFR2;HOXB4;DSCAML1;HOXB9;LRP6;HOXC4;SPEF2;HOXA9;FUZ;MEGF8;HOXD4;ANKRD11;HOXD3;LRP5;WWOX;RFLNB
prerank,actin nucleation (GO:0045010),-0.47882714442507257,-1.4249620629791961,0.0921409214092141,0.5705173838879032,1.0,14/21,38.93%,JMY;ARPC3;IQGAP2;ACTR2;LMOD1;ARPC1A;ARPC5;TRIM27;WASHC1;ARPC5L;ARPC1B;SPIRE2;SPIRE1;SCIN
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.5075136252909911,-1.424598382932519,0.07272727272727272,0.5683254152236691,1.0,8/18,14.28%,PICALM;ROCK2;EPHA4;CASP3;GSK3A;SP1;ABCA2;ABCG1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6172987970857445,1.4243423876132666,0.10234899328859061,0.7443544185491029,1.0,3/16,4.48%,APOD;DLC1;SRC
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6172987970857445,1.4243423876132666,0.10234899328859061,0.7443544185491029,1.0,3/16,4.48%,APOD;DLC1;SRC
prerank,respiratory system development (GO:0060541),0.5273761797597605,1.4238883887805922,0.08211143695014662,0.7434697544639786,1.0,4/32,2.92%,STRA6;FGF7;FGF1;GLI2
prerank,regulation of nuclear division (GO:0051783),0.5948707762913757,1.4228380407098224,0.10091743119266056,0.745093732174883,1.0,5/20,7.63%,FBXO43;KIF20B;CAV2;CDK13;FBXO5
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4767676327585121,1.4224009147048942,0.06717363751584284,0.7442026240625362,1.0,6/67,2.16%,VIT;CDH13;UTRN;DOCK5;ECM2;DOCK1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.42592612531660606,-1.420736672398197,0.06050955414012739,0.5779654785572198,1.0,10/35,9.40%,IRAG1;KSR1;RAPGEF2;PDE7B;ADGRG6;ADCY1;AKAP6;APOE;ADCY2;PDE2A
prerank,negative regulation of secretion by cell (GO:1903531),0.5155040686677849,1.4207355972803597,0.09078212290502793,0.7480096102750114,1.0,1/38,0.06%,STXBP6
prerank,myeloid leukocyte differentiation (GO:0002573),-0.36974800901694793,-1.4200257684219864,0.043478260869565216,0.5765325331859202,1.0,21/65,19.29%,LEF1;IL31RA;FOXP1;CDC42;BMP4;KIT;CBFA2T3;EP300;MT1G;DEK;CAMK4;TNFRSF11A;CDK4;PIR;LGALS9;PDE1B;CSF1;CASP8;SBNO2;MYH9;PARP1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3744377192319787,-1.4198158226020965,0.032520325203252036,0.5737996215709489,1.0,8/57,6.94%,IGF1;IL31RA;GHR;IL6R;LYN;KIT;IL18;JAK2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5946210081516553,-1.419718038865616,0.09219858156028368,0.5706181097125331,1.0,4/10,21.43%,ADGRV1;PDZD7;TSKU;PLS1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5315106506427157,1.4193241278209918,0.08645533141210375,0.7509350499177389,1.0,4/34,5.05%,RORA;TRIB2;WNT5A;TRIO
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5584373805505576,1.4184730183665795,0.10410557184750734,0.7517316872017085,1.0,6/24,7.28%,ITPR2;ITPR3;ERO1A;PTPRC;IBTK;CHERP
prerank,mesenchyme development (GO:0060485),-0.5137418707605921,-1.4184235422134261,0.07571801566579635,0.5714848669217911,1.0,5/15,10.53%,BMP4;TGFBR1;BMPR2;FGFR2;BMP2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4462962608166981,-1.4181957571152193,0.07848837209302326,0.5689284440856887,1.0,9/28,12.48%,PID1;ENPP1;GRB10;APPL2;RPS6KB1;PIP4K2A;PRKCZ;GSK3A;PIP4K2C
prerank,positive regulation of phospholipase C activity (GO:0010863),0.513846784307471,1.4172275330640522,0.08039492242595205,0.7541655785048285,1.0,8/40,6.49%,NTRK3;FGFR1;LPAR1;EGFR;ITK;TXK;GNAQ;ABL2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.596821850170908,-1.4170327083243361,0.06746987951807229,0.5695324164364292,1.0,9/10,35.85%,PARD3;PLPP1;GAP43;PRKD3;PICK1;HTR2B;F2R;CHRM1;DGKH
prerank,phospholipid translocation (GO:0045332),0.5369634344743799,1.4166620300028103,0.07871720116618076,0.7537572157771788,1.0,11/28,9.88%,ATP8B3;ATP8B1;ANO6;ABCC1;ATP9B;ATP11C;PLSCR1;ATP9A;ATP8B2;ABCA1;ATP10B
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5284296306137372,-1.4157403537967042,0.06958762886597938,0.570403469478011,1.0,5/15,19.18%,PRKCH;IL18;AGTR1;CSF1;AGT
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.574198293434008,-1.4151463998568776,0.0951219512195122,0.5692078751342219,1.0,4/11,1.89%,RSPO3;NKD1;DAB2;WNT5B
prerank,sterol homeostasis (GO:0055092),0.4770844185794764,1.4146426653267195,0.07948717948717948,0.7593299052989065,1.0,4/65,4.10%,RORA;CAV1;CYP7B1;GRAMD1B
prerank,triglyceride homeostasis (GO:0070328),0.5602201465212042,1.4145826478753234,0.09495548961424333,0.7568974006279116,1.0,1/26,0.04%,RORA
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.5033691160025342,-1.4140162022687388,0.08310249307479224,0.5698192491301894,1.0,7/17,23.52%,LYN;PDCD10;ARL6IP5;TAOK2;TGFB2;NOD2;STK25
prerank,regulation of hydrolase activity (GO:0051336),0.4746860099484048,1.4133470879142485,0.07364341085271318,0.7595061829953038,1.0,16/71,8.85%,CAV1;EFNA5;SIPA1L1;ARHGAP12;ARHGAP9;CFAP73;TDG;NF1;VAV2;PLXNA3;ARHGEF5;RAB3GAP2;RDX;PAFAH1B1;RAPGEF6;OCRL
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6625635325052832,1.4124023923139075,0.12162162162162163,0.7606235991361291,1.0,2/10,4.48%,DCN;SRC
prerank,protein localization to cell surface (GO:0034394),0.5638754284647763,1.4122230853275353,0.09752321981424149,0.758764553425531,1.0,3/26,2.89%,PIGU;FGF7;RIC3
prerank,postsynaptic membrane organization (GO:0001941),0.6008085803127527,1.4122063272436014,0.11949685534591195,0.7562114071198016,1.0,3/17,1.81%,LRP4;CEL;MUSK
prerank,presynaptic endocytosis (GO:0140238),0.5501346921004543,1.412052023404394,0.09984871406959153,0.7541824366515614,1.0,11/24,22.12%,CEL;STX1A;OPHN1;STON1;STON2;SNCG;PACSIN1;AMPH;VAMP2;NLGN3;NLGN2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.573058481604483,-1.411799356922228,0.11682242990654206,0.573720514542809,1.0,4/11,12.75%,TGFBR3;TGFBR1;BMP2;TGFB2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6179999964429914,1.4117788115919705,0.11447811447811448,0.752694869018578,1.0,2/15,0.70%,SMOC2;FGFR1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5525076941153862,1.4113262112729892,0.0927536231884058,0.75189145088568,1.0,5/27,5.76%,DCN;CSPG4;XYLT2;CHST7;NCAN
prerank,regulation of cellular senescence (GO:2000772),-0.44177298548936084,-1.4111904942306042,0.06031746031746032,0.5723223530830193,1.0,11/28,19.73%,SLC30A10;AKT3;B2M;ZKSCAN3;RBL1;CDK6;YPEL3;NUAK1;EEF1E1;VASH1;CGAS
prerank,myofibril assembly (GO:0030239),-0.4022938123135471,-1.4110590274742536,0.034482758620689655,0.5695700260603275,1.0,10/42,11.30%,PGM5;PDGFRB;ACTN2;PDGFRA;TPM1;OBSL1;TMOD3;CFLAR;CSRP2;LMOD1
prerank,detection of mechanical stimulus (GO:0050982),0.5810570152978092,1.4100952339293427,0.1109375,0.7543552196764453,1.0,5/19,13.09%,PIEZO2;CSRP3;CDH2;PIEZO1;PKD1
prerank,sterol metabolic process (GO:0016125),-0.3755034352656627,-1.4098776095847385,0.05439330543933055,0.5704432046074164,1.0,17/60,14.98%,PRKAG2;CYP26B1;PPARD;INSIG2;CYP1B1;ARV1;APOE;SCAP;OSBPL1A;LDLRAP1;OSBPL5;GBA2;NSDHL;PMVK;ABCG1;FDXR;LIPA
prerank,heart development (GO:0007507),0.4288459527568289,1.4098754349056664,0.027932960893854747,0.7527157626637112,1.0,39/150,15.69%,STRA6;CXADR;GPC3;DLC1;NTRK3;PLCE1;SGCD;PCSK5;PDLIM4;GLI2;NF1;AKAP13;SMYD4;SGCG;SOX9;CSRP3;BMP5;FN1;MTHFD1;APLN;SH3PXD2B;COL3A1;TBX2;ISL1;POU4F1;LEFTY1;TAB2;POPDC3;NDUFV2;PTEN;KDM6B;PKD1;SOX4;FLRT2;ERBB4;FOXF1;TNNI3;POU6F1;FOXC2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6088129304766511,1.4095786176319705,0.116751269035533,0.751298105432939,1.0,5/15,8.91%,GLI1;FAM83D;PAF1;CUL3;DDRGK1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5505199099986253,-1.409445275362901,0.10444444444444445,0.5687228033217844,1.0,5/13,15.22%,LEF1;IL18;TNFRSF21;PRKCZ;LGALS9
prerank,long-chain fatty acid transport (GO:0015909),-0.44048816712400524,-1.4088568233943881,0.06349206349206349,0.567688760160227,1.0,12/30,14.68%,PRKAG2;ACSL1;ACSL3;APOE;RPS6KB1;ABCD4;CPT2;PRKAB2;ABCD2;MFSD2A;CPT1A;MID1IP1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5335773376360112,1.4085530073840975,0.08132530120481928,0.752902279268757,1.0,1/31,0.01%,PTCH1
prerank,embryonic digit morphogenesis (GO:0042733),-0.5050543422897327,-1.407451806666537,0.07547169811320754,0.5690664979454984,1.0,7/18,9.26%,ECE1;OSR1;MAP3K20;GLI3;TBX3;HDAC1;WDPCP
prerank,cellular iron ion homeostasis (GO:0006879),-0.37484732213516825,-1.4072979962549204,0.028925619834710745,0.566388656465077,1.0,19/55,23.51%,BMP6;ABCG2;FTH1;TFRC;SCARA5;FTL;SLC11A2;SLC39A14;NEDD8;FXN;SLC40A1;HFE;SMAD4;CUL1;SKP1;CYBRD1;BOLA2;CCDC115;ISCU
prerank,triglyceride metabolic process (GO:0006641),0.5050142728785816,1.407172327856866,0.08119079837618404,0.7557889971042231,1.0,5/48,3.74%,CAV1;MOGAT2;MOGAT3;GPAT3;AGMO
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5229260606091574,-1.406283391705909,0.09669211195928754,0.5666234707385839,1.0,10/15,35.07%,JMY;ARPC3;IQGAP2;ACTR2;ARPC1A;ARPC5;TRIM27;WASHC1;ARPC5L;ARPC1B
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6256285582221396,1.4047551491509662,0.13485113835376533,0.7632468589874707,1.0,1/12,0.24%,CAV1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5237276974415592,1.4043459789279928,0.10419681620839363,0.7621938939469555,1.0,9/33,8.91%,GLI1;EGFR;CCND3;ADAMTS1;UBE2E2;FAM83D;RDX;PAF1;DDRGK1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4668393515752992,1.4042341764033013,0.0648508430609598,0.7601468704595173,1.0,15/72,8.07%,DLC1;ARHGEF28;F11R;LPAR1;RIPOR2;SCAI;RTN4R;AKAP13;OPHN1;KANK2;ABL2;COL3A1;KANK1;CUL3;STARD13
prerank,regulation of smooth muscle contraction (GO:0006940),0.5682852401459494,1.403021811390449,0.12264150943396226,0.7624392259593644,1.0,2/20,1.21%,CAV1;PLCE1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6657844873680139,1.4030056107469198,0.125,0.7599841402165607,1.0,2/10,4.23%,LBP;PTPN22
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.4996054319471658,1.402908687741248,0.0846774193548387,0.7578373783837484,1.0,9/41,7.28%,ITPR2;ITPR3;SLC24A1;TRPV4;ERO1A;ATP2B4;PTPRC;IBTK;CHERP
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6318100583839649,1.4021268860006326,0.11806797853309481,0.7583742461046378,1.0,1/12,0.24%,CAV1
prerank,endothelial tube morphogenesis (GO:0061154),-0.575411926899856,-1.402022844628452,0.10772833723653395,0.5779065533696278,1.0,5/10,16.70%,RBPJ;BMP4;ACVRL1;RHOB;CSNK2B
prerank,myelin assembly (GO:0032288),0.6654933138407072,1.402010685644444,0.09210526315789473,0.7563055494526899,1.0,5/10,14.63%,EPB41L3;CD9;CNTNAP1;NCMAP;DICER1
prerank,cyclooxygenase pathway (GO:0019371),-0.5977506466253195,-1.4017319117406344,0.10550458715596331,0.5757463303558453,1.0,5/10,17.61%,PTGIS;PTGS1;PTGDS;TBXAS1;HPGDS
prerank,superoxide metabolic process (GO:0006801),-0.44406248322617137,-1.4011870998121156,0.06109324758842444,0.5745992439634979,1.0,9/29,11.33%,NOS3;ATP7A;SOD3;PRDX2;NOX4;NRROS;CYBA;NOX1;NCF2
prerank,regulation of synapse assembly (GO:0051963),0.48231223621363123,1.4011487689657611,0.07989347536617843,0.7572407893937323,1.0,5/46,6.39%,CLSTN2;MUSK;GPC6;CLSTN3;EPHB2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.5602484381907472,1.400848570572762,0.12441679626749612,0.7559252680908672,1.0,7/23,16.15%,PLK2;WEE1;CHFR;CHMP4C;ZWILCH;ZW10;INTS3
prerank,sodium ion homeostasis (GO:0055078),0.5785764871663092,1.4007951380799486,0.10950080515297907,0.7536402461371872,1.0,5/21,9.40%,NEDD4L;SLC12A2;SLC12A3;ATP1A2;ATP1B3
prerank,transition metal ion homeostasis (GO:0055076),-0.4409378780741272,-1.4004861834568332,0.057926829268292686,0.5737345709382634,1.0,7/28,7.56%,PICALM;NEO1;COMMD1;B2M;FTL;SLC39A14;BDH2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.5618683022483655,-1.3999923160537433,0.08200455580865604,0.5722459201714208,1.0,8/11,32.77%,NPM1;TRIM37;KAT2B;KAT2A;CCNF;BRCA1;CDK5RAP2;MDM1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.479597534730137,1.3997716695976645,0.11231393775372124,0.7553488532990967,1.0,22/52,18.96%,ASS1;FOLR2;MDH1B;AADAT;NIT2;MTHFD1;HOGA1;ALDH18A1;OGDH;ALDH5A1;MDH1;DLST;ACOT8;L2HGDH;GOT1;SLC46A1;GGT1;PHYH;ME2;ALDH1L2;SLC19A1;GPT2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.662757592347522,1.3994764353468245,0.12323943661971831,0.7541220706499167,1.0,2/10,3.53%,RAPGEF3;KMT2A
prerank,regulation of establishment of planar polarity (GO:0090175),0.45335951068619135,1.398930128171615,0.05392156862745098,0.7538869428109927,1.0,28/88,18.76%,ROR2;PRICKLE1;PRICKLE2;FZD2;SPEF1;SAPCD2;PSME3;DACT1;WNT5A;PSMB5;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,vascular transport (GO:0010232),-0.34738440211759025,-1.398895460968469,0.005555555555555556,0.572686091688074,1.0,27/81,13.71%,SLC24A3;SLC16A12;SLC13A3;SLC22A8;SLC6A6;INSR;SLCO3A1;ABCC4;LRP1;SLC6A9;ABCG2;SLC7A5;SLCO1C1;TFRC;ABCC9;SLC5A6;SLC7A1;SLC15A2;SLC2A10;ATP1B2;SLC16A2;SLC16A7;SLC1A3;ABCA2;SLC6A1;MFSD2A;SLC1A1
prerank,positive regulation of ERAD pathway (GO:1904294),0.6292845389223365,1.3988831165328934,0.11833333333333333,0.7516499329469416,1.0,6/13,18.42%,CAV1;USP13;NFE2L2;RNF185;UBQLN1;TMEM259
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5353157601047264,1.3988619546187686,0.09774436090225563,0.7493099708028342,1.0,3/27,2.99%,CAV1;CAMK2D;PDE4D
prerank,toxin transport (GO:1901998),0.6636325105045366,1.3986332801326964,0.12072072072072072,0.7477464222204614,1.0,5/10,12.51%,RAB29;SLC29A4;SLC22A3;ADAM10;RAB40B
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5584701284770045,1.3973027500252646,0.11746031746031746,0.7507440643504389,1.0,5/24,7.17%,PPARGC1A;LEPR;SDHAF4;LYRM7;COX15
prerank,negative regulation of transport (GO:0051051),-0.3820661294687959,-1.3966638435289684,0.07692307692307693,0.5772234435985466,1.0,19/51,23.77%,EPHA3;CTTNBP2NL;DYSF;NR1H3;SIRPA;PIP4P2;ARL6IP5;BST2;NR1H2;SCAMP5;RUBCN;CRYAB;PXK;EGF;YRDC;RACK1;RAB7A;PRKD1;ERBB3
prerank,histone H2A monoubiquitination (GO:0035518),-0.493367640370564,-1.3962469207173607,0.08672086720867209,0.5755634944956896,1.0,12/17,29.65%,PCGF5;KDM2B;PCGF2;BMI1;RYBP;TRIM37;SKP1;RNF2;PCGF6;RING1;DDB1;BCOR
prerank,transport across blood-brain barrier (GO:0150104),-0.34354918149587726,-1.3958256489291787,0.010869565217391304,0.5739031996010718,1.0,27/83,13.71%,SLC24A3;SLC16A12;SLC13A3;SLC22A8;SLC6A6;INSR;SLCO3A1;ABCC4;LRP1;SLC6A9;ABCG2;SLC7A5;SLCO1C1;TFRC;ABCC9;SLC5A6;SLC7A1;SLC15A2;SLC2A10;ATP1B2;SLC16A2;SLC16A7;SLC1A3;ABCA2;SLC6A1;MFSD2A;SLC1A1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5212778780879745,-1.395294200586195,0.09510869565217392,0.5725975209577717,1.0,7/16,13.98%,NPR3;HIF1A;APOE;GCH1;AKT1;S100A1;DHFR
prerank,regulation of neuron differentiation (GO:0045664),0.45873189491706134,1.3950860792354292,0.06682867557715674,0.7569755743747032,1.0,7/76,5.24%,NGF;FGFR1;DTX1;ZC4H2;MMD2;NBL1;HEYL
prerank,protein localization to cell periphery (GO:1990778),0.43143876703313677,1.3946256634712793,0.04408352668213457,0.7563112538646435,1.0,18/133,9.40%,PTCH1;CAV1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;RAB29;KCNIP4;FLOT2;RABEP1;RDX;EHD2;RAB3A;EFR3A;RAPGEF6;ZDHHC23;ATP1B3
prerank,regulation of cellular respiration (GO:0043457),-0.5070704836775033,-1.3932512392507284,0.11704834605597965,0.5762896674105519,1.0,6/17,17.34%,CBFA2T3;IL10RB;PRDM16;VCP;NOA1;IFNAR1
prerank,retinoic acid metabolic process (GO:0042573),0.6113997173917174,1.3932250697234483,0.12376237623762376,0.759034464848042,1.0,3/14,8.34%,ALDH1A3;CYP2S1;SCPEP1
prerank,positive regulation of cell aging (GO:0090343),-0.5655353701932861,-1.3931910248568051,0.09832134292565947,0.5734991632169658,1.0,5/11,19.73%,B2M;YPEL3;LMNA;EEF1E1;CGAS
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6362536682698865,1.3929273805092421,0.14260249554367202,0.7578190095117978,1.0,3/11,8.37%,CAMK2D;SESTD1;NOS1AP
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6232147119792666,1.392866548240414,0.12186978297161936,0.7556728378901667,1.0,7/13,17.74%,CDH13;CD9;ABCA1;CD81;SYK;PPARG;LPL
prerank,cellular response to gamma radiation (GO:0071480),-0.4901588175850782,-1.3923689428531878,0.09042553191489362,0.5732812637882603,1.0,6/17,14.74%,MAP3K20;WRN;RPL26;KDM1A;CRYAB;HSF1
prerank,glycine transport (GO:0015816),-0.5814286231467836,-1.3922614963267577,0.1103448275862069,0.5706994812789805,1.0,4/10,22.37%,SLC6A9;SLC25A38;SLC38A5;SLC6A17
prerank,RNA splicing (GO:0008380),0.4420497846422319,1.3911166430852795,0.06408706166868199,0.7602022703758025,1.0,24/95,17.58%,DHX8;PPARGC1A;HNRNPC;SF3B2;SF3B1;RBM8A;RNPC3;SRSF4;ZRSR2;SNRPF;PRPF3;SRPK1;SRPK2;DBR1;TCERG1;SNRPA1;SFPQ;PPIG;DHX16;TRA2B;PDCD7;SYNCRIP;YJU2;SLU7
prerank,negative regulation of cell aging (GO:0090344),-0.5053833612158439,-1.390852861064278,0.09660574412532637,0.5725627241484809,1.0,5/16,7.77%,SLC30A10;AKT3;ZKSCAN3;RBL1;CDK6
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.447945680747722,1.3908272534957624,0.07389162561576355,0.7589828437426763,1.0,9/86,5.33%,THBS4;EFNA5;FGF7;TEC;CSPG4;EGFR;SRC;PTPRC;BANK1
prerank,positive regulation of GTPase activity (GO:0043547),0.4168843679063411,1.38953339225568,0.03282275711159737,0.7617050114932188,1.0,31/188,11.44%,ARHGAP42;ITGA6;SIPA1L1;DOCK9;NTRK3;F11R;RGS6;TIAM2;GRTP1;RAPGEF3;RAP1A;ARAP1;SGSM2;NF1;RTN4R;CAV2;ARHGEF5;ZC3H15;RAPGEF6;PKP4;TBC1D16;GSK3B;FOXJ1;SLC27A4;TBC1D2;FERMT2;TBC1D8;DOCK7;RIC1;DVL3;PLXNB1
prerank,diterpenoid metabolic process (GO:0016101),0.48260250186355613,1.3892888913451495,0.07859078590785908,0.7602444573980718,1.0,13/55,13.34%,STRA6;GPC3;RDH10;GPC6;RDH5;AWAT2;BCO1;OPN1MW;SDC1;AKR1B10;GPC2;SDC3;HSPG2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.44020239707105285,-1.3889021532401653,0.06542056074766354,0.5759143876161845,1.0,8/27,19.18%,PRKCH;IL18;NR1H3;AGTR1;NR1H2;ABCG1;CSF1;AGT
prerank,regulation of centrosome duplication (GO:0010824),0.5300162865399691,1.388572838642436,0.1187683284457478,0.7605798133307541,1.0,8/29,12.90%,PLK2;STIL;CEP131;CHMP5;PDCD6IP;CHMP4B;CHMP4C;GEN1
prerank,negative regulation of TOR signaling (GO:0032007),-0.40964332551572336,-1.3883593385774746,0.087248322147651,0.5748463616827053,1.0,15/36,27.54%,UBR1;FNIP1;DEPDC5;RNF152;TMEM127;GSK3A;SPAAR;DEPTOR;TNFAIP8L1;CASTOR2;CASTOR1;FLCN;PRKAA1;ATM;TSC1
prerank,glycogen catabolic process (GO:0005980),-0.5192739447207925,-1.3869882545107373,0.11442786069651742,0.576113729706404,1.0,10/15,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,regulation of cellular localization (GO:0060341),0.4868131604259231,1.3867816576675922,0.10206896551724139,0.7650648845113485,1.0,10/46,11.20%,EFNA5;CAMK2D;PARD6B;ADCY5;GOSR1;BRSK1;FER;TRIM46;WWC1;DVL3
prerank,iron ion transmembrane transport (GO:0034755),-0.5754415332856486,-1.3866572147094454,0.1103448275862069,0.574593682984819,1.0,5/10,15.49%,SCARA5;SLC39A8;SLC11A2;SLC39A14;SLC40A1
prerank,negative regulation of response to wounding (GO:1903035),0.571956783762507,1.3865268577277723,0.13580246913580246,0.7636736664077742,1.0,6/19,10.73%,CLDN19;AJAP1;CASK;RTN4R;INPP5F;RTN4RL1
prerank,positive regulation of calcium ion import (GO:0090280),-0.5351112212905972,-1.3860439676436076,0.11037527593818984,0.5737359838026836,1.0,2/12,6.45%,PDGFRB;CXCL12
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5986768939121176,1.3854494182185493,0.13787085514834205,0.7656081353245322,1.0,1/16,0.38%,TRIB2
prerank,organophosphate ester transport (GO:0015748),-0.44793819125768725,-1.384810356073275,0.10179640718562874,0.5749131273015201,1.0,10/24,14.16%,OSBPL8;PLTP;PITPNB;LDLR;TNFAIP8L3;OSBPL5;SCP2;EPG5;PRELID2;PRELID3A
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.46848185471212234,1.3845477584496255,0.10686015831134564,0.7666325229605909,1.0,9/54,11.37%,CAV1;NEDD4L;KCNJ4;KCNJ16;KCNIP4;GABBR2;NOS1AP;KCNAB1;NEDD4
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5127832360997825,-1.3843269812019037,0.10526315789473684,0.5738210848790299,1.0,6/16,22.64%,LRP1;APOE;HDAC1;MYOCD;CLU;SRF
prerank,negative regulation of growth (GO:0045926),-0.3249409651398615,-1.3837976591563268,0.031007751937984496,0.5727232330305951,1.0,23/121,7.81%,NOTCH2;SMAD3;ENPP1;SLIT2;SMARCA2;GJA1;ACVRL1;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;BMPR2;CCN3;NPR1;DNAJB2;APBB2;SOX17;JADE1;BST2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5942419995305436,1.3836206135276894,0.13268608414239483,0.7678161043748836,1.0,10/16,25.37%,LEPROT;CHMP5;CHMP4A;CHMP4B;CHMP4C;LEPROTL1;VPS36;SNF8;TMEM50B;STAM
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.45625192192275876,1.3833919225265274,0.0799492385786802,0.7662940837091724,1.0,9/69,4.09%,NGF;FGFR1;PLCD3;PLCE1;PLCB3;OGT;NF1;PLCL1;TPTE
prerank,negative regulation of coagulation (GO:0050819),-0.5206144947574037,-1.3833111479464537,0.11405835543766578,0.57146769110942,1.0,5/14,6.50%,TFPI;THBD;SERPINE2;APOE;CD34
prerank,organic hydroxy compound transport (GO:0015850),0.5105474021544748,1.38260533368568,0.10709117221418235,0.7668081801983547,1.0,3/36,1.94%,STRA6;CEACAM1;ATP8B1
prerank,negative regulation of defense response (GO:0031348),0.44805739027770797,1.3823891346124026,0.08208955223880597,0.7653520642396117,1.0,16/77,11.15%,RORA;CDH5;CXCL17;PCBP2;FNDC4;IRAK3;TNFAIP3;TRIM21;SELENOS;MAPK7;PTGER4;ISL1;ACOD1;TRAFD1;SHARPIN;PROC
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6047891504362786,1.38121425718995,0.12521150592216582,0.7673790755387524,1.0,8/13,22.42%,AADAT;OGDH;DLST;L2HGDH;GOT1;PHYH;GPT2;IDH2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5993078585495318,1.380712715353447,0.12685337726523888,0.7670059664385995,1.0,2/14,2.89%,PPARGC1A;GPLD1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4520821713520583,-1.380367597897344,0.0847953216374269,0.5780614986460128,1.0,11/26,14.68%,PRKAG2;LPGAT1;ADIPOR2;NR1H3;ERLIN1;WDTC1;NR1H2;PRKAB2;SLC45A3;ERLIN2;MID1IP1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.4014296334797069,-1.3802679350737495,0.06312292358803986,0.5756797421208247,1.0,10/40,13.08%,SLC7A11;SLC13A3;SLC7A5;SLC5A6;SLC38A11;SLC7A6;SLC25A30;SLC25A11;SLC16A7;SLC38A7
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6340860730052803,1.3794547338188885,0.15966386554621848,0.7697329964515538,1.0,1/11,0.50%,CDH13
prerank,negative regulation of leukocyte activation (GO:0002695),-0.5176354982249558,-1.3792844644608735,0.09018567639257294,0.5759956294296055,1.0,11/15,34.98%,IL31RA;NR1H3;CD200;ZC3H12A;GRN;FCGR2B;MILR1;CD300LF;CD300A;LRFN5;CD84
prerank,protein lipidation (GO:0006497),0.47217427164416365,1.3788308154716615,0.08408796895213454,0.7697488688135589,1.0,15/59,14.87%,PIGU;GPLD1;PGAP3;ZDHHC1;ATG5;ZDHHC7;PIGB;ZDHHC23;PIGA;ZDHHC13;ATG7;ZDHHC20;GLUL;ZDHHC8;PIK3C3
prerank,platelet degranulation (GO:0002576),-0.3236267811615684,-1.3785276964672937,0.012903225806451613,0.5757600720317045,1.0,29/118,14.25%,IGF1;TIMP3;VWF;ACTN2;ABCC4;PECAM1;PCDH7;CLEC3B;SPARC;LYN;CDC37L1;IGF2;NHLRC2;CALM1;PROS1;TGFB3;VEGFC;CYRIB;QSOX1;SYTL4;PHACTR2;FLNA;MANF;TGFB2;VEGFD;THBS1;TMSB4X;F5;LGALS3BP
prerank,protein neddylation (GO:0045116),-0.5393333291056448,-1.3783244239844288,0.10377358490566038,0.57374066018492,1.0,7/13,25.22%,RBX1;UBA3;NEDD8;NAE1;DCUN1D4;UBE2F;DCUN1D3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.31023493569742433,-1.3780246839157402,0.021505376344086023,0.5720830050547838,1.0,50/182,15.25%,IGF1;ROBO1;SLC24A3;PICALM;NOTCH2;ENG;ROCK2;CLDN5;FOXP1;BMP4;SLC7A5;WNT4;ACVRL1;ANKRD13A;LDLR;HIF1A;RBL1;XDH;KLF4;PDCD10;KDR;MYADM;APOE;CD34;HDAC1;HINFP;RBMS3;SUB1;MAP2K2;CRKL;CITED2;GATA2;LGMN;SLC2A10;AGO3;ZC3H12A;BMP2;ESR1;TTBK1;NOCT;TGFB2;MOV10;ID2;MAPT;AGO4;SH3GL2;PARP10;TLE5;LGALS9;RBL2
prerank,circulatory system development (GO:0072359),0.4271098246363912,1.3767168713996558,0.058343057176196034,0.7753751764744912,1.0,34/118,17.02%,STRA6;CXADR;NTRK3;PLCE1;PCSK5;PDLIM4;CDH5;GLI2;NF1;AKAP13;SMYD4;SOX9;FN1;MTHFD1;SH3PXD2B;COL3A1;ISL1;POU4F1;TAB2;POPDC3;PTEN;NXN;KDM6B;PKD1;HSPG2;SOX4;ERBB4;FOXF1;TNNI3;POU6F1;FOXC2;FGF12;FBXW7;PDLIM2
prerank,histone H3-K4 trimethylation (GO:0080182),0.6348633861502112,1.3766433188718437,0.14136125654450263,0.7733587814834479,1.0,3/11,3.72%,OGT;KMT2A;BEND3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5300653766257641,1.3760304341273948,0.11585365853658537,0.773269707386018,1.0,10/30,16.06%,CAV1;PTPRC;SRCIN1;INPP5F;SEMA4D;NF2;MVP;PTPN6;PIBF1;SOCS1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5090890839673204,1.3757243354652042,0.10709117221418235,0.7722179822345687,1.0,6/33,9.49%,MEOX2;ATP2B4;CARD10;STARD13;MECP2;HMGB1
prerank,cellular response to increased oxygen levels (GO:0036295),0.6157494561799477,1.375259060206658,0.14186851211072665,0.7717255213822443,1.0,1/11,0.24%,CAV1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5957214697144272,1.3742427049828723,0.13079470198675497,0.7734747788481648,1.0,4/15,5.71%,CDH13;CEACAM1;EGFR;FER
prerank,morphogenesis of an epithelium (GO:0002009),0.5450974769916656,1.3739791647290047,0.11969696969696969,0.7721717654109004,1.0,7/25,9.11%,RIPK4;WNT10A;ARHGAP12;SOX9;LAMA5;DAG1;TBX18
prerank,positive regulation of response to wounding (GO:1903036),0.5382787987278577,1.3738315788979705,0.11897590361445783,0.7704480751299051,1.0,5/24,10.37%,CLDN1;PRKCE;KANK1;OCLN;ADRA2A
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5485281723149166,-1.373656957266472,0.10141509433962265,0.5829897003243849,1.0,4/12,13.34%,FOXP1;LYN;FNIP1;NOC2L
prerank,response to progesterone (GO:0032570),0.5733496413931461,1.3735542141007036,0.14082278481012658,0.7691641082644894,1.0,4/18,8.59%,CAV1;SRC;CATSPERD;ACOD1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.5686102947757373,-1.3726920357278551,0.1070615034168565,0.5833323747997692,1.0,3/10,6.45%,RAPGEF2;LYN;CXCL12
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5003060755211333,1.3726633779572481,0.09843081312410841,0.770320187494919,1.0,5/39,1.42%,UTRN;SLMAP;NEDD4L;PRKCE;CAMK2D
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.4841227488148952,1.3726332290423553,0.10242587601078167,0.768213818485397,1.0,10/46,11.28%,DGKA;DDHD1;GPAT3;ACP6;DGKZ;SLC27A1;AGPAT4;LCLAT1;PLD1;AGPAT5
prerank,purine-containing compound salvage (GO:0043101),-0.5385401027925483,-1.372197605727071,0.12114014251781473,0.5821892623146766,1.0,2/12,3.33%,ADK;HPRT1
prerank,negative regulation of nuclear division (GO:0051784),0.6294416100042092,1.371938062766023,0.13756613756613756,0.7685921261636655,1.0,4/11,9.47%,FBXO43;TOM1L1;FBXO5;TOM1L2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5394964687323076,-1.3715133855343151,0.11764705882352941,0.5817039299165082,1.0,4/12,6.29%,PICALM;ROCK2;FKBP1A;APOE
prerank,response to interferon-gamma (GO:0034341),-0.3497661207036819,-1.370923262684615,0.037914691943127965,0.5807848805214924,1.0,25/67,28.12%,DAPK1;SP100;CXCL16;SIRPA;GBP3;GBP4;GCH1;BST2;RPL13A;GAPDH;GBP6;CCL13;GBP7;LGALS9;GBP2;CD40;PDE12;DAPK3;SHFL;CCL19;AQP4;KYNU;IRF8;CASP1;CIITA
prerank,response to gamma radiation (GO:0010332),-0.44384386801101716,-1.3700391548730912,0.08333333333333333,0.5808388642587258,1.0,13/24,27.27%,MAP3K20;WRN;RPL26;KDM1A;CRYAB;HSF1;TRIM13;HRAS;FANCD2;LIG4;DCUN1D3;PRKAA1;ATM
prerank,cellular response to chemical stress (GO:0062197),0.4342842277896033,1.3692529792947046,0.0591016548463357,0.776472270805946,1.0,19/96,13.79%,CAV1;PPARGC1A;LRRC8D;GPX8;MGAT3;ETV5;TRPV4;ERO1A;FOXO3;KEAP1;FANCC;SELENOS;SLC4A11;LONP1;STX2;NFE2L2;ATG7;BRF2;HTRA2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5848113663886749,1.3690352906467944,0.1266233766233766,0.7750902387432027,1.0,4/15,3.42%,TEC;EGFR;ITK;TXK
prerank,carboxylic acid catabolic process (GO:0046395),0.616055067247386,1.3684509692997209,0.14408233276157806,0.7751142299158447,1.0,5/12,14.46%,IL4I1;BCKDK;NAGK;ACOT8;GNPDA2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.43561101297429006,-1.3678548921757188,0.09146341463414634,0.5850605268590454,1.0,6/26,3.66%,IGF1;OSBPL8;INSR;PIK3R1;CREBL2;C2CD5
prerank,dendritic spine organization (GO:0097061),-0.43860157475329237,-1.3675826608442072,0.078125,0.5832183851741223,1.0,6/26,9.43%,IGF1R;INSR;SHANK3;CDC42;ITGA3;LGMN
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.6118621820029697,1.366861361778152,0.1343804537521815,0.7788327855116411,1.0,3/13,4.81%,TDG;UPP2;NTHL1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5428511656629247,1.3666389707902165,0.14106583072100312,0.7774212554444992,1.0,6/25,4.10%,SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B
prerank,myeloid cell differentiation (GO:0030099),-0.37781045187733675,-1.3658605068551841,0.057692307692307696,0.5862525116879904,1.0,22/47,32.34%,LYN;SNRK;MFHAS1;KIT;UBA5;JAK2;RPS19;CASP3;SLC25A38;TAL1;TET2;INHBA;RPS14;JAK3;RASGRP4;KMT2E;ALAS2;CEBPA;KAT6A;UFL1;EPO;CDKN2B
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.44716552279124216,-1.3653900804294707,0.1044776119402985,0.5824763084736284,1.0,8/23,17.04%,ZEB2;DAB2;EP300;CITED2;SNW1;SLC2A10;THBS1;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.44716552279124216,-1.3653900804294707,0.1044776119402985,0.5824763084736284,1.0,8/23,17.04%,ZEB2;DAB2;EP300;CITED2;SNW1;SLC2A10;THBS1;SMAD4
prerank,negative regulation of cytokine production (GO:0001818),0.41006928142052207,1.3633904994624648,0.05458515283842795,0.7879642636388912,1.0,26/163,10.19%,APOD;TRIB2;INHBB;HOMER2;CEACAM1;UBE2L6;BCL3;PCBP2;PTPN22;IRAK3;PTPRC;FN1;CHID1;TNFAIP3;ANXA4;N4BP1;SELENOS;RARA;PTGER4;ACOD1;CD200R1;FOXJ1;HMGB1;NPLOC4;AXL;TAX1BP1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5436519468794269,1.36315645591417,0.13149847094801223,0.7866776962859409,1.0,9/23,15.79%,TPTE;MTMR7;MTMR6;OCRL;INPP5F;MTMR3;PTEN;MTMR12;MTMR1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.43952407923246695,1.361972502751439,0.09382716049382717,0.788845953460491,1.0,10/75,6.83%,THBS4;CDH13;FGFR1;NRARP;NRP2;PRKCA;WNT5A;APLN;NRAS;EGFL7
prerank,regulation of membrane depolarization (GO:0003254),0.5706493479263586,1.3609167487654852,0.14285714285714285,0.7907365957315512,1.0,6/18,13.19%,NEDD4L;CAMK2D;SCN10A;SCN2B;ABCD1;FHL1
prerank,neuron migration (GO:0001764),-0.37339091758227777,-1.3602174802965086,0.052434456928838954,0.5961678196492464,1.0,17/48,14.97%,NAV1;RAPGEF2;MARK1;ADGRL3;CEP85L;NDNF;SPOCK1;ELP3;DCX;NR4A2;CDKL5;DCDC2;TUBB2A;MDGA1;MAP1B;CDK5R1;NRP1
prerank,small GTPase mediated signal transduction (GO:0007264),0.422025245639634,1.3595334133094577,0.07547169811320754,0.7937542124190804,1.0,21/103,11.23%,PLK2;NTN1;TIAM2;ARHGAP31;PLCE1;USP50;ARHGAP18;ARHGAP32;RGL1;MRAS;NF1;NUCB1;USP8;NRAS;KRAS;RREB1;RAPGEF6;KSR2;LAT;ADRA2A;PLD1
prerank,translation (GO:0006412),-0.29260084439120326,-1.3585456776218257,0.0,0.5988328376544539,1.0,85/208,25.05%,RPL37A;RRBP1;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RPS24;RPLP0;HARS1;RPS19;HBS1L;RPL31;QRSL1;RPL41;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;RPLP1;YARS1;RPS17;EEF1D;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;RPS8;RPS12;RPL18A;ABCE1;RPS21;MRPL32;MRPL18;APEH;RARS1;NOA1;EEF1B2;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;MRPL9;MRPL28;PPA1;EEF1E1;GSPT2;MRPS11;MRPS16;RPL14;MRPS18B;QARS1;RPS2;MRPL42;GATC;RPL10A;RPL39;RPL34;RPL5;MRPS12;RPL22;MRPL55;EEF2;MRPS34;RPS9;MRPL36;RPS14;TRMT112;RPS25
prerank,positive regulation of integrin activation (GO:0033625),0.6317726688261244,1.3577813436912762,0.15478260869565216,0.7982997448541888,1.0,5/11,10.07%,CDH17;SRC;PIEZO1;PLEK;FERMT2
prerank,phosphatidic acid metabolic process (GO:0046473),0.47432779900747113,1.3577385418165466,0.10533333333333333,0.796233422030458,1.0,10/48,11.28%,DGKA;DDHD1;GPAT3;ACP6;DGKZ;SLC27A1;AGPAT4;LCLAT1;PLD1;AGPAT5
prerank,linoleic acid metabolic process (GO:0043651),0.5733832757733119,1.3576525560995296,0.13366336633663367,0.7943371024866263,1.0,6/17,12.77%,ELOVL5;ALOXE3;ELOVL1;ELOVL2;ABCD1;PNPLA8
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.40684866081069404,-1.3575043639394175,0.0926517571884984,0.5995534040777228,1.0,9/33,15.54%,IGF1;OMA1;TFRC;AKT1;ACAA2;FXN;MAPT;GHITM;OPA1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5084885646733812,-1.3571283531509986,0.11764705882352941,0.5980641456138464,1.0,8/15,29.81%,IGF1;AKT1;FXN;GHITM;OPA1;CLU;PSMD10;TRIAP1
prerank,modulation by symbiont of entry into host (GO:0052372),0.5728203662129925,1.356460697367572,0.1650485436893204,0.7966089727159917,1.0,4/16,15.72%,CAV1;TRIM21;HS3ST5;TRIM5
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5573443200260881,1.3562308326411512,0.13943028485757122,0.7952597361500278,1.0,4/21,5.76%,DCN;CSPG4;CHST7;NCAN
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.4815122837494715,-1.3550608275046456,0.125,0.6024629144852437,1.0,4/17,6.63%,ITGA1;PDGFRB;PPP1R12A;CALM1
prerank,mononuclear cell differentiation (GO:1903131),-0.44014841713009134,-1.3545398507024198,0.11370262390670553,0.6015994805950251,1.0,8/24,18.52%,IL31RA;LYN;BMP4;MT1G;PIR;PDE1B;TRPM2;MYH9
prerank,amino acid transport (GO:0006865),-0.3819606583138726,-1.3541087481205167,0.06130268199233716,0.6002666361786888,1.0,18/49,24.62%,SLC7A11;SLC6A6;SLC7A5;SLC7A1;SLC38A11;SLC7A6;SLC43A2;SLC38A7;SLC25A47;SLC3A2;SLC38A5;SLC25A29;SLC1A4;SLC6A17;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5344977725759924,1.353910907851514,0.13097072419106318,0.8019066641197629,1.0,10/25,17.85%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ADPGK;ENO3;GCK;PGK1;ENO2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6140758909100481,1.353588287086307,0.14091680814940577,0.8009025040166639,1.0,2/11,1.69%,DLC1;FAP
prerank,negative regulation of chemokine production (GO:0032682),0.6117101122072559,1.3535815576205414,0.1407035175879397,0.7987321921392005,1.0,1/14,0.19%,APOD
prerank,positive regulation of glucose import (GO:0046326),-0.4616519222363719,-1.3532465466897536,0.12462908011869436,0.6005004687687533,1.0,5/21,2.55%,IGF1;OSBPL8;INSR;PIK3R1;CREBL2
prerank,lung development (GO:0030324),0.50076757591251,1.353216765203713,0.12099125364431487,0.7979262419386305,1.0,4/33,2.92%,STRA6;FGF7;FGF1;GLI2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5054861235612176,-1.3512074606211744,0.12781954887218044,0.6045048802314418,1.0,9/16,33.90%,AGTR1;PDCD10;GATA2;THBS1;APLNR;DLL4;PPP1R16B;HMOX1;JCAD
prerank,androgen metabolic process (GO:0008209),0.575145328233356,1.3505779021351905,0.1546707503828484,0.8060184718810653,1.0,2/18,7.98%,HSD17B3;HSD17B4
prerank,regulation of chromatin organization (GO:1902275),-0.5008608829659333,-1.3500277004634684,0.12028301886792453,0.6057034541767959,1.0,5/14,7.05%,SETD5;IGF2;PARG;SETD1A;CDK9
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.38516872886356546,1.3489133158394377,0.011258955987717503,0.810288065539808,1.0,43/390,7.09%,NGF;ROR2;GAB1;ROR1;EFNA5;FGF7;SIPA1L1;NTRK3;ARHGEF28;UBASH3B;SORBS1;FGFR1;PXN;SH2D2A;RGS14;SULF1;EGFR;MUSK;EFNB1;CYFIP2;FGF1;NRP2;DOCK1;GPLD1;RBFOX2;SPRED1;GIGYF2;APH1B;CAV2;EIF2AK3;VAV2;SRC;DNM1;ATP6V0D2;KIF16B;PDK4;FER;NCSTN;EPHB2;NCK2;SHB;LCP2;EFNB2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5329204808343186,-1.3486745029636855,0.13559322033898305,0.6048312816433726,1.0,4/12,8.51%,IGF1;CAMTA1;AKAP6;SLC9A1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5329204808343186,-1.3486745029636855,0.13559322033898305,0.6048312816433726,1.0,4/12,8.51%,IGF1;CAMTA1;AKAP6;SLC9A1
prerank,regulation of acrosome reaction (GO:0060046),-0.56209388731839,-1.3481132504068205,0.13347921225382933,0.6039738053696654,1.0,1/10,0.08%,PLCB1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.6409424852562614,1.3478498262340133,0.15703971119133575,0.8123053966519593,1.0,1/10,0.21%,ETV4
prerank,sterol biosynthetic process (GO:0016126),-0.40852340123834585,-1.346759336110781,0.09034267912772585,0.6057260659190877,1.0,11/33,19.79%,PRKAG2;INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7
prerank,copper ion homeostasis (GO:0055070),-0.48312132632896176,-1.3456862897081343,0.13043478260869565,0.6065935469877262,1.0,4/17,5.15%,ATP7A;COMMD1;SLC31A1;SLC31A2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2797536092377871,-1.3452522774202784,0.0,0.6055286459142024,1.0,122/306,25.07%,RPL37A;RRBP1;CREBL2;WRN;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;TOP3A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RBMS1;BLM;RPS24;APOE;RPLP0;ATRIP;MEF2A;HARS1;PTMA;MCM6;RPS19;HBS1L;RPL31;RPL41;RPL13A;RPL30;ORC2;RPL29;MRPS6;RPS16;RPL3;NR4A2;RPLP1;RRAGC;RPS17;EEF1D;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;POLR3A;RPS8;POLA1;RPS12;MMS19;RPL18A;RPS21;MRPL32;CLSPN;CDC7;MRPL18;TOPBP1;RAD1;GCNT1;EEF1B2;BARD1;RPS18;RPLP2;EIF4G1;TIPIN;RPS6;RPS15A;MRPL9;MRPL28;PWP1;RNPS1;HOXD3;RAD17;POLR2F;GSPT2;RFC2;MRPS11;POLR2A;POLR2J;RAD9B;GAL3ST2;POLR2D;MRPS16;POLR2K;RPL14;MRPS18B;TIMELESS;RPS2;TOP1MT;MRPL42;RPL10A;THAP1;INHBA;THRB;ALAS1;RPL39;RPL34;RPL5;MRPS12;FUT9;RPL22;MRPL55;POLD2;EEF2;RPS9;RMI2;CDC45;MRPL36;RPS14;POLA2;CDK2;BRCA1;RPS25;PCLAF
prerank,glycogen metabolic process (GO:0005977),-0.4309020970496278,-1.345160639287252,0.10632183908045977,0.603399644458965,1.0,10/27,17.91%,PRKAG2;PGM2L1;CALM1;GBE1;UGP2;AGL;PPP1R3C;PHKG1;PYGB;PER2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3743725611422338,-1.3450911133310883,0.0782312925170068,0.6010884052260386,1.0,15/45,17.04%,ENG;RBPMS;BMP6;DAB2;BMP4;TGFBR1;ACVRL1;BMPR2;TGFB3;BMP2;TGFB2;HFE;CSNK2B;TWSG1;SMAD4
prerank,regulation of NMDA receptor activity (GO:2000310),-0.41638113539511956,-1.3450114974470502,0.08783783783783784,0.5988840150637299,1.0,8/32,9.11%,DAPK1;ACTN2;SLC6A9;GRIA2;NEFL;GRIN2B;CAMK2A;GRIN1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.581529960994986,1.3448717442983857,0.13741721854304637,0.8217426699413081,1.0,2/15,2.06%,SMOC2;FGF1
prerank,negative regulation of viral life cycle (GO:1903901),-0.5059580300919029,-1.3447763842513027,0.14615384615384616,0.5971998557404191,1.0,3/15,7.81%,LY6E;MID2;BST2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.48347900706026326,1.344532280785238,0.13096862210095497,0.8209008307444229,1.0,7/44,12.99%,NGF;SRC;SFN;RPS6KA3;USP47;DHCR24;AQP1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.631387527728874,1.3440809159050733,0.14685314685314685,0.8204106648513083,1.0,3/10,1.42%,NEDD4L;PRKCE;CAMK2D
prerank,regulation of catabolic process (GO:0009894),0.5565739280711951,1.3437722074367129,0.1515625,0.8194363893671578,1.0,5/18,12.13%,NEDD4L;FAP;FAM83D;ZDHHC7;FAF1
prerank,regulation of leukocyte activation (GO:0002694),-0.5172637301707267,-1.3436466075671907,0.12051282051282051,0.598154261128229,1.0,6/14,13.76%,LYN;MFHAS1;CD200;GPR137B;MYO18A;PJA2
prerank,regulation of blood coagulation (GO:0030193),0.5231732603809518,1.3435067343743405,0.1430722891566265,0.8183171761477197,1.0,3/27,1.69%,CAV1;ST3GAL4;FAP
prerank,regulation of myoblast fusion (GO:1901739),0.6141303426190261,1.3409613268766316,0.15,0.8258860261953254,1.0,3/11,6.93%,RIPOR2;CD53;EHD2
prerank,regulation of protein kinase activity (GO:0045859),0.42212793354255873,1.3408805545154718,0.08816705336426914,0.8240039777178373,1.0,19/106,11.08%,TRIB2;UBASH3B;PLCE1;CEACAM1;RAP1A;SPRED1;NF1;PRKAG1;MMD2;GNAQ;PTPRC;LCP2;SFN;RASSF2;LAT;CEP85;RELN;RTRAF;TAB2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3931605278205367,-1.3408771026124373,0.08417508417508418,0.6045579471775536,1.0,11/39,9.43%,ITGA1;TGFA;ERRFI1;PTPN3;RNF115;CDC42;ZFYVE28;DUSP3;SH3KBP1;EPS15;LGMN
prerank,positive regulation of cell junction assembly (GO:1901890),0.4584473612062796,1.3407000117153756,0.10225763612217796,0.8225365138388756,1.0,6/56,8.21%,CLSTN2;CAV1;CLDN19;CLSTN3;EPHB2;PTPRJ
prerank,response to ATP (GO:0033198),-0.4799492059997939,-1.340517279517014,0.11263736263736264,0.6032581960516703,1.0,7/18,27.71%,TRPC3;ABCC9;P2RX7;P2RX4;CIB2;P2RY12;P2RY1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.32715549965702617,-1.340137146742602,0.03260869565217391,0.6020368894331335,1.0,37/84,20.32%,SASH1;TEK;ETS1;ANXA3;ROCK2;ANGPT1;NOS3;SPARC;FOXP1;BMP4;AKT3;BMPR2;HIF1A;KDR;AKT1;GATA2;LGMN;AAMP;ZC3H12A;RHOB;PROX1;SP1;FLT4;THBS1;MAP2K3;TMSB4X;EDN1;NRP1;P2RX4;RIN2;EGF;HSPB1;CD40;AGT;BCAR1;MET;GFUS
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4968815959973491,1.3399703715185955,0.13736263736263737,0.8232456142675503,1.0,10/35,15.73%,NR3C2;RBFOX2;PGR;SRC;UBR5;DDX17;TMF1;NEDD4;GPER1;YAP1
prerank,primary alcohol metabolic process (GO:0034308),-0.4285535927964236,-1.3387784625531587,0.11275964391691394,0.6037197981821274,1.0,5/25,4.13%,IGF1;GPD2;RBP4;CYP1B1;NAPEPLD
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5050264453770307,1.3381113455284168,0.1228813559322034,0.828153743259552,1.0,8/32,9.83%,MYBBP1A;PPP1R13B;BCL3;FHIT;PHLDA3;HIPK1;MSH2;POU4F1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6416519687280202,1.3380256764748995,0.1487758945386064,0.8263150557195598,1.0,3/10,4.10%,PKDCC;SOX9;BMPR1B
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4332040439440431,1.338002736393968,0.09035409035409035,0.8242108803922322,1.0,25/85,18.76%,ROR2;PRICKLE1;PRICKLE2;FZD2;PSME3;WNT5A;PSMB5;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,Golgi to endosome transport (GO:0006895),-0.49145892793635704,-1.3379097731087948,0.14175257731958762,0.6039096117098808,1.0,11/16,27.02%,AP2A1;VPS13C;WIPI1;DOP1B;EPS15;SORT1;MON2;SYS1;AP1AR;CORO7;KLHL20
prerank,heart morphogenesis (GO:0003007),-0.35756376778958193,-1.3378555109283072,0.07883817427385892,0.6016654540238985,1.0,15/50,14.54%,ENG;INSR;TGFBR3;NOS3;CHD7;FKBP1A;TBX3;TGFBR1;ACVRL1;TBX1;SOX17;BMP2;TGFB2;MEGF8;PTK2
prerank,regulation of MAPK cascade (GO:0043408),0.40369530489420924,1.337439864190334,0.07789232531500573,0.8242785622859519,1.0,25/157,9.49%,ROR2;CAV1;ROR1;NTRK3;FGFR1;LPAR1;CEACAM1;EGFR;PELI2;MINK1;SPRED1;NF1;CAV2;FAM83D;PTPRC;FN1;STYX;ULK4;ARHGEF5;DAG1;PHLPP1;PIK3R2;PTPRJ;STK3;HMGB1
prerank,arachidonic acid secretion (GO:0050482),-0.5618839161237452,-1.337332884055274,0.13151927437641722,0.5986034711547394,1.0,3/10,7.39%,ACE;BDKRB2;ANXA1
prerank,arachidonate transport (GO:1903963),-0.5618839161237452,-1.337332884055274,0.13151927437641722,0.5986034711547394,1.0,3/10,7.39%,ACE;BDKRB2;ANXA1
prerank,response to iron ion (GO:0010039),-0.5344763094193277,-1.3360167575834376,0.1288056206088993,0.6003376776813129,1.0,6/12,16.13%,BMP6;B2M;HIF1A;SLC11A2;FXN;HFE
prerank,inositol lipid-mediated signaling (GO:0048017),0.4629219033150798,1.3357213464269226,0.13150684931506848,0.8287736679494271,1.0,7/50,3.86%,NGF;FGFR1;PLCD3;PLCE1;PLCB3;OGT;PLCL1
prerank,negative regulation of heart contraction (GO:0045822),0.6098890673891869,1.3356818858511252,0.14893617021276595,0.8267818667907824,1.0,3/11,5.19%,PDE4D;FKBP1B;ATP1A2
prerank,xenobiotic transport (GO:0042908),-0.4886877485665868,-1.335298221798194,0.12244897959183673,0.6002503659715381,1.0,7/17,10.05%,SLC47A1;ABCG2;SLC7A5;GJA1;SLC22A4;SLC15A2;SLC22A18
prerank,cell-cell junction assembly (GO:0007043),0.453610082214316,1.335215124198987,0.11083123425692695,0.826487447157164,1.0,11/63,4.42%,CLDN11;TLN2;CDH11;EPB41L3;PARD6B;CDH5;CDH9;TRPV4;CD9;PRKCA;CNTNAP1
prerank,autonomic nervous system development (GO:0048483),0.5690128341307925,1.3349447203712086,0.17096774193548386,0.8254671562852038,1.0,5/17,13.45%,NF1;FN1;SEMA3A;KIF26A;SOX4
prerank,central nervous system neuron development (GO:0021954),-0.5022196843767189,-1.334851201462749,0.1417910447761194,0.5993335466915024,1.0,5/15,14.31%,RAPGEF2;ATP7A;ARHGAP35;GBA2;MAPT
prerank,positive regulation of cell communication (GO:0010647),0.5147964324301211,1.334791122036994,0.13537117903930132,0.8239587723615943,1.0,3/28,6.58%,CLSTN2;CLSTN3;RIMS2
prerank,female gonad development (GO:0008585),0.557964150348923,1.3336090177191293,0.16253869969040247,0.826310389645676,1.0,2/19,0.77%,INHBB;NR2F2
prerank,establishment of melanosome localization (GO:0032401),-0.45228147605232727,-1.3334533086815774,0.12396694214876033,0.6014910591460239,1.0,9/19,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,neurotransmitter uptake (GO:0001504),0.6166093830740607,1.3334064920484001,0.1565217391304348,0.8249543443704842,1.0,5/12,6.69%,SLC1A7;SLC29A4;SLC22A3;ATP1A2;SLC1A6
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5323247898615757,-1.33275162102108,0.125,0.6013872297437747,1.0,9/12,40.87%,AKT1;PPP1R3B;PPP1R3C;RUBCNL;KHK;PPP1R3E;PPP1R3F;PPP1R3D;GCGR
prerank,epithelial cell-cell adhesion (GO:0090136),0.6070068927040387,1.3326156512989358,0.1746880570409982,0.8261058666829133,1.0,1/11,0.16%,THBS4
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5504164051079659,1.3321088388958038,0.15161290322580645,0.8260091752470273,1.0,6/18,7.68%,DLC1;RIPOR2;SCAI;ABL2;KANK1;CUL3
prerank,aorta development (GO:0035904),-0.5013862114592804,-1.331261207547928,0.12335958005249344,0.603819834199816,1.0,5/14,9.40%,ROBO1;PDGFRB;LRP1;TBX1;PDE2A
prerank,cell junction organization (GO:0034330),0.44489587361373556,1.3311475059498836,0.11458333333333333,0.8276607175099336,1.0,7/71,3.66%,CLDN1;CXADR;LRP4;RAB8B;PPFIA2;TJP2;OPHN1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.48259481591990233,1.3310195708023238,0.14326241134751774,0.8260387503987374,1.0,11/39,15.22%,EFNA5;JAG1;AJAP1;CASK;SPRY4;KANK1;GCNT2;NF2;FZD7;PTPRO;PLG
prerank,collagen fibril organization (GO:0030199),0.42906088617251276,1.3303222831422297,0.10225921521997622,0.82654397383483,1.0,8/88,4.90%,ITGB4;ITGA6;ADAMTS14;PXDN;COL6A3;NF1;COL5A3;SERPINH1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5626053187374932,1.3301066267298451,0.15066225165562913,0.825323992159431,1.0,6/17,16.38%,CEACAM1;DGKZ;PTPN22;PTPRJ;SH2D1A;EZR
prerank,regulation of RNA metabolic process (GO:0051252),0.440430745234779,1.3296325639640607,0.1141732283464567,0.8250461296139517,1.0,13/59,14.85%,AHNAK;AHNAK2;CLK1;PCBP2;CELF1;ZNF326;SON;CLK4;IGF2BP2;PTBP3;PTBP2;RBM38;TRA2B
prerank,negative regulation of macrophage activation (GO:0043031),-0.4821897635215008,-1.3291543588148231,0.1361111111111111,0.6080028071151219,1.0,5/16,10.21%,IL31RA;NR1H3;LDLR;CD200;ZC3H12A
prerank,BMP signaling pathway (GO:0030509),-0.35342585812286054,-1.3284046544655363,0.05416666666666667,0.6082630953491427,1.0,15/62,13.17%,ENG;SMAD3;BMP6;SMAD6;TGFBR3;BMP4;SMAD9;ACVRL1;BMPR2;SMAD5;TGFB3;SLC33A1;BMP2;TGFB2;MEGF8
prerank,muscle organ development (GO:0007517),0.45279954238625014,1.3281257074078356,0.11548556430446194,0.8290039666396892,1.0,10/54,5.73%,UTRN;LAMA2;SGCD;COL6A3;MRAS;ITGA7;SGCG;CHD2;CACNA1H;ANKRD2
prerank,cellular sodium ion homeostasis (GO:0006883),0.578878209022294,1.32805621381342,0.17560975609756097,0.827175544892903,1.0,4/15,9.40%,NEDD4L;SLC12A2;ATP1A2;ATP1B3
prerank,phospholipid dephosphorylation (GO:0046839),0.4894456616727351,1.3280242310226995,0.125,0.8252295898010231,1.0,12/37,15.79%,PLPP2;TPTE;PLPP3;MTMR7;MTMR6;OCRL;INPP5F;MTMR3;PTEN;MTMR12;PLPPR1;MTMR1
prerank,lipoprotein catabolic process (GO:0042159),-0.5438035214604089,-1.3273004799877435,0.13012048192771083,0.6094313748453717,1.0,6/11,14.11%,APOE;LYPLA1;NOTUM;CTSD;ABHD17B;LYPLAL1
prerank,iron ion transport (GO:0006826),-0.37057995475354477,-1.3266398206149104,0.06640625,0.6091283927326624,1.0,16/47,19.98%,STEAP3;FTH1;TFRC;SCARA5;ATP6V0A4;SLC11A2;ARHGAP1;SLC39A14;ATP6V0C;ATP6V1C1;SLC40A1;HFE;ATP6V1D;TTYH1;RAB11B;ATP6V1F
prerank,myotube differentiation (GO:0014902),-0.4808100431706378,-1.3257641690020663,0.12158808933002481,0.609445385607279,1.0,8/17,21.03%,IGF1;ADAMTS5;KCNH1;ADAMTS15;SORT1;MYEF2;NOS1;ADAM12
prerank,regulation of protein import into nucleus (GO:0042306),0.4815150962863484,1.3249941864676416,0.13768115942028986,0.8344363809731384,1.0,6/36,8.05%,APOD;MDFIC;UBR5;BAG3;RBM22;PIK3R2
prerank,positive regulation of immune system process (GO:0002684),-0.4861497430855408,-1.3247801645986759,0.14805825242718446,0.6101207269832365,1.0,5/16,22.17%,ANXA1;TGFB2;LGALS9;RSAD2;NCKAP1L
prerank,cellular glucose homeostasis (GO:0001678),0.47765020201588987,1.3247530300254817,0.13342503438789546,0.8332523218600142,1.0,15/41,15.58%,PPARGC1A;LRRC8D;HK2;ZBTB20;FOXK1;PIK3R2;FOXK2;ERN1;GCK;SOX4;NUCKS1;UNC13B;TRA2B;GPER1;ADCY8
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3856763850148498,-1.3242435151055065,0.09602649006622517,0.6095226066202346,1.0,7/35,8.47%,PICALM;HIP1;TNK2;B2M;HNRNPK;HIP1R;LDLRAP1
prerank,positive regulation of protein catabolic process (GO:0045732),0.4312645307471017,1.323778368572099,0.10891089108910891,0.8348751787824569,1.0,22/84,17.81%,PLK2;GPC3;VGLL4;NEDD4L;AXIN1;GPLD1;DACT1;WNT5A;TNFAIP3;RDX;GSK3B;ADRA2A;APC;NEDD4;FAF1;ATG7;WWP2;FZR1;EZR;ITCH;VPS11;STX5
prerank,cellular response to nitrogen compound (GO:1901699),-0.45157832138908016,-1.3230916811838438,0.11286089238845144,0.6109592465577925,1.0,10/20,21.44%,ROCK2;BLM;EPG5;HSF1;DDI2;NSMCE3;PDE12;TIMELESS;NR1H4;RIOK3
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.4675849224700048,-1.3230473388780373,0.13895781637717122,0.6088139198425406,1.0,6/16,20.15%,NUPR1;ATP7A;VCP;SLC25A33;PDE12;COX7A2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4448682263031707,-1.3225133386212997,0.13020833333333334,0.6082398283841507,1.0,6/21,10.68%,PRKCH;FOXP1;LYN;SLC39A10;ELF2;LPXN
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5034514930988517,1.321842921218928,0.14506172839506173,0.8402387033086497,1.0,4/27,3.58%,AHNAK;CAMK2D;PDE4D;FKBP1B
prerank,striated muscle tissue development (GO:0014706),0.5121941568074042,1.3217390607861927,0.15348837209302327,0.8385833952555378,1.0,8/29,12.65%,CAV1;SGCD;SGCG;CSRP3;BMP5;TBX2;POPDC3;NDUFV2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5357710966080647,-1.32152036535032,0.16473317865429235,0.6089738078010405,1.0,4/10,10.52%,GLI3;BMP4;IRF1;ZC3H8
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.494885394748224,1.3214118113750122,0.13839285714285715,0.8377775088110294,1.0,7/26,17.54%,EFNA5;GPLD1;ADCY5;ADRA2A;ADCY8;STX4;KLF7
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5798194650789478,1.3213176107382658,0.16139767054908485,0.8360971886861448,1.0,5/14,12.75%,EHHADH;DECR2;HSD17B4;ACOT8;ABCD1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.446281628992054,-1.321251998211463,0.13186813186813187,0.6075234884622442,1.0,8/22,17.34%,AEBP1;HSPA8;APOE;CAMSAP1;GBA2;MAP1B;MAPT;ARL2
prerank,cognition (GO:0050890),0.48683570872132736,1.3209260741620514,0.13585434173669467,0.8355566290862577,1.0,4/42,3.23%,STRA6;ST3GAL4;MGAT3;NF1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.46611204960484837,-1.32080796230746,0.13131313131313133,0.606625490532561,1.0,5/17,8.19%,ROBO1;SLIT2;PIK3R3;KDR;AKT1
prerank,regulation of protein neddylation (GO:2000434),-0.5714435338515664,-1.3207548191985148,0.14666666666666667,0.6045227687574038,1.0,9/10,40.78%,HIF1A;EPAS1;DCUN1D4;RPL5;DCUN1D3;RPL11;DCUN1D5;COPS9;DCUN1D1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4407456413172191,-1.3204025021515051,0.1276595744680851,0.6034287527354618,1.0,10/22,25.47%,PAXIP1;MED17;SUB1;MED24;ESR1;DHX36;MED14;MED30;SRF;PSMC5
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5658852575720984,1.3203981322046667,0.16773162939297126,0.8356014451336431,1.0,7/16,19.33%,CDK13;DDX17;CELF4;HNRNPM;SFPQ;SLU7;DHX9
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.41046687215675703,-1.3201454537007011,0.13015873015873017,0.6020318137170868,1.0,6/30,6.22%,FLT1;BMP4;KIT;HOXB4;ACE;KDR
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4447749546747944,1.3190669353392503,0.1227390180878553,0.8385434431902938,1.0,8/62,6.66%,NGF;F11R;LPAR1;RTN4R;AKAP13;MMD2;LRRC59;COL3A1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5479152638632009,-1.3188470474806362,0.1558139534883721,0.6037503960921207,1.0,3/10,6.94%,GHR;LYN;JAK2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5781617620759019,1.3184374768700664,0.15384615384615385,0.838994007402155,1.0,2/14,4.46%,HNRNPC;HNRNPA0
prerank,regulation of gastrulation (GO:0010470),-0.5044315807553067,-1.318423335078178,0.1575,0.6028171500447006,1.0,2/14,1.09%,PHLDB2;OSR1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5229566863044504,1.3182732145653193,0.15870570107858242,0.8376180938928182,1.0,3/26,4.23%,CAV1;LBP;PTPN22
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5185640353213021,1.3179756300250458,0.16793893129770993,0.8367441397697589,1.0,8/25,15.24%,LEO1;CDK13;ELL;NELFB;SUPT4H1;HEXIM1;TCERG1;RECQL5
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.6239194885589804,1.3178884060709717,0.17258883248730963,0.8350675287501287,1.0,2/10,4.99%,CEACAM1;PTPRC
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.34691110893389115,-1.317199065785347,0.07604562737642585,0.6043021053611083,1.0,17/56,17.04%,ENG;RBPMS;BMP6;SMAD6;DAB2;BMP4;TGFBR1;ACVRL1;BMPR2;TGFB3;BMP2;TGFB2;BMPER;HFE;CSNK2B;TWSG1;SMAD4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5085867726541833,1.317170951308953,0.14391691394658754,0.8358974605498594,1.0,6/29,13.03%,DHX34;DND1;TENT5C;AXIN2;TENT5D;TAF15
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4924392279792139,1.31708658524374,0.15451895043731778,0.8342083892761641,1.0,10/34,15.20%,UBASH3B;PTPN13;PTPRF;PTPN22;PTPRJ;PTPRT;PTPN18;DUSP8;PTPRO;PTPN6
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5181534293864115,-1.3165227809034088,0.1488833746898263,0.6041315163605835,1.0,7/12,28.70%,NOTCH2;DOCK11;LFNG;MFNG;FCGR2B;DLL1;DOCK10
prerank,cGMP-mediated signaling (GO:0019934),-0.5126135919878475,-1.3154761516177351,0.16266666666666665,0.6051914542340168,1.0,3/13,9.40%,IRAG1;APOE;PDE2A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4833470822084747,-1.315346173634321,0.13554987212276215,0.6034256812538402,1.0,4/15,6.34%,PDGFRA;TGFBR1;FGFR2;TBX1
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.34547285587915866,-1.3152384466014513,0.06451612903225806,0.6016005857643609,1.0,23/66,19.53%,FLT1;PDGFD;ROBO1;SASH1;PDGFRB;KIT;PDCD10;TRAF6;PIK3R6;MAP3K10;IL34;RPS3;LRRK2;TNFRSF11A;EDN1;EDN3;DVL2;EGF;CD40;DIRAS2;TPD52L1;CD24;MST1R
prerank,cellular metal ion homeostasis (GO:0006875),0.4203960361188394,1.3142018724349207,0.09334889148191365,0.8429436314408102,1.0,12/102,5.19%,CAV1;STC2;NEDD4L;CTRC;SLC12A2;SLC8B1;CDH5;SLC24A1;TRPV4;CSRP3;ATP2B4;ATP1A2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.41696828956068765,-1.3141727084007029,0.10086455331412104,0.6027814615103394,1.0,7/26,8.78%,ROCK2;SHANK3;SYNPO2;CDC42;ASAP3;SLC9A1;ACTG1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5238871975458921,1.3141579584596081,0.1700787401574803,0.8410841576063854,1.0,1/22,0.14%,AHNAK
prerank,regulation of cell motility (GO:2000145),0.4084127637196371,1.3135832031579895,0.08912037037037036,0.841168459075457,1.0,20/121,8.86%,FGF7;NTN1;CEACAM1;ARHGAP18;LDB2;EGFR;KIF2A;FGF1;PARD6B;AMOTL1;MGAT3;MINK1;LMO4;PLXNA3;CAVIN1;AMOT;ABL2;SRCIN1;FGF18;INPP5F
prerank,fibrinolysis (GO:0042730),0.587801271071496,1.3135796002426425,0.17565217391304347,0.8391746135699917,1.0,1/13,0.68%,SERPINB2
prerank,regulation of receptor internalization (GO:0002090),-0.37944164382976636,-1.3130898820138492,0.10576923076923077,0.6038431430306919,1.0,13/35,25.49%,INSR;ANGPT1;ANKRD13A;AHI1;EGF;FLOT1;PICK1;MKLN1;NTF3;GREM1;ANKRD13D;RIN3;ARRB2
prerank,positive regulation of cellular component organization (GO:0051130),-0.31367410119391964,-1.3130837874723367,0.02564102564102564,0.601739697626192,1.0,33/107,12.75%,ASAP1;IGF1R;TRABD2B;INSR;ATP10A;SHANK3;LRP1;DAB2;TGFBR1;TFRC;BCL2L11;FNIP1;TMED9;FNIP2;APOE;FRMPD4;RHOC;SLF2;TGFB3;SH3GLB1;NOX1;SURF4;VCP;SLF1;RPS3;AR;AJUBA;CLIP3;BID;MMP1;MPP7;NRXN1;TGFB2
prerank,lipid oxidation (GO:0034440),0.6086124757202722,1.3129006198834028,0.17962003454231434,0.8398670627479666,1.0,1/12,0.58%,PPARGC1A
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5303692984888037,-1.3124481269170767,0.16273584905660377,0.6013501284483165,1.0,6/11,35.89%,AGTR1;ABCG1;AGT;PLA2G7;LIPC;PLA2G5
prerank,regulation of dopamine secretion (GO:0014059),-0.43389793832847345,-1.3120555794293476,0.14367816091954022,0.6004497816049741,1.0,18/25,43.51%,SYT9;SYT7;DTNBP1;SYT13;SYT6;KCNA2;CHRNA4;SYT15;SYT1;SYT5;SYT17;CHRNB2;SNCA;SYT4;SYT3;DRD3;FGF20;SYT8
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.47782797391490506,-1.31169226701581,0.12121212121212122,0.5994501993621408,1.0,4/16,6.29%,NOS3;NDNF;DDAH1;APOE
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3931561715121802,-1.3115136658829438,0.11875,0.597865822658504,1.0,20/33,34.40%,ACER2;LYN;CYP1B1;EPHA8;RET;NEXMIF;TGFB2;PTK2;NCKAP1L;FERMT3;CIB1;RAC3;PLAU;PDE3B;P2RY12;JAM3;ADA;SNAI2;HRG;SERPINE1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4484673597865477,1.311117269045575,0.11081794195250659,0.8446119793035666,1.0,18/57,20.63%,DCN;PPARGC1A;DDHD1;CIDEB;FIS1;MIEF1;GSK3B;HTRA2;HTT;GPER1;BAD;BNIP3;RALBP1;PINK1;BAX;RALA;PRKN;MUL1
prerank,regulation of endocytosis (GO:0030100),0.4415083151741719,1.3107269188456985,0.13559322033898305,0.844039402894343,1.0,13/61,10.09%,GPC3;CDH13;NEDD4L;OPHN1;TFR2;SRC;LRSAM1;ZFYVE16;STON1;ABL2;PACSIN2;STON2;CALY
prerank,megakaryocyte differentiation (GO:0030219),-0.5379218315785307,-1.3106479099554054,0.16589861751152074,0.5982785409149572,1.0,3/11,13.79%,KIT;UBA5;TAL1
prerank,endosome organization (GO:0007032),0.4744665399776008,1.3106108684224378,0.14265734265734265,0.8424891425156033,1.0,14/41,17.52%,USP50;HOOK2;PI4K2B;PHETA2;DNM1;USP8;SNX10;HOOK3;LAPTM4B;PI4K2A;ANXA8;ANXA8L1;ALS2;VPS11
prerank,amyloid-beta metabolic process (GO:0050435),0.5625727534663575,1.3104021350131345,0.16831683168316833,0.8412817708389818,1.0,6/16,10.88%,MGAT3;APH1B;NCSTN;DYRK1A;BACE2;MME
prerank,negative regulation of angiogenesis (GO:0016525),0.4254847604108154,1.3103858307684606,0.12285012285012285,0.8393796190551711,1.0,9/84,5.10%,DCN;THBS4;SULF1;SLC12A2;ADAMTS1;SPRED1;ATP2B4;AMOT;CREB3L1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5007658533079119,-1.310271830314202,0.14320987654320988,0.5972966641084888,1.0,4/14,9.97%,DMD;ATP1B1;SLC9A1;ANK3
prerank,positive regulation of cytokinesis (GO:0032467),0.4928868261239236,1.3097660496215253,0.1744868035190616,0.8397058615700402,1.0,10/32,13.55%,PRKCE;KIF20B;RACGAP1;SPAST;OPN1MW;CSPP1;CUL3;PKP4;CDC6;CIT
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.5054283146487173,-1.3097075542713372,0.15402843601895735,0.5969687646756757,1.0,6/13,9.58%,ATG10;UBA5;UBA3;UBA2;NAE1;UBA7
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5873560317174981,1.3096430441856304,0.18092105263157895,0.8381977537062524,1.0,6/13,13.29%,ELOVL5;HACD4;ELOVL1;ELOVL2;HACD2;ELOVL6
prerank,negative regulation of response to stimulus (GO:0048585),-0.3474093631017676,-1.309519660020385,0.05855855855855856,0.595564133583272,1.0,17/60,8.46%,SLIT2;SLC30A10;LYN;IGFBP3;APPL2;DDAH1;BRAP;AKT3;NR1H3;ZKSCAN3;RBL1;KLF4;CD34;VPS13C;CDK6;NR1H2;AQP11
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4445693599810585,-1.308673681782731,0.13333333333333333,0.5961780467786567,1.0,4/21,8.56%,ROCK2;ENPP1;NOS3;ASPN
prerank,regulation of proteolysis (GO:0030162),0.4558047803823868,1.3084856125535291,0.14859437751004015,0.8405418885594115,1.0,10/48,11.48%,CAV1;CYFIP2;OGT;CLN8;LTBP4;PERP;HDAC2;IST1;HDAC6;SPOPL
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.4061000384665651,1.3081266175311554,0.10532276330690826,0.8400295598776623,1.0,37/119,20.74%,PIGU;PTPN13;SOCS5;PI4K2B;SLC27A1;PIP4K2B;PIK3R4;PGAP3;SOCS6;PLEKHA4;MTMR7;PIK3R2;EFR3A;PIGB;MTMR6;OCRL;INPP5F;MTMR3;PIGA;SOCS4;SOCS7;PTEN;PLEKHA1;PIK3C3;MTMR12;PI4K2A;MTMR1;SOCS1;PITPNM2;SOCS2;RAB5A;PITPNM3;ITPKA;FIG4;VAC14;PIK3C2B;CISH
prerank,sensory organ development (GO:0007423),0.4497842317230143,1.3061661941736846,0.1335149863760218,0.8454174139434045,1.0,9/51,8.69%,STRA6;WNT10A;PBX1;BMPR1B;HIPK1;SH3PXD2B;SHROOM2;FREM2;ABCB5
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.505608845958681,-1.3059978349730945,0.1417910447761194,0.6023139781128817,1.0,6/13,9.87%,NUPR1;USP19;NR1H3;NR1H2;AQP11;MANF
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.4996222925543788,-1.3044761656445243,0.15466666666666667,0.6048014996079182,1.0,4/14,6.95%,IGF1;LDLR;TNFRSF1B;CD200
prerank,membrane depolarization (GO:0051899),0.4868696857406315,1.3044150929974365,0.16079632465543645,0.8503198441955462,1.0,3/32,4.79%,CAV1;SCN10A;CACNA1H
prerank,muscle cell differentiation (GO:0042692),0.48956204885287863,1.3040825070329145,0.17073170731707318,0.8496519585129262,1.0,2/32,1.68%,RORA;GLMN
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4525948455240686,1.3040520514579808,0.14624505928853754,0.8477872039492692,1.0,18/54,17.78%,GPC3;XYLT2;GPC6;NDST1;SDC1;SLC35D2;GCNT2;HEXA;HS3ST6;HS3ST5;GPC2;SDC3;HSPG2;EXT1;HGSNAT;EXT2;GPC5;SDC4
prerank,negative regulation of protein ubiquitination (GO:0031397),0.450163831149524,1.3037434038422073,0.1268357810413885,0.846912501581844,1.0,15/50,17.14%,CAV1;SH3RF2;OGT;TNFAIP3;N4BP1;FBXO5;SIRT7;SPOPL;NXN;USP4;SOX4;GNL3L;BAG2;MINAR1;CHP1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5332064631236983,-1.3035956297532727,0.17142857142857143,0.6055790083200695,1.0,6/11,32.84%,LYN;TNFRSF21;RC3H1;ATM;FCGR2B;CD300A
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4648989366268866,1.302748693605214,0.15519568151147098,0.8486674326379449,1.0,5/42,4.67%,VIT;ECM2;MINK1;NF1;RAC2
prerank,positive regulation of cell migration (GO:0030335),0.3817888347983177,1.3025724116755952,0.055613850996852045,0.8474339856739134,1.0,32/253,7.63%,ROR2;GAB1;CLDN1;ITGA6;CAV1;NTRK3;CDH13;DOCK5;PRKCE;EGFR;GTSE1;FGF1;DOCK1;SEMA4B;SH3RF2;CDH5;KIF20B;ITGAX;SOX9;PRKCA;SRC;PTPRC;FN1;FER;TRADD;ADAM10;EPHB2;RDX;RIPOR1;SEMA3A;RREB1;FBXO5
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4171346533479156,1.3025660620939923,0.11918951132300358,0.8455313397030261,1.0,5/90,2.59%,EBF2;CAV1;PPARGC1A;LEPR;OGT
prerank,negative regulation of MAP kinase activity (GO:0043407),0.462414259208423,1.3020896468567047,0.15247252747252749,0.845355864562974,1.0,9/44,10.68%,RGS14;STK38;NF1;SPRY1;PTPN22;SPRY4;IRAK3;PTPRJ;MAPK8IP1
prerank,ion homeostasis (GO:0050801),0.5013953351003146,1.3018051397614356,0.17040358744394618,0.844477434515931,1.0,5/30,7.04%,NEDD4L;CAMK2D;SLC4A3;SLC4A4;SLC4A11
prerank,negative regulation of platelet activation (GO:0010544),-0.481404155620194,-1.3016175289439094,0.15443037974683543,0.6093830540090046,1.0,6/16,6.29%,PRKG1;PDGFRA;NOS3;THBD;SERPINE2;APOE
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.551054032218879,-1.3015938341489695,0.17362637362637362,0.6074157469537118,1.0,6/10,21.91%,EPHA4;ANXA2;RGP1;FURIN;CDK5RAP3;NELL1
prerank,positive regulation of developmental growth (GO:0048639),0.45448409619906105,1.3008557911460519,0.149519890260631,0.8460073430753848,1.0,3/49,0.85%,NGF;NEDD4L;NTN1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.41320936875010494,-1.3008151268125054,0.14326647564469913,0.6077717750344999,1.0,8/27,12.48%,PID1;ENPP1;GRB10;RPS6KB1;PIP4K2A;PRKCZ;GSK3A;PIP4K2C
prerank,histone deubiquitination (GO:0016578),0.5427417871475875,1.3002241804844592,0.17609046849757673,0.8463669613045467,1.0,5/18,13.25%,BRCC3;TAF10;UIMC1;TRRAP;USP15
prerank,establishment of epithelial cell polarity (GO:0090162),-0.4495399525708701,-1.2995909534563796,0.15404040404040403,0.609325346153358,1.0,4/19,2.84%,PARD3;MSN;CDC42;CYTH3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.41896010073090784,-1.2992630530635594,0.14613180515759314,0.6082532408040141,1.0,7/23,6.84%,ACSL1;ACSL3;FAR2;ACOT7;ELOVL7;ACSL6;HSD17B12
prerank,negative regulation of cell junction assembly (GO:1901889),0.515510522132694,1.2990372348345778,0.16765578635014836,0.848923586876758,1.0,3/25,4.48%,APOD;DLC1;SRC
prerank,membrane lipid biosynthetic process (GO:0046467),0.4491027446855105,1.2982320843009785,0.14580645161290323,0.8499195952224083,1.0,14/58,13.29%,SGMS2;ST3GAL4;CERS6;ACER3;ELOVL5;PLPP2;PLPP3;HACD4;ELOVL1;ELOVL2;CERT1;HACD2;SCCPDH;ELOVL6
prerank,RNA processing (GO:0006396),0.3906847993035866,1.2977343156561807,0.08849557522123894,0.8497745799831007,1.0,37/176,15.00%,DHX8;PPARGC1A;HNRNPC;NUFIP1;SF3B2;SF3B1;PIWIL2;RBM8A;RNPC3;CELF1;SRSF4;HNRNPA0;TSEN54;ZRSR2;SNRPF;SON;PABPC4;HNRNPR;TUT1;FASTKD2;PRPF3;DDX17;CSTF3;SRPK1;RBM5;LIN28B;CELF2;SUPT4H1;SRPK2;TSEN34;TCERG1;SNRPA1;SFPQ;PPIG;DICER1;DHX16;PDCD7
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.36262733960738164,-1.2975876899946213,0.1111111111111111,0.6112432397978984,1.0,20/48,18.01%,ETS1;ANGPT1;NOS3;AKT3;HIF1A;HDAC7;HDAC9;KDR;ANXA1;AKT1;PIK3C2A;GATA2;SP1;THBS1;MAP2K3;SRPX2;TMSB4X;P2RX4;HSPB1;CD40
prerank,cellular response to growth factor stimulus (GO:0071363),-0.29151376282566743,-1.2973387787415411,0.016260162601626018,0.6099386982542222,1.0,51/151,19.63%,FLT1;SOX5;RAPGEF2;SMAD3;BMP6;PDE8A;CLEC3B;BMP4;SMAD9;NDNF;TGFBR1;APPL2;WNT4;ACVRL1;GAS1;MT1G;STMN2;BMPR2;DSTYK;SEMA6A;EEF1A1;KLF4;DUSP3;KDR;TBX1;RPS6KB1;ANXA1;CRKL;AKT1;PDE2A;RAMP2;LGMN;BMP2;SOX6;FLT4;MAPKAPK2;MAP2K3;SPHK1;PLK5;MAPT;NRP1;ZPR1;SMAD4;ZFP36;NOS1;HSPB1;WWOX;HAS1;LIMS1;RACK1;BCAR1
prerank,sulfur compound biosynthetic process (GO:0044272),0.40616937452176155,1.296827990187839,0.10788863109048724,0.8512565250481159,1.0,20/104,11.72%,DCN;CSPG4;ST3GAL4;PRELP;UST;GLCE;SLC35B2;B4GAT1;MGST2;CHST7;NCAN;SLC35D2;CHST2;GSTZ1;GSTA4;TPK1;GGTA1;CHST12;GSTA3;GSTK1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.46579806904695753,-1.2965448865913212,0.12623762376237624,0.6101515438342957,1.0,8/17,22.44%,CDK9;CCNT1;ZC3H3;HSF1;NCBP1;CPSF7;CPEB1;CPSF6
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5352684909715627,1.2958393723744617,0.1842948717948718,0.8531957598658583,1.0,4/21,2.40%,SULF1;EXTL3;XYLT2;GLCE
prerank,positive regulation of T cell proliferation (GO:0042102),-0.35216541378075505,-1.2953570274074284,0.08745247148288973,0.6117235406111718,1.0,10/55,11.02%,IGF1;IGFBP2;TFRC;IGF2;IL18;SLC7A1;VCAM1;ANXA1;RPS3;CD80
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5252469870592635,-1.2952293669711188,0.13647058823529412,0.6101625873167614,1.0,6/12,25.08%,EPHA4;SERPINE2;BMP2;ID2;CLCF1;NOTCH1
prerank,heterochromatin organization (GO:0070828),-0.4840120514563611,-1.2950264165270402,0.16452442159383032,0.608732297138077,1.0,3/14,9.20%,MECOM;PRDM16;BAHD1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5470482248401516,-1.2943312457094545,0.16478555304740405,0.6088916647785322,1.0,4/10,21.90%,UBE2J1;OS9;DERL2;SVIP
prerank,regulation of sodium ion transport (GO:0002028),0.4821320646085244,1.2938532863165921,0.15497076023391812,0.8587707700847097,1.0,3/34,4.74%,CNKSR3;SLMAP;ATP2B4
prerank,protein localization to cilium (GO:0061512),0.4863142209106207,1.293835967781304,0.16905444126074498,0.8569229252460925,1.0,14/32,23.17%,ZNF423;RAB29;RABEP1;SNX10;TCTN2;TTC21B;NPHP4;INVS;EHD1;BBS1;TCTN1;TULP2;IFT140;ARL3
prerank,positive regulation of chemotaxis (GO:0050921),0.4616586549750862,1.2936940865338924,0.15047879616963064,0.8555065871602887,1.0,4/43,4.59%,SMOC2;NTRK3;CDH13;DSCAM
prerank,indolalkylamine catabolic process (GO:0046218),0.5973214588200273,1.2933790929777786,0.19791666666666666,0.8546894921659525,1.0,2/10,3.76%,IL4I1;AADAT
prerank,focal adhesion assembly (GO:0048041),0.5332376945521814,1.2930260471952477,0.19254658385093168,0.8540690774871589,1.0,4/21,4.48%,DLC1;SORBS1;PEAK1;SRC
prerank,calcium import into the mitochondrion (GO:0036444),-0.542078794222835,-1.2925273952264087,0.18309859154929578,0.6123204888435583,1.0,5/10,20.55%,SMDT1;SLC25A23;MICU1;MICU2;MAIP1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5064725757777565,1.2922810998723917,0.16,0.8550132250542852,1.0,12/26,22.64%,OGT;KMT2A;BEND3;KMT5C;SUV39H1;ATPSCKMT;KMT2D;SETD2;SUV39H2;ETFBKMT;VCPKMT;EEF2KMT
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.48310615906500504,1.291927851395733,0.15080527086383602,0.8544754364274193,1.0,12/33,16.96%,GLI1;FAM83D;PSME3;ATP2B4;PAF1;DDRGK1;INO80;PTEN;PKD1;PTPN6;FBXW7;E2F1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5225317709782734,1.2917845471537728,0.1921259842519685,0.8531047889341162,1.0,9/21,20.81%,GLI1;KIF7;PDCL;SMO;RAB34;TEDC1;ARMC9;TUBD1;STK36
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.32087497758402705,-1.2917648835010065,0.06666666666666667,0.6126410079239547,1.0,29/88,16.42%,EXOC6B;MYO1B;CLINT1;MYO5A;ARFGEF2;AP1S2;FTH1;DNAJC6;NAPA;COMMD1;AP2A1;FTL;HSPA8;VPS35L;VPS13C;EXOC6;DOP1B;EPS15;EXOC4;OSBPL5;AP4E1;SORCS1;TXNDC5;VAMP7;SH3GL2;DTNBP1;SORT1;MON2;SCFD1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.4603350967274156,-1.2915728383652605,0.16971279373368145,0.6112282912195554,1.0,2/16,0.63%,IGF1R;INSR
prerank,glucose catabolic process to pyruvate (GO:0061718),0.5169638399156923,1.2912203121376113,0.18181818181818182,0.8515066720521711,1.0,11/24,22.50%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,canonical glycolysis (GO:0061621),0.5169638399156923,1.2912203121376113,0.18181818181818182,0.8515066720521711,1.0,11/24,22.50%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5757869193564508,1.2910663198958736,0.20136518771331058,0.8501678747781155,1.0,3/13,5.73%,PRICKLE1;SOX9;ANKRD2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3994852742806443,-1.291027612454888,0.12280701754385964,0.6108635725074133,1.0,8/31,7.87%,CDC42;IGF2;FGFR2;HDAC9;MEF2A;MAPK12;CDK9;CDON
prerank,response to estradiol (GO:0032355),0.48170317621346376,1.2907299850937917,0.1774193548387097,0.8495504183271636,1.0,12/31,20.45%,EGFR;SSTR1;NRIP1;POU4F1;NCOA3;LCOR;GPER1;CCDC62;GGT1;SOCS2;RUVBL2;STAT5B
prerank,alpha-amino acid catabolic process (GO:1901606),0.4900992980047717,1.290331433895644,0.17302052785923755,0.8491559516065681,1.0,7/29,10.44%,PRODH;IL4I1;AADAT;HOGA1;ACAT1;BLMH;GSTZ1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.524997981832766,-1.2897208573231147,0.16923076923076924,0.6129488651295153,1.0,6/11,19.17%,EP300;SIK1;C1QTNF3;PGP;CLK2;CRY1
prerank,cellular response to mechanical stimulus (GO:0071260),0.45846149247828616,1.289230685000109,0.16869095816464239,0.8513705916967318,1.0,12/46,16.94%,F11R;PIEZO2;MAP3K1;SOX9;TLR7;PTGER4;PIEZO1;TMEM150C;AQP1;KCNK4;BAD;BNIP3
prerank,genitalia development (GO:0048806),0.5846929751942286,1.288587337022419,0.1923743500866551,0.8520239362995046,1.0,2/12,4.96%,STRA6;WNT5A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5445753499967556,1.288370064623536,0.19370078740157481,0.8510085563828158,1.0,3/18,4.23%,ASS1;IL4I1;PTPN22
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.38979395567479236,1.2878605410771458,0.08415300546448087,0.8511118279290333,1.0,26/190,9.13%,RORA;CAV1;VGLL4;PPM1N;ARHGAP12;TNIP3;PDE4D;SPRED1;NF1;PHLDA3;SPI1;SRC;ATP2B4;PPM1A;UACA;BANK1;TNFAIP3;NDUFS3;MCL1;DAG1;CGNL1;PHLPP1;PIK3R2;PTPRJ;TNIP1;PLEK
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5770733721601607,1.2878412095542,0.21,0.8493561432619078,1.0,6/13,15.81%,MGAT3;CHST7;EXTL2;CHST2;NAGK;OGA
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.40771316625327214,-1.2874147438429473,0.10759493670886076,0.6180717900316871,1.0,10/28,12.13%,PRKAG2;ADIPOR2;MITF;SIRPA;TNFRSF1B;JAK2;PRKAB2;CTNS;AVIL;FGFR4
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.46050812163737664,-1.2872594029262705,0.1625615763546798,0.6165849838402256,1.0,7/18,23.75%,PRKAG2;C2CD5;CLIP3;SLC2A1;NR4A3;C3;PRKCB
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.4342301217979456,-1.2871537530725312,0.1745152354570637,0.614958431448028,1.0,4/22,3.95%,GHR;KIT;IL10RB;CYP1B1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5347704187349966,1.2865323212792792,0.18354430379746836,0.8526299072787106,1.0,4/20,9.65%,LBP;PRKCE;PTPN22;TICAM1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.49131828395391103,-1.2862553586847834,0.16452442159383032,0.6155962954155252,1.0,7/15,35.59%,PLTP;APOE;ABCG1;SCARB1;LCAT;APOC1;LIPC
prerank,negative regulation of cell population proliferation (GO:0008285),0.36699670207069784,1.2862021201767975,0.04912998976458546,0.8519795797825802,1.0,66/351,15.22%,NGF;ROR2;ZBTB7C;APOD;IGFBP6;DLC1;CDH13;VGLL4;CLDN19;GLMN;FAP;ADAMTS1;SSTR1;GPLD1;GNRH1;NF1;IL1A;PTPN14;PTHLH;SOX9;TPTE;BMPR1B;CELF1;MFN2;BMP5;MORC3;KLF10;NUP62;WNT5A;ACVR1C;PDS5B;KANK2;TNFAIP3;NCK2;CTCF;PEX2;CHERP;DIS3L2;RBM5;PTPRJ;CNOT7;DLG3;PBRM1;MTSS1;STRN;AXIN2;RARG;APC;PLXNB1;ZBTB49;MEN1;NF2;WNT9A;PTEN;CDC6;EMD;SOX4;CDKN1C;CTNNBIP1;DNAJA3;CLMN;PTPRU;ERBB4;GPER1;PTPN6;PLG
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.471665215870049,-1.2861453657241186,0.16844919786096257,0.6140147483397513,1.0,6/17,10.37%,GJC1;GJD3;GJA1;SLC8A1;ATP1B1;ATP1B2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3678364120694431,-1.286054212823015,0.11940298507462686,0.6123762367760857,1.0,7/41,3.93%,ENG;TGFBR3;RBPJ;TPM1;FKBP1A;BMP4;FGFR2
prerank,neuropeptide signaling pathway (GO:0007218),0.4404983117697152,1.2859809700057308,0.15706806282722513,0.8509971976431255,1.0,4/58,4.70%,SORCS2;SSTR1;KISS1R;CPE
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5589609777650273,1.2859129511739198,0.18719211822660098,0.8494528016008747,1.0,2/16,4.99%,CEACAM1;PTPRC
prerank,negative regulation of histone methylation (GO:0031061),-0.5377091601162604,-1.284896955342356,0.18032786885245902,0.6138821182426898,1.0,7/10,29.65%,JARID2;KDM1A;DNMT3B;BRCA1;AASS;WDR5;BCOR
prerank,positive regulation of synapse assembly (GO:0051965),0.49130778178629336,1.2834225635752305,0.1795252225519288,0.8567772680719684,1.0,3/27,6.39%,CLSTN2;CLSTN3;EPHB2
prerank,regulation of kinase activity (GO:0043549),0.4154603077509641,1.2832724938421871,0.13708690330477355,0.8554741936259764,1.0,8/89,1.81%,ROR2;ROR1;NTRK3;FGFR1;PLCE1;LDB2;EGFR;MUSK
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5536668589251752,1.2830530971914773,0.1750841750841751,0.8544231528644641,1.0,7/15,20.84%,ATL2;REEP3;LNPK;RTN4;ZFYVE27;RAB18;REEP4
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.2945374105568317,-1.2822957475115357,0.022222222222222223,0.6196879862091024,1.0,72/168,22.82%,CNOT6L;RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;TENT2;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;PABPC1;RPLP1;RPS17;ZC3H12A;RPS3;RPL23;RPL17;PNRC2;RPL9;RPL38;RPL36;RPS26;NBAS;RPS8;RPS12;RPL18A;RPS21;CNOT11;MAGOH;TUT7;MTPAP;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;NCBP1;CTIF;MAGOHB;RNPS1;ZFP36;CNOT9;RC3H1;GSPT2;PDE12;POLR2D;RPL14;RPS2;RPL10A;NBDY;DCP2;RPL39;RPL34;RPL5;EIF3E;RPL22;PPP2R1A
prerank,regulation of transmembrane transport (GO:0034762),0.48973671564015203,1.2818216118814447,0.17256637168141592,0.8571854493882766,1.0,6/31,8.23%,NEDD4L;KCNJ4;SCN10A;KCNJ16;KCNJ13;OCLN
prerank,gene expression (GO:0010467),-0.25638639374036715,-1.2815562667418914,0.0,0.6200609998588369,1.0,122/348,22.69%,RBPMS;RPL37A;RRBP1;CREBL2;ADAR;NUP107;RPL19;RPL8;RPL37;SNRNP40;RPS15;RPS29;FARSB;RPL35A;RPS7;HNRNPK;RPS20;RPL32;AAAS;EEF1A1;RPS27;RPL26;SEH1L;RPL27;RBMS1;NUP133;RPS24;NOX4;RPLP0;FYTTD1;MEF2A;HARS1;PTMA;RPS19;HBS1L;THOC2;RBMS2;RPL31;RPL41;GLE1;TSPAN17;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;HNRNPH3;NR4A2;RPLP1;RRAGC;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;POLR3A;RPS8;ZC3H11A;RPS12;MMS19;RPL18A;RPS21;MRPL32;MAGOH;MRPL18;LMF2;NUP88;CDC40;RPS18;RPLP2;EIF4G1;RPS6;NOL9;ANGPT2;HHEX;RPS15A;NCBP1;MRPL9;DNAJB11;MRPL28;CPSF1;PWP1;DDX20;MAGOHB;RNPS1;HOXD3;POLR2F;GSPT2;CLP1;MRPS11;POLR2A;POLR2J;TSPAN5;POLR2D;MRPS16;POLR2K;RPL14;MRPS18B;U2AF2;NOVA1;HNRNPH1;RPS2;SRRM1;THOC7;MRPL42;NUP54;RPL10A;DUSP11;THAP1;THRB;RPL39;RPL34;RPL5;MRPS12;RPL22;SRSF1;MRPL55
prerank,protein-containing complex subunit organization (GO:0043933),0.4024491122893131,1.2814426228787714,0.1207897793263647,0.8568162201222221,1.0,14/109,8.39%,MAGI1;PPARGC1A;WIPF1;LAMC1;REPS2;PARD6B;CD3G;KMT2A;SOX9;CARD10;FANCC;TAPBP;OCLN;DARS1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.42522296755377614,-1.280903796871035,0.15485564304461943,0.6201573136858811,1.0,6/21,8.47%,IGF1;MEF2D;IGFBP5;GJA1;MMP2;LDLRAP1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.4284233021073662,-1.2808409756277324,0.14772727272727273,0.618414280266306,1.0,8/21,14.37%,RAD51B;NPM1;CDC25B;CDC25A;RAB11A;CDK4;CDC7;RAD51C
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5201387591975475,-1.280819572173283,0.1784037558685446,0.6165748885226093,1.0,7/12,26.39%,DMD;ATP1B1;ANK3;ATP1B2;NOS1;WNK1;WNK2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.49169371440186405,1.280631832263493,0.16090225563909774,0.8579953194682344,1.0,5/30,6.66%,F11R;LPAR1;RTN4R;AKAP13;COL3A1
prerank,skeletal muscle tissue development (GO:0007519),0.47825426058950515,1.279281516008319,0.18584070796460178,0.8609653148866624,1.0,3/32,4.33%,CAV1;CAV2;CSRP3
prerank,positive regulation of DNA binding (GO:0043388),0.4760186867065992,1.2788902700499336,0.17391304347826086,0.8606534327831663,1.0,1/31,0.03%,NGF
prerank,regulation of cell migration (GO:0030334),0.36856752947169324,1.2778986531108822,0.04231166150670795,0.8627259952653598,1.0,48/382,7.57%,ROR2;NTNG2;NTNG1;CLDN1;ITGA6;CAV1;FGF7;DLC1;NTRK3;CDH13;CEACAM1;SULF1;CLDN19;LDB2;EGFR;GTSE1;KIF2A;FGF1;PARD6B;JAG1;AMOTL1;SEMA4B;SCAI;MGAT3;SH3RF2;CDH5;MINK1;ITGAX;NF1;ARPIN;FOXO3;PRKCA;LMO4;SRC;PLXNA3;AMOT;FER;ULK4;TRADD;ADAM10;EPHB2;RDX;DAG1;RIPOR1;SEMA3A;LDLRAD4;SRCIN1;KANK1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5806317250919327,1.2778233921386994,0.18165784832451498,0.861203067948924,1.0,4/13,7.23%,CYFIP2;CIDEB;NLRC4;PERP
prerank,regulation of exocytosis (GO:0017157),0.4451346647324946,1.277769873032219,0.1713091922005571,0.8595985170978153,1.0,5/46,7.29%,STXBP6;RAB8B;RIMS2;RAB3A;CPLX1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.47290586365523407,1.2773731466527225,0.17105263157894737,0.85921793963422,1.0,5/41,8.28%,MAGI1;ADAM19;PLPP3;PIEZO1;GCNT2
prerank,negative regulation of neuron projection development (GO:0010977),0.4368607109830586,1.2770355542664826,0.16245006657789615,0.8587143489059896,1.0,16/56,17.05%,LRP4;LPAR1;RAB29;RTN4R;TRPV4;GDI1;EFNB2;SEMA3A;KANK1;HDAC2;RTN4RL1;PTEN;RTN4;PTPRO;EFNB3;MINAR1
prerank,neuromuscular junction development (GO:0007528),0.5046166413666731,1.2768236963080088,0.18333333333333332,0.8577135628378767,1.0,4/24,2.68%,LRP4;PDZRN3;MUSK;ZC4H2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4364688878128894,-1.2767765660111625,0.13966480446927373,0.6269234587436567,1.0,6/23,14.18%,TGFBR3;TPM1;FKBP1A;FGFR2;PROX1;ID2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5126127042669204,-1.2765029467377174,0.17411764705882352,0.6258345519508081,1.0,4/12,8.19%,PLCB1;SLIT2;CCN3;AKT1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.43219801511101424,-1.2763997050578,0.17941952506596306,0.6242459596129725,1.0,4/21,6.47%,ERRFI1;ROCK2;BMP4;CTSL
prerank,response to purine-containing compound (GO:0014074),-0.4632842275265606,-1.2758191252695343,0.17754569190600522,0.6241232536121423,1.0,6/17,19.06%,TRPC3;ABCC9;P2RX7;P2RX4;TRPM2;P2RY6
prerank,positive regulation of nervous system development (GO:0051962),0.4502198163517057,1.2755186400909546,0.1582537517053206,0.8608172885096407,1.0,4/42,6.39%,CLSTN2;RGS14;CLSTN3;EPHB2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.4354053886836733,-1.2748234168358217,0.14720812182741116,0.6251573673716291,1.0,10/21,25.16%,PAXIP1;MITF;MED17;SUB1;MED24;DHX36;MED14;MED30;SRF;BCLAF1
prerank,positive regulation of catabolic process (GO:0009896),0.4295495849032225,1.2742556349968996,0.15424164524421594,0.8637708505593638,1.0,13/65,15.38%,PLK2;GPC3;NEDD4L;AXIN1;DACT1;WNT5A;TNFAIP3;GSK3B;APC;NEDD4;ATG7;WWP2;FZR1
prerank,cellular response to dsRNA (GO:0071359),0.5383041979038548,1.273951440665765,0.21150592216582065,0.8630380713442315,1.0,1/15,0.24%,CAV1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3743142613382583,-1.2738124487399929,0.08940397350993377,0.6263479914876594,1.0,9/37,8.47%,IGF1;PRKG1;TPM1;MEF2D;IGFBP5;GJA1;TGFB3;MMP2;LDLRAP1
prerank,positive regulation of macroautophagy (GO:0016239),0.448115363252328,1.2737617353789636,0.16182572614107885,0.8619634097677479,1.0,17/48,22.24%,DCN;LRSAM1;PIP4K2B;SCOC;RAB3GAP2;BAG3;SESN1;IRGM;PAFAH1B2;HTT;TBK1;BNIP3;PINK1;ADRB2;TSC2;GNAI3;RAB3GAP1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.39764767892060743,-1.2732694876981232,0.125,0.6262065746228784,1.0,6/30,5.61%,ENG;SMAD3;TGFBR3;LATS2;FKBP1A;ITGA3
prerank,endothelial cell migration (GO:0043542),0.4645649533440557,1.2729269453875596,0.18502202643171806,0.8632486083850157,1.0,6/37,8.07%,CDH13;PXN;FAP;CDH5;DPP4;STARD13
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.49044868944053244,-1.2722146262438665,0.17647058823529413,0.6274577241019693,1.0,3/13,2.60%,NFIB;PPARD;BMP4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.41990009889271274,-1.2717760362733497,0.14285714285714285,0.6268098825358198,1.0,9/23,19.41%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;EGF;ENTPD5;GAPDHS
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3064924312109638,-1.2715747066466303,0.06293706293706294,0.6254925782696514,1.0,26/110,12.42%,TRABD2B;CDC42;TFRC;BCL2L11;EP300;PREB;NAPA;FNIP1;HSPA8;FNIP2;APOE;RHOC;SLF2;SH3GLB1;VCP;SLF1;RPS3;ANKRA2;GFAP;AJUBA;PRKCZ;BID;MMP1;MPP7;CRYAB;SAR1B
prerank,ether lipid metabolic process (GO:0046485),0.554463661169984,1.271531358081972,0.18983050847457628,0.866888783970869,1.0,4/14,12.01%,AGMO;NCEH1;PAFAH1B1;LIPE
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5814192032591785,1.2714539733730095,0.22831858407079647,0.8654202739242303,1.0,4/11,7.57%,ARPIN;SRC;RREB1;KANK1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.325547920351963,-1.2714234020135566,0.0945945945945946,0.6241329705373732,1.0,21/69,17.43%,UBXN4;USP19;TRIM25;ERLIN1;DNAJB2;UBE4A;STT3B;SGTA;SEC61B;SYVN1;VCP;UBE2J1;FBXO17;ERLIN2;UBE4B;OS9;RNF103-CHMP3;ANKZF1;SGTB;DERL2;FBXO44
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.4819843027869185,-1.2700951883367506,0.20422535211267606,0.6263744816911522,1.0,5/13,10.43%,ANK2;GJC1;GJA1;CACNB2;KCNN2
prerank,positive regulation of cell division (GO:0051781),0.4641002684538067,1.2700808507265164,0.18934081346423562,0.8687239608989146,1.0,11/38,13.55%,PRKCE;FGF1;KIF20B;RACGAP1;SPAST;OPN1MW;CSPP1;CUL3;PKP4;CDC6;CIT
prerank,mRNA metabolic process (GO:0016071),0.4074040102238207,1.2698554713177752,0.12393681652490887,0.8678031462545941,1.0,19/90,13.67%,PPARGC1A;SF3B2;PCBP2;CNOT10;CELF1;SRSF4;HNRNPA0;SNRPF;SON;DXO;HNRNPR;PRPF3;CSTF3;DIS3L2;SUPT4H1;ZFP36L2;ERN1;TCERG1;SFPQ
prerank,negative regulation of kinase activity (GO:0033673),0.4259636241246966,1.269716338234954,0.14561855670103094,0.8665948592268066,1.0,21/62,21.81%,TRIB2;UBASH3B;CEACAM1;SPRED1;NF1;GNAQ;PTPRC;SFN;CEP85;RTRAF;CDKN1C;YWHAG;DBNDD1;WARS1;CHP1;IRS2;PDPK1;PPM1E;CEP43;TSC2;GSKIP
prerank,regulation of heart contraction (GO:0008016),0.40917580830803696,1.2694487507511372,0.14993954050785974,0.8658511350618736,1.0,16/90,10.60%,CORIN;ITPR2;ITPR3;CAMK2D;SCN10A;PDE4D;FKBP1B;ATP2B4;CACNA1H;ATP1A2;APLN;TBX2;CASQ2;CELF2;ATP1B3;FXYD6
prerank,activation of GTPase activity (GO:0090630),0.4078672190579925,1.269038754396495,0.13598074608904934,0.8656051751913441,1.0,13/89,10.91%,ARHGAP42;SIPA1L1;NTRK3;TIAM2;GRTP1;SGSM2;ARHGEF5;TBC1D16;FOXJ1;SLC27A4;TBC1D2;TBC1D8;DOCK7
prerank,inner dynein arm assembly (GO:0036159),0.6118187339464771,1.2689398544812762,0.2291296625222025,0.8641967452649768,1.0,3/10,15.14%,CFAP73;CCDC39;CCDC40
prerank,positive regulation of cation channel activity (GO:2001259),-0.36713346827303983,-1.2687212687403828,0.11552346570397112,0.6285828860968765,1.0,13/40,23.26%,ANK2;ACTN2;SHANK3;AKAP6;CALM1;ANK3;TMSB4X;CALM3;JPH2;P2RY6;STAC3;GSTO1;LRRC38
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5519092847875345,1.2686798868263458,0.20869565217391303,0.8633962555107701,1.0,2/15,2.92%,EDA;GLI2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.47573785786700185,-1.2684199502702869,0.17857142857142858,0.6276168156040294,1.0,6/13,15.04%,SHANK3;ADCY1;SQSTM1;LGMN;EIF2AK4;ZDHHC2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5714592473450689,1.2680234093514622,0.20068027210884354,0.8640818540266196,1.0,4/12,13.32%,JAG1;N4BP2L2;NELFB;ZFP36L2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.38759196166683924,1.267575108020553,0.11950394588500564,0.8640256939890143,1.0,23/118,12.28%,EFNA5;SIPA1L1;FMNL2;NEDD4L;CEACAM1;PPFIA2;CAPZB;NF1;LZTS3;BRSK1;TNFAIP3;DAG1;SRCIN1;CDH2;GSK3B;SARM1;ZMYM6;PHLDB1;FERMT2;NEDD4;HTATIP2;SEMA4D;STAT2
prerank,regulation of synapse organization (GO:0050807),-0.4103694248902431,-1.2672532679514634,0.14565826330532214,0.6294488839923439,1.0,8/26,13.93%,EPHA4;SETD5;ARHGAP22;PDLIM5;CDKL5;MDGA1;ABHD17B;YWHAZ
prerank,positive regulation of phosphorylation (GO:0042327),0.37168879175218733,1.2672290735131655,0.07415254237288135,0.8635550137723612,1.0,26/240,6.42%,ROR2;ITGA6;ROR1;EFNA5;FGF7;NTRK3;FGFR1;CLDN19;LEPR;GLMN;EGFR;CCND3;MUSK;ZBTB20;PELI2;FGF1;AXIN1;FXR2;SOX9;LMO4;DSCAM;LIMK2;SLC4A4;NBN;EPHB2;KRAS
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4178271909301151,-1.2669878376071873,0.15634218289085547,0.6283904772359604,1.0,8/24,6.34%,ROBO1;ENG;SMAD6;BMP4;SEMA3C;BMPR2;FGFR2;TBX1
prerank,regulation of cholesterol transport (GO:0032374),-0.4323350069782466,-1.2669518893088514,0.17379679144385027,0.6266458013335182,1.0,11/20,32.71%,LRP1;NR1H3;ARV1;NR1H2;ABCA2;NAXE;ABCB4;TSPO;ABCA13;NUS1;APOC1
prerank,regulation of angiogenesis (GO:0045765),0.3755290528849663,1.266373426524612,0.1061269146608315,0.8649441566333362,1.0,21/192,5.87%,GAB1;DCN;THBS4;SMOC2;CEACAM1;SULF1;RAPGEF3;HK2;ADAMTS1;FGF1;CDH5;SPRED1;ITGAX;NF1;IL1A;PRKCA;ATP2B4;WNT5A;AMOT;HIPK1;TNFAIP3
prerank,mesenchymal cell differentiation (GO:0048762),-0.3437624877858203,-1.2656806434691803,0.13261648745519714,0.6286087261585466,1.0,15/51,12.75%,RANBP3L;ENG;LEF1;ROCK2;TGFBR3;RBPJ;TGFBR1;WNT4;FGFR2;HIF1A;LRP6;TRIM28;BMP2;LOXL3;TGFB2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.40412498807558883,1.2656143495084742,0.13294117647058823,0.8659595333296884,1.0,44/94,25.61%,DYNLL1;MKS1;SFI1;CEP89;CEP131;CEP78;NEDD1;TUBG1;CKAP5;CEP162;PAFAH1B1;CCP110;TCTN2;C2CD3;NDE1;CEP290;SSNA1;CETN2;RPGRIP1L;FBF1;PCM1;NPHP4;YWHAG;B9D2;YWHAE;CEP57;OFD1;CEP250;DCTN2;ALMS1;TCTN1;HAUS8;CEP43;CC2D2A;HAUS3;SCLT1;HAUS7;TMEM67;CEP83;DYNC1I2;NPHP1;TTBK2;CSNK1D;RAB3IP
prerank,cellular amino acid catabolic process (GO:0009063),0.40778493602763183,1.2656073540555823,0.12980769230769232,0.864275253410346,1.0,22/87,14.06%,PRODH;ARG1;IL4I1;ACAD8;AADAT;HMGCLL1;BCKDK;HOGA1;OGDH;GCDH;ACAT1;ALDH5A1;ABAT;BLMH;DLST;GSTZ1;GLDC;BCKDHB;BCAT2;GOT1;GLUL;HYKK
prerank,macrophage chemotaxis (GO:0048246),0.6159606278899519,1.2646660557946037,0.23024054982817868,0.8660959401770719,1.0,1/10,2.64%,CXCL17
prerank,neuromuscular process (GO:0050905),0.5357157765287766,1.2636361803617213,0.214170692431562,0.8680877931798143,1.0,1/16,0.21%,STRA6
prerank,response to interleukin-4 (GO:0070670),-0.5258235292921689,-1.2635546649980673,0.19704433497536947,0.6331345394876988,1.0,1/10,0.70%,LEF1
prerank,C4-dicarboxylate transport (GO:0015740),0.5614345633867157,1.2631878039940465,0.2191780821917808,0.8679540252107848,1.0,5/14,13.00%,LRRC8D;SLC25A12;SLC1A6;SLC25A13;SLC25A22
prerank,positive regulation of metabolic process (GO:0009893),0.3985085198330228,1.2627161570567509,0.13704994192799072,0.8679688459430167,1.0,17/103,13.52%,EBF2;CAV1;PPARGC1A;LEPR;OGT;BEND3;MFN2;ACACA;TSHR;PIGA;KSR2;APC;PRLR;KDM6B;TRPV2;ELOVL6;HCRT
prerank,cellular response to interleukin-4 (GO:0071353),-0.5301893439094864,-1.2620323536178226,0.19796954314720813,0.635949082561323,1.0,1/10,0.70%,LEF1
prerank,positive regulation of signaling (GO:0023056),0.46665391745160534,1.2619235087680891,0.180028129395218,0.8692082485400768,1.0,5/37,8.86%,CLSTN2;RAB29;CLSTN3;RIMS2;INPP5F
prerank,regulation of inclusion body assembly (GO:0090083),-0.5181837989105028,-1.2613958334554536,0.1985981308411215,0.6359966193135032,1.0,7/11,32.19%,SNCAIP;DNAJB2;DNAJA4;HSPA1A;DNAJB1;HSPA1B;HSPA2
prerank,protein K11-linked ubiquitination (GO:0070979),0.4872733301624915,1.2613007193064505,0.19148936170212766,0.869679576094049,1.0,11/27,20.41%,UBE2E2;ANAPC5;ANAPC7;ANAPC11;ANAPC2;UBE2D3;ANAPC4;FZR1;CDC23;UBE2W;PRKN
prerank,negative regulation of protein transport (GO:0051224),0.4999740878633383,1.260738454214941,0.20923076923076922,0.8700956989043673,1.0,1/25,0.23%,PKDCC
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3807313033411042,1.2589874120092903,0.1273957158962796,0.8748878734471781,1.0,28/150,12.80%,CNKSR3;CAV1;TRIB2;NTRK3;UBASH3B;PTPN13;CEACAM1;PDE4D;SPRED1;NF1;PLPP3;GNAQ;PTPRC;IBTK;EPHB2;NCK2;LDLRAD4;OCLN;SFN;NLRP2B;RASSF2;CEP85;SNX25;RTRAF;MEN1;SEMA4D;MVP;PTEN
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5535129282266418,1.2587228351009645,0.23205342237061768,0.8740661294763614,1.0,2/13,0.91%,PPARGC1A;GUCA1A
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.38060698645878444,-1.2576263683214186,0.1453287197231834,0.6453951393515507,1.0,5/34,3.56%,IGF1;INSR;TGFA;PDGFRB;IGF2
prerank,cardiolipin metabolic process (GO:0032048),0.5525244413275635,1.257570764919516,0.24196277495769883,0.8765656062710521,1.0,5/13,12.77%,SLC27A1;HADHB;PTPMT1;LCLAT1;PNPLA8
prerank,cellular response to alkaloid (GO:0071312),-0.455379353386798,-1.257137702844302,0.1649746192893401,0.6450573999241075,1.0,4/17,7.29%,TGM2;SLC8A1;BLM;CASP3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4411208762518042,1.2571305888103912,0.18900804289544235,0.8764466354183285,1.0,7/50,12.99%,NGF;SRC;SFN;RPS6KA3;USP47;DHCR24;AQP1
prerank,intracellular lipid transport (GO:0032365),-0.43067180729749927,-1.2563075950828764,0.1778975741239892,0.645802220931397,1.0,8/21,14.68%,PRKAG2;ARV1;ABCD4;CPT2;PRKAB2;ABCD2;CPT1A;MID1IP1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.397501479298094,1.2561936851070339,0.13348946135831383,0.8782649264073723,1.0,29/109,18.76%,TEC;NFATC2;NFATC1;ITK;MAP3K1;MAPK10;VAV2;PSME3;FER;LCP2;PIK3R2;PSMB5;GAB2;LAT;TAB2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;SYK;BTK;PSME4;NFATC3;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.49614994215312835,1.2559328103553218,0.21417565485362094,0.8775630276784048,1.0,8/23,19.61%,OTOP1;ARG1;TXK;IRGM;SOCS1;PPARG;JAK1;SUMO1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.41624759879752976,-1.2557274127434692,0.1710914454277286,0.6455678693300156,1.0,5/23,6.94%,GHR;KIT;IL10RB;CYP1B1;JAK2
prerank,regulation of protein localization to centrosome (GO:1904779),0.5704700331633672,1.2556140041388217,0.2218370883882149,0.8770471556489632,1.0,6/10,26.75%,NUP62;GSK3B;APC;CEP250;NSFL1C;MARK4
prerank,regulation of cytokinesis (GO:0032465),0.4105241235262889,1.2550330126641818,0.17037037037037037,0.8774625547944316,1.0,20/78,13.55%,PLK2;PRKCE;KIF20B;RACGAP1;PIK3R4;SPAST;OPN1MW;CSPP1;KIF13A;CUL3;CCP110;PKP4;KLHL21;ZFYVE26;CHMP4C;MAP9;CETN2;AHCTF1;CDC6;CIT
prerank,muscle filament sliding (GO:0030049),-0.3670466276098475,-1.2547784822157753,0.13029315960912052,0.6446949560696641,1.0,8/38,14.52%,ACTN2;DMD;TPM1;MYL6;TPM3;TPM2;DES;VIM
prerank,actin-myosin filament sliding (GO:0033275),-0.3670466276098475,-1.2547784822157753,0.13029315960912052,0.6446949560696641,1.0,8/38,14.52%,ACTN2;DMD;TPM1;MYL6;TPM3;TPM2;DES;VIM
prerank,regulation of monocyte differentiation (GO:0045655),-0.48132318503438515,-1.2535822316459257,0.18673218673218672,0.6464531664107113,1.0,5/14,19.93%,FOXP1;CDK6;IL34;CSF1;FES
prerank,hexose transmembrane transport (GO:0008645),-0.4109984976552948,-1.2535272599883818,0.15384615384615385,0.644776811060009,1.0,10/21,27.12%,PPARD;SLC2A12;SLC2A10;SLC45A3;SLC2A8;SLC2A9;SLC2A1;SLC45A1;SLC2A3;SLC2A4
prerank,regulation of GTPase activity (GO:0043087),0.3800485073885175,1.2533164580780347,0.12960893854748604,0.8819804462316171,1.0,30/177,11.44%,ITGA6;EFNA5;SIPA1L1;DOCK9;F11R;RGS6;ARHGAP12;RAPGEF3;RAP1A;ARHGAP9;ARAP1;SGSM2;NF1;RTN4R;CAV2;VAV2;PLXNA3;ARHGEF5;ZC3H15;RAB3GAP2;RDX;RAPGEF6;PKP4;OCRL;GSK3B;TBC1D2;FERMT2;RIC1;DVL3;PLXNB1
prerank,dendrite self-avoidance (GO:0070593),-0.4524376046690465,-1.2525391990587127,0.171990171990172,0.6458893550461231,1.0,6/16,13.47%,BSG;DSCAML1;NEXN;PALLD;ROBO4;CNTN2
prerank,cAMP-mediated signaling (GO:0019933),-0.4082774939799462,-1.2520310251628946,0.19613259668508287,0.6457154469966595,1.0,8/24,9.40%,KSR1;RAPGEF2;PDE7B;ADGRG6;ADCY1;AKAP6;ADCY2;PDE2A
prerank,vitamin transport (GO:0051180),0.4758023823546111,1.2516440717379593,0.20827178729689808,0.8865675768581998,1.0,11/29,14.92%,FOLR1;FOLR2;SLC27A1;SLC2A2;SLC52A1;TTPA;CD320;CUBN;GC;AMN;SLC46A1
prerank,negative regulation of bone remodeling (GO:0046851),0.5779984454588476,1.2514577407847165,0.2117437722419929,0.8855989309042926,1.0,2/11,5.87%,UBASH3B;TNFAIP3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5291187140173896,1.251284638316008,0.2191780821917808,0.8845135583859056,1.0,8/18,17.56%,VGLL4;DACT1;RDX;RIC1;FAF1;EZR;VPS11;WDR91
prerank,negative regulation of chemotaxis (GO:0050922),-0.3898487395450475,-1.2511210268400275,0.13099041533546327,0.6467091205721245,1.0,7/31,6.12%,ROBO1;SEMA6D;SLIT2;SEMA7A;SEMA3C;SEMA6A;DUSP3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41388538846991524,1.2510768902299085,0.16270337922403003,0.8835328084295795,1.0,12/72,14.18%,FGF7;FGFR1;FGF1;RBFOX2;SPRED1;KIF16B;FGF18;HNRNPM;GTF2F2;SPRED2;FLRT2;TIAL1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.5478867544071022,1.2508139815619779,0.21061093247588425,0.8828315725017754,1.0,2/16,4.23%,TNFSF8;PTPN22
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5043620272137078,1.2506934508974115,0.22274143302180685,0.8815717932399136,1.0,6/22,16.87%,NFATC2;IL4I1;CBFB;SOCS1;LAG3;MDK
prerank,regulation of protein acetylation (GO:1901983),0.5741464751286388,1.2499030658368204,0.24390243902439024,0.8827197308729451,1.0,3/12,14.15%,RAPGEF3;GSK3B;FAM161A
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5222201056172857,1.2498678786840296,0.200652528548124,0.8811604749987577,1.0,5/19,8.21%,PTGFR;FKBP1B;FIS1;PTPRC;PTPRJ
prerank,cellular response to interleukin-12 (GO:0071349),-0.34453619449018363,-1.2498087189254516,0.11538461538461539,0.6487665727029907,1.0,9/48,9.16%,PLCB1;MSN;CDC42;SIRPA;CFL1;ANXA2;RPLP0;JAK2;CNN2
prerank,sterol transport (GO:0015918),0.5126041572226704,1.2489072101838565,0.20727848101265822,0.8830441389728927,1.0,1/19,0.24%,CAV1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.47913388382387506,-1.248735564654143,0.1957040572792363,0.650249750415043,1.0,7/13,20.69%,MID2;TRIM35;TRIM28;CHMP3;TRIM8;TRIM13;TRIM11
prerank,renal system development (GO:0072001),0.42605673192664356,1.248677169211246,0.17183462532299743,0.8822333843819969,1.0,5/52,2.92%,STRA6;LRP4;SULF1;PCSK5;GLI2
prerank,positive regulation of cilium assembly (GO:0045724),-0.4388133608532981,-1.2478828785713283,0.20256410256410257,0.6510511487112383,1.0,6/18,14.46%,ARHGAP35;ENTR1;CEP135;FUZ;CEP120;CROCC
prerank,motor neuron axon guidance (GO:0008045),0.5485363742810863,1.2468840726653323,0.23597359735973597,0.8874221918575345,1.0,5/15,7.26%,NTN1;RAC2;NTN5;SEMA3A;NTN3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.369353868979938,1.2465254123581575,0.10843373493975904,0.8870179832294192,1.0,30/199,11.88%,PTCH1;LRP4;DLX1;IL18R1;LAMA4;ZNF423;EGFR;SPRED1;SPRY1;SPI1;PLCL1;SOX9;PCTP;BMP5;ATP2B4;ACVR1C;ACOT13;N4BP1;HOXC10;LDLRAD4;PTGER4;LNPEP;TBX18;GSK3B;SDHAF2;DOCK7;WWC1;PROC;HS3ST5;RAB11FIP5
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5282902918170538,-1.2464838363277477,0.19294117647058823,0.6534559284860719,1.0,6/10,36.70%,NOC2L;BRCA1;THAP7;CTBP1;SNCA;KLF15
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3671727242633682,-1.2464019156975166,0.14334470989761092,0.6518933185187682,1.0,9/39,10.78%,SNCAIP;RAPGEF2;ROCK2;MSN;TIE1;HSPA8;APOE;ANKRA2;GFAP
prerank,alanine transport (GO:0032328),-0.5265206387854878,-1.2460674744410092,0.21479713603818615,0.6510877328213781,1.0,4/10,23.93%,SLC6A6;SLC1A4;SLC6A17;SLC7A10
prerank,positive regulation of hemostasis (GO:1900048),0.5879608818908426,1.2455991346980266,0.23201438848920863,0.8869587998826849,1.0,1/10,0.79%,ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.5879608818908426,1.2455991346980266,0.23201438848920863,0.8869587998826849,1.0,1/10,0.79%,ST3GAL4
prerank,anterior/posterior pattern specification (GO:0009952),-0.33901281660950366,-1.2455653142639953,0.14396887159533073,0.6508293979918501,1.0,17/53,17.58%,WLS;HOXA3;TGFBR1;BMPR2;HOXB4;HOXA5;HOXB9;TBX1;HOXC4;BMP2;HOXA9;HOXA6;HOXB7;HOXD4;HHEX;HOXD3;LRP5
prerank,negative chemotaxis (GO:0050919),-0.3781421422648338,-1.245509900187472,0.13504823151125403,0.6492528825613475,1.0,7/33,5.19%,ROBO1;EPHA7;SEMA6D;SLIT2;SEMA7A;SEMA3C;SEMA6A
prerank,positive regulation of cellular senescence (GO:2000774),-0.5233013746672692,-1.244771497486599,0.21749408983451538,0.6495469714369977,1.0,4/10,19.73%,B2M;YPEL3;EEF1E1;CGAS
prerank,lipid phosphorylation (GO:0046834),0.5904260372555852,1.2439084219904282,0.25689655172413794,0.8915586778685809,1.0,2/10,3.58%,DGKA;DGKZ
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3771323190499423,1.243623137341331,0.1404109589041096,0.8909270142652019,1.0,11/152,5.35%,GNA14;LPAR1;ADGRG5;ADGRG2;PTGFR;AKAP12;GPR161;MC5R;PTHLH;GNAQ;ADCY5
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5020752924963807,1.2424371503545164,0.21786833855799373,0.8936764199688989,1.0,6/20,11.37%,NEDD4L;PRKCE;CAMK2D;CASQ2;ADRA2A;NEDD4
prerank,ephrin receptor signaling pathway (GO:0048013),0.3984974771004951,1.2420741803221693,0.17267080745341615,0.8932843020806394,1.0,13/82,8.46%,EFNA5;SIPA1L1;ARHGEF28;EFNB1;APH1B;VAV2;SRC;DNM1;NCSTN;EPHB2;NCK2;EFNB2;KALRN
prerank,bone development (GO:0060348),-0.34792341341754623,-1.2420168566542849,0.15267175572519084,0.6560559472595728,1.0,9/39,7.80%,RANBP3L;GNAS;CYP26B1;TGM2;GJA1;FGFR2;PLS3;NOTUM;LRP6
prerank,lysine catabolic process (GO:0006554),0.5734746831576603,1.2416108394007208,0.23488773747841105,0.8916653249689267,1.0,5/12,14.06%,AADAT;OGDH;GCDH;DLST;HYKK
prerank,lysine metabolic process (GO:0006553),0.5734746831576603,1.2416108394007208,0.23488773747841105,0.8916653249689267,1.0,5/12,14.06%,AADAT;OGDH;GCDH;DLST;HYKK
prerank,protein localization to membrane (GO:0072657),0.37052950692855646,1.2401918827855691,0.11293859649122807,0.8952600900750232,1.0,23/187,10.07%,PTCH1;CAV1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;RAB29;KCNIP4;FLOT2;CPE;SH3PXD2B;RABEP1;RDX;EHD2;RAB3A;ITGB7;EFR3A;RAPGEF6;ZDHHC23;ATP1B3;DLG3;FERMT2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5488971657675343,1.2401542170445965,0.21453287197231835,0.8937197391171602,1.0,5/12,24.20%,SOX9;SMO;PAX2;LHX1;SIX1
prerank,sphingolipid biosynthetic process (GO:0030148),0.4133977907763535,1.240027999271836,0.17364532019704434,0.8925382468081895,1.0,16/71,11.60%,SGMS2;CERS6;ACER3;ELOVL5;A4GALT;PLPP2;PLPP3;ALOXE3;CLN8;HACD4;ELOVL1;ELOVL2;CERT1;ST8SIA5;ST8SIA3;HACD2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.558505145522526,1.2393124611326465,0.23235800344234078,0.8936144967366444,1.0,8/13,27.06%,NELFB;SUPT4H1;HEXIM1;TCERG1;RECQL5;EAPP;HNRNPU;NELFA
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5343870590906764,1.239235252199376,0.20922570016474465,0.8922495292939263,1.0,1/15,0.21%,ETV4
prerank,potassium ion export across plasma membrane (GO:0097623),0.5590802937547258,1.2390416060013811,0.2231404958677686,0.8912253060538029,1.0,2/13,8.17%,KCNA5;KCNK5
prerank,regulation of protein localization to membrane (GO:1905475),0.4785264301613912,1.238964385147214,0.19568567026194145,0.8899143969987016,1.0,10/28,17.60%,GPC3;GPC6;ZDHHC7;VAMP8;SLC5A3;GPC2;CRIPT;MMP14;GPC5;SPTBN1
prerank,positive regulation of cellular respiration (GO:1901857),-0.5081143857500285,-1.2381126458751297,0.2266949152542373,0.6655960179836293,1.0,5/11,23.51%,NUPR1;IL10RB;VCP;IFNAR1;ISCU
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.44675268438646815,-1.2375974747160219,0.19899244332493704,0.6654055140539066,1.0,11/17,29.93%,ATP5PD;VPS9D1;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3713328835566901,1.2375846207660335,0.14927048260381592,0.8933857356835213,1.0,45/161,18.76%,CAV1;IGFBP6;LRP4;GLI1;PRICKLE1;DKKL1;AXIN1;MLLT3;SOX9;CHD8;PSME3;DACT1;WNT5A;ZNRF3;CUL3;AMFR;PSMB5;TBX18;STK3;GSK3B;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;KREMEN1;EMD;PSMB2;PSMA2;PTPRU;PTPRO;PSMA6;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7;MDK;INVS;PSME4;PSMC4;PSMB6;PSMD12;RUVBL2;PSMD14
prerank,C-terminal protein amino acid modification (GO:0018410),0.5739066185833275,1.2375107993710506,0.23488773747841105,0.8920311489539857,1.0,7/11,18.81%,GPLD1;AGBL4;ATG5;ATG7;LCMT1;AGBL1;ICMT
prerank,cardiac ventricle development (GO:0003231),0.5127790174033349,1.23711578291958,0.21496815286624205,0.8917463125604347,1.0,2/20,5.24%,STRA6;HEYL
prerank,hemopoiesis (GO:0030097),-0.3066588739356887,-1.2368889883997078,0.10326086956521739,0.6656955043123806,1.0,21/87,13.79%,FLT1;MECOM;NOTCH2;TEK;TGFBR3;BMP4;SNRK;KIT;FGFR2;MEIS1;FLT3LG;KDR;CD34;MKNK2;PGM3;KIRREL3;BMI1;TOX;FLT4;TGFB2;TAL1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.40292217057365853,-1.2365799837927909,0.1952662721893491,0.664788478335221,1.0,4/25,6.00%,ANK2;TRPC1;CACNB2;AKAP6
prerank,regulation of integrin activation (GO:0033623),0.527265520442847,1.2365602635795219,0.24668874172185432,0.8921449386228739,1.0,5/15,10.07%,SRC;PTGER4;PIEZO1;PLEK;FERMT2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.42504244944302294,-1.235255615398587,0.17210682492581603,0.667079761680935,1.0,7/18,12.46%,FRS2;CCN3;HDAC1;BMP2;GSK3A;SOX6;BDNF
prerank,protein K63-linked deubiquitination (GO:0070536),0.46735683748193796,1.2342116423220764,0.2227342549923195,0.89884310827777,1.0,11/31,18.76%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;UIMC1;USP13;OTUD7B;STAMBPL1;STAMBP;PSMD14
prerank,Fc receptor signaling pathway (GO:0038093),0.3903706454197181,1.2341852008926626,0.14736842105263157,0.8973065631206202,1.0,29/110,18.76%,TEC;NFATC2;NFATC1;ITK;MAP3K1;MAPK10;VAV2;PSME3;FER;LCP2;PIK3R2;PSMB5;GAB2;LAT;TAB2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;SYK;BTK;PSME4;NFATC3;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,regulation of feeding behavior (GO:0060259),0.5615573035666492,1.233995698244897,0.24369747899159663,0.8963100706745826,1.0,4/11,16.33%,LEPR;SGIP1;CFAP20;AGRP
prerank,early endosome to Golgi transport (GO:0034498),-0.4979643523335694,-1.2336671184323489,0.2123456790123457,0.6700090589637813,1.0,4/11,8.88%,TRAPPC10;TMED9;RBSN;SURF4
prerank,DNA dealkylation (GO:0035510),0.5774242301916502,1.2335021213597053,0.23105360443622922,0.8948232328209159,1.0,9/10,32.35%,MGMT;ALKBH1;ASCC2;ASCC1;ALKBH2;ALKBH3;FTO;MPG;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5774242301916502,1.2335021213597053,0.23105360443622922,0.8948232328209159,1.0,9/10,32.35%,MGMT;ALKBH1;ASCC2;ASCC1;ALKBH2;ALKBH3;FTO;MPG;ALKBH5
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.4808065436634743,-1.2334978081644867,0.19518072289156627,0.6687525289334812,1.0,5/12,21.80%,PIK3R1;BCL2L11;BOK;XBP1;ATF6
prerank,potassium ion import across plasma membrane (GO:1990573),0.4432871440752622,1.2327387379524017,0.19749652294853964,0.8959799065804743,1.0,7/41,5.58%,KCNJ4;SLC12A2;KCNJ16;SLC12A4;SLC12A3;ATP1A2;KCNJ13
prerank,eye development (GO:0001654),0.41841052882100993,1.232038975286055,0.19154557463672392,0.8969824953968087,1.0,9/54,8.69%,STRA6;EFEMP1;PBX1;BMPR1B;HIPK1;SH3PXD2B;SHROOM2;FREM2;ABCB5
prerank,negative regulation of T cell proliferation (GO:0042130),0.4745466955866031,1.2316104405287878,0.20783132530120482,0.896935531163082,1.0,4/28,7.34%,ARG1;GLMN;IL4I1;CRTAM
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.43888582882819616,-1.230977377941018,0.19505494505494506,0.6742370100252375,1.0,4/19,8.44%,IGF1;PICALM;APOE;RTN1
prerank,L-glutamate transmembrane transport (GO:0015813),0.575409191275439,1.2308108133968834,0.25359712230215825,0.8981963633763801,1.0,5/10,13.00%,SLC25A12;PRAF2;SLC1A6;SLC25A13;SLC25A22
prerank,cellular response to interferon-gamma (GO:0071346),-0.30047098825243895,-1.23043534908539,0.06395348837209303,0.6741824696574245,1.0,24/88,19.77%,DAPK1;SP100;IRF2;TRIM25;SIRPA;B2M;VCAM1;GBP3;JAK2;GBP4;RPL13A;CAMK2A;IRF1;GAPDH;GBP6;CCL13;GBP7;LGALS9;GBP2;MT2A;TRIM8;PDE12;DAPK3;ICAM1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.283476834553574,-1.2303715313658654,0.0472972972972973,0.6725942526794295,1.0,27/124,14.92%,FRY;PTPRM;RAPGEF2;TPM1;LYN;FRYL;STMN2;RASGRF1;GPRIN3;APOE;EPHA8;TBC1D24;STMN4;CAMSAP1;WDPCP;RAB13;LAMB1;MANF;ATP1B2;RAB11A;STMN1;LGI1;MAPT;SH3GL2;DTNBP1;MICALL1;CDK5R1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4819456517605277,-1.2303534079054153,0.2119047619047619,0.670880711737549,1.0,6/12,21.63%,LDLR;APOE;VBP1;CRYAB;PFDN4;CLU
prerank,cilium organization (GO:0044782),0.36384567115075095,1.2302520489068545,0.13132400430570507,0.898544516744809,1.0,57/209,18.88%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;DYNC2I1;CYS1;EXOC3;CNGB1;INTU;CEP89;CEP131;IFT81;CEP78;CNGA4;EHD2;SNX10;CEP162;CLUAP1;CCP110;ARMC2;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;HDAC6;CFAP20;EXOC5;CEP290;FAM161B;PKD1;FBF1;PCM1;PDE6D;IQCG;FAM161A;DNAH5;CFAP298;CFAP70;PIBF1;CFAP61;CFAP410;B9D2;CDC14A;DYNC2H1;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.45780981436359935,1.2297799762427941,0.19825072886297376,0.8986054118572931,1.0,5/35,3.59%,CAV1;NR2F2;SULF1;NF1;CAV2
prerank,positive regulation of B cell proliferation (GO:0030890),0.47386125535734513,1.2288602116036398,0.22018348623853212,0.9003390677850508,1.0,7/29,13.16%,NFATC2;PTPRC;EPHB2;CD320;GPR183;CD81;IL7
prerank,glucose metabolic process (GO:0006006),0.41343324430150374,1.228841302607774,0.20160213618157544,0.8987915533441281,1.0,14/58,17.85%,APOD;PPARGC1A;SLC25A12;ALDOB;PGM1;ADPGK;MDH1;SLC25A13;ENO3;GOT1;HECTD4;PGK1;IRS2;ENO2
prerank,positive regulation of dendrite extension (GO:1903861),0.5185666908656785,1.2283912117709133,0.24193548387096775,0.8987252440049134,1.0,3/17,9.00%,NEDD4L;RIMS2;CPNE9
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.35872666832447136,1.2280711303494676,0.11814345991561181,0.8983187109421582,1.0,69/259,18.88%,DYNLL1;CDH13;PARVA;NTN1;UBXN10;RAP1A;RAB8B;ABLIM3;EMP1;MKS1;MINK1;SPEF1;ANO6;PTPDC1;DZIP1;OPHN1;DYNC2I1;CYS1;EXOC3;CNGB1;INTU;CEP89;CEP131;IFT81;ABLIM2;CNGA4;EHD2;SNX10;ARF6;CEP162;CLUAP1;RAPGEF6;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;MTSS1;HDAC6;CFAP20;EXOC5;CEP290;ARHGEF6;PKD1;FBF1;PCM1;PDE6D;FAM161A;DNAH5;PTPRO;VSTM5;CFAP298;CFAP70;PIBF1;CFAP410;EZR;B9D2;CDC14A;ARHGEF7;DYNC2H1;S1PR2;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4415811050246735,1.2279727105902936,0.2211126961483595,0.8970896685661544,1.0,3/38,1.84%,CAV1;CAMK2D;KCNA5
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3534867155372786,-1.227873128183032,0.18027210884353742,0.676488692170918,1.0,9/41,7.30%,PRKAG2;NUP107;EP300;LACC1;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,carnitine shuttle (GO:0006853),-0.5049575624243414,-1.227309983542411,0.22727272727272727,0.6764849768661688,1.0,5/11,14.68%,PRKAG2;CPT2;PRKAB2;CPT1A;MID1IP1
prerank,protein autophosphorylation (GO:0046777),-0.27271764675823273,-1.22728167202434,0.07407407407407407,0.6748130163978464,1.0,39/157,13.57%,FLT1;IGF1R;DAPK1;INSR;TEK;PDGFRB;PDGFRA;GRK5;LYN;DDR1;EPHA4;KIT;FGFR2;STK17B;SIK1;KDR;BMX;EPHA8;CDK12;JAK2;MAP2K2;STK10;MKNK2;AKT1;ULK2;CAMK2A;MAP3K10;CDKL5;EIF2AK4;MKNK1;CAMK4;OXSR1;LRRK2;FGFR4;TAOK2;FLT4;MAPKAPK2;PIM3;MAPKAPK3
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.48150989216142026,1.2266576390136605,0.2253731343283582,0.9002008382284232,1.0,7/26,13.79%,FGFR1;EYA1;IL1A;MCL1;MAPK7;PPP2R1B;HTRA2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3523936685461116,1.2265642719412033,0.09713701431492842,0.898943073840017,1.0,31/348,5.38%,NGF;THBS4;CAV1;EFNA5;FGF7;TEC;NTRK3;INHBB;CSPG4;CLDN19;LEPR;EGFR;RAPGEF3;CCND3;MUSK;RAP1A;PELI2;FGF1;AXIN1;FXR2;PRKAG1;MMD2;SOX9;SRC;BMP5;ATP2B4;LIMK2;PTPRC;BANK1;TOM1L1;BMP15
prerank,positive regulation of axonogenesis (GO:0050772),0.4375276696852212,1.2264162986972615,0.19941775836972345,0.8978942185534722,1.0,3/43,1.05%,NGF;NTN1;TIAM2
prerank,cellular response to chemokine (GO:1990869),0.4351913037801147,1.226322354989213,0.228,0.8966333906415337,1.0,3/46,1.71%,ACKR3;RIPOR2;SLC12A2
prerank,sodium ion transport (GO:0006814),0.3978970223165719,1.22623193072897,0.17967781908302355,0.8954065587301806,1.0,12/85,7.04%,NEDD4L;SCN10A;NALCN;SLC12A2;ANO6;SLC24A1;SLC12A3;KCNK1;ATP1A2;SLC6A13;SLC4A4;SLC4A11
prerank,glycoprotein biosynthetic process (GO:0009101),-0.30762207556122295,-1.225545582694948,0.0967741935483871,0.6784560817722246,1.0,20/79,14.84%,IGF1;ST3GAL6;ST3GAL5;ST8SIA4;CSGALNACT1;CHST11;ATP7A;COG7;BMPR2;CSGALNACT2;ST6GALNAC2;ALG5;FAM20B;B4GALT7;ALG1;GOLGA2;B3GALT2;ST8SIA2;CHST9;GCNT1
prerank,mRNA stabilization (GO:0048255),0.43535754397295207,1.2254871822673237,0.22312925170068026,0.8964642402277408,1.0,11/40,19.35%,HNRNPC;DND1;HNRNPA0;TENT5C;AXIN2;TENT5D;TAF15;SYNCRIP;E2F1;DHX9;YBX3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3576208516989959,1.2254321820723508,0.11808510638297873,0.8951011532700786,1.0,70/248,18.76%,CAV1;IGFBP6;GPC3;LRP4;GLI1;PRICKLE1;PPM1N;DKKL1;NRARP;FOLR1;EGFR;AXIN1;MLLT3;SOX9;CHD8;GNAQ;PSME3;DACT1;WNT5A;PPM1A;USP8;UBR5;PLEKHA4;FAM53B;KANK1;ZNRF3;CUL3;AMFR;CSNK1G3;PSMB5;RNF220;STK3;GSK3B;USP47;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;COL1A1;KREMEN1;EMD;SOX4;PSMB2;FZD7;CAPRIN2;PSMA2;PTPRU;PTPRO;PSMA6;FZD9;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7;MDK;PPP1CA;INVS;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;RUVBL2;PSMD14
prerank,regulation of glycolytic process (GO:0006110),-0.3178835640865197,-1.2248802141086923,0.1050228310502283,0.6786613324398307,1.0,12/68,7.30%,PRKAG2;IGF1;INSR;NUPR1;NUP107;CBFA2T3;EP300;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3414816495097588,-1.2248298181144628,0.1510791366906475,0.6770288983736363,1.0,18/47,21.72%,IMMT;ATP5PD;DMAC2L;ATP5MC3;MICOS13;SAMM50;GHITM;ATP5PF;OPA1;MTX2;ATP5ME;ATP5PO;TIMM10B;TIMM8B;ROMO1;MAIP1;TIMM29;ATP5MC2
prerank,T cell activation (GO:0042110),0.398163320379489,1.2247137511623951,0.173053152039555,0.8961883761898782,1.0,10/69,7.89%,CXADR;LEPR;ITK;CD3G;RAB29;PTPN22;PTPRC;NCK2;CRTAM;DPP4
prerank,energy reserve metabolic process (GO:0006112),-0.4323687508033991,-1.2246962967284685,0.22281167108753316,0.6756732645811919,1.0,4/19,7.21%,PRKAG2;PID1;GBE1;UGP2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3758256822178963,1.22458645060091,0.15113636363636362,0.8950344964058342,1.0,28/140,8.85%,DLC1;TIAM2;ARHGAP31;PLCE1;ARHGAP18;ARHGAP12;ARHGAP32;ARHGAP9;ARAP1;DEPDC1B;AKAP13;OPHN1;RACGAP1;VAV2;SRC;RAC2;NUP62;TRIO;ARHGEF5;ARHGAP26;RHOJ;ARHGEF1;CGNL1;PIK3R2;STARD13;KALRN;OBSCN;OCRL
prerank,glutamate receptor signaling pathway (GO:0007215),-0.36473121795136765,-1.2244680461479156,0.14093959731543623,0.6747232175042785,1.0,10/37,9.11%,PLCB1;KCNB1;GRM3;GRIA2;CPEB4;GRIN3A;GRIN2B;DAGLA;GRIK2;GRIN1
prerank,ceramide metabolic process (GO:0006672),0.421162862968827,1.224030743944604,0.2147477360931436,0.8954436304702292,1.0,8/49,6.26%,SGMS2;CERS6;ACER3;PLPP2;PLPP3;ALOXE3;CLN8;CERK
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4205718633904378,1.2238753404789238,0.20675675675675675,0.8944283921320766,1.0,15/54,17.14%,CAV1;SH3RF2;OGT;TNFAIP3;TRIM21;N4BP1;SIRT7;SPOPL;NXN;USP4;SOX4;GNL3L;BAG2;MINAR1;CHP1
prerank,protein localization to plasma membrane (GO:0072659),0.37765780236947344,1.2237772204744362,0.16878612716763006,0.8932039987240777,1.0,15/129,9.40%,PTCH1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;KCNIP4;FLOT2;RDX;EHD2;RAB3A;EFR3A;RAPGEF6;ZDHHC23;ATP1B3
prerank,regulation of defense response to virus (GO:0050688),0.5373997411165979,1.223710543394268,0.252129471890971,0.8918995626194899,1.0,6/14,20.98%,PCBP2;TNFAIP3;ZMPSTE24;ITCH;DHX9;TRAF3
prerank,positive regulation of protein acetylation (GO:1901985),0.5711549879672476,1.2236049406680058,0.2233502538071066,0.8907614067592313,1.0,2/12,4.33%,RAPGEF3;DIP2A
prerank,regulation of mRNA processing (GO:0050684),0.46038891294171214,1.2231951346028513,0.21594202898550724,0.8906607927174451,1.0,18/32,26.68%,QKI;SON;SRPK1;SLTM;KHDRBS2;SRPK2;SF1;CWC22;SRSF3;DHX9;TIA1;SRSF10;YTHDC1;JMJD6;IWS1;PABPN1;SAFB2;RBM39
prerank,axonogenesis (GO:0007409),0.35606392180534374,1.2230092532879109,0.12249208025343189,0.8898204960039581,1.0,36/237,11.18%,NTNG2;NTNG1;GAB1;EFNA5;LAMA2;EFNB1;NRP2;PARD6B;SEMA4B;GLI2;OPHN1;S100A6;PRKCA;SRC;DSCAM;WNT5A;BRSK1;ARTN;LAMA5;EPHB2;RAB3A;DAG1;EFNB2;SEMA3A;NTN3;SIAH1;MAPK7;S100B;ISL1;TNR;NTN4;GAB2;POU4F1;RELN;DOCK7;SLC9A6
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4180203777493211,-1.2230087916047516,0.18699186991869918,0.6773736351280238,1.0,4/19,6.38%,PARD3;CLIC4;ERBIN;SYNJ2BP
prerank,proteolysis (GO:0006508),0.3543329367649369,1.2226554400443017,0.11330561330561331,0.8895303109023635,1.0,52/252,17.66%,PTCH1;CTRC;ADAMTS12;TINAGL1;FAP;NAALAD2;PCSK5;ADAM19;OGT;SENP6;MMP15;APH1B;CPE;CAPN6;CPA2;RNPEP;NCSTN;ADAM10;LVRN;DPP4;FBXO3;PSMB5;LNPEP;UFSP2;PCSK7;BACE2;LONP1;MMP12;MME;PROC;CELA1;TASP1;XPNPEP3;MMP16;CAPN2;MIPEP;ATG4C;HTRA2;PSMA6;PLG;GGT1;FAM111A;TYSND1;NLN;ZMPSTE24;BACE1;MBTPS1;PM20D2;MMP14;TMPRSS7;BMP1;CTSB
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3715263598082946,1.2219577516346127,0.16176470588235295,0.8905200853546008,1.0,12/140,7.88%,CAV1;LPAR1;ACKR3;PLCE1;ITPR3;PTGFR;CD55;TRPV4;FIS1;ADCY5;ABL2;PTGER4
prerank,regulation of osteoblast proliferation (GO:0033688),-0.43919564697305497,-1.221737661394862,0.23057644110275688,0.6793765520738738,1.0,5/17,10.53%,NPR3;FGFR2;MN1;CCN1;BMP2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.44147161842885335,-1.2217320298855339,0.22432432432432434,0.6776707748700791,1.0,7/18,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;HPGDS;MIF
prerank,protein K48-linked deubiquitination (GO:0071108),0.4855341259966982,1.2215372154802093,0.24434389140271492,0.8905954071714963,1.0,6/23,11.06%,USP50;TNFAIP3;USP8;OTUB2;MINDY2;OTUD7B
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.522137633529319,1.2214417198517042,0.23383084577114427,0.8894214913335313,1.0,2/16,2.06%,FOXD1;FGF1
prerank,regulation of dendrite extension (GO:1903859),0.5132730320023142,1.2213886199799382,0.24121405750798722,0.8880885252209224,1.0,3/18,9.00%,NEDD4L;RIMS2;CPNE9
prerank,regulation of protein catabolic process (GO:0042176),0.3908222024437813,1.221031296476829,0.17295980511571254,0.8879266306326058,1.0,11/99,6.08%,PLK2;GPC3;NEDD4L;EGFR;AXIN1;FAM83D;IRAK3;DACT1;WNT5A;TNFAIP3;AZIN2
prerank,regulation of vasoconstriction (GO:0019229),0.4733090323418304,1.2205911314082152,0.22205438066465258,0.8879930992642624,1.0,3/27,3.83%,CAV1;SMTNL1;SMTNL2
prerank,establishment of endothelial barrier (GO:0061028),0.468089459989088,1.2202860496937573,0.21568627450980393,0.8875965358357263,1.0,7/29,8.68%,F11R;RAPGEF3;RAP1A;PDE4D;TJP2;RDX;RAPGEF6
prerank,regulation of sequestering of calcium ion (GO:0051282),0.55051609416603,1.2201289574192231,0.24555160142348753,0.8866440281549153,1.0,3/12,9.04%,UBASH3B;FKBP1B;CASQ2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4009496041917288,1.22001804166108,0.20558375634517767,0.8855568409519673,1.0,7/75,5.06%,DCN;THBS4;SULF1;ADAMTS1;SPRED1;ATP2B4;AMOT
prerank,maintenance of protein localization in organelle (GO:0072595),0.5122448568852759,1.219372050955271,0.25196850393700787,0.8863658174280213,1.0,3/19,4.75%,HK2;BCL3;MORC3
prerank,regulation of interleukin-2 production (GO:0032663),0.43336666092615345,1.2185007086459387,0.2096128170894526,0.8879050468898272,1.0,6/43,5.87%,HOMER2;GLMN;PDE4D;IL1A;PTPRC;TNFAIP3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4350850829099454,-1.2183294847268165,0.19576719576719576,0.6860644936369832,1.0,7/17,36.15%,LPGAT1;PLA2G4F;CRLS1;LPCAT1;PLA2G4B;PLA2G5;LPCAT4
prerank,hexose metabolic process (GO:0019318),0.43058652104867357,1.218320062823686,0.21181556195965417,0.8870861640694626,1.0,10/39,19.40%,APOD;ALDOB;PGM1;ADPGK;GALK1;GALK2;PMM1;HECTD4;IRS2;SLC37A4
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.521172196267511,1.2176750579168092,0.24790619765494137,0.8879908379157021,1.0,3/17,7.45%,JAG1;CD55;MSH2
prerank,membrane fusion (GO:0061025),-0.3704207452686568,-1.2172669902209072,0.1950354609929078,0.6874756212876411,1.0,4/33,3.74%,MYOF;DNM3;DYSF;NAPA
prerank,response to nutrient levels (GO:0031667),-0.43543615125555646,-1.2166640058290685,0.21558441558441557,0.6875386842841882,1.0,8/17,32.24%,KCNB1;RPS6KB1;EIF4G1;ATF4;FAM107A;PRKAA1;MEAK7;ULK1
prerank,endodermal cell fate commitment (GO:0001711),0.5770968824367251,1.21640357166065,0.2603978300180832,0.8910442112389733,1.0,4/10,20.09%,LEO1;PAF1;RTF1;CDC73
prerank,acyl-CoA biosynthetic process (GO:0071616),0.521825574384557,1.2161170246177806,0.25949367088607594,0.8905301664447635,1.0,5/16,7.77%,DIP2A;SCD5;ACACA;GCDH;ACAT1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5080392765765703,1.216068064926014,0.2353870458135861,0.889234585326813,1.0,6/19,17.59%,HNRNPC;SRC;STN1;EXOSC10;GNL3L;TERF2
prerank,regulation of intracellular protein transport (GO:0033157),0.45679253365034056,1.216000804145915,0.23269513991163476,0.8879824201748809,1.0,10/32,13.86%,RAB29;KIF20B;PTPN14;CEP131;RIPOR1;SIRT7;GCC2;TPR;CEP290;PCM1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.37336112089689333,-1.2157917820579074,0.15868263473053892,0.6884102195291809,1.0,6/31,6.38%,PARD3;MSN;CDC42;LIN7A;ERBIN;SYNJ2BP
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4614528104190705,-1.215438833918784,0.21658986175115208,0.6877892857408721,1.0,7/14,16.79%,SEMA7A;KIT;PLCG2;BCL10;CAMK4;LAPTM5;GPRC5B
prerank,T cell mediated immunity (GO:0002456),0.5468556716020118,1.2147180937227908,0.25538971807628524,0.8909702080743456,1.0,3/13,7.34%,JAG1;CD55;CRTAM
prerank,kidney development (GO:0001822),0.4054426700195521,1.2136639153960387,0.20737913486005088,0.8930549353391846,1.0,7/65,5.45%,STRA6;LRP4;SULF1;PCSK5;GLI2;NF1;KANK2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.4474671942311219,-1.213603171878652,0.2467866323907455,0.691513539860541,1.0,2/15,5.90%,MOXD1;SAT1
prerank,regulation of focal adhesion assembly (GO:0051893),0.4125704797954975,1.213449759638849,0.20394736842105263,0.8923037329753777,1.0,5/54,4.48%,APOD;EFNA5;DLC1;PEAK1;SRC
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.34403318324900856,-1.213252674046538,0.1724137931034483,0.6908170195909494,1.0,10/43,7.71%,ITGA1;TGFA;ERRFI1;PTPN3;RNF115;CDC42;ZFYVE28;DUSP3;SH3KBP1;EPS15
prerank,regulation of peptidase activity (GO:0052547),0.501020501945174,1.2130461730396496,0.25728155339805825,0.8921733259912814,1.0,1/19,0.24%,CAV1
prerank,prostanoid biosynthetic process (GO:0046457),-0.46144755886254446,-1.212645183474213,0.21173469387755103,0.6907690641777922,1.0,6/15,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;MIF
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.42871969342599003,1.2125813845896054,0.22479564032697547,0.8923364833862372,1.0,7/46,8.41%,CNKSR3;RGS14;SPRED1;SPRY1;PTPRC;EPHB2;TNIP1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.393670766696359,-1.2123362872406735,0.19519519519519518,0.6900750655020759,1.0,7/23,16.28%,SASH1;TRAF6;MAP3K10;RPS3;TNFRSF11A;EDN1;DVL2
prerank,peptide catabolic process (GO:0043171),-0.4045901213604731,-1.2123243628980342,0.1933534743202417,0.6883879619573374,1.0,5/23,8.79%,ECE1;CPQ;CTSH;ACE;TPP1
prerank,retina homeostasis (GO:0001895),-0.3988410452888894,-1.2121660622724595,0.2057142857142857,0.6871557487506863,1.0,8/23,21.96%,B2M;ACTB;POTEF;ACTG1;ATP1B2;POC1B;HSPB1;TULP1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.42607867539650646,-1.2115156383997558,0.18548387096774194,0.687492713522439,1.0,4/20,11.67%,IGF1;EP300;TRAF6;H1-0
prerank,regulation of histone acetylation (GO:0035065),0.4527719556271872,1.2108190504731204,0.24057971014492754,0.8970715581831733,1.0,4/33,3.65%,PPARGC1A;RAPGEF3;KMT2A;SPI1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.42677552977448885,-1.2103082174298077,0.23040380047505937,0.6893061705908665,1.0,3/16,2.56%,PLCB1;RANBP3L;IGFBP3
prerank,artery morphogenesis (GO:0048844),0.45244292325393887,1.2099628989065248,0.24415204678362573,0.898608106778071,1.0,4/30,3.23%,STRA6;FOLR1;JAG1;NF1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4602261452592884,1.2094903508861738,0.24289772727272727,0.8987629622329255,1.0,4/30,5.76%,DCN;CSPG4;CHST7;NCAN
prerank,endocardial cushion development (GO:0003197),-0.39907516596431397,-1.209373912729382,0.21705426356589147,0.6903385750513066,1.0,5/21,3.88%,ENG;NOS3;BMP4;ACVRL1;BMPR2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3942194696397714,1.2087216987757659,0.1967821782178218,0.9000051017530895,1.0,11/79,5.62%,DLX1;ADAMTS12;SULF1;CASK;SPRY1;BMPR1B;NBL1;SPRY4;ATP2B4;CREB3L1;APLN
prerank,positive regulation of catalytic activity (GO:0043085),0.4470352111605037,1.2085400958231212,0.23676880222841226,0.8991480628180802,1.0,6/37,7.45%,CAV1;MSH6;NCSTN;AZIN2;ABL2;MSH2
prerank,positive regulation of signal transduction (GO:0009967),-0.25282788450543686,-1.2083515151139013,0.06557377049180328,0.6918079915804678,1.0,62/238,14.97%,IGF1;ROBO1;SASH1;VWF;TEK;PTGIS;CCBE1;RSPO3;SHANK3;BMP6;WLS;RBPJ;GRB10;NOS3;PIK3R1;TGFBR1;IGF2;EP300;MBD5;FGFR2;MN1;CCN3;F3;HIF1A;FAS;DSTYK;RSPO2;PDCD10;CUX2;SLC39A14;JAK2;JAG2;CITED2;GRIN1;TRIM16;ATP6V0C;ASXL2;FLNA;SNW1;TXNDC15;DCDC2;TM2D3;RPS3;MACF1;BMP2;KLF2;CD80;LRRK2;PRKCZ;CTBP2;TTC23;NRXN1;LOXL3;BDNF;TGFB2;CSNK2A1;CDKN2AIP;MAML3;ILK;RWDD3;ESM1;NRP1
prerank,thyroid hormone generation (GO:0006590),-0.4935858056356618,-1.2083272874481392,0.24161073825503357,0.6901720117717989,1.0,5/10,34.12%,CPQ;DIO2;FOXE1;TG;CTSK
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3291356984754357,-1.2078423774078118,0.16666666666666666,0.689957916671278,1.0,26/57,28.24%,TGS1;RPS15;RPL35A;RPS7;RPL26;NPM1;HEATR3;RPS24;RPS19;RPS16;RPS17;WDR12;RPL38;RIOK1;NOC2L;RPS6;DHX37;RPL14;RPL5;MRPL36;RPS25;PAK1IP1;RPF2;RPL7;RPL11;NOP16
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.41946504248828037,-1.2078258591920668,0.18867924528301888,0.6883344601744099,1.0,9/19,36.26%,ADK;HPRT1;CDA;POLD2;APRT;ADA;POLL;TYMS;GMPR
prerank,endothelial cell differentiation (GO:0045446),-0.4791646309059601,-1.2074247769792903,0.22588832487309646,0.6878367881989035,1.0,6/12,10.38%,TIE1;ACVRL1;BMPR2;KDR;SCUBE1;PROX1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.48293104830830075,1.207055953460845,0.24566473988439305,0.9028887611488084,1.0,5/21,9.41%,IL4I1;PTPN22;BANK1;TNFAIP3;FOXJ1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.35635206120613183,1.206965877907527,0.14285714285714285,0.9017231651541106,1.0,19/214,6.39%,ROR2;CNKSR3;ROR1;NTRK3;ACKR3;RGS14;CEACAM1;EGFR;RAP1A;SPRED1;SPRY1;PTPN22;PRKCA;FAM83D;PTPRC;FN1;STYX;ARHGEF5;EPHB2
prerank,tryptophan catabolic process (GO:0006569),0.5458317101705347,1.2067578912480796,0.25510204081632654,0.9010236521510687,1.0,2/11,3.76%,IL4I1;AADAT
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37149924860923017,1.206653739372738,0.17445838084378562,0.8998801728793957,1.0,46/129,21.95%,CAV1;GPC3;PPM1N;NRARP;EGFR;AXIN1;PSME3;DACT1;PPM1A;USP8;UBR5;PLEKHA4;FAM53B;KANK1;CSNK1G3;PSMB5;RNF220;USP47;AXIN2;COL1A1;SOX4;PSMB2;CAPRIN2;PSMA2;PSMA6;FZD9;PSMD13;PSMA7;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;PSMD14;PIN1;TRPM4;RNF146;USP34;CCAR2;PSMB3;GSKIP;GID8
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5762492811617828,1.206410960217209,0.24558303886925795,0.899298837004341,1.0,3/10,9.58%,OGT;SELENOS;SIRT7
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.565053977405666,1.2063768420880705,0.2701252236135957,0.8979516585602291,1.0,6/10,21.05%,SESTD1;FKBP1B;ATP1A2;ADRA2A;YWHAE;CBARP
prerank,positive regulation of epithelial cell migration (GO:0010634),0.38643637682746107,1.2063571783068714,0.19904076738609114,0.8965693060526126,1.0,12/92,4.96%,FGF7;SMOC2;DOCK5;PRKCE;FGF1;NRP2;DOCK1;GPLD1;SOX9;PRKCA;SRC;WNT5A
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4546723435552351,-1.206058209678966,0.22774869109947643,0.6902172946014049,1.0,4/15,13.37%,OSBPL8;OSBPL11;ABHD5;PLIN3
prerank,ganglion development (GO:0061548),0.5663854182771341,1.2058412094664845,0.26798561151079137,0.8969041193977408,1.0,3/11,14.91%,NRP2;SEMA3A;FZD3
prerank,positive regulation of cell differentiation (GO:0045597),-0.2554602148426505,-1.2057744921027436,0.06779661016949153,0.6893283889805674,1.0,47/237,10.53%,TCF4;PLCB1;IGF1;RANBP3L;SOX5;SLC6A6;RAPGEF2;SMAD3;LEF1;PRKCH;BMP6;ARHGEF2;DAB2;IL6R;CCN2;TMEM64;PPARD;CDC42;CREBL2;IGFBP3;BMP4;GJA1;TGFBR1;WNT4;ACVRL1;BMPR2;IL18;HOXB4;HOXA5;BRINP3;AGTR1;KDR;CD34;MEF2A;MAPK12;GLIPR2;CDON;TGFB3;AKT1;CMKLR1;CREB1;ASXL2;LRRC8A;ZC3H12A;CCN1;AR;BMP2
prerank,negative regulation of protein processing (GO:0010955),-0.48465369376473555,-1.2054728721092043,0.23627684964200477,0.6884929885106612,1.0,4/12,13.20%,GAS1;SERPINE2;LRRK2;THBS1
prerank,negative regulation of axonogenesis (GO:0050771),0.4600751220705248,1.204491921339655,0.25274725274725274,0.9000922742130301,1.0,9/27,18.52%,LRP4;RTN4R;CDKL3;GDI1;TRIM46;PTEN;RTN4;EFNB3;RHOA
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.45169292491713675,1.203514862770175,0.24631268436578171,0.9020154976899307,1.0,5/30,8.91%,OGT;FHIT;STYX;N4BP1;DDRGK1
prerank,T-helper cell differentiation (GO:0042093),-0.4516231075586451,-1.2027628236431853,0.22139303482587064,0.6951002252815836,1.0,3/14,3.31%,LEF1;FOXP1;ATP7A
prerank,lung epithelium development (GO:0060428),0.5558660099654245,1.2023135797299713,0.2737226277372263,0.9049282822538899,1.0,1/10,0.21%,STRA6
prerank,histone H4-K16 acetylation (GO:0043984),0.5092985893688324,1.2021847538322747,0.25826771653543307,0.9039501248798898,1.0,4/19,7.54%,OGT;KMT2A;KANSL2;MSL3
prerank,regulation of establishment of cell polarity (GO:2000114),0.5220641826336907,1.2019429079878845,0.25967741935483873,0.9033757457974194,1.0,4/16,7.57%,RIPOR2;CDH5;KIF20B;KANK1
prerank,positive regulation of cell motility (GO:2000147),0.3550032799260214,1.2019365922747427,0.15982721382289417,0.90194607319252,1.0,23/205,7.12%,ROR2;CLDN1;ITGA6;CAV1;NTRK3;CDH13;NTN1;EGFR;GTSE1;FGF1;SEMA4B;SH3RF2;CDH5;ITGAX;PRKCA;CAVIN1;FER;TRADD;ADAM10;EPHB2;RDX;RIPOR1;SEMA3A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.39238345438035216,1.2013107814851018,0.22588832487309646,0.9026934126562633,1.0,12/80,11.89%,TENM2;RIPOR2;PLCE1;ARAP1;CDC42EP4;RAC2;PALM;CCP110;OCLN;GPM6A;APC;AKIRIN1
prerank,melanosome localization (GO:0032400),-0.402690190200383,-1.2011007724749083,0.21739130434782608,0.6983950713253404,1.0,9/21,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,response to exogenous dsRNA (GO:0043330),0.4985031713485284,1.2005799044424788,0.2634146341463415,0.9038011080325736,1.0,3/18,9.65%,CAV1;IRAK3;TICAM1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.43020112591632054,-1.1999191113676297,0.2271604938271605,0.7002819739778993,1.0,4/18,7.84%,UNC13C;NAPA;GRIA2;GRIK2
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.3007660613043054,-1.1988922240514228,0.13157894736842105,0.7017348052712663,1.0,18/85,9.51%,IGF1;MCC;TGFA;OSR1;ANGPT1;BMP6;TGFBR3;NUPR1;BMP4;TIE1;ACVRL1;FGFR2;B2M;DUSP10;TBX1;CDK6;AQP11;LAMB1
prerank,secretion (GO:0046903),-0.4567559301863515,-1.1988803795662084,0.24285714285714285,0.7000938232046022,1.0,4/14,5.70%,SLC22A6;SLC22A4;NPR1;FBLN5
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5695879241325013,1.1988003293683471,0.2830188679245283,0.9087184788604865,1.0,2/10,4.65%,ARHGAP12;BMP5
prerank,nitric oxide metabolic process (GO:0046209),-0.44380373480632895,-1.1986510281041562,0.22982885085574573,0.69912345239666,1.0,4/14,8.19%,NOS3;CYP1B1;GCH1;AKT1
prerank,positive regulation of cyclase activity (GO:0031281),0.517704145357039,1.1976855596241267,0.26700680272108845,0.9112160750324427,1.0,2/14,3.23%,GUCA1A;NF1
prerank,natural killer cell activation (GO:0030101),0.47790002525700737,1.1967059562747995,0.24921135646687698,0.9131239311353986,1.0,6/23,18.49%,PBX1;PTPRC;IL21R;AXL;ULBP1;RABL3
prerank,epithelial cell migration (GO:0010631),0.4403551693748654,1.1966821587707615,0.23597122302158274,0.9117549569296775,1.0,7/37,8.07%,CDH13;PXN;FAP;KANK2;KANK1;DPP4;STARD13
prerank,gastrulation (GO:0007369),0.5135020565027746,1.196659652675847,0.2620232172470978,0.9103769382202418,1.0,1/15,0.41%,GPC3
prerank,actomyosin structure organization (GO:0031032),0.3871069438359758,1.1964113026207737,0.21192893401015228,0.9097530588595456,1.0,12/75,8.79%,F11R;SORBS1;EPB41L4A;EPB41L2;EPB41L3;TMOD2;CSRP3;SRC;KRT19;CUL3;TMOD1;OBSCN
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.383397835690058,-1.196319610825021,0.2127659574468085,0.7047428279877873,1.0,6/25,7.06%,SLC7A5;KIT;LACC1;B2M;TRAF6;PLCG2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.474042498625608,-1.1960687210626135,0.2553191489361702,0.7038303783792672,1.0,6/12,22.77%,LRRK2;TMEM9;CLN5;GRN;CLN6;CCDC115
prerank,cellular copper ion homeostasis (GO:0006878),-0.4487428444665117,-1.195762337856382,0.22966507177033493,0.7030051802826996,1.0,3/14,5.15%,ATP7A;SLC31A1;SLC31A2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.403357882628619,-1.1957293239728237,0.22674418604651161,0.7014286293068508,1.0,3/21,2.21%,OSBPL8;OSBPL10;PLA1A
prerank,negative regulation of cell communication (GO:0010648),0.4993997462247257,1.1952594946761104,0.2778625954198473,0.9123893877364041,1.0,2/21,2.26%,UBASH3B;SOCS5
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4995123122158823,-1.1946598624734055,0.24824355971896955,0.7029319818433797,1.0,2/10,4.80%,GRB10;HIF1A
prerank,heterocycle biosynthetic process (GO:0018130),-0.4533364317382256,-1.1939949247853037,0.26448362720403024,0.7033100058483436,1.0,9/14,40.89%,GCH1;NFS1;PYCR2;MOCS3;PYCR3;PYCR1;ALOX5;GPHN;NOXRED1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5181838165712414,1.1937377628789916,0.2631578947368421,0.9163287034492764,1.0,4/13,11.54%,KPNA7;KPNA2;CBLB;RANBP2
prerank,positive regulation of dendrite development (GO:1900006),0.5644704009204249,1.1934530772357135,0.26548672566371684,0.9158491236409345,1.0,2/10,4.65%,COBL;BMP5
prerank,axonal fasciculation (GO:0007413),-0.47116278978471454,-1.1932943127045212,0.24941176470588236,0.7036968548924561,1.0,6/12,16.72%,EPHA3;EPHA4;ARHGAP35;MEGF8;CDK5R1;EPHB3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.44645901437123325,1.193030001517295,0.2525399129172714,0.9159493978326929,1.0,3/31,3.05%,ARG1;GLMN;IL4I1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4031848795434108,1.1920840923860907,0.2237851662404092,0.9178361741636573,1.0,6/63,5.90%,ITGA6;CAV1;FGFR1;SRC;PSME3;TRADD
prerank,cellular response to interleukin-7 (GO:0098761),0.5008286809770733,1.1917621236152325,0.26324237560192615,0.9160750607517664,1.0,9/17,20.74%,IL7;IL2RG;SOCS1;BRWD1;IRS2;JAK1;SOCS2;STAT5B;CISH
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5008286809770733,1.1917621236152325,0.26324237560192615,0.9160750607517664,1.0,9/17,20.74%,IL7;IL2RG;SOCS1;BRWD1;IRS2;JAK1;SOCS2;STAT5B;CISH
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.4357907094849921,1.1902799642822088,0.2702702702702703,0.9198866497527579,1.0,5/36,8.91%,OGT;FHIT;OPHN1;N4BP1;DDRGK1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.38756338536340984,1.1901545346412596,0.22139303482587064,0.9188907283155547,1.0,5/85,2.95%,ROR1;HOMER2;PIEZO2;RIPOR2;EYA1
prerank,positive regulation of glycolytic process (GO:0045821),-0.4148012965418464,-1.189728693207362,0.21348314606741572,0.7112436770282251,1.0,8/20,19.41%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;ENTPD5;GAPDHS
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.4148012965418464,-1.189728693207362,0.21348314606741572,0.7112436770282251,1.0,8/20,19.41%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;ENTPD5;GAPDHS
prerank,endothelial cell proliferation (GO:0001935),-0.4175081272310755,-1.188544530638906,0.21298701298701297,0.7132171243245017,1.0,5/17,6.50%,TEK;BMP4;ACVRL1;BMPR2;CD34
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3524919318055968,1.188424459326165,0.17980022197558268,0.9235440070274656,1.0,41/186,15.71%,CAV1;IGFBP6;LRP4;VGLL4;GLI1;PRICKLE1;DKKL1;NFATC1;AXIN1;MLLT3;SOX9;CHD8;PSME3;DACT1;WNT5A;HIC1;ZNRF3;CUL3;AMFR;PSMB5;STK3;GSK3B;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;KREMEN1;NXN;EMD;CTNNBIP1;PSMB2;PSMA2;PTPRU;PTPRO;PSMA6;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7
prerank,rRNA transcription (GO:0009303),0.5137589300461646,1.1883566751320371,0.2947882736156352,0.922301790500887,1.0,6/17,13.76%,CAVIN1;GTF3C6;POLR1E;SIRT7;SPIN1;GTF3C5
prerank,actin crosslink formation (GO:0051764),-0.4622553684315605,-1.1883524708827153,0.22300469483568075,0.7120861649959298,1.0,3/12,11.56%,EPS8;FLNA;BAIAP2L1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.36401530635348023,1.1883053878805128,0.20270270270270271,0.9210838304134132,1.0,8/138,1.81%,NGF;ROR2;ROR1;NTRK3;FGFR1;EGFR;PTPRF;MUSK
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3889245366972356,1.188236036616643,0.21481481481481482,0.9198885591588234,1.0,13/78,12.28%,CAV1;TRIB2;PRICKLE1;SOCS5;SH3RF2;KEAP1;CDC20;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B;NFE2L2
prerank,neuron differentiation (GO:0030182),0.3567499022831417,1.188175434498266,0.18638392857142858,0.9186752004306793,1.0,13/165,5.56%,TENM2;WNT10A;PBX1;FZD2;BHLHE22;NEUROD6;RUNX2;GLI2;WNT2B;OPHN1;WNT16;WNT5A;BRSK1
prerank,negative regulation of innate immune response (GO:0045824),0.4300427374922132,1.187955346269838,0.24132947976878613,0.9180428072698823,1.0,10/34,13.25%,SERPING1;IRAK3;TNFAIP3;TRIM21;SUSD4;ACOD1;TRAFD1;CNOT7;STAT2;USP15
prerank,triglyceride biosynthetic process (GO:0019432),0.5006713849237927,1.1874222248404385,0.26242236024844723,0.9185519816481303,1.0,4/18,3.74%,MOGAT2;MOGAT3;GPAT3;AGMO
prerank,cellular response to lipid (GO:0071396),0.35291110932455116,1.186901924680097,0.17926565874730022,0.9189439213817593,1.0,43/191,16.18%,RORA;LBP;EGFR;SSTR1;TNIP3;GPLD1;IL1A;SOX9;WNT5A;ATP1A2;PDK4;ADCY5;TNFAIP3;NRIP1;ABL2;SELENOS;PAF1;BRINP1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;RORB;TICAM1;POU4F1;AXL;NCOA3;NFKBIB;WNT9A;AQP1;HTRA2;KCNK4;FZD7;LCOR;GPER1;CCR5;CCDC62;ADCY8;ADCY3;TICAM2;PLAA;TESC
prerank,positive regulation of lipid metabolic process (GO:0045834),0.48076861848000574,1.186864942601033,0.24071322436849926,0.9176268823620429,1.0,2/22,1.88%,SORBS1;ZBTB20
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3907598985841054,-1.186858144230366,0.2261904761904762,0.7148002127475571,1.0,5/22,11.15%,TIMP3;PTPN3;TNFRSF1B;APOE;FURIN
prerank,regulation of DNA binding (GO:0051101),0.42013885017516156,1.186834952411729,0.24151967435549526,0.916296593016212,1.0,18/44,23.02%,NGF;BCL3;HJURP;HMGB1;SMO;TXN;E2F1;PPARG;SUMO1;NME1;PRKN;HABP4;MAPK8;RSF1;FOXC1;JUN;SIRT2;ZBTB7A
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.502395888514415,1.1865352829745617,0.25806451612903225,0.9159144776744053,1.0,7/18,17.52%,VGLL4;DACT1;RDX;FAF1;CD81;EZR;VPS11
prerank,positive regulation of cartilage development (GO:0061036),0.49098706117702656,1.1856239275422764,0.2761904761904762,0.917608506924161,1.0,3/17,4.10%,PKDCC;SOX9;BMPR1B
prerank,substrate-dependent cell migration (GO:0006929),0.5152360875674452,1.185121702500832,0.2903225806451613,0.917973067017951,1.0,3/14,4.99%,NTN1;OPHN1;PTPRC
prerank,monocyte chemotaxis (GO:0002548),-0.3576369522483883,-1.1847391425282785,0.19528619528619529,0.7197254819210072,1.0,6/32,13.49%,FLT1;IL6R;RPS19;ANXA1;CCL13;TNFRSF11A
prerank,amyloid fibril formation (GO:1990000),0.4180693032914929,1.184546780617629,0.22684563758389262,0.9185642933931462,1.0,6/51,7.41%,TGFBI;UBE2L6;APH1B;NCSTN;ADAM10;SIAH1
prerank,regulation of protein polymerization (GO:0032271),-0.34904939284372116,-1.1839789517591004,0.2125,0.7202871632724006,1.0,13/35,23.91%,ARHGAP28;ESAM;FCHSD2;CAMSAP1;HAX1;GBA2;TTBK1;DBN1;MAPT;ARL2;PFN1;DBNL;TPPP3
prerank,respiratory electron transport chain (GO:0022904),0.5074872465585039,1.1837621754553433,0.2646566164154104,0.9198546089875622,1.0,2/14,1.98%,PPARGC1A;SLC25A12
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.5352085313364581,1.18353458325149,0.27796610169491526,0.9192800336462122,1.0,3/12,15.49%,SORBS1;C1QTNF12;SNX5
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.44021731080404336,-1.183185179816342,0.25,0.7210621477737007,1.0,9/14,37.06%,FLNA;SLC2A10;LOXL3;LIMS2;LIMS1;PRKD1;TIMP1;BST1;PHACTR4
prerank,response to reactive oxygen species (GO:0000302),0.4113631040624762,1.1831038175306863,0.22804718217562253,0.9194002619286645,1.0,5/54,5.71%,APOD;PXN;EGFR;MPV17;FER
prerank,regulation of mononuclear cell migration (GO:0071675),-0.392932409031829,-1.1818689611523552,0.23275862068965517,0.7234684968594899,1.0,10/23,18.75%,MSN;SLIT2;LYN;STK10;CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4023039089286599,1.181834221063582,0.24619289340101522,0.9223607652490486,1.0,8/59,11.08%,ALDH1A3;CYP7B1;OSBPL6;HOGA1;ACACA;HSD17B4;ACOT8;GAMT
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.43160882962743496,-1.181830881779078,0.2660332541567696,0.72192567815163,1.0,9/16,32.05%,WRN;BLM;MCM6;SSBP1;MCMDC2;TWNK;RAD51;MCM7;MCM2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.449891000363585,-1.1818018353204298,0.25476190476190474,0.7203511717031251,1.0,4/13,8.19%,NOS3;CYP1B1;GCH1;AKT1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.49244937640927267,1.181759889267006,0.27076923076923076,0.9212092068899412,1.0,4/18,9.03%,POR;SIRT3;ABL2;PDP2
prerank,regulation of cilium assembly (GO:1902017),-0.31362764374654506,-1.181696526023946,0.15454545454545454,0.7190467443354971,1.0,18/62,14.46%,TBC1D1;RABGAP1;TBC1D30;USP6NL;TBC1D2B;ARHGAP35;ENTR1;TBC1D24;SGSM3;CDKL5;DCDC2;EVI5L;FUZ;CEP97;TBC1D22B;CEP120;TCHP;CROCC
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5431311351458791,1.1816772131835156,0.26497277676951,0.9201278526781624,1.0,4/11,13.08%,PRODH;MAP3K5;STK24;DIABLO
prerank,response to chemokine (GO:1990868),0.5152672231510956,1.1816122291741493,0.2762063227953411,0.9189533803593779,1.0,2/13,1.71%,RIPOR2;SLC12A2
prerank,negative regulation of catalytic activity (GO:0043086),-0.3783175362341016,-1.1815132928323453,0.22691292875989447,0.7180131218834368,1.0,11/24,33.72%,PPP1R12A;NES;CAMK2A;IFIT1;NOS1;PLN;OXA1L;NOTCH1;NOSIP;TIMP1;APBA3
prerank,response to retinoic acid (GO:0032526),-0.30792211860420515,-1.1813905421767215,0.1623931623931624,0.7167199374807064,1.0,14/59,12.69%,EPHA3;CTSH;ACER2;WNT5B;LYN;ADNP2;RBP4;BRINP3;TBX1;CREB1;TRIM16;SNW1;RET;GATA6
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5460043348785196,1.1813432436136724,0.29401408450704225,0.9184872649316294,1.0,1/11,0.87%,PXDN
prerank,positive regulation of calcium ion transport (GO:0051928),-0.34319033068525523,-1.18074861191323,0.21908127208480566,0.717068340016995,1.0,9/36,9.11%,PDGFRB;ANK2;MYLK;TRPC3;CACNB2;ORAI1;CXCL12;CAMK2A;GRIN1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.42688455206134546,1.1805678630979803,0.24964336661911554,0.9198073716072901,1.0,11/41,12.77%,EPHX1;ELOVL5;ALOXE3;DECR2;ELOVL1;SCD5;ELOVL2;HSD17B4;ACOT8;ABCD1;PNPLA8
prerank,negative regulation of cell adhesion (GO:0007162),0.3870483902107405,1.180550006305057,0.23047375160051217,0.9185046314870027,1.0,18/72,15.39%,TGFBI;CDH13;RIPOR2;JAG1;DSCAM;PLXNA3;PTPRC;ADAM10;EPHB2;GCNT2;PLXNB1;SEMA4D;NF2;FZD7;PTPRO;SIPA1;PLG;CDH1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3188548907529266,-1.1803630759461712,0.17857142857142858,0.7166157565140153,1.0,21/54,18.40%,ETS1;ANGPT1;NOS3;AKT3;ACVRL1;PRCP;HIF1A;KDR;APOE;AKT1;GATA2;SP1;THBS1;MAP2K3;TMSB4X;P2RX4;ANGPT2;CSNK2B;HSPB1;CD40;VASH1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5546307553711489,1.1803320008632086,0.30594405594405594,0.9178426326075394,1.0,3/10,6.72%,CEACAM1;CD9;RDX
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.36978624723933434,-1.180197750482306,0.2367601246105919,0.7154211246923684,1.0,16/30,33.80%,INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7;TM7SF2;MVD;PLPP6;SQLE;EBP;LBR
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.47948509632557623,-1.1801013048743758,0.25365853658536586,0.7140386426107754,1.0,5/11,25.28%,ARHGEF2;NUPR1;CASP8;RIPK1;BIRC3
prerank,regulation of cation transmembrane transport (GO:1904062),0.4420315960454525,1.1796236496546257,0.2746268656716418,0.9189467479909128,1.0,8/29,21.41%,SLMAP;KCNIP4;ATP2B4;KCNAB1;FGF12;KCNIP1;SNTA1;CD63
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3730605991914333,1.1794373794817372,0.22482435597189696,0.9182130251191055,1.0,22/108,14.10%,MDFIC;GPC3;VGLL4;SULF1;NFATC1;FOLR1;AXIN1;DEPDC1B;GNAQ;DACT1;TNFAIP3;HIC1;FAM53B;KANK1;TMEM237;KREMEN1;SPIN1;NXN;EMD;CTNNBIP1;CBFB;FZD7
prerank,positive regulation of leukocyte activation (GO:0002696),0.4862668944296715,1.179404621416458,0.27768860353130015,0.9169485092751553,1.0,3/18,10.36%,LBP;WNT5A;KARS1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4739998525221716,1.1787315931078686,0.28056426332288403,0.9179089651177533,1.0,6/22,16.38%,CEACAM1;DGKZ;PTPN22;PTPRJ;SH2D1A;EZR
prerank,Ras protein signal transduction (GO:0007265),0.35911158598479237,1.178243826478966,0.21046643913538113,0.9182554506959575,1.0,23/137,10.37%,PLK2;CDH13;NTN1;PLCE1;USP50;RAPGEF3;RAP1A;CDC42EP4;MRAS;NF1;RAC2;USP8;GDI1;NRAS;KRAS;RIPOR1;ARHGEF1;RREB1;RAPGEF6;CTNNAL1;KSR2;LAT;ADRA2A
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5419082203133186,1.1782431251033438,0.2981260647359455,0.9168889991324217,1.0,6/12,18.88%,STX1A;STX2;STX19;STX4;SNAP23;SNAP29
prerank,regulation of cell cycle process (GO:0010564),0.3731032783185471,1.1782270572143267,0.21925754060324826,0.9155698303930655,1.0,20/104,12.39%,PLK2;FBXO43;KIF20B;CAV2;RACGAP1;SOX9;PIK3R4;RPRD1B;CDK13;KIF13A;FBXO5;CCP110;E4F1;CEP85;APC;KLHL21;ZFYVE26;MAP9;CETN2;AHCTF1
prerank,regulation of myoblast differentiation (GO:0045661),-0.3539848204325492,-1.1780523987357447,0.23214285714285715,0.7186035735934484,1.0,5/32,2.75%,PLCB1;RANBP3L;IGFBP3;BMP4;TBX3
prerank,lipoprotein transport (GO:0042953),-0.49541520948560747,-1.1779977036784346,0.2924107142857143,0.7171416907863738,1.0,3/10,6.59%,LRP1;ZDHHC17;VMP1
prerank,positive regulation of protein secretion (GO:0050714),-0.30033344939192874,-1.1777429902751366,0.19248826291079812,0.7163505436757345,1.0,14/69,14.28%,IGF1;MYRIP;BMP6;WLS;RBP4;C1QTNF3;TGFB3;MYH10;NNAT;SYTL4;LRRC8A;TGFB2;MYO18A;ABCG1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3290294952388373,-1.1776029651676945,0.19767441860465115,0.7151572376991485,1.0,9/47,7.55%,IGF1R;TGFBR3;FOXO1;FAS;PDCD10;ARL6IP5;IGBP1;NBR1;MAP2K2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5546695463551508,1.1774547531367554,0.29081632653061223,0.9168579731628534,1.0,2/10,2.89%,PRKCE;GPLD1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4835373153873631,1.177448017359802,0.26677316293929715,0.9155205169810202,1.0,3/18,5.87%,HOMER2;PTPRC;TNFAIP3
prerank,receptor internalization (GO:0031623),0.4167943233009075,1.1773982236022686,0.2413793103448276,0.9143230488294758,1.0,5/44,4.57%,CAV1;ACKR3;CEACAM1;CD9;DNM1
prerank,organic substance transport (GO:0071702),-0.2814551841019836,-1.177086386692941,0.14685314685314685,0.715032756422204,1.0,31/121,19.21%,SLC47A1;PLTP;CHKA;TXNIP;ABCG2;TOM1;CALCRL;SLC22A6;SLC22A4;ABCA4;SPNS2;TCN2;ARL6IP5;TAP2;ABCA9;SLCO2A1;RAMP2;SCAMP5;SLC22A18;ABCD2;SLC35F3;ABCA2;MFSD2A;ARRDC4;ABCG1;CHMP3;ARRDC2;SLC22A2;CHMP2B;MYH9;RCN3
prerank,Notch signaling pathway (GO:0007219),0.39827542035801716,1.1768911290189137,0.2362002567394095,0.9146495840615927,1.0,15/59,13.12%,ZNF423;NRARP;PBX1;DTX1;JAG1;MAML2;APH1B;HEYL;NCSTN;ADAM10;POFUT1;DTX4;WWC1;GMDS;CREBBP
prerank,cytoskeleton organization (GO:0007010),-0.27393520380820113,-1.176819473744228,0.11851851851851852,0.714181328806864,1.0,31/114,12.85%,RHOBTB1;NEDD9;MARK1;TPM1;FGD5;MAST4;OBSL1;PLD2;DST;RHOBTB3;CFL1;SYNE3;ARAP3;SEMA6A;WASF3;PRPF40A;APOE;RHOC;SH3KBP1;CAMSAP1;CNN2;WDPCP;DIAPH1;PALLD;RHOH;RHOB;AJUBA;PAK5;DES;CECR2;CCL13
prerank,regulation of phosphate metabolic process (GO:0019220),-0.4322581896137525,-1.1766990726516118,0.2543352601156069,0.712985752011581,1.0,7/16,18.52%,IGBP1;PGAM1;SRPX2;IKBKB;BARD1;RAD17;CD24
prerank,purine nucleotide metabolic process (GO:0006163),0.4670647476081211,1.1764969575279485,0.2794561933534743,0.9146776009162856,1.0,8/24,11.63%,FHIT;MTHFD1;PPAT;NT5E;PRPSAP2;NT5C2;PRPS1;PRPS1L1
prerank,cardiac muscle cell differentiation (GO:0055007),0.48327920745360653,1.1762113109741656,0.29213483146067415,0.9143655782117975,1.0,2/21,3.33%,CXADR;AKAP13
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.3850389017505954,-1.175839562407046,0.24331550802139038,0.7140032723390676,1.0,6/23,16.54%,IGF1;AKAP6;PROX1;EDN1;MYOCD;ATP11A
prerank,"phagocytosis, engulfment (GO:0006911)",0.42648586357047436,1.175652668163785,0.26256983240223464,0.9148948365259497,1.0,6/36,8.30%,ARHGAP12;XKR7;DOCK1;XKR4;RAC2;XKR8
prerank,nuclear transport (GO:0051169),0.4987488832085999,1.1753290095023092,0.2652388797364086,0.9146633282680259,1.0,2/16,5.19%,RGS14;RBM15B
prerank,camera-type eye morphogenesis (GO:0048593),0.5499877632662956,1.1749115568011848,0.2992957746478873,0.9147805915648759,1.0,3/10,7.23%,NF1;SHROOM2;TBX2
prerank,positive regulation of organelle assembly (GO:1902117),-0.327715645930734,-1.174527373590159,0.21052631578947367,0.7162548272344273,1.0,13/44,14.46%,ASAP1;CNOT6L;G3BP2;STX18;ARHGAP35;ENTR1;SH3GLB1;CAPG;PIP4K2A;FUZ;PIP4K2C;CEP120;CROCC
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.4758800240436314,-1.1745036024388185,0.28640776699029125,0.7147567419706922,1.0,2/12,4.03%,LY6E;MID2
prerank,response to metal ion (GO:0010038),0.39697206913498373,1.1742059600137567,0.25256410256410255,0.9157877635758961,1.0,6/67,4.18%,CAV1;NEDD4L;ITPR3;SLC25A12;IL1A;TFR2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.38014383157463105,1.1739472274724176,0.23514851485148514,0.9153570488515196,1.0,35/84,24.14%,FXR2;RBFOX2;QKI;RBM8A;CELF1;SRSF4;RBM15B;SON;DDX17;SRPK1;RBM5;CELF2;CELF4;KHDRBS2;SRPK2;SFSWAP;RBMXL1;NSRP1;FXR1;TRA2B;SF1;CWC22;SRSF3;PRDX6;MBNL2;SAP18;SRSF12;TIA1;SRSF10;YTHDC1;JMJD6;ZBTB7A;RBMX;REST;PUF60
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.47054073624274106,-1.1738169882881009,0.2687651331719128,0.7151037012484,1.0,5/11,30.47%,TIMM10B;TIMM8B;ROMO1;TIMM29;TIMM10
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.40610125570019484,1.1732065740461801,0.25396825396825395,0.916456327092237,1.0,22/52,23.03%,LEPROT;PPP1R13B;ABLIM3;RAC2;SFN;HTRA2;UBE2J2;UBE2D3;BAD;NMT1;YWHAG;FBXW7;YWHAE;E2F1;VPS11;CSNK2A2;PINK1;UBL5;MAPK8;TFDP1;YWHAB;SAE1
prerank,synaptic vesicle recycling (GO:0036465),0.440177832993247,1.1728929401582897,0.27421758569299554,0.9161558380995792,1.0,13/31,22.12%,CEL;STX1A;OPHN1;STON1;RAB3A;STON2;SNCG;RAB5A;PACSIN1;AMPH;VAMP2;NLGN3;NLGN2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.4780464821432424,1.1724215660499757,0.27856025039123633,0.9164530989085351,1.0,6/20,14.09%,FKBP5;FKBP1B;PPIE;PPIL6;PPIC;PPIG
prerank,negative regulation of protein kinase activity (GO:0006469),0.37675783712167177,1.1723855760486181,0.23880597014925373,0.9152274261807777,1.0,13/88,10.78%,CAV1;TRIB2;UBASH3B;CEACAM1;SPRED1;NF1;GNAQ;PTPRC;SRCIN1;SFN;PTPRT;CEP85;RTRAF
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3556918333729423,-1.172159678089251,0.21016949152542372,0.7185164209555962,1.0,5/33,8.57%,IGF1R;IGF1;PIK3R1;AKT1;PIK3C2A
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4075609476354972,-1.1721473927727495,0.26063829787234044,0.7169738172862449,1.0,7/18,14.37%,RAD51B;CDC25B;CDC25A;RAB11A;CDK4;CDC7;RAD51C
prerank,cellular response to acid chemical (GO:0071229),-0.36997530005636464,-1.1720265569900084,0.2276657060518732,0.71576083875521,1.0,15/27,31.64%,CPEB4;LAMTOR3;RRAGC;KLF2;GLRA2;SPAAR;RRAGD;CPEB1;XBP1;LAMTOR2;SLC38A9;NSMF;LAMTOR4;SH3BP4;GLRA1
prerank,peptidyl-tyrosine modification (GO:0018212),0.4077745295271872,1.172014762424985,0.2584856396866841,0.9151561015702138,1.0,9/56,6.49%,PKDCC;TEC;FGFR1;EFEMP1;EGFR;SRC;FER;EPHB2;ABL2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.34016745379531654,1.1719578136591793,0.1731958762886598,0.9140500935166235,1.0,39/308,11.50%,EBF2;ETV4;CAV1;INHBB;PPARGC1A;LBP;SMTNL1;FOXD1;LEPR;GLMN;ITK;OGT;ITGAX;TXK;IL1A;SMTNL2;SOX9;BMPR1B;MFN2;KMT5C;SLC27A1;WNT5A;RREB1;CRTAM;FBXO5;PTGER4;GCNT2;TSHR;FOXJ1;ABCA1;KSR2;FERMT2;HILPDA;ADRA2A;AXIN2;APC;COL1A1;VAMP8;PRLR
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2959690100112042,-1.1713001892077646,0.18719211822660098,0.7163534487750346,1.0,15/70,13.12%,CHKA;ENPP2;GPAT4;CHPT1;NR1H3;LPIN2;DBI;PCYT1A;SLC44A5;NR1H2;ABHD3;CEPT1;LPIN3;CSNK2A1;MFSD2A
prerank,positive regulation of dephosphorylation (GO:0035306),0.4453972056998306,1.1709929785153974,0.280359820089955,0.9159442607192029,1.0,3/27,4.48%,DLC1;CDH5;SRC
prerank,homeostasis of number of cells (GO:0048872),-0.4634556779078596,-1.1707014679504304,0.24105011933174225,0.7166563543934588,1.0,3/12,4.37%,NOS3;NAPEPLD;CCN3
prerank,regulation of T cell proliferation (GO:0042129),0.3953516348599812,1.1705716823291437,0.265359477124183,0.9161203533839013,1.0,6/61,6.40%,TNFSF8;ARG1;GLMN;IL4I1;PTPRC;NCK2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.44375003989411116,1.1689992613871814,0.2703862660944206,0.9202361395510161,1.0,4/33,5.62%,KLF5;SPI1;FOXO3;APLN
prerank,rRNA metabolic process (GO:0016072),-0.2584670606820803,-1.1688799930719818,0.14893617021276595,0.7203445819032269,1.0,62/160,25.05%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;DIS3L;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;MAPT;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;WDR3;RPS14;RPS25
prerank,cilium assembly (GO:0060271),0.33795126264110553,1.16864120318473,0.1652892561983471,0.9201527033596201,1.0,103/296,24.50%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;GORAB;DYNC2I1;CYS1;EXOC3;SFI1;CNGB1;INTU;CEP89;CEP131;IFT81;CEP78;CNGA4;NEDD1;KIF3C;EHD2;SNX10;TUBG1;CCDC39;CKAP5;BBOF1;CEP162;PAFAH1B1;CLUAP1;CCP110;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;C2CD3;HDAC6;CFAP20;NDE1;EXOC5;CEP290;SSNA1;CETN2;RPGRIP1L;TTC21B;PKD1;TRIP11;FBF1;PCM1;PDE6D;FAM161A;DNAH5;CCDC40;NPHP4;CFAP298;CFAP70;PIBF1;YWHAG;DYNC2LI1;CFAP410;B9D2;YWHAE;CDC14A;CEP57;DYNC2H1;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29;TMEM80;DCTN2;ALMS1;TCTN1;HAUS8;STK36;IFT57;CEP43;CPLANE2;IFT140;WDR90;RILPL1;CC2D2A;HAUS3;CEP19;SCLT1;ARL3;HAUS7;TMEM67;FHDC1;CEP83;CFAP52;ARF4;SPATA6;MAK;DYNC1I2;TRAPPC14;NPHP1
prerank,lamellipodium organization (GO:0097581),0.4482318245185011,1.1682234944641492,0.2725947521865889,0.9202625751103395,1.0,10/29,16.89%,CDH13;ABLIM3;SPEF1;ABLIM2;SNX2;ARHGEF6;CTTN;PTPRO;SNX1;ARHGEF7
prerank,positive regulation by host of viral transcription (GO:0043923),-0.42799130623693604,-1.1681672478429117,0.25870646766169153,0.7208647792361869,1.0,5/15,12.56%,LEF1;EP300;CCNT1;SNW1;SP1
prerank,positive regulation of cell adhesion (GO:0045785),0.38989364112144587,1.1672576316056462,0.2455919395465995,0.9222097071653823,1.0,3/74,0.80%,MAGI1;VIT;ECM2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.45675894677935486,1.1671691898122496,0.2671641791044776,0.9212016168920233,1.0,1/23,1.14%,MBOAT2
prerank,glucose transmembrane transport (GO:1904659),-0.4116226707439976,-1.16715923497651,0.25205479452054796,0.7221678243826772,1.0,10/18,28.09%,PPARD;SLC2A10;SORT1;SLC2A8;SLC2A9;SLC2A1;SLC45A1;SLC2A3;SLC2A4;RAB4B
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.48849368986550235,1.1666840924993556,0.2943089430894309,0.9215299824668094,1.0,2/19,0.56%,VGLL4;GLI1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.45737602008788447,-1.1665673046686158,0.2932330827067669,0.7224677524047176,1.0,11/12,54.30%,ZBTB1;CCR2;SLC11A1;PRKCQ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,response to cytokine (GO:0034097),-0.26392974932755303,-1.1664517957135152,0.11965811965811966,0.721253935763109,1.0,24/141,8.47%,TIMP3;ALDH1A2;IL1R1;SMAD3;LEF1;PID1;OSMR;IL6R;SP100;IFNAR2;YTHDC2;ADAR;CXCL16;LIFR;AKAP6;TRAF6;JAK2;CDK9;IGBP1;CASP3;ANXA1;GCH1;BST2;LDLRAP1
prerank,regulation of interleukin-4 production (GO:0032673),-0.4001282944419603,-1.1655361626751153,0.23013698630136986,0.7222691711687684,1.0,5/21,15.22%,LEF1;SLC7A5;PRKCZ;CEBPB;LGALS9
prerank,thymus development (GO:0048538),-0.45363222277290394,-1.1653826643233423,0.2832080200501253,0.7211165759917666,1.0,4/13,16.72%,TGFBR1;TBX1;ZBTB1;EPHB3
prerank,mismatch repair (GO:0006298),0.4516717500340406,1.1651891110455908,0.28005865102639294,0.9253261667666006,1.0,8/27,21.53%,TDG;MSH6;MSH2;ERCC1;SETD2;MLH3;MLH1;RPA3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.35665132517878756,1.1649746571782453,0.2264367816091954,0.9247737083325633,1.0,17/136,10.19%,PTCH1;SPI1;GLIS2;HDAC4;IRAK3;KEAP1;HEYL;BHLHE40;TNFAIP3;ANXA4;TRIM21;ZNF431;ACOD1;FOXJ1;NLRP2B;HDAC2;TAX1BP1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3631610757599984,1.164927199303112,0.22748267898383373,0.9236285015736759,1.0,42/125,23.10%,PLK2;DYNLL1;KIF2A;STIL;TUBG1;DSN1;CKAP5;PAFAH1B1;EML1;CDC20;NUP160;MECP2;DYNLL2;NUP37;RANBP2;BUB3;MAP4;WDR62;NDE1;AHCTF1;PTPA;TUBG2;ZWILCH;ZW10;CENPU;RAN;TBCE;CENPH;B9D2;CENPK;SETD2;MAD1L1;DCTN2;DYNC1LI2;CENPL;DYNC1I1;NUP43;GPSM2;MIS12;DCTN6;SEC13;SBDS
prerank,cellular response to ionizing radiation (GO:0071479),-0.32258953325698236,-1.1647302197498202,0.1984732824427481,0.7214861386671956,1.0,17/47,24.88%,MAP3K20;WRN;RPL26;BLM;EEF1D;RHOB;NET1;KDM1A;CRYAB;RAD1;HSF1;RAD9B;KDM4D;HRAS;GRB2;RAD51;LIG4
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.37942463355180445,-1.1643564023640693,0.24926686217008798,0.7211512840771099,1.0,8/25,15.98%,INSR;SMAD3;DDAH1;KLF4;AKT1;KLF2;EDN1;P2RX4
prerank,myeloid cell development (GO:0061515),-0.40677124174427104,-1.1640392140975775,0.2713936430317848,0.7205560506230885,1.0,7/18,22.17%,FOXP1;KIT;ANXA2;NRROS;ABCB10;ALAS1;NCKAP1L
prerank,synaptic vesicle membrane organization (GO:0048499),0.49558414693830305,1.1639805833548904,0.28044871794871795,0.9255194434964337,1.0,7/17,18.88%,STX1A;SYNGR2;STX2;STX19;STX4;SNAP23;SNAP29
prerank,negative regulation of stress fiber assembly (GO:0051497),0.45447615724099755,1.1639062095626547,0.27060653188180406,0.9244698672453772,1.0,3/24,2.02%,DLC1;F11R;ARAP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3590156099687767,1.1633073702043824,0.22083805209513024,0.9251559967557216,1.0,12/133,4.74%,CAV1;STC2;CTRC;CAMK2D;SLC8B1;CDH5;SLC24A1;TRPV4;FKBP1B;CAV2;CSRP3;ATP2B4
prerank,protein autoprocessing (GO:0016540),-0.41524018865834644,-1.1632752755670583,0.2549019607843137,0.7214733098021106,1.0,5/17,17.69%,OMA1;CTSL;SPRTN;FXN;CASP4
prerank,steroid metabolic process (GO:0008202),0.38973245221577385,1.1631484865520256,0.25555555555555554,0.9243814322564758,1.0,13/72,15.05%,HSD17B3;CYP7B1;SULT1A1;RDH5;DHRS4;HSD17B4;CUBN;GC;PRLR;MSMO1;DHCR24;STARD3;LSS
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5409085899238674,1.16279718034522,0.2875,0.9242629736820851,1.0,3/10,11.94%,FAP;DPP4;CHADL
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4745522735216463,1.1624036517403327,0.27416798732171155,0.9242576629665703,1.0,6/20,13.51%,NR2F2;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,microglial cell activation (GO:0001774),-0.3997285798847129,-1.1623082809862493,0.2349570200573066,0.7228937210151809,1.0,12/21,36.29%,JAK2;MAPT;C1QA;CLU;GRN;ITGB2;ITGAM;AGER;AIF1;TREM2;IFNGR1;SNCA
prerank,protein heterotetramerization (GO:0051290),-0.43678904967950355,-1.1620665277248936,0.2944038929440389,0.7221076481735851,1.0,6/13,26.98%,FARSB;GRIN2B;GRIN1;CPSF7;CPSF6;HSD17B8
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4437510122158308,1.1615514893701158,0.27155172413793105,0.9258626484457995,1.0,5/29,4.69%,SORBS1;ZBTB20;ELOVL5;GPLD1;SLC27A1
prerank,cellular response to insulin stimulus (GO:0032869),0.36073996469944347,1.1614438936318157,0.23076923076923078,0.9249299944254178,1.0,19/124,9.63%,GAB1;INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;GPLD1;CAV2;ATP6V0D2;SLC27A1;PDK4;FER;SELENOS;ZDHHC7;SYAP1;PIK3R2;ATP6V0A1;GSK3B;SLC27A4
prerank,odontogenesis (GO:0042476),0.43057171420130713,1.1613896513973272,0.2755102040816326,0.9238083354575196,1.0,4/35,3.17%,EDA;WNT10A;GLI2;TUFT1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4409792431063634,1.1611850608376075,0.28257686676427524,0.9231979323904901,1.0,7/29,13.50%,SPRED1;SPRY1;BMP5;LDLRAD4;SDHAF2;PTEN;SPRED2
prerank,negative regulation of organelle assembly (GO:1902116),-0.34252663002882955,-1.160805830234935,0.21806853582554517,0.7242256815935441,1.0,16/35,21.65%,NUPR1;TBC1D30;EVI5L;LRRK2;CEP97;TCHP;TRIM37;FEZ2;SCFD1;SMAD4;KAT2B;KAT2A;TESK1;STYXL1;SEC22B;NBDY
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4526070097996126,1.1602882917671546,0.2859375,0.9249192710129649,1.0,6/23,17.56%,GUCA1A;CNGB1;FNTA;FNTB;NMT1;CAMKMT
prerank,protein heterooligomerization (GO:0051291),-0.4073267243332337,-1.1601914776702271,0.27461139896373055,0.7245476037965367,1.0,7/17,26.98%,FARSB;GRIN2B;GRIN1;TMEM120A;CPSF7;CPSF6;HSD17B8
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4710663771282407,-1.1600611279115587,0.2850356294536817,0.7234191295438642,1.0,6/11,24.51%,ATG10;APOE;WIPI1;WIPI2;WDR45B;WDR45
prerank,regulation of isotype switching (GO:0045191),-0.4348564074716972,-1.1598502166449975,0.2847058823529412,0.7224492172664004,1.0,4/14,8.41%,TFRC;PAXIP1;SHLD2;SLC15A4
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4458254979707027,1.1587169921825389,0.29283489096573206,0.9289427997464109,1.0,6/26,9.33%,PCBP2;IRAK3;TNFAIP3;TRIM21;ACOD1;TRAFD1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4977801235282575,1.1583578169066566,0.2943089430894309,0.928891560806938,1.0,2/16,5.65%,APOD;CHID1
prerank,acidic amino acid transport (GO:0015800),0.49187243628993615,1.1582985264572574,0.2777777777777778,0.9278142004442124,1.0,7/17,13.00%,LRRC8D;SLC25A12;PRAF2;SLC6A13;SLC1A6;SLC25A13;SLC25A22
prerank,mammary gland development (GO:0030879),0.4753654161976674,1.1582438203451104,0.29566563467492263,0.9267044652629951,1.0,3/21,5.62%,CAV1;GLI2;APLN
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.42117081917469085,-1.1571716648503565,0.30025445292620867,0.7288990097046556,1.0,8/17,25.08%,TNFRSF1B;SERPINE2;IL34;BMP2;ID2;PTN;CLCF1;NOTCH1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.49394908278525435,-1.156989436159354,0.3044496487119438,0.727876928846042,1.0,6/10,14.68%,LPGAT1;NR1H3;NR1H2;SLC45A3;ABCD2;MID1IP1
prerank,negative regulation of signaling (GO:0023057),0.4598363041653717,1.1568137665076235,0.29335260115606937,0.9304164527894776,1.0,2/25,2.26%,UBASH3B;SOCS5
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.32868974140672874,-1.1561011816225641,0.2323943661971831,0.7288840327752751,1.0,12/41,19.18%,TGFA;NEDD9;EPHA4;ACE;DOCK3;NOX4;LRP8;IL34;BDNF;GPRC5B;EGF;AGT
prerank,vasodilation (GO:0042311),-0.44872637096740464,-1.1551528050134556,0.2571428571428571,0.730292969973466,1.0,4/13,17.44%,NOS3;KCNMA1;KLF2;NOS1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.40887050712142553,-1.1551242508974509,0.2892768079800499,0.7288644959918983,1.0,13/17,34.81%,ANK2;SLC8A1;KCNJ2;CACNB2;CACNA1G;SCN4B;SCN1B;HCN2;CACNA1D;SCN5A;CACNA2D1;CACNA1C;HCN4
prerank,regulation of protein secretion (GO:0050708),0.35545625303974643,1.154746085916676,0.23940435280641467,0.9361110858380359,1.0,15/119,7.89%,ITPR2;ITPR3;SLC12A2;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;IL1A;PRKCA;FRMD4A;RAPGEF4;SLC2A2;ARF6;DPP4
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3730106860169203,-1.1543441082394643,0.23391812865497075,0.7295547865389045,1.0,8/26,15.98%,INSR;SMAD3;DDAH1;KLF4;AKT1;KLF2;EDN1;P2RX4
prerank,positive regulation of ATPase activity (GO:0032781),0.4157359249729106,1.1541944195463658,0.29058663028649384,0.9367340838064842,1.0,13/41,19.80%,DYNLL1;MSH6;ALDOB;MSH2;PLSCR1;DNAJC9;ATP1B3;DYNLL2;AHSA1;FGF10;DNAJC24;DHX9;PFN2
prerank,actin filament bundle assembly (GO:0051017),-0.3540743323412465,-1.1541283045451702,0.2326388888888889,0.7286235432442847,1.0,5/33,5.73%,EPS8;NEDD9;MYO1B;PAWR;PLS3
prerank,ERAD pathway (GO:0036503),-0.29190966405729907,-1.1538218149653052,0.19889502762430938,0.72800570891862,1.0,25/83,20.74%,UBXN4;USP19;TRIM25;ERLIN1;DNAJB2;UBE4A;STT3B;SGTA;SEC61B;SYVN1;VCP;UBE2J1;FBXO17;UBXN6;ERLIN2;UBE4B;OS9;RNF103-CHMP3;ANKZF1;SGTB;DERL2;FBXO44;RCN3;TRIM13;RNF121
prerank,diol metabolic process (GO:0034311),-0.40578905056761283,-1.1536805486384083,0.2613065326633166,0.7268747564931698,1.0,7/19,13.41%,NOS3;PLPP1;DEGS2;CALM1;GCH1;AKT1;SPHK1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5257394245955934,1.153224958857978,0.3235294117647059,0.938762856267548,1.0,7/12,27.06%,NELFB;HEXIM1;TCERG1;RECQL5;EAPP;HNRNPU;NELFA
prerank,protein N-linked glycosylation (GO:0006487),-0.2979217195959162,-1.1526473874370287,0.17699115044247787,0.7283260935706565,1.0,18/66,17.65%,MGAT4C;ST3GAL1;MGAT4A;SLC39A8;DPM1;ALG5;STT3B;GAL3ST1;PGM3;UBE2J1;B4GALT1;B4GALT7;ALG1;RPN2;FUT8;OST4;ENTPD5;ASGR1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3253998778070666,-1.1524990688514691,0.23166023166023167,0.7272638913972763,1.0,8/46,9.16%,PLCB1;MSN;CDC42;CFL1;ANXA2;RPLP0;JAK2;CNN2
prerank,cation transport (GO:0006812),0.34851602749032273,1.1524653282147173,0.2320627802690583,0.9398658845007335,1.0,21/167,8.17%,PIEZO2;NEDD4L;KCNJ4;TRPM3;SLC12A2;SLC8B1;KCNA5;KCNJ16;ANO6;SLC29A4;KCNS2;SLC12A3;KCNK1;SLC22A3;CNGB1;ATP1A2;KCNJ13;SLC4A4;SLC4A11;PIEZO1;KCNK5
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.36077940654248664,1.1522544905917067,0.2634730538922156,0.939263334995774,1.0,15/102,8.77%,CAV1;INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;GPLD1;SRC;ADCY5;FER;SELENOS;SYAP1;PRKAR2A;PIK3R2;TSHR
prerank,positive regulation of macrophage activation (GO:0043032),0.48464612376509447,1.1518184753147118,0.3021702838063439,0.9394255808928627,1.0,3/17,10.36%,LBP;WNT5A;KARS1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.34910203478771445,1.151730503966167,0.21690767519466073,0.9384326023603162,1.0,51/152,21.95%,CAV1;GPC3;PPM1N;SULF1;NRARP;EGFR;AXIN1;DEPDC1B;PSME3;DACT1;PPM1A;TNFAIP3;USP8;UBR5;PLEKHA4;FAM53B;KANK1;CSNK1G3;PSMB5;RNF220;USP47;AXIN2;COL1A1;SPIN1;SOX4;PSMB2;CAPRIN2;PSMA2;PSMA6;FZD9;PSMD13;PSMA7;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;PSMD14;PIN1;CDC73;TRPM4;RNF146;USP34;CCAR2;PSMB3;GSKIP;GID8
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5211487396687984,1.1516302096103412,0.3143350604490501,0.9374721310016328,1.0,2/13,1.44%,PRODH;ARG1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.37506814717195824,-1.1511332935429681,0.28106508875739644,0.7297681190704944,1.0,13/25,24.04%,HIP1;RBPJ;AFAP1L2;HIP1R;AKT1;BCAR3;SHKBP1;CNOT9;AGT;NEU3;PLAUR;PDE6H;DOK1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.4106203474192682,-1.150944734949196,0.26273458445040215,0.7288363242123582,1.0,11/19,47.90%,LRP6;NR4A2;MANF;LMX1B;LMX1A;WNT2;SHH;FOXA1;EN1;FOXA2;CDNF
prerank,epiboly involved in wound healing (GO:0090505),-0.42204930463083296,-1.1508921908755603,0.2828282828282828,0.7274944793110169,1.0,7/16,10.23%,DDR1;PDCD10;ARHGAP35;RHOC;TMEFF2;FLNA;CCN1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5197058385988892,1.150869164279138,0.32379248658318427,0.9386662760891247,1.0,6/12,12.75%,ELOVL5;ELOVL1;ELOVL2;HSD17B4;ACOT8;ABCD1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3802721609322887,-1.1508157865579804,0.2636363636363636,0.726242984411018,1.0,7/24,10.58%,TEK;ANGPT1;NDNF;KDR;GATA2;RAMP2;SCG2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4309135911600146,1.1507867253878874,0.275811209439528,0.9376410093533403,1.0,4/32,8.07%,MEOX2;CARD10;RHOJ;STARD13
prerank,ion transport (GO:0006811),0.35860192684119546,1.150748478543041,0.25029797377830754,0.9365206010580093,1.0,20/111,13.00%,VDAC2;PIEZO2;TRPM3;SLC12A2;SLC8B1;SLC26A9;ANO6;SLC24A1;SLC1A7;SLC12A4;SLC12A3;CNGB1;SLC1A6;PIEZO1;SLC9A7;SLC9A6;PANX2;SLC25A26;ANO10;SLC25A22
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.29232155415836214,-1.1505667066408696,0.17757009345794392,0.7254774276669725,1.0,29/72,21.63%,SHANK3;PLEKHH2;ARHGEF2;SLIT2;KANK3;STMN2;LDLR;HSPA8;HIP1R;TWF1;MYADM;APOE;EML2;CYRIB;CAMSAP1;VBP1;CLIP3;STMN1;APC2;CRYAB;MID1IP1;TUBB4A;SMAD4;PFN1;SSH2;SSH3;KATNB1;PFDN4;CLU
prerank,vesicle transport along microtubule (GO:0047496),0.4584410836569093,1.1504986054616948,0.296411856474259,0.9360713005285294,1.0,8/23,22.14%,KIF13A;PAFAH1B1;NDE1;KIF5A;KIF5B;HTT;DYNC1I1;FBXW11
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.39809469812338283,-1.1504021178767982,0.24233983286908078,0.7244910227521751,1.0,11/20,25.08%,RBPJ;SMAD9;EP300;SMAD5;HIF1A;BMP2;SMAD4;ATF4;XBP1;SMAD1;NOTCH1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.4187256293578332,-1.1503416445284453,0.2822384428223844,0.7232166912511853,1.0,10/16,29.93%,ATP5PD;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,metal ion export (GO:0070839),0.4385174247030706,1.1502463567766048,0.30447330447330445,0.9356463680285962,1.0,6/31,9.40%,KCNA5;ATP2B4;ATP1A2;SLC4A4;KCNK5;ATP1B3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5392977057230878,1.1500255896943286,0.328881469115192,0.9351840891047908,1.0,5/10,24.33%,EIF2AK3;NFE2L2;QRICH1;DDIT3;HSPA5
prerank,negative regulation of blood coagulation (GO:0030195),-0.32887509474595256,-1.1497295372934282,0.22483221476510068,0.7235679853093643,1.0,8/38,6.50%,PDGFRA;TFPI;NOS3;THBD;F3;SERPINE2;APOE;CD34
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.39481744027074933,1.1496695743919105,0.297111416781293,0.9351666039710455,1.0,23/52,25.63%,FXR2;RBFOX2;RBM8A;CELF1;RBM15B;DDX17;RBM5;CELF2;CELF4;KHDRBS2;NSRP1;FXR1;TRA2B;MBNL2;SAP18;SRSF12;YTHDC1;ZBTB7A;RBMX;REST;PUF60;FMR1;THRAP3
prerank,organelle disassembly (GO:1903008),-0.3397570067167123,-1.14960558464611,0.19594594594594594,0.7224323794892823,1.0,9/33,13.99%,UBA5;KLC1;ULK2;UFM1;VCP;EIF2D;GOLGA2;MTIF2;PLK5
prerank,regulation of postsynapse organization (GO:0099175),0.439006927235749,1.1495550943756085,0.2804878048780488,0.9342684357869518,1.0,5/28,7.43%,SIPA1L1;PPFIA2;LZTS3;WNT5A;SRCIN1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.43512754008743626,-1.1495096330818202,0.26715686274509803,0.7212650651408686,1.0,3/14,4.18%,TFRC;PAXIP1;SHLD2
prerank,cellular response to amino acid stimulus (GO:0071230),-0.34374660422375997,-1.1494382832952141,0.25075528700906347,0.7200255118222234,1.0,14/33,24.17%,UBR1;CPEB4;LAMTOR3;RRAGC;GLRA2;SPAAR;RRAGD;CPEB1;CASTOR2;CASTOR1;XBP1;LAMTOR2;SLC38A9;NSMF
prerank,intestinal lipid absorption (GO:0098856),0.527926960279374,1.1489851207316875,0.31762652705061084,0.9348735422844934,1.0,1/11,1.67%,CEL
prerank,spliceosomal complex assembly (GO:0000245),0.4076019231688358,1.1488681128354803,0.26264044943820225,0.9340063030872638,1.0,10/46,11.36%,SF3B1;CELF1;ZRSR2;SMN1;SRPK1;RBM5;CELF2;CELF4;SRPK2;LUC7L2
prerank,MAPK cascade (GO:0000165),-0.24057804376931466,-1.1485690628936975,0.030303030303030304,0.7212563877361382,1.0,43/295,8.53%,IGF1;KSR1;RAPGEF2;TEK;TGFA;PDGFRB;PTPN3;ACTN2;SHANK3;PDGFRA;MAP3K20;ANGPT1;IL31RA;CTSH;NRK;PIK3R1;RASGRP3;KL;PSMA1;KIT;BRAP;FRS2;FGFR2;NEFL;IL18;RBX1;LAMTOR3;FLT3LG;RASGRF1;GRIN2B;KDR;LYPLA1;PSMD11;CALM1;MEF2A;MAPK12;JAK2;RASGRF2;MAP2K2;PSMD7;RGL2;CAMK2A;PSMD4
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.44274649098431634,1.1484970007100315,0.30454545454545456,0.9339752142663068,1.0,4/30,5.57%,NGF;MMD2;SRC;LRRC59
prerank,positive regulation of kinase activity (GO:0033674),0.36409622958591137,1.1484785177342134,0.26383981154299174,0.9327856122637694,1.0,14/107,7.00%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK;RAP1A;PRKAG1;MMD2;LMO4;PTPRC;NBN;EPHB2;LCP2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.43034249603092006,1.1483839270093288,0.29515418502202645,0.9318484400664198,1.0,8/33,16.38%,CEACAM1;RAB29;DGKZ;PTPN22;PTPRJ;CD81;SH2D1A;EZR
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.36364984035927367,-1.1483796997896119,0.28823529411764703,0.7204003461957565,1.0,8/28,14.16%,ARHGAP28;ESAM;ARHGAP35;CXCL12;FCHSD2;HAX1;GBA2;DBN1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.38403813282239196,-1.1483516268564933,0.22781065088757396,0.7190372461385913,1.0,9/22,23.51%,CIAPIN1;NFS1;MMS19;NFU1;CIAO3;FXN;ISCA2;GLRX5;ISCU
prerank,heart process (GO:0003015),0.5143480565497369,1.148346483655437,0.3283582089552239,0.9307246131692555,1.0,2/14,3.80%,SGCD;SGCG
prerank,T cell proliferation (GO:0042098),-0.44300615474339267,-1.1482294940242557,0.2947103274559194,0.7179399037872847,1.0,2/13,1.74%,MSN;CTPS1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.27329531176437066,-1.1481118262446435,0.16535433070866143,0.7168379566145798,1.0,29/113,16.25%,ASAP1;TRABD2B;TFRC;BCL2L11;FNIP1;RASIP1;RBX1;FNIP2;RHOC;SLF2;SH3GLB1;MED25;CAPG;VCP;SLF1;RPS3;AJUBA;BID;MMP1;ESR1;MPP7;TTBK1;DHX33;ERCC2;TAL1;XPA;ISG15;EIF4G1;SKAP1
prerank,embryonic organ morphogenesis (GO:0048562),0.4097667580040665,1.147813682457905,0.2916666666666667,0.9311736355723984,1.0,4/42,3.74%,ALDH1A3;EFEMP1;MFAP5;DYNC2I1
prerank,regulation of microtubule polymerization (GO:0031113),-0.3302541182078805,-1.1470937336518425,0.23103448275862068,0.718436269981632,1.0,14/40,20.24%,CLIP1;STMN2;EML2;CAMSAP1;RPS3;CLIP3;GBA2;STMN1;MAPT;CDK5R1;TUBB4A;ARL2;FES;MET
prerank,pulmonary valve morphogenesis (GO:0003184),0.49003544622357764,1.1469898334331277,0.3034257748776509,0.9326420929706543,1.0,4/17,5.24%,STRA6;NFATC1;JAG1;HEYL
prerank,cobalamin metabolic process (GO:0009235),0.4835857536853472,1.1468952850070402,0.2948717948717949,0.9317228123838609,1.0,6/17,12.76%,CTRC;ABCC1;CD320;CUBN;MMAB;AMN
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3475518167629508,1.1468316400429532,0.25942857142857145,0.9306797160388866,1.0,55/144,23.12%,LEPROT;GTSE1;RAPGEF3;PPP1R13B;ABLIM3;RAB29;KIF20B;RAC2;FIS1;CEP131;UBR5;RIPOR1;BAG3;RBM22;PIK3R2;MIEF1;SFN;GSK3B;TPR;CEP290;CD81;EMD;HTRA2;TMEM30A;PCM1;UBE2J2;UBE2D3;RAN;BAD;CDH1;NMT1;ERBB2;YWHAG;FBXW7;YWHAE;E2F1;CHP1;VPS11;CSNK2A2;PINK1;TM9SF4;HDAC3;UBL5;CEMIP;AKT2;MAPK8;VAMP2;TCF7L2;TENM1;XPO4;TFDP1;YWHAB;OAZ2;SAE1;PRNP
prerank,defense response to protozoan (GO:0042832),-0.45524978595962196,-1.146655139029614,0.3106796116504854,0.7183059450850676,1.0,8/12,33.93%,GBP4;GBP6;GBP7;GBP2;CD40;MYD88;SLC11A1;BATF2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.48729297192866705,1.146638674560883,0.30345911949685533,0.9300568826492097,1.0,3/17,3.82%,F11R;CDH5;ADD1
prerank,positive regulation of blood coagulation (GO:0030194),0.48395602899878204,1.146292344292405,0.29642248722316866,0.9299357476953739,1.0,2/17,2.66%,ST3GAL4;ANO6
prerank,negative regulation of protein metabolic process (GO:0051248),0.40275044158205475,1.146009775287054,0.2759084791386272,0.9296011074221745,1.0,5/48,6.08%,INHBB;EGFR;FLOT2;IRAK3;AZIN2
prerank,response to tumor necrosis factor (GO:0034612),-0.2742008298467207,-1.1457443200781,0.14285714285714285,0.7194786866043138,1.0,26/91,18.63%,PID1;ARHGEF2;YTHDC2;CXCL16;GSDME;ERBIN;TNFRSF21;ZFAND6;GBP3;JAK2;IGBP1;CASP3;GCH1;AKT1;ZC3H12A;RPS3;BAG4;CCL13;SPHK1;TNFRSF11A;IKBKB;GBP2;ZFP36;CASP8;CD40;CACTIN
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.466324759164728,-1.1457051682714494,0.2938388625592417,0.7181757222847454,1.0,6/12,23.71%,PLCG2;CYBA;GRIN1;ADGRB1;RAB27A;ZNF205
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.35227891622406104,1.1455074875685902,0.25549132947976877,0.9300411454417161,1.0,29/124,18.76%,ROR2;PRICKLE1;PRICKLE2;NFATC1;PLCB3;FZD2;PSME3;WNT5A;PSMB5;AGO1;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD9;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.31939671856755186,1.1452382166265291,0.031,0.9296972233359497,1.0,269/1668,15.37%,PTCH1;EBF2;RORA;MEOX2;TENM2;ZBTB7C;DCN;KLF5;ETV4;ITGA6;CAV1;CDH13;NFATC2;ETV1;GLI1;PPARGC1A;PAX9;FOXD2;NR2F2;TSHZ3;NEDD4L;NR3C2;DLX1;POU4F3;RARB;FOXP2;FOXD1;NFATC1;CAMK2D;ZBTB32;KLF12;LDB2;PBX1;ZSCAN25;EGFR;BHLHE22;ZBTB20;NPAS3;NEUROD6;FGF1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;IL4I1;ZKSCAN7;IRF2BP1;CHD3;CRTC1;MAML2;TXK;LMO1;LMO7;KLF3;KMT2A;SPI1;FOXK1;BEND3;PHF21A;ZNF418;FOXO3;SOX9;UBE2I;BMPR1B;PGR;FOXP4;NPAS2;TFR2;ZBTB8A;GLIS2;CHD8;CSRP3;ZNF585B;ZNF585A;SLC30A9;KAT6B;HDAC4;REL;CHD2;SATB1;BMP5;ZBTB3;ATP2B4;CHD1;KLF10;DACT1;WNT5A;POU5F2;CREB3L1;N4BP2L2;PPM1A;HEYL;ZFP3;ZNF697;ATAD2;ZFP1;SP3;KANK2;BHLHE40;MED18;ZFP90;RPRD1B;TARBP1;CDK13;ANKRD2;ARID3A;ONECUT1;ANXA4;NRIP1;ZFP14;RCOR3;MED12L;NCK2;SIN3B;TEAD3;CDK7;CTCF;NFE2L1;NRF1;HIC1;PEX2;PAF1;ZNF431;NCOR1;PAX3;NCOA5;HOXC10;ZFP62;TBX2;DDX17;ONECUT3;RREB1;DBX2;PIAS2;MAPK7;RARA;SUV39H1;MAFG;USF2;RPAP2;LHX6;KCTD1;PIK3R2;MYPOP;ISL1;PKNOX2;E4F1;FOXK2;TNIP1;MED7;ZNF462;AATF;ZBTB6;AGO1;DDRGK1;TCF20;PLSCR1;TBX18;MED13;TET1;SLTM;MECP2;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;RPRD1A;HDAC2;BAZ2B;LEFTY1;DBP;TLX3;TMF1;CTDSP1;TFEB;TPR;FHOD1;ZHX1;PAXBP1;RTRAF;SIX5;MMP12;WWC1;NCOR2;OTUD7B;RARG;FBXL19;EN2;DVL3;PHF20L1;EGR1;MZF1;MED23;ZBTB49;HEXIM1;ZNF148;HTATIP2;JMJD1C;ERF;AKIRIN1;MEN1;INO80;SEMA4D;NCOA3;NFE2L2;STAT2;CD81;HOPX;PEG3;PTEN;TTC21B;KDM6B;CRLF3;PKD1;CREBBP;NCOA2;NFATC4;BCL9;GTF2H1;ARID4A;SOX4;GMEB1;NUCKS1;DPF3;TCERG1;SFPQ;ZFP57;CBFB;DNAJA3;KAT8;TIAL1;UBE2D3;UBE2D1;CAMTA2;CAPRIN2;RAI1;PPIL4;RIPPLY2;EPC2;DICER1;FOXJ2;ZNF182;FOXF1;ZNF260;BRD8;WWP2;COPS5;NR5A1;LCOR;GPER1;MED8;CCDC62;TADA2A;MED12;ZMYM5;POU6F1;TOX4
prerank,maturation of 5.8S rRNA (GO:0000460),0.4908114000226499,1.1450330147601333,0.30806451612903224,0.9291663016840666,1.0,5/17,11.38%,RRP15;C1D;PES1;EXOSC10;RPF1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4589499486524085,1.1449859287015878,0.3172302737520129,0.9280625337659038,1.0,2/22,3.14%,FGF7;CASK
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.40978432738046905,-1.1449772415524968,0.2759493670886076,0.7187120282800018,1.0,8/16,25.40%,SHLD2;POLQ;UBQLN4;CGAS;MAD2L2;RMI2;SMCHD1;PARPBP
prerank,regulation of phosphorylation (GO:0042325),0.35791336181818145,1.1445422211995087,0.2616279069767442,0.9283373493857594,1.0,23/120,14.10%,ITGA6;DYNLL1;LDB2;GLMN;EGFR;CDH5;OGT;PRKAG1;DSCAM;NUP62;FN1;FER;NUP160;NUP37;TPR;NUP50;RANBP2;STAT2;NUP210;NUP153;GCK;CDKN1C;FZD7
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.36337742891118285,-1.1445262921670656,0.27586206896551724,0.7185246341595555,1.0,14/27,36.22%,ETS1;SIRPA;TRAF6;CYRIB;SKAP1;NR4A3;ITGB2;PYCARD;HAS2;CCR2;HSPD1;CCL2;PRKCQ;THY1
prerank,regulation of complement activation (GO:0030449),0.41697441069873886,1.144350385592232,0.2898134863701578,0.9277442213430116,1.0,6/40,13.20%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,epithelial to mesenchymal transition (GO:0001837),-0.32149871532519203,-1.1439169017646937,0.23344947735191637,0.7188990990819403,1.0,9/47,4.80%,ENG;LEF1;ROCK2;TGFBR3;RBPJ;TBX3;TGFBR1;WNT4;HIF1A
prerank,cellular response to fluid shear stress (GO:0071498),0.5188326820298836,1.1438880916972602,0.32148900169204736,0.9280286988151162,1.0,4/12,12.28%,ASS1;MAPK7;MTSS1;NFE2L2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.38528678388952176,1.1437079397097656,0.2880299251870324,0.9273840408370506,1.0,11/67,6.49%,PKDCC;TEC;FGFR1;EFEMP1;EGFR;ITK;TXK;SRC;FER;EPHB2;ABL2
prerank,protein-DNA complex disassembly (GO:0032986),-0.41071430804510406,-1.143330882189285,0.2847222222222222,0.7192125705395119,1.0,4/16,10.95%,SMARCE1;SMARCD1;RPL23;ARID2
prerank,ovarian follicle development (GO:0001541),0.5151602735938866,1.1433271497220057,0.2976588628762542,0.9274507465262856,1.0,1/13,0.54%,INHBB
prerank,cellular respiration (GO:0045333),0.40719469383974405,1.143134253111666,0.2650771388499299,0.9268495176212102,1.0,5/41,7.17%,PPARGC1A;SDHAF4;LYRM7;SIRT3;COX15
prerank,cellular response to oxidative stress (GO:0034599),0.3579194580111753,1.1426582955730316,0.2632183908045977,0.9270630196669173,1.0,16/118,7.04%,PPARGC1A;PXN;EGFR;GPX8;MGAT3;ETV5;ERO1A;MPV17;FOXO3;WNT16;KEAP1;FANCC;FER;ANKRD2;SELENOS;SLC4A11
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.37312518344637324,-1.1425573479640985,0.2745664739884393,0.7200375464563862,1.0,12/24,25.67%,B2M;ACE;TAP2;SEC23A;SAR1B;HFE;TAPBPL;ERAP1;SEC31A;PDIA3;MFSD6;TAP1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3633611984259661,1.1423078043669772,0.2585596221959858,0.9269677184921087,1.0,16/101,9.89%,LBP;PRKCE;TNIP3;IL1A;PTPN22;WNT5A;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;AXL
prerank,regulation of cation channel activity (GO:2001257),0.3659848547542143,1.141239898915681,0.2806372549019608,0.9292290185597966,1.0,8/89,4.22%,AHNAK;SLMAP;CAMK2D;MINK1;PDE4D;GRIA3;FKBP1B;KCNS2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.37472759709381337,1.1411789995022137,0.2820838627700127,0.9281853735627148,1.0,2/69,0.58%,NGF;PPARGC1A
prerank,actin filament depolymerization (GO:0030042),-0.4666268877317903,-1.140556229677311,0.31116389548693585,0.7244172568023213,1.0,3/11,6.07%,DSTN;CFL1;TWF1
prerank,regulation of nervous system process (GO:0031644),-0.40174149146609117,-1.1395192651237083,0.2743589743589744,0.7259983138370929,1.0,3/18,2.30%,ROCK2;NOS3;SLC8A3
prerank,ceramide catabolic process (GO:0046514),0.5064251364642555,1.139476949130231,0.3339285714285714,0.9324760980258886,1.0,6/14,18.22%,ACER3;NAGA;NEU1;HEXA;HEXB;ASAH1
prerank,endoderm development (GO:0007492),0.5136631969047616,1.1388361069223605,0.3126079447322971,0.9333507038399119,1.0,2/13,5.23%,LAMC1;KIF16B
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4477714562258996,1.1387890811253838,0.29472140762463345,0.9322959219570517,1.0,4/25,4.99%,GLMN;PDE4D;IL1A;PTPRC
prerank,response to amino acid (GO:0043200),-0.3501780156478609,-1.138289071914181,0.257396449704142,0.7280501721051792,1.0,17/31,31.64%,CPEB4;LAMTOR3;GRIN1;RRAGC;GLRA2;SPAAR;RRAGD;CPEB1;XBP1;LAMTOR2;TMBIM6;SLC38A9;NSMF;LAMTOR4;SH3BP4;MEAK7;GLRA1
prerank,receptor clustering (GO:0043113),0.4430838290120565,1.138235280122748,0.31008902077151335,0.932878621363243,1.0,4/27,10.00%,LRP4;MUSK;ITGB7;DLG3
prerank,engulfment of apoptotic cell (GO:0043652),0.4983333344247476,1.1381299738139263,0.31239388794567063,0.9320161081042719,1.0,4/15,8.30%,XKR7;XKR4;RAC2;XKR8
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.4152054892472362,-1.1381165342438677,0.2741514360313316,0.7271921977399896,1.0,3/17,8.44%,IGF1;APOE;RTN1
prerank,response to peptide hormone (GO:0043434),0.40688253129718005,1.1378353874963603,0.2878179384203481,0.9317560883271246,1.0,5/43,4.69%,CAV1;OGT;EIF2B3;SRC;SLC27A1
prerank,regulation of platelet activation (GO:0010543),0.45989468901856695,1.137816558032091,0.315359477124183,0.9306036751369277,1.0,3/21,4.28%,TEC;TXK;PRKCA
prerank,nucleotide metabolic process (GO:0009117),0.453678790781596,1.1376008723646551,0.3241167434715822,0.9300737118565675,1.0,9/23,20.00%,AK5;RNASEH2B;FHIT;NMNAT3;REXO2;CTPS2;DCK;AK7;NUDT5
prerank,response to lipid (GO:0033993),-0.27029661953529466,-1.1374165843709982,0.15568862275449102,0.7278761235505629,1.0,26/105,15.22%,CTSH;ACER2;SMAD6;NOS3;FOXP1;PAQR7;PPARD;RBP4;FOXO1;ERBIN;ALPL;JAK2;ANXA1;GCH1;TRIM16;TRIB1;ESR1;FGFR4;NOCT;GATA6;MAPKAPK2;ABCA2;TNFRSF11A;MAPKAPK3;ABCG1;LGALS9
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.31703354446129883,-1.1369608320854834,0.2471042471042471,0.7279114080949399,1.0,9/48,7.30%,PRKAG2;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PRDM16;PGAM1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3650202366858927,-1.1368658475363131,0.26229508196721313,0.7267959690524692,1.0,3/24,4.80%,GRB10;TMEM204;HIF1A
prerank,inhibitory synapse assembly (GO:1904862),0.5348919362820374,1.1366398203872345,0.3094017094017094,0.9319294050503646,1.0,4/11,12.26%,WNT5A;GABRG2;PLXNB1;GABRB3
prerank,anterior/posterior axis specification (GO:0009948),-0.43012399669239754,-1.1364236831884242,0.27791563275434245,0.7267031861594171,1.0,2/15,2.75%,WLS;TBX3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4716915195789326,1.1357352837314438,0.314873417721519,0.933715691450365,1.0,6/19,14.06%,AADAT;OGDH;GCDH;DLST;GOT1;HYKK
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5258949653104374,1.1354069841958636,0.3338983050847458,0.933575640348116,1.0,3/11,8.68%,F11R;TJP2;RAPGEF6
prerank,lipid transport (GO:0006869),-0.2741915882937697,-1.1353849929087687,0.19796954314720813,0.7281418815526571,1.0,24/97,14.28%,OSBPL8;SLCO3A1;ACSL1;PLTP;CHKA;ABCC4;PITPNB;PPARD;SLCO1C1;LDLR;ABCA4;SPNS2;APOE;TNFAIP8L3;ABCA9;SLCO2A1;OSBPL5;SCP2;ABCD2;ABCA2;MFSD2A;PRELID2;PRELID3A;ABCG1
prerank,phospholipid catabolic process (GO:0009395),-0.37119247871504035,-1.1350767023720991,0.26704545454545453,0.7276108695230377,1.0,3/24,8.38%,GPCPD1;ENPP2;PNPLA6
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4269545778487557,1.1347258452288407,0.3140376266280753,0.9346003647070488,1.0,7/33,12.80%,APOD;MFN2;APLN;TNFAIP3;TAFA5;EFEMP2;PTEN
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4189223017827809,-1.1347243745906397,0.2743142144638404,0.7271422060179806,1.0,4/16,11.10%,ANK2;SEC16A;SEC16B;LRRK2
prerank,regulation of plasminogen activation (GO:0010755),-0.4515181016131641,-1.1347000653008887,0.297423887587822,0.7258173801071109,1.0,3/12,13.20%,CLEC3B;SERPINE2;THBS1
prerank,autophagosome maturation (GO:0097352),-0.3410731302988791,-1.1346817924620347,0.26380368098159507,0.7244997377142897,1.0,14/32,21.76%,UVRAG;GABARAPL1;VMP1;CALM1;VCP;GABARAP;STX17;TECPR1;EPG5;VAMP7;CHMP3;MAP1LC3A;WIPI2;VTI1B
prerank,toll-like receptor signaling pathway (GO:0002224),0.369604746518666,1.134602397270364,0.273176761433869,0.9338270949901076,1.0,20/84,17.66%,LBP;PIK3AP1;SCARA3;TNIP3;MAP3K1;IRAK3;PIK3R4;TLR7;TNIP1;RPS6KA3;HMGB1;TICAM1;S100A9;TAB2;UBE2D3;UBE2D1;PIK3C3;TICAM2;BTK;CTSB
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.509213016116805,1.1340347529759307,0.3422818791946309,0.9344706023565266,1.0,5/12,21.62%,PPARGC1A;ABCD1;IRS2;AKT2;TWIST1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.3465831210346806,-1.134018958407745,0.23841059602649006,0.72499287331984,1.0,8/33,10.58%,TEK;ANGPT1;NUPR1;NDNF;KDR;GATA2;RAMP2;SCG2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.31654298930925084,-1.133984710468349,0.25622775800711745,0.7237309582016875,1.0,6/43,3.88%,IGF1;BMP6;IL6R;BMP4;WNT4;BMPR2
prerank,mitotic recombination (GO:0006312),0.4915387941709632,1.1339265910494363,0.32663316582914576,0.9336207964029509,1.0,4/15,12.90%,SMC5;ERCC1;TEP1;GEN1
prerank,tetrapyrrole metabolic process (GO:0033013),0.4710220718197746,1.13365135327493,0.3142857142857143,0.9332919260860636,1.0,6/18,12.76%,CTRC;ABCC1;CD320;CUBN;MMAB;AMN
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.46345567560262574,-1.1335767956036673,0.3225806451612903,0.7234981273797858,1.0,7/11,40.83%,SP100;MAD2L2;RPS27L;KAT5;TFAP4;MUC1;FOXM1
prerank,regulation of endothelial cell migration (GO:0010594),0.3665485756222119,1.1335650070429746,0.2639225181598063,0.9323757813420975,1.0,10/85,4.96%,DCN;SMOC2;NR2F2;CEACAM1;FGF1;NRP2;GPLD1;NF1;PRKCA;WNT5A
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.47136474881061474,-1.132949041377498,0.3140877598152425,0.7239094230117288,1.0,6/10,29.40%,BMP6;NEXMIF;MAD2L2;NOTCH4;NOTCH1;PPM1F
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4634093382674257,1.1324927940504006,0.3145539906103286,0.9346738048607565,1.0,5/21,9.34%,ADAM19;NCSTN;ADAM10;DAG1;BACE2
prerank,lipoprotein localization (GO:0044872),-0.4561706190117335,-1.1324153782678927,0.3087557603686636,0.7241235822424049,1.0,3/11,6.59%,LRP1;ZDHHC17;VMP1
prerank,positive regulation of translational initiation (GO:0045948),-0.3984267201165941,-1.1322576009613805,0.2891891891891892,0.7232059357389669,1.0,8/18,28.27%,RPS6KB1;YTHDF1;YTHDF2;POLR2D;KHDRBS1;YTHDF3;RPS6KB2;DDX3X
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.3238644800360147,-1.132031920057061,0.25675675675675674,0.7225797766508688,1.0,8/41,7.30%,PRKAG2;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,regulation of viral release from host cell (GO:1902186),-0.3802467943237159,-1.1319658889284205,0.2836676217765043,0.7214168914520188,1.0,10/21,20.69%,MID2;TRIM25;VPS4A;TRIM35;TRIM28;CHMP3;CHMP2B;TRIM8;TRIM13;TRIM11
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39617017226400014,1.131721251022064,0.3005390835579515,0.9359770010704971,1.0,6/47,7.57%,EFNA5;DOCK5;DOCK1;SPRY4;RREB1;KANK1
prerank,regulation of cardiac conduction (GO:1903779),0.38705626419275835,1.1315278493671306,0.300531914893617,0.9354519111792597,1.0,9/54,10.60%,CORIN;ITPR2;ITPR3;FKBP1B;ATP2B4;ATP1A2;CASQ2;ATP1B3;FXYD6
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.39143391541829625,1.1310019916727965,0.30614973262032086,0.9359662234445889,1.0,11/48,13.79%,BCL3;MSH6;PHLDA3;CIDEB;HIPK1;HIC1;MCL1;MSH2;SFN;CDIP1;HTRA2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4434717350226716,-1.1307516697633595,0.3255208333333333,0.7234023333399547,1.0,7/13,23.14%,PDE8A;GPR37;LRRK2;GPR37L1;RACK1;MET;NR4A3
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3531579035279276,1.1303058499032526,0.27304550758459745,0.937033582933151,1.0,5/121,0.71%,THBS4;EFNA5;FGF7;TEC;CSPG4
prerank,positive regulation of hydrolase activity (GO:0051345),0.35022189099088785,1.1302172366540788,0.27963176064441886,0.9361544330496857,1.0,22/137,12.06%,ITGA6;DOCK9;F11R;RGS6;RAPGEF3;RAP1A;ARAP1;SGSM2;NF1;RTN4R;CAV2;ZC3H15;RAPGEF6;PKP4;GSK3B;TBC1D2;FERMT2;FNTA;RIC1;DVL3;PLXNB1;SEMA4D
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2770466979753002,-1.130083383088216,0.18012422360248448,0.7238597504427413,1.0,20/95,10.51%,ENG;ZEB2;SMAD3;SMAD6;DAB2;TGFBR3;LATS2;FKBP1A;SKIL;TGFBR1;EP300;ITGA3;PRDM16;LEMD3;VASN;ASPN;CITED2;SNW1;SLC2A10;HTRA3
prerank,anion transport (GO:0006820),0.41806171702093387,1.1300601946463948,0.3029411764705882,0.9354391017294789,1.0,4/33,4.89%,VDAC2;LRRC8D;SLC26A9;SLC22A3
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.31901659979666763,-1.1295772915151907,0.22105263157894736,0.7239517842225617,1.0,10/41,10.43%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;KCNJ10;FLNA;ANK3;KCNN2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4404281351719321,1.1295292329896631,0.2965722801788376,0.9359830836141124,1.0,10/26,17.54%,HOMER2;EFHB;ATP2B4;CHERP;RCAN1;GSK3B;HOMER3;STIMATE;CHP1;DYRK2
prerank,regulation of cellular component organization (GO:0051128),0.3437679431216687,1.1293520851632153,0.2709750566893424,0.9353581326088004,1.0,21/135,9.45%,PTCH2;CDH13;PLCE1;CEACAM1;CAMK2D;RAP1A;MLLT3;OPHN1;IRAK3;WNT5A;ZFYVE16;STON1;HJURP;ANGPTL7;ABL2;PACSIN2;LTBP4;STK38L;EBAG9;IRGM;STON2
prerank,regulation of neutrophil migration (GO:1902622),0.5345026116529121,1.1291725131364918,0.3367521367521368,0.934749077337098,1.0,2/10,4.67%,MPP1;RAC2
prerank,in utero embryonic development (GO:0001701),-0.35805871836670794,-1.129163016802629,0.2887537993920973,0.7237665019201485,1.0,7/25,10.53%,CHD7;TGFBR1;IGF2;FGFR2;HINFP;TGFB3;BMP2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.49194932055443136,1.1290565859700803,0.3242320819112628,0.9339224638911062,1.0,4/15,7.64%,GPC3;SPEF1;DACT1;ZNRF3
prerank,regulation of aerobic respiration (GO:1903715),-0.4164203271191335,-1.1289563636412887,0.28756476683937826,0.7229996654319001,1.0,4/15,11.80%,ATP7A;CBFA2T3;VCP;SLC25A33
prerank,positive regulation of vasculature development (GO:1904018),0.36083583956125903,1.1289135860783452,0.2889963724304716,0.9331847627462913,1.0,11/94,5.28%,GAB1;SMOC2;RAPGEF3;HK2;FGF1;CDH5;ITGAX;IL1A;PRKCA;WNT5A;HIPK1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.403326057379352,-1.1287650451339124,0.2882205513784461,0.7222753888839137,1.0,4/17,2.58%,IGF1;DOCK4;PDGFRB;IGFBP5
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3917889765098467,-1.1278927352202148,0.28688524590163933,0.7235256759181435,1.0,8/19,17.70%,CUX1;OBSL1;CUX2;LRP8;CDKL5;DBN1;PTPRD;DHX36
prerank,mitochondrion distribution (GO:0048311),-0.4543304810314094,-1.1278906170019822,0.29836829836829837,0.722197006102825,1.0,3/12,14.31%,MEF2A;LRRK2;MAPT
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.45609732035939116,1.1278130931617036,0.33890577507598785,0.9356226452108168,1.0,9/21,18.05%,FBXO5;CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4068571973976781,1.1277509842084197,0.32180851063829785,0.9346521516876785,1.0,12/40,15.15%,FXR2;WDR76;NPAS2;UBE2V2;MCL1;FBXO5;SIRT7;ARMT1;RFWD3;ETAA1;FXR1;NEK4
prerank,cardiac muscle cell development (GO:0055013),-0.38514311846535054,-1.1271479092880063,0.327683615819209,0.7229106170205231,1.0,7/20,8.74%,SORBS2;PDGFRB;PDGFRA;SLC8A1;OBSL1;MYH11;PDLIM5
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.41366676326597784,-1.1271230635894038,0.28116710875331563,0.7216605927052825,1.0,6/16,8.51%,IGF1;ROCK2;TRPC3;AKAP6;MEF2A;SLC9A1
prerank,negative regulation of vascular permeability (GO:0043116),-0.4477565346243792,-1.1263656946458025,0.3136792452830189,0.722418138526361,1.0,6/12,9.43%,ANGPT1;CLDN5;SLIT2;DDAH1;PDE2A;RAMP2
prerank,female gamete generation (GO:0007292),0.4234119052139928,1.1262366625213762,0.3218045112781955,0.9385523228954459,1.0,7/29,18.82%,PIWIL2;DIAPH2;BMP15;MEI4;KMT2D;MDK;USP9X
prerank,regulation of cell communication (GO:0010646),0.40828418561379676,1.1261648850037176,0.30303030303030304,0.9376172641098955,1.0,6/35,9.11%,CXADR;CAMK2D;CDC42SE2;NUP62;CASQ2;TBX18
prerank,positive chemotaxis (GO:0050918),0.4819493231251131,1.125983707107127,0.3395585738539898,0.9370556408908524,1.0,1/17,0.26%,FGF7
prerank,regulation of programmed cell death (GO:0043067),-0.2506411547236722,-1.125957924362174,0.16,0.7222693930081842,1.0,28/161,11.36%,MECOM;DAPK1;HIP1;ACTN2;OMA1;TPT1;ACER2;STEAP3;TGM2;IGFBP3;BCL2L11;WRN;GAS1;MADD;FAS;PRDX2;USP42;LRP8;JAK2;AKT1;HS1BP3;NAE1;VCP;HAX1;RPS3;LRRK2;USP36;BID
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3688151514089939,-1.1258805529661318,0.2375,0.7211553499993637,1.0,10/24,23.51%,CIAPIN1;NFS1;MMS19;NFU1;CIAO3;FXN;ISCA2;GLRX5;BOLA2;ISCU
prerank,negative regulation of peptidase activity (GO:0010466),-0.31307127774882243,-1.1257313882156845,0.26148409893992935,0.7202369526155399,1.0,10/47,10.66%,TIMP3;SPOCK2;LRP1;SERPIND1;SERPINI1;SPOCK1;SERPINE2;AKT1;SERPINB9;GAPDH
prerank,positive regulation of autophagy (GO:0010508),0.36989916140072904,1.1253921669449447,0.2947103274559194,0.9378126428266255,1.0,13/81,11.10%,DCN;PLK2;TPCN1;FOXO3;SCOC;TRIM21;SESN1;IRGM;GSK3B;HMGB1;TICAM1;TFEB;PAFAH1B2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.48268471568071925,1.1248561226015117,0.322061191626409,0.9383308009438429,1.0,2/17,1.76%,EGFR;CCND3
prerank,signal transduction by p53 class mediator (GO:0072331),0.4311686720993479,1.124695445351083,0.3236994219653179,0.937647953529745,1.0,6/30,9.83%,MYBBP1A;PPP1R13B;BCL3;FHIT;NBN;POU4F1
prerank,carbohydrate biosynthetic process (GO:0016051),0.45920170528823256,1.1238299634023674,0.31458966565349544,0.9392726799925388,1.0,2/21,2.69%,ST3GAL4;B3GALT1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5079214018473382,1.1235992511786816,0.3516295025728988,0.9388346358930132,1.0,2/12,4.76%,B3GALT1;B4GAT1
prerank,endomembrane system organization (GO:0010256),0.33632817142480803,1.1233952545844936,0.26033519553072626,0.9382839135794655,1.0,50/178,18.40%,ATP8B3;USP50;HOOK2;ATP8B1;RAB29;PI4K2B;A4GALT;CAV2;LMAN2;PHETA2;EIF2AK3;DNM1;RAB30;USP8;SNX10;ATL2;GOLGB1;SYNGR2;ATP8B2;NPLOC4;LYSMD3;TMED4;SUN1;CSNK1A1;REEP3;LNPK;HOOK3;TRIP11;OTOF;HTT;LAPTM4B;ZW10;FBXW8;NUP93;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;ANXA8;ANXA8L1;OSBPL2;TBC1D20;ARHGEF7;DYNC2H1;ALS2;VPS11;SPTBN1;LEMD2;COG3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.33355734628184996,1.1233622180342708,0.27185501066098083,0.9372109252758477,1.0,25/208,11.08%,RORA;ROR1;PLK2;LPAR1;PPM1N;PELI2;TNIP3;AKAP13;SLC35B2;REL;NUP62;WNT5A;PPM1A;TNFAIP3;TRADD;TRIM21;S100B;TNIP1;TFG;TICAM1;TMED4;CANT1;SHARPIN;OTUD7B;TAB2
prerank,mRNA processing (GO:0006397),0.3244566395950489,1.1232240018778643,0.2557894736842105,0.9364647016120394,1.0,81/287,22.78%,DHX8;PPARGC1A;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;CELF1;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;SON;RPRD1B;HNRNPR;SF3B5;PPIE;CDK7;PRPF3;CSTF3;CHERP;DDX46;RBM22;RBM5;ELAVL2;DNAJC8;SNU13;SUPT4H1;RPRD1A;HNRNPM;DBR1;UPF3B;SRRM2;GTF2F2;ERN1;GTF2H1;TCERG1;SNRPA1;SFPQ;THOC3;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;CMTR1;PSPC1;THOC5;SYNCRIP;PRMT9;CWC22;SLU7;SYMPK;GTF2H3;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3731130477992847,-1.122914561241855,0.31419939577039274,0.7268724336975487,1.0,10/23,18.07%,PREB;TMED9;SEC61B;SURF4;SYVN1;SEC16A;VCP;OS9;DERL2;TECPR2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.28079779818079353,-1.1219765798626415,0.21195652173913043,0.7281842135198495,1.0,17/78,11.25%,PICALM;NUMB;PID1;EPHA3;PRKCH;LRP1;DAB2;PIK3R1;SQSTM1;STX8;ITGA3;ACTB;AKT1;LDLRAP1;VPS4A;AR;CLIP3
prerank,ceramide transport (GO:0035627),-0.4428113610002925,-1.1216242415457855,0.3185011709601874,0.7279198163894439,1.0,8/12,33.90%,PLTP;ABCA2;PLEKHA3;ABCB4;PLEKHA8;ABCA13;PSAP;CPTP
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3565728848064851,-1.1215371836767585,0.28888888888888886,0.7268301689163569,1.0,14/27,20.34%,SLC47A1;SLC6A9;SLC7A5;SLC7A1;ARL6IP5;SLC25A38;SLC1A3;SLC1A1;SLC3A2;SLC22A2;SLC38A5;SLC25A18;SLC25A29;SLC1A4
prerank,Wnt signaling pathway (GO:0016055),0.35171365447931047,1.1214111669843816,0.29940828402366865,0.9411552107201604,1.0,23/92,14.91%,WNT10A;FZD2;AXIN1;WNT2B;WNT16;PLPP3;CPE;WNT5A;CSNK1G3;GSK3B;CSNK1A1;FERMT2;STRN;RARG;APC;DVL3;WNT9A;PTEN;NXN;BCL9;FZD7;FZD9;FZD3
prerank,response to organophosphorus (GO:0046683),-0.415075180330774,-1.1213086741281921,0.3266832917705736,0.7261915227526329,1.0,5/16,15.98%,TRPC3;ABCC9;TRIM16;P2RX7;P2RX4
prerank,regulation of immune effector process (GO:0002697),0.4064689687268259,1.1212100032299896,0.32474964234620884,0.9406463571074182,1.0,6/41,13.20%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,cellular response to organic substance (GO:0071310),-0.26054953493961086,-1.1210114315740596,0.22758620689655173,0.7256937448957903,1.0,22/116,11.10%,SMAD3;LEF1;PID1;GHR;CLEC3B;SLIT2;IGFBP5;TGFBR1;ACVRL1;BMPR2;CYP1B1;IL18;KLF4;AKAP6;RPS6KB1;TRAF6;ARL6IP5;CDK9;LDLRAP1;RAMP2;HAX1;LRRK2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3755467177804901,-1.120697756996889,0.29210526315789476,0.7252669173642737,1.0,5/21,7.59%,ADCY1;ADCY7;NPR1;ADCY4;ADCY2
prerank,mitotic DNA replication (GO:1902969),-0.47442428733195063,-1.1205729152712276,0.3275488069414317,0.7243441876393466,1.0,7/10,32.05%,MCM6;POLA1;MCMDC2;CDC45;GINS1;MCM3;MCM2
prerank,response to insulin (GO:0032868),0.36741748971424204,1.120563772824194,0.29161451814768463,0.9416167937263645,1.0,12/80,8.05%,INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;OGT;GPLD1;SLC27A1;FER;SELENOS;SYAP1;PIK3R2
prerank,response to calcium ion (GO:0051592),0.35679157312185145,1.1205503009150415,0.2939024390243902,0.9404857887394094,1.0,8/102,4.96%,CAV1;GUCA1A;ITPR3;CAMK2D;SLC25A12;GPLD1;ADD1;WNT5A
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3440803944813005,1.1204626139880909,0.2694063926940639,0.939611065548598,1.0,22/138,13.35%,RORA;PPARGC1A;NR3C2;RARB;MAML2;PGR;TAF10;TAF4B;TEAD3;CDK7;NCOR1;RARA;MED7;RORB;NRBF2;NCOR2;RARG;MED23;GTF2F2;TAF15;CREBBP;GTF2H1
prerank,body fluid secretion (GO:0007589),-0.4039046115131828,-1.1203102463800054,0.3140495867768595,0.723708510829153,1.0,3/15,4.51%,GPAT4;SLC22A4;NPR1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5080816920435176,1.1202647387979772,0.3373287671232877,0.9390520606177329,1.0,7/12,20.46%,MTHFD1;PPAT;PRPSAP2;PRPS1;PRPS1L1;GART;ADSL
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3597373863341643,-1.1197355364029073,0.2893258426966292,0.724141275620531,1.0,6/25,24.76%,IGF1;TRAF6;H1-0;PER2;MAD2L2;TRIM6
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4025629400580774,1.1192421027715023,0.3112676056338028,0.9411540248482266,1.0,6/42,11.55%,CDH13;UTRN;PTPRJ;GSK3B;FERMT2;EFEMP2
prerank,activin receptor signaling pathway (GO:0032924),0.48932554635543646,1.1191107820208703,0.33934426229508197,0.9404381058392562,1.0,2/15,5.04%,INHBB;ACVR1C
prerank,regulated exocytosis (GO:0045055),-0.2473028257656636,-1.118813132505321,0.17142857142857143,0.7254469186504087,1.0,54/173,23.84%,IGF1;TIMP3;VWF;ACTN2;ABCC4;PECAM1;PCDH7;CLEC3B;SPARC;LYN;CDC37L1;IGF2;NHLRC2;SYT9;SYT7;CALM1;PROS1;TGFB3;VEGFC;CYRIB;ARHGAP17;QSOX1;SYTL4;PHACTR2;FLNA;MANF;TGFB2;VEGFD;THBS1;VAMP7;TMSB4X;F5;LGALS3BP;TLN1;DNAJC5;CPLX2;EGF;RAB11FIP1;FAM3C;RAB11B;MYH9;RARRES2;SYT13;TUBA4A;SYT6;RIMS1;CLU;VTI1B;SNAP25;RAB10;A2M;RIMS3;TAGLN2;PCYOX1L
prerank,cellular response to peptide (GO:1901653),-0.2913464123019816,-1.1186416231012901,0.28879310344827586,0.7246393145788613,1.0,11/56,10.49%,IGF1R;IGF1;LRP1;ARHGEF2;GJA1;EPHA4;VCAM1;NOD1;GRIN1;LGMN;RPL23
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.35618676842302743,-1.117977095966624,0.2522255192878338,0.7251928661430197,1.0,7/26,12.18%,SHANK3;SLC8A3;CUX2;GRIN1;LRRK2;PRKCZ;NRXN1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4155557442615074,1.1169440929237402,0.31971830985915495,0.9464149524841825,1.0,6/36,8.37%,CAV1;EGFR;IL1A;ATP2B4;DDAH2;NOS1AP
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.40995162919121536,-1.1168545440105833,0.29916897506925205,0.7269918386183537,1.0,9/17,32.36%,ANK2;SCN4B;SCN1B;KCNE4;KCNH2;SCN5A;GJA5;KCNQ1;CACNA2D1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.40128550883559416,-1.116712340293576,0.31202046035805625,0.7261256404652638,1.0,5/16,6.00%,IGF1;TGFBR3;RBPJ;FGFR2;AKAP6
prerank,positive regulation of lyase activity (GO:0051349),0.4876083783509744,1.1165833887173922,0.34440559440559443,0.946381892149988,1.0,2/14,3.23%,GUCA1A;NF1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4022727415823949,1.1162305115446411,0.3221476510067114,0.9464008506004726,1.0,15/39,20.74%,SOCS5;PI4K2B;PIP4K2B;SOCS6;PIK3R2;EFR3A;SOCS4;SOCS7;PIK3C3;PI4K2A;SOCS1;SOCS2;ITPKA;PIK3C2B;CISH
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.35953289882615724,1.1160708152553698,0.3020706455542022,0.9457557797472328,1.0,24/82,21.11%,DYNLL1;GTSE1;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;PAFAH1B1;CCP110;NDE1;CEP290;SSNA1;CETN2;PCM1;YWHAG;YWHAE;CEP57;OFD1;CEP250;DCTN2;ALMS1;HAUS8;CEP43
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.39899851801867114,-1.1158077327237843,0.2871536523929471,0.727504258817068,1.0,5/17,10.53%,NOTCH2;RBPJ;BMP4;GALNT11;BMP2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.44610411251121973,-1.1157958913914812,0.3380281690140845,0.7262605969975341,1.0,6/11,17.04%,FOXO1;LMNA;GSK3A;MLIP;P2RX4;SMAD4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.46364686540089606,-1.115609678831446,0.3058252427184466,0.725515962093643,1.0,6/10,23.66%,PDE8A;GPR37;LRRK2;GPR37L1;RIPK1;STK26
prerank,oligosaccharide biosynthetic process (GO:0009312),0.46025408989037864,1.1155574804593187,0.3250388802488336,0.9462716845916498,1.0,2/20,2.69%,ST3GAL4;B3GALT1
prerank,modulation by host of symbiont process (GO:0051851),-0.33816501848425456,-1.1153425028928776,0.27672955974842767,0.7249392040849371,1.0,7/31,12.56%,LEF1;EP300;NAPEPLD;HDAC1;CCNT1;SNW1;SP1
prerank,negative regulation of gene expression (GO:0010629),-0.22805703590467893,-1.1151687490409776,0.023809523809523808,0.7241557933569968,1.0,88/302,21.79%,IGF1;ROBO1;SLC24A3;DAPK1;PICALM;NOTCH2;ENG;ROCK2;CLDN5;LGR4;FOXP1;IGFBP5;BMP4;SLC7A5;WNT4;ACVRL1;RPS6KA5;HIF1A;RBL1;XDH;KLF4;PDCD10;HDAC9;KDR;MYADM;APOE;CD34;HDAC1;HINFP;RBMS3;MAP2K2;CRKL;PPP1R11;PAIP2;RPL13A;JARID2;CITED2;GATA2;LGMN;SLC2A10;AGO3;ZC3H12A;RPS3;BMP2;GAPDH;BMI1;ESR1;RPS26;TTBK1;NOCT;NUDT12;TGFB2;NCL;DHFR;MOV10;ID2;MAPT;AGO4;SH3GL2;PARP10;TLE5;LGALS9;RBL2;SUZ12;DNMT3B;TWSG1;ASB1;ZFP36;CNOT9;TNRC6C;DHX36;KAT2B;METTL16;YTHDF2;ANXA7;EED;RACK1;DAPK3;MIF;ZC3H10;TASOR;DNMT3A;HRAS;CILP;RIDA;TMBIM6;DCP2;APLNR
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4608890206770476,1.1146411362519182,0.3389830508474576,0.9481742813247904,1.0,8/20,17.80%,PSMG2;PFDN6;PSMG1;LONP1;CCT2;HOPX;PSMG3;HSPA4
prerank,regulation of amyloid fibril formation (GO:1905906),-0.40743607351647726,-1.1142954014922821,0.3133159268929504,0.7253591058158576,1.0,6/15,21.63%,LDLR;APOE;VBP1;CRYAB;PFDN4;CLU
prerank,cellular response to metal ion (GO:0071248),-0.2549314776377615,-1.1142441312362974,0.18382352941176472,0.7242231997150517,1.0,26/123,11.74%,ADGRV1;BMP6;CLIC4;ADCY1;ADCY7;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;B2M;SYT9;SYT7;KCNH1;RASGRP2;MEF2A;PLCG2;SLC41A1;AKT1;LGMN;ANK3;LRRK2;GLRA2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3557024024865859,1.1139398640951703,0.30917874396135264,0.9492625175151475,1.0,37/91,23.05%,CDH13;RAB8B;OPHN1;SRC;PTPRC;ZFYVE16;STON1;ABL2;PACSIN2;RIMS2;RAB3A;CPLX1;RINT1;INPP5F;ATP9A;STON2;PLD1;RUFY2;MBTPS1;SYK;RAB33B;RAB21;STX4;SNX12;DENND10;RAB5A;PACSIN3;NSF;SNX17;PACSIN1;RALA;CPLANE2;VAMP2;TSC2;HCK;AP2S1;MAPK1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5108111776567263,1.113777746620023,0.35650623885918004,0.9486331622245342,1.0,6/11,17.26%,THTPA;TPK1;CTPS2;NT5C3A;SLC25A19;DCK
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.374993176011276,-1.113627691778929,0.3292307692307692,0.7246313711931607,1.0,11/22,38.21%,SLC7A5;RFTN1;IL18;SPHK1;NR1H4;NOD2;MYD88;PRKCQ;TGFB1;LY9;SLAMF6
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4315260606199933,-1.1134885653183801,0.3236009732360097,0.7237809551591813,1.0,7/13,16.79%,SEMA7A;PLCG2;TGFB3;CUEDC2;TGFB2;LAPTM5;GPRC5B
prerank,epidermal cell differentiation (GO:0009913),0.3964805902057653,1.113435549952031,0.3140495867768595,0.9486583986637646,1.0,4/41,4.96%,GLI1;JAG1;WNT16;WNT5A
prerank,brain development (GO:0007420),0.34251153724991673,1.1130719014433406,0.27364864864864863,0.9486847178637468,1.0,12/136,9.41%,PTCH1;APOD;PBX1;NF1;CHD8;SHROOM2;AMIGO2;PAFAH1B1;CDH2;EML1;COL4A1;FOXJ1
prerank,granulocyte differentiation (GO:0030851),-0.3891839838657162,-1.1127367104774004,0.3097560975609756,0.7245923483289579,1.0,6/18,13.79%,LEF1;CBFA2T3;EP300;DEK;CDK4;TAL1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.42966665180165103,-1.1126684494304975,0.34760705289672544,0.7235069942037594,1.0,5/13,8.78%,ROCK2;CDC42;ASAP3;SLC9A1;ACTG1
prerank,positive regulation of leukocyte migration (GO:0002687),-0.35277376984440945,-1.1123559659622908,0.3111111111111111,0.7231675302458718,1.0,10/27,31.49%,IL6R;CSF1;EDN3;PTN;ICAM1;NCKAP1L;ADAM8;JAM3;ADAM17;AIF1
prerank,positive regulation of transferase activity (GO:0051347),0.339057935593395,1.111732674983796,0.28036322360953464,0.951876859240101,1.0,13/142,6.39%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK;AXIN1;UBE2I;LMO4;NEK7;RFC3;NBN;EPHB2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.33722935872052257,-1.11168817315137,0.2633333333333333,0.723824853255358,1.0,7/35,8.04%,ITGA1;PDGFRB;FKBP1A;PPP4R4;PPP1R12A;CALM1;PPP1R11
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3863939937556645,1.1113480708684056,0.30758988015978694,0.9519265956927646,1.0,8/49,7.60%,CAV1;EIF2AK3;SRC;FIS1;NDUFS3;MCL1;SIAH1;PTPMT1
prerank,regulation of gluconeogenesis (GO:0006111),0.4346836922454713,1.1112272062135835,0.32200886262924666,0.9511644303231215,1.0,6/27,13.40%,PPARGC1A;OGT;SELENOS;SIRT7;C1QTNF12;GCK
prerank,regulation of cell adhesion (GO:0030155),0.34333108520593647,1.1110539550140168,0.30786773090079816,0.9505851774113028,1.0,13/129,6.49%,TGFBI;EFNA5;CDH13;RIPOR2;MINK1;PRKCA;SRC;DSCAM;RAC2;PLXNA3;ADAM10;EPHB2;ABL2
prerank,calcium ion homeostasis (GO:0055074),0.35988517329838854,1.1106223473851673,0.3079754601226994,0.9507545859715454,1.0,9/95,4.74%,CAV1;STC2;CTRC;SLC8B1;CDH5;SLC24A1;TRPV4;CSRP3;ATP2B4
prerank,mRNA catabolic process (GO:0006402),0.39875969191969757,1.1106152967216976,0.33242876526458615,0.9496160473730872,1.0,8/44,13.35%,DHX34;CNOT10;DXO;DIS3L2;AGO1;EXOSC10;ZFP36L2;ERN1
prerank,mitochondrion localization (GO:0051646),-0.3905248883412105,-1.110199379551228,0.33773087071240104,0.7266809177896177,1.0,4/19,11.10%,MARK1;ZBED3;MEF2A;LRRK2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.443977178525539,-1.1098363053239464,0.34375,0.7263904576248567,1.0,3/12,6.47%,CTSH;LMO2;CTSL
prerank,positive regulation of cell death (GO:0010942),0.3744350791941797,1.1095228611121248,0.312987012987013,0.9519465482915321,1.0,15/59,12.13%,PRODH;CIDEB;CELF1;WNT5A;SLC6A13;EFNB2;MAP3K5;GSK3B;SARM1;AXIN2;RARG;APC;EGR1;HTATIP2;FAF1
prerank,positive regulation of developmental process (GO:0051094),0.33871858851494013,1.1092383839250364,0.2967525195968645,0.9517091261794528,1.0,24/164,9.72%,DCN;FGFR1;DLX1;COBL;FOXD1;RAPGEF3;DDHD1;SOX9;BMPR1B;SRC;KMT5C;BMP5;FIS1;WNT5A;TMEM79;LLPH;DAG1;RREB1;FBXO5;ISL1;CDC20;MIEF1;RPS6KA3;PHLDB1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.38259077209486264,-1.1089171109110745,0.32926829268292684,0.7275515806244724,1.0,6/18,12.75%,ENG;NOS3;BMP4;ACVRL1;BMP2;TGFB2
prerank,positive regulation of isotype switching (GO:0045830),-0.40912672862491717,-1.1085586159668768,0.31009615384615385,0.7272255867379903,1.0,8/15,26.08%,TFRC;PAXIP1;SHLD2;CD40;MAD2L2;CLCF1;TNFSF13;HMCES
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.38236177288463813,1.1085274107347245,0.31989247311827956,0.9528565781593301,1.0,12/53,14.11%,EGFR;FXR2;BRCC3;EYA1;SPRED1;NPAS2;HIC1;UIMC1;WRAP53;ERCC6;SPRED2;FXR1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.41019501024654526,1.107947327538338,0.3342981186685962,0.9535343578994453,1.0,5/36,9.49%,DCN;NR2F2;ATP2B4;MECP2;HMGB1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.38964086307703566,-1.1079023478524226,0.3163538873994638,0.7279324440778708,1.0,7/18,15.04%,STX8;ACTB;LDLRAP1;VPS4A;AR;ABCA2;ZDHHC2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3715600460651376,-1.1078953806626215,0.3323170731707317,0.7266991579334872,1.0,8/24,12.73%,IGF1;INSR;ENPP1;IGF2;AKT1;PPP1R3B;GSK3A;PPP1R3C
prerank,fat cell differentiation (GO:0045444),-0.29713133831399197,-1.1077515634144306,0.26609442060085836,0.7258263867940883,1.0,16/57,12.88%,OSBPL8;PID1;SMAD6;WNT5B;FOXO1;EP300;KLF4;OSBPL11;PRDM16;ATF5;C1QTNF3;NR4A2;CLIP3;CTBP2;TMEM120A;BBS2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.34587884764276566,1.1076135137687544,0.3068181818181818,0.9534934861825004,1.0,20/132,10.54%,DCN;PLK2;VGLL4;ZBTB20;TPCN1;GPLD1;FOXO3;DACT1;DXO;SLC4A4;TRIM21;RDX;IRGM;LIN28B;GSK3B;HMGB1;TICAM1;CNOT7;ADRA2A;TFEB
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3875603952359844,1.1074557961572957,0.30831099195710454,0.9528290345990754,1.0,13/45,17.36%,PLK2;WEE1;TOM1L1;CHFR;BRINP1;TOM1L2;ZFP36L2;CDKN1C;ZWILCH;ZW10;FZD3;RGCC;SCRIB
prerank,cellular component maintenance (GO:0043954),0.5139603175670251,1.107406235795601,0.3577512776831346,0.9518620355912949,1.0,1/12,0.18%,CLDN1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3570534621212213,1.1070306689712814,0.32250300842358604,0.9519572034476906,1.0,13/87,14.18%,FGF7;FGFR1;FGF1;RBFOX2;SPRED1;KIF16B;FGF18;HNRNPM;GTF2F2;ZFP36L2;SPRED2;FLRT2;TIAL1
prerank,actin filament bundle organization (GO:0061572),-0.3401557778428948,-1.1067253445691667,0.3087248322147651,0.7275429738827591,1.0,5/33,5.73%,EPS8;NEDD9;MYO1B;PAWR;PLS3
prerank,response to fatty acid (GO:0070542),0.4651687761589619,1.1064586425461433,0.35093696763202725,0.9526297542089088,1.0,7/17,17.74%,FOXO3;SOX9;PDK4;GLDC;KCNK4;SCD;LPL
prerank,regulation of lipid metabolic process (GO:0019216),0.35735530378293134,1.105852311245594,0.3031055900621118,0.9534713026688357,1.0,7/88,7.02%,RORA;CAV1;CHD9;SC5D;SIN3B;NCOR1;ACACA
prerank,regulation of JUN kinase activity (GO:0043506),-0.3263076557814527,-1.1054760563073316,0.29333333333333333,0.7299175115508034,1.0,9/33,16.28%,SASH1;DUSP10;DNAJA1;TRAF6;MAP3K10;RPS3;TNFRSF11A;EDN1;DVL2
prerank,positive regulation of protein modification process (GO:0031401),0.328777832201151,1.1054719970265092,0.2872454448017149,0.9535182428368892,1.0,23/203,8.84%,EFNA5;FGF7;DLC1;NTRK3;CLDN19;LEPR;EGFR;RAPGEF3;CCND3;MUSK;PELI2;FGF1;AXIN1;CDH5;FXR2;SOX9;LIMK2;KRAS;RAB3GAP2;DYRK1A;NOS1AP;FGF18;IRGM
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3670071604068576,-1.1053388302911977,0.3296398891966759,0.7290494956943677,1.0,8/23,20.73%,BCL2L11;SAMM50;TIMM10B;TIMM8B;COX18;ROMO1;MAIP1;TIMM29
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.322037625233299,-1.105311493016773,0.2876712328767123,0.7278767361313212,1.0,16/36,30.27%,PCGF2;PHC3;BMI1;RYBP;CDC7;SUZ12;EED;EHMT2;RAD51;L3MBTL2;BRCA1;RNF2;PCGF6;RING1;MAX;E2F6
prerank,fatty acid transmembrane transport (GO:1902001),-0.39301045591764994,-1.1052242685936982,0.3360655737704918,0.7268769133748179,1.0,7/19,14.68%,PRKAG2;ABCD4;CPT2;PRKAB2;ABCD2;CPT1A;MID1IP1
prerank,carbohydrate homeostasis (GO:0033500),-0.2849624432336404,-1.1050916392305008,0.24757281553398058,0.7260318971727932,1.0,7/67,3.87%,IGF1R;INSR;KCNB1;ADIPOR2;RBP4;APPL2;MBD5
prerank,early endosome to late endosome transport (GO:0045022),0.4483229392564068,1.104971649886654,0.3463338533541342,0.954056633993937,1.0,9/20,21.66%,HOOK2;WDR81;KIF16B;HOOK3;PIK3C3;LMTK2;WDR91;RAB5A;AKTIP
prerank,protein-containing complex disassembly (GO:0032984),0.3815754754692066,1.104835876468621,0.34,0.9533825157075766,1.0,16/54,19.50%,CAV1;FZD2;AXIN1;TSG101;GSK3B;CSNK1A1;APC;DVL3;VAMP8;LIX1;PYM1;UBQLN1;PPP1CA;SNAP29;MAP1LC3B;LAMP2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.43465801256405834,1.1043422062807668,0.34915773353751917,0.953841591836248,1.0,5/26,6.72%,EGFR;CCND3;ADAMTS1;UBE2E2;RDX
prerank,acute inflammatory response (GO:0002526),0.4359482806569499,1.1040077188721642,0.34651898734177217,0.9537305492173369,1.0,4/23,13.61%,LBP;ANO6;PLSCR1;CTNNBIP1
prerank,glutamate metabolic process (GO:0006536),0.46662962810910835,1.1039071114649295,0.36142625607779577,0.9529466642248469,1.0,7/19,15.30%,PRODH;AADAT;ALDH18A1;ALDH5A1;GOT1;GLUL;GGT1
prerank,aggrephagy (GO:0035973),0.43098305520222,1.1034157456694593,0.351937984496124,0.9533834749038046,1.0,5/27,11.27%,DYNLL1;WDR81;ATG5;DYNLL2;HDAC6
prerank,regulation of macrophage activation (GO:0043030),-0.3450778311916397,-1.1030278546979442,0.2909698996655518,0.7306160164719978,1.0,11/30,13.76%,IL31RA;MFHAS1;NR1H3;IL33;CD200;ZC3H12A;GPR137B;THBS1;SPHK1;MYO18A;PJA2
prerank,negative regulation of programmed cell death (GO:0043069),-0.22867956623124905,-1.1028096894548562,0.11538461538461539,0.7299528144162926,1.0,68/355,14.08%,IGF1R;IGF1;MECOM;NOTCH2;TEK;LEF1;OSR1;ANGPT1;GRK5;IL31RA;CTSH;TPT1;SMAD6;DAB2;PIK3R1;DNAJC3;NUPR1;BMP4;TBX3;FOXO1;TFRC;SQSTM1;CFL1;HNRNPK;CAT;FAS;DSTYK;GPX4;ZFAND6;AREL1;NPM1;NAA15;PDCD10;PRDX2;KDR;RPS6KB1;DNAJA1;HDAC1;IFIT3;TRAF6;PTMA;RNF144B;CASP3;ANXA1;ATF5;AKT1;UFM1;CFLAR;CITED2;SERPINB9;ARHGDIA;FLNA;CIAPIN1;UBE2O;HAX1;BID;BABAM2;TXNDC5;BAG4;CRYAB;FLT4;GATA6;THBS1;SPHK1;MYO18A;PIM3;YWHAZ;FXN
prerank,muscle contraction (GO:0006936),-0.2599976400354862,-1.1027671268437964,0.2605633802816901,0.7288303856131676,1.0,28/126,15.17%,MYOF;ITGA1;ROCK2;ACTN2;MYLK;DMD;TPM1;GJC1;SLC8A1;DYSF;SNTB1;TMOD3;BDKRB2;CALM1;MYL9;MYL6;MYH11;TPM3;LMOD1;ACTA2;TPM2;EDNRA;CRYAB;DES;ITGB5;SLC6A8;VIM;TLN1
prerank,mitotic spindle organization (GO:0007052),0.3360537733071604,1.1026565263440822,0.3137472283813747,0.9546019389144389,1.0,49/153,23.10%,PLK2;DYNLL1;KIF2A;STIL;SMC3;SPAST;TUBG1;DSN1;CKAP5;PAFAH1B1;EML1;CDC20;NUP160;MECP2;DYNLL2;NUP37;RANBP2;BUB3;MAP4;WDR62;NDE1;MAP9;AHCTF1;PTPA;TUBG2;ZWILCH;ZW10;CENPU;ARHGEF10;RAN;PIBF1;TBCE;CENPH;B9D2;CENPK;MAD1L1;OFD1;RHOA;DCTN2;DYNC1LI2;CENPL;DYNC1I1;NUP43;GPSM2;PRC1;MIS12;DCTN6;SEC13;SBDS
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.31083679858412805,1.1025393285464382,0.19,0.9538620031050153,1.0,125/834,13.67%,RORA;MEOX2;DCN;KLF5;ETV4;ITGA6;CDH13;ETV1;GLI1;PPARGC1A;FOXD2;NR2F2;DLX1;POU4F3;RARB;NFATC1;LDB2;PBX1;EGFR;FGF1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;GLI2;IL4I1;CRTC1;MAML2;TXK;LMO1;LMO7;KMT2A;SPI1;FOXO3;SOX9;BMPR1B;PGR;NPAS2;TFR2;GLIS2;CHD8;CSRP3;SLC30A9;KAT6B;HDAC4;REL;BMP5;KLF10;LEO1;WNT5A;HEYL;ATAD2;SP3;RPRD1B;APLN;CDK13;ONECUT1;NRIP1;NCK2;CDK7;NRF1;PAX3;HOXC10;DDX17;RREB1;MAPK7;RARA;USF2;PIK3R2;ISL1;E4F1;FOXK2;ELL;TNIP1;ZNF462;AATF;AGO1;DDRGK1;TCF20;PLSCR1;MED13;TET1;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;HDAC2;DBP;TMF1;TFEB;FHOD1;PAXBP1;RTRAF;MMP12;WWC1;RARG;DVL3;EGR1;MZF1;ZBTB49;HTATIP2;AKIRIN1;MEN1;INO80;NCOA3;NFE2L2;CD81;PEG3;KDM6B;CRLF3;PKD1;CREBBP;NCOA2;BCL9;SOX4;DPF3;TCERG1;SFPQ
prerank,regulation of histone deacetylation (GO:0031063),0.4978066313336858,1.1020853799344166,0.34105960264900664,0.9541076281940555,1.0,3/13,15.59%,CAMK2D;PRMT6;SAP30BP
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3529343474682844,1.1020365067748747,0.32816229116945106,0.9531473482366278,1.0,21/94,17.01%,PRODH;MYBBP1A;PPP1R13B;MSH6;FHIT;ERO1A;CIDEB;HIC1;MCL1;CUL3;MAP3K5;STK24;SFN;POU4F1;DIABLO;ERN1;HTRA2;BAD;BNIP3;E2F1;QRICH1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3353803344668053,1.1020032602144822,0.31543624161073824,0.9521207282848884,1.0,9/151,4.99%,ROR2;ROR1;NTRK3;ACKR3;EGFR;RAP1A;PTPN22;PRKCA;PTPRC
prerank,nuclear pore complex assembly (GO:0051292),0.5212087056264364,1.1017833565076038,0.3608058608058608,0.9516546657782466,1.0,5/10,15.46%,TPR;AHCTF1;NUP153;RTN4;NUP93
prerank,regulation of cell junction assembly (GO:1901888),0.4199517280922455,1.1016425765428943,0.3514328808446455,0.9509854736674106,1.0,3/27,1.89%,F11R;CLDN19;RAP1A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.369036209012768,1.101213204595191,0.3272490221642764,0.9512043674402603,1.0,11/67,8.05%,PXN;SH2D2A;SULF1;CYFIP2;NRP2;DOCK1;VAV2;SRC;NCK2;SHB;PIK3R2
prerank,microtubule polymerization (GO:0046785),0.42277752983274236,1.1010909559393829,0.32554744525547447,0.9504568773292168,1.0,17/28,29.88%,TRPV4;TUBG1;CKAP5;TUBGCP5;NDE1;TUBG2;SLAIN2;TUBGCP6;PIN1;MAP7D3;FGF13;CSNK1D;CLASP2;CCDC57;HDGFL3;NDEL1;CLASP1
prerank,negative regulation of metabolic process (GO:0009892),0.3831771380073426,1.1009042528362363,0.3342503438789546,0.949955349382905,1.0,10/54,8.81%,IL18R1;LAMA4;ZNF423;PLCL1;PCTP;FIS1;ACOT13;HOXC10;ZDHHC7;LNPEP
prerank,blood circulation (GO:0008015),0.38403221740513693,1.100849803467893,0.31842818428184283,0.9489957164218098,1.0,4/49,3.80%,MEOX2;SGCD;SERPING1;SGCG
prerank,synapse organization (GO:0050808),0.34447493533759144,1.0999416936966386,0.2952941176470588,0.9508039521593917,1.0,9/125,2.70%,NTNG1;LRP4;PDZRN3;PTPRF;MUSK;GPC6;PPFIA2;ZC4H2;RAB29
prerank,regulation of DNA repair (GO:0006282),0.39156527452038464,1.099708247653067,0.3393103448275862,0.9504320304073861,1.0,11/44,10.80%,EGFR;BRCC3;EYA1;NPAS2;UBR5;UBE2V2;UIMC1;WRAP53;SIRT7;ERCC6;AXIN2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4222260007631526,1.0994520750454126,0.33781763826606875,0.9501595183940685,1.0,9/26,16.76%,NEDD4L;KCNS2;CASQ2;ATP1B3;KCNAB1;NEDD4;FHL1;WWP2;YWHAE
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3318198227845924,1.0992119782957583,0.310989010989011,0.949779371988233,1.0,27/166,13.35%,RORA;PPARGC1A;NR3C2;RARB;MAML2;PGR;TAF10;CAVIN1;TAF4B;TEAD3;CDK7;POLR1E;NCOR1;RARA;MED7;RORB;NRBF2;TFB2M;NCOR2;RARG;MED23;NAT14;GTF2F2;TAF15;CREBBP;BRF2;GTF2H1
prerank,organelle fusion (GO:0048284),0.4378790190484983,1.098395914654488,0.3470319634703196,0.9512254431728374,1.0,9/22,22.21%,MFN2;FIS1;MIEF1;MIGA1;STX4;VPS11;BAX;CHCHD3;THG1L
prerank,positive regulation of viral transcription (GO:0050434),0.4311273321260949,1.0982569830962985,0.34355828220858897,0.9505514383915055,1.0,4/25,12.47%,MDFIC;NELFB;SUPT4H1;GTF2F2
prerank,leukotriene metabolic process (GO:0006691),0.4518683056762717,1.097958141160978,0.3385093167701863,0.9504064730642404,1.0,5/19,15.30%,MGST2;ABCC1;ABCC10;LTA4H;GGT1
prerank,myotube cell development (GO:0014904),-0.45453698445961677,-1.0977952651179783,0.35683760683760685,0.7415019567364706,1.0,2/10,7.43%,IGF1;SELENON
prerank,cellular response to interleukin-15 (GO:0071350),-0.4225938209485729,-1.097661921445441,0.33668341708542715,0.7393680981742918,1.0,2/13,7.60%,PLCB1;IL15RA
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4225938209485729,-1.097661921445441,0.33668341708542715,0.7393680981742918,1.0,2/13,7.60%,PLCB1;IL15RA
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4661894696918743,1.0976376825991414,0.36570561456752654,0.9503663456179224,1.0,5/17,15.35%,PTPRC;N4BP2L2;LTBP3;FERMT2;PDCD2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.42288650933115535,1.0972031517283696,0.32066869300911854,0.9505959606458306,1.0,11/30,19.95%,LEPROT;ABLIM3;RAC2;HTRA2;UBE2J2;UBE2D3;FBXW7;VPS11;CSNK2A2;PINK1;UBL5
prerank,histone H3-K36 demethylation (GO:0070544),-0.4487225281866359,-1.0970043698003773,0.3795811518324607,0.7399534521029388,1.0,3/10,12.83%,PHF8;KDM2B;KDM7A
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.40269339891629086,-1.0968975335823312,0.34782608695652173,0.7390089824558755,1.0,3/16,1.14%,PDGFD;PDGFRB;PDGFRA
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3476870981774144,1.0968285017817776,0.3070489844683393,0.9507663981140317,1.0,14/100,11.57%,TRIB2;PRICKLE1;GLMN;SOCS5;SH3RF2;OGT;FHIT;KEAP1;N4BP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B
prerank,actin polymerization or depolymerization (GO:0008154),-0.30685881129353343,-1.096266178900165,0.24603174603174602,0.7394702750035727,1.0,12/50,11.27%,SVIL;DSTN;ARHGAP6;CFL1;WASF3;TWF1;JAK2;CAPG;DIAPH1;ABI1;EVL;AVIL
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3646709157784119,-1.0960911256883323,0.3293768545994065,0.7387088030029496,1.0,10/23,19.17%,NUPR1;CBFA2T3;EP300;SIK1;C1QTNF3;GSK3A;PGP;CLK2;PFKFB1;CRY1
prerank,positive regulation of rRNA processing (GO:2000234),0.517215578901389,1.0960602030415434,0.379073756432247,0.951986510779738,1.0,3/10,9.58%,BUD23;UTP15;SIRT7
prerank,positive regulation of innate immune response (GO:0045089),0.4163098387795099,1.0960282485271302,0.3545878693623639,0.9509771521595378,1.0,6/30,12.75%,LBP;SPI1;WNT5A;POLR3G;PLSCR1;POLR3D
prerank,chondrocyte differentiation (GO:0002062),0.40670524102409794,1.0959963152585515,0.3476968796433878,0.9499896029715764,1.0,7/32,4.10%,SULF1;RUNX2;GPLD1;WNT2B;EIF2AK3;SOX9;BMPR1B
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4647459844371562,1.0958170821602011,0.35949764521193095,0.9494421476313779,1.0,8/19,17.31%,EXTL3;XYLT2;GLCE;NDST1;HS3ST5;HS6ST3;EXT1;EXT2
prerank,negative regulation of cyclase activity (GO:0031280),-0.41507665807725286,-1.0955627431707076,0.35172413793103446,0.7390448815540074,1.0,2/14,2.36%,ADGRV1;GRM3
prerank,carboxylic acid metabolic process (GO:0019752),-0.33140490871930606,-1.0952705785350583,0.2905405405405405,0.7386754664960141,1.0,12/33,25.69%,PTGIS;ST3GAL1;DDO;CSGALNACT1;TBXAS1;SLC2A1;AGXT;MIF;GSTO1;CYB5A;GSTO2;SLC2A3
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.39195912392763566,1.0948547279299043,0.3595505617977528,0.9513837862566609,1.0,10/39,16.76%,UTRN;NEDD4L;FXYD6;SCN2B;NEDD4;FHL1;CHRM3;WWP2;FGF12;YWHAE
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.43694719440800606,1.09406485597496,0.3588957055214724,0.9527601164237134,1.0,6/22,13.51%,NR2F2;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3263264176630428,-1.094027949783965,0.308411214953271,0.7409944600208347,1.0,10/31,11.44%,IGF1;CSGALNACT1;NDST3;CHST11;BMPR2;CSGALNACT2;PXYLP1;FAM20B;B4GALT7;HS3ST3B1
prerank,glycerolipid metabolic process (GO:0046486),0.5098753228075699,1.0938413752281357,0.375,0.9523632665101122,1.0,2/11,3.58%,DGKA;DGKZ
prerank,peptidyl-proline modification (GO:0018208),0.42278801218481976,1.0936838793884767,0.3409436834094368,0.951730590480597,1.0,6/25,14.09%,FKBP5;FKBP1B;PPIE;PPIL6;PPIC;PPIG
prerank,oligodendrocyte development (GO:0014003),0.4754127063300786,1.0933957844277198,0.37225042301184436,0.9515669199658495,1.0,4/15,13.10%,EIF2B3;CNTNAP1;EIF2B4;NSUN5
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.33432655197379757,1.0933086404270411,0.336644591611479,0.9507551624685372,1.0,12/149,6.99%,EDA;CAV1;ROR1;IL18R1;RIPK4;FLOT2;IRAK3;WNT5A;FER;TRADD;TRIM21;NLRC4
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3922819562580494,-1.093010695807388,0.31725888324873097,0.7425419436200204,1.0,3/18,8.30%,KIF1B;TBC1D24;FCHSD2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.38400828594606806,-1.0929446259253073,0.32061068702290074,0.7415181600277716,1.0,3/18,2.16%,SLIT2;IL6R;LYN
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2704736674551036,-1.092931476610146,0.225,0.7403335603100072,1.0,22/87,13.40%,ENG;PARD3;SMAD3;CLDN5;SMAD6;TGFBR3;FKBP1A;SMAD9;TGFBR1;APPL2;PTPRK;ACVRL1;SMAD5;NRROS;TGFB3;LPXN;ZFYVE9;FURIN;PRKCZ;TGFB2;FMOD;ITGB5
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3678524327353573,1.09280665301962,0.3410553410553411,0.9511849372391515,1.0,11/61,10.74%,SMOC2;EGFR;BRCC3;EYA1;NPAS2;NBN;UIMC1;WRAP53;MECP2;HMGB1;ERCC6
prerank,regulation of organelle organization (GO:0033043),-0.2749436277366176,-1.091354329892997,0.291866028708134,0.74352494647051,1.0,17/80,9.40%,ZEB2;PDE4DIP;MSN;MYO5A;CLIC4;EP300;PREB;SQSTM1;TMED9;STX18;USP6NL;PDCD10;RBSN;NEXN;SURF4;DIAPH1;PDE2A
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.41756625587676593,1.0909763435072977,0.35015290519877673,0.95583303243458,1.0,3/27,2.02%,DLC1;F11R;ARAP1
prerank,ribosome assembly (GO:0042255),-0.3009997366216304,-1.090640019355998,0.3035019455252918,0.7442769614321065,1.0,25/47,29.48%,RPS15;RPS27;NPM1;RPLP0;RPS19;RPL3;EIF2A;RRP7A;MRPL20;DHX37;MRPS11;DHX29;NLE1;PPAN;RPS27L;RPL5;C1QBP;PWP2;RPS14;ERAL1;RPF2;RPL11;DDX3X;MRPS2;RPL24
prerank,cytosolic calcium ion transport (GO:0060401),-0.34291360084240596,-1.090457543471442,0.32087227414330216,0.7435931238203821,1.0,10/28,15.72%,SLC8A1;SLC35G1;JPH1;SMDT1;SLC25A23;MICU1;MICU2;ATP2B3;JPH2;JPH4
prerank,cell projection organization (GO:0030030),0.4051746152505066,1.0899705832528233,0.34876989869753977,0.957876994974232,1.0,5/30,9.13%,PARVA;RAC2;PACSIN2;RHOJ;PLEK
prerank,T cell homeostasis (GO:0043029),-0.456359442804647,-1.0897432008145933,0.34942528735632183,0.744257288821096,1.0,5/10,25.45%,FAS;AKT1;ZC3H8;NCKAP1L;JAK3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.3965296271087494,-1.0896864678161666,0.3559322033898305,0.7432130038784782,1.0,4/16,2.58%,IGF1;IGFBP2;IGFBP3;IGFBP5
prerank,Golgi inheritance (GO:0048313),-0.44206165824754273,-1.0895764687359173,0.35714285714285715,0.7423199445719193,1.0,8/11,37.67%,PDCD10;GOLGA2;YWHAZ;PLK5;STK25;PLK3;VRK1;CDK1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4874116523000316,1.0895672810237322,0.38215488215488214,0.9580439030551688,1.0,3/13,5.70%,PIK3AP1;PIK3R4;TLR7
prerank,DNA replication checkpoint signaling (GO:0000076),-0.39011823119893096,-1.0894464930534236,0.3132832080200501,0.7414611615007104,1.0,8/16,24.14%,NAE1;CLSPN;TOPBP1;TIPIN;RAD17;RAD9B;TIMELESS;CDC45
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.36264129564294806,-1.0892980543936943,0.336283185840708,0.740638328482088,1.0,11/22,19.29%,IGF1;ROCK2;MEF2A;SLC9A1;MLIP;EDN1;P2RX4;SMAD4;LMCD1;AGT;PARP1
prerank,neuron maturation (GO:0042551),-0.3904291667336329,-1.0890259666401352,0.3359173126614987,0.7402483998205444,1.0,10/18,31.83%,EPHA8;LGI4;CLN5;C1QA;PICK1;C3;SCARF1;ACTL6B;RND1;MTCH1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5063768585285892,1.088750972680983,0.3532423208191126,0.9594807620472665,1.0,3/10,7.45%,IRAK3;PTPRC;MAPK7
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.35365129658308897,1.0884629606432565,0.3366214549938348,0.9593106527356229,1.0,17/80,16.76%,NGF;SRC;FIS1;ACVR1C;UACA;MAP3K5;SFN;RPS6KA3;HMGB1;USP47;DHCR24;AQP1;HTRA2;GPER1;BAD;SYK;YWHAE
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.31588407131298096,-1.088350239723216,0.28923076923076924,0.7410216582428933,1.0,13/39,20.66%,ENG;SLIT2;BMP4;TIE1;RASIP1;KDR;LRP6;BMP2;NRP1;SALL1;LRP5;MET;NOTCH4
prerank,B cell differentiation (GO:0030183),-0.30651062443694166,-1.087676538651386,0.31970260223048325,0.7416109791565472,1.0,10/46,9.83%,KLF6;KIT;CEBPG;FNIP1;VCAM1;HDAC9;PLCG2;NHEJ1;SYVN1;DCAF1
prerank,histone H2A ubiquitination (GO:0033522),-0.38973979167436335,-1.0874978715311374,0.34759358288770054,0.740946926239793,1.0,9/17,29.65%,KDM2B;RYBP;RNF8;TRIM37;SKP1;RNF2;RING1;DDB1;BCOR
prerank,calcium ion import across plasma membrane (GO:0098703),0.47586212402796557,1.0874884079723144,0.3622704507512521,0.9612860034947975,1.0,3/14,4.74%,SLC24A1;TRPV4;ATP2B4
prerank,DNA packaging (GO:0006323),0.46381260761739584,1.0874120583288567,0.3760129659643436,0.9604418649154942,1.0,3/16,4.87%,HAT1;CDAN1;BANF2
prerank,sodium ion transmembrane transport (GO:0035725),0.3533404267181945,1.0873623019240628,0.3387096774193548,0.959512499459823,1.0,14/84,11.18%,SCN10A;NALCN;SLC12A2;ANO6;SLC24A1;SLC12A3;KCNK1;ATP1A2;SLC6A13;SLC4A4;ATP1B3;SCN2B;SLC9A7;SLC9A6
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4509818036788047,1.0873361749292194,0.3712,0.9585215486299551,1.0,4/18,19.17%,IL4I1;CRTAM;ZFP36L2;XRCC6
prerank,protein modification process (GO:0036211),0.3559821694178179,1.0872952315875026,0.3267080745341615,0.9575667657954549,1.0,17/76,14.89%,SLC35A1;UBE2L6;DUSP12;STK38;MMP15;ERO1A;UBE2I;CDKL3;CPE;ABL2;CSNK1G3;MANBA;FBXO11;LCMT1;UBE2D3;CHRM3;WWP2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.32911614509942694,1.0867966744281397,0.3219026548672566,0.9580428246847121,1.0,23/151,11.72%,SGMS2;ST3GAL4;CERS6;ARG1;ASS1;PCSK5;ACER3;ELOVL5;PLPP2;PLPP3;PCTP;SLC27A1;MGST2;HACD4;ELOVL1;ELOVL2;TNIP1;CERT1;GSTZ1;GSTA4;GSTA3;HACD2;GSTK1
prerank,inorganic anion transport (GO:0015698),-0.3009019667608134,-1.086345302963718,0.3201754385964912,0.7429939658411023,1.0,10/53,9.30%,SLC26A7;ENPP1;SLC4A10;ANO1;CLIC4;ANO4;ENPP3;CLIC5;SLC25A30;SLC25A11
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.47283858472677986,1.0863153673278967,0.36902800658978585,0.9583972122086809,1.0,2/15,2.99%,HSPH1;CD55
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4847329023729566,1.0861069372825711,0.3711340206185567,0.9579825912277777,1.0,2/13,4.76%,B3GALT1;B4GAT1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4286884933159955,1.0860296458201317,0.3620689655172414,0.9571382603148096,1.0,8/26,23.61%,ST3GAL4;TNIP1;SCCPDH;GK;GBGT1;TKT;GOLPH3;RRM2B
prerank,protein sumoylation (GO:0016925),0.37363744645511227,1.0859704744630643,0.3356258596973865,0.9562504914062685,1.0,12/49,13.02%,STX1A;EYA1;UBE2I;NUP62;PIAS2;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.36070575258648274,1.0856958045307432,0.3359683794466403,0.956016601231772,1.0,8/66,4.05%,CAV1;NR2F2;CEACAM1;SULF1;CASK;NF1;CAV2;SOX9
prerank,regulation of humoral immune response (GO:0002920),0.3890658671411114,1.0856414127779923,0.3741307371349096,0.9551152491503384,1.0,6/44,13.20%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,receptor signaling pathway via STAT (GO:0097696),-0.34429668175167155,-1.0855947564790698,0.33424657534246577,0.7438216219271092,1.0,4/25,6.94%,IL31RA;GHR;IFNAR2;JAK2
prerank,negative regulation of cellular process (GO:0048523),0.30868932767205354,1.0855018403868353,0.2815338042381433,0.9544365772594051,1.0,87/521,15.22%,NGF;ROR2;ZBTB7C;TGFBI;IGFBP6;DLC1;CDH13;VGLL4;RIPOR2;CLDN19;GLMN;ADAMTS1;DCBLD2;PPP1R13B;SSTR1;SPEF1;GPLD1;GNRH1;CASK;PIWIL2;IL1A;PTPN14;WNT16;EIF2AK3;PTHLH;CD9;TPTE;CELF1;NPAS2;DSCAM;BMP5;PLXNA3;KLF10;NUP62;PDS5B;KANK2;ADAM10;EPHB2;NCK2;ATG5;NDUFS3;CTCF;CHERP;FBXO5;BRINP1;DIS3L2;RBM5;PTPRJ;PLSCR1;NLRP2B;SIRT7;CNOT7;DLG3;PBRM1;FERMT2;CHMP4B;STRN;AXIN2;RARG;APC;VAMP8;PLXNB1;ZBTB49;MEN1;SEMA4D;TEX15;NF2;HOPX;WNT9A;PTEN;CDC6;CRLF3;FHL1;SOX4;HTRA2;NAIF1;DNAJA3;CLMN;RTN4;CAPRIN2;PTPRU;ERBB4;SIPA1;NDRG3;GPER1;PTPN6;PLG
prerank,cellular defense response (GO:0006968),0.39397504587090537,1.0853689135026976,0.35342465753424657,0.953754175682014,1.0,3/40,3.98%,LBP;ITK;CD5L
prerank,positive regulation of receptor internalization (GO:0002092),-0.3559399208013418,-1.0853128469921007,0.3275862068965517,0.7433884546672948,1.0,8/22,25.49%,INSR;ANGPT1;AHI1;EGF;PICK1;NTF3;GREM1;ARRB2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.37629089335065397,1.0851274940715545,0.35278514588859416,0.9534475852814682,1.0,3/53,3.10%,HRH1;SSTR1;MC5R
prerank,response to thyroid hormone (GO:0097066),-0.42647910902094704,-1.0850852772550923,0.375609756097561,0.7428712439887096,1.0,3/13,6.47%,CTSH;LMO2;CTSL
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.36514378909873985,1.0848464230837132,0.3485424588086185,0.9532317428012043,1.0,20/67,19.63%,CAV1;ATP8B1;CAPZB;FXR2;FER;ATG5;RDX;ARF6;TBC1D16;TBC1D2;TBC1D8;PLD1;EVI5;FXR1;DYNC2LI1;TBC1D20;TBC1D5;RAB5A;ATG3;TBC1D10A
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.30388498353535043,1.0848182454352364,0.235,0.9522537868697608,1.0,105/807,12.06%,PTCH1;TENM2;CAV1;MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;NEDD4L;PHC2;DLX1;RARB;FOXP2;ZNF423;FOXD1;ZBTB32;KLF12;LDB2;ATP8B1;MYBBP1A;BCL3;ETV5;RUNX2;RBFOX2;GLI2;IRF2BP1;CHD3;SFMBT2;CIART;SPI1;L3MBTL3;FOXK1;BEND3;PHF21A;FOXO3;SOX9;UBE2I;FOXP4;GLIS2;CHD8;KAT6B;HDAC4;LANCL2;SATB1;KLF10;DACT1;WNT5A;CREB3L1;N4BP2L2;PPM1A;RBM15B;HEYL;SP3;KANK2;BHLHE40;ZFP90;ANKRD2;NRIP1;RCOR3;SIN3B;CTCF;HIC1;PEX2;PAF1;ZNF431;NCOR1;NCOA5;TBX2;RREB1;RARA;SUV39H1;KCTD1;MYPOP;ISL1;E4F1;FOXK2;UIMC1;TSC22D4;MECP2;FOXJ1;HMGB1;SIRT7;RORB;USP47;SUPT4H1;POU4F1;HDAC2;CNOT7;LEFTY1;TPR;ZHX1;WWC1;NCOR2;ILF3;OTUD7B;RARG;HDAC6;MZF1;HEXIM1;ZNF148;ERF;MEN1;KDM8;SEMA4D
prerank,mitochondrial transcription (GO:0006390),0.49976619499252034,1.0847727030938386,0.3454861111111111,0.9513323447690568,1.0,4/10,14.07%,FOXO3;TFB2M;MTERF2;TEFM
prerank,sphingosine metabolic process (GO:0006670),0.4577296857519792,1.0847028171648878,0.3572593800978793,0.9504797529827939,1.0,3/17,4.15%,ACER3;PLPP2;PLPP3
prerank,mitochondrial fusion (GO:0008053),0.4490156249281442,1.084687313182746,0.3568075117370892,0.9494737089921029,1.0,8/18,22.21%,MFN2;FIS1;MIEF1;MIGA1;BAX;CHCHD3;STOML2;THG1L
prerank,B cell activation involved in immune response (GO:0002312),0.4920133759735893,1.0843789717087229,0.3760262725779967,0.9494301050910772,1.0,4/13,16.40%,MSH6;MSH2;GPR183;BATF
prerank,positive regulation of vasculogenesis (GO:2001214),0.5118403413250854,1.0839618909086033,0.3924268502581756,0.9496601927184241,1.0,2/10,1.89%,CEACAM1;RAP1A
prerank,insulin receptor signaling pathway (GO:0008286),0.3609913195366985,1.083953008245029,0.36649874055415615,0.9486407334103699,1.0,10/69,9.35%,GAB1;SORBS1;GPLD1;CAV2;ATP6V0D2;PDK4;FER;PIK3R2;ATP6V0A1;GSK3B
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.38535945670912963,1.083612978764365,0.35135135135135137,0.9486241452224641,1.0,17/42,21.52%,HNRNPC;CHD3;CHD8;SMARCAD1;ACTR8;SMARCD2;HDAC2;PBRM1;ERCC6;INO80;INO80B;ACTR6;SPTY2D1;ZNHIT1;RBBP4;ARID1B;ARID1A
prerank,amyloid precursor protein metabolic process (GO:0042982),0.45783475137491153,1.083448248884067,0.3715670436187399,0.94807880726872,1.0,4/18,6.14%,ADAM19;APH1B;NCSTN;ADAM10
prerank,chromosome condensation (GO:0030261),-0.3150231316823625,-1.0832022483562156,0.33559322033898303,0.7468948049815295,1.0,16/36,28.61%,PHF8;SMC4;NCAPD3;MCPH1;H1-0;CSNK2A1;AKAP8L;CSNK2B;NCAPG2;NCAPD2;NUSAP1;TOP2A;AIFM1;BANF1;NCAPH;TTN
prerank,ncRNA processing (GO:0034470),-0.23217766416031166,-1.083185867209393,0.16923076923076924,0.7457502970444083,1.0,73/200,25.42%,SMAD3;RPL37A;INTS9;SSB;ADAR;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;AGO3;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;PUS10;INTS1;AGO4;TUT7;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;SMAD1;PWP2;RPS9;MRPL44;WDR3;RPS14;RPS25;TRPT1;INTS5
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4818761350673309,1.0831276391655555,0.3677966101694915,0.9479282360037334,1.0,3/13,15.49%,SORBS1;C1QTNF12;SNX5
prerank,retinol metabolic process (GO:0042572),0.4735756020425272,1.0827887883652152,0.38166666666666665,0.9479052463881599,1.0,1/14,0.63%,RDH10
prerank,epithelial tube morphogenesis (GO:0060562),-0.3249561504716167,-1.0827564434922439,0.3460410557184751,0.7457509997768407,1.0,8/32,13.17%,SLIT2;BMP4;ACVRL1;RASIP1;SOX17;PODXL;RHOB;MEGF8
prerank,cell junction assembly (GO:0034329),0.3410407768874919,1.0825602929077194,0.34560570071258906,0.9475846851988698,1.0,16/100,10.07%,ITGA6;TLN2;CDH11;PARD6B;CDH5;RAB29;CDH9;TRPV4;OPHN1;DSCAM;FN1;CDH2;PKP4;GPM6A;POU4F1;FERMT2
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.3239014518433766,-1.0823024047360013,0.2991202346041056,0.7458564602012756,1.0,14/35,26.38%,ETS1;LYN;HOXA5;HIF1A;CDK6;TAL1;ZFP36;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3
prerank,ribosome biogenesis (GO:0042254),-0.23568848227037612,-1.0820679509152218,0.275,0.7453051750068664,1.0,69/187,25.29%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;NPM1;HEATR3;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;WDR12;RPL23;RPL17;EIF2A;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;ABCE1;RIOK1;NOC2L;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;DHX29;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;MRPL36;WDR3;RPS14;RPS25;PAK1IP1
prerank,adherens junction organization (GO:0034332),0.3811380162172637,1.0818814483972492,0.3583106267029973,0.9486769795884183,1.0,5/48,3.26%,CDH13;CDH11;CDH5;CDH17;CDH9
prerank,phosphorylation (GO:0016310),0.31084807862946323,1.0818712169264448,0.2893660531697341,0.9476540690583272,1.0,52/385,9.94%,TEC;PLK2;FAM20C;TRIB2;CDK15;FGFR1;HCST;DGKA;PRKCE;CAMK2D;MINK1;STK38;MAP3K1;TXK;MAPK10;DGKZ;PRKAG1;EIF2AK3;BMPR1B;PRKCA;CDKL3;PEAK1;MORC3;LIMK2;IRAK3;ACVR1C;PDK4;HIPK1;PIK3R4;BRSK1;NEK7;FER;CDK13;BCKDK;COQ8A;ADAM10;CERK;EPHB2;GMFB;CDK7;BMP2K;STK38L;RARA;MAP3K5;SRPK1;DYRK1A;NRBP2;STK24;STK3;GSK3B;CSNK1A1;TYK2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4085805196268786,1.0816104082722187,0.3654390934844193,0.9474069397346234,1.0,5/37,9.65%,APOD;IL17RA;CHID1;PLD3;TICAM1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.46405361041690407,-1.0813479234368628,0.381294964028777,0.7461095825263453,1.0,4/10,25.00%,JARID2;KDM1A;DNMT3B;BRCA1
prerank,gluconeogenesis (GO:0006094),0.38821669137284626,1.0813189764092255,0.35511363636363635,0.9473064530308102,1.0,13/39,21.47%,PPARGC1A;SLC25A12;ALDOB;PGM1;MDH1;SLC25A13;ENO3;GOT1;PGK1;ENO2;SLC37A4;SLC25A10;ENO1
prerank,regulation of JNK cascade (GO:0046328),-0.2575620549024289,-1.0812501097991745,0.20994475138121546,0.7452181102306866,1.0,13/101,6.74%,IGF1R;PLCB1;MECOM;TNFRSF19;TGFBR3;CCN2;MFHAS1;SIRPA;SH3RF3;DUSP10;DUSP3;ANKRD6;TRAF6
prerank,cellular response to organic cyclic compound (GO:0071407),0.3287614076907679,1.0806603061930837,0.3276255707762557,0.9482462704987016,1.0,23/141,15.58%,RORA;HRH1;FOLR1;EGFR;RAPGEF3;RAP1A;SSTR1;ATP1A2;ADCY5;NRIP1;GABRG2;POU4F1;EGR1;NCOA3;GABRB3;AQP1;CTNNA1;LCOR;GPER1;CCDC62;CDH1;ADCY8;ADCY3
prerank,cristae formation (GO:0042407),-0.33914576468562585,-1.0803340675530595,0.30994152046783624,0.7466644027945625,1.0,13/27,29.93%,IMMT;ATP5PD;DMAC2L;ATP5MC3;MICOS13;SAMM50;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3235110248869339,1.0802576851358294,0.3257328990228013,0.9484623129867967,1.0,56/184,19.16%,DYNLL1;PSME3;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;FBXO5;CUL3;PAFAH1B1;CCP110;CDC20;PSMB5;ANAPC5;ANAPC7;ANAPC11;BUB3;NDE1;CEP290;INO80;SSNA1;CETN2;CDC6;PKD1;ZFP36L2;ANAPC2;PCM1;PSMB2;UBE2D1;PSMA2;PSMA6;ZW10;ANAPC4;PTPN6;FZR1;PSMD13;PSMA7;YWHAG;NEK11;YWHAE;CDC14A;RGCC;E2F1;CEP57;PSME4;ANAPC16;KLHL18;OFD1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;CEP250;DCTN2
prerank,pulmonary valve development (GO:0003177),0.4602727210888504,1.080022587022868,0.3658940397350993,0.9481241107751255,1.0,4/18,5.24%,STRA6;NFATC1;JAG1;HEYL
prerank,response to interferon-alpha (GO:0035455),-0.39219960241348256,-1.0798025408961185,0.35658914728682173,0.7469987277325317,1.0,5/16,18.78%,IFNAR2;ADAR;BST2;IFNAR1;PDE12
prerank,endothelial cell development (GO:0001885),-0.3504599375193938,-1.0796146402920395,0.34076433121019106,0.7463963296986388,1.0,8/25,9.92%,RAPGEF2;COL22A1;MSN;PECAM1;COL15A1;MYADM;PDE2A;ROBO4
prerank,negative regulation of transmembrane transport (GO:0034763),-0.45257471811065836,-1.0793158029733503,0.37922705314009664,0.7460655542525854,1.0,3/10,13.20%,CTTNBP2NL;AKT1;THBS1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4756556029301481,1.0792630221096542,0.3836065573770492,0.9494236142873222,1.0,3/13,9.49%,FGFR1;APLN;HMGB1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4209316523933317,-1.0791017672563534,0.3613636363636364,0.7454594002232112,1.0,2/13,2.36%,ADGRV1;GRM3
prerank,sulfate transport (GO:0008272),-0.4073018019083341,-1.0787360775948367,0.36609336609336607,0.7453287888354247,1.0,4/14,9.30%,SLC26A7;SLC26A2;SLC25A30;SLC25A11
prerank,regulation of biosynthetic process (GO:0009889),-0.4434749858765928,-1.0785352918639475,0.3805104408352668,0.7447292597364751,1.0,11/11,55.69%,SLC25A33;MID1IP1;SNCA;ALOX5;SPHK2;THRSP;GSTP1;CCN6;PIKFYVE;UCP1;PCK1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.37882137079860473,1.0779360125895474,0.33972602739726027,0.9525150955051221,1.0,17/46,21.77%,GTSE1;RAPGEF3;UBR5;BAG3;RBM22;PIK3R2;GSK3B;TPR;NEDD4;EMD;RAN;CDH1;YWHAE;DHX9;HDAC3;TCF7L2;XPO4
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.402651421186741,-1.0774093815973007,0.3477157360406091,0.7467372667199942,1.0,3/15,6.01%,DAB2;TNK2;HIP1R
prerank,cellular response to UV (GO:0034644),-0.26710021756483443,-1.077191751741612,0.2679425837320574,0.7462171569625609,1.0,20/76,19.92%,USP28;PTPRK;EP300;RPL26;NPM1;MMP2;CDC25A;EIF2AK4;MFAP4;MMP1;KDM1A;NOC2L;XPA;POLK;ZBTB1;NSMCE3;DHX36;ATF4;PARP1;ERCC4
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.41247127850901166,-1.0766239924178727,0.35362997658079626,0.7466116892336245,1.0,6/13,27.27%,DEPDC5;RNF152;SPAAR;CASTOR2;CASTOR1;ATM
prerank,acute-phase response (GO:0006953),0.4871647480607752,1.076051401220123,0.3838209982788296,0.9572414196093754,1.0,2/12,9.00%,LBP;PLSCR1
prerank,lamellipodium assembly (GO:0030032),0.4221639091962848,1.075967778954922,0.3609467455621302,0.9564611941189679,1.0,4/26,6.47%,CDH13;ABLIM3;SPEF1;ABLIM2
prerank,diol biosynthetic process (GO:0034312),-0.4044197224201502,-1.075757683875609,0.36496350364963503,0.7478582705406096,1.0,6/15,13.98%,ACER2;GCH1;QDPR;ABCA2;SPHK1;DHFR
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.30333293069525535,-1.075576328919344,0.29343629343629346,0.7471783347930431,1.0,26/50,28.01%,CCNT2;BLM;MNAT1;ACTB;CNPPD1;CDC25A;CCNT1;CAMK2N1;TTBK1;SERTAD1;CDK5R1;CCNE2;CCNH;CCNJL;CDK5RAP3;BCCIP;CDC37;STOX1;CCND2;CCNF;CDKN2C;CDKN1B;CCNK;CDKN2D;CCND1;CCNB2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5064778717661256,1.0755559280890783,0.3855633802816901,0.9566638385759392,1.0,4/10,21.16%,HMGB1;CBFB;SOCS1;RUNX1
prerank,regulation of MAP kinase activity (GO:0043405),0.3465837202053277,1.0754530894562333,0.3515815085158151,0.9559399321700596,1.0,11/92,5.46%,TRIB2;FGFR1;RGS14;EGFR;FGF1;STK38;NF1;SPRY1;SPRY4;IRAK3;TSG101
prerank,negative regulation of interleukin-6 production (GO:0032715),0.429239391180985,1.075449378429415,0.3913690476190476,0.9549102449951083,1.0,6/27,9.41%,PTPN22;IRAK3;TNFAIP3;SELENOS;CD200R1;FOXJ1
prerank,regulation of protein processing (GO:0070613),-0.36724525535220864,-1.0754001604181125,0.33159268929503916,0.7465251762262889,1.0,5/21,14.64%,CCBE1;GAS1;SERPINE2;LRRK2;NKD2
prerank,cell projection assembly (GO:0030031),0.42887460693250834,1.0753356108353693,0.36615384615384616,0.9542253886333437,1.0,3/22,7.01%,PARVA;RAC2;RHOJ
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.47129791781400643,1.0745093736117017,0.3847487001733102,0.9556949083605,1.0,6/13,22.77%,VDAC2;BAD;BNIP3;BAX;BLOC1S2;RHOT2
prerank,nucleotide catabolic process (GO:0009166),-0.37446664801178486,-1.0744482309335741,0.361323155216285,0.7480280654634759,1.0,6/16,18.92%,SAMHD1;XDH;NUDT3;VCP;NT5C;NT5C1A
prerank,B cell homeostasis (GO:0001782),-0.4589626050265886,-1.0743859657061496,0.39097744360902253,0.7470315108886093,1.0,2/10,2.16%,DOCK11;LYN
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.41410893949934696,1.074290325722748,0.3984732824427481,0.9553302261698585,1.0,4/26,9.70%,SMOC2;PRKCA;CUL3;EIF4E
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3436827346798216,1.074145127274949,0.3490566037735849,0.9547545472136907,1.0,11/107,4.74%,CAV1;STC2;CTRC;SLC8B1;SLC39A13;CDH5;SLC24A1;TRPV4;CSRP3;SLC30A9;ATP2B4
prerank,regulation of BMP signaling pathway (GO:0030510),0.355157820231932,1.0740965000834324,0.36351875808538164,0.9538754292205343,1.0,8/73,4.27%,DLX1;SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B;NBL1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.37334535828716103,1.0740462975363154,0.3394255874673629,0.9529820276593456,1.0,7/52,7.65%,SORBS1;EPB41L2;PRKCE;EGFR;ATP2B4;EPHB2;ARF6
prerank,Rac protein signal transduction (GO:0016601),0.4452468775069226,1.0738883201880927,0.38925081433224756,0.9523905343883001,1.0,2/18,4.67%,CDH13;RAC2
prerank,atrial septum morphogenesis (GO:0060413),-0.4524910579766248,-1.073696327115917,0.35990888382687924,0.7479294488542062,1.0,3/10,12.75%,NOTCH2;BMPR2;TGFB2
prerank,negative regulation of apoptotic process (GO:0043066),-0.2202677670355938,-1.0734952540264127,0.045454545454545456,0.7473351827490097,1.0,85/444,13.50%,IGF1R;IGF1;NOTCH2;TEK;LEF1;OSR1;PRKCH;ANGPT1;GRK5;IL31RA;RNF213;CTSH;TPT1;SMAD6;DAB2;SLC30A10;PIK3R1;DNAJC3;NUPR1;BMP4;TBX3;NDNF;KDM2B;FOXO1;TFRC;FNIP1;CPEB4;SQSTM1;CFL1;HNRNPK;CAT;FAS;DSTYK;ZFAND6;AREL1;NPM1;NAA15;KLF4;PDCD10;PRDX2;KDR;APOE;TBX1;RPS6KB1;DNAJA1;HDAC1;MAZ;IFIT3;TRAF6;PTMA;IGBP1;RNF144B;CASP3;ANXA1;ATF5;UNC5B;TGFB3;AKT1;UFM1;CFLAR;CITED2;SERPINB9;MERTK;ARHGDIA;LGMN;NR4A2;FLNA;CIAPIN1;UBE2O;ZC3H12A;HAX1;BID;FOXQ1;BABAM2;TXNDC5;BAG4;CRYAB;BDNF;FLT4;GATA6;CSNK2A1;THBS1;SPHK1;MYO18A;PIM3
prerank,negative regulation of bone mineralization (GO:0030502),-0.41741279825590827,-1.0733699152906293,0.3788235294117647,0.7464736429855282,1.0,6/13,34.96%,ENPP1;RFLNB;GREM1;RFLNA;BCOR;AHSG
prerank,positive regulation of DNA recombination (GO:0045911),-0.34793515787986257,-1.0731387701482928,0.3293768545994065,0.7459253388991925,1.0,10/27,20.59%,TFRC;PAXIP1;SHLD2;ACTR2;ARID2;MMS19;ERCC2;PARP1;TIMELESS;MAD2L2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.4338107377324924,1.0726193297555295,0.3843700159489633,0.9542974897578879,1.0,5/20,11.72%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),0.4338107377324924,1.0726193297555295,0.3843700159489633,0.9542974897578879,1.0,5/20,11.72%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.31235334620011584,1.072591259953641,0.3439153439153439,0.9533520957369153,1.0,74/264,22.78%,DHX8;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;HNRNPR;CDK13;SF3B5;PPIE;PRPF3;DDX17;CSTF3;CHERP;SMN1;DDX46;RBM22;SRPK1;RBM5;ELAVL2;DNAJC8;SNU13;CELF4;HNRNPM;SRPK2;DBR1;UPF3B;SRRM2;GTF2F2;SNRPA1;SFPQ;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;PSPC1;SYNCRIP;CWC22;SLU7;SYMPK;STRAP;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;DCPS;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,nucleoside catabolic process (GO:0009164),0.49028684536389283,1.072288053091801,0.40878378378378377,0.9532173271080508,1.0,5/11,15.08%,DPYS;UPP2;NT5E;DERA;NT5C3A
prerank,L-serine metabolic process (GO:0006563),-0.44608053187707053,-1.0722078997713633,0.39816933638443935,0.747281096723066,1.0,6/10,34.20%,SERINC3;PSPH;CBS;PHGDH;SHMT2;SHMT1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4217300378128708,1.072059730522955,0.38088012139605465,0.9529040205836236,1.0,5/26,9.26%,ST3GAL4;PRELP;B4GAT1;SLC35D2;CHST2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3072980447294734,1.071753288732058,0.3302752293577982,0.9528101622009748,1.0,95/366,21.50%,RORA;BNC2;NFATC2;PPARGC1A;ZNF423;EFEMP1;MYBBP1A;NFIA;CHD3;SPI1;FOXO3;KAT6B;SMC3;TOM1L1;SP3;BHLHE40;ONECUT1;ORC5;TGFBRAP1;PPIE;HIC1;ZNF431;LIN54;RREB1;MSL3;FBXO5;ELAVL2;ZNF628;FOXK2;POFUT1;MLF2;ACTR8;RORB;EIF4E;SUPT4H1;ORC3;TRRAP;TFEB;OBI1;USP13;ATXN2;WWC1;SAP30L;EIF2B4;MZF1;MED23;JMJD1C;SPIN1;CREBBP;NCOA2;SOX4;NUCKS1;SFPQ;BAZ2A;FZD7;REXO4;TAF5;KMT2D;SRRT;DMTF1;PSPC1;E2F1;GMNN;ESRRA;HP1BP3;MAGED1;USP37;DSCC1;MTF2;BACH1;CREM;CELSR2;FOXO4;RABL3;ASCC2;SPTY2D1;FADS1;ASCC1;PPP2CA;TCF7L1;TCF3;HNRNPD;ZNF22;HCFC2;HMG20A;GZF1;DDIT3;RNF14;ARNT2;ATXN1L;ZSCAN21;DAXX;CCAR2;SRSF10;FOXC1
prerank,keratan sulfate catabolic process (GO:0042340),0.4887984593152621,1.0708297854268334,0.38220757825370677,0.9545310229793829,1.0,3/11,14.23%,PRELP;HEXA;HEXB
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.29901728757300294,1.070718736443904,0.184,0.9538598082624052,1.0,279/1646,16.44%,EBF2;RORA;MEOX2;ZBTB7C;BNC2;KLF5;ETV4;FGF7;MDFIC;CDK15;NFATC2;VGLL4;ETV1;GLI1;PPARGC1A;PRICKLE1;PAX9;FOXD2;NR2F2;TSHZ3;PHC2;NR3C2;DLX1;POU4F3;RGS14;FOXP2;ZNF423;FOXD1;NFATC1;CAMK2D;ZBTB32;EFEMP1;KLF12;PBX1;ZSCAN25;FZD2;EGFR;BHLHE22;ZBTB20;NPAS3;ATP8B1;MYBBP1A;NEUROD6;BCL3;AXIN1;ETV5;OGT;RUNX2;NFIA;ZSCAN18;HIVEP2;RBFOX2;HOXB6;GLI2;TEF;ZKSCAN7;IRF2BP1;CHD3;SFMBT2;MLLT3;KLF3;KMT2A;CIART;SPI1;L3MBTL3;FOXK1;ZNF418;FOXO3;SOX9;UBE2I;PGR;FOXP4;NPAS2;ZBTB8A;GLIS2;CHD8;ZNF585B;ZNF585A;KAT6B;HDAC4;REL;LANCL2;CHD2;SATB1;ZBTB3;ATP2B4;CHD1;KLF10;NUP62;WNT5A;POU5F2;CREB3L1;PPM1A;RBM15B;HEYL;ZFP3;ZNF697;ATAD2;ZFP1;ZNF326;SP3;BHLHE40;MED18;ZFP90;TARBP1;RGMB;ANKRD2;ARID3A;ONECUT1;ANXA4;ZFP14;RCOR3;TGFBRAP1;PPIE;MED12L;TEAD3;CTCF;NFE2L1;NRF1;HIC1;ZNF431;NCOR1;PAX3;LIN54;HOXC10;ZFP62;TBX2;DDX17;ONECUT3;RREB1;DBX2;PIAS2;RARA;SUV39H1;MAFG;MSL3;USF2;FBXO5;MAP3K5;POLR3G;ILF2;LHX6;KCTD1;ELAVL2;MYPOP;ISL1;PKNOX2;ZNF628;E4F1;FOXK2;DYRK1A;MED7;UIMC1;TSC22D4;AATF;ZBTB6;POFUT1;TCF20;MLF2;TBX18;MED13;SLTM;MECP2;FOXJ1;RPS6KA3;ACTR8;HMGB1;SMARCD2;RORB;USP47;SUPT4H1;POU4F1;HDAC2;CNOT7;BAZ2B;DBP;TRRAP;TLX3;KARS1;CTDSP1;TFEB;ZHX1;USP13;ERCC6;SIX5;WWC1;NCOR2;ILF3;SAP30L;FBXL19;EN2;DVL3;HDAC6;COL1A1;TASP1;PHF20L1;EGR1;MZF1;MED23;ZBTB49;HEXIM1;ZNF148;HTATIP2;JMJD1C;ERF;MEN1;BICRA;KDM8;CEP290;NAT14;NFE2L2;STAT2;SPIN1;HOPX;PEG3;TTC21B;CDC6;CRLF3;TAF15;CREBBP;NCOA2;NFATC4;BRF2;GTF2H1;ARID4A;SOX4;GMEB1;CDKN1C;NUCKS1;DPF3;SFPQ;MBD1;ZFP57;BAZ2A;CBFB;FZD7;KAT8;TIAL1;CAMTA2;RAI1;SFMBT1;ERBB4;EPC2;REXO4;FOXJ2;ZNF182;FOXF1;ZNF260;WWP2;NR5A1;LCOR;NEK4;MED8;TADA2A;MED12;SCML2;POU6F1;TOX4;CDH1;PRMT6;SNX5;TAF5;FOXC2;YAP1;SCML4;KMT2D;ERBB2;GBX1;RELB;TESC;PBX4;MED29;PCGF3;SRRT;DMTF1;PCBD2;BATF;ARHGEF11;PSPC1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.42640771667970956,1.070375887834042,0.3644578313253012,0.9538892756128605,1.0,4/24,9.57%,HNRNPC;SRC;STN1;EXOSC10
prerank,tryptophan metabolic process (GO:0006568),0.48993157468973086,1.0701730673188077,0.38620689655172413,0.9535299549877427,1.0,2/11,3.76%,IL4I1;AADAT
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3602656456137745,-1.0701642499462372,0.3471502590673575,0.751876680752367,1.0,5/21,14.44%,ITGA1;PDGFRB;CALM1;BMP2;CALM3
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3540324585319038,-1.0699707549800734,0.36936936936936937,0.7512930704153714,1.0,2/22,1.30%,ALDH1A2;RBP1
prerank,supramolecular fiber organization (GO:0097435),0.30735863801994184,1.0698643119979547,0.3371134020618557,0.9534499051915188,1.0,35/333,9.18%,ITGB4;TGFBI;ITGA6;TNXB;ADAMTS14;PXDN;UBE2L6;ARHGAP12;HOOK2;KIF2A;COL6A3;BFSP1;NCKAP5L;NF1;TRPV4;COL5A3;APH1B;FIGNL2;TMOD2;RAC2;SERPINH1;NCSTN;ADAM10;SHROOM2;POF1B;SPAST;COL3A1;CKAP5;SIAH1;ADAMTS2;CGNL1;TMOD1;LTBP3;LTBP2;COL4A1
prerank,positive regulation of neurogenesis (GO:0050769),0.35577767345428174,1.06940981297358,0.35797665369649806,0.9538486669927461,1.0,5/68,4.73%,NGF;RGS14;TIAM2;CDKL3;PLXNA3
prerank,activation of protein kinase B activity (GO:0032148),0.4075560475041319,1.0691938207472194,0.40416047548291234,0.9534656310312375,1.0,6/29,10.37%,NTRK3;PRR5;FGF1;WNT5A;MAPKAP1;ADRA2A
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.31411349785854775,-1.069174254686232,0.31399317406143346,0.7524123743606232,1.0,22/38,35.58%,ARHGEF2;SP100;NOS3;MADD;FAS;CFLAR;FEM1B;THBS1;TNFSF10;CASP8;ICAM1;RIPK1;BRCA1;RNF34;DDX3X;SFRP1;TRAF2;RFFL;HMOX1;FAIM2;SERPINE1;PMAIP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.45649960237493364,1.0691428838561743,0.38294314381270905,0.9526117514626073,1.0,3/16,6.94%,CEACAM1;SOX9;NCOR1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.26262965202502814,-1.0689005387510013,0.3287671232876712,0.7520080677510274,1.0,14/94,8.53%,PLCB1;IL1R1;IL1RAP;PSMA1;RPS6KA5;SQSTM1;IRAK4;RBX1;PSMD11;TRAF6;UBE2N;NOD1;PSMD7;PSMD4
prerank,intracellular protein transmembrane transport (GO:0065002),-0.3078938627708423,-1.0681393645057178,0.30111524163568776,0.7530467832325934,1.0,20/42,33.28%,C2CD5;SEC61B;TIMM44;SEC62;PAM16;PEX26;TIMM17B;PEX6;PEX1;PEX10;ROMO1;GRPEL1;DNLZ;AIFM1;TIMM50;HSPD1;PEX5;TIMM23;TIMM21;RTN2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4913736128172648,1.0681096353264146,0.39434276206322794,0.9547158391504628,1.0,3/12,6.74%,ATIC;PFAS;PPAT
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3776949787548903,-1.068064531015975,0.34656084656084657,0.7521162781664805,1.0,6/18,12.66%,TNFRSF21;OPALIN;TNFRSF1B;IL34;SLC45A3;DAAM2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.42328640945756335,-1.067831177604634,0.3640661938534279,0.751609143185955,1.0,6/12,20.32%,CSGALNACT1;PARG;UGP2;FUT8;SLC35A3;GFUS
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3498257134068482,1.067509164655048,0.3814814814814815,0.9555395344272339,1.0,10/75,5.58%,KCNJ4;SLC12A2;KCNJ16;SLC24A1;TRPV4;SLC12A4;SLC12A3;ATP2B4;ATP1A2;KCNJ13
prerank,positive regulation of programmed cell death (GO:0043068),0.31049848634777183,1.0668586139337728,0.35318704284221525,0.9564715890936389,1.0,60/272,17.01%,NGF;ITGA6;DKKL1;TIAM2;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;FOXO3;VAV2;ACVR1C;TRIO;TRADD;ARHGEF5;NCSTN;PHLDA1;NLRC4;ARHGEF1;SIAH1;MAP3K5;RBM5;KALRN;OBSCN;STK3;HMGB1;NLRP2B;RASSF2;SLC27A4;RARG;APC;HDAC6;HTATIP2;ARHGEF6;FAF1;PTPA;ADAMTSL4;DIABLO;ATG7;SOX4;HTRA2;HTT;UNC13B;FZD9;GPER1;BAD;PDCD2;AIFM2;CTNNBL1;PLEKHG2;ARHGEF11;SYK;ARHGEF7;BNIP3;E2F1;QRICH1
prerank,negative regulation of cell division (GO:0051782),-0.44445171351453805,-1.06677604834684,0.38461538461538464,0.7533131278465818,1.0,3/11,9.80%,TXNIP;BLM;VPS4A
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3271596523032344,-1.0667018255424427,0.352112676056338,0.7523555380841086,1.0,18/29,31.33%,RPS19;RPS16;RPS8;NOP9;RPS21;HEATR1;TSR1;DHX37;MRPS11;KRI1;TBL3;UTP4;PWP2;RPS14;RRP36;WDR46;UTP6;ABT1
prerank,secondary alcohol metabolic process (GO:1902652),-0.30724355939622366,-1.0662425026106839,0.3420074349442379,0.7524765533471138,1.0,21/42,35.53%,PPARD;APOE;SCAP;OSBPL1A;LDLRAP1;OSBPL5;GBA2;NSDHL;ABCG1;TSKU;CLN6;PIP4P1;CH25H;LCAT;IDH3G;SOAT2;RXRA;SQLE;EBP;IDH3A;SULT2B1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.29744824641935835,-1.0661733176724713,0.33073929961089493,0.7515094350939727,1.0,21/47,29.79%,NR1H3;AGTR1;KLF4;APOE;NR1H2;AKT1;EIF2A;TCOF1;EDN1;CSF1;EIF4G1;AGT;RBM4B;INHBA;GEMIN5;TSC1;MTPN;NANOS3;RBM3;VPS35;GRM5
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.29833128419583443,-1.066054251004518,0.3244274809160305,0.7506752395916886,1.0,11/44,10.43%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;ATP1B1;KCNJ10;FLNA;ATP1B2;KCNN2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.35859602991865125,-1.065873722650059,0.3352272727272727,0.7500997433205386,1.0,4/21,7.55%,IGF1;CTSH;KDR;MAP2K2
prerank,regulation of protein transport (GO:0051223),-0.3379250489293748,-1.0658504272674834,0.35454545454545455,0.7490365775837179,1.0,7/27,17.39%,DNAJC1;HSPA8;DNAJA1;RHBDF2;LLGL2;SCFD1;GAPVD1
prerank,glial cell differentiation (GO:0010001),-0.3289324845271234,-1.0658375692816369,0.3742138364779874,0.7479612948384916,1.0,3/28,2.30%,NFIB;ADGRG6;SLC8A3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4393287883928741,1.0658037516345031,0.3882896764252696,0.9585788073126831,1.0,5/19,12.88%,BCL3;PHLDA3;HIPK1;MSH2;CDIP1
prerank,RNA metabolic process (GO:0016070),0.3322052174551996,1.0654883253344896,0.36292134831460676,0.9585049951216176,1.0,22/127,14.63%,DHX8;HNRNPC;RNASEH2B;NUFIP1;RBFOX2;PCBP2;HNRNPA0;WDR74;PABPC4;HNRNPR;FASTKD2;DDX17;RBM5;SIDT2;AGO1;CELF2;HNRNPM;ATXN2;GTF2F2;ALKBH1;FASTKD1;DICER1
prerank,excitatory postsynaptic potential (GO:0060079),-0.3699470274458766,-1.0654554769398576,0.3764705882352941,0.7479212228150931,1.0,5/19,11.97%,GRIN2B;AKT1;GRIN1;LRRK2;GSK3A
prerank,estrogen metabolic process (GO:0008210),0.4658198043830123,1.065380386596136,0.38235294117647056,0.9577955634674173,1.0,3/15,11.26%,SULT1A1;HSD17B4;HSD17B2
prerank,response to hexose (GO:0009746),0.4254794882586899,1.0649784787193906,0.3776435045317221,0.9579884285807596,1.0,8/25,21.69%,GPLD1;EIF2B3;SELENOS;EIF2B4;IRS2;LPL;VAMP2;TCF7L2
prerank,protein-containing complex assembly (GO:0065003),0.3143284119036206,1.0649025030329213,0.36,0.9572070307622301,1.0,47/259,15.77%,CLDN1;MAGI1;PPARGC1A;WIPF1;LAMC1;FOLR1;REPS2;AXIN1;PARD6B;CD3G;ANO6;KMT2A;SOX9;LEO1;FN1;CARD10;FANCC;SH3PXD2B;TRADD;TAPBP;CNIH1;ADAM10;TRAPPC9;CUL3;OCLN;DARS1;GSK3B;TFG;CSNK1A1;GRIA1;FERMT2;TRRAP;AXIN2;APC;PYGO1;MEN1;CREBBP;BCL9;GSDMD;ZW10;MDN1;BAD;TMED2;SEC23IP;ADCY8;YAP1;KMT2D
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3119631345625925,-1.0648006337404947,0.36363636363636365,0.7485535058264211,1.0,4/39,2.67%,MYO1D;MYO1B;MYO5A;MYO6
prerank,positive regulation of DNA repair (GO:0045739),0.37129098282833856,1.0647953578771714,0.3608108108108108,0.9565376670881116,1.0,10/46,12.87%,EGFR;FAM168A;BRCC3;EYA1;NPAS2;UIMC1;WRAP53;HMGB1;ERCC6;MGMT
prerank,central nervous system development (GO:0007417),0.31056502830770794,1.0644236653175763,0.362962962962963,0.9566189990616921,1.0,23/250,9.42%,PTCH1;APOD;VIT;PBX1;NF1;SOX9;NPAS2;GLIS2;CHD8;LSR;NCAN;SHROOM2;AMIGO2;TAGLN3;CDH2;ALDH5A1;S100B;EML1;JRKL;PTS;COL4A1;FOXJ1;RPS6KA3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.371089171546778,-1.0642989882692593,0.39037433155080214,0.7488126822384181,1.0,5/18,6.84%,ACSL1;ACSL3;ELOVL7;ACSL6;HSD17B12
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.30397399606596615,-1.062989707885146,0.3356643356643357,0.751125742240794,1.0,17/40,29.81%,IGF1;BCL2L11;AKT1;BID;MLLT11;FXN;GHITM;OPA1;TNFSF10;BBC3;PLAUR;CLU;PYCARD;PSMD10;BIK;BMF;TRIAP1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4071856897899122,-1.0626074379548853,0.37371134020618557,0.7511217314880769,1.0,6/13,25.47%,KDR;IL33;JAK2;EDN1;NOD2;NAMPT
prerank,regulation of cell cycle phase transition (GO:1901987),0.33891068391612167,1.062224846737285,0.3708133971291866,0.9622416583683833,1.0,28/91,18.76%,GTSE1;PSME3;ATP2B4;FBXO5;CDC20;PSMB5;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;PSMB2;UBE2D1;PSMA2;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;NEK11;FBXW7;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.38917055527816385,1.061940874781435,0.38968481375358166,0.9620397677207884,1.0,12/38,21.60%,PHLDA3;BANK1;DAG1;PHLPP1;PTPRJ;PTEN;PLEKHA1;GPER1;DDIT3;MUL1;TSC2;PPP2R5C
prerank,cellular response to interleukin-6 (GO:0071354),-0.34724616527765306,-1.0619145075610468,0.37572254335260113,0.7519361275774302,1.0,4/26,1.80%,ST3GAL6;PTGIS;PID1;IL6R
prerank,mitochondrial genome maintenance (GO:0000002),-0.4291028417802554,-1.0618573765261508,0.3914081145584726,0.7509823242037078,1.0,6/11,19.29%,AKT3;TOP3A;MEF2A;SLC25A33;OPA1;PARP1
prerank,metal ion homeostasis (GO:0055065),0.3850308473896562,1.0617595833928815,0.3656821378340366,0.9616076413597686,1.0,4/40,4.35%,CAV1;SLC12A2;SLC12A4;SLC12A3
prerank,negative regulation of DNA binding (GO:0043392),-0.32149578009248986,-1.0617227847585662,0.3450479233226837,0.750246708723789,1.0,6/28,20.59%,LEF1;SP100;JAK2;KDM1A;PER2;MAD2L2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4328699345458591,1.0616935477017755,0.3853211009174312,0.9608048092989683,1.0,2/20,1.76%,EGFR;CCND3
prerank,negative regulation of interleukin-8 production (GO:0032717),0.449323597738676,1.0614775086493804,0.3857374392220421,0.9604708626950003,1.0,4/17,11.06%,BCL3;PTPN22;ANXA4;OTUD7B
prerank,long-chain fatty acid import into cell (GO:0044539),-0.43785678264224437,-1.0614493749199303,0.3894230769230769,0.749889575466267,1.0,3/10,6.35%,ACSL1;ACSL3;RPS6KB1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.35417879422588683,1.0611991552583797,0.39011703511053314,0.960278509810835,1.0,14/64,13.29%,AIG1;EPHX1;ELOVL5;ALOXE3;ELOVL1;ELOVL2;HSD17B4;SLC27A4;ACOT8;ACOT2;LTA4H;ABCD1;PNPLA8;ELOVL6
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3114624566967867,1.061162905489731,0.3588362068965517,0.9593808502724662,1.0,66/241,22.78%,DHX8;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;HNRNPR;SF3B5;PPIE;PRPF3;CSTF3;CHERP;DDX46;RBM22;RBM5;ELAVL2;DNAJC8;SNU13;HNRNPM;DBR1;UPF3B;SRRM2;GTF2F2;SNRPA1;SFPQ;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;PSPC1;SYNCRIP;CWC22;SLU7;SYMPK;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4578866720066458,1.0609699096222778,0.39258114374034003,0.9589498333833228,1.0,6/17,16.67%,MAPK7;NFE2L2;SFPQ;HTRA2;P4HB;UBQLN1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.26225132603033147,-1.0605179238289117,0.3314917127071823,0.7512293376080602,1.0,19/88,11.84%,TRABD2B;SMAD3;SYNPO2;TFRC;BCL2L11;FNIP1;STX18;FNIP2;RHOC;SLF2;SH3GLB1;VCP;VPS4A;SLF1;RPS3;AJUBA;BID;MMP1;MPP7
prerank,regulation of osteoblast differentiation (GO:0045667),0.3410279608706759,1.0601606622266777,0.3706467661691542,0.9603817549396773,1.0,4/82,4.10%,PTCH1;RUNX2;SOX9;BMPR1B
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.49142808834016516,1.05932028783311,0.38648180242634317,0.9619471170922828,1.0,6/11,24.13%,LANCL1;P4HB;UBQLN1;PINK1;PRKN;REST
prerank,protein transport (GO:0015031),-0.21654846395565672,-1.0591812265070124,0.2857142857142857,0.7535817849568559,1.0,95/332,22.35%,TBC1D4;STXBP3;VAMP5;TXNIP;LRP1;WLS;STEAP3;ARHGEF2;TBC1D1;MYO6;RABGAP1;TOM1;TFRC;CALCRL;RAB6B;RAB3C;COG7;TBC1D12;PREB;NAPA;TMED9;ATP6V0A4;AP2A1;STX8;TBC1D30;USP6NL;TBC1D2B;NPM1;ZDHHC17;ARHGAP1;APOE;VMP1;ARL6IP5;SGSM3;RAMP2;ATP6V0C;COPZ1;RAB13;SCAMP5;ANK3;COPZ2;EIF2D;STX17;EVI5L;MACF1;SCG2;RAB5C;ATP6V1C1;TMED3;TBC1D22B;SAR1B;RAB24;BBS2;VPS26B;ARRDC4;STX12;HERC2;SVBP;PREPL;ABCG1;CTSA;GGA3;TMED1;CHMP3;RAB3B;STX6;ARF5;HFE;LAPTM5;ARRDC2;SCFD1;ATP6V1D;STX16;SYS1;SEC31A;CHMP2B;RAB11B;MYH9;RCN3;RAB32;SLC10A7;SYNDIG1;ATP6V1F;TMED7;TBC1D17;PICK1;MON1A;ARF3;RAB7A;OPTN;CLU;RAB10;ATP6V1E1;ARL4C;ARL5B
prerank,tyrosine metabolic process (GO:0006570),0.48871569435029577,1.0589709192067096,0.40467625899280574,0.9620267764328361,1.0,2/11,10.44%,IL4I1;GSTZ1
prerank,stress-activated MAPK cascade (GO:0051403),-0.26918106115401635,-1.0588348309868592,0.3183856502242152,0.7534320221233198,1.0,17/61,19.93%,TNFRSF19;MAP3K20;TRAF6;UBE2N;NOD1;CRKL;MAP3K10;TRIB1;TAOK2;MAP2K3;IKBKB;LGALS9;ZFP36;IRAK2;CUL1;GPS1;SKP1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.3277826158833469,-1.0587262356015903,0.3487544483985765,0.7526347660959902,1.0,16/31,33.15%,TIMM44;PAM16;PEX26;TIMM17B;PEX6;PEX1;PEX10;ROMO1;GRPEL1;DNLZ;AIFM1;TIMM50;HSPD1;PEX5;TIMM23;TIMM21
prerank,negative regulation of blood pressure (GO:0045776),-0.41443575397169463,-1.058683201052681,0.36989795918367346,0.751619759001264,1.0,5/13,18.48%,NOS3;BMPR2;PRCP;NOS1;GPR37L1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.4180457856155745,-1.058567121461436,0.3900709219858156,0.7507742473067928,1.0,8/12,45.80%,INSIG2;OS9;TAPT1;GPAA1;ANKRD13C;KDELR1;KDELR2;RER1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5075255474344172,1.0583024391527545,0.4308231173380035,0.9630202981305253,1.0,5/10,19.36%,INPP5F;NF2;PIBF1;SOCS1;PPP2CA
prerank,skeletal system development (GO:0001501),0.3230019308478985,1.0581625657792983,0.387458006718925,0.9624488397188149,1.0,17/148,5.78%,PKDCC;FGFR1;SULF1;PRELP;CDH11;KIAA1217;PCSK5;GLI2;AKAP13;EIF2AK3;PTHLH;SOX9;BMPR1B;BMP5;WNT5A;NCAN;SH3PXD2B
prerank,calcium-mediated signaling (GO:0019722),0.3425292327322257,1.0574724022873454,0.3723150357995227,0.9635369059488934,1.0,13/93,10.18%,ACKR3;PLCE1;PTGFR;EGFR;FKBP1B;EIF2AK3;FIS1;PTPRC;RCAN1;PTPRJ;IRGM;KSR2;LAT
prerank,glucose homeostasis (GO:0042593),0.34393267997574484,1.0574712416602956,0.3781818181818182,0.9625444246515134,1.0,20/83,17.88%,PPARGC1A;LRRC8D;LEPR;SLC8B1;HK2;FOXK1;PDK4;PIK3R2;FOXK2;BACE2;ADRA2A;GCK;SOX4;NUCKS1;BAD;ADCY8;HECTD4;PPARG;KLF7;WFS1
prerank,nucleic acid metabolic process (GO:0090304),0.3488129383638371,1.0573928034932694,0.39949748743718594,0.961810606085583,1.0,14/69,15.26%,HNRNPC;RBFOX2;PCBP2;HNRNPA0;WDR74;DXO;HNRNPR;KPNA2;NT5E;HNRNPM;ATXN2;GTF2F2;RECQL5;RAN
prerank,oogenesis (GO:0048477),0.4539110944175445,1.05700685828848,0.3918032786885246,0.9619711714440174,1.0,4/15,16.87%,PIWIL2;MEI4;KMT2D;MDK
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4364729637961765,1.0568169690463554,0.4050632911392405,0.9615419257677681,1.0,3/18,10.36%,LBP;DOCK2;KARS1
prerank,positive regulation of binding (GO:0051099),0.33925763994553454,1.0567396466684411,0.3817733990147783,0.9607882346441228,1.0,10/84,9.49%,NGF;CAV1;ADD1;DACT1;TRIM21;RARA;AMFR;STK3;GSK3B;HMGB1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4444317079314595,-1.056658547888406,0.3826879271070615,0.7550036985742573,1.0,6/10,40.83%,SP100;RPS27L;KAT5;TFAP4;MUC1;FOXM1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5056789926965968,1.0565635769571453,0.43112701252236135,0.9603398707981528,1.0,4/10,17.11%,RARB;RARA;RARG;PPARG
prerank,regulation of protein phosphorylation (GO:0001932),0.30617668237856194,1.0562783394884874,0.3634453781512605,0.9601284568679647,1.0,24/256,6.42%,EFNA5;FGF7;NTRK3;PLCE1;PTPN13;CLDN19;LEPR;EGFR;CCND3;MUSK;PELI2;FGF1;AXIN1;CDH5;FXR2;EIF2AK3;SOX9;PLPP3;LIMK2;IBTK;FN1;FER;EPHB2;KRAS
prerank,regulation of actin filament-based process (GO:0032970),0.35389865058620373,1.0560750856096415,0.37660668380462725,0.9597894778582103,1.0,6/70,5.92%,EFNA5;DLC1;F11R;ARHGAP18;RAC2;ARHGEF5
prerank,non-motile cilium assembly (GO:1905515),0.40428218663864435,1.0559249524201328,0.37787356321839083,0.9592867922738365,1.0,11/30,20.83%,GORAB;CEP89;C2CD3;CEP290;RPGRIP1L;PCM1;PIBF1;BBS1;CEP250;TMEM80;IFT57
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.29501048597573976,-1.055267730290581,0.30223880597014924,0.7576535610641539,1.0,10/47,10.66%,TIMP3;SPOCK2;RECK;SERPIND1;SERPINI1;SPOCK1;SERPINE2;AKT1;SERPINB9;GAPDH
prerank,histone H3-K4 methylation (GO:0051568),0.4089467868554197,1.0552129034482711,0.3895522388059702,0.9602958866203049,1.0,6/26,15.77%,OGT;KMT2A;BEND3;MEN1;DYDC2;KMT2D
prerank,neurotransmitter transport (GO:0006836),0.349358247618857,1.0550413651189918,0.3743718592964824,0.9598493590019,1.0,12/73,7.29%,PPFIA2;STX1A;CASK;SLC38A2;SLC1A7;SLC29A4;SLC22A3;ATP1A2;BRSK1;SLC1A6;RAB3A;CPLX1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.38346758127495784,-1.0550409104480931,0.3934010152284264,0.7571361071465684,1.0,6/16,13.12%,NR1H3;LDLR;CTDNEP1;ABHD5;NR1H2;MFSD2A
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.49319125211674686,1.0549992827838244,0.40963855421686746,0.9590002300623859,1.0,3/10,16.06%,CD55;CD81;SOCS1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.39940713027684227,1.0541627117937078,0.39212827988338195,0.9604661212382225,1.0,10/30,13.29%,ELOVL5;HACD4;ELOVL1;PEX2;ELOVL2;SLC27A4;ACOT2;HACD2;ABCD1;ELOVL6
prerank,regulation of ERAD pathway (GO:1904292),-0.4376571012683369,-1.0538484636434249,0.39903846153846156,0.7593182238197814,1.0,3/11,8.46%,USP19;RNFT1;AQP11
prerank,pseudouridine synthesis (GO:0001522),0.4618221946464846,1.0536879376349313,0.3983050847457627,0.960869210334108,1.0,3/13,6.98%,RPUSD2;PUS7;PUS3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.39314765574621935,1.053425354679835,0.3945868945868946,0.9606790459380349,1.0,3/35,1.75%,NTRK3;F11R;RAPGEF3
prerank,leukotriene biosynthetic process (GO:0019370),0.45705055289071894,1.0532882593709438,0.40728476821192056,0.9600912151400995,1.0,4/14,15.30%,MGST2;GGTA1;LTA4H;GGT1
prerank,rRNA processing (GO:0006364),-0.2346813955418445,-1.0528410316801344,0.3614457831325301,0.7610906616800018,1.0,75/172,30.26%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;RIOK1;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;RIOK3;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;WDR3;RPS14;RPS25;NOB1;RPL36A;NHP2;RPL7;NAT10;RPL11;PIH1D2;SART1;RPL24;RRP36;RRP9;WDR46;UTP6
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.38609858544022463,1.0526560943866936,0.39337175792507206,0.9610360514090296,1.0,7/38,12.70%,CAV1;PTPRC;NCK2;SRCIN1;DLG3;RELN;MVP
prerank,regulation of ossification (GO:0030278),0.38813432588659363,1.0524405676743367,0.36746143057503505,0.9607586552121156,1.0,5/36,6.92%,LRP4;SGMS2;SOX9;WNT5A;BMP2K
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3736294234997749,1.0523589605447503,0.4065040650406504,0.96002597657654,1.0,9/45,9.58%,EGFR;SLC38A2;BUD23;DXO;UTP15;RBM22;DYRK1A;LIN28B;SIRT7
prerank,plasma membrane repair (GO:0001778),-0.39625554060353807,-1.0522563572604002,0.36077481840193704,0.7616234122269878,1.0,4/13,9.25%,MYOF;DYSF;SYT7;SYTL4
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.42552815821728107,1.0522327192711305,0.39908256880733944,0.9594240772193777,1.0,4/23,5.25%,SLC12A2;SLC12A4;SLC12A3;PDK4
prerank,regulation of ruffle assembly (GO:1900027),0.4212110063875431,1.0515497954221582,0.39490445859872614,0.9604322448258548,1.0,3/23,7.57%,CAV1;RDX;KANK1
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.316117489384118,-1.0511364607143532,0.345565749235474,0.7637070214714536,1.0,8/32,16.66%,SNCAIP;MCTP2;SYN1;CAMK2A;LRRK2;PREPL;DTNBP1;CPLX2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3960239361843163,1.051110134092076,0.4071942446043165,0.9607410253685787,1.0,1/32,0.24%,CAV1
prerank,macrophage activation involved in immune response (GO:0002281),0.46447843127282706,1.0508005146774273,0.4099173553719008,0.9606994384349926,1.0,1/13,0.73%,LBP
prerank,positive regulation of angiogenesis (GO:0045766),0.33124079668647854,1.0498225382676953,0.3942307692307692,0.9626643284243241,1.0,11/108,5.28%,GAB1;SMOC2;RAPGEF3;HK2;FGF1;CDH5;ITGAX;IL1A;PRKCA;WNT5A;HIPK1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.29534884337321465,1.0488916043490213,0.316,0.9643868891524425,1.0,154/1082,13.67%,RORA;MEOX2;DCN;KLF5;ETV4;ITGA6;FGF7;MDFIC;CDH13;NFATC2;ETV1;GLI1;PPARGC1A;FOXD2;NR2F2;DLX1;POU4F3;RARB;ZNF423;NFATC1;LDB2;PBX1;FZD2;EGFR;NPAS3;FGF1;BCL3;AXIN1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;GLI2;IL4I1;CRTC1;MAML2;MLLT3;TXK;LMO1;LMO7;KMT2A;SPI1;FOXK1;FOXO3;EIF2AK3;SOX9;BMPR1B;PGR;NPAS2;TFR2;GLIS2;CHD8;CSRP3;SLC30A9;KAT6B;HDAC4;REL;BMP5;KLF10;NUP62;WNT5A;PPM1A;HEYL;ATAD2;SP3;ZFP90;RPRD1B;RGMB;ONECUT1;NRIP1;NCK2;CDK7;CTCF;NRF1;UTP15;PAX3;HOXC10;DDX17;RREB1;MAPK7;RARA;USF2;MAP3K5;ILF2;PIK3R2;ISL1;E4F1;FOXK2;ELL;DYRK1A;TNIP1;ZNF462;AATF;AGO1;DDRGK1;TCF20;PLSCR1;MED13;TET1;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;HDAC2;DBP;KARS1;TMF1;TFEB;FHOD1;ERCC6;PAXBP1;RTRAF;MMP12;ILF3;RARG;DVL3;COL1A1;TASP1;EGR1;MZF1;ZBTB49;HTATIP2;AKIRIN1;MEN1;BICRA;KDM8;CEP290;INO80;NCOA3;NAT14;NFE2L2;CD81;SPIN1;PEG3;KDM6B;CRLF3;TAF15;PKD1;CREBBP;NCOA2;BCL9;GTF2H1;SOX4;CDKN1C;DPF3;TCERG1;SFPQ
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3315602841631286,-1.0479267214525556,0.3390804597701149,0.7714799628802469,1.0,11/24,27.00%,TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2;RNF34;UBB
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3447202011225085,1.0476878744585143,0.39076154806491886,0.9669762806707481,1.0,11/74,9.35%,ITGA6;EYA1;IL1A;SRC;PSME3;BMP5;TNFAIP3;TRADD;MCL1;MAPK7;GSK3B
prerank,membrane repolarization during action potential (GO:0086011),-0.40058097357731726,-1.0474226998348617,0.40458015267175573,0.7717520706378986,1.0,6/13,30.79%,KCNJ2;ATP1B1;KCNE4;KCNH2;ATP1A1;KCNQ1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.33977190246829286,-1.047305197950246,0.375,0.7709322473893223,1.0,7/26,13.41%,ACER2;NOS3;CYP1B1;GCH1;AKT1;ABCA2;SPHK1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3143087196952728,-1.046929126649001,0.38305084745762713,0.7708275211926255,1.0,8/35,9.63%,PLXNA2;PLXNA4;SEMA6D;SEMA7A;SEMA3C;SEMA6A;ARHGDIA;FLNA
prerank,protein import into nucleus (GO:0006606),0.34685075690199735,1.046783370375072,0.39896373056994816,0.9686504454717153,1.0,16/66,16.49%,PRICKLE1;KPNA7;IPO8;NUP62;KPNA2;FAM53B;CBLB;TPR;MMP12;NUP50;RANBP2;CSE1L;NUP153;RAN;NUP93;SYK
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3692113272297989,1.0460251975139432,0.39339752407152684,0.9698732954387772,1.0,5/47,4.74%,CAV1;DKKL1;CEACAM1;SLC27A1;ATP2B4
prerank,mammary gland epithelium development (GO:0061180),-0.3894436257542515,-1.0457782248852634,0.40617577197149646,0.7729219578761293,1.0,4/14,14.18%,WNT4;JAK2;AKT1;ID2
prerank,positive regulation of apoptotic process (GO:0043065),0.30373221500813513,1.0455032096348655,0.3890641430073607,0.9705218320787201,1.0,62/293,17.01%,NGF;ITGA6;DLC1;DKKL1;TIAM2;FAP;MYBBP1A;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;FOXO3;VAV2;ACVR1C;TRIO;TRADD;ARHGEF5;NCSTN;PHLDA1;NLRC4;ARHGEF1;SIAH1;MAP3K5;RBM5;KALRN;OBSCN;STK3;HMGB1;NLRP2B;RASSF2;SLC27A4;SRPK2;RARG;APC;ARHGEF6;FAF1;PTPA;ADAMTSL4;DIABLO;ATG7;SOX4;HTRA2;HTT;UNC13B;FZD9;GPER1;BAD;PDCD2;AIFM2;CTNNBL1;BACE1;PLEKHG2;ARHGEF11;ARHGEF7;BNIP3;E2F1;QRICH1
prerank,cholesterol transport (GO:0030301),0.371562787026333,1.045284226651056,0.390646492434663,0.9702420249695426,1.0,6/45,14.27%,CAV1;CEL;SOAT1;ABCA1;STARD3;STARD5
prerank,ureteric bud morphogenesis (GO:0060675),-0.39083252785351175,-1.0452171221990891,0.4183168316831683,0.7733161976622973,1.0,5/16,24.58%,BMP4;BMP2;SALL1;WNT11;NPNT
prerank,membrane assembly (GO:0071709),0.38697724628625624,1.0449787542482596,0.40520984081041966,0.9701376589821002,1.0,13/34,22.12%,LRP4;CEL;FLOT2;SPAST;CHMP4B;STX2;PTEN;STX4;SPTBN1;S100A10;CHMP2A;NLGN3;NLGN2
prerank,signal transduction in response to DNA damage (GO:0042770),-0.28779987596465967,-1.0448078050994576,0.384297520661157,0.7733389866708951,1.0,10/49,14.63%,MAP3K20;ACER2;USP28;MYO6;PAXIP1;ATRIP;HINFP;BID;CLSPN;RAD1
prerank,ncRNA transcription (GO:0098781),0.46729903417819574,1.0447920055138826,0.41223832528180354,0.9696925447581044,1.0,4/13,12.39%,CAVIN1;RPAP2;SIRT7;SPIN1
prerank,organic anion transport (GO:0015711),0.3419656051486703,1.0443242602950418,0.4027603513174404,0.9700618586771379,1.0,11/76,7.50%,LRRC8D;SLC35A1;SLC4A3;SLC26A9;SLC35B2;SLC22A3;SLC4A4;SLC35C2;SLC2A2;SLC4A11;SLC52A1
prerank,cholesterol metabolic process (GO:0008203),-0.26831557296765024,-1.0441922119458942,0.3623853211009174,0.7739465114156705,1.0,25/68,26.09%,PPARD;INSIG2;ARV1;APOE;HMGCS1;SCAP;OSBPL1A;LDLRAP1;OSBPL5;ACAA2;GBA2;ACLY;NSDHL;PMVK;ABCG1;MVK;ACAT2;DHCR7;TSKU;CLN6;PIP4P1;TM7SF2;SCARF1;CH25H;LCAT
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3636052701723292,1.0439675197006215,0.4095890410958904,0.9701389035252533,1.0,7/48,8.17%,IL18R1;PDE4D;TXK;PTPN22;TLR7;CRTAM;ISL1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4472328927475032,1.0438938158443478,0.4080645161290323,0.9694113722149684,1.0,2/15,9.52%,USP50;NLRP2B
prerank,calcium ion import into cytosol (GO:1902656),0.4533537386457726,1.0438145769527725,0.4193011647254576,0.968680613964649,1.0,3/15,4.74%,SLC24A1;TRPV4;ATP2B4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4381703550205004,1.0436108601458194,0.41533546325878595,0.9682980473780276,1.0,4/18,7.57%,RIPOR2;CDH5;KIF20B;KANK1
prerank,regulation of intracellular signal transduction (GO:1902531),0.2982696441308523,1.0435313034492875,0.3721881390593047,0.9675791878424224,1.0,59/420,10.01%,DLC1;NTRK3;TIAM2;ARHGAP31;PRR5;PTPN13;CEACAM1;ARHGAP18;ARHGAP12;ARHGAP32;AKAP12;EGFR;ARHGAP9;ARAP1;FGF1;PPP1R13B;BCL3;MINK1;DEPDC1B;SPRED1;GPAT3;CHD3;AKAP13;OPHN1;RACGAP1;PRKAG1;TPTE;PTPN22;FAM83D;VAV2;RAC2;TAF10;PIP4K2B;WNT5A;TRIO;HIPK1;TAF4B;RFC3;ULK4;ARHGEF5;NBN;ARHGAP26;CCNG1;RHOJ;ARHGEF1;PTPMT1;PHLPP1;PRKAR2A;PIK3R2;STARD13;KALRN;OBSCN;OCRL;STK3;DIPK2A;RASSF2;POU4F1;HDAC2;MAPKAP1
prerank,autophagosome organization (GO:1905037),-0.2812150130948909,-1.0434345941101018,0.37218045112781956,0.7749443023137926,1.0,16/50,24.51%,ATG16L2;BECN1;GABARAPL1;VMP1;WIPI1;ULK2;GABARAP;AMBRA1;STX12;ATG13;MAP1LC3A;RAB7A;WIPI2;ATG12;WDR45B;WDR45
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4217845597664449,-1.0432298588071451,0.41262135922330095,0.7732786463020498,1.0,5/11,20.66%,AGO3;AGO4;ZFP36;TNRC6C;NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4217845597664449,-1.0432298588071451,0.41262135922330095,0.7732786463020498,1.0,5/11,20.66%,AGO3;AGO4;ZFP36;TNRC6C;NOTCH4
prerank,monocarboxylic acid transport (GO:0015718),-0.2881246412724541,-1.0431496078739992,0.3592592592592593,0.7724283477958681,1.0,11/51,11.94%,SLC16A12;SLCO3A1;ABCC4;ABCG2;SLCO1C1;SLC5A6;SLC16A6;SLC16A4;SLCO2A1;SLC16A2;SLC16A7
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.43763211512151867,-1.04309496487452,0.4117647058823529,0.7714640397375951,1.0,1/10,1.02%,SHANK3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.36644476680372623,1.0430599956334667,0.3989290495314592,0.9680052970018111,1.0,17/51,26.87%,HNRNPC;SRC;NEK7;STN1;NAF1;EXOSC10;CCT2;GNL3L;TERF2;ATR;CCT3;SMG6;MAPK1;TENT4B;TNKS;HNRNPU;SMG5
prerank,negative regulation of neuron death (GO:1901215),0.3302383223917794,1.0429228734209577,0.38066825775656327,0.9674400415880884,1.0,10/93,10.71%,NGF;PPARGC1A;MSH2;ISL1;NRBP2;CD200R1;GSK3B;POU4F1;CHMP4A;CHMP4B
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.330133455832138,-1.042667316301966,0.39009287925696595,0.7715586948660118,1.0,13/29,27.09%,IFNAR2;SAMHD1;UBE2K;USP18;ABCE1;ISG15;YTHDF2;CACTIN;CDC37;YTHDF3;TRIM6;ZBP1;TTLL12
prerank,blood vessel endothelial cell migration (GO:0043534),-0.3481974594483894,-1.042061210092744,0.36555891238670696,0.7720933422332196,1.0,5/22,8.19%,ROBO1;SLIT2;PIK3R3;KDR;AKT1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.44847742797839796,1.0417957200692487,0.41533546325878595,0.9696992958041459,1.0,4/14,8.59%,DPYS;UPP2;NT5E;CAD
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3244301530837251,-1.041188248833109,0.38387096774193546,0.7733849547355195,1.0,14/33,24.04%,HIP1;TGFA;AFAP1L2;HIP1R;AKT1;BCAR3;SHKBP1;EGF;CNOT9;AGT;NEU3;PLAUR;PDE6H;DOK1
prerank,lymphocyte proliferation (GO:0046651),-0.34661754834305525,-1.0409371634521631,0.3858695652173913,0.7729570561725035,1.0,2/22,1.74%,MSN;CTPS1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4313365533217354,1.0409179080926445,0.40644171779141103,0.9712779858123637,1.0,4/20,9.40%,NEDD4L;SLC12A2;ATP1A2;ATP1B3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4251227714609856,1.040609971773437,0.42242703533026116,0.9712555901815234,1.0,4/20,10.63%,FMNL2;ARF6;PLEK;FHOD1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4197089856569664,1.040395979371639,0.40271493212669685,0.9709037536649564,1.0,1/22,0.42%,DYNLL1
prerank,negative regulation of defense response to virus (GO:0050687),0.490973249304697,1.0403686070233773,0.3967391304347826,0.970018539417858,1.0,4/10,21.89%,PCBP2;ITCH;MUL1;TSPAN6
prerank,keratan sulfate metabolic process (GO:0042339),0.3924779460417931,1.0397362518576951,0.4320809248554913,0.9709737681797489,1.0,6/31,10.86%,ST3GAL4;PRELP;B4GAT1;SLC35D2;CHST2;HEXA
prerank,rRNA pseudouridine synthesis (GO:0031118),0.4901710585703759,1.0395514747395989,0.42736486486486486,0.9705408915899025,1.0,3/10,18.26%,RPUSD2;NAF1;RPUSD4
prerank,dicarboxylic acid transport (GO:0006835),0.39321158417806185,1.0391648185162266,0.41284403669724773,0.9707180934583781,1.0,6/28,6.69%,FOLR1;FOLR2;SLC25A12;SLC1A7;PRAF2;SLC1A6
prerank,negative regulation of hippo signaling (GO:0035331),0.47316992012616765,1.039126091863053,0.44206773618538325,0.9698771836716893,1.0,3/12,13.55%,VGLL4;WWC1;CIT
prerank,regulation of transposition (GO:0010528),0.464154988704349,1.0386469927835145,0.4390681003584229,0.9702918111397726,1.0,3/13,12.29%,PIWIL2;SIRT7;TEX15
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.35365038083856193,1.038511308825167,0.4194407456724368,0.969769130811122,1.0,13/54,19.72%,PLK2;GTSE1;CNOT10;ARID3A;SFN;CNOT7;SOX4;RGCC;TNKS1BP1;E2F1;CNOT8;CNOT1;BAX
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.40250045318234956,-1.0383159063685086,0.4027777777777778,0.7791623364313944,1.0,5/13,15.12%,RPS15;NPM1;NOP9;ABCE1;NUP88
prerank,smooth muscle cell differentiation (GO:0051145),-0.41740722010505094,-1.037413710462598,0.43467336683417085,0.7805282008852817,1.0,5/12,21.79%,BMP4;TMEM204;GATA6;MYOCD;APLNR
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.4420230321775962,1.0374095318044596,0.4219001610305958,0.9720809032510973,1.0,6/16,15.08%,DPYS;UPP2;NT5E;DPYSL2;DPYSL5;NT5C3A
prerank,regulation of B cell differentiation (GO:0045577),0.43636143525751003,1.036951100447773,0.4216133942161339,0.9724930706551722,1.0,6/17,16.92%,IL4I1;ZFP36L2;PPP2R3C;SYK;BTK;MMP14
prerank,positive regulation of cellular protein localization (GO:1903829),0.3439699132950363,1.0365548117829833,0.42727272727272725,0.972682023744847,1.0,19/69,20.41%,GTSE1;RIC3;EIF2AK3;LIMK2;NUP62;CARD10;DDRGK1;GSK3B;FERMT2;APC;SLC5A3;RTN4;YAP1;GNL3L;STX4;TM9SF4;CEP250;LAMTOR5;PRKN
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4555516466193734,1.0353967157167834,0.4117647058823529,0.9751420796498803,1.0,7/13,28.83%,WNT5A;AXL;IL7;DHX9;IFIH1;TRIM44;MAVS
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.32722704109023654,1.0352125032118165,0.39294117647058824,0.9747447091293833,1.0,14/95,9.89%,LBP;TNIP3;IL1A;WNT5A;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;AXL
prerank,zymogen activation (GO:0031638),0.37501491402215525,1.0351719847983816,0.42028985507246375,0.9739293453192547,1.0,6/39,7.23%,KLK2;CYFIP2;CIDEB;CD5L;NLRC4;PERP
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3224446597256813,-1.0349597883431831,0.3834808259587021,0.7860358173284886,1.0,10/26,23.42%,ALPK1;TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2
prerank,regulation of extracellular matrix organization (GO:1903053),-0.38284212730427286,-1.0345961602360685,0.43434343434343436,0.7858754432082118,1.0,6/15,12.13%,AEBP1;LRP1;DDR1;TIE1;SLC2A10;FGFR4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3426606719269987,1.0344906373078342,0.4139650872817955,0.97490893986343,1.0,9/76,5.90%,NR3C2;EGFR;BCL3;SPI1;PTPN22;PPM1A;UACA;TLR7;TRADD
prerank,fatty acid oxidation (GO:0019395),0.3514397641196637,1.0343221591407687,0.41923076923076924,0.9744288191240307,1.0,8/57,8.66%,PPARGC1A;EHHADH;HADHB;PEX2;ACAT1;HSD17B4;ADH5;ACADS
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.291062679832914,1.0341100982377271,0.39152371342078707,0.974083028860728,1.0,73/572,12.06%,PTCH1;TENM2;CAV1;NR2F2;NEDD4L;DLX1;RARB;FOXP2;ZBTB32;KLF12;LDB2;ETV5;GLI2;IRF2BP1;CHD3;SPI1;BEND3;PHF21A;FOXO3;SOX9;UBE2I;FOXP4;GLIS2;CHD8;HDAC4;SATB1;KLF10;DACT1;N4BP2L2;PPM1A;KANK2;BHLHE40;ZFP90;ANKRD2;NRIP1;SIN3B;CTCF;HIC1;PEX2;PAF1;ZNF431;NCOR1;NCOA5;TBX2;RREB1;RARA;BAG3;SUV39H1;KCTD1;MYPOP;ISL1;E4F1;MECP2;FOXJ1;HMGB1;SIRT7;SUPT4H1;POU4F1;HDAC2;LEFTY1;TPR;ZHX1;WWC1;NCOR2;OTUD7B;RARG;NEDD4;MZF1;HEXIM1;ZNF148;ERF;MEN1;SEMA4D
prerank,response to estrogen (GO:0043627),0.39682760629325187,1.0337626952151395,0.4108187134502924,0.9741504873976929,1.0,3/31,7.46%,CAV1;KRT19;RARA
prerank,vasculature development (GO:0001944),0.4445670546434431,1.0336049375881904,0.4304,0.9736597370187926,1.0,2/16,2.58%,STRA6;CDH5
prerank,regulation of stress fiber assembly (GO:0051492),0.33880724084787867,1.0335145412925002,0.4178168130489335,0.9729804502012457,1.0,6/74,2.02%,DLC1;F11R;LPAR1;PXN;RAPGEF3;ARAP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.39774853255074843,-1.0334151642273164,0.4067357512953368,0.7880323586226899,1.0,6/13,28.04%,MMS19;NFU1;ISCA2;GLRX5;BOLA2;CIAO2B
prerank,regulation of interleukin-12 production (GO:0032655),-0.28326229330914493,-1.033396634147088,0.3886792452830189,0.7869894748697774,1.0,13/47,25.45%,PLCB1;FOXP1;PLCG2;CMKLR1;THBS1;LGALS9;LAPTM5;CD40;TLR3;C1QBP;CCL19;IRF5;JAK3
prerank,blood vessel morphogenesis (GO:0048514),0.35989319005005915,1.0331187954835142,0.43119266055045874,0.9731452548999181,1.0,9/54,10.33%,STRA6;CAV1;GLMN;NF1;EGFL7;EFNB2;CDH2;COL4A1;AGGF1
prerank,negative regulation of endocytosis (GO:0045806),0.41584861068788603,1.0330905650779711,0.4036979969183359,0.9722986642359376,1.0,3/24,7.65%,CAV1;LRSAM1;ARF6
prerank,glutamine family amino acid metabolic process (GO:0009064),0.39033909756452584,1.033078523759471,0.42450142450142453,0.9713964859335658,1.0,10/33,15.30%,PRODH;AADAT;NIT2;DDAH2;ALDH18A1;ALDH5A1;CAD;GOT1;GLUL;GGT1
prerank,nucleic acid-templated transcription (GO:0097659),-0.2964080569055608,-1.0329608148484308,0.375,0.7871421001333805,1.0,17/42,21.82%,CREBL2;MEF2A;PTMA;NR4A2;RRAGC;POLR3A;MMS19;PWP1;RNPS1;HOXD3;POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;THAP1;THRB
prerank,melanosome organization (GO:0032438),0.4016438521739001,1.032472443683035,0.4270833333333333,0.9722765329234869,1.0,4/26,7.55%,RAB29;HPS1;SHROOM2;KIF13A
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3085876990859872,1.0323529110824352,0.4136413641364136,0.9716626066825095,1.0,15/166,5.81%,SMOC2;GLI1;PPARGC1A;SORBS1;ASS1;EGFR;BCL3;ELOVL5;FXR2;GPLD1;GLI2;PIWIL2;SLC27A1;DDAH2;STN1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4300973728515357,-1.0322704227829225,0.41445783132530123,0.7879430032104779,1.0,3/10,18.03%,EP300;KAT2B;KAT2A
prerank,tricarboxylic acid metabolic process (GO:0072350),0.45676896518840737,1.031941373858604,0.43493761140819964,0.9718849490566757,1.0,1/12,1.60%,ASS1
prerank,regulation of neuron apoptotic process (GO:0043523),0.3265055424037509,1.031760580252288,0.4323671497584541,0.971444507298246,1.0,10/96,10.90%,NGF;PPARGC1A;NF1;FOXO3;EGLN3;MSH2;ISL1;NRBP2;POU4F1;SRPK2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2928951177463663,1.0308962437852371,0.3890577507598784,0.9730054335452046,1.0,60/509,11.44%,ROR2;GAB1;DCN;CAV1;ROR1;FGF7;PLK2;NTRK3;CDH13;FGFR1;LPAR1;NR3C2;HCST;PIK3AP1;EGFR;PELI2;FGF1;AKAP13;CAV2;WNT16;SOX9;SLC35B2;SRC;REL;RAC2;WDR24;NUP62;FIS1;WNT5A;PTPRC;FN1;PPM1A;MIOS;TLR7;TRADD;TRIM21;SIAH1;PIK3R2;S100B;PTPRJ;GCNT2;NOS1AP;FGF18;HMGB1;TFG;TICAM1;TMED4;GAB2;AXL;CANT1;FERMT2;SHARPIN;ADRA2A;RELN;STRN;S100A9;WWC1;TAB2;NEDD4;PLXNB1
prerank,regulation of phospholipase C activity (GO:1900274),0.44556281028009176,1.0308132481540715,0.4096989966555184,0.9723173076141025,1.0,2/15,0.70%,NTRK3;FGFR1
prerank,regulation of hormone secretion (GO:0046883),-0.37978087183795367,-1.029838196695819,0.39325842696629215,0.7936001185655752,1.0,8/15,40.26%,ANXA1;EDN1;EDN3;SCG5;NMB;IL11;VAMP3;LIF
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.4191823567486855,1.0296072251735207,0.4182098765432099,0.973966448025951,1.0,4/21,7.45%,EYA1;IL1A;MCL1;MAPK7
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.4191823567486855,1.0296072251735207,0.4182098765432099,0.973966448025951,1.0,4/21,7.45%,EYA1;IL1A;MCL1;MAPK7
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35076224363917613,1.0295625256769052,0.43870967741935485,0.9731488063007365,1.0,11/56,10.95%,EGFR;CCND3;ADAMTS1;UBE2E2;RDX;FBXO5;CUL3;ANAPC5;ANAPC7;MECP2;ANAPC11
prerank,response to hydrogen peroxide (GO:0042542),-0.2897703988630978,-1.0293016833171056,0.35687732342007433,0.793967957666136,1.0,14/45,17.53%,CYP1B1;SIRPA;CAT;PDCD10;ANXA1;OSER1;RHOB;RPS3;NET1;GLRX2;FXN;APTX;ANKZF1;TRPM2
prerank,negative regulation of macroautophagy (GO:0016242),-0.32250925246662304,-1.029168979612914,0.4235294117647059,0.7932248856486647,1.0,9/26,16.42%,NUPR1;AKT1;QSOX1;RUBCN;LRRK2;USP36;UBQLN4;FEZ2;SCFD1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.33169196274214197,-1.0291553392044686,0.4117647058823529,0.7921581961769038,1.0,6/26,12.14%,SLC30A10;PLCG2;CYBA;GRIN1;SLC25A33;ABCD2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.45306101992643316,1.0286740055269794,0.4335548172757475,0.9747806846432073,1.0,4/14,16.49%,CD55;PTPN22;CD81;SYK
prerank,chemical homeostasis (GO:0048878),0.35144300350597635,1.0284213123327135,0.4167776298268975,0.9745354597617333,1.0,14/61,18.05%,NEDD4L;SLC4A3;ZBTB20;CLN8;SLC4A4;SLC4A11;USF2;TLCD3A;THADA;PNPLA8;FBXW7;PPARG;IRS2;VGF
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4094738769002225,1.0283900519773317,0.42457231726283046,0.973691784999097,1.0,4/24,7.38%,KIF2A;NCKAP5L;TRPV4;CKAP5
prerank,neuron development (GO:0048666),-0.23484311537873745,-1.02834861114799,0.44642857142857145,0.7932811994875674,1.0,36/141,14.92%,FRY;PTPRM;RAPGEF2;LYN;PBX3;FRYL;ATP7A;STMN2;RASGRF1;GPRIN3;APOE;EPHA8;TBC1D24;STMN4;THOC2;DCX;VSX1;CAMSAP1;RAB13;LAMB1;MANF;LGI4;RP1;MYT1L;GBA2;RAB11A;STMN1;HS6ST1;TGFB2;LGI1;MAPT;SH3GL2;DTNBP1;CLN5;MICALL1;CDK5R1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3944083708556857,-1.0283408362730895,0.4320388349514563,0.7922000678366365,1.0,2/14,1.72%,RAPGEF2;PKIG
prerank,regulation of mRNA metabolic process (GO:1903311),0.4704894840830614,1.028019043770593,0.421875,0.9738499580036413,1.0,6/11,25.71%,SRPK1;SLTM;SRPK2;DHX9;IWS1;SAFB2
prerank,negative regulation of receptor binding (GO:1900121),0.4852924943937872,1.027605729925652,0.4551971326164875,0.974140468625047,1.0,1/10,1.78%,PTPRF
prerank,regulation of sprouting angiogenesis (GO:1903670),0.38283381343296957,1.0274588784265246,0.4180451127819549,0.9736272874175648,1.0,10/33,18.55%,CEACAM1;FGF1;CREB3L1;RHOJ;FGF18;CEMIP2;GLUL;ITGA5;JAK1;PDPK1
prerank,response to laminar fluid shear stress (GO:0034616),0.4832735627049557,1.027373856682747,0.437609841827768,0.972963018625966,1.0,4/10,12.28%,ASS1;MAPK7;ABCA1;NFE2L2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.30132142124394456,-1.0272769461990763,0.38870431893687707,0.793970126953697,1.0,21/39,26.21%,RPS15;RPS7;RPS27;NPM1;RPS24;RPS19;RPS16;RPS17;RRP7A;RIOK1;RPS6;MRPS11;RIOK3;UTP4;RPS27L;PWP2;WDR3;RPS14;ERAL1;RPS25;NOB1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.30446387385304224,-1.027151796170004,0.40540540540540543,0.7932054981860568,1.0,10/33,22.92%,LEF1;TRAF6;IL34;HAX1;ID2;HSF1;CSF1;CASP8;FES;RIPK1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.44475619515952247,1.026651133437258,0.425,0.9740908977147485,1.0,4/17,13.18%,COX5A;COX15;COX7C;COX5B
prerank,positive regulation of B cell activation (GO:0050871),0.3568871528855186,1.0263424440072952,0.40482573726541554,0.9740613425109225,1.0,13/50,17.63%,NFATC2;KMT5C;PTPRC;EPHB2;CD320;GPR183;CD81;IL7;PPP2R3C;SYK;BTK;MMP14;IRS2
prerank,negative regulation of ossification (GO:0030279),0.412601215036352,1.0260946786619365,0.4427001569858713,0.9738507766239396,1.0,2/23,4.05%,LRP4;SOX9
prerank,nucleotide biosynthetic process (GO:0009165),0.4270573719786548,1.0259123833008608,0.43760399334442596,0.9734053581674307,1.0,6/18,11.63%,MTHFD1;PPAT;NMNAT3;PRPSAP2;PRPS1;PRPS1L1
prerank,ganglioside metabolic process (GO:0001573),-0.34274493837982445,-1.0258155002837515,0.403899721448468,0.7957966609352074,1.0,8/20,22.46%,ST3GAL5;ST8SIA4;ST6GALNAC3;ABCA2;ST8SIA2;NEU3;ST6GALNAC4;CLN6
prerank,high-density lipoprotein particle assembly (GO:0034380),0.4879143214493404,1.025653728009295,0.44483985765124556,0.9732287539254507,1.0,4/10,17.49%,ABCA1;PRKACB;ZDHHC8;BMP1
prerank,cation transmembrane transport (GO:0098655),0.36832805294817833,1.0255895354354976,0.41609822646657574,0.972478809437212,1.0,6/44,5.22%,TRPM3;SFXN2;SLC29A4;CACNA1H;ATP1A2;SLC25A20
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3343425589629777,1.0255645750260716,0.43073047858942065,0.9716147703643369,1.0,14/75,13.51%,NR2F2;RGS14;STK38;NF1;SPRY1;SPRY4;IRAK3;PRKAR2A;PTPRJ;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.36237149443823535,1.0255179093767341,0.4195804195804196,0.970833150134785,1.0,14/42,20.18%,RARS2;TARS2;VARS1;CARS2;DARS1;KARS1;AIMP1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;TARS3
prerank,bone morphogenesis (GO:0060349),-0.3916233104006146,-1.025488281008552,0.41625615763546797,0.7955678366527351,1.0,4/14,7.80%,CYP26B1;BMPR2;FGFR2;LRP6
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.36245141164182804,1.024514211766371,0.4329608938547486,0.9727376437202427,1.0,9/46,10.91%,IL18R1;LAMA4;ZNF423;PLCL1;PCTP;ACOT13;HOXC10;LNPEP;DOCK7
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4722732711762836,1.0243764732794702,0.44424778761061945,0.9722231431434799,1.0,2/11,1.53%,NEDD4L;LEPROT
prerank,vasculogenesis (GO:0001570),0.38482172889910965,1.023797230262426,0.4480796586059744,0.9728887307543759,1.0,4/32,6.83%,CAV1;GLMN;SPRED1;EGFL7
prerank,regulation of vasculogenesis (GO:2001212),0.4504708833287589,1.0234782215009823,0.441747572815534,0.9729286851118272,1.0,2/14,1.89%,CEACAM1;RAP1A
prerank,ventricular septum development (GO:0003281),-0.3027008835522807,-1.0234563493234965,0.3944636678200692,0.800210578523717,1.0,10/37,12.75%,ROBO1;TGFBR3;SLIT2;TGFBR1;BMPR2;CITED2;PDE2A;PROX1;DAND5;TGFB2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.27255387487718075,-1.0229795228804806,0.3860294117647059,0.8003749783302947,1.0,21/51,25.08%,SMAD6;SKIL;SMAD9;BMPR2;SMAD5;CRIM1;GREM2;LEMD3;HTRA3;BMP2;DAND5;CHRDL1;BMPER;SMAD4;VWC2L;SMURF2;FSTL3;BAMBI;SMAD1;GREM1;NOTCH1
prerank,protein import into peroxisome membrane (GO:0045046),0.41583022283493115,1.0228185235509255,0.4475743348982786,0.9738530039918759,1.0,7/22,19.83%,RAB8B;FIS1;PEX2;PXMP2;ABCD1;SLC25A17;PEX13
prerank,cellular response to heat (GO:0034605),0.3745574627874261,1.0226944828472635,0.4233576642335766,0.9733120257147272,1.0,12/35,21.74%,FGF1;TRPV4;IL1A;BAG3;TPR;CLPB;HTRA2;YWHAE;SLU7;SUMO1;DAXX;RBBP7
prerank,anion transmembrane transport (GO:0098656),0.34231200689962604,1.022660303823148,0.4164490861618799,0.972492503475392,1.0,10/67,6.69%,LRRC8D;SLC35A1;SLC25A12;SFXN2;PRAF2;SLC27A1;ABCC1;SLC6A13;SLC35C2;SLC1A6
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.37187399073560945,1.0226417955023923,0.44154057771664373,0.9716392775521862,1.0,5/43,5.62%,KLF5;SPI1;FOXO3;SOX9;APLN
prerank,intermediate filament organization (GO:0045109),-0.36233623274662907,-1.022356275685705,0.40966921119592875,0.8009370755942785,1.0,5/17,14.52%,NEFL;BFSP2;GFAP;DES;VIM
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.33776177015103037,1.0223082450810608,0.4345006485084306,0.9716722944341776,1.0,15/63,19.72%,PLK2;GTSE1;CNOT10;ARID3A;FBXO31;SFN;CNOT7;RFWD3;SOX4;RGCC;TNKS1BP1;E2F1;CNOT8;CNOT1;BAX
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3389135865610377,1.022012177186688,0.43243243243243246,0.9715575075687207,1.0,12/73,11.27%,GLMN;MYBBP1A;TDG;SF3B1;SPI1;HDAC4;POLR1E;CTCF;MECP2;PPHLN1;ERCC6;HDAC6
prerank,regulation of cell differentiation (GO:0045595),0.3104733269527924,1.022004471110995,0.4330011074197121,0.9706724101154359,1.0,15/148,9.72%,NGF;FGFR1;DLX1;MBOAT2;RUNX2;NF1;FLOT2;PTHLH;BMPR1B;LTBP4;DAG1;DDX17;ISL1;RPS6KA3;PHLDB1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.38877581197199734,1.0218779922726853,0.4185692541856925,0.9700926772003953,1.0,11/29,21.16%,AXIN1;KANK2;ISL1;DDRGK1;UFSP2;CBFB;YAP1;KMT2D;VPS11;CNOT1;RUNX1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4147898155163237,1.0215743940048096,0.43956043956043955,0.9699945965981585,1.0,4/22,8.59%,LBP;PTPN22;TNFAIP3;ACOD1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.345828977133759,-1.0215297985225105,0.3875968992248062,0.8020605002146216,1.0,6/18,11.86%,ADCY1;RPS6KA5;CRTC3;LRP8;CD200;CRTC2
prerank,protein dephosphorylation (GO:0006470),0.314384154799289,1.0212674143282616,0.43827859569648925,0.9698931946275039,1.0,30/135,14.48%,UBASH3B;PTPN13;PTPRF;DUSP12;EYA1;PTPN14;TPTE;PTPN22;PTPRC;PPM1A;RPRD1B;PPM1M;MTMR7;RPAP2;PTPRJ;MTMR6;MTMR3;PDP2;PTPRT;RPRD1A;SDHAF2;CTDSP1;PPP2R1B;PTPN18;PTEN;PTPRA;DUSP8;CTDSP2;PTPRU;PTPRO
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.2600451358655428,-1.0209097830996086,0.4189189189189189,0.802635849822023,1.0,13/74,12.75%,PHLDB2;SMAD3;LEF1;EPHA3;DAB2;TGFBR1;MCRIP1;GLIPR2;TGFB3;VASN;BMP2;USF3;TGFB2
prerank,triglyceride catabolic process (GO:0019433),-0.36236977655054026,-1.020697088845451,0.4438202247191011,0.8020978399947466,1.0,9/19,43.46%,PNPLA3;FABP7;FABP3;FABP5;LIPH;LIPC;FABP4;PNPLA2;FABP12
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3550468120111044,-1.0204486365498293,0.42487046632124353,0.8016731111633802,1.0,8/18,24.87%,HIP1R;ACAA2;BID;GSK3A;BOK;CHCHD10;ZNF205;HSPA1A
prerank,positive regulation of biosynthetic process (GO:0009891),-0.2983522511928433,-1.0202630351916684,0.4061433447098976,0.8011285978831949,1.0,11/40,9.11%,CREBL2;BMP4;WNT4;LARP6;APOE;PLCG2;CYBA;TGFB3;AKT1;CREB1;GRIN1
prerank,L-amino acid transport (GO:0015807),0.3889253095389451,1.0201799141572327,0.43202416918429004,0.9720432896564098,1.0,7/28,13.00%,SLC25A12;SLC38A2;PRAF2;SLC1A6;SLC7A2;SLC25A13;SLC25A22
prerank,bile acid and bile salt transport (GO:0015721),0.4014373042058216,1.0201471223300798,0.43213728549141966,0.9712257022533721,1.0,2/24,1.94%,CEACAM1;ATP8B1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4157527047431747,1.0201037814900216,0.433489827856025,0.969525261018289,1.0,10/22,22.43%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4157527047431747,1.0201037814900216,0.433489827856025,0.969525261018289,1.0,10/22,22.43%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,positive regulation of gene expression (GO:0010628),0.2914835183504594,1.0200961277145024,0.46417759838546924,0.9686468887999359,1.0,61/442,11.60%,NGF;FGF7;NTRK3;PPARGC1A;FOXD1;CLDN19;GLMN;EGFR;MUSK;MYBBP1A;FGF1;BCL3;ITK;ADAM19;SLC26A9;CDH5;FXR2;SF3B1;SLC38A2;ITGAX;PIWIL2;TXK;IL1A;PRKAG1;WNT16;EIF2AK3;SOX9;CELF1;TFR2;PTPN22;WNT5A;FN1;EPHB2;KRAS;RIMS2;UBR5;POLR1E;RDX;CTCF;CRTAM;PTGER4;RBM22;OCLN;DYRK1A;NOS1AP;FGF18;AGO1;DDRGK1;PLSCR1;GSK3B;TICAM1;POU4F1;HILPDA;ADRA2A;METTL5;ERCC6;SRPK2;PLD1;UPF3B;EGR1;MED23
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.356212144392943,1.019974265324468,0.43699731903485256,0.9671753156518256,1.0,21/51,22.92%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,mitotic nuclear membrane organization (GO:0101024),0.356212144392943,1.019974265324468,0.43699731903485256,0.9671753156518256,1.0,21/51,22.92%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3968856392949208,-1.0192734921733284,0.42417061611374407,0.8027721034112263,1.0,7/13,38.12%,UBE2J1;OS9;DERL2;SVIP;BCAP31;EDEM1;UBAC2
prerank,response to hydroxyurea (GO:0072710),-0.40963398889815883,-1.0192432723798621,0.4377880184331797,0.8017528288735881,1.0,4/11,19.72%,BLM;DDI2;NSMCE3;TIMELESS
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.39248449783492706,-1.01910953662246,0.44072164948453607,0.8010359360205067,1.0,4/13,8.19%,IGF1;INSR;IGF2;AKT1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.406762444491379,1.0190576521027646,0.4439178515007899,0.9688348116953915,1.0,1/24,0.21%,ETV4
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4350432759727276,-1.0188839818836528,0.4527027027027027,0.8005662091435563,1.0,7/10,33.39%,DNAJB2;DNAJA4;HSPA1A;DNAJB1;HSPA1B;HSPA2;SORL1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4337917349084387,1.0187801223881994,0.4461028192371476,0.9687127390289667,1.0,3/17,9.49%,CXCL17;ANO6;HMGB1
prerank,endocytic recycling (GO:0032456),-0.2795447698782012,-1.0185677752014486,0.4052044609665427,0.8002871937678192,1.0,15/50,22.32%,VPS39;VPS35L;ENTR1;EPS15;RAB13;DENND1A;EIPR1;EHD4;MICALL1;STX6;RAB11FIP3;RAB11B;ANKRD27;RAB7A;ARL4C
prerank,negative regulation of hormone secretion (GO:0046888),-0.42487095426741883,-1.0185373499850545,0.4288990825688073,0.7992953150773964,1.0,3/10,17.29%,GJA1;RAB11FIP3;RAB11FIP1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.38149747926302235,1.0184732091423723,0.4273381294964029,0.9687046036912933,1.0,1/29,0.24%,CAV1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4220635423462505,1.018152716758552,0.45691056910569106,0.9686886783724924,1.0,9/19,23.75%,CHD8;POLR3G;ELL;BRF2;RPTOR;TENM1;ICE2;POLR3C;MTOR
prerank,negative regulation of type I interferon production (GO:0032480),0.36526798651583936,1.0180742728965613,0.4318488529014845,0.967996105677725,1.0,10/40,17.27%,UBE2L6;PCBP2;REL;TNFAIP3;ACOD1;NPLOC4;TAX1BP1;TBK1;RELB;ITCH
prerank,negative regulation of epithelial cell migration (GO:0010633),0.38518185293626445,1.018069748365224,0.43522561863173215,0.967120432825532,1.0,2/33,0.77%,DCN;NR2F2
prerank,positive regulation of protein processing (GO:0010954),-0.359136680444411,-1.0180474863199165,0.41237113402061853,0.7995962824301318,1.0,2/19,1.69%,CCBE1;CLEC3B
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.39511551017997537,-1.0178646606089663,0.44029850746268656,0.7990129616718864,1.0,2/13,6.74%,ETS1;TRAF6
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.458368266907271,1.0175780702645818,0.44919786096256686,0.9675894495890699,1.0,8/12,30.07%,CLCN2;RAN;MBTPS1;MBTPS2;SEC14L2;SREBF2;DGKQ;SREBF1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.35924370108471704,1.017238932674897,0.42265193370165743,0.9676186753078596,1.0,6/43,7.46%,LBP;PTPN22;IRAK3;TNFAIP3;SELENOS;RARA
prerank,positive regulation of cell growth (GO:0030307),0.32172673158489534,1.0172143549502968,0.44057623049219685,0.96679065467008,1.0,12/96,12.06%,NGF;NEDD4L;NTN1;EGFR;ADAM10;RIMS2;CPNE9;RPS6KA3;USP47;S100A9;INO80;SEMA4D
prerank,negative regulation of developmental process (GO:0051093),-0.26101531284864077,-1.017145719805423,0.4340425531914894,0.7998296855118784,1.0,20/69,18.40%,NFIB;ROCK2;OMA1;NOS3;BMP4;TFRC;GRIN3A;TBX1;CDK6;WDR77;SINHCAF;BMP2;FUZ;ARHGEF15;DCC;MAPT;SUZ12;RC3H1;WNT11;VASH1
prerank,regulation of T cell activation (GO:0050863),0.3704244183317479,1.0166562850654406,0.43437077131258456,0.9674518682604093,1.0,5/42,10.18%,TNFSF8;IL4I1;PTPN22;CRTAM;LAT
prerank,DNA modification (GO:0006304),0.3989429213274192,1.0166107030992597,0.4385692068429238,0.9666961767845346,1.0,3/22,5.32%,TDG;NTHL1;EXOSC5
prerank,alcohol catabolic process (GO:0046164),0.482589481281546,1.0164278319421127,0.4265232974910394,0.9663120414204118,1.0,1/10,1.67%,CEL
prerank,positive regulation of actin nucleation (GO:0051127),-0.41711593374274125,-1.0162474315952483,0.4569377990430622,0.8012575840127449,1.0,2/11,8.30%,WASF3;FCHSD2
prerank,cellular component assembly (GO:0022607),0.29813698047184295,1.0159389639362726,0.45215562565720296,0.9668119024417267,1.0,27/253,9.41%,MAGI1;PPARGC1A;PARVA;WIPF1;LAMC1;REPS2;PARD6B;CD3G;SPEF1;KMT2A;OPHN1;ADD1;SOX9;CDAN1;RAC2;WNT5A;CARD10;FANCC;TEX11;TAPBP;SHROOM2;SPAG17;RHOJ;OCLN;DARS1;CALD1;FOXJ1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3094137555078818,1.0158824920347387,0.43907793633369924,0.966071762330936,1.0,34/163,18.76%,TEC;NFATC2;ITK;CD3G;PDE4D;TXK;EIF2B3;PTPN22;PSME3;PTPRC;LCP2;PIK3R2;PTPRJ;PSMB5;LAT;TAB2;EIF2B4;CD276;PSMB2;PSMA2;PSMA6;PLEKHA1;PSMD13;PSMA7;NFKBIZ;SYK;BTK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,myelin maintenance (GO:0043217),0.47669797038122846,1.0158147187222624,0.4560530679933665,0.9653484294852246,1.0,5/10,22.23%,EPB41L3;ABCD1;PTEN;PRX;MYRF
prerank,heme biosynthetic process (GO:0006783),-0.33517330688325103,-1.0156872167088629,0.3923705722070845,0.8017116073395704,1.0,11/22,24.33%,ABCG2;SLC25A38;FECH;CPOX;FXN;ABCB10;ALAS1;UROD;HMBS;TSPO;ALAD
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4282267016623238,-1.0156406561142173,0.46,0.8007380501193442,1.0,6/11,35.97%,UQCRC2;CYC1;UQCRQ;UQCRFS1;UQCR10;UQCR11
prerank,protein homotetramerization (GO:0051289),0.3604941885231074,1.015579387386343,0.43741588156123823,0.9651376152281079,1.0,4/49,7.02%,ALDH1A3;ALDH9A1;ACOT13;ACACA
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.28702021447798,-1.0154510088338347,0.4160839160839161,0.8001342727565435,1.0,16/42,25.40%,SHLD2;ACTR2;ARID2;KDM1A;MMS19;POLQ;UBQLN4;PPP4R2;PARP1;TIMELESS;CGAS;MAD2L2;RMI2;RAD51;SMCHD1;PARPBP
prerank,spindle assembly checkpoint signaling (GO:0071173),0.41837144069731125,1.0154156382806725,0.434850863422292,0.962944724534503,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.41837144069731125,1.0154156382806725,0.434850863422292,0.962944724534503,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.41837144069731125,1.0154156382806725,0.434850863422292,0.962944724534503,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.31897958636680224,-1.0151678924767937,0.41411042944785276,0.799822710192996,1.0,8/29,9.00%,SHANK3;PLEKHH2;SLIT2;KANK3;HIP1R;TWF1;MYADM;CYRIB
prerank,response to ketone (GO:1901654),0.4025194222835574,1.0139465382600112,0.4346456692913386,0.9660560839435348,1.0,1/24,0.24%,CAV1
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.40330531656002244,-1.0139369215594265,0.43946188340807174,0.8022012396540423,1.0,9/12,32.05%,MCM6;CDC7;MUS81;MCMDC2;CDC45;MCM3;MCM7;MCM5;MCM2
prerank,regulation of immune response (GO:0050776),0.31082867481595655,1.0137035953752327,0.4583808437856328,0.965900228708537,1.0,22/135,16.49%,CXADR;HCST;CD3G;CD300LG;IL4I1;PTPN22;N4BP1;COL3A1;ITGB7;CRTAM;PLSCR1;CD200R1;COL1A1;LAIR1;CD276;CD81;ULBP1;SH2D1A;IL15;ZMPSTE24;LAG3;SYK
prerank,regulation of response to external stimulus (GO:0032101),0.3139876904973689,1.01361119499337,0.43283582089552236,0.9652635460321566,1.0,12/121,7.09%,CAV1;GUCA1A;ADAMTS12;PIK3AP1;CD55;CELF1;PTPN22;WNT5A;CNGB1;EPHB2;N4BP1;EFNB2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3038834148920963,1.0134711348617083,0.4642857142857143,0.9647422225587602,1.0,63/173,25.29%,DYNLL1;FOLR1;CAPZB;RAB29;CD55;TRAPPC3L;LMAN2;GOSR1;CNIH1;SPAST;ACTR10;ATL2;CUL3;COG6;GOLGB1;NRBP2;TFG;TMED4;GRIA1;DYNLL2;ANK1;PROC;COPE;GOLT1A;COPG1;TRIP11;TEX261;ZW10;COPA;TMED2;TICAM2;TBC1D20;TRAPPC3;ERGIC1;SPTBN1;ARCN1;STX5;COG3;BET1;DCTN2;SEC24B;NSF;DYNC1LI2;CNIH4;SPTB;USO1;COG5;DYNC1I1;TRAPPC8;SPTBN5;PGAP1;DCTN6;SEC13;F8;VAPA;ARF4;VAPB;DYNC1I2;SAR1A;SPTAN1;PEF1;WHAMM;LMAN1
prerank,endodermal cell differentiation (GO:0035987),0.38161114392790363,1.0134686967296977,0.4424778761061947,0.9638769937182715,1.0,9/31,17.35%,MMP15;ITGA7;LEO1;FN1;PAF1;MMP14;ITGA5;RTF1;SETD2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.42137472164440076,1.013317931154199,0.43211920529801323,0.9634327353658383,1.0,2/17,4.81%,TDG;NTHL1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.4763954310997981,1.0131271894130274,0.44363636363636366,0.9630963746042358,1.0,1/10,0.24%,CAV1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3515703579067461,1.0128676478263248,0.44794520547945205,0.9629287589893635,1.0,10/59,9.71%,CDH13;CEACAM1;MPZL2;CDH17;HMCN1;TRO;DSCAM;AMIGO2;CDH2;PTPRT
prerank,regulation of defense response (GO:0031347),-0.2522670785711486,-1.0127099268997302,0.3953488372093023,0.8044914404763774,1.0,21/76,17.73%,IL1R1;FOXP1;SEMA7A;APPL2;SAMHD1;LACC1;AREL1;AGTR1;APOE;LRP8;JAK2;ANXA1;USP18;IRF1;CASP12;TMSB4X;ERAP1;ACE2;CASP8;CASP4;SBNO2
prerank,cellular protein modification process (GO:0006464),0.2849553806062135,1.0123657797078032,0.4574574574574575,0.9634673200123622,1.0,209/983,18.42%,PIGU;TEC;PLK2;FAM20C;TRIB2;CDK15;GPC3;STC2;FGFR1;ST3GAL4;HCST;SLC35A1;PRKCE;PTPN13;UBE2L6;CAMK2D;LAMB2;LAMC1;CEL;PTPRF;FBXL15;UST;UBE2E2;SOCS5;CD3G;DUSP12;MINK1;B3GALT1;ASB6;STK38;MAP3K1;MMP15;TXK;LMO7;MAPK10;PTPN14;ERO1A;SCG3;PRKAG1;EIF2AK3;UBE2I;TPTE;BMPR1B;PTPN22;PRKCA;CDKL3;SPSB4;PEAK1;PSME3;NUCB1;CPE;MORC3;LIMK2;IRAK3;PTPRC;ACVR1C;KEAP1;FN1;PPM1A;EGLN3;PDK4;HIPK1;PIK3R4;BMP15;SUMF1;BRSK1;NEK7;FER;CDK13;BCKDK;COQ8A;ADAM10;SOCS6;PTP4A2;SIRT3;ATG5;PPM1M;ABL2;GOLM1;GMFB;COL3A1;CDK7;BMP2K;RAB3A;STK38L;RARA;FBXO31;CUL3;MTMR7;MAP3K5;RCN1;CDH2;SRPK1;PTPRJ;GCNT2;DYRK1A;NRBP2;CSNK1G3;MTMR6;PSMB5;DCAF13;MTMR3;PDP2;STK24;STK3;GSK3B;SIRT7;PTPRT;CSNK1A1;SDHAF2;TYK2;CTDSP1;SRPK2;ST8SIA5;ILF3;MANBA;FBXL19;PROC;PRKCSH;PPP2R1B;ST8SIA3;KLHL21;HS3ST5;FBXL5;PTPN18;MEN1;SGK1;LIPE;HUNK;FBXO11;PARP6;OARD1;DAD1;MAP3K21;PTEN;PTPRA;DUSP8;PRKACB;ATG7;SIK3;ERN1;FBXO21;LCMT1;PSMB2;P4HB;UBE2D3;STT3A;PSMA2;KLHL22;CTDSP2;PTPRU;PTPRO;CHM;FNTB;FEM1C;PSMA6;PARP8;CHRM3;CHGB;PIK3C3;WWP2;COPS5;NEK4;PTPN6;PSMD13;FBXW8;SERP2;CDKL2;PSMA7;MAN2A2;OGA;FBXO41;DDB2;ERBB2;TBK1;NEK11;TBCK;FBXL12;MBTPS1;SYK;FBXW7;BTK;FBXL3;PAK3;MAP3K9;PPP1CA;CUL4B;LMTK2;PP2D1;RNF7;DYRK2;PSME4;VCAN;CALU;FSTL1;BTBD6;WFS1;JAK1;PINK1;VGF;DAPK2;PTAR1;SOCS2;PSMC4;FBN1;ILKAP;COG3;PSMB6;PSMD12
prerank,cellular response to osmotic stress (GO:0071470),0.4131044596220129,1.0123198410582086,0.4459665144596651,0.9627410778426609,1.0,3/21,7.04%,LRRC8D;TRPV4;SLC4A11
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3614650763315616,-1.0120313605116422,0.43896103896103894,0.8052011240615583,1.0,4/17,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2953664105177131,-1.0117044676845566,0.4143835616438356,0.8050312245410631,1.0,11/39,13.91%,ROBO1;RBPJ;NOS3;EP300;CCN3;PDCD10;JAG2;SNW1;TM2D3;TGFB2;MAML3
prerank,regulation of macrophage differentiation (GO:0045649),-0.37210758567551894,-1.0114414707087556,0.4476439790575916,0.8046562544712663,1.0,7/15,22.92%,IL34;ID2;HSF1;CSF1;CASP8;INHBA;RIPK1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.32609310524133317,-1.0111940533166235,0.41846153846153844,0.8043200168973723,1.0,6/26,16.05%,PICALM;DNAJC6;AP2A1;FCHSD2;LMBRD1;FNBP1L
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.32343853471700157,-1.011111023104398,0.453125,0.8034858001976717,1.0,12/25,31.33%,ETS1;HIF1A;TAL1;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3;HSPA1B;ACVR2A
prerank,regulation of dephosphorylation (GO:0035303),0.44520403551708504,1.0111053028063515,0.44932432432432434,0.9653426687256423,1.0,7/15,26.87%,SRC;MTMR3;SMG7;MTMR1;SMG6;PPP1R16A;SMG5
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.39942490602489883,-1.0110567501004826,0.4552058111380145,0.8025439305517784,1.0,6/13,20.02%,ERLIN1;APOE;SCAP;BMP2;ERLIN2;DKK3
prerank,negative regulation of cell projection organization (GO:0031345),0.356565997469599,1.0109783879864709,0.4334705075445816,0.9648258806911898,1.0,11/48,14.48%,LPAR1;RAB29;RTN4R;TRPV4;EFNB2;SEMA3A;KANK1;HDAC2;RTN4RL1;PTEN;PTPRO
prerank,response to steroid hormone (GO:0048545),0.3822245999989165,1.0105577939352663,0.44285714285714284,0.9651570628769872,1.0,3/31,7.19%,CAV1;ATP1A2;CATSPERD
prerank,regulation of phospholipase activity (GO:0010517),0.4819933190529852,1.0105168985803967,0.46,0.9644107998327934,1.0,1/10,0.70%,FGFR1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.31250721001180115,1.0103619963594486,0.4431687715269805,0.9639755638507941,1.0,21/128,10.56%,F11R;INHBB;PXN;CDH5;RUNX2;BMPR1B;SRC;BMP5;ACVR1C;BMP15;ZFYVE16;RGMB;TGFBRAP1;COL3A1;GCNT2;LTBP2;CGN;FERMT2;LEFTY1;FNTA;ZYX
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3825567733501709,1.0100147630999794,0.44942196531791906,0.9640241889633228,1.0,7/31,14.31%,SIPA1L1;PPFIA2;LZTS3;SRCIN1;RELN;PTEN;CAPRIN2
prerank,protein monoubiquitination (GO:0006513),0.36845552059443765,1.0100078473884004,0.4458874458874459,0.9631722941681314,1.0,15/36,23.22%,LEO1;TRIM21;PAF1;CUL3;UBE3D;OBI1;UBE2D3;KLHL22;FANCL;UBE2R2;UBE2W;CDC73;PRKN;RNF20;DTX3L
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.40397553399892394,1.0099224516248098,0.46504559270516715,0.9616589022286185,1.0,11/23,24.31%,PPP1R13B;SFN;BAD;NMT1;YWHAG;YWHAE;E2F1;MAPK8;TFDP1;YWHAB;YWHAQ
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.40397553399892394,1.0099224516248098,0.46504559270516715,0.9616589022286185,1.0,11/23,24.31%,PPP1R13B;SFN;BAD;NMT1;YWHAG;YWHAE;E2F1;MAPK8;TFDP1;YWHAB;YWHAQ
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3616270639875984,1.0098763304815013,0.4311797752808989,0.9609323802670914,1.0,6/41,7.46%,LBP;PTPN22;IRAK3;TNFAIP3;SELENOS;RARA
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.36662687171501146,-1.009719286748832,0.4198895027624309,0.8050949237757791,1.0,3/16,2.25%,ST3GAL5;ST8SIA4;ST6GALNAC3
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4065078629609056,-1.0096164021949567,0.42857142857142855,0.8043005338181218,1.0,8/12,32.67%,UNC13C;SYT7;UNC13A;RIMS1;RIMS3;SYT1;SYT5;DOC2B
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.32619300258310996,1.009461265228796,0.4542079207920792,0.9611891382492986,1.0,26/84,18.76%,PSME3;FBXO31;FBXO5;CUL3;CDC20;PSMB5;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;PSMB2;UBE2D1;PSMA2;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3098669537987173,1.0092624765735476,0.4557823129251701,0.9608760623334878,1.0,41/128,22.51%,DYNLL1;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;NEDD1;CDK7;PHLDA1;TUBG1;CKAP5;PAFAH1B1;CCP110;MASTL;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;LCMT1;PCM1;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;CEP57;BACH1;OFD1;CEP250;DCTN2;ALMS1;TAF2;HAUS8;CEP43;FBXW11;BORA;HAUS3
prerank,negative regulation of lyase activity (GO:0051350),-0.3684590440368939,-1.0092362963394563,0.4558139534883721,0.8042818280232554,1.0,2/16,2.36%,ADGRV1;GRM3
prerank,receptor metabolic process (GO:0043112),0.34672996121441835,1.0090307751480236,0.4392156862745098,0.960667432758761,1.0,7/53,5.29%,CAV1;ACKR3;PHETA2;CD9;DNM1;KIF16B;PIK3R4
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3824243331889566,-1.0089086530197997,0.42081447963800905,0.8040670404055502,1.0,2/13,1.37%,PLXNA2;PLXNA4
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.33222168520002004,1.0088818406342135,0.449438202247191,0.9601829478314857,1.0,6/73,6.99%,NGF;DLC1;EIF2AK3;EGLN3;TRADD;NLRC4
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.32599439701360866,-1.008773066426431,0.42696629213483145,0.8033683758150784,1.0,11/24,24.87%,NR1H3;NR1H2;AQP11;SYVN1;LRRK2;OPA1;RACK1;XBP1;CLU;TMBIM6;HSPA1A
prerank,establishment of protein localization to organelle (GO:0072594),0.335067893965985,1.0083654263102821,0.4574742268041237,0.9607806717424578,1.0,28/72,26.57%,PRICKLE1;HK2;IPO8;LRSAM1;NUP62;FAM53B;LAMP1;TPR;MMP12;NUP50;CSE1L;NUP153;RAN;NUP93;SYK;PINK1;LAMP2;RPAIN;RALA;TSC2;SEC13;SPRN;IPO13;PTTG1IP;CD68;NUP188;RANBP17;TNPO1
prerank,negative regulation of inflammatory response (GO:0050728),0.2984363412419153,1.0083126462007383,0.45714285714285713,0.9600563068175919,1.0,19/182,9.01%,RORA;PLK2;CD3G;CDH5;CXCL17;MC5R;FNDC4;PTHLH;SRC;ADCY5;TNFAIP3;SELENOS;MAPK7;PTGER4;PRKAR2A;ISL1;ACOD1;TSHR;CD200R1
prerank,isotype switching (GO:0045190),0.4838114985367221,1.008178829304279,0.4686971235194585,0.9595811720780197,1.0,3/10,16.40%,MSH6;MSH2;BATF
prerank,icosanoid biosynthetic process (GO:0046456),0.4697549462907664,1.0081076284904977,0.4679715302491103,0.9589409006870435,1.0,4/10,22.80%,MGST2;LTA4H;FADS1;PLA2G4A
prerank,mRNA splice site selection (GO:0006376),0.3813073255703844,1.0080949836383502,0.43623188405797103,0.9581200992279214,1.0,11/30,24.14%,CELF1;CELF2;CELF4;LUC7L2;SFSWAP;SF1;SLU7;SRSF12;SRSF10;YTHDC1;PUF60
prerank,phasic smooth muscle contraction (GO:0014821),-0.40687001163014164,-1.008001305137954,0.43665158371040724,0.8044320727104178,1.0,3/10,24.12%,EDN1;EDN3;HTR2B
prerank,sphingolipid metabolic process (GO:0006665),0.317409735024123,1.007740757934423,0.47306791569086654,0.9582290999141977,1.0,16/108,8.73%,SGMS2;CERS6;ACER3;ELOVL5;PLPP2;TEX2;PLPP3;ALOXE3;SUMF1;CLN8;HACD4;CERK;ELOVL1;NEU1;ELOVL2;CERT1
prerank,transferrin transport (GO:0033572),-0.3032520229954981,-1.00716342326558,0.45017182130584193,0.8055391881593055,1.0,11/33,22.14%,STEAP3;TFRC;ATP6V0A4;ARHGAP1;ATP6V0C;ATP6V1C1;HFE;ATP6V1D;RAB11B;ATP6V1F;ATP6V1E1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.29199756646770936,-1.0069489863821561,0.41134751773049644,0.8050692073192403,1.0,20/38,37.41%,PCGF2;PHC3;BMI1;RYBP;CDC7;SUZ12;EED;EHMT2;RAD51;L3MBTL2;BRCA1;RNF2;PCGF6;RING1;MAX;E2F6;CDKN2B;EHMT1;DAB2IP;PHC1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4089737639316932,-1.006202343025968,0.4382284382284382,0.8060238336604996,1.0,4/11,13.76%,LYN;MFHAS1;CYBA;PJA2
prerank,positive regulation of potassium ion transport (GO:0043268),-0.28902331114112445,-1.0059921308558388,0.44481605351170567,0.8055009787204251,1.0,9/38,10.43%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;KCNJ10;FLNA;KCNN2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.368596702075872,-1.0059387669948108,0.45,0.8045849095663852,1.0,4/16,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.2954965552731834,-1.0055318093778505,0.42813455657492355,0.8046119770198554,1.0,6/36,7.19%,MECOM;FOXO1;SIRPA;DUSP10;DUSP3;IGBP1
prerank,positive regulation of immune effector process (GO:0002699),0.39452613855843155,1.0050548434203879,0.44242424242424244,0.9648064411493144,1.0,4/27,12.38%,LBP;PTPRC;PTPRJ;CD81
prerank,nuclear membrane reassembly (GO:0031468),0.34859060563424293,1.0050443707259609,0.4624664879356568,0.9639867810076328,1.0,21/54,22.92%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,negative regulation of wound healing (GO:0061045),0.38541154348499773,1.0050159944855233,0.4518950437317784,0.9632092605281983,1.0,4/28,3.14%,CLDN19;SLC12A2;AJAP1;CASK
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.28736800146235025,1.0049590171795506,0.483248730964467,0.9625069540247281,1.0,57/417,11.94%,MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;FOXP2;ZNF423;FOXD1;ATP8B1;MYBBP1A;BCL3;RUNX2;RBFOX2;SFMBT2;CIART;SPI1;L3MBTL3;FOXK1;SOX9;UBE2I;GLIS2;CHD8;KAT6B;HDAC4;LANCL2;KLF10;WNT5A;CREB3L1;RBM15B;HEYL;SP3;BHLHE40;RCOR3;CTCF;NCOR1;TBX2;RARA;SUV39H1;KCTD1;FOXK2;UIMC1;TSC22D4;MECP2;RORB;USP47;HDAC2;CNOT7;ZHX1;NCOR2;ILF3;HDAC6;HEXIM1;ZNF148;MEN1;KDM8
prerank,microtubule anchoring (GO:0034453),0.44263091446091507,1.003802135800702,0.4413793103448276,0.9648579693623051,1.0,3/12,13.86%,DAG1;GCC2;PCM1
prerank,pore complex assembly (GO:0046931),0.42146076200136107,1.0037201557983433,0.4494195688225539,0.9642399225649818,1.0,9/19,15.46%,ANO6;ADAM10;TPR;AHCTF1;NUP153;GSDMD;RTN4;BAD;NUP93
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3392813670933922,1.0034794557927074,0.44689119170984454,0.9640540711042541,1.0,14/66,13.19%,EGFR;CCND3;ADAMTS1;UBE2E2;WEE1;PSME3;DACT1;KANK2;RDX;APC;INO80;PTEN;PKD1;FHL1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.41819505841794324,1.0033715666609102,0.48366013071895425,0.9634932124570801,1.0,1/18,0.54%,INHBB
prerank,negative regulation of protein depolymerization (GO:1901880),-0.32968407278524253,-1.0031957618070055,0.45058139534883723,0.8099711868041024,1.0,6/24,14.68%,PLEKHH2;ARHGEF2;STMN2;CAMSAP1;APC2;MID1IP1
prerank,glial cell development (GO:0021782),0.38457171927090433,1.0031307267928393,0.4535768645357686,0.9632720014879445,1.0,7/25,16.87%,NF1;EIF2B3;S100A9;EIF2B4;NSUN5;SOX4;MDK
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2893403988588397,1.0027512550364628,0.48390446521287644,0.9634134749788366,1.0,52/291,16.38%,RORA;LBP;PXN;FOLR1;EGFR;RAPGEF3;RAP1A;SSTR1;TNIP3;GPLD1;IL1A;MPV17;SOX9;ATP2B4;WNT5A;PDK4;FER;TNFAIP3;NRIP1;ABL2;SELENOS;PAF1;BRINP1;DEFA6;ACOD1;TSHR;IRGM;CHMP5;HMGB1;RORB;TICAM1;POU4F1;AXL;EGR1;NCOA3;NFKBIB;WNT9A;AQP1;CAPN2;RRAGB;HTRA2;KCNK4;FZD7;LCOR;GPER1;CCR5;CCDC62;CPEB3;TICAM2;PLAA;TESC;EZR
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.43981587930697874,1.002608832538392,0.4794520547945205,0.9629841119671497,1.0,2/15,2.68%,PPARGC1A;ELOVL5
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4030971689381949,-1.0025479780001458,0.4419134396355353,0.8107299282415678,1.0,7/11,43.24%,GRK3;ADM;ARRB2;DRD3;ADRB3;ARR3;SAG
prerank,regulation of B cell activation (GO:0050864),0.3988618460124721,1.002460625419223,0.4723076923076923,0.9625563267102641,1.0,5/25,13.32%,IL4I1;BANK1;TNFAIP3;FOXJ1;ZFP36L2
prerank,eosinophil migration (GO:0072677),-0.3736011190599656,-1.0020564100027873,0.4517766497461929,0.809911497762981,1.0,11/14,51.71%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.3736011190599656,-1.0020564100027873,0.4517766497461929,0.809911497762981,1.0,11/14,51.71%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.24609224954846207,-1.0019019660247628,0.42702702702702705,0.8092558830315285,1.0,19/93,13.76%,PLCB1;SASH1;TNFRSF19;CCN2;MFHAS1;SH3RF3;XDH;PDCD10;ANKRD6;TRAF6;ARL6IP5;MAP3K10;ZC3H12A;BMP2;TAOK2;FLT4;TGFB2;SPHK1;PJA2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3291709630679139,1.0018598208435705,0.47782002534854245,0.9633005666178742,1.0,12/76,12.80%,TRIB2;PRICKLE1;AXIN1;SOCS5;SH3RF2;KEAP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B;PTEN
prerank,sensory perception of sound (GO:0007605),0.3254998025140228,1.001708361587758,0.47146401985111663,0.9628633852834451,1.0,5/88,4.62%,ROR1;HOMER2;RIPOR2;EYA1;TMC2
prerank,regulation of protein kinase B signaling (GO:0051896),0.2996375960309226,1.0016186424945943,0.49032258064516127,0.9622544208112883,1.0,21/193,10.07%,GAB1;FGF7;NTRK3;FGFR1;PIK3AP1;EGFR;FGF1;PHLDA3;TPTE;SRC;RAC2;BANK1;DAG1;PHLPP1;PIK3R2;PTPRJ;GCNT2;FGF18;GAB2;AXL;FERMT2
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3802635312911241,-1.0014204915655294,0.45012165450121655,0.8094530443162931,1.0,6/14,18.01%,ADGRV1;MYADM;GPD1L;FLT4;WNT11;CD40
prerank,potassium ion transmembrane transport (GO:0071805),0.30611765967397325,1.0011453770814447,0.4666666666666667,0.9627309862630716,1.0,18/135,11.18%,KCNJ4;NALCN;SLC12A2;KCNA5;KCNJ16;SLC24A1;SLC12A4;KCNS2;SLC12A3;KCNK1;ATP1A2;KCNJ13;KCNK5;ATP1B3;KCNS3;KCNAB1;SLC9A7;SLC9A6
prerank,intracellular cholesterol transport (GO:0032367),-0.37799533115797723,-1.000617898861313,0.48081841432225064,0.8105084626887733,1.0,5/15,14.28%,LDLR;LRP6;LDLRAP1;VPS4A;ABCG1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4478850747500513,1.0002589314762949,0.47068676716917923,0.9642369203844704,1.0,1/12,0.98%,IL18R1
prerank,protein prenylation (GO:0018342),0.46288094363410237,1.0001489044614869,0.44285714285714284,0.9636873564366426,1.0,4/10,18.12%,FNTA;CHM;FNTB;PTAR1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.31016795144228043,0.9997444384706576,0.46136363636363636,0.96393052434918,1.0,9/122,3.28%,SMOC2;GLI1;SORBS1;EGFR;BCL3;HSPH1;FXR2;GLI2;PIWIL2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3702018911535103,0.9995966358747377,0.45588235294117646,0.9634844456766863,1.0,13/38,20.41%,LEPROT;ABLIM3;RAC2;SIAH3;HTRA2;UBE2J2;UBE2D3;FBXW7;VPS11;CSNK2A2;PINK1;UBL5;PRKN
prerank,positive regulation of actin filament polymerization (GO:0030838),0.35337160862834377,0.9994637651263901,0.4483695652173913,0.962972937461552,1.0,12/44,21.99%,PRKCE;CDC42EP4;FER;NCK2;ARF6;CTTN;CDC42EP3;BAIAP2;PFN2;NCK1;TENM1;HCK
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.31643393919274787,0.9993118953958802,0.47539015606242496,0.9625505183495441,1.0,24/101,16.38%,VGLL4;CYFIP2;BCL3;OGT;FXR2;PIWIL2;DACT1;RDX;PERP;HDAC2;IST1;METTL5;PLD1;UPF3B;FAF1;NSUN5;ATG7;SOX4;FXR1;PYM1;BAD;CPEB3;ERBB2;EZR
prerank,regulation of dendrite development (GO:0050773),0.3638386210339721,0.999064784193428,0.437410071942446,0.9624021754384537,1.0,7/37,12.06%,NEDD4L;COBL;BMP5;GSK3B;SARM1;NEDD4;SEMA4D
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.28809226486696127,0.9987265971306339,0.5092402464065708,0.9624195832093018,1.0,80/327,21.50%,RORA;BNC2;NFATC2;PPARGC1A;ZNF423;EFEMP1;MYBBP1A;NFIA;CHD3;SPI1;KAT6B;SP3;BHLHE40;ONECUT1;TGFBRAP1;PPIE;HIC1;ZNF431;LIN54;RREB1;MSL3;ELAVL2;ZNF628;FOXK2;POFUT1;MLF2;ACTR8;RORB;SUPT4H1;TRRAP;TFEB;USP13;WWC1;SAP30L;MZF1;MED23;JMJD1C;SPIN1;CREBBP;NCOA2;SOX4;SFPQ;BAZ2A;FZD7;REXO4;TAF5;KMT2D;SRRT;DMTF1;PSPC1;E2F1;ESRRA;HP1BP3;MAGED1;MTF2;BACH1;CREM;CELSR2;FOXO4;ASCC2;SPTY2D1;FADS1;ASCC1;PPP2CA;TCF7L1;TCF3;HNRNPD;ZNF22;HCFC2;HMG20A;GZF1;DDIT3;RNF14;ARNT2;ATXN1L;ZSCAN21;DAXX;CCAR2;SRSF10;FOXC1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.42846520967517265,0.9984339060001624,0.4402618657937807,0.9623962343392706,1.0,3/15,10.44%,IL4I1;AADAT;GSTZ1
prerank,positive regulation of exosomal secretion (GO:1903543),0.4369063710524163,0.9984230503057747,0.46766169154228854,0.9616014227726761,1.0,7/15,25.37%,TSG101;SDC1;PDCD6IP;SDC4;CHMP2A;SNF8;STAM
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2956845698572738,0.9979653242152982,0.5,0.9619772505393313,1.0,19/234,6.99%,EDA;CAV1;ROR1;PPARGC1A;IL18R1;RIPK4;FZD2;LPAR5;CRTC1;FLOT2;PLPP3;HDAC4;IRAK3;WNT5A;FER;TRADD;ARHGEF5;TRIM21;NLRC4
prerank,regulation of fatty acid metabolic process (GO:0019217),0.4284923421031284,0.9977729757100683,0.44353518821603927,0.9616740628983033,1.0,3/17,6.94%,CAV1;PDK4;NCOR1
prerank,synaptic vesicle endocytosis (GO:0048488),0.3766661438682692,0.9977618551340525,0.46480938416422285,0.9608689513481626,1.0,13/33,22.12%,CEL;STX1A;OPHN1;DNM1;STON1;STON2;SNCG;PACSIN1;AMPH;VAMP2;ITSN1;NLGN3;NLGN2
prerank,regulation of protein localization to nucleus (GO:1900180),0.3510772596237255,0.9976407831236007,0.47527472527472525,0.9603352973110223,1.0,11/43,15.73%,GTSE1;EIF2AK3;LIMK2;CARD10;GSK3B;FERMT2;TPR;OTUD7B;GLUL;CTNNA1;YAP1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.34100916041881574,0.9976387614062817,0.47244094488188976,0.9595108540665138,1.0,10/57,9.49%,USP50;CYFIP2;CIDEB;FIS1;ACVR1C;UACA;NLRC4;PERP;MAP3K5;HMGB1
prerank,regulation of gene expression (GO:0010468),0.2809480220513342,0.997620525232707,0.525,0.9587396484708146,1.0,112/903,11.79%,NGF;RORA;BNC2;AHNAK;FGF7;NTRK3;NFATC2;STC2;PPARGC1A;AFF3;ZNF423;FOXD1;CLDN19;EFEMP1;GLMN;MUSK;AHNAK2;MYBBP1A;FGF1;ADAM19;SLC26A9;CDH5;TDG;NFIA;COQ7;CLK1;SLC38A2;ITGAX;CHD3;SFMBT2;TXK;PCBP2;IL1A;SPI1;PRKAG1;WNT16;EIF2AK3;FLOT2;PTHLH;SOX9;CELF1;PGR;PTPN22;DIP2A;KAT6B;HDAC4;REL;ATP2B4;WNT5A;PTPRC;ATXN7L3B;CREB3L1;FN1;ZNF326;SON;SP3;BHLHE40;APLN;ONECUT1;TAPBP;ADAM10;TGFBRAP1;C1D;PPIE;EPHB2;KRAS;TRIM21;RIMS2;UBR5;RDX;CTCF;HIC1;ZNF431;CLK4;LIN54;RREB1;MSL3;IGF2BP2;ELAVL2;OCLN;ZNF628;GCNT2;FOXK2;NOS1AP;ZNF462;FGF18;AGO1;POFUT1;DDRGK1;MLF2;PLSCR1;MECP2;GSK3B;ACTR8;RORB;TICAM1;SUPT4H1;POU4F1;CNOT7;TRRAP;PTBP3;TFEB;USP13;SRPK2;WWC1;SAP30L;HDAC6;EGR1;MZF1;MED23;ZNF148;JMJD1C
prerank,stem cell differentiation (GO:0048863),-0.2834858588781045,-0.9972190356482686,0.45660377358490567,0.8186393555948503,1.0,8/39,8.66%,OSR1;KIT;FGFR2;HOXB4;ACE;PSMD11;LRP6;JARID2
prerank,sulfur compound transport (GO:0072348),0.3831721822473871,0.9971260056060631,0.42835820895522386,0.959226011235939,1.0,5/27,5.55%,LRRC8D;RACGAP1;SLC35B2;SLC27A1;SLC6A13
prerank,negative regulation of immune response (GO:0050777),0.30111901360705207,0.9969708265083165,0.4576271186440678,0.9588216923242799,1.0,18/154,9.33%,PLK2;CD3G;MC5R;PCBP2;SPI1;PTHLH;SRC;IRAK3;ADCY5;FER;TNFAIP3;TRIM21;COL3A1;PTGER4;PRKAR2A;ACOD1;TSHR;TRAFD1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.39090110811162726,-0.9969350256009034,0.45,0.8183506507740118,1.0,5/12,29.81%,RPL26;KDM1A;MIF;TAF9;TRIAP1
prerank,negative regulation of biosynthetic process (GO:0009890),0.42461842248525683,0.9967864896962825,0.46645367412140576,0.9584632903599051,1.0,6/16,20.67%,CEACAM1;ABCD1;ABCB7;GPER1;COA8;IL6
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.43664986063699845,0.9967113376522506,0.46740858505564387,0.9578344117613106,1.0,3/15,13.46%,HOMER2;GRM1;HOMER3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3935283744839986,0.996616972007804,0.45395799676898224,0.9572638490240077,1.0,5/21,9.04%,CAMK2D;PDE4D;FKBP1B;ATP1A2;CASQ2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3937203276828486,0.9965855537653391,0.4572713643178411,0.9565170691644478,1.0,7/25,14.38%,LEPROT;CHMP5;CHMP4A;CHMP4B;CHMP4C;LEPROTL1;LAPTM4B
prerank,regulation of protein dephosphorylation (GO:0035304),0.3637460706139473,0.996377736998672,0.4606413994169096,0.9562407385783999,1.0,14/37,24.11%,DLC1;CDH5;ENSA;PTPA;HTT;PPP6R3;SYMPK;PIN1;PPP6R1;CALM2;CDCA2;YWHAB;PPP6R2;PRKCD
prerank,mitochondrial RNA metabolic process (GO:0000959),0.435219709473372,0.9961793956627207,0.45805369127516776,0.9559680978020796,1.0,5/14,14.41%,FOXO3;TFB2M;MTERF2;TEFM;FASTKD1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.28890641630114977,-0.9957261042019863,0.4542483660130719,0.8205500288941463,1.0,10/36,19.72%,MAP3K20;USP28;ATRIP;HINFP;CLSPN;RAD1;TIPIN;RAD17;RAD9B;TIMELESS
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.34957813141450467,-0.995625182663668,0.46005509641873277,0.8198083398905728,1.0,1/19,0.12%,IGF1
prerank,negative regulation of protein binding (GO:0032091),0.33142722096119154,0.9954081373774096,0.47191011235955055,0.9572014401148154,1.0,5/71,5.27%,CAV1;EFHB;PTPRF;DACT1;STYX
prerank,regulation of p38MAPK cascade (GO:1900744),0.3670848597204915,0.9953114533857665,0.4484240687679083,0.9566539263105395,1.0,6/35,8.02%,RELL1;MINK1;SPI1;PTPN22;ULK4;PHLPP1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4006130868887028,0.9952407875523533,0.47129909365558914,0.9560022867973414,1.0,2/20,4.33%,PPARGC1A;DIP2A
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3387933644068104,-0.9952380780665269,0.45910290237467016,0.8198357381730349,1.0,10/20,27.94%,ENTPD1;TXNIP;IL18;P2RX7;P2RX4;ENTPD5;C3;SUGT1;PYCARD;CASP1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.47168114078810464,0.9946906586424763,0.46996466431095407,0.9566611045332354,1.0,3/10,8.54%,DPYS;UPP2;NT5E
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4300347684662411,0.9946550370862675,0.48031496062992124,0.9559465206217457,1.0,2/16,1.86%,PLCB3;KLK2
prerank,protein phosphorylation (GO:0006468),0.28308439357309734,0.9944998561876102,0.5015228426395939,0.9555347347510447,1.0,76/479,13.55%,PKDCC;TEC;PLK2;FAM20C;TRIB2;CDK15;FGFR1;HCST;PRKCE;CAMK2D;EFEMP1;EGFR;MUSK;MINK1;STK38;MAP3K1;TXK;MAPK10;PRKAG1;EIF2AK3;BMPR1B;PRKCA;CDKL3;PEAK1;SRC;MORC3;LIMK2;IRAK3;ACVR1C;PDK4;HIPK1;PIK3R4;BRSK1;NEK7;TLR7;FER;CDK13;BCKDK;COQ8A;ADAM10;EPHB2;ABL2;GMFB;CDK7;BMP2K;STK38L;RARA;MAP3K5;SRPK1;DYRK1A;NRBP2;CSNK1G3;CAD;STK24;STK3;GSK3B;RPS6KA3;MASTL;CSNK1A1;TYK2;RELN;SRPK2;ILF3;TOP1;HTATIP2;SGK1;LIPE;HUNK;MAP3K21;PKD1;USP15;PRKACB;SIK3;ERN1;GTF2H1;CIT
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.32968424543548636,0.9944024610139931,0.46114649681528663,0.9549637974601882,1.0,9/70,8.13%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,regulation of exosomal secretion (GO:1903541),0.41917100035548266,0.993984446498063,0.47208931419457734,0.9552179711002603,1.0,9/19,25.37%,TSG101;SDC1;PDCD6IP;ATP9A;SDC4;PRKN;CHMP2A;SNF8;STAM
prerank,positive regulation of cell cycle process (GO:0090068),-0.24206875923097337,-0.9935592778300234,0.4277456647398844,0.8234070164709901,1.0,9/91,3.96%,IGF1;INSR;TGFA;PDGFRB;SVIL;MAP3K20;CDC42;IGF2;USP19
prerank,cellular response to hydroxyurea (GO:0072711),-0.4136617740614251,-0.9933401189423599,0.463302752293578,0.8229583707292004,1.0,4/10,19.72%,BLM;DDI2;NSMCE3;TIMELESS
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3632388255591916,-0.993147399453678,0.48470588235294115,0.822416443362976,1.0,7/16,22.54%,SOX5;HOXB4;SOX6;TGFB2;DHX36;PTN;SP7
prerank,regulation of epithelial cell migration (GO:0010632),0.3482601505159514,0.99300556599554,0.4509283819628647,0.9570619378405804,1.0,8/51,7.32%,DOCK5;PRKCE;CEACAM1;DOCK1;SOX9;SRC;RHOJ;RREB1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3272749751914708,0.9929361199468779,0.47191011235955055,0.9564441218273595,1.0,25/73,21.62%,LMO1;KMT2A;SPI1;PSME3;PUS7;PSMB5;PSMB2;CBFB;PSMA2;PSMA6;PDCD2;KITLG;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;RUNX1;FOXC1;PSMB3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4101341463425297,0.9919181785189539,0.48012718600953896,0.9582966618299145,1.0,8/18,20.67%,SPI1;SRC;FER;IL6ST;YAP1;JAK1;ST18;IL6
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.46577841176114343,0.9918579359293075,0.47368421052631576,0.9576533785849687,1.0,2/10,6.14%,WNT5A;ADAM10
prerank,T cell receptor signaling pathway (GO:0050852),0.3068111250425647,0.9918421238023211,0.48536036036036034,0.9568791823528339,1.0,30/138,18.76%,TEC;ITK;CD3G;PDE4D;TXK;EIF2B3;PTPN22;PSME3;PTPRC;LCP2;PIK3R2;PTPRJ;PSMB5;LAT;TAB2;EIF2B4;CD276;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;NFKBIZ;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3547138926648269,-0.9917900144595564,0.4822888283378747,0.8250086199906105,1.0,5/18,12.82%,CCT7;CORO2B;CEP135;CCT8;CEP120
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3959726971605787,-0.9911240666776228,0.47255369928400953,0.8257595324952703,1.0,4/11,19.63%,STMN1;NRP1;MST1R;BCAR1
prerank,cholesterol biosynthetic process (GO:0006695),-0.3069520941731887,-0.9910715214630196,0.4709480122324159,0.8248426999021222,1.0,10/31,19.79%,INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7
prerank,negative regulation of neurogenesis (GO:0050768),0.3691000269175208,0.9908481383211237,0.4743777452415813,0.9587353879126387,1.0,8/34,14.25%,LRP4;NF1;RTN4R;GDI1;HOOK3;PTEN;PCM1;RTN4
prerank,postreplication repair (GO:0006301),0.3539896225616626,0.9905117191231877,0.485054347826087,0.95879116480185,1.0,6/45,7.45%,UBE2L6;USP43;POLI;RFC3;UBE2V2;MSH2
prerank,negative regulation of cellular protein localization (GO:1903828),0.36200224870482944,0.9904684918482063,0.471004243281471,0.9581075998875651,1.0,4/34,3.65%,NEDD4L;RIPOR2;LEPROT;SPI1
prerank,cellular response to BMP stimulus (GO:0071773),0.3316322089266068,0.9897293791114148,0.46981627296587924,0.9592337068211358,1.0,9/66,5.67%,DLX1;ADAMTS12;RUNX2;SOX9;BMPR1B;BMP5;BMP15;ZFYVE16;RGMB
prerank,positive regulation of reproductive process (GO:2000243),0.37420433997722313,0.9897213167594152,0.481962481962482,0.9584408556513251,1.0,3/31,6.64%,INHBB;CACNA1H;LHFPL2
prerank,cellular response to interleukin-1 (GO:0071347),-0.22314980239388588,-0.9892567035506514,0.4351851851851852,0.8286244082436409,1.0,18/143,8.53%,PLCB1;IL1R1;PTGIS;IL1RAP;PSMA1;RPS6KA5;SQSTM1;SIRPA;IRAK4;RBX1;HIF1A;PSMD11;GBP3;TRAF6;UBE2N;NOD1;PSMD7;PSMD4
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3274496309122252,0.9892108406704405,0.4664131812420786,0.9589255110509954,1.0,9/71,8.13%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3991890516399545,-0.9890555187966342,0.47294117647058825,0.828109015470032,1.0,5/11,30.79%,KCNJ2;ATP1B1;KCNH2;ATP1A1;KCNQ1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.39574188958423395,-0.9887632575745977,0.4702842377260982,0.8278443593449216,1.0,4/12,8.19%,IGF1;INSR;IGF2;AKT1
prerank,axon guidance (GO:0007411),0.2915275665013056,0.9887526834328856,0.5080042689434365,0.9593073739111065,1.0,25/201,7.45%,GAB1;EFNA5;LAMA2;NTN1;EFNB1;NRP2;SEMA4B;GLI2;OPHN1;PRKCA;SRC;DSCAM;RAC2;PLXNA3;WNT5A;NTN5;ARTN;LAMA5;EPHB2;DAG1;EFNB2;SEMA3A;NTN3;SIAH1;MAPK7
prerank,positive regulation of viral process (GO:0048524),0.3376514234942633,0.9887304041329779,0.49868766404199477,0.9585567450122263,1.0,10/60,12.47%,MDFIC;KPNA2;PPIE;SRPK1;NELFB;SUPT4H1;AXL;CNOT7;SRPK2;GTF2F2
prerank,regulation of pH (GO:0006885),-0.39564562493538674,-0.9886931513042503,0.46633416458852867,0.826987141101769,1.0,3/11,8.51%,ATP6V0A4;LACC1;SLC9A1
prerank,negative regulation of DNA recombination (GO:0045910),-0.28721982287872366,-0.9886610791620881,0.48464163822525597,0.8260156238319508,1.0,19/43,26.75%,SHLD2;BLM;H1-0;POLQ;UBQLN4;ZRANB3;POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;CGAS;MAD2L2;ACD;RMI2;SMCHD1;PARPBP;POLR2I;PARP3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.286047099286982,-0.9884553710881803,0.4867549668874172,0.8255506961910809,1.0,8/40,12.75%,SMAD3;LEF1;DAB2;TGFBR1;GLIPR2;TGFB3;BMP2;TGFB2
prerank,defense response to tumor cell (GO:0002357),0.4782382210590717,0.9881785486005203,0.48336252189141854,0.9591639815772104,1.0,2/10,3.65%,DLEC1;SPI1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.4721080215728258,0.9880983423398079,0.4730639730639731,0.9585913628210324,1.0,3/10,19.30%,MTMR3;MTMR1;DNAJC19
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3804006647462006,0.9880357434779293,0.47218259629101283,0.9579503742985662,1.0,9/26,18.29%,FBXO5;CUL3;ANAPC5;ANAPC7;ANAPC11;CDC6;LCMT1;ANAPC4;CDC23
prerank,cellular response to retinoic acid (GO:0071300),-0.2821806254769512,-0.9878104266002953,0.45614035087719296,0.8262230007781326,1.0,9/42,11.19%,EPHA3;WNT5B;LYN;ADNP2;BRINP3;TBX1;CREB1;SNW1;RET
prerank,mitotic cell cycle phase transition (GO:0044772),0.29293059710384567,0.9874132078715554,0.4989270386266094,0.9587116687410145,1.0,44/203,17.29%,PLK2;DYNLL1;CCND3;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;SPAST;NEDD1;CCNG1;CDK7;PHLDA1;TUBG1;CKAP5;CUL3;PAFAH1B1;CCP110;CCNJ;ANAPC7;MASTL;EIF4E;CHMP4B;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;CRLF3;LCMT1;PCM1;POLE;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;E2F1;CEP57;USP37;CUL4B
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4249588264751998,0.9871595984702571,0.47987117552334946,0.9585498674622166,1.0,3/16,6.74%,ATIC;PFAS;PPAT
prerank,mitochondrion organization (GO:0007005),0.30216889902029903,0.9869469165600832,0.49666666666666665,0.9583026766547761,1.0,38/165,20.71%,CXADR;PPARGC1A;PISD;HK2;RAB29;WDR81;CAV2;MPV17;TOMM34;MFN2;DNM1;FIS1;ATPAF1;SIRT3;NRF1;MIEF1;IMMP2L;TFB2M;LONP1;MTX1;NIPSNAP2;TOMM40;DNAJA3;POLG2;BCS1L;AIFM2;BNIP3;ESRRA;MIGA1;TMEM70;PINK1;GABPA;DNAJC19;BAX;CHCHD3;PRKN;MUL1;ATP5F1D
prerank,adrenergic receptor signaling pathway (GO:0071875),0.4009825763374607,0.9869234024598948,0.47929936305732485,0.957565922905012,1.0,5/20,11.99%,PDE4D;AKAP13;GPR101;ADRA2A;ADCY9
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4636772540227224,0.9868349639264423,0.46953405017921146,0.9562011519465285,1.0,3/10,14.98%,CDC42EP4;APC;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.4636772540227224,0.9868349639264423,0.46953405017921146,0.9562011519465285,1.0,3/10,14.98%,CDC42EP4;APC;CDC42EP3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.30485344634154804,-0.9868194883386764,0.46835443037974683,0.8279207639927616,1.0,16/32,37.23%,TRPC1;AKAP6;CALM1;CALM3;JPH2;P2RY6;GSTO1;APLNR;NPSR1;F2R;CASQ1;CXCL10;CAPN3;THY1;SNCA;TRDN
prerank,cAMP biosynthetic process (GO:0006171),-0.42043676335322555,-0.9868076810089607,0.4672489082969432,0.8269043425041172,1.0,4/10,7.59%,ADCY1;ADCY7;ADCY4;ADCY2
prerank,carbohydrate catabolic process (GO:0016052),0.36018256860439896,0.9867942625089572,0.46285714285714286,0.9555204752790046,1.0,11/38,17.85%,HK2;NAGA;NEU1;ALDOB;PGM1;MANBA;ENO3;DERA;GCK;PGK1;ENO2
prerank,regulation of ion transport (GO:0043269),0.3216031059392985,0.9867891433174455,0.47959183673469385,0.9547368482969665,1.0,5/76,2.41%,NEDD4L;KCNJ4;SCN10A;KCNA5;KCNJ16
prerank,proton transmembrane transport (GO:1902600),0.36465867010179515,0.9867573646303933,0.47538677918424754,0.9540374137679584,1.0,5/36,10.02%,OTOP1;ATP1A2;SLC4A11;COX15;NNT
prerank,regulation of inflammatory response (GO:0050727),0.29441320719321845,0.9866824250182454,0.49455337690631807,0.953432118236257,1.0,24/190,11.15%,RORA;ADAMTS12;PIK3AP1;CDH5;CXCL17;FNDC4;CELF1;MGST2;WNT5A;ABCC1;IL17RA;TLR7;TNFAIP3;TRADD;SELENOS;MAPK7;PTGER4;ISL1;TNIP1;ACOD1;CD200R1;SHARPIN;S100A9;PROC
prerank,regulation of cell population proliferation (GO:0042127),0.27694477478034585,0.9863284065038834,0.5460921843687375,0.9535749082355008,1.0,91/691,12.87%,NGF;ROR2;ZBTB7C;FGF7;IGFBP6;DLC1;NTRK3;CDH13;GLI1;FGFR1;CLDN19;PTGFR;GLMN;FOLR2;EGFR;ADAMTS1;FGF1;JAG1;SSTR1;ACER3;KIF20B;GPLD1;RBFOX2;GNRH1;ITGAX;IL1A;PTPN14;PTHLH;SAPCD2;SOX9;TPTE;CELF1;HDAC4;BMP5;KLF10;NUP62;FN1;EGLN3;PDS5B;KANK2;RPRD1B;FER;CDK13;CEP131;ADAM10;NCK2;KRAS;CTCF;EFNB2;HOXC10;TBX2;CHERP;RARA;FBXO5;CUL3;DIS3L2;DPP4;S100B;RBM5;PTPRJ;GCNT2;FGF18;TSHR;DDRGK1;TET1;MECP2;GAB2;HDAC2;TRNP1;CNOT7;DLG3;PBRM1;HILPDA;ADRA2A;TBC1D8;STRN;AXIN2;SRPK2;RARG;APC;IL6ST;PRLR;ZBTB49;MEN1;SGK1;STAT2;CD81;NF2;WNT9A;PTEN;CDC6
prerank,membrane lipid metabolic process (GO:0006643),0.3946266369451638,0.9861193701472609,0.471875,0.9532970423256725,1.0,5/22,6.26%,AGMO;TEX2;ALOXE3;MGST2;CERK
prerank,protein import (GO:0017038),0.31940046342960626,0.9860230404272077,0.49753086419753084,0.9527336167520137,1.0,22/84,19.83%,PRICKLE1;RAB8B;IPO8;NUP62;FIS1;PEX2;FAM53B;PXMP2;TPR;MMP12;NUP50;CSE1L;ABCD1;NUP153;RAN;NUP93;SYK;HSPA4;SLC25A17;LAMP2;RPAIN;PEX13
prerank,cell cycle G2/M phase transition (GO:0044839),0.30153894064633247,0.9859397767609588,0.503954802259887,0.9521508800555972,1.0,40/129,22.51%,DYNLL1;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;NEDD1;CDK7;PHLDA1;TUBG1;CKAP5;PAFAH1B1;CCP110;MASTL;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;LCMT1;PCM1;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;CEP57;OFD1;CEP250;DCTN2;ALMS1;TAF2;HAUS8;CEP43;FBXW11;BORA;HAUS3
prerank,sphingoid metabolic process (GO:0046519),0.44391422633219013,0.9858092757656293,0.4722689075630252,0.9516990452675228,1.0,2/12,4.15%,PLPP2;PLPP3
prerank,negative regulation of GTPase activity (GO:0034260),0.3978850700240589,0.9855812877173099,0.48085758039816234,0.9515006181807387,1.0,2/22,6.72%,F11R;RDX
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.34751276387018937,-0.9855021403939194,0.4730878186968839,0.8293142832188795,1.0,7/19,25.08%,SMAD6;BMPR2;BMP2;TGFB2;SMAD4;OLFM1;NOTCH1
prerank,regulation of transferase activity (GO:0051338),0.4131205548886127,0.9848700361139767,0.4512,0.9525515638255468,1.0,1/17,1.61%,LDB2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32239839355785554,0.9847713320830118,0.48375,0.952022130041937,1.0,9/73,8.13%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,oxoacid metabolic process (GO:0043436),-0.308152669891172,-0.9843775000492851,0.5016077170418006,0.8312371796936449,1.0,8/27,20.44%,ENPP1;DDO;BPNT2;TPST1;PPA1;AGXT;MIF;SULT4A1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3008906695135523,-0.9841736856636636,0.47305389221556887,0.8307606292471595,1.0,8/31,24.68%,PLCB1;PLCG2;LGALS9;LAPTM5;CD40;TLR3;CCL19;IRF5
prerank,connective tissue development (GO:0061448),0.36463966146063376,0.984145956068175,0.48401162790697677,0.9528692815182692,1.0,7/35,13.69%,SULF1;SLC39A13;SOX9;SH3PXD2B;DDRGK1;PKD1;TRIP11
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.29995379453310445,-0.984127763162259,0.503030303030303,0.8298240490544179,1.0,13/33,26.38%,ETS1;HOXA5;HIF1A;TAL1;FES;RAB7B;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3
prerank,positive regulation of phagocytosis (GO:0050766),0.34657862424797226,0.9841265928619435,0.4800531914893617,0.9521328014221982,1.0,6/47,8.21%,C2;ANO6;LMAN2;PTPRC;DOCK2;PTPRJ
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.33586875184934817,-0.9835128682870662,0.4435695538057743,0.8303698817807752,1.0,8/21,16.19%,SLC8A3;TGM2;RAP1GDS1;SMDT1;SLC25A23;MICU1;MICU2;ANXA6
prerank,cellular response to ATP (GO:0071318),-0.3759300196498445,-0.9834046549958491,0.49264705882352944,0.8296235857295859,1.0,5/14,27.71%,P2RX7;P2RX4;CIB2;P2RY12;P2RY1
prerank,histone deacetylation (GO:0016575),0.35297117239629383,0.9833258668619432,0.46703296703296704,0.9534747291750768,1.0,18/43,24.13%,HDAC4;SMARCAD1;RCOR3;SIN3B;MSL3;SIRT7;HDAC2;HDAC6;SFPQ;BAZ2A;MORF4L2;MTA3;HDAC3;BRMS1L;SIRT2;SIN3A;SUDS3;REST
prerank,actin filament polymerization (GO:0030041),0.3691220221635779,0.9832354747528866,0.45790251107828656,0.9529068282837495,1.0,4/29,9.93%,COBL;GAS7;WASHC3;DIAPH3
prerank,ubiquinone metabolic process (GO:0006743),0.4199801083321543,0.9831927768241279,0.5132890365448505,0.9522293340270147,1.0,5/15,16.95%,COQ7;COQ8A;COQ9;AIFM2;COQ6
prerank,regulation of organelle assembly (GO:1902115),0.32841575965009945,0.9831672256929567,0.48557089084065247,0.9515158848955083,1.0,25/72,21.99%,PLK2;SENP6;STIL;TSG101;ATG5;RDX;MTMR3;PDCD6IP;TBC1D16;TBC1D2;TBC1D8;ATXN2;EVI5;DYNC2LI1;EZR;TBC1D20;VPS11;TBC1D5;RAB5A;ATG3;TBC1D10A;ALMS1;CDKL1;IFT140;HCK
prerank,regulation of catecholamine secretion (GO:0050433),-0.31155285382000875,-0.983159381010753,0.45652173913043476,0.8292691668478144,1.0,21/29,43.51%,KCNB1;SYT9;SYT7;DTNBP1;SYT13;SYT6;KCNA2;CHRNA4;SYT15;SYT1;SYT5;SYT17;CHRNB2;SNCA;SYT4;SYT3;DRD3;FGF20;HRH3;CHGA;SYT8
prerank,plasma membrane tubulation (GO:0097320),0.4449757900586823,0.9829410539616298,0.4799357945425361,0.9513314235910213,1.0,6/13,19.97%,PACSIN2;EHD2;CHMP4A;CAVIN2;PACSIN3;PACSIN1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4177650420573415,0.9826281490924282,0.48299319727891155,0.9513400215275891,1.0,3/15,9.77%,FGFR1;CELF1;CELF4
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.31702864677592935,0.9825059997748293,0.4830097087378641,0.9508956152174048,1.0,8/87,6.49%,EFNA5;DLC1;F11R;ARHGAP18;RAPGEF3;RAC2;ARHGEF5;ABL2
prerank,cellular response to hormone stimulus (GO:0032870),0.32686375344787066,0.982430531337504,0.4860759493670886,0.9503357043720874,1.0,16/69,18.50%,CAV1;SRC;CACNA1H;ATP1A2;RDX;RARA;ADRA2A;NCOA3;NCOA2;GCK;BRD8;GPER1;CTSB;SFR1;SOCS2;LHCGR
prerank,wound healing (GO:0042060),0.33143383238738816,0.9823932898618456,0.4839124839124839,0.9496482669641652,1.0,8/62,7.05%,CLDN1;AHNAK2;FGF1;DCBLD2;NF1;WNT5A;COL3A1;RAB3A
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.30524463514655,-0.9822539968461508,0.4627831715210356,0.8296381164324975,1.0,9/29,19.96%,GPAT4;ACOT7;DBI;ACSL6;MLYCD;ACLY;ACOT6;ACOT11;OXSM
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.30524463514655,-0.9822539968461508,0.4627831715210356,0.8296381164324975,1.0,9/29,19.96%,GPAT4;ACOT7;DBI;ACSL6;MLYCD;ACLY;ACOT6;ACOT11;OXSM
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3989453523326939,0.9820431103325181,0.4583333333333333,0.9497919339832996,1.0,8/21,18.94%,CNOT10;SAMD4B;CNOT7;PAN2;TNKS1BP1;CNOT8;PNLDC1;CNOT1
prerank,alpha-amino acid metabolic process (GO:1901605),0.3518485987442727,0.9820393381967423,0.4904891304347826,0.9490254403497048,1.0,10/45,13.54%,ASS1;NAALAD2;SLC25A12;AADAT;MTHFD1;DDAH2;ALDH18A1;SLC25A13;GOT1;GLUL
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.40089486199846325,-0.9815469405868316,0.48284313725490197,0.8305311565175595,1.0,2/11,1.71%,MSN;DAB2
prerank,regulation of T cell differentiation (GO:0045580),0.36442536702561107,0.9815207708605506,0.48121387283236994,0.9495683474129811,1.0,5/33,16.87%,NFATC2;CRTAM;IL7;CBFB;MDK
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.29616397307257053,0.9812480495682385,0.4988962472406181,0.9494848095765341,1.0,36/172,16.38%,DGKA;PTPN13;PISD;DDHD1;PI4K2B;GPAT3;ACP6;DGKZ;PCTP;SLC27A1;PIP4K2B;AGPAT4;PIK3R4;PLEKHA4;MTMR7;PIK3R2;MTMR6;OCRL;INPP5F;MTMR3;PLSCR1;LCLAT1;ETNK2;PLD1;AGPAT5;CDS2;PTEN;PLEKHA1;PIK3C3;MTMR12;GPD1;STARD10;PI4K2A;MTMR1;PITPNM2;HDHD5
prerank,regulation of cell division (GO:0051302),0.3259507953072195,0.9803518182308566,0.4968474148802018,0.9509739838303287,1.0,13/72,12.39%,PLK2;FGF1;MLLT3;PIK3R4;CSPP1;KIF13A;CCP110;SFN;KLHL21;ZFYVE26;NCOA3;CETN2;AHCTF1
prerank,regulation of viral life cycle (GO:1903900),0.40009257228777273,0.9803344773916024,0.47335423197492166,0.9502396414140977,1.0,6/21,15.72%,TSG101;KPNA2;TRIM21;AXL;HS3ST5;TRIM5
prerank,ethanol metabolic process (GO:0006067),-0.38418956218272216,-0.9802856635086876,0.5,0.8330277939130929,1.0,1/12,0.05%,ALDH1A1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3617700996217835,0.9801877158404245,0.4776536312849162,0.9498567471569137,1.0,14/37,23.97%,RNASEH2B;PABPC4;SIDT2;DFFB;NUDT18;ENTPD2;RNASE3;MTREX;HNRNPD;NUDT5;EXOSC7;NUDT1;RNASEH1;DNASE1L1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.34575768023456194,0.9799977997849255,0.4844804318488529,0.9495493600533343,1.0,4/46,5.87%,APOD;CDH13;MFN2;TNFAIP3
prerank,positive regulation of cellular component movement (GO:0051272),-0.32843792979684794,-0.979991106552345,0.4659090909090909,0.8327671723295861,1.0,5/24,7.20%,ETS1;SPOCK2;LYN;TGFBR1;RPS19
prerank,protein palmitoylation (GO:0018345),0.3755347752618885,0.9795910062682062,0.48759124087591244,0.9497929538539986,1.0,13/30,22.52%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7;ZDHHC5
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.28879898521572583,-0.9793931787994239,0.4511784511784512,0.8333250043015688,1.0,8/37,17.04%,PRKAG2;PARD3;CALM1;UBE2K;SPHK1;CALM3;EIF4G1;EGF
prerank,positive regulation of neuron migration (GO:2001224),-0.4058379329845866,-0.9793434994812507,0.5024630541871922,0.8324151698742155,1.0,3/11,5.19%,RAPGEF2;ARHGEF2;SEMA6A
prerank,organelle organization (GO:0006996),0.2811318557452209,0.9791732427951346,0.5264765784114053,0.9501551601236233,1.0,78/388,17.17%,CAV1;CXADR;FMNL2;PPARGC1A;ATP8B3;PLCE1;ATP8B1;CAPZB;RAB29;PI4K2B;WDR81;CAV2;LMAN2;EIF2AK3;CNTNAP1;RAB30;ZFYVE16;TMEM135;TNFAIP3;CEP78;SIRT3;PACSIN2;NRF1;PEX2;ATL2;RANBP10;GOLGB1;MICAL3;ARMC2;CHMP5;PDCD6IP;ATP8B2;NPLOC4;ZMYM6;LYSMD3;TMED4;CSNK1A1;DIAPH3;HILPDA;TFB2M;LNPK;CHMP4A;CHMP4B;ANK1;LONP1;CHMP4C;DPYSL2;MTX1;FAM161B;NIPSNAP2;ABCD1;TRIP11;HTT;DNAJA3;IQCG;POLG2;FAM161A;RAB34;SPRYD3;SIPA1;ZW10;FBXW8;BCS1L;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;CFAP61;CFAP410;TBC1D20;MDK;ARHGEF7;BRWD1;GEM;ESRRA;DYNC2H1;STX4
prerank,regulation of calcium ion transport (GO:0051924),0.33820922834361045,0.9791404558097309,0.49867724867724866,0.9494694386666075,1.0,3/54,1.76%,HOMER2;EFHB;SLC8B1
prerank,regulation of cellular protein localization (GO:1903827),0.34438539301180493,0.9788449091655592,0.47956403269754766,0.9495220949398612,1.0,9/45,17.75%,GPC3;GPC6;TRIM46;DVL3;RAB11FIP5;GPC2;SETD2;GPC5;LCP1
prerank,regulation of spindle assembly (GO:0090169),0.3830789300839509,0.9778109999423847,0.4781954887218045,0.9513935017309963,1.0,6/25,11.97%,SENP6;CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C
prerank,modified amino acid transport (GO:0072337),0.42141836362506324,0.9774768682790171,0.49310344827586206,0.9515266369243884,1.0,3/15,5.55%,FOLR1;FOLR2;SLC6A13
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3931075049527444,-0.9772601000754608,0.4788732394366197,0.8371309309065013,1.0,7/11,29.36%,SLIT2;CCN3;MIF;DUSP1;GREM1;RIN3;DDT
prerank,membrane raft organization (GO:0031579),-0.3500025334634479,-0.9770166810060148,0.5084337349397591,0.8367459065696565,1.0,5/15,18.34%,RFTN1;ANXA2;MYADM;NAXE;FLOT1
prerank,chromatin disassembly (GO:0031498),-0.36942332805403116,-0.9769154032095965,0.48036951501154734,0.8349505596583253,1.0,3/14,10.95%,SMARCE1;SMARCD1;ARID2
prerank,nucleosome disassembly (GO:0006337),-0.36942332805403116,-0.9769154032095965,0.48036951501154734,0.8349505596583253,1.0,3/14,10.95%,SMARCE1;SMARCD1;ARID2
prerank,neuron projection regeneration (GO:0031102),0.45594931297315666,0.9768463143598058,0.512280701754386,0.9523965497078871,1.0,2/10,10.73%,FOLR1;RTN4RL1
prerank,telomere maintenance via recombination (GO:0000722),0.44838989522292183,0.9762245994474373,0.4938704028021016,0.9531602891180203,1.0,3/11,12.80%,SMC5;ERCC1;TEP1
prerank,carnitine metabolic process (GO:0009437),0.44232165847442045,0.9761908319452965,0.4741235392320534,0.9524701544377889,1.0,1/12,1.67%,ALDH9A1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.43580306674179664,0.976168702242544,0.48983050847457626,0.9517591542528767,1.0,2/13,4.11%,NR3C2;PGR
prerank,response to acidic pH (GO:0010447),-0.3851815263798384,-0.9760368171881266,0.5241545893719807,0.8363062922934463,1.0,6/13,25.96%,SLC9A1;GPR4;LGMN;RAB11B;PKD2L1;PKD1L3
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.21681065270891345,-0.9758791014357945,0.48,0.8357023223782811,1.0,30/170,13.88%,IGF1;ROCK2;PRDM6;FOXP1;ADNP2;SLC8A1;PRDM5;NOVA2;SIRPA;LDLR;HNRNPK;HIF1A;ZNF507;APOE;HINFP;PCBP1;ATP1B1;CDK6;TRIM14;PRDM2;ZC3H12A;PROX1;ANKRA2;BMI1;PCBP4;MEGF8;CDK4;AHR;CIAO3;CAVIN4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.33150163851173553,-0.9754594237713408,0.4808743169398907,0.8358008634652923,1.0,5/21,10.31%,PRKCH;FOXP1;SLC39A10;BCL10;RPS3
prerank,DNA conformation change (GO:0071103),0.41818297706084206,0.9752123019605382,0.5178571428571429,0.9533750741573688,1.0,5/17,14.96%,HAT1;TOP3B;HMGB1;TOP1;NAA10
prerank,regulation of protein metabolic process (GO:0051246),-0.27491013031450723,-0.9750817783716627,0.5156794425087108,0.835793372664223,1.0,11/44,12.04%,ROCK2;FKBP1A;LDLR;ACE;SPOP;KLF4;APOE;NEDD8;KLF2;FURIN;TMEM9
prerank,regulation of vasculature development (GO:1901342),-0.3140565660417399,-0.9748461740951365,0.48554913294797686,0.8354536318373331,1.0,3/26,2.71%,ETS1;SP100;EGLN1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4439693367868205,0.9747466412464504,0.49830508474576274,0.9537730903747569,1.0,1/12,1.60%,ASS1
prerank,histone H3 deacetylation (GO:0070932),0.41707866822156087,0.9747307968657127,0.5007974481658692,0.9530453684498222,1.0,5/15,13.67%,HDAC4;SMARCAD1;SIRT7;HDAC2;SFPQ
prerank,regulation of actin filament polymerization (GO:0030833),0.3215878448072479,0.9746090801925866,0.5025125628140703,0.9525802229663743,1.0,8/69,7.65%,KANK4;PRKCE;ARHGAP18;CDC42EP4;FER;NCK2;KANK1;ARF6
prerank,second-messenger-mediated signaling (GO:0019932),0.3213987764833746,0.9739934425422447,0.4963592233009709,0.9533636702808608,1.0,8/82,10.18%,HRH1;ACKR3;PLCE1;EIF2AK3;DDAH2;RCAN1;KSR2;LAT
prerank,regulation of interferon-gamma production (GO:0032649),0.32073062737080116,0.9739285232125371,0.49039692701664533,0.9527655074293401,1.0,10/71,9.89%,IL18R1;PDE4D;TXK;PTPN22;TLR7;CRTAM;RARA;ISL1;HMGB1;AXL
prerank,negative regulation of cell development (GO:0010721),-0.30709994531575224,-0.9736146930455507,0.5,0.8377071209759632,1.0,3/25,4.54%,IGF1;APPL2;B2M
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.32612883921727254,-0.9734433375622937,0.48641304347826086,0.83710930051646,1.0,5/23,5.61%,ENG;SMAD3;TGFBR3;LATS2;ITGA3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.40056006006817335,0.9732925174977746,0.4917293233082707,0.9535844778915888,1.0,1/20,0.23%,PKDCC
prerank,regulation of cellular catabolic process (GO:0031329),-0.25629454192781204,-0.973148521974487,0.5069767441860465,0.8368966273367323,1.0,16/62,14.68%,DAPK1;ITPR1;ACER2;NUPR1;EP300;DEPDC5;DRAM1;PIP4K2A;USP33;RRAGC;GPR137B;LRRK2;PIP4K2C;BOK;MAPT;RRAGD
prerank,positive regulation of protein localization to membrane (GO:1905477),0.30752248834127477,0.9730053591374703,0.4835294117647059,0.9535180188025726,1.0,33/98,22.52%,SORBS1;PRKCE;EGFR;PPP1R13B;ATP2B4;FIS1;EPHB2;ARF6;MIEF1;SFN;SLC5A3;CD81;KIF5B;ZDHHC8;GPER1;BAD;NMT1;ERBB2;YWHAG;YWHAE;E2F1;CHP1;STX4;SPTBN1;PDPK1;CEMIP;PRKN;AKT2;ITGB1;MAPK8;TFDP1;YWHAB;ZDHHC5
prerank,regulation of telomere capping (GO:1904353),0.38603374874844293,0.9728951336632863,0.514018691588785,0.953020497958891,1.0,8/23,26.70%,NEK7;NBN;TERF2;HNRNPD;SMG6;MAPK1;TNKS;RAD50
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.35570392921747873,0.9724965948862591,0.48691860465116277,0.9532651205631064,1.0,1/34,0.10%,GAB1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3921510688378888,-0.9724887443098893,0.5023364485981309,0.8377040631367854,1.0,2/11,1.57%,ITM2A;NECAB1
prerank,cortical cytoskeleton organization (GO:0030865),0.35099525094229383,0.972476130330378,0.5006993006993007,0.9525537355442059,1.0,12/41,18.52%,FMNL2;EPB41L3;TRPV4;RAC2;ARF6;PLEK;FHOD1;RND2;PPP2R3C;EZR;LCP1;RHOA
prerank,maturation of LSU-rRNA (GO:0000470),0.37480852674302073,0.9724523557544785,0.4896755162241888,0.9518577514590999,1.0,5/26,11.38%,RRP15;RPL35;SNU13;PES1;RPF1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.27751365688017055,0.9722586195806748,0.5904954499494439,0.9515679174806926,1.0,67/497,11.94%,MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;FOXP2;ZNF423;FOXD1;ATP8B1;MYBBP1A;BCL3;RUNX2;FXR2;RBFOX2;SFMBT2;GIGYF2;CIART;SPI1;L3MBTL3;FOXK1;EIF2AK3;SOX9;CNOT10;UBE2I;GLIS2;CHD8;CDAN1;KAT6B;HDAC4;LANCL2;KLF10;SAMD4B;WNT5A;CREB3L1;RBM15B;HEYL;SP3;BHLHE40;PUS7;RCOR3;SELENOS;CTCF;NCOR1;TBX2;RARA;SUV39H1;KCTD1;IGF2BP2;FOXK2;UIMC1;TSC22D4;MECP2;GSK3B;RORB;USP47;HDAC2;CNOT7;ZHX1;NCOR2;ILF3;HDAC6;HEXIM1;ZNF148;MEN1;KDM8
prerank,establishment of spindle localization (GO:0051293),-0.3686305624662019,-0.9713931938299114,0.5059665871121718,0.8395872767733507,1.0,6/14,31.25%,CFL1;ZBED3;LLGL2;NUSAP1;TLE6;DYNC1H1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3192988089419869,0.9709986124272237,0.5130111524163569,0.9539099363810128,1.0,9/86,5.38%,INHBB;SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B;BMP5;BMP15
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.31404580865005016,-0.9709140708977488,0.502906976744186,0.8398581308989627,1.0,8/26,13.98%,NPR3;ATP7A;HIF1A;APOE;GCH1;AKT1;S100A1;DHFR
prerank,fatty acid catabolic process (GO:0009062),0.321573448331699,0.9709003530812625,0.4980891719745223,0.9533965122067674,1.0,11/67,10.29%,EHHADH;CEL;AIG1;PCCB;HADHB;PEX2;ACAT1;HSD17B4;ACADS;SLC27A4;ACOT8
prerank,monosaccharide transmembrane transport (GO:0015749),-0.35168199882879037,-0.9707852913301303,0.4805194805194805,0.8391869021904919,1.0,5/16,17.76%,SLC2A12;SLC2A10;SLC45A3;SLC2A8;SLC2A9
prerank,primary miRNA processing (GO:0031053),-0.4117306800543237,-0.9706668305264264,0.49206349206349204,0.8384787635486131,1.0,5/10,27.66%,SMAD3;PUS10;SMAD1;MRPL44;SMAD2
prerank,mitotic cytokinetic process (GO:1902410),0.40659375323443553,0.9688758541826196,0.48859934853420195,0.957767897009184,1.0,6/20,11.97%,CHMP5;PDCD6IP;CNTROB;CHMP4A;CHMP4B;CHMP4C
prerank,regulation of adaptive immune response (GO:0002819),-0.34329921127836854,-0.9687827609678703,0.5196629213483146,0.8423758649439863,1.0,9/18,28.07%,ADCY7;IRF1;EIF2AK4;SAMSN1;AHR;SKAP1;PYCARD;TRIM27;FCGR2B
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.43748570412162,0.9687426021617155,0.4921190893169877,0.9573112835812544,1.0,2/12,1.97%,DOCK5;ADAMTS1
prerank,intraciliary retrograde transport (GO:0035721),0.4396380501900975,0.9687237248459639,0.5066225165562914,0.9566021359871183,1.0,6/12,25.86%,DYNC2I1;TTC21B;DYNC2LI1;DYNC2H1;IFT140;DYNC2I2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.24975133723936666,-0.9686823764353873,0.5025125628140703,0.8416367297843728,1.0,19/69,19.50%,POU2F1;INTS9;CCNT2;CDK9;RPRD2;PHAX;CCNT1;SNAPC1;ZC3H8;SP1;INTS1;NCBP1;POLR2F;POLR2A;POLR2J;SNAPC5;POLR2D;POLR2K;TAF6
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.39721010992198874,-0.9680342016834639,0.5333333333333333,0.8424068484894792,1.0,4/11,13.20%,SEMA6A;SYNJ2BP;KLF2;THBS1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.40947138736086053,-0.9678529236463681,0.5044642857142857,0.8418653795153582,1.0,4/10,14.20%,MTHFS;MTHFR;DHFR;MTHFD1L
prerank,negative regulation of catabolic process (GO:0009895),0.3389201004878728,0.9677394092936428,0.4856396866840731,0.9583187130394488,1.0,7/47,10.37%,EGFR;HDAC4;IRAK3;AZIN2;NCOR1;ZDHHC7;ADRA2A
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.45025601338878624,0.9676418606415376,0.5034843205574913,0.9577836857280386,1.0,3/11,13.45%,JAG1;ISL1;SOX4
prerank,protein K48-linked ubiquitination (GO:0070936),0.32924579471685267,0.9672754009555046,0.5204216073781291,0.9579508386268235,1.0,16/54,21.61%,NEDD4L;UBE2E2;TNFAIP3;UBR5;CUL3;AMFR;TTC3;FBXO38;UBE2D3;UBE2D1;UBE2R2;ITCH;KBTBD7;PRKN;RNF146;ZNRF1
prerank,cAMP metabolic process (GO:0046058),0.4239767347779101,0.9668094875323284,0.48677248677248675,0.958374651727183,1.0,6/13,15.58%,PDE4D;PTHLH;ADCY5;ADCY9;ADCY8;ADCY3
prerank,positive regulation of nervous system process (GO:0031646),0.4063977926774151,0.9663952271106646,0.5103011093502378,0.9586564096346363,1.0,7/18,14.63%,ITGAX;RIMS2;NCMAP;ATPSCKMT;HCRT;UNC13B;DICER1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.31252307925407113,-0.9663879465713756,0.5057142857142857,0.8447515410045348,1.0,8/25,13.57%,ARHGAP24;SLIT2;TBC1D30;EVL;EVI5L;CEP97;ARHGAP44;TCHP
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.38914926365621233,0.9662073431866869,0.4946070878274268,0.958372637111005,1.0,3/22,3.65%,RELL1;MINK1;SPI1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2781487873859711,0.9659959727082972,0.5742067553735927,0.9581472634846488,1.0,41/348,9.83%,NGF;FGF7;NTRK3;PPARGC1A;FOXD1;CLDN19;MUSK;FGF1;ADAM19;SLC26A9;CDH5;RAB29;SLC38A2;ITGAX;IL1A;PRKAG1;WNT16;EIF2AK3;SOX9;CELF1;PTPN22;WNT5A;FN1;EPHB2;KRAS;RIMS2;UBR5;RDX;CTCF;MAPK7;OCLN;NOS1AP;FGF18;AGO1;INPP5F;DDRGK1;PLSCR1;GSK3B;RESF1;TICAM1;POU4F1
prerank,protein polymerization (GO:0051258),0.3302023165828002,0.9659582110752084,0.504,0.9574775758289706,1.0,9/55,10.71%,COBL;TRPV4;GAS7;CKAP5;WASHC3;CASQ2;DIAPH3;CHMP4A;CHMP4B
prerank,purine-containing compound catabolic process (GO:0072523),-0.3675798383111415,-0.9658486898599755,0.5024038461538461,0.8451966549906668,1.0,5/13,24.18%,DPYD;XDH;NT5C;NT5C1A;GDA
prerank,mitochondrion transport along microtubule (GO:0047497),-0.383890705568778,-0.9657258715827403,0.5036674816625917,0.8444899733923633,1.0,7/13,27.00%,NEFL;HIF1A;MAPT;OPA1;RHOT1;LRPPRC;UBB
prerank,regulation of lipid biosynthetic process (GO:0046890),0.36514315207711523,0.9655562303123267,0.5202231520223152,0.957717612937489,1.0,4/32,5.25%,SORBS1;CEACAM1;ZBTB20;PDK4
prerank,lymphocyte chemotaxis (GO:0048247),0.37002563606349737,0.9655478037501835,0.4964131994261119,0.9569803926698216,1.0,2/34,2.15%,SLC12A2;CYP7B1
prerank,regulation of mitochondrial translation (GO:0070129),0.38802726200760057,0.9652042656667982,0.5105421686746988,0.9570745456268197,1.0,9/21,23.15%,RMND1;FASTKD2;MPV17L2;ALKBH1;MTG2;RPUSD4;MALSU1;TSFM;MTG1
prerank,extracellular transport (GO:0006858),0.4466126058476582,0.9649831533310731,0.5074135090609555,0.9568777249031738,1.0,4/12,15.14%,TSG101;SPAG17;WWP2;CCDC40
prerank,regulation of lipid kinase activity (GO:0043550),-0.39386715744622747,-0.9639094636446542,0.4909090909090909,0.848419127505123,1.0,5/11,15.25%,PIK3R1;PIK3R3;RBL1;PPP2R5A;RBL2
prerank,microtubule depolymerization (GO:0007019),0.4103264777717492,0.9638933177357021,0.5238879736408567,0.9588492231954792,1.0,3/17,7.38%,KIF2A;NCKAP5L;CKAP5
prerank,regulation of fat cell differentiation (GO:0045598),0.3222862185564794,0.9638809323844634,0.5051020408163265,0.9581341215878694,1.0,4/74,5.05%,RORA;TRIB2;WNT5A;TRIO
prerank,chromatin remodeling (GO:0006338),0.30537336150353006,0.9633919692082139,0.5166270783847982,0.9586249961324905,1.0,33/100,21.52%,HNRNPC;CHD3;SOX9;CHD8;HDAC4;SATB1;SMARCAD1;GATAD1;ACTR8;SMARCD2;HDAC2;BAZ2B;PBRM1;ERCC6;TOP1;INO80;KDM6B;BAZ2A;TADA2A;INO80B;CHD1L;KDM4B;SUV39H2;RUVBL2;NUDT5;HCFC2;RBBP4;CHRAC1;KDM5B;ARID1B;DAXX;RSF1;ARID1A
prerank,regulation of blood circulation (GO:1903522),-0.29155333259505956,-0.9629921827776944,0.49310344827586206,0.849825038751259,1.0,11/34,19.18%,ECE1;TPM1;ACE;BDKRB2;AGTR1;DES;S100A1;SRI;ACE2;PER2;AGT
prerank,regulation of cytoplasmic translation (GO:2000765),-0.36939754046916584,-0.9624218180003674,0.5218446601941747,0.8503094982793464,1.0,5/14,18.05%,CPEB4;CPEB2;UNK;DHX36;CPEB1
prerank,response to muscle stretch (GO:0035994),-0.3539111626224054,-0.9623728679694711,0.493573264781491,0.8494329752929188,1.0,4/15,14.54%,DMD;SLC8A1;SLC9A1;PTK2
prerank,positive regulation of endocytosis (GO:0045807),0.335908885513922,0.9620268923485242,0.5055096418732782,0.9612418478332824,1.0,7/45,10.09%,GPC3;NEDD4L;ANO6;TFR2;SGIP1;AXL;CALY
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3526209391009534,-0.9619856685490354,0.5064599483204134,0.8493970773848162,1.0,9/17,25.21%,PID1;NUPR1;CBFA2T3;PFKFB1;PDE12;PARP1;GIT1;TIGAR;FLCN
prerank,snRNA transcription (GO:0009301),-0.24511606104121544,-0.9618196049540055,0.5270935960591133,0.848877460521097,1.0,19/70,19.50%,POU2F1;INTS9;CCNT2;CDK9;RPRD2;PHAX;CCNT1;SNAPC1;ZC3H8;SP1;INTS1;NCBP1;POLR2F;POLR2A;POLR2J;SNAPC5;POLR2D;POLR2K;TAF6
prerank,phospholipid transport (GO:0015914),0.33536175276145924,0.9616944375269396,0.5176151761517616,0.9613263125998124,1.0,11/52,9.88%,ATP8B3;ATP8B1;PITPNC1;PCTP;ABCC1;ATP9B;ATP11C;ATP9A;ATP8B2;ABCA1;ATP10B
prerank,7-methylguanosine RNA capping (GO:0009452),-0.3005017809144456,-0.9616823691128926,0.5254777070063694,0.8472160074836265,1.0,14/31,27.73%,MNAT1;ERCC2;RAMAC;NCBP1;CCNH;POLR2F;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;POLR2I;CMTR2;GTF2H5
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.3005017809144456,-0.9616823691128926,0.5254777070063694,0.8472160074836265,1.0,14/31,27.73%,MNAT1;ERCC2;RAMAC;NCBP1;CCNH;POLR2F;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;POLR2I;CMTR2;GTF2H5
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3482316982214576,-0.9614706351875825,0.5251256281407035,0.8467764828760258,1.0,5/16,12.92%,ARHGAP24;RASGRF1;ARHGAP17;GABARAP;ARHGAP44
prerank,generation of neurons (GO:0048699),0.2831365927955664,0.9611924479009806,0.5492957746478874,0.9618282561548374,1.0,26/190,11.17%,FGFR1;WNT10A;FZD2;BHLHE22;NEUROD6;RUNX2;WNT2B;OPHN1;RACGAP1;WNT16;WNT5A;HEYL;BHLHE40;BRSK1;ARTN;SEMA3A;PAFAH1B1;LHX6;EML1;NRBP2;GPM6A;RELN;ERCC6;LRP12;DOCK7;EN2
prerank,regulation of axon regeneration (GO:0048679),0.45253578213431933,0.9607595339363426,0.5139372822299652,0.9621520483133059,1.0,4/12,10.73%,RTN4R;INPP5F;STK24;RTN4RL1
prerank,mRNA methylation (GO:0080009),-0.3627601830459175,-0.9606162306527111,0.5076530612244898,0.8479686110324185,1.0,8/15,36.62%,NSUN2;TRMT61B;METTL16;METTL8;METTL14;TRMT6;TRMT61A;TRMT10C
prerank,protein glycosylation (GO:0006486),-0.21644133164436163,-0.9605751294868686,0.528,0.8470537072774539,1.0,23/125,11.94%,ST3GAL6;MGAT4C;ST3GAL5;ST3GAL1;ST8SIA4;MGAT4A;EOGT;SLC39A8;COG7;DPM1;ST6GALNAC2;ALG5;PLOD2;STT3B;PLOD1;GAL3ST1;AQP11;PGM3;B4GALT1;B4GALT7;ALG1;GOLGA2;RPN2
prerank,potassium ion homeostasis (GO:0055075),0.3870428399824339,0.9603433840715043,0.518348623853211,0.9624025309755959,1.0,5/23,9.40%,SLC12A2;SLC12A4;SLC12A3;ATP1A2;ATP1B3
prerank,response to interleukin-1 (GO:0070555),-0.24360948015572467,-0.9602942625009091,0.5175879396984925,0.8467612622533897,1.0,19/73,18.68%,IL1R1;PTGIS;YTHDC2;SIRPA;HIF1A;GBP3;TRAF6;IGBP1;ANXA1;ZC3H12A;CCL13;TNFRSF11A;TLE5;LGALS9;GBP2;RC3H1;CD40;CACTIN;IRAK2
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.2943242827635007,-0.9602043970279749,0.5432098765432098,0.8460246815741719,1.0,4/31,4.18%,RBP4;TFRC;PAXIP1;SHLD2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.40564116616545054,-0.9599637472968338,0.4931506849315068,0.845650932671508,1.0,2/10,6.29%,DBI;APOE
prerank,regulation of interleukin-6 production (GO:0032675),0.31290031629009185,0.9596429748389146,0.5379061371841155,0.9634270981415861,1.0,13/96,9.49%,LBP;IL1A;PTPN22;IRAK3;WNT5A;IL17RA;TLR7;TNFAIP3;SELENOS;ISL1;CD200R1;FOXJ1;HMGB1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.45031767744858475,0.9595491797600058,0.5252525252525253,0.9629206758943871,1.0,2/10,8.66%,GCDH;ACADS
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3339997862334891,0.9594364523456139,0.5068681318681318,0.9624319194708625,1.0,4/48,3.58%,UBASH3B;CAMK2D;PDE4D;FKBP1B
prerank,motile cilium assembly (GO:0044458),0.4389673166411667,0.9592713019912811,0.5127334465195246,0.9620934741400184,1.0,3/12,15.14%,CCDC39;BBOF1;CCDC40
prerank,response to glucose (GO:0009749),0.340579187912931,0.9590173872882088,0.5187667560321716,0.9620002133109684,1.0,17/46,21.69%,ZBTB20;GPLD1;EIF2B3;SELENOS;EIF2B4;ERN1;GCK;SOX4;UNC13B;TRA2B;GPER1;ADCY8;IRS2;LPL;PAX2;VAMP2;TCF7L2
prerank,protein hydroxylation (GO:0018126),-0.36069437424122514,-0.9589369092750023,0.5156626506024097,0.8472596424087203,1.0,6/15,16.80%,PLOD2;PLOD1;P3H2;JMJD4;P3H3;P3H4
prerank,histone H4-K5 acetylation (GO:0043981),0.42657666348176715,0.958910577692497,0.5170178282009724,0.9607609673536843,1.0,3/15,14.16%,OGT;KANSL2;KAT8
prerank,histone H4-K8 acetylation (GO:0043982),0.42657666348176715,0.958910577692497,0.5170178282009724,0.9607609673536843,1.0,3/15,14.16%,OGT;KANSL2;KAT8
prerank,gliogenesis (GO:0042063),-0.34943882022912476,-0.9583205651596434,0.46634615384615385,0.8479017077989305,1.0,4/15,12.75%,NFIB;ANXA1;CDK6;TGFB2
prerank,phospholipid biosynthetic process (GO:0008654),0.3553510642519948,0.958318856288578,0.4985875706214689,0.9614742947856807,1.0,9/36,20.41%,SGMS2;AGPAT4;AGPAT5;DHDDS;DPAGT1;HDHD5;FADS1;DOLK;DOLPP1
prerank,regulation of exit from mitosis (GO:0007096),0.3531159267324365,0.9582137338782545,0.5117241379310344,0.9609699602808953,1.0,13/38,18.29%,CDC20;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;UBE2D1;ZW10;ANAPC4;CDC14A;RGCC;ANAPC16;CDC23
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3001967123583661,-0.9579990659560751,0.5274390243902439,0.8476835548975556,1.0,7/28,17.71%,MAP3K20;USP28;ATRIP;HINFP;CLSPN;RAD1;RAD17
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.31775395465826073,0.9578545101647832,0.5461254612546126,0.9603216248566254,1.0,22/78,22.90%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.31775395465826073,0.9578545101647832,0.5461254612546126,0.9603216248566254,1.0,22/78,22.90%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,regulation of DNA metabolic process (GO:0051052),0.33619125012041734,0.9578126019697027,0.5083102493074793,0.9596758410851666,1.0,8/44,9.58%,MPV17;WDR18;SMARCAD1;TOM1L1;KPNA2;NBN;UBE2V2;SIRT7
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3158191607675659,0.9577894259583295,0.5263819095477387,0.9589735506951166,1.0,23/70,21.62%,LMO1;KMT2A;PSME3;N4BP2L2;PUS7;PSMB5;PSMB2;CBFB;PSMA2;PSMA6;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;RUNX1;FOXC1;PSMB3
prerank,positive regulation of dendritic spine development (GO:0060999),-0.329819078033646,-0.9577092631799802,0.49572649572649574,0.8474044645842258,1.0,4/20,6.87%,SHANK3;APOE;CUX2;LRP8
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.32423134878076004,-0.9571660323355266,0.5181818181818182,0.8478345855656604,1.0,7/24,11.67%,DACH1;ACVRL1;BMPR2;BLM;SUB1;RPS3;H1-0
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3393495929840961,-0.9570018746439143,0.5165745856353591,0.8472800870644782,1.0,6/19,12.24%,ENPP1;BPNT2;PAPSS1;SLC26A2;TPST1;SLC35B3
prerank,regulation of T cell chemotaxis (GO:0010819),0.4352165013204021,0.956984259184677,0.5207612456747405,0.9601839373711825,1.0,2/11,6.14%,WNT5A;ADAM10
prerank,signal release from synapse (GO:0099643),-0.27612949038382095,-0.9569659136869557,0.5318352059925093,0.8463661344087386,1.0,20/43,29.33%,STXBP3;LIN7A;HSPA8;SYN1;GAD1;NRXN1;SYN3;NRXN2;DNAJC5;CPLX2;UNC13A;SYN2;RIMS1;SNAP25;SLC32A1;PPFIA3;PIP5K1C;PTPRN2;GRM4;SYT1
prerank,artery development (GO:0060840),0.3846162231031033,0.9569061581709016,0.5152439024390244,0.9596371560442877,1.0,2/23,3.23%,STRA6;NF1
prerank,response to muramyl dipeptide (GO:0032495),-0.3837703189615773,-0.9561451975317814,0.5100502512562815,0.8475565222541548,1.0,7/12,24.68%,ARHGEF2;ERBIN;NOD1;VIM;TRIM41;NOD2;IRF5
prerank,regulation of axon extension (GO:0030516),0.3463772031671351,0.9560964858049772,0.49853801169590645,0.960845155430337,1.0,8/37,14.25%,NTN1;RTN4R;CDKL3;SEMA3A;GSK3B;TRIM46;CTTN;RTN4
prerank,modulation by host of viral genome replication (GO:0044827),-0.36281221435437405,-0.9558127999285307,0.5239294710327456,0.8474810931670943,1.0,7/13,28.83%,YTHDC2;ZC3H12A;EIF2AK4;PPIB;FBXL2;CCNK;IFI27
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.28373195008123714,-0.9556618497681713,0.5107692307692308,0.8468659428564589,1.0,12/36,22.09%,AFDN;VAMP5;GORASP2;ANK3;MACF1;BBS2;PREPL;GGA3;SYS1;RAB7A;OPTN;RAB10
prerank,regulation of cellular metabolic process (GO:0031323),0.3397085174579116,0.9556023287492103,0.5086782376502003,0.9612951015797415,1.0,11/45,18.00%,COQ7;MPV17;KIF16B;PDK4;ACACA;TBC1D16;NCOR2;ACACB;PANK2;PM20D2;PINK1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.24763733647363192,-0.9553981916622931,0.5860215053763441,0.8466232295513807,1.0,14/74,12.63%,RBPJ;PSMA1;EGLN1;EP300;RBX1;HIF1A;PSMD11;PSMD7;PSMD4;CITED2;EPAS1;CUL2;HIF3A;PSMB4
prerank,Notch signaling involved in heart development (GO:0061314),-0.38876084812908274,-0.955073598558321,0.5310344827586206,0.8464618140488723,1.0,3/11,7.04%,NOTCH2;RBPJ;GALNT11
prerank,calcium ion transport into cytosol (GO:0060402),0.3826768364696006,0.9549751420072473,0.5113122171945701,0.9621199770303214,1.0,3/21,4.74%,ITPR3;TRPV4;ATP2B4
prerank,regulation of lamellipodium assembly (GO:0010591),0.3557022178532748,0.9545573204184405,0.4868804664723032,0.9623914452897776,1.0,6/34,11.89%,PLCE1;CAPZB;RAC2;FER;OCLN;AKIRIN1
prerank,inner ear morphogenesis (GO:0042472),-0.3144044778812072,-0.9542245851987049,0.529891304347826,0.8476464422453475,1.0,4/22,6.34%,CHD7;MYO6;FGFR2;TBX1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4536926630524203,0.9540987125531134,0.5008375209380235,0.9627515497197339,1.0,2/10,8.41%,NUFIP1;NAF1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.37535774962187307,0.9537771282126785,0.5348484848484848,0.9628499272755486,1.0,6/25,17.58%,SF3B1;SRSF4;PRPF3;DBR1;TRA2B;SLU7
prerank,myelination (GO:0042552),-0.26119300036986065,-0.9536891657063432,0.5795454545454546,0.8480889168598112,1.0,12/46,13.83%,PARD3;ADGRG6;SLC8A3;TNFRSF21;BCAS1;PLLP;CMTM8;GAL3ST1;LGI4;SBF2;ABCD2;DEGS1
prerank,regulation of chemokine production (GO:0032642),-0.27739957663468473,-0.9526695836095408,0.5387323943661971,0.8496526424094405,1.0,5/36,6.53%,IL6R;FOXP1;IL18;HIF1A;IL33
prerank,cellular protein localization (GO:0034613),0.27474300076070796,0.9518475025928738,0.5712788259958071,0.9669075292716601,1.0,75/285,20.78%,PIGU;FGF7;GRTP1;EPB41L3;EGFR;RAB29;STX1A;RIC3;SGSM2;SIL1;CSRP3;CNTNAP1;MFN2;CPE;ARL11;WNT5A;AMOT;SH3PXD2B;RAB3GAP2;SYNRG;KIF13A;ARF6;OCLN;TBC1D16;ARL4A;FOXJ1;TMED4;TBC1D2;FERMT2;TBC1D8;AXIN2;RIC1;HDAC6;STX2;STX19;RTP3;CTTN;USP4;EVI5;RRAGB;PTPRU;CNTNAP2;ARL5A;COPA;TMED2;SEC23IP;TICAM2;TBCK;AP3B1;SNX1;CELSR1;RAB21;STX4;SLU7;ARCN1;FAM91A1;STX5;SCFD2;FGF10;TBC1D5;EHD1;COG3;RABL3;TM9SF4;TM9SF2;CEP250;RAB5A;NSF;SNX17;TBC1D10A;PACSIN1;PIGK;TBC1D8B;RAB18;USO1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.24637285368335834,-0.9515791594076686,0.5560975609756098,0.8515104159505926,1.0,27/72,27.84%,UVSSA;EP300;RBX1;MNAT1;ERCC2;XPA;POLK;ISY1;LIG3;COPS6;CCNH;POLR2F;RFC2;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;GPS1;ERCC4;ERCC5;POLD2;POLR2I;RFC4;UBB;GTF2H5;DDB1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.30904168458129566,-0.9512980412442613,0.511049723756906,0.8512758281872194,1.0,11/24,24.33%,ABCG2;SLC25A38;FECH;CPOX;FXN;ABCB10;ALAS1;UROD;HMBS;TSPO;ALAD
prerank,negative regulation of DNA replication (GO:0008156),0.42375709741610085,0.9511110551093361,0.5299003322259136,0.9679495609248622,1.0,4/13,20.51%,CDAN1;CDC6;GMNN;ATR
prerank,regulation of viral transcription (GO:0046782),0.3450130863362682,0.951101674029043,0.5221745350500715,0.967232412642928,1.0,6/39,12.47%,MDFIC;TRIM21;NELFB;SUPT4H1;HEXIM1;GTF2F2
prerank,response to nitric oxide (GO:0071731),-0.37473124146936887,-0.9502217114859003,0.49056603773584906,0.8530787620965696,1.0,5/13,24.97%,EGLN1;FOXO1;MTR;CCL19;CDK2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3663178957623725,-0.9500973222647207,0.5364705882352941,0.8524005333064205,1.0,2/13,4.13%,SOX13;NAPEPLD
prerank,hexose biosynthetic process (GO:0019319),0.3362064081513188,0.9498045336108724,0.5084745762711864,0.9696169889946981,1.0,13/42,21.47%,PPARGC1A;SLC25A12;ALDOB;PGM1;MDH1;SLC25A13;ENO3;GOT1;PGK1;ENO2;SLC37A4;SLC25A10;ENO1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.38862470798727244,0.9497940360722495,0.519872813990461,0.9681546299333251,1.0,5/20,11.49%,ACAD8;BCKDK;ACAT1;BCKDHB;BCAT2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.38862470798727244,0.9497940360722495,0.519872813990461,0.9681546299333251,1.0,5/20,11.49%,ACAD8;BCKDK;ACAT1;BCKDHB;BCAT2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3853400710547281,0.9497335265249898,0.521193092621664,0.9675553771514045,1.0,3/20,10.79%,CAMK2D;FIS1;THADA
prerank,sodium ion export across plasma membrane (GO:0036376),0.4275598374173527,0.9496505560747376,0.5041736227045075,0.9670253507998212,1.0,3/13,9.40%,ATP1A2;SLC4A4;ATP1B3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.29610292450334835,0.9496036605557412,0.549645390070922,0.9664056074720748,1.0,15/110,10.37%,LPAR1;ADGRG5;ADGRG2;PTGFR;GPR161;MC5R;PTHLH;GNAQ;ADCY5;PTGER4;TSHR;GNAL;GPR101;ABCA1;ADRA2A
prerank,leukocyte cell-cell adhesion (GO:0007159),0.37800281988395457,0.9495411926609492,0.5217391304347826,0.9658090683709553,1.0,6/24,16.49%,F11R;TNIP1;NT5E;SEMA4D;EZR;SYK
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.3242373680790914,-0.9493822306797468,0.5100864553314121,0.8532342960232785,1.0,9/21,20.27%,CYP26B1;PPARD;LPIN2;FAH;LPIN3;ACBD5;AGXT;ACOX1;PLA2G15
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3902894553674729,0.949259900451235,0.5321821036106751,0.9657579349500508,1.0,4/20,12.78%,RGS14;GPRASP1;PLEK;RPGRIP1L
prerank,regulation of interleukin-17 production (GO:0032660),-0.30187716372292017,-0.9491417289786438,0.5220338983050847,0.8528861710269621,1.0,8/31,25.87%,SLC7A5;RFTN1;IL18;SPHK1;NR1H4;NCKAP1L;NOD2;MYD88
prerank,platelet aggregation (GO:0070527),-0.29400112991847915,-0.9490151773966435,0.5513698630136986,0.8522549980332005,1.0,11/33,18.52%,STXBP3;GNAS;PDGFRA;ACTB;MYL9;ACTG1;FLNA;ILK;TLN1;HSPB1;MYH9
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.37952296443324246,0.9488850380198498,0.5099846390168971,0.9659219300817418,1.0,7/22,16.58%,LEO1;CDK13;ELL;SUPT4H1;ERCC6;TCERG1;THOC5
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3522414910402946,-0.9484985303665238,0.5505050505050505,0.8526914492781009,1.0,6/15,13.12%,NR1H3;LDLR;SIK1;CTDNEP1;NR1H2;MFSD2A
prerank,homocysteine metabolic process (GO:0050667),-0.3940549628743101,-0.9482322693188175,0.5230414746543779,0.852411717384672,1.0,6/11,30.82%,NOX4;MTHFR;MTRR;CBS;CTH;MPST
prerank,macromolecule catabolic process (GO:0009057),0.3695538466433532,0.9480277184657584,0.5438335809806835,0.9672618190019493,1.0,7/26,11.37%,LRSAM1;KIF16B;PIK3R4;CLN8;SIAH1;SNX25;NEDD4
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3100230387865135,-0.9474682286191968,0.5228571428571429,0.8533710088192217,1.0,9/25,27.69%,EPHA4;RPS7;SGTA;RPL23;CSNK2A1;HFE;RPL5;ALAD;RPL11
prerank,response to lipopolysaccharide (GO:0032496),0.2881459760589066,0.9474274257448787,0.5599547511312217,0.9679290143591723,1.0,21/138,11.08%,LBP;TNIP3;IL1A;PTPN22;HNRNPA0;IRAK3;WNT5A;FER;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;RPS6KA3;HMGB1;TICAM1;AXL;S100A9;TAB2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.40906001493620775,0.9473529253528115,0.5161290322580645,0.9673950943467647,1.0,2/15,2.89%,PRKCE;GPLD1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3300703243824086,-0.9472529209083344,0.5409836065573771,0.8529453086362893,1.0,4/19,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,response to glucagon (GO:0033762),-0.33639401793972895,-0.9470438125913216,0.5134408602150538,0.8524893760941883,1.0,8/19,19.17%,ADCY1;ADCY7;ADCY4;ADCY2;CREB1;PRKAR2B;CYSLTR2;CRY1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3188599292032682,0.9460655979666873,0.5454545454545454,0.9698206425425837,1.0,14/65,18.00%,RORA;EGLN3;SUV39H1;HILPDA;AQP1;P4HB;BAD;PGK1;UBQLN1;RGCC;BNIP3;HP1BP3;SUV39H2;PINK1
prerank,positive regulation of histone methylation (GO:0031062),0.3761147681189169,0.9459976111289488,0.5332326283987915,0.9692353939963061,1.0,6/24,17.37%,OGT;KMT2A;PAF1;TET1;AUTS2;MTF2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.36533811329257926,-0.9459167145311665,0.5183374083129584,0.854585836620633,1.0,2/12,5.95%,FOXP1;KLF4
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.31200900722532743,0.9455947118500118,0.5665445665445665,0.9694994631895494,1.0,22/79,22.90%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,regulation of lipase activity (GO:0060191),0.42262076502794116,0.9446552007023046,0.5376712328767124,0.9710323098742415,1.0,4/13,18.52%,PCSK5;LMF1;LPL;RHOA
prerank,epithelial cell morphogenesis (GO:0003382),-0.3386205043705329,-0.9444186298312688,0.5324675324675324,0.8575559269629154,1.0,5/17,20.24%,COL22A1;COL15A1;COL18A1;DACT2;MET
prerank,neuromuscular process controlling balance (GO:0050885),-0.37667048806885617,-0.9444087363292737,0.5202020202020202,0.8565908032581102,1.0,3/12,12.18%,PCDH15;TPP1;NRXN1
prerank,neuron projection organization (GO:0106027),-0.3465546654880929,-0.9443876845726451,0.552,0.8556615523662376,1.0,5/15,21.43%,INSR;LGMN;ABCD2;PICK1;PLS1
prerank,cellular potassium ion homeostasis (GO:0030007),0.4263385818628946,0.9443009882487533,0.5291181364392679,0.9711449927651166,1.0,3/13,9.40%,SLC12A2;ATP1A2;ATP1B3
prerank,regulation of neuron death (GO:1901214),0.3084325875559942,0.9439911114742372,0.5600490196078431,0.9711791912840393,1.0,19/82,17.14%,PPARGC1A;RAB29;WNT5A;EGLN3;EFNB2;MAP3K5;CD200R1;GSK3B;SARM1;CHMP4A;CHMP4B;EGR1;LANCL1;SNCG;DHCR24;HTRA2;TBK1;GPR75;CHP1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3247998723033603,-0.9437497058048543,0.5497076023391813,0.8563417570194664,1.0,5/20,13.27%,FAS;CASP3;GSK3A;BOK;DCC
prerank,regulation of fatty acid oxidation (GO:0046320),0.4025519086860277,0.9435735089492285,0.5374376039933444,0.9714993207766992,1.0,3/16,5.25%,PPARGC1A;SOX9;PDK4
prerank,import into cell (GO:0098657),0.3376158760690155,0.9429242362737982,0.5324137931034483,0.9723322069624032,1.0,8/41,6.69%,LRRC8D;SLC1A7;SLC12A4;SLC27A1;LRSAM1;ATP1A2;SLC6A13;SLC1A6
prerank,purine ribonucleotide transport (GO:0015868),0.4090548276226279,0.9427006274384067,0.5363036303630363,0.9721374154064922,1.0,2/16,4.44%,LRRC8D;SLC35B2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.33012507486003706,-0.9424038679506681,0.5621761658031088,0.8588441770906847,1.0,5/18,19.00%,NUP133;THOC2;ZC3H11A;HHEX;DDX19A
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.32493194374678447,-0.9423171181991785,0.5543478260869565,0.8580755151521269,1.0,4/18,7.43%,FLT1;AKT3;IGF2;COL4A3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.43821733942638585,0.9416220674868213,0.5301794453507341,0.9740154927859567,1.0,5/12,21.84%,DND1;NCOR1;NCOR2;PPARG;ELAVL1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.28342435576330977,-0.9411697267199988,0.5612535612535613,0.8600457523264144,1.0,4/29,6.94%,IL31RA;GHR;IFNAR2;JAK2
prerank,quinone biosynthetic process (GO:1901663),0.40980368636069386,0.9410096832166855,0.5559265442404007,0.9747268531047376,1.0,3/14,8.82%,COQ7;COQ8A;COQ9
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3976914369176663,0.9408808762190372,0.5163398692810458,0.9743046146627347,1.0,6/17,21.40%,KCNS2;NOS1AP;KCNAB1;KCNRG;SUMO1;VAMP2
prerank,inorganic cation transmembrane transport (GO:0098662),0.2740173578973517,0.940857990535013,0.6222684703433923,0.9736238201803603,1.0,38/268,13.98%,KCNJ4;OTOP1;SCN10A;NALCN;TRPM3;SLC12A2;KCNA5;SLC39A13;KCNJ16;ANO6;SLC24A1;TRPV4;KCNS2;SLC12A3;KCNK1;ATP2B4;CACNA1H;ATP1A2;SLC6A13;SLC4A4;SLC30A6;SLC4A11;COX15;KCNK5;ATP1B3;NNT;KCNS3;TRPC4AP;KCNAB1;SCN2B;SLC9A7;SLC9A6;PKD1;TRPV2;ABCB7;KCNK10;KCNK4;SLC6A4
prerank,regulation of cytoskeleton organization (GO:0051493),0.2973045964615319,0.9407943190679745,0.5669856459330144,0.973038169264654,1.0,8/108,5.92%,EFNA5;DLC1;F11R;ARHGAP18;SPEF1;RAC2;CAPN6;ARHGEF5
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.3072359992787828,-0.9405433432363421,0.5519125683060109,0.8606702288959134,1.0,4/24,6.22%,TEK;PIK3R1;DUSP3;KDR
prerank,barbed-end actin filament capping (GO:0051016),0.3958791188289722,0.9404867673544842,0.5173501577287066,0.9723266699537019,1.0,4/18,7.68%,ADD3;CAPZB;ADD1;VILL
prerank,actin filament capping (GO:0051693),0.3958791188289722,0.9404867673544842,0.5173501577287066,0.9723266699537019,1.0,4/18,7.68%,ADD3;CAPZB;ADD1;VILL
prerank,negative regulation of insulin secretion (GO:0046676),0.39669684570818414,0.9404561233159068,0.5214521452145214,0.9716734184135916,1.0,1/17,0.54%,INHBB
prerank,regulation of lymphocyte migration (GO:2000401),-0.403375904982654,-0.9401230662325545,0.5535307517084282,0.8608085594375987,1.0,3/10,8.19%,MSN;STK10;AKT1
prerank,regulation of cell development (GO:0060284),-0.28502267141073273,-0.9398064160691039,0.5589225589225589,0.8606486231841203,1.0,5/36,8.19%,NOTCH2;FOXO1;HDAC9;RPS19;AKT1
prerank,microvillus organization (GO:0032528),0.4189926902238324,0.9393657063447579,0.5051020408163265,0.973628031979627,1.0,3/13,8.68%,RAP1A;MINK1;RAPGEF6
prerank,membrane organization (GO:0061024),-0.19947030247654432,-0.939162350407261,0.704225352112676,0.8612420638089072,1.0,32/227,9.97%,MYOF;PICALM;HIP1;TGFA;ANK2;DNM3;DAB2;TFRC;DNAJC6;DYSF;NAPA;TRIP10;AP2A1;STX18;LDLR;SYT9;HSPA8;HIP1R;MYADM;ATP2C1;ACTB;SH3KBP1;CTDNEP1;EPS15;SH3GLB1;LEMD3;LDLRAP1;PIK3C2A;ACTG1;ARPC3;VPS4A;ANK3
prerank,glucose import (GO:0046323),0.41943655069510244,0.9390004315628708,0.5162337662337663,0.9737488592014883,1.0,3/13,9.63%,SLC27A1;ZDHHC7;SLC27A4
prerank,positive regulation of telomere maintenance (GO:0032206),0.3487175133239465,0.9386754156073364,0.5414285714285715,0.9737729943950759,1.0,12/31,26.70%,NEK7;NBN;NAF1;ERCC1;MRE11;HNRNPD;SLX4;MAPK1;ATRX;TNKS;PML;RAD50
prerank,negative regulation of phosphorylation (GO:0042326),0.30395025947376186,0.9386665375547634,0.5566382460414129,0.973069231304315,1.0,9/85,8.23%,DYNLL1;NTRK3;PTPN13;PLPP3;HDAC4;IBTK;EPHB2;NCOR1;OCLN
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.38771460064697405,-0.9385296889393423,0.5491071428571429,0.8618597844475274,1.0,5/11,25.54%,HIF1A;ATF4;RACK1;NR4A3;FBXO7
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3937357498004576,0.9382449516911294,0.5171232876712328,0.9733611320913184,1.0,4/16,9.04%,CAMK2D;FKBP1B;ATP1A2;CASQ2
prerank,regulation of biomineral tissue development (GO:0070167),0.36867939627972485,0.9381404404838231,0.5279034690799397,0.9728801371259627,1.0,5/26,10.71%,SGMS2;SOX9;BMP2K;FBXO5;ANKH
prerank,post-translational protein modification (GO:0043687),0.27013287431653626,0.9380178161862376,0.6275933609958506,0.9724630735172556,1.0,77/332,19.43%,FAM20C;GPC3;STC2;LAMB2;LAMC1;FBXL15;SOCS5;ASB6;LMO7;SCG3;SPSB4;PSME3;NUCB1;KEAP1;FN1;BMP15;SUMF1;ADAM10;SOCS6;PTP4A2;ATG5;GOLM1;RAB3A;FBXO31;CUL3;RCN1;CDH2;PSMB5;DCAF13;FBXL19;PROC;PRKCSH;KLHL21;FBXL5;MEN1;FBXO11;FBXO21;PSMB2;P4HB;STT3A;PSMA2;KLHL22;CHM;FEM1C;PSMA6;CHGB;COPS5;PSMD13;FBXW8;PSMA7;FBXO41;DDB2;FBXL12;MBTPS1;FBXW7;FBXL3;DSCC1;CUL4B;RNF7;PSME4;VCAN;CALU;FSTL1;BTBD6;WFS1;VGF;SOCS2;PSMC4;FBN1;PSMB6;PSMD12;PSMD14;ICMT;RAB5A;ZBTB16;DDA1;KBTBD7
prerank,cellular response to inorganic substance (GO:0071241),-0.32515074518131004,-0.937770070113822,0.547486033519553,0.8628037607536216,1.0,6/21,19.72%,FOXO1;BLM;MTR;DDI2;NSMCE3;TIMELESS
prerank,adenine nucleotide transport (GO:0051503),0.4016408625096208,0.9374027525410568,0.5500821018062397,0.9731737607383296,1.0,2/17,4.44%,LRRC8D;SLC35B2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.3275860417825752,-0.9370527261957383,0.5541561712846348,0.8626127156936125,1.0,9/19,33.50%,POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;ACD;POLR2I;TINF2;POLR2B
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.3275860417825752,-0.9370527261957383,0.5541561712846348,0.8626127156936125,1.0,9/19,33.50%,POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;ACD;POLR2I;TINF2;POLR2B
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.31688654008265654,0.9369572324542507,0.5447368421052632,0.9735446587231282,1.0,13/63,18.02%,NFATC2;PTPRC;EPHB2;NCK2;CD320;IL6ST;GPR183;CD276;CD81;IL7;IL15;IRS2;FGF10
prerank,regulation of cellular component size (GO:0032535),-0.29899280819807,-0.9367310808062245,0.5460122699386503,0.8625079502003891,1.0,3/30,1.25%,PICALM;EPS8;MSN
prerank,cardiocyte differentiation (GO:0035051),-0.40404836578750525,-0.9366928559466423,0.5558312655086849,0.8616109126948693,1.0,6/10,15.43%,SIK1;BMP2;GATA6;TGFB2;EEF1AKMT4-ECE2;MYOCD
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3680005504989492,-0.9365431681837664,0.5024038461538461,0.860990799505164,1.0,6/12,16.52%,LAMA3;ACTB;ACTG1;FUZ;VANGL2;AHI1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4303795514739182,0.936392843018394,0.5139372822299652,0.9742051232469622,1.0,3/12,10.47%,TET1;RESF1;PPHLN1
prerank,mesenchyme morphogenesis (GO:0072132),-0.3282574113755038,-0.9360669645895514,0.5397196261682243,0.861220013230428,1.0,5/17,12.75%,ENG;NOS3;ACVRL1;BMP2;TGFB2
prerank,fatty acid beta-oxidation (GO:0006635),0.3212265568598594,0.9359563368813786,0.5517693315858454,0.9745088743602609,1.0,9/51,10.29%,EHHADH;DECR2;HADHB;PEX2;GCDH;ACAT1;HSD17B4;ACADS;ACOT8
prerank,apoptotic cell clearance (GO:0043277),0.3497441536986148,0.935926400325627,0.5466666666666666,0.9738654390077978,1.0,6/30,9.49%,XKR7;XKR4;RAC2;RARA;XKR8;HMGB1
prerank,macrophage migration (GO:1905517),0.4351234519175295,0.9354981268485564,0.5371621621621622,0.9741410222479311,1.0,1/13,2.64%,CXCL17
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3653229225704293,0.9353560918172606,0.5383411580594679,0.9737692108893542,1.0,10/26,22.57%,EGFR;SOX9;SYAP1;ZFP36L2;ERBB2;PDPK1;PTPN12;STAT5B;FOXC1;IQGAP1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.38740216731768706,-0.9352597021424165,0.5590909090909091,0.8622575928572751,1.0,5/10,29.40%,DNAJA1;CORO2B;MAPT;NDFIP2;PPM1F
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.23061721387074252,-0.9351139782442246,0.6408839779005525,0.8616350381208183,1.0,18/80,14.52%,PICALM;ROCK2;EPHA4;LARP6;PRR16;EIF3C;RPL26;NPM1;RPS6KB1;CASP3;ZCCHC4;GSK3A;YTHDF1;SP1;ABCA2;THBS1;ABCG1;VIM
prerank,protein kinase A signaling (GO:0010737),0.42600031913418146,0.9350992937867467,0.5652920962199313,0.9736485948404714,1.0,4/12,17.75%,RDX;PRKACB;EZR;LCP1
prerank,regulation of cell death (GO:0010941),0.2956417609563803,0.9350637100423277,0.5525059665871122,0.9730195726811273,1.0,18/94,13.45%,PRODH;ACER3;SPEF1;RAB29;WNT16;CIDEB;CELF1;NPAS2;ATG5;SARM1;FERMT2;CHMP4B;AXIN2;APC;FAF1;SNCG;DHCR24;SOX4
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3371667733192012,-0.9343244859691701,0.5380577427821522,0.8626964294962227,1.0,1/17,1.51%,LPGAT1
prerank,hepaticobiliary system development (GO:0061008),0.3852774453731267,0.9340485891313305,0.5364667747163695,0.9747094417218245,1.0,4/20,6.10%,COBL;NF1;LSR;GFER
prerank,positive regulation of inflammatory response (GO:0050729),0.2982881153970371,0.9337893370776527,0.5521844660194175,0.9746065082055214,1.0,14/86,12.38%,LBP;MGST2;WNT5A;ABCC1;IL17RA;TLR7;TRADD;PTGER4;TNIP1;KARS1;S100A9;IL6ST;VAMP8;CD81
prerank,regulation of DNA damage checkpoint (GO:2000001),0.447284659598672,0.9336306390035828,0.5357766143106457,0.9742719276176984,1.0,5/10,21.38%,WDR76;RFWD3;ETAA1;THOC5;CCAR2
prerank,glycolipid metabolic process (GO:0006664),0.3264209173295165,0.9335080144790219,0.5520974289580515,0.9738390707885731,1.0,17/47,24.26%,ST3GAL4;NAGA;SUMF1;PGAP3;CERK;NEU1;HEXA;SCCPDH;HEXB;GBGT1;ASAH1;ST6GALNAC6;SUMF2;PGAP1;ESYT2;ARSA;SMPD2
prerank,regulation of cellular component movement (GO:0051270),-0.2530653914438023,-0.9334650262539268,0.5495867768595041,0.8637832833694181,1.0,13/49,13.25%,ETS1;ROCK2;TGFBR3;SP100;LYN;TGFBR1;IGBP1;RPS19;CDK6;DIAPH1;ZSWIM6;YTHDF1;ZSWIM4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.3551539099448923,0.9333988403557325,0.5370101596516691,0.9733714069536793,1.0,7/30,17.59%,HNRNPC;SRC;STN1;EXOSC10;MEN1;GNL3L;TERF2
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.38646298567369436,0.9331715593047207,0.5501519756838906,0.9732294847182955,1.0,5/20,13.40%,DKKL1;BCKDK;NCOR1;C1QTNF12;GCK
prerank,response to X-ray (GO:0010165),0.4156591123152757,0.9331345368653441,0.5599343185550082,0.9725977829990271,1.0,4/14,13.53%,BRCC3;IKBIP;MSH2;NUCKS1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3719599524695391,0.9330817768435091,0.5279878971255674,0.972024577472756,1.0,2/21,4.40%,EFNA5;PEAK1
prerank,tRNA wobble base modification (GO:0002097),-0.3517019260830475,-0.9330190980357188,0.5436893203883495,0.8639132759828364,1.0,9/14,37.22%,ELP3;TRMT9B;ELP4;GTPBP3;MOCS3;KTI12;ADAT2;CTU2;CTU1
prerank,negative regulation of protein secretion (GO:0050709),-0.276019705233067,-0.9329807326175384,0.5821917808219178,0.8630340582561851,1.0,12/38,18.56%,KCNB1;CCN3;NR1H3;MIDN;APOE;CD200;SERGEF;RHBDF2;RAB11FIP3;RAB11FIP1;RSAD2;OPRM1
prerank,nervous system development (GO:0007399),0.2638295325221198,0.9329725697192164,0.6608606557377049,0.9715721095087376,1.0,66/429,13.59%,NGF;EFNA5;LPAR1;LDB2;JAG1;ZC4H2;RAB29;RBFOX2;NF1;STIL;OPHN1;TMOD2;NPAS2;GLIS2;NBL1;HDAC4;DSCAM;PCDHB15;DACT1;ACVR1C;INTU;FN1;NTN5;CLN8;NCAN;ARTN;LSAMP;ARHGAP26;EPHB2;GMFB;SCD5;TAGLN3;CHERP;SIAH1;CDH2;ALDH5A1;S100B;IGF2BP2;DYRK1A;JRKL;KALRN;PTS;DOC2A;GPM6A;MPZ;UNC119B;RPS6KA3;BTBD2;POU4F1;AXL;RELN;ERCC6;BPNT1;TMEM223;APC;PRPS1;WDR62;FBXL17;DPYSL2;NDUFV2;PTEN;CHRM2;PKD1;SMO;SDK1;DPF3
prerank,negative regulation of RNA splicing (GO:0033119),0.3793843992256027,0.9329003758450133,0.5401929260450161,0.9710427494606501,1.0,9/19,24.09%,SRSF4;RPS13;PTBP3;SFSWAP;PTBP2;SAP18;SRSF12;SRSF10;RBMX
prerank,ncRNA metabolic process (GO:0034660),0.3425468528393726,0.9326014107526472,0.5376955903271693,0.9710504614322789,1.0,12/37,25.77%,PIWIL2;DDX17;DGCR8;DICER1;RAN;PRKRA;XPO5;DTD1;TDRD9;MEPCE;TENT4B;AGO2
prerank,visual perception (GO:0007601),0.3020847460415657,0.9325730732784165,0.5682382133995038,0.9703915765004878,1.0,9/84,11.96%,RDH10;POU4F3;EFEMP1;SLC24A1;CNGB1;CRYBB3;BEST1;COL1A1;CRYBG3
prerank,histone H3-K9 demethylation (GO:0033169),-0.3814622243509047,-0.9325636509199731,0.5522388059701493,0.8631128835113253,1.0,4/11,20.15%,PHF8;KDM1A;KDM7A;KDM4D
prerank,histone lysine demethylation (GO:0070076),-0.30944045821448246,-0.9324473593818648,0.525974025974026,0.8624456665519166,1.0,5/25,12.83%,KDM5C;PHF8;KDM2B;KDM1A;KDM7A
prerank,cilium movement (GO:0003341),0.33104445122481085,0.9324266251120042,0.5561643835616439,0.9700383795306748,1.0,13/47,22.53%,CFAP73;SPEF1;SPAG17;CCDC39;DNAH5;CCDC40;CFAP70;CFAP61;ODAD1;ZBBX;TTC29;DNAI4;CFAP100
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.3036516381243775,-0.9323660073776587,0.5501519756838906,0.861713236509243,1.0,9/26,20.24%,CLIP1;STMN2;RPS3;MAPT;CDK5R1;ARL2;FES;KATNB1;MET
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.31695002567488806,0.9320974374672629,0.5774647887323944,0.9701144787209401,1.0,16/61,18.76%,CAV1;PSME3;PDK4;PSMB5;NCOR2;PSMB2;PSMA2;PSMA6;PANK2;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3912091138287174,-0.9319502943056542,0.565410199556541,0.8618435534045333,1.0,6/10,39.53%,CALM1;CALM3;GPR35;CRHR1;GNB5;DRD3
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3527261159564169,0.9317616223051606,0.5073313782991202,0.9701732171643261,1.0,8/32,16.89%,PLCE1;SRC;RAC2;RREB1;OCLN;AKIRIN1;AUTS2;ARHGEF7
prerank,regulation of B cell proliferation (GO:0030888),0.3330062045976702,0.9315902841810467,0.5495867768595041,0.9698637048567741,1.0,7/44,13.16%,NFATC2;PTPRC;EPHB2;CD320;GPR183;CD81;IL7
prerank,RNA export from nucleus (GO:0006405),0.2935568423827732,0.9314879009528825,0.5728038507821901,0.9694120364029268,1.0,33/100,23.30%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;RAN;NUP93;THOC5;MCM3AP;XPO5;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33
prerank,brain morphogenesis (GO:0048854),-0.3656795476462457,-0.9314067133805928,0.5928571428571429,0.8622950408295225,1.0,4/12,14.89%,SHANK3;SPEF2;BBS2;MKKS
prerank,phosphatidylinositol metabolic process (GO:0046488),0.29485129315926767,0.9306287968014755,0.5995203836930456,0.9706883137338994,1.0,17/109,9.15%,PTPN13;PLCB3;PI4K2B;TPTE;SLC27A1;PIP4K2B;PIK3R4;PGAP3;PLEKHA4;MTMR7;PIK3R2;MTMR6;OCRL;INPP5F;MTMR3;PLEK;LCLAT1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2649991524300951,-0.9304569828575914,0.603112840466926,0.8637301580128888,1.0,18/48,19.45%,NEDD9;CUX1;CDC42;OBSL1;TRIOBP;MYADM;CUX2;CRK;CRKL;FLNA;CDKL5;ILK;NRP1;PTPRD;CARMIL1;LIMS2;TESK1;LIMS1
prerank,myoblast differentiation (GO:0045445),-0.3520636338136684,-0.9304023890536331,0.5377358490566038,0.8628943089028187,1.0,4/14,10.59%,IGF1;HINFP;MAPK12;EPAS1
prerank,neutrophil chemotaxis (GO:0030593),0.3265077811048768,0.9297056792942555,0.5403973509933775,0.9721340142924364,1.0,1/53,0.29%,CXADR
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.2620567612806315,-0.9295242140441604,0.5645161290322581,0.8642154451265824,1.0,12/45,19.77%,SP100;IRF2;TRIM25;B2M;VCAM1;JAK2;CAMK2A;IRF1;GBP2;MT2A;TRIM8;ICAM1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.31059107961340626,-0.9293797669034495,0.5654596100278552,0.8636209372303536,1.0,6/23,17.04%,PRKAG2;CALM1;UBE2K;SPHK1;CALM3;EGF
prerank,inorganic anion transmembrane transport (GO:0098661),-0.23874126287438335,-0.9293046262198402,0.5822784810126582,0.8628803909851378,1.0,23/63,22.16%,ANO1;SLC12A6;ANO4;SLC5A6;ANO3;GABRA2;SLC26A2;SLC25A30;SLC25A11;LRRC8A;GABRB1;SLC12A5;GLRA2;SLC1A3;SLC6A1;SLC1A1;ANO5;SLC12A7;GABRE;GABRA5;SLC37A1;ANO2;SLC12A9
prerank,RNA 3'-end processing (GO:0031123),0.3097721580065149,0.9287668506079186,0.5633074935400517,0.9736497763541673,1.0,24/69,25.76%,CSTF1;RBM8A;SRSF4;RPRD1B;TUT1;CSTF3;LIN28B;RPRD1A;UPF3B;THOC3;THOC5;SLU7;SYMPK;SRSF3;DHX38;NUDT21;SRSF11;PCF11;CPSF2;WDR33;SARNP;PABPN1;TENT4B;PNPT1
prerank,axonal transport (GO:0098930),-0.2768260006546349,-0.9286511274117513,0.5614617940199336,0.8636009156112331,1.0,9/36,18.23%,KIF1B;DST;NEFL;HIF1A;MAPT;DTNBP1;OPA1;TMEM108;BLOC1S6
prerank,regulation of ATP biosynthetic process (GO:2001169),0.39662282807202753,0.9283568842943075,0.5191986644407346,0.9739247971382685,1.0,1/16,0.58%,PPARGC1A
prerank,transcription by RNA polymerase II (GO:0006366),0.26748046017321553,0.9280546865828859,0.6184074457083765,0.973903568356078,1.0,57/305,18.15%,RORA;PPARGC1A;NR3C2;RARB;DTX1;CSTF1;MAML2;MLLT3;PGR;INTS10;TAF10;LEO1;SNRPF;MED18;RPRD1B;TAF4B;CDK13;TEAD3;CDK7;PAF1;NCOR1;CSTF3;RREB1;RARA;RPAP2;ELL;MED7;NELFB;RORB;SUPT4H1;RPRD1A;NRBF2;ERCC6;NCOR2;RARG;MED23;GTF2F2;TAF15;CREBBP;GTF2H1;TRIP11;MBD1;CBFB;NR5A1;TAF5;YAP1;INTS3;SRRT;ELOA;ESRRA;PPARG;RTF1;TCEA1;SETD2;SYMPK;TSC22D1;GTF2H3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.4302721925793161,0.9278754590692638,0.5488721804511278,0.9736155482604387,1.0,1/10,5.04%,CNGB1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3959248057566329,0.9274721426335691,0.5257731958762887,0.9738584621619767,1.0,2/15,4.62%,PIEZO2;TMC2
prerank,regulation of acute inflammatory response (GO:0002673),-0.3215140456010497,-0.9273982236978239,0.5408653846153846,0.8657764271226723,1.0,1/18,1.18%,OSMR
prerank,chromatin organization (GO:0006325),0.2847452883455099,0.9272511517529336,0.5886363636363636,0.9736126754128932,1.0,44/132,21.52%,SPI1;SOX9;CDAN1;HDAC4;SATB1;CHD1;SMARCAD1;SUV39H1;GATAD1;SMARCD2;SUPT4H1;HDAC2;BAZ2B;PBRM1;TOP1;INO80;KDM6B;NUCKS1;BAZ2A;TADA2A;CHD1L;KDM4B;MCM3AP;BRWD1;HP1BP3;SETD2;MTF2;SUV39H2;HMGN2;RUVBL2;TCF7L1;HDAC3;NUDT5;HCFC2;RBBP4;HMG20A;CHRAC1;LOXL2;KDM5B;DAXX;SETDB1;RSF1;DDX11;ARID1A
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.35368479217733745,0.9272496736422811,0.5306427503736921,0.972904580835703,1.0,12/29,21.69%,LEO1;TRRAP;AXIN2;PYGO1;MEN1;CREBBP;BCL9;KMT2D;TCF7L1;CDC73;ASH2L;TCF7L2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.339508720431596,0.9271484354587094,0.5603932584269663,0.9724245795324926,1.0,5/38,8.37%,CAV1;ASS1;ATP2B4;DDAH2;NOS1AP
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.41530135299953186,0.9268470528693313,0.545774647887324,0.9724147874879016,1.0,4/13,17.17%,LAMP1;GAB2;SYK;STX4
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.335373358677136,-0.9262640655686059,0.554089709762533,0.8676235378869231,1.0,4/17,10.46%,SASH1;BMP6;NFKBIL1;TRIB1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3157818885745534,0.9261833787097666,0.5710659898477157,0.9732832491360929,1.0,6/70,9.35%,NGF;HIPK1;TRADD;MCL1;BAG3;GSK3B
prerank,intracellular protein transport (GO:0006886),-0.19026923683927877,-0.9256269792315657,0.8292682926829268,0.8682581329126818,1.0,74/304,20.65%,RANBP3L;TBC1D4;STXBP3;WLS;ARHGEF2;KIF13B;IPO9;TBC1D1;MYO6;RABGAP1;APPL2;RAB6B;COG7;NUP107;TBC1D12;PREB;C2CD5;NAPA;TMED9;AP2A1;STX8;TBC1D30;USP6NL;TBC1D2B;NPM1;HEATR3;AKAP6;NUP133;RANBP6;RASSF9;AKT1;SURF4;SGSM3;COPZ1;SEC16A;GABARAP;COPZ2;EIF2D;STX17;EVI5L;AP4E1;RAB5C;CLIP3;RANBP3;TMED3;TBC1D22B;SAR1B;RAB24;VPS26B;STX12;HERC2;CTSA;NUP88;GGA3;TMED1;STX6;ARF5;LAPTM5;SCFD1;XPO6;STX16;TECPR2;SEC31A;COX18;RAB32;CDC37;SYNDIG1;E2F3;KATNB1;TMED7;TBC1D17;VPS28;MAIP1;PICK1
prerank,embryonic skeletal system development (GO:0048706),0.3391777353976283,0.9255251641319909,0.5552367288378766,0.9741470354339051,1.0,5/35,4.96%,SULF1;KIAA1217;PCSK5;DYNC2I1;WNT5A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3973319997941076,-0.9254592708795237,0.5682819383259912,0.8677289219682663,1.0,5/10,21.72%,ATP5PD;VPS9D1;ATP5MC3;ATP5PO;ATP5MC2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.31960218603208657,-0.9254274550952499,0.5396825396825397,0.8668436026330825,1.0,2/18,6.91%,PLCB1;AGRN
prerank,cartilage development (GO:0051216),0.3197637575491502,0.9251940287433361,0.5668523676880223,0.9742417122177734,1.0,6/49,4.05%,SULF1;RUNX2;GPLD1;WNT2B;TRPV4;SOX9
prerank,covalent chromatin modification (GO:0016569),-0.3478799817933494,-0.9251227138859694,0.5678391959798995,0.8666219406518278,1.0,4/14,12.46%,SETD5;HDAC1;HLCS;PARP2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4197106713247357,0.9250715412997815,0.5618556701030928,0.9738217676811577,1.0,2/13,7.23%,GLI1;TBX2
prerank,ubiquinone biosynthetic process (GO:0006744),0.39595801805492337,0.9250074261507728,0.5665024630541872,0.9732567112696068,1.0,3/15,8.82%,COQ7;COQ8A;COQ9
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3679533600654787,-0.9249836971588975,0.551980198019802,0.8660479901864613,1.0,3/12,14.28%,NR1H3;NR1H2;ABCG1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.41483733233655296,0.924809915251854,0.5504132231404959,0.9730333784237026,1.0,4/13,11.67%,SOCS5;TSG101;CBLB;SOCS4
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.28105316843139383,-0.9246915404947927,0.6435643564356436,0.8658252123005687,1.0,6/31,9.71%,STXBP3;KCNB1;SYT9;SYT7;CACNA1G;SCAMP5
prerank,Rho protein signal transduction (GO:0007266),0.3147875658255264,0.9246611301491272,0.5590969455511288,0.972659419432435,1.0,13/53,17.25%,CDH13;NTN1;CDC42EP4;RHOJ;RIPOR1;ARHGEF1;CTNNAL1;ADRA2A;CDC42EP3;ARHGEF11;CELSR1;RTKN;ARHGDIB
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.34938839989529547,0.92460342159262,0.5644444444444444,0.9721045857274904,1.0,6/28,16.92%,NRARP;EGFR;EGFL7;WWP2;FBXW7;MMP14
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.42267704504060055,0.9242411833532669,0.542314335060449,0.9722234143468393,1.0,3/11,17.17%,SPI1;TICAM1;STX4
prerank,regulation of cholesterol storage (GO:0010885),-0.3445369559910741,-0.9240388908887384,0.5572139303482587,0.8664366123788553,1.0,4/15,14.28%,PPARD;NR1H3;NR1H2;ABCG1
prerank,lipid catabolic process (GO:0016042),0.3844967664299231,0.923985715985316,0.5450236966824644,0.9720917123098606,1.0,5/18,22.92%,CEL;LIPE;LPL;HSD11B1;SIRT2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3273507735887934,-0.923477234729556,0.5726256983240223,0.8668973926544659,1.0,5/18,12.18%,SHANK3;CUX2;GRIN1;PRKCZ;NRXN1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.34189171589896405,0.9233117239317146,0.5528571428571428,0.9729724380833856,1.0,11/35,18.99%,AWAT2;HMGCLL1;SCD5;ACACA;GCDH;ACAT1;GGTA1;GGT1;HPGD;SCD;BDH1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.27842747913395144,0.9232137478723547,0.6087912087912087,0.9725009582096803,1.0,18/158,11.08%,ROR1;PLK2;LPAR1;PELI2;AKAP13;SLC35B2;REL;NUP62;PPM1A;TRADD;TRIM21;S100B;TFG;TICAM1;TMED4;CANT1;SHARPIN;TAB2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.26311936637877154,0.9230802074372424,0.7038539553752535,0.972127648208868,1.0,81/476,17.11%,RORA;FGF7;MDFIC;NFATC2;GLI1;PPARGC1A;NR2F2;ZNF423;NFATC1;FZD2;EGFR;NPAS3;BCL3;AXIN1;RUNX2;GLI2;MLLT3;KMT2A;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;CHD8;KAT6B;HDAC4;NUP62;WNT5A;PPM1A;ATAD2;SP3;ZFP90;RGMB;CTCF;PAX3;RREB1;RARA;MAP3K5;ILF2;FOXK2;DYRK1A;MED13;RORB;HDAC2;KARS1;TFEB;ILF3;DVL3;COL1A1;TASP1;EGR1;BICRA;KDM8;CEP290;NAT14;SPIN1;CRLF3;TAF15;CREBBP;GTF2H1;SOX4;CDKN1C;FZD7;KAT8;RAI1;ERBB4;FOXF1;NEK4;MED12;CDH1;SNX5;FOXC2;YAP1;TESC;PBX4;PCBD2;ARHGEF11;TFE3;E2F1;QRICH1;PPARG
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.30957756142519577,-0.9226136259065799,0.5678670360110804,0.8681163254424112,1.0,11/22,20.17%,SLIT2;KANK3;HIP1R;TWF1;MYADM;TMSB10;CYRIB;TMSB4X;PFN1;SSH2;SSH3
prerank,protein destabilization (GO:0031648),0.35606113504712505,0.9226136014046419,0.5726256983240223,0.9725125816964642,1.0,15/32,23.12%,TRIM21;PEX2;CUL3;IRGM;KDM8;CREBBP;HTT;FBXL3;SENP2;CDC73;PRKN;MUL1;DERL1;FBXW11;PRNP
prerank,N-glycan processing (GO:0006491),-0.3310128523400702,-0.9223944231819314,0.5961538461538461,0.8677039121579331,1.0,5/18,14.85%,ST8SIA4;MGAT4A;GANC;ST8SIA2;FUT8
prerank,potassium ion transport (GO:0006813),0.2849870946498023,0.922387234441583,0.5794392523364486,0.9723601886690604,1.0,18/120,13.89%,KCNJ4;NALCN;KCNA5;KCNJ16;SLC24A1;KCNS2;KCNK1;ATP1A2;KCNJ13;KCNK5;ATP1B3;KCNS3;KCNAB1;SLC9A7;SLC9A6;AQP1;KCNK10;KCNK4
prerank,autophagosome assembly (GO:0000045),-0.24787743900901718,-0.9221823018254754,0.5896414342629482,0.8673046945306306,1.0,17/52,24.51%,ATG16L2;BECN1;GABARAPL1;VMP1;WIPI1;ULK2;GABARAP;STX17;AMBRA1;STX12;ATG13;MAP1LC3A;RAB7A;WIPI2;ATG12;WDR45B;WDR45
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3304531033515978,-0.9221564885110358,0.5706806282722513,0.8664199083301054,1.0,4/17,16.00%,PARD3;CALM1;CALM3;EIF4G1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.40905636449150296,0.9217563848678457,0.5536626916524702,0.9731213564751483,1.0,2/14,6.14%,WNT5A;ADAM10
prerank,negative regulation of interleukin-1 production (GO:0032692),0.37081916427390604,0.9216453653833457,0.5577507598784195,0.9726656417464588,1.0,3/23,9.52%,CEACAM1;TNFAIP3;NLRP2B
prerank,divalent inorganic cation homeostasis (GO:0072507),0.36487728869440633,0.9214796609884588,0.5517241379310345,0.972383273979223,1.0,1/25,0.24%,CAV1
prerank,regulation of cellular response to heat (GO:1900034),0.298985120845956,0.9213122254029823,0.5921717171717171,0.972066933197683,1.0,27/77,23.75%,CAMK2D;HSPH1;NUP62;BAG3;NUP160;GSK3B;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;CREBBP;NUP93;CHORDC1;DNAJC7;YWHAE;BAG2;CAMK2G;RPTOR;ATR;CCAR2;NUP43;RPA3;SEC13;MAPK1;MTOR
prerank,regulation of potassium ion transport (GO:0043266),0.34047118352805184,0.9211277297684426,0.5677710843373494,0.9718197546734688,1.0,7/31,13.61%,KCNA5;KCNIP4;CASQ2;ADRA2A;KCNAB1;FHL1;KIF5B
prerank,positive regulation of intracellular transport (GO:0032388),0.33727528923956646,0.9210942275464016,0.5552367288378766,0.9712047312316603,1.0,15/38,22.66%,RAB29;KIF20B;CEP131;EHD2;RIPOR1;TPR;NEDD4;CEP290;PCM1;TBC1D20;EHD1;VAMP2;TENM1;PGAP1;OAZ2
prerank,cellular response to glucose starvation (GO:0042149),0.33205970692120196,0.9208874500154991,0.5440340909090909,0.9710116639317623,1.0,8/41,8.96%,MYBBP1A;PRKAG1;FOXO3;EIF2AK3;PIK3R4;BRSK1;SESN1;MTMR3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3319107328383845,0.9207793816415487,0.556,0.9705688293568303,1.0,7/46,12.67%,TSHZ3;DGKZ;OPHN1;ATP1A2;CDH2;RELN;GRM1
prerank,nuclear membrane organization (GO:0071763),0.38037753346508624,0.9206888715360242,0.5552,0.970093044770731,1.0,5/19,15.10%,NEMP1;SPAST;CHMP4B;EMD;GPER1
prerank,neuron projection extension (GO:1990138),0.338541751024238,0.9204742340129409,0.5592972181551976,0.9699105837670354,1.0,11/32,22.57%,NRP2;CDKL3;LLPH;SEMA3A;SLC9A6;AUTS2;USP9X;SPG11;NLGN3;IMPACT;IQGAP1
prerank,import into nucleus (GO:0051170),0.3043608114440147,0.9202657212193758,0.589974293059126,0.9696901525920684,1.0,15/73,16.49%,PRICKLE1;IPO8;NUP62;SNRPF;FAM53B;SMN1;TPR;MMP12;NUP50;HTATIP2;CSE1L;NUP153;RAN;NUP93;SYK
prerank,regulation of myotube differentiation (GO:0010830),-0.2918406333041001,-0.9198683181224746,0.5800604229607251,0.8711814389370123,1.0,11/24,29.12%,CCN3;SIK1;HDAC9;HDAC1;BDNF;ATP11A;XBP1;DMPK;NOTCH1;RBM24;FBXO22
prerank,regulation of viral entry into host cell (GO:0046596),-0.2858155021060249,-0.9198624239580957,0.6163934426229508,0.8702502392683098,1.0,12/30,32.61%,LY6E;MID2;TRIM25;TRIM14;LGALS9;TRIM11;TRIM6;TRIM27;CIITA;LGALS1;IFITM2;TRIM62
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3918776844795081,-0.9197151345420865,0.5769230769230769,0.8696614372895284,1.0,4/10,23.94%,DCLRE1B;DCLRE1C;ACD;TFIP11
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.38864014761686483,0.9194314964837395,0.5321821036106751,0.9709338415630087,1.0,1/16,0.79%,ST3GAL4
prerank,regulation of receptor recycling (GO:0001919),0.39409162452120666,0.9192898414640548,0.5368248772504092,0.9705482332128663,1.0,4/16,9.12%,RAB29;KIF16B;INPP5F;TBC1D16
prerank,dephosphorylation (GO:0016311),0.2799585727692293,0.9192762910896284,0.6155580608793687,0.9698800676549546,1.0,31/147,15.20%,PTPN13;PTPRF;DUSP12;PLPP2;ACP6;PTPN14;TPTE;PLPP3;PTPN22;PTPRC;THTPA;PPM1A;PPM1M;MTMR7;PTPRJ;MTMR6;MTMR3;PDP2;PTPRT;SDHAF2;CTDSP1;PPP2R1B;PTPN18;PTEN;PTPRA;DUSP8;CTDSP2;PTPRU;PTPRO;PLPPR1;PTPN6
prerank,regulation of cartilage development (GO:0061035),0.382136967735933,0.9191865181761658,0.5316045380875203,0.9693934325594598,1.0,4/18,4.10%,MBOAT2;PTHLH;SOX9;BMPR1B
prerank,positive regulation of MAPK cascade (GO:0043410),0.2703416100006272,0.9191205356947075,0.6504751847940866,0.9688807574371774,1.0,14/245,4.99%,ROR2;ROR1;NTRK3;FGFR1;LPAR1;ACKR3;EGFR;RAP1A;PELI2;FGF1;CAV2;PTPN22;PRKCA;PTPRC
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.2897116798956849,-0.9189498615463381,0.6,0.8705868287246322,1.0,12/27,36.82%,MAP3K20;TAOK2;IKBKB;CUL1;SKP1;IKBKG;TNIP2;UBB;MAP3K8;CCDC88C;RPS27A;UBC
prerank,protein insertion into membrane (GO:0051205),0.3415694961781821,0.9188139047351822,0.5446559297218155,0.9688990892089087,1.0,13/32,24.81%,EGFR;STX1A;TRAM1;RTP3;EMD;OTOF;UBE2J2;SEC61G;STX5;VAMP2;PRNP;VAPA;SERP1
prerank,apoptotic mitochondrial changes (GO:0008637),0.3540430240035225,0.9186201607477202,0.5653450807635829,0.9686691294343452,1.0,12/32,21.38%,HK2;FIS1;SFN;NAIF1;ERBB4;FZD9;BAD;AIFM2;BNIP3;ATG3;BAX;CCAR2
prerank,lymphocyte migration (GO:0072676),-0.2760659732952712,-0.9186162427888944,0.5993265993265994,0.8704827420797768,1.0,24/32,51.86%,MSN;RET;CCL13;CCL19;ADAM8;CCL2;S1PR1;CCL25;MYO1G;CCL5;CCL11;CCL15;ZAP70;CCL4;GATA3;CCL7;CCL8;MSMP;CCR6;CKLF;CCL1;CCL3;TBX21;XCL1
prerank,cellular response to hexose stimulus (GO:0071331),-0.308166183499889,-0.9185480093814563,0.5739130434782609,0.8697137573777753,1.0,3/23,6.86%,IGF1R;KCNB1;SLC39A14
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2837455314049633,-0.9183811211071977,0.5861027190332326,0.869191470928952,1.0,8/30,17.65%,DPM1;ALG5;STT3B;UBE2J1;RPN2;FUT8;OST4;ASGR1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.27599638199170745,-0.9183438006690534,0.5981308411214953,0.868354907238373,1.0,10/34,17.44%,ANK2;SLC8A1;CALM1;ATP1B1;SLC9A1;ZC3H12A;CALM3;SRI;P2RX4;NOS1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2966294589689234,-0.9182457154602874,0.5567567567567567,0.8676478752158152,1.0,3/23,2.70%,WNT5B;BMP4;GJA1
prerank,negative regulation of viral transcription (GO:0032897),-0.36535357801825474,-0.9179824426478899,0.5663265306122449,0.8673810361583568,1.0,6/13,20.69%,MID2;TRIM14;UBP1;ZFP36;TRIM13;TRIM11
prerank,negative regulation of JNK cascade (GO:0046329),0.35249041332188585,0.9176653757294788,0.5478395061728395,0.9702114656926272,1.0,14/31,24.59%,SH3RF2;PTPN22;DACT1;NCOR1;MAPK8IP1;MEN1;ITCH;PINK1;HDAC3;PRKN;AIDA;TAOK3;PDCD4;CYLD
prerank,NAD biosynthetic process (GO:0009435),0.3737346627401444,0.9174935846355959,0.555735056542811,0.969930251624203,1.0,4/20,12.57%,NAPRT;NADSYN1;NMNAT3;NAXD
prerank,prostaglandin metabolic process (GO:0006693),-0.2882989751276174,-0.9171118676735248,0.5861027190332326,0.8685859547658203,1.0,8/26,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;HPGDS;ACOX1;MIF
prerank,synapse assembly (GO:0007416),-0.238782591978628,-0.9169123903333111,0.587378640776699,0.8681440749670308,1.0,6/67,2.92%,FARP1;SHANK3;DNM3;SPOCK2;ADGRL3;OBSL1
prerank,positive regulation of lipid localization (GO:1905954),-0.3687097230622739,-0.9167293661200904,0.5637583892617449,0.8676510599501178,1.0,2/11,10.21%,LRP1;ZC3H12A
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.28773526233095037,0.9166796398873331,0.6206496519721578,0.9711278664351813,1.0,10/108,7.80%,NGF;DLC1;EIF2AK3;FIS1;ACVR1C;EGLN3;UACA;TRADD;NLRC4;MAP3K5
prerank,regulation of bone mineralization (GO:0030500),0.3170971020101436,0.9163875572302271,0.5760869565217391,0.9711405465841986,1.0,4/55,4.10%,PKDCC;SGMS2;ANO6;BMPR1B
prerank,gonad development (GO:0008406),0.32904302430133797,0.916340825466681,0.5708390646492435,0.9705719853216324,1.0,5/41,7.45%,NR2F2;WNT2B;SOX9;WNT5A;MSH2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3433095918724855,0.9162833518006989,0.5633001422475107,0.9700062230198383,1.0,8/29,13.29%,ELOVL5;ELOVL1;SCD5;ACACA;GCDH;ELOVL2;HACD2;ELOVL6
prerank,regulation of interleukin-8 production (GO:0032677),0.3050829916800021,0.916153842647204,0.5809284818067754,0.9696172411488889,1.0,8/69,11.06%,LBP;BCL3;PTPN22;PTPRC;TLR7;ANXA4;HMGB1;OTUD7B
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.36022767570058645,-0.9161470588966161,0.5872641509433962,0.868084709685602,1.0,4/12,14.40%,AP2A1;TMEFF2;AR;EDN1
prerank,regulation of striated muscle contraction (GO:0006942),0.3508456445845925,0.9157749584607551,0.5839524517087668,0.9697610202349033,1.0,3/27,5.19%,MYBPH;SCN10A;ATP1A2
prerank,fatty acid transport (GO:0015908),-0.33121695532129314,-0.9157526998965789,0.5744125326370757,0.8680726478036281,1.0,3/17,6.29%,ACSL1;PPARD;APOE
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.29985991727609884,0.9157470818934407,0.5892634207240949,0.9691393377631625,1.0,8/76,9.13%,NTRK3;PRKCE;CDC42EP4;NUP62;FER;NCK2;ARF6;PLEK
prerank,nuclear body organization (GO:0030575),0.4123886616380662,0.9156106113441909,0.5709219858156028,0.9687836002370087,1.0,3/12,10.90%,USP50;WRAP53;SRPK2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3908706718385548,0.9155590187427551,0.5914332784184514,0.9682369891541799,1.0,1/17,0.47%,NTRK3
prerank,regulation of telomerase activity (GO:0051972),0.3246666550217808,0.9153163519506549,0.5768156424581006,0.9681219368940754,1.0,6/45,12.08%,SRC;NEK7;NAF1;WRAP53;MEN1;CCT2
prerank,regulation of TORC1 signaling (GO:1903432),-0.27649639615282984,-0.91523021142555,0.5863192182410424,0.868450587990923,1.0,12/33,27.27%,SEH1L;DEPDC5;RNF152;RRAGC;GPR137B;SPAAR;RRAGD;CASTOR2;CASTOR1;PIP4P1;FLCN;ATM
prerank,hippo signaling (GO:0035329),0.35182935687210587,0.9151041869594401,0.5596465390279823,0.9679250497885432,1.0,9/26,16.76%,AMOTL1;TJP2;AMOT;TEAD3;STK3;WWC1;NPHP4;YAP1;YWHAE
prerank,activation of protein kinase activity (GO:0032147),0.28550991879670606,0.9142524440946035,0.5892857142857143,0.9691418922357261,1.0,20/106,15.87%,NTRK3;PRR5;FGF1;AXIN1;MINK1;WNT5A;CARD10;TOM1L1;ADCY5;PRKAR2A;STK3;MAPKAP1;ADRA2A;PRLR;ADCY9;PRKACB;TXN;ADCY8;ADCY3;PIBF1
prerank,protein secretion (GO:0009306),0.30972644778085345,0.9140719654643072,0.5645805592543276,0.9688890962888761,1.0,7/56,9.72%,TANGO6;PCSK5;RAB8B;RIMS2;RAB3A;LTBP2;ABCA1
prerank,positive regulation of histone acetylation (GO:0035066),0.36280430360900245,0.9140388841242952,0.5786259541984733,0.9682776860169937,1.0,1/23,0.58%,PPARGC1A
prerank,positive regulation of protein metabolic process (GO:0051247),0.28884880262675405,0.9140202514369893,0.6018735362997658,0.9676519687012309,1.0,13/110,11.37%,PLK2;GPC3;NEDD4L;AXIN1;TFR2;DACT1;WNT5A;TNFAIP3;MAPK7;ISL1;GSK3B;APC;NEDD4
prerank,regulation of protein localization to cell surface (GO:2000008),0.34252596105325067,0.9140086269735846,0.5696969696969697,0.9669974777080492,1.0,3/33,2.89%,NEDD4L;LEPROT;RIC3
prerank,cellular response to estrogen stimulus (GO:0071391),-0.34371408482397836,-0.9138354883577002,0.578125,0.8708973315120775,1.0,4/14,13.08%,SERPINB9;AR;NCOA4;ARID5A
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3829382531079215,0.9137686857806115,0.5585443037974683,0.9668812265219705,1.0,1/17,0.82%,NEDD4L
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4091214270418457,0.9136875011027048,0.5578583765112263,0.9663729583878843,1.0,4/12,11.37%,PTPN14;SIRT7;TPR;NEDD4
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.3143198953052282,-0.9129847217228351,0.5977961432506887,0.8720629907210499,1.0,4/20,12.93%,ARV1;APOE;LDLRAP1;ABCA2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2839578712119986,0.9129457633108972,0.6111757857974389,0.9674257901231372,1.0,25/114,22.11%,EDA;TNFSF8;FOXO3;PSME3;TRADD;PSMB5;CDIP1;TNFRSF11B;TXNDC17;PSMB2;PSMA2;PSMA6;TNFRSF14;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;ST18;TRAF3;TRAF5;PSMB3;LTBR
prerank,positive regulation of phospholipase activity (GO:0010518),0.3756626533577737,0.9127054596542845,0.5734157650695518,0.9672923986618993,1.0,2/22,0.70%,NTRK3;FGFR1
prerank,midbody abscission (GO:0061952),0.3942142587111239,0.912650903884993,0.5502471169686985,0.9667455115149095,1.0,5/17,11.97%,CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C
prerank,positive regulation of ossification (GO:0045778),0.32964147234886637,0.9123868137617617,0.5574712643678161,0.9666436227712917,1.0,4/39,4.96%,PKDCC;ANO6;BMPR1B;WNT5A
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.28794723295296615,0.9117934187606347,0.5952095808383233,0.9672920212090771,1.0,31/96,23.30%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33
prerank,regulation of autophagy (GO:0010506),0.26941948440452684,0.9117550016896462,0.6574761399787911,0.96669713530983,1.0,31/216,11.37%,DCN;PLK2;LEPR;TPCN1;FOXK1;PRKAG1;FOXO3;PTPN22;WDR41;ATP6V0D2;WDR24;PIP4K2B;KEAP1;ABL2;TRIM21;MCL1;RMC1;PIK3R2;FOXK2;ATP6V0A1;IRGM;MTMR3;GSK3B;HMGB1;TICAM1;EIF4E;TFEB;USP13;TAB2;HDAC6;NEDD4
prerank,chromatin assembly (GO:0031497),0.3298793913340501,0.9117508129014664,0.5754583921015515,0.9660310510402735,1.0,6/38,7.08%,SOX9;CDAN1;KAT6B;CTCF;PAF1;LIN54
prerank,regulation of osteoclast differentiation (GO:0045670),0.3492277590518153,0.9115625769131112,0.5701624815361891,0.9657748639833569,1.0,1/33,0.50%,UBASH3B
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3742200452051532,0.9115203151836525,0.5695581014729951,0.9651927412911089,1.0,3/20,6.14%,APH1B;NCSTN;ADAM10
prerank,regulation of microtubule-based movement (GO:0060632),0.42487008774576757,0.9110637458384143,0.5698324022346368,0.9655190544726531,1.0,4/11,15.69%,LAMP1;HDAC6;TTC21B;CFAP298
prerank,bile acid biosynthetic process (GO:0006699),0.36163352264634424,0.9109987430898214,0.5833333333333334,0.9650175839249336,1.0,4/24,10.29%,CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.29870265757677616,0.9109867381552431,0.5959595959595959,0.9643641190479104,1.0,14/78,13.51%,NR2F2;EGFR;CCND3;CCNG1;CDK7;CCNJ;APC;HEXIM1;MEN1;PTEN;CDC6;PKD1;GTF2H1;CDKN1C
prerank,water-soluble vitamin metabolic process (GO:0006767),0.29900078763241106,0.9105107577700365,0.5997474747474747,0.9647600998521547,1.0,16/68,15.44%,CTRC;FOLR2;PCCB;ACP5;THTPA;MTHFD1;ABCC1;SLC52A1;CD320;CUBN;MMAB;TPK1;AMN;SLC46A1;PANK2;SLC25A19
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3011830453074155,0.9099713170263192,0.6104060913705583,0.9652213445762519,1.0,8/72,9.99%,PLK2;GTSE1;BCL3;CNOT10;ARID3A;NBN;SFN;CNOT7
prerank,tRNA wobble uridine modification (GO:0002098),-0.3507784768901011,-0.9099188927010365,0.5889724310776943,0.8786972545395527,1.0,9/14,37.22%,ELP3;TRMT9B;ELP4;GTPBP3;MOCS3;KTI12;ELP1;CTU2;CTU1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.35326540519666655,-0.9098792878715668,0.5807228915662651,0.8778648650946518,1.0,5/13,14.60%,GREM2;NRROS;BMP2;DAND5;CHRDL1
prerank,organelle assembly (GO:0070925),0.2606601269910216,0.9097727920188731,0.6929375639713409,0.9649695685968108,1.0,89/384,19.81%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;DYNC2I1;TMOD2;CYS1;EXOC3;NUP62;CNGB1;INTU;HPS1;CEP89;TSG101;NEK7;CEP131;SH3PXD2B;IFT81;ATG5;CNGA4;EHD2;NCOR1;SNX10;CEP162;CLUAP1;TMOD1;IRGM;OCRL;CHMP5;PDCD6IP;UNC119B;TCTN2;TMEM237;FOXJ1;IST1;DYNLL2;IFT74;TUBGCP5;CHMP4A;CHMP4B;ATXN2;HDAC6;CFAP20;CHMP4C;EXOC5;CEP290;INO80;CDS2;CSDE1;UBAP2L;MAPRE2;PKD1;ATG7;DDX6;FLII;FBF1;PCM1;PDE6D;FAM161A;DNAH5;PIK3C3;CFAP298;CFAP70;PIBF1;CFAP410;B9D2;MRPL22;UBQLN1;CDC14A;DYNC2H1;EHD1;OFD1;ATG2B;ARMC9;BBS1;CEP250;SNAP29;MAP1LC3B;G3BP1;LSM3;ATG3;HDAC3;TUBGCP6;TCTN1;RB1CC1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.388067981774726,-0.9097088851803358,0.6095444685466378,0.8773068588810236,1.0,2/10,2.52%,MSN;CDC42
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.34070064865742855,-0.9097079551130778,0.5774278215223098,0.8763781445102844,1.0,7/15,19.29%,IGF1;ROCK2;MEF2A;SLC9A1;EDN1;AGT;PARP1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.23323602176434086,-0.9096622030856457,0.6682242990654206,0.8755676452774532,1.0,20/76,18.68%,PTGIS;G3BP2;COMMD1;CYP1B1;ERBIN;KLF4;CD200;CMKLR1;NFKBIL1;LRRC14;ZC3H12A;COMMD7;TMSB4X;PARP10;NLRC3;RWDD3;TRIM37;CDK5RAP3;CACTIN;IRAK2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3750309399918149,-0.9096603035882453,0.5831265508684863,0.8746427449494979,1.0,5/11,13.12%,NR1H3;LDLR;CTDNEP1;NR1H2;MFSD2A
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.30692290867284605,-0.9095738439701423,0.6057441253263708,0.8739338605992059,1.0,5/22,14.44%,PDGFD;ACE;CALM1;TAOK2;CALM3
prerank,negative regulation of cell cycle (GO:0045786),-0.22744549390671845,-0.9091314359627127,0.6648648648648648,0.8740483479895724,1.0,13/73,12.02%,SMAD3;PTPN3;LATS2;NUPR1;BMP4;PTPRK;GAS1;BRINP3;CDK6;TRIM35;RHOB;BMP2;CAMK2N1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3838656407746689,0.9088732409079158,0.5833333333333334,0.9662837715633988,1.0,4/17,14.75%,CTCF;BUB3;ZWILCH;ZW10
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.37988076764317913,0.9088005885592337,0.5725429017160687,0.9657858069867679,1.0,4/20,10.48%,ATIC;PFAS;PPAT;NT5C2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.31389577773723626,-0.9084812083417635,0.5932642487046632,0.8747127128566141,1.0,5/20,11.05%,HOXA5;MEIS1;CDK6;HOXB8;HOXA9
prerank,regulation of fibroblast proliferation (GO:0048145),-0.25476892909910664,-0.9080793215824192,0.6021505376344086,0.8747379237435445,1.0,11/45,14.53%,IGF1;PDGFRA;FTH1;CDK6;MED25;BMI1;B4GALT7;SPHK1;CDK4;PARP10;NLRC3
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.302064996774158,0.907867861630183,0.6070496083550914,0.9672249887261402,1.0,21/71,20.41%,ADAMTS12;FAP;TNFAIP3;SOCS6;CHFR;PDCD6IP;CHMP4B;LONP1;OTUD7B;HDAC6;ZYG11B;FBXL17;CHMP4C;CAPN2;PSMA6;CUL4B;CTSB;USP9X;HM13;UBE2W;PRKN
prerank,response to light stimulus (GO:0009416),0.3130995268909994,0.9074684826762062,0.6073781291172595,0.9674796794723582,1.0,8/55,11.92%,MSH6;SLC24A1;MAPK10;BRSK1;OPN1MW;OPN1MW3;ERCC6;MEN1
prerank,glycerolipid catabolic process (GO:0046503),-0.31829524815403376,-0.9073656478628006,0.6083086053412463,0.8755037592213052,1.0,3/19,12.51%,GPCPD1;PNPLA6;ABHD2
prerank,protein O-linked mannosylation (GO:0035269),-0.3141224149377274,-0.9073262382013164,0.6136986301369863,0.8746882643016464,1.0,3/18,4.35%,TMTC2;TMTC1;DPM1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4140830797565608,0.9073176939422738,0.5572916666666666,0.9671441506907311,1.0,3/13,9.89%,LAMP1;TICAM1;AXL
prerank,regulation of hippo signaling (GO:0035330),0.3836156815550452,0.9071999660570466,0.551433389544688,0.9667585049743093,1.0,4/17,13.55%,VGLL4;WWC1;NF2;CIT
prerank,defense response to fungus (GO:0050832),-0.32089608826428134,-0.9071010925321514,0.5786802030456852,0.8742666230151922,1.0,4/17,18.75%,PLCG2;BCL10;GAPDH;RARRES2
prerank,positive regulation of cell development (GO:0010720),-0.2734471517181305,-0.9069708552119956,0.6234939759036144,0.8736535673625299,1.0,4/31,4.92%,NUMB;TGM2;BMP4;RFX3
prerank,regulation of phagocytosis (GO:0050764),-0.24890538246701466,-0.9065217110799054,0.64,0.8738315403934248,1.0,9/53,9.19%,TGM2;DYSF;SIRPA;SYT7;PIP4P2;IL15RA;CYBA;GATA2;MERTK
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.29000123610762124,-0.9064481541478704,0.6309523809523809,0.873126648202307,1.0,5/25,11.97%,GRIN2B;AKT1;GRIN1;LRRK2;GSK3A
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3290432319962239,-0.9064116686336285,0.5754475703324808,0.87230490267492,1.0,2/16,4.13%,SOX13;NAPEPLD
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2854003506935061,0.9063755244025913,0.6148325358851675,0.9678722681439441,1.0,18/112,10.56%,F11R;PXN;DLX1;WNT10A;CDH5;SOX9;SRC;WNT5A;TGFBRAP1;COL3A1;MAPK7;GCNT2;LTBP2;CGN;FERMT2;LEFTY1;FNTA;ZYX
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.376944131485891,0.9063629886024674,0.583076923076923,0.967227622079677,1.0,8/19,19.17%,AXL;IL7;PPP2R3C;SYK;BTK;MDK;MMP14;XRCC6
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.293106602802793,-0.9062696831636499,0.5764705882352941,0.8717212924621103,1.0,6/27,13.59%,IGF1;PDGFRA;CDK6;BMI1;SPHK1;CDK4
prerank,cytosolic transport (GO:0016482),-0.2091945449981169,-0.9061297332855678,0.74375,0.8711530732163378,1.0,33/108,21.76%,MYO1D;DENND5A;RAB6B;RHOBTB3;GOSR2;AP2A1;STX8;BECN1;RBSN;VPS13C;DOP1B;EPS15;UBE2O;RGP1;SNX16;VPS26B;BET1L;PREPL;CLN5;SORT1;MON2;STX6;LAPTM5;HEATR5A;STX16;SYS1;YKT6;PLEKHJ1;TBC1D17;ANKRD27;RAB7A;RNF126;VTI1B
prerank,substantia nigra development (GO:0021762),-0.2724161602941708,-0.9058143651693584,0.6122448979591837,0.8709894651975861,1.0,14/37,15.09%,CDC42;CKB;GNB4;CALM1;ACTB;MAOB;COX6B1;SEC16A;CNP;TTBK1;S100A1;CALM3;RAD1;ATP5PF
prerank,sensory perception of light stimulus (GO:0050953),0.289952247818061,0.905724646148033,0.6106304079110012,0.9679971943837195,1.0,9/87,11.96%,RDH10;POU4F3;EFEMP1;SLC24A1;CNGB1;CRYBB3;BEST1;COL1A1;CRYBG3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.34128367476272675,0.9054764719231341,0.5598845598845599,0.9678784571838519,1.0,7/33,14.04%,KLK2;AXIN1;DDRGK1;UFSP2;HDAC6;NCOA2;CBFB
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.32508032805130027,-0.9054444574974096,0.6095717884130982,0.8709051495452752,1.0,4/17,15.22%,SLC7A5;PRKCZ;CEBPB;LGALS9
prerank,cochlea morphogenesis (GO:0090103),0.43042716911147155,0.9052953758786948,0.575591985428051,0.9676325747673732,1.0,4/10,20.87%,SOX9;TBX18;MYO3B;PAX2
prerank,cellular protein catabolic process (GO:0044257),0.30349524534066213,0.9048174743197569,0.5924932975871313,0.9679914927028358,1.0,16/59,22.85%,ADAMTS12;FAP;PISD;CPA2;LONP1;CAPN2;HTRA2;PSMA6;AP2A2;BNIP3;CTSB;PRKN;TCIRG1;YME1L1;AP2S1;CLTA
prerank,negative regulation of phosphatase activity (GO:0010923),0.3551072140004237,0.9046615037094536,0.5754276827371695,0.9676793998666373,1.0,7/25,12.92%,SH3RF2;FKBP1B;BOD1L1;GSK3B;MASTL;SEMA4D;PTPA
prerank,bicarbonate transport (GO:0015701),0.36041266065732125,0.9046037111779085,0.5623052959501558,0.9671258966696418,1.0,4/25,7.04%,SLC4A3;SLC26A9;SLC4A4;SLC4A11
prerank,autophagy of mitochondrion (GO:0000422),-0.25452960965499816,-0.9045679442532986,0.6714285714285714,0.872060539703961,1.0,16/38,26.21%,SQSTM1;BECN1;GABARAPL1;WIPI1;ULK2;GABARAP;AMBRA1;ATG13;USP30;MAP1LC3A;WIPI2;ATG12;WDR45B;WDR45;FBXO7;CISD2
prerank,protein complex oligomerization (GO:0051259),0.294968950451761,0.9045610335575858,0.6163366336633663,0.9665583311528719,1.0,25/85,24.23%,CLDN1;LRRC8D;BEND3;SPAST;NLRC4;ATL2;PDCD6IP;GSDMD;VSTM5;ADCY8;HGSNAT;GLRA3;ALS2;EHD1;MS4A1;NUDT21;STOML2;CHMP2A;YME1L1;ELAVL1;MPP2;JMJD6;PRMT8;RBMX;DNM1L
prerank,regulation of protein localization (GO:0032880),-0.23899913317944924,-0.9045124748171849,0.6625,0.8712791421590175,1.0,15/58,19.63%,PICALM;AFDN;FKBP1A;TRIM25;TRIM14;WDPCP;VPS4A;CTSD;KDM1A;MMD;STX6;TESK1;PARP1;RACK1;PLEKHM2
prerank,regulation of cell killing (GO:0031341),0.39294802749985175,0.9042230034930231,0.5829228243021346,0.9666722735411593,1.0,5/16,14.10%,CD55;WNT5A;NOXO1;CFH;FZD7
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.35455128656564333,0.903933744414282,0.5757142857142857,0.9666830871530545,1.0,9/27,18.67%,KAT6B;MSL3;TRRAP;PHF20L1;CREBBP;KAT8;BRD8;MORF4L2;RUVBL2
prerank,protein localization to Golgi apparatus (GO:0034067),-0.2857779513197437,-0.9037248529099056,0.6294117647058823,0.8720993008535408,1.0,4/27,6.91%,VPS13D;OBSL1;COG7;VPS13C
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.2790184314901798,-0.9027787895006611,0.5820433436532507,0.8734986223600899,1.0,6/29,15.04%,SLC4A10;APOE;GRIK2;CAMK2A;DBN1;ZDHHC2
prerank,plasma membrane invagination (GO:0099024),0.33877803644087756,0.9026579836641064,0.5871156661786238,0.9688072337002528,1.0,2/29,2.16%,ARHGAP12;DOCK1
prerank,peptidyl-asparagine modification (GO:0018196),-0.2769896131166852,-0.90263142519518,0.6036585365853658,0.8729596496504282,1.0,8/31,17.65%,DPM1;ALG5;STT3B;UBE2J1;RPN2;FUT8;OST4;ASGR1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2809591253948236,-0.9025522783547831,0.5980707395498392,0.8722449687104473,1.0,10/28,23.42%,LACC1;TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2
prerank,cytoplasmic microtubule organization (GO:0031122),0.30952705795651836,0.9024736554453211,0.5636856368563685,0.9685447096344936,1.0,17/54,21.79%,HOOK2;TRPV4;FIGNL2;LIMK2;SPAST;TUBGCP5;HOOK3;PCM1;SLAIN2;CRIPT;EZR;CHP1;RHOA;KATNAL1;TUBGCP6;CLIP4;CCDC88B
prerank,membrane protein proteolysis (GO:0033619),0.32808396419456554,0.9024064766292745,0.5639204545454546,0.9680372029750548,1.0,6/37,9.34%,ADAM19;APH1B;NCSTN;ADAM10;DAG1;BACE2
prerank,RNA modification (GO:0009451),0.311847699212586,0.9022647119989462,0.59254327563249,0.9676857103330669,1.0,18/54,23.23%,MRM2;RBM15B;PUS7;PUS3;WDR4;CDKAL1;FTSJ1;NSUN5;ALKBH1;ANKRD16;URM1;TYW5;ADARB1;THG1L;TFB1M;TRMT1;JMJD6;MEPCE
prerank,arachidonic acid metabolic process (GO:0019369),-0.2672237391473171,-0.9022351671367583,0.6270627062706271,0.8720476606784031,1.0,7/35,10.30%,PTGIS;CYP1B1;GPX4;DAGLA;PTGS1;PTGDS;TBXAS1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2790094115813023,0.9022218510922733,0.6162790697674418,0.9671121398729743,1.0,20/117,16.60%,PLK2;CD3G;MC5R;PTHLH;SRC;ADCY5;PTGER4;PRKAR2A;TSHR;KARS1;ADCY9;CD81;PRKACB;GGT1;ADCY8;ADCY3;PTH2R;GPR27;SYK;RXFP1
prerank,striated muscle cell differentiation (GO:0051146),0.3875187935004547,0.9019536738523837,0.5629251700680272,0.9670469777485203,1.0,5/16,12.86%,AKAP13;PLD3;SDC1;POPDC3;KDM6B
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.40794850971542995,0.9014289753707753,0.589527027027027,0.9675769317427839,1.0,2/12,6.12%,WDR18;NBN
prerank,ketone body metabolic process (GO:1902224),-0.36994190749017253,-0.9013867355362514,0.5757575757575758,0.8731409082051257,1.0,4/10,8.90%,HMGCL;BDH2;HMGCS2;ACSS3
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.39627209437187855,0.9012903873809881,0.5912280701754385,0.9672343929085316,1.0,1/13,0.88%,NAPRT
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.34055166377116924,-0.9009510793436812,0.6277372262773723,0.8732839634085985,1.0,4/14,6.94%,GHR;LYN;PIK3R1;JAK2
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.2307999876261513,-0.9007194638646614,0.6699507389162561,0.8729520808746296,1.0,17/68,20.44%,ENPP1;GPAT4;HPRT1;ACOT7;BPNT2;DBI;ACSL6;TPST1;MLYCD;LRRK2;ACLY;ACOT6;OPA1;ACOT11;HINT1;OXSM;SULT4A1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.38105995349983673,0.9007115987491703,0.6052631578947368,0.9678466485027979,1.0,2/17,3.14%,SULF1;CASK
prerank,epithelial cell development (GO:0002064),0.37148272821245854,0.9006608531551359,0.573228346456693,0.9672909018380093,1.0,4/20,10.12%,BFSP1;POF1B;TMEM79;LRTOMT
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.32855701635503093,0.9003383333048324,0.5879828326180258,0.9673650892357956,1.0,4/36,4.96%,NFATC1;PLCB3;FZD2;WNT5A
prerank,peptidyl-proline hydroxylation (GO:0019511),0.41772816509105004,0.9002600687779082,0.5730897009966778,0.9668595772499953,1.0,4/11,14.09%,EGLN3;P4HTM;P4HA1;P4HB
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3694916312289419,-0.9001172040454657,0.5746606334841629,0.8734060889390963,1.0,4/11,15.43%,FRS2;BMP2;SOX6;MYOCD
prerank,amino acid transmembrane transport (GO:0003333),0.3167839967850687,0.8994411351403726,0.5891156462585034,0.9680489893198994,1.0,6/45,6.69%,LRRC8D;SLC25A12;SFXN2;SLC38A2;SLC6A13;SLC1A6
prerank,phosphate-containing compound metabolic process (GO:0006796),0.26718771095945326,0.8994075805006615,0.6695371367061357,0.967466567268739,1.0,22/198,7.21%,PLCD3;PLCE1;PLCB3;HK2;DUSP12;PFKP;PLPP2;ACP6;TPTE;PLPP3;LIMK2;PIP4K2B;PTPRC;THTPA;PPM1A;CLN8;BCKDK;COQ8A;CERK;EPHB2;PPIP5K2;ALDOB
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.29014969132285773,0.8988885603649387,0.6297662976629766,0.9679888990102262,1.0,21/85,20.54%,TRIB2;PRICKLE1;SOCS5;SH3RF2;KEAP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;USP13;ZYG11B;RNF185;FBXW7;BAG2;RNF180;TMEM259;DDA1;SUMO1;TMTC3;PRKN;RNF14
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.24500964884972187,-0.8985356051161727,0.6932270916334662,0.8761704527006079,1.0,22/54,29.48%,RPL35A;RPL26;NPM1;HEATR3;RPLP0;RPL3;WDR12;NOC2L;LAS1L;MRPL20;RPL14;NLE1;PPAN;RPL10A;RPL5;PAK1IP1;RPF2;NHP2;RPL7;RPL11;NOP16;RPL24
prerank,defense response to symbiont (GO:0140546),-0.2167457650089522,-0.8985252635320014,0.6380368098159509,0.875291366316196,1.0,24/92,21.48%,SERINC3;IFNAR2;ABCC9;SAMHD1;IRF2;IFIT2;IFIT3;AGBL5;BST2;FLNA;IRF1;NDUFAF4;ABCE1;MOV10;ISG15;IFIT1;CD40;RSAD2;PDE12;OPRK1;CGAS;TLR3;BNIP3L;SHFL
prerank,regulation of translational initiation (GO:0006446),-0.23884256301884588,-0.8980658538773182,0.6639004149377593,0.8754256662444758,1.0,22/63,23.50%,DNAJC3;NPM1;RPS6KB1;GLE1;PAIP2;EIF2AK4;YTHDF1;MTIF2;CEBPB;EIF4G1;NCBP1;CTIF;HSPB1;YTHDF2;KLHL25;ATF4;DDX1;POLR2D;EIF1B;KHDRBS1;EIF3E;YTHDF3
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.36230696615516944,-0.8980231384803871,0.6055045871559633,0.8746199247297524,1.0,6/11,22.92%,IL34;ID2;HSF1;CSF1;CASP8;RIPK1
prerank,dendritic cell differentiation (GO:0097028),-0.2976821563603573,-0.8979499047968791,0.5967741935483871,0.8738784244176042,1.0,10/22,35.39%,LYN;CAMK4;LGALS9;TRPM2;CCL19;IRF8;PRTN3;TREM2;BATF2;LILRB1
prerank,mesonephros development (GO:0001823),-0.36920120390270394,-0.8978414769609249,0.6157407407407407,0.8732565432081756,1.0,2/11,2.60%,OSR1;BMP4
prerank,rRNA methylation (GO:0031167),0.36364537891780563,0.8972610437970966,0.5775075987841946,0.9708869201811716,1.0,6/22,16.72%,MRM2;BUD23;TFB2M;METTL5;NSUN5;MRM1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.29013664516417353,0.8968997619526531,0.6088050314465409,0.9710938700015407,1.0,4/75,1.21%,RGS6;GUCA1A;RGS14;PLCE1
prerank,microvillus assembly (GO:0030033),0.3975232772320446,0.8963960363003073,0.5456081081081081,0.9715592812956435,1.0,3/14,8.68%,RAP1A;MINK1;RAPGEF6
prerank,placenta development (GO:0001890),0.4072251910353628,0.895994380199766,0.5604203152364273,0.9717998018138971,1.0,1/12,2.24%,ADAM19
prerank,neuron apoptotic process (GO:0051402),-0.31185153723554776,-0.8955751934575791,0.6185286103542235,0.8776360823478835,1.0,5/19,11.36%,TNFRSF21;FAS;NAE1;GAPDH;BID
prerank,cellular response to leucine starvation (GO:1990253),0.41109167465581403,0.8952813234987563,0.5724381625441696,0.972671056861117,1.0,5/10,23.75%,SESN1;RRAGB;GCN1;IMPACT;MTOR
prerank,mitochondrion morphogenesis (GO:0070584),-0.3575725087673153,-0.8947159646029145,0.602803738317757,0.8787205447005131,1.0,2/11,12.89%,PID1;SLIRP
prerank,protein import into mitochondrial matrix (GO:0030150),-0.32122550859578825,-0.8940402990969247,0.6267806267806267,0.8793318460891208,1.0,9/18,33.15%,TIMM44;PAM16;TIMM17B;ROMO1;GRPEL1;DNLZ;TIMM50;TIMM23;TIMM21
prerank,reticulophagy (GO:0061709),-0.3588335472000883,-0.8937542717801509,0.6275510204081632,0.8790793846081585,1.0,3/12,8.62%,UBA5;ULK2;UFM1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3055791865951404,-0.8936369635946291,0.6207792207792208,0.878457672993832,1.0,8/20,18.80%,MTHFS;GCLM;PLOD2;PTDSS2;CNDP2;GGCT;GCLC;GATM
prerank,negative regulation of B cell activation (GO:0050869),-0.30475726445647483,-0.8927188099952171,0.6217765042979942,0.8795414789495515,1.0,11/21,28.88%,LYN;TNFRSF21;SAMSN1;ID2;LAPTM5;RC3H1;INHBA;PARP3;ATM;FCGR2B;SFRP1
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.27655270499067985,-0.8926705481758126,0.6350974930362117,0.8787366316339968,1.0,16/27,38.93%,SYT9;SYT7;ARHGAP17;VAMP7;SYT13;SYT6;RIMS1;RIMS3;SYT15;SYT1;SYT5;DOC2B;SYT17;SYT4;SYT3;SCIN
prerank,histone H4 deacetylation (GO:0070933),0.4135534815902533,0.8924342561188525,0.5931623931623932,0.9781928474984527,1.0,6/10,24.13%,HDAC4;SMARCAD1;HDAC2;HDAC3;SIRT2;REST
prerank,fatty acid biosynthetic process (GO:0006633),0.3019093027809119,0.8924035148650352,0.6237244897959183,0.9775959415246004,1.0,15/63,19.24%,ELOVL5;DECR2;HACD4;ELOVL1;SCD5;ACACA;ELOVL2;HACD2;LTA4H;ABCD1;ELOVL6;HPGD;SCD;LPL;FADS1
prerank,central nervous system neuron differentiation (GO:0021953),-0.2700530047867068,-0.8923303073922288,0.63125,0.8785581522656536,1.0,9/33,14.31%,ATP7A;SPOCK1;LRP6;NR4A2;PROX1;MDGA1;GBA2;TOX;MAPT
prerank,mitotic nuclear division (GO:0140014),0.29729521349288973,0.8922919290030361,0.6086956521739131,0.9771905501740757,1.0,19/71,18.52%,KIF2A;SMC3;NUP62;SPAST;TUBG1;DSN1;CHMP4B;NDE1;MAP9;INO80;TUBG2;KLHL22;ZW10;ARHGEF10;RAN;PIBF1;CENPK;OFD1;RHOA
prerank,protein polyubiquitination (GO:0000209),0.25927809664825985,0.8922545639057122,0.7154811715481172,0.9766160201922662,1.0,81/297,21.66%,NEDD4L;UBE2L6;ZNRF2;FBXL15;PELI2;UBE2E2;IRF2BP1;UBE3C;LMO7;PSME3;LRSAM1;TMEM129;TNFAIP3;TRIM21;UBR5;CHFR;UBE2V2;SIAH1;FBXO31;CUL3;AMFR;PSMB5;BLMH;LNPEP;ANAPC5;ANAPC7;UBE3D;SHARPIN;ANAPC11;FBXL19;LONRF1;NEDD4;FBXL5;FBXL17;TTC3;FBXO11;FBXO21;FBXO38;ANAPC2;PSMB2;ANKRD39;CBFB;UBE2J2;UBE2D3;UBE2D1;PSMA2;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;FBXW8;PSMA7;TRIM5;FBXO41;DDB2;UBE2R2;FBXL12;FBXW7;FBXL3;ITCH;PSME4;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;DDA1;KBTBD7;HECTD2;UBE2W;PRKN;MKRN1;RNF146;RNF14;MUL1;TRAF3;TRAF5;ZNRF1;PSMB3;AKTIP
prerank,regulation of fibrinolysis (GO:0051917),0.4034789566987736,0.8921811632747876,0.6027633851468048,0.9761162942922373,1.0,1/13,1.69%,FAP
prerank,regulation of spindle organization (GO:0090224),0.38097174255007826,0.8920759350154178,0.5799373040752351,0.9756817367174729,1.0,3/18,12.02%,SENP6;NUP62;MAP9
prerank,positive regulation of cell cycle (GO:0045787),0.2983869671641036,0.891304184423592,0.6166666666666667,0.9767440481049666,1.0,8/62,10.90%,SMOC2;EGFR;CCND3;PRKCA;TRIM21;RARA;EIF4E;SRPK2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3211400870916872,-0.8910001017666822,0.6146095717884131,0.8806481181137255,1.0,6/17,14.28%,ERLIN1;APOE;SCAP;ABCA2;ERLIN2;ABCG1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3654074872630283,-0.8908451697407812,0.610705596107056,0.8801276778385011,1.0,5/12,18.03%,GCLM;BDH2;CNDP2;GGCT;GCLC
prerank,regulation of stem cell differentiation (GO:2000736),0.2848052497727107,0.8906022291189671,0.6326034063260341,0.9776723249509198,1.0,27/89,21.62%,JAG1;LMO1;KMT2A;PSME3;PUS7;SLC4A11;NELFB;PSMB5;ZFP36L2;PSMB2;CBFB;PSMA2;PSMA6;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;OCIAD1;NUDT21;RUNX1;PSMB3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3045544373389405,0.8904297841793419,0.6248348745046235,0.977412392061149,1.0,12/60,20.69%,SMOC2;NEK7;RFC3;NAF1;WRAP53;CCT2;POLG2;RGCC;DSCC1;ATR;CCT3;HGF
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.3962135250334265,0.8901789168478336,0.5881410256410257,0.9773205488398289,1.0,1/14,0.43%,CORIN
prerank,zinc ion transmembrane transport (GO:0071577),-0.29469257546358946,-0.8898422520811756,0.6228070175438597,0.8815901278893369,1.0,4/22,6.86%,SLC30A10;SLC39A10;SLC39A8;SLC39A14
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3743290338762185,0.8897721667626279,0.6061588330632091,0.9775647144465057,1.0,3/17,7.05%,STX1A;CACNA1H;RAB3A
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.24415282525715604,-0.8895490586982233,0.6704545454545454,0.8813465746550029,1.0,14/51,19.75%,IL6R;CXCL12;CMKLR1;VEGFC;LGMN;IL34;VEGFD;THBS1;PTK2;LGALS9;CSF1;EDN3;RARRES2;PTN
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.23739197538772475,-0.8895124265511034,0.7241379310344828,0.8805333621587494,1.0,14/62,14.34%,LYN;EP300;HOXA5;MEIS1;SETD1A;HDAC1;MYL9;CDK6;AGO3;HOXB8;HOXA9;THBS1;MOV10;AGO4
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.26511464222469006,-0.8887534071554294,0.6677524429967426,0.8813266510149642,1.0,9/36,17.04%,TGFA;SHANK3;HIF1A;HDAC1;JAK2;EDN1;NRP1;HFE;EGF
prerank,plasma membrane organization (GO:0007009),0.30756143733172103,0.8884661622729056,0.6217948717948718,0.9797607964446884,1.0,21/61,19.97%,EPB41L3;AHNAK2;ANO6;A4GALT;PACSIN2;EHD2;RAB3A;PLSCR1;CHMP4A;STX2;ARL8B;ABCD1;OTOF;OSBPL2;STX4;SPTBN1;CAVIN2;PACSIN3;NSF;FA2H;PACSIN1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.34671236251598836,0.8883389778507517,0.5996860282574569,0.9793799574189798,1.0,9/26,21.19%,FKBP1B;ATP1A2;CASQ2;ADRA2A;THADA;UBQLN1;YWHAE;CBARP;CALM2
prerank,positive regulation of peptidase activity (GO:0010952),0.365199298930842,0.8882653651106869,0.612012987012987,0.9788732175905586,1.0,4/20,8.91%,APH1B;PSME3;NCSTN;DDRGK1
prerank,embryonic heart tube development (GO:0035050),-0.3347978413389086,-0.8882396938394491,0.6005154639175257,0.8815653007463788,1.0,4/14,16.59%,SOX17;CITED2;MEGF8;SOX18
prerank,ncRNA 3'-end processing (GO:0043628),-0.3415368691487393,-0.8882133924108578,0.5886699507389163,0.8807224336674676,1.0,2/14,5.87%,SSB;TRNT1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.27342518026409374,0.8877976897034559,0.6894618834080718,0.9792118481558156,1.0,16/150,10.75%,GAB1;FGF7;FGFR1;PIK3AP1;EGFR;FGF1;SRC;RAC2;PIK3R2;PTPRJ;GCNT2;FGF18;GAB2;AXL;FERMT2;STRN
prerank,calcium ion import (GO:0070509),-0.27984439766803415,-0.8877847834284284,0.6497005988023952,0.8808417231744289,1.0,7/28,12.84%,SLC8A1;CACNB2;CACNA1G;SMDT1;SLC25A23;MICU1;MICU2
prerank,microtubule nucleation (GO:0007020),0.3717141545378989,0.8877055082118777,0.5977198697068404,0.9787624255238278,1.0,11/19,29.88%,TUBG1;TUBGCP5;NDE1;TUBG2;SLAIN2;TUBGCP6;CSNK1D;CLASP2;CCDC57;NDEL1;CLASP1
prerank,Golgi organization (GO:0007030),0.2761160120786469,0.8876322232979847,0.6506447831184057,0.9782822216279693,1.0,29/112,18.79%,ATP8B3;ATP8B1;RAB29;PI4K2B;LMAN2;RAB30;ATL2;GOLGB1;ATP8B2;NPLOC4;LYSMD3;TMED4;CSNK1A1;GCC2;TRIP11;HTT;ZW10;FBXW8;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;TBC1D20;ARHGEF7;DYNC2H1;STX5;COG3;BET1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.29813245197747756,0.8875300776818779,0.6253263707571801,0.9778528381488173,1.0,8/65,5.71%,CDH13;CEACAM1;EGFR;ARAP1;SPRY1;NUP62;TSG101;FER
prerank,base conversion or substitution editing (GO:0016553),-0.3662590221638403,-0.8874998446554497,0.6082949308755761,0.8805878900395216,1.0,1/11,3.22%,ADAR
prerank,regulation of sister chromatid cohesion (GO:0007063),0.4027006576119664,0.887243369932428,0.6029143897996357,0.9778214267682624,1.0,2/12,10.80%,CTCF;AXIN2
prerank,modification-dependent protein catabolic process (GO:0019941),0.266540695995387,0.8869736705187896,0.6886486486486486,0.9777117582020496,1.0,46/193,18.76%,NEDD4L;UBE2L6;RNF130;WDR81;UBE3C;UBE2I;SPSB4;KEAP1;CHFR;SIAH1;ZNRF3;CUL3;UBL7;CDC20;AMFR;ANAPC5;ANAPC7;NPLOC4;RCHY1;TRPC4AP;LONP1;ANAPC11;NEDD4;BUB3;TTC3;FBXO11;RNF185;FBXO21;FBXO8;ANAPC2;UBA1;UBE2D1;KLHL15;FEM1C;ANAPC4;FZR1;PSMD13;UBE2R2;UBQLN1;ITCH;RNF7;WDR91;ANAPC16;PINK1;CDC23;PSMD14
prerank,rRNA modification (GO:0000154),0.35975136852280604,0.8864549112213687,0.6036308623298033,0.9781912785398691,1.0,4/21,10.57%,MRM2;BUD23;TFB2M;METTL5
prerank,neuron projection development (GO:0031175),0.2650514930995235,0.8863471730073158,0.6719101123595506,0.9777749863101903,1.0,25/168,13.06%,NGF;EPB41L3;MINK1;KIF20B;GAS7;OPHN1;NBL1;DIP2A;CNTNAP1;TRIO;EPHB2;GPM6A;GSK3B;HMGB1;POU4F1;ERCC6;LRP12;DOCK7;SLC9A6;NEDD4;PLXNB1;MAP4;SGK1;PTEN;CTTN
prerank,"phototransduction, visible light (GO:0007603)",0.3869932904300212,0.8863029703525527,0.6086956521739131,0.9772210925980735,1.0,2/14,5.04%,GNAQ;CNGB1
prerank,negative regulation of phagocytosis (GO:0050765),-0.31401782823741275,-0.8862654527513844,0.6178861788617886,0.8824583132251369,1.0,3/17,6.62%,DYSF;SIRPA;PIP4P2
prerank,positive regulation of heart rate (GO:0010460),-0.32337903101847887,-0.8861822628591031,0.599476439790576,0.8817472759195178,1.0,5/17,15.95%,TPM1;ADRA1B;EDN1;ADM;EDN3
prerank,cell chemotaxis (GO:0060326),0.30610105159723716,0.8861316867508243,0.6186107470511141,0.9769565592990879,1.0,3/60,0.78%,PARVA;LPAR1;ACKR3
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3186253969824508,-0.8859930915144623,0.5960099750623441,0.8812915507595837,1.0,7/15,16.18%,HMGCS1;HMGCS2;MLYCD;ACLY;PMVK;MVK;ACSS1
prerank,peptidyl-amino acid modification (GO:0018193),-0.37783010580989895,-0.8856775186705883,0.6071428571428571,0.8811447187280935,1.0,1/10,3.31%,ATP7A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.30223053757629836,0.8855174646263136,0.642570281124498,0.9775913832239377,1.0,10/57,15.58%,LPAR1;AKAP12;ADCY5;GNAL;ADRA2A;ADCY9;CHRM2;CHRM3;ADCY8;ADCY3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2688570645258634,0.8853905567820594,0.6935123042505593,0.9772165262420753,1.0,37/145,19.70%,DYNLL1;PSME3;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;FBXO5;PAFAH1B1;CCP110;PSMB5;MECP2;USP47;NDE1;CEP290;SSNA1;CETN2;FHL1;PCM1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;YWHAG;YWHAE;CEP57;PSME4;OFD1;PSMC4;PSMB6;PSMD12;PSMD14;CEP250;DCTN2;ALMS1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.38200578696711324,0.8853660192299884,0.608359133126935,0.9766195852162546,1.0,5/17,13.12%,PBX1;MAML2;HEYL;WWC1;CREBBP
prerank,negative regulation of cell growth (GO:0030308),-0.20836126794437262,-0.8853299710372157,0.7540983606557377,0.8810558691378125,1.0,30/121,17.78%,SMAD3;ENPP1;SLIT2;SMARCA2;GJA1;ACVRL1;BMPR2;CCN3;NPR1;DNAJB2;APBB2;SOX17;RNF6;JADE1;BST2;ULK2;GSK3A;TGFB2;DCC;CDKN2AIP;TCHP;SERTAD3;CCDC85B;CGRRF1;BTG1;MAG;SEMA3G;SMAD4;RERG;WNT11
prerank,ceramide biosynthetic process (GO:0046513),0.3231940871000805,0.8850860478714919,0.6069444444444444,0.9765748499388685,1.0,4/40,5.64%,SGMS2;CERS6;ALOXE3;CLN8
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3574625539629638,0.8848932641520835,0.5917065390749602,0.9763377745365946,1.0,2/20,2.99%,IL18R1;CD55
prerank,regulation of centrosome cycle (GO:0046605),0.35714263932551027,0.8847019443982973,0.6018662519440124,0.9761458147794442,1.0,6/21,12.90%,CEP131;CHMP5;PDCD6IP;CHMP4B;CHMP4C;GEN1
prerank,nucleocytoplasmic transport (GO:0006913),0.3146417938234591,0.8843743321012404,0.6064425770308123,0.9762320660376599,1.0,6/40,14.55%,RGS14;SNRPF;RBM15B;SMN1;HTATIP2;LSG1
prerank,amino sugar metabolic process (GO:0006040),-0.3679843322880313,-0.8842011114813094,0.6333333333333333,0.8826689904974437,1.0,2/10,2.65%,ST3GAL1;CSGALNACT1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.28022848202859263,-0.8840744452838966,0.6504297994269341,0.8820843454763104,1.0,10/26,25.81%,LGR4;APPL2;NFKBIL1;LRRC14;IRF1;FLOT1;CACTIN;TLR3;BIRC3;SMPDL3B
prerank,regulation of cell aging (GO:0090342),-0.36261935254948297,-0.8839432072723464,0.6384615384615384,0.8814929743206511,1.0,4/11,19.84%,LMNA;NUAK1;VASH1;MIF
prerank,embryonic hemopoiesis (GO:0035162),-0.34848983672646205,-0.8838523069250965,0.6223776223776224,0.8808115268874395,1.0,5/12,18.59%,KIT;FLT3LG;KDR;TAL1;ATF4
prerank,cellular response to organonitrogen compound (GO:0071417),0.2779911116222169,0.8838112347291405,0.652542372881356,0.976783021498099,1.0,16/99,16.38%,HRH1;FOLR1;RAPGEF3;RAP1A;SOX9;TSHR;GABRG2;EGR1;GABRB3;AQP1;CAPN2;RRAGB;CTNNA1;CDH1;CPEB3;EZR
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3694287066592681,0.8837702283488625,0.6435483870967742,0.9762179249299647,1.0,3/18,9.35%,RAP1A;RIMS2;GSK3B
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3157536182883371,0.883698178559797,0.6002785515320335,0.9757237028589691,1.0,9/43,16.06%,SORBS1;OGT;PIP4K2B;KANK1;SLC27A4;C1QTNF12;NUCKS1;SNX5;SOCS1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4010787648929586,0.8834987473058039,0.5788561525129983,0.9754912310806007,1.0,3/11,13.61%,SOX9;WNT5A;CTNNBIP1
prerank,myeloid dendritic cell activation (GO:0001773),0.40245173671071754,0.8831794752949926,0.5971223021582733,0.9755237095745766,1.0,3/12,16.40%,DOCK2;HMGB1;BATF
prerank,positive regulation of bone mineralization (GO:0030501),0.3249890864411489,0.882816257954199,0.6109510086455331,0.9756081717816837,1.0,3/35,4.10%,PKDCC;ANO6;BMPR1B
prerank,mitochondrion disassembly (GO:0061726),-0.25437636692303056,-0.8826261069631726,0.6677852348993288,0.8827651133395301,1.0,15/34,26.21%,SQSTM1;BECN1;GABARAPL1;WIPI1;ULK2;GABARAP;AMBRA1;USP30;MAP1LC3A;WIPI2;ATG12;WDR45B;WDR45;FBXO7;CISD2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4058102027137693,0.8820650003464221,0.6145833333333334,0.9765516329388381,1.0,3/11,10.62%,RESF1;PPHLN1;TPR
prerank,mRNA export from nucleus (GO:0006406),0.27629667986629175,0.8813980147436568,0.6480380499405469,0.9772977706585266,1.0,35/102,24.85%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33;IWS1;SARNP;PABPN1;NXF1
prerank,homotypic cell-cell adhesion (GO:0034109),0.319529289875837,0.8808785300279949,0.5885634588563459,0.9777264375855351,1.0,4/39,5.16%,UBASH3B;TJP2;PLPP3;FN1
prerank,regulation of secretion by cell (GO:1903530),-0.23784912092546465,-0.8808664373509333,0.66796875,0.8857188805496323,1.0,12/54,16.66%,SNCAIP;DNAJC1;RAB3C;MCTP2;ANXA1;SYN1;CAMK2A;RAB13;RHBDF2;LLGL2;RAB3B;CPLX2
prerank,RNA catabolic process (GO:0006401),0.3146784455816738,0.880842881446076,0.6410958904109589,0.9771463995618362,1.0,15/46,23.67%,RNASEH2B;CNOT10;PABPC4;DXO;DIS3L2;SIDT2;ZFP36L2;ERN1;RNASE3;MTREX;HNRNPD;EXOSC7;LSM2;RNASEH1;RNH1
prerank,relaxation of cardiac muscle (GO:0055119),0.39365898994679416,0.8808414159057364,0.5986277873070326,0.9765072440490786,1.0,2/13,5.19%,CAMK2D;ATP1A2
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2804308355359336,-0.8804033041477103,0.6559485530546624,0.8858597369783083,1.0,3/27,8.38%,GPCPD1;ENPP2;PNPLA6
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3206054389803561,-0.8803779113375635,0.6269035532994924,0.8850352679888583,1.0,1/15,1.05%,GNAS
prerank,regulation of interleukin-1 production (GO:0032652),0.388321132994904,0.8802051003728443,0.5962837837837838,0.9772064134974159,1.0,2/15,9.49%,CEACAM1;HMGB1
prerank,RNA destabilization (GO:0050779),0.36630977842670986,0.8798841446010874,0.600328947368421,0.9772721192217154,1.0,4/18,9.07%,GIGYF2;CELF1;DXO;LIN28B
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.238225163512087,-0.8798741445552991,0.6916666666666667,0.8852191227186595,1.0,8/57,10.71%,DAPK1;ACTN2;GRIA2;NEFL;GRIN2B;CAMK2A;GRIN1;CACNG7
prerank,regulation of endopeptidase activity (GO:0052548),0.3077581553833593,0.8797453376560942,0.6495263870094723,0.9769064611259484,1.0,6/59,6.01%,SERPINB2;SERPING1;APH1B;PSME3;SERPINH1;NCSTN
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.3493884864176019,-0.8795771941987004,0.6291390728476821,0.8849960819451517,1.0,2/11,6.50%,MECOM;CD34
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.29640055715679386,-0.8795598854536806,0.6363636363636364,0.884170445014487,1.0,3/22,5.81%,ADGRV1;GRM3;ORAI1
prerank,protein targeting to membrane (GO:0006612),0.28370440427158616,0.8795068114471758,0.6167664670658682,0.9768084995143212,1.0,23/83,20.37%,RAB8B;SIL1;FIS1;ZDHHC1;PEX2;ZDHHC7;ZDHHC23;PXMP2;TRAM1;CHMP4A;CHMP4B;RTP3;ABCD1;ZDHHC20;CHM;ZDHHC19;GOLGA7B;ICMT;SLC25A17;ATG3;PEX13;ZDHHC3;ZDHHC12
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3988186769365117,0.8793832127631381,0.5808080808080808,0.9764380872583206,1.0,1/12,1.25%,CEACAM1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3445261223560056,0.8793537709344956,0.601823708206687,0.9758683181206887,1.0,4/25,13.98%,CDH13;PLEK;TMBIM4;HTT
prerank,protein deacetylation (GO:0006476),0.3168318287431198,0.8791404485275749,0.6101231190150479,0.9756784398010672,1.0,16/41,24.08%,HDAC4;RCOR3;SIRT3;SIN3B;MSL3;SIRT7;HDAC2;HDAC6;BAZ2A;MORF4L2;MTA3;HDAC3;BRMS1L;SIRT2;SIN3A;SUDS3
prerank,heart contraction (GO:0060047),0.32057571079366226,0.8790069747120628,0.6157024793388429,0.9753260749189189,1.0,7/41,12.41%,SGCD;SGCG;CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.2758815979090024,-0.8789337141250044,0.6408668730650154,0.8846921558013958,1.0,7/28,15.19%,SMAD3;PIK3R1;FLNA;ZC3H12A;TRIM28;ZIC1;ZPR1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2498430049985565,0.8787724976481622,0.8082744702320888,0.9751687116470293,1.0,35/532,7.15%,RORA;EDA;TEC;SERPINB2;LBP;TNFSF8;ACKR3;IL19;IL18R1;CEACAM1;CAMK2D;LEPR;PELI2;IL17C;SOCS5;STX1A;ITGAX;IL1A;SPI1;FOXO3;SRC;PSME3;SLC27A1;IRAK3;FN1;IL17RA;FER;TRADD;SOCS6;LAMA5;IL21R;ABL2;TRIM21;MCL1;SDC1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4082807143298425,0.8787692946615728,0.5913793103448276,0.9745399325634235,1.0,1/11,2.26%,SOCS5
prerank,regulation of mitotic spindle assembly (GO:1901673),0.36572388324282523,0.8787467854656889,0.5944625407166124,0.9739530385985202,1.0,5/19,11.97%,CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C
prerank,cellular response to calcium ion (GO:0071277),0.2910981488827114,0.8787381662358309,0.6349614395886889,0.9733295488434953,1.0,5/67,4.96%,GUCA1A;CAMK2D;GPLD1;ADD1;WNT5A
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4171597695750459,0.8784863605857807,0.6024734982332155,0.973218581238859,1.0,2/10,7.80%,EMC9;EMC7
prerank,extracellular matrix disassembly (GO:0022617),0.2993303237996637,0.8783674463673571,0.6238159675236806,0.9728545175087151,1.0,13/53,17.75%,LAMC1;KLK2;MMP15;SH3PXD2B;ADAM10;MMP12;NOXO1;MMP16;CAPN2;PLG;MMP14;BMP1;LCP1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.2420217849567073,-0.8782245048017108,0.6854838709677419,0.8853658081871845,1.0,25/54,31.67%,MADD;UBE2K;CFLAR;RNF31;CLIP3;SPHK1;IKBKB;PELI3;LAPTM5;CASP8;CASP4;RACK1;TRAIP;IKBKG;RIPK1;SPPL2B;HSPA1A;BIRC3;SPATA2;PYCARD;CASP1;HSPA1B;TRAF2;ADAM17;RFFL
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2727395280820032,0.878173483875462,0.6670574443141852,0.9726376387520336,1.0,19/116,16.60%,PLK2;CD3G;MC5R;PTHLH;SRC;ADCY5;SELENOS;PTGER4;PRKAR2A;TSHR;ADCY9;PRKACB;GGT1;ADCY8;ADCY3;PTH2R;GPR27;SYK;RXFP1
prerank,protein O-linked glycosylation (GO:0006493),0.2778256426214721,0.8781470685029363,0.6499402628434886,0.9720545046180751,1.0,12/96,9.87%,ST3GAL4;GALNTL6;OGT;C1GALT1C1;GCNT4;B4GAT1;FKRP;B3GLCT;POFUT1;TET1;ST6GAL1;GALNT18
prerank,positive regulation of secretion by cell (GO:1903532),-0.21814376103759403,-0.8779265219404352,0.7256637168141593,0.885174737848891,1.0,15/70,15.98%,IGF1;BMP6;KCNB1;CADPS;TGFB3;MYH10;SYTL4;BMP2;TGFB2;MYO18A;ABCG1;EDN1;DTNBP1;EDN3;P2RX4
prerank,cellular component disassembly (GO:0022411),0.29983313277010604,0.8770606483184991,0.6326530612244898,0.9737022814894323,1.0,13/53,17.75%,LAMC1;KLK2;MMP15;SH3PXD2B;ADAM10;MMP12;NOXO1;MMP16;CAPN2;PLG;MMP14;BMP1;LCP1
prerank,negative regulation of axon extension (GO:0030517),0.33473082813208305,0.877027657151195,0.6072992700729927,0.973144837710949,1.0,10/30,18.71%,SEMA4B;RTN4R;CDKL3;SEMA3A;TRIM46;SEMA4D;SEMA6C;RTN4;SEMA4C;SEMA4A
prerank,positive regulation of ion transport (GO:0043270),0.3064035219439375,0.8769281830000141,0.6313617606602476,0.972724082672262,1.0,2/48,2.66%,CNKSR3;ANO6
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.37546510831380164,-0.8768348044126418,0.628755364806867,0.8866879494749714,1.0,3/10,15.22%,IL18;PRKCZ;LGALS9
prerank,ameboidal-type cell migration (GO:0001667),0.31008034952995855,0.8766892049252074,0.6426701570680629,0.9726280267451509,1.0,6/51,7.33%,GPC3;AMOTL1;SEMA4B;AMOT;SEMA3A;ITGB7
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3705270368726895,-0.8765843891834527,0.594272076372315,0.8854635130974464,1.0,5/10,29.21%,KLF4;MYADM;WNK1;MAP2K5;MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3705270368726895,-0.8765843891834527,0.594272076372315,0.8854635130974464,1.0,5/10,29.21%,KLF4;MYADM;WNK1;MAP2K5;MBP
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2894058270707418,0.8762296984999867,0.6511024643320363,0.9729400679611397,1.0,16/64,18.15%,MLLT3;LEO1;CDK13;CDK7;POLR1E;PAF1;ELL;NELFB;SUPT4H1;GTF2F2;GTF2H1;ELOA;RTF1;TCEA1;SETD2;GTF2H3
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30154465280966797,0.8760314602452939,0.6337837837837837,0.9727137734308064,1.0,13/53,20.41%,GLMN;OPHN1;PSME3;DDRGK1;TMF1;PKD1;FBXW7;BAG2;RHBDF1;PINK1;PSMD14;TMTC3;PRKN
prerank,transcription preinitiation complex assembly (GO:0070897),0.394704367783665,0.8755532026292672,0.6081081081081081,0.9731177895972328,1.0,7/12,31.78%,POLR1E;BDP1;TAF1;TBP;GTF2A2;TAF7;TAF1B
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.32548207348260283,-0.8754135597277289,0.6466165413533834,0.8871108599832243,1.0,8/15,31.43%,SAMHD1;USP18;ISG15;YTHDF2;CACTIN;YTHDF3;TTLL12;NLRC5
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2926348965404154,-0.8753160194394395,0.6473988439306358,0.8864294993849668,1.0,8/22,22.17%,ROCK2;FKBP1A;PPP4R4;PPP1R11;IKBKB;STYXL1;CRY2;NCKAP1L
prerank,regulation of DNA biosynthetic process (GO:2000278),0.34635628633134236,0.8750069755604931,0.620845921450151,0.9736337126653726,1.0,2/27,5.34%,SMOC2;TOM1L1
prerank,organonitrogen compound catabolic process (GO:1901565),0.29464897517764727,0.8749585592012584,0.6405228758169934,0.9731067764359148,1.0,12/57,15.15%,IL4I1;LRSAM1;CLN8;BCKDK;LVRN;SIAH1;LNPEP;NAGK;LTA4H;PNPLA8;GNPDA2;TXN2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.338674316543522,0.8746600649250331,0.6310395314787701,0.9730842860857094,1.0,7/30,13.12%,KLK2;HEYL;NCOR1;PIAS2;NCOR2;HDAC6;NCOA2
prerank,development of primary male sexual characteristics (GO:0046546),0.3232560849579865,0.8746581200818608,0.6126255380200861,0.9724601247460033,1.0,8/34,15.36%,WNT2B;SOX9;WNT5A;LHFPL2;MSH2;CSDE1;NR5A1;KITLG
prerank,relaxation of muscle (GO:0090075),0.3915419587373403,0.8746228357078953,0.6102564102564103,0.9719167830228487,1.0,2/13,5.19%,CAMK2D;ATP1A2
prerank,positive regulation of cellular process (GO:0048522),0.2465538173820567,0.8744513055817891,0.8205645161290323,0.9716618832710174,1.0,88/565,14.63%,CAV1;FGF7;PRODH;NTRK3;GLI1;FGFR1;LBP;DLX1;PTGFR;FOLR2;EGFR;FGF1;SMC5;ACER3;FXR2;KIF20B;ITGAX;FKBP1B;LMAN2;CIDEB;PTHLH;SAPCD2;SOX9;BMPR1B;CELF1;PRKCA;HDAC4;BMP5;WNT5A;FN1;DOCK2;RPRD1B;FER;CDK13;CEP131;ADAM10;KRAS;TRIM21;ACACA;EFNB2;HOXC10;TBX2;RARA;CSPP1;FBXO5;CUL3;DPP4;S100B;ISL1;PTPRJ;GCNT2;FGF18;TSHR;DDRGK1;TET1;NCMAP;MECP2;RPS6KA3;USP47;GAB2;HDAC2;CNOT7;HILPDA;ADRA2A;TBC1D8;S100A9;AXIN2;SRPK2;APC;IL6ST;PRLR;INO80;FAF1;NOXO1;CD81;PTEN;CDC6;IL7;SOX4;HBEGF;P4HB;FZD7;CCKBR;FXR1;IL2RG;KLHL22;ERBB4;DICER1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.25572713323894214,-0.8743436683389773,0.6875,0.8877056090208072,1.0,11/42,16.59%,ENG;TBX3;NPHP3;SOX17;ZIC3;DAND5;MEGF8;VANGL2;MKKS;AHI1;SOX18
prerank,icosanoid metabolic process (GO:0006690),0.3166195249409486,0.8742692402479362,0.6400560224089635,0.971406707043579,1.0,15/40,24.58%,EPHX1;CYP2S1;ALOXE3;ABCC1;ABCC10;LTA4H;PNPLA8;GGT1;HPGD;FADS1;FAAH;PON3;PLA2G4A;PTGR1;DAGLB
prerank,cellular response to cAMP (GO:0071320),0.33219113780050913,0.8742606577219955,0.6151603498542274,0.9707967317913043,1.0,2/30,1.89%,RAPGEF3;RAP1A
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3467629705582499,0.8741952725704085,0.5996908809891809,0.9703012070861738,1.0,4/24,11.89%,PLCE1;RAC2;OCLN;AKIRIN1
prerank,signal peptide processing (GO:0006465),0.4020055943328549,0.8736697153772675,0.6061120543293718,0.9707289477916705,1.0,1/11,2.16%,PCSK5
prerank,positive regulation of vacuole organization (GO:0044090),0.42085941580129815,0.8734692880034396,0.6097560975609756,0.9705064273869669,1.0,3/10,6.44%,LRSAM1;PIP4K2B;RAB3GAP2
prerank,RNA transport (GO:0050658),0.29121733827021845,0.8730477751265474,0.6501950585175552,0.9707633181569607,1.0,17/71,19.26%,RBM8A;SRSF4;NUP62;CKAP5;SIDT2;EIF4E;TPR;RTRAF;ATXN2;UPF3B;NUP153;THOC3;THOC5;XPO5;SLU7;SRSF3;DHX38
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.28052485670524535,-0.8729750019464665,0.6205882352941177,0.8898189490923479,1.0,2/25,4.69%,PICALM;ANKRD13A
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4118221295106623,0.8729594278041896,0.6096256684491979,0.9703185383884925,1.0,2/11,9.57%,EXOSC5;EXOSC10
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3283420933527368,-0.8728899250511959,0.6346153846153846,0.8891446847130989,1.0,1/14,1.18%,OSMR
prerank,positive regulation of proteolysis (GO:0045862),0.2992715665511514,0.8722053417287705,0.6376440460947503,0.9712694805265786,1.0,9/55,10.37%,CYFIP2;OGT;GPLD1;NLRC4;PERP;TNIP1;HDAC2;IST1;ADRA2A
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.34375920269757765,-0.8717861327385598,0.625866050808314,0.890631094746044,1.0,5/12,29.88%,SEH1L;RMDN1;CENPC;CENPE;NDC80
prerank,multivesicular body assembly (GO:0036258),0.33700251517883417,0.8717104639489538,0.609129814550642,0.9716476476917193,1.0,7/30,11.97%,TSG101;CHMP5;PDCD6IP;IST1;CHMP4A;CHMP4B;CHMP4C
prerank,mRNA transport (GO:0051028),0.27469022821921535,0.8717064539163472,0.6602870813397129,0.9710352310225842,1.0,34/101,24.99%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33;SARNP;NXF1;FMR1
prerank,regulation of protein ubiquitination (GO:0031396),0.2743634263608106,0.871466043515983,0.6608187134502924,0.9709084067954513,1.0,24/108,18.00%,CAV1;PRICKLE1;AXIN1;SH3RF2;OGT;TNFAIP3;N4BP1;CUL3;SIRT7;RCHY1;SPOPL;NXN;USP4;SOX4;UBE2D1;FBXW7;UBQLN1;GNL3L;BAG2;MINAR1;CHP1;WFS1;PHF23;PINK1
prerank,replicative senescence (GO:0090399),0.3998523271099148,0.8713441441812676,0.6068515497553018,0.9705539234017857,1.0,2/12,10.88%,WNT16;MME
prerank,folic acid metabolic process (GO:0046655),0.3616895287552624,0.8711638156135041,0.6,0.9703140321584661,1.0,6/18,17.89%,FOLR2;MTHFD1;SLC46A1;ALDH1L2;PM20D2;SLC19A1
prerank,regulation of cellular response to stress (GO:0080135),0.2700900420414551,0.8710439983571865,0.6916764361078547,0.9699471750822246,1.0,38/115,23.05%,CAMK2D;HSPH1;SLC38A2;NPAS2;NUP62;MCL1;BAG3;AMFR;NUP160;GSK3B;NUP37;TPR;NUP50;RANBP2;NUP210;ARMT1;ABCD1;NUP153;CREBBP;NEK4;NUP93;ADCY8;AIFM2;CHORDC1;DNAJC7;YWHAE;BAG2;CAMK2G;PINK1;RPTOR;PRKN;ATR;CCAR2;NUP43;RPA3;MBTPS2;SEC13;MAPK1
prerank,regulation of lymphocyte activation (GO:0051249),0.3975227084447014,0.8707803859997991,0.6037414965986394,0.969872967420706,1.0,2/12,10.18%,CRTAM;LAT
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.32109215056828255,0.870732079820026,0.6121562952243126,0.9693485728948831,1.0,2/32,2.58%,DLC1;CDH5
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.34751277097178856,0.8705868763614345,0.6053882725832013,0.9690291730063865,1.0,4/21,13.40%,HK2;RPE;DERA;GCK
prerank,granulocyte chemotaxis (GO:0071621),0.3033433291815844,0.8705279971786585,0.6266490765171504,0.9685437113428815,1.0,1/55,0.29%,CXADR
prerank,protein localization to synapse (GO:0035418),-0.3481181913550245,-0.8698875598221887,0.6278481012658228,0.8939272083801767,1.0,3/12,14.94%,BSN;NRXN1;NRXN2
prerank,calcium ion transport (GO:0006816),0.2724651350802674,0.8697549750428482,0.6569767441860465,0.9695178388284723,1.0,8/113,4.79%,CAV1;NALCN;TRPM3;ANO6;SLC24A1;TRPV4;ATP2B4;CACNA1H
prerank,regulation of ATP metabolic process (GO:1903578),0.30307631171493676,0.8688154060314783,0.635989010989011,0.9707849640189566,1.0,14/54,13.40%,OGT;BEND3;PRKAG1;NUP62;FIS1;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;ABCD1;NUP153;GCK
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3594590608999414,0.8687447006690194,0.610223642172524,0.9703166439848362,1.0,3/20,4.69%,CEACAM1;BMP5;SLC27A1
prerank,cellular response to purine-containing compound (GO:0071415),-0.3629030672953881,-0.8687033674131401,0.6312056737588653,0.8955053522711198,1.0,5/10,30.96%,SLC8A1;TRPM2;P2RY6;P2RY1;RYR2
prerank,chloride transmembrane transport (GO:1902476),0.3039819474910095,0.8686963868409591,0.6253481894150418,0.9697969562534537,1.0,9/48,12.26%,SLC12A2;ANO6;SLC12A4;SLC12A3;CLCN1;GABRR2;GABRG2;GABRG1;GABRB3
prerank,positive regulation of secretion (GO:0051047),-0.3540912210733579,-0.8686428973612113,0.6571428571428571,0.894769740318366,1.0,2/11,4.51%,ACSL3;NPR1
prerank,lymphocyte differentiation (GO:0030098),0.29109603127343014,0.8680981759112754,0.6422250316055625,0.9704114547557248,1.0,9/68,9.89%,LEPR;PBX1;TPD52;PTPN22;HDAC4;PTPRC;MSH2;PTPRJ;AXL
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.28882798448379315,0.8678166747761721,0.6530612244897959,0.9703648167555226,1.0,14/66,15.73%,GTSE1;EIF2AK3;LIMK2;CARD10;UBR5;BAG3;RBM22;PIK3R2;FERMT2;TPR;CCT2;RAN;CDH1;YAP1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3206012283975217,-0.8670874324234714,0.6379746835443038,0.8972636060349298,1.0,8/16,29.65%,PAXIP1;SNW1;KDM1A;DNMT3B;SMAD4;BRCA1;WDR5;BCOR
prerank,positive regulation of stress fiber assembly (GO:0051496),0.30788218648787513,0.8667013922799915,0.6378600823045267,0.9720548166642082,1.0,14/44,21.25%,LPAR1;PXN;RAPGEF3;ARHGEF5;FERMT2;FHOD1;NF2;ARHGEF10L;ARHGEF10;RGCC;RHOA;PFN2;PPM1E;S100A10
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2869994561265275,0.8664419160834108,0.6575875486381323,0.9720012367891754,1.0,8/69,9.49%,LBP;IL1A;WNT5A;PTPRC;EPHB2;ISL1;PTPRJ;HMGB1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3239013836638289,-0.8663959861632916,0.6102941176470589,0.8978579427024382,1.0,5/14,10.09%,CHKA;LPIN2;ETNK1;CEPT1;LPIN3
prerank,innate immune response (GO:0045087),-0.1886552578253459,-0.8663686174615817,0.9245283018867925,0.8970419472077009,1.0,47/217,22.42%,SP100;SERINC3;LYN;MFHAS1;ADAR;CXCL16;TNK2;MID2;TRIM25;B2M;IRAK4;ALPK1;PLCG2;GCH1;NRROS;CYBA;BST2;TRIM14;BCL10;TRIM35;TRIM28;PGLYRP1;MFAP4;NCF2;AKAP1;POLR3A;PJA2;CFP;PTK2;IKBKB;TRIM59;ISG15;IFIT1;MASP1;CYBC1;CD40;TRIM8;RARRES2;COLEC12;TLR3;FES;TRIM13;TRIM11;SHFL;RPL39;IKBKG;RNF187
prerank,positive regulation of ATP metabolic process (GO:1903580),0.3278311159991103,0.8663266819148553,0.6324167872648335,0.9716149011700023,1.0,4/32,6.02%,PPARGC1A;ZBTB20;BEND3;SLC4A4
prerank,apoptotic nuclear changes (GO:0030262),0.34513041616095297,0.8660974585590032,0.6431924882629108,0.9714563507687969,1.0,6/24,15.10%,ACVR1C;DFFB;HMGB1;EXOG;DICER1;GPER1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.36347905232581895,0.8659296994676476,0.6237623762376238,0.9712171307289857,1.0,1/19,0.87%,PXDN
prerank,ribosomal small subunit assembly (GO:0000028),0.3722250018462336,0.8657673411278162,0.6347402597402597,0.9709318614034673,1.0,1/16,0.72%,RPSA
prerank,stress fiber assembly (GO:0043149),0.3788212745631716,0.8657163161784516,0.6139130434782609,0.969802133489847,1.0,4/15,10.56%,SORBS1;SRC;CUL3;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),0.3788212745631716,0.8657163161784516,0.6139130434782609,0.969802133489847,1.0,4/15,10.56%,SORBS1;SRC;CUL3;ZYX
prerank,cellular response to interleukin-2 (GO:0071352),0.39885122810473606,0.8649760457408207,0.6097972972972973,0.9700397902784292,1.0,6/11,29.49%,IL2RG;SYK;JAK1;STAT5B;STAT5A;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.39885122810473606,0.8649760457408207,0.6097972972972973,0.9700397902784292,1.0,6/11,29.49%,IL2RG;SYK;JAK1;STAT5B;STAT5A;SHC1
prerank,regulation of mitochondrion organization (GO:0010821),0.29998656116944583,0.8647978528235234,0.6438172043010753,0.9697763057601765,1.0,15/47,21.24%,PPARGC1A;PISD;FIS1;GSK3B;SIRT7;HDAC6;STAT2;HTRA2;PRMT6;FBXW7;CSNK2A2;PINK1;PRKN;MUL1;GOLPH3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3598642799221487,-0.8647370717157007,0.636986301369863,0.8997206939757003,1.0,3/10,7.68%,CSGALNACT1;CSGALNACT2;PXYLP1
prerank,actin filament network formation (GO:0051639),0.3995925463306769,0.864593347186642,0.6169154228855721,0.9695611065676859,1.0,2/11,10.63%,COBL;FHOD1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4120334889137122,0.8639150164485051,0.6312056737588653,0.9703087725713997,1.0,5/10,20.61%,LEO1;PAF1;CPEB3;CDC73;NUDT21
prerank,glycerol metabolic process (GO:0006071),-0.3600226084649172,-0.8636140548080541,0.6487695749440716,0.9012598702478665,1.0,3/10,13.53%,TPI1;COQ3;PGP
prerank,response to organonitrogen compound (GO:0010243),-0.25808213859093143,-0.8634470479875368,0.7111801242236024,0.9007575002266779,1.0,12/38,25.13%,HLCS;SYVN1;VCP;RRAGC;GLRA2;UBXN6;DHFR;TRPM2;RCN3;NR1H4;IRF5;KYNU
prerank,glycoprotein catabolic process (GO:0006516),0.3621664790040336,0.8634194692544697,0.6351575456053068,0.9707368047940026,1.0,5/17,18.96%,ADAMTS12;MMP12;MANBA;OGA;EDEM2
prerank,axonal transport of mitochondrion (GO:0019896),-0.3547856848718835,-0.863396581003229,0.6355555555555555,0.8999867505612326,1.0,4/11,15.54%,NEFL;HIF1A;MAPT;OPA1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.29906458319563856,0.8627938619098989,0.6458055925432756,0.9713681557164398,1.0,6/52,7.65%,SORBS1;PRKCE;EGFR;ATP2B4;EPHB2;ARF6
prerank,regulation of Notch signaling pathway (GO:0008593),0.2819778885607026,0.8624013117549055,0.681930693069307,0.9715463734669265,1.0,16/76,16.92%,NRARP;EGFR;DTX1;JAG1;MAML2;SRC;EGFL7;BMP2K;POFUT1;IL6ST;TSPAN14;CREBBP;WWP2;YAP1;FBXW7;MMP14
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.24350534388585798,-0.8622341043089345,0.71875,0.9015288517997755,1.0,13/48,15.31%,ADCY1;ADCY7;NPR1;ACOT7;PAPSS1;SLC26A2;ADCY4;ADCY2;PANK1;SLC35B3;PPCDC;IMPDH1;NUDT2
prerank,regulation of type I interferon production (GO:0032479),0.27969748277255096,0.8621417045860571,0.685785536159601,0.9715018809221156,1.0,27/84,24.59%,UBE2L6;PCBP2;PTPN22;TNFAIP3;TRIM21;POLR3G;ACOD1;DTX4;NPLOC4;NLRP4;TAX1BP1;POLR3D;CREBBP;TBK1;CRCP;ITCH;MRE11;G3BP1;XRCC6;DHX9;PIN1;TRAF3;IFIH1;DHX58;POLR3C;POLR3K;CYLD
prerank,translesion synthesis (GO:0019985),0.31269095435217525,0.8621324785457581,0.6428571428571429,0.9709095406057258,1.0,6/42,10.64%,UBE2L6;USP43;POLI;RFC3;NPLOC4;RCHY1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3104335292679474,0.8620157253151184,0.6728045325779037,0.9705295417178184,1.0,5/39,9.72%,TANGO6;RAB8B;RAB3A;LTBP2;ABCA1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.22807955577359101,-0.8619873728657862,0.7350746268656716,0.9012156446634534,1.0,18/52,22.19%,CNOT6L;EDC3;NT5C3B;HBS1L;EDC4;CNOT11;TUT7;EXOSC3;LSM7;ZFP36;DIS3;CNOT9;RC3H1;EXOSC1;PDE12;POLR2D;DCP2;LSM5
prerank,cellular macromolecule catabolic process (GO:0044265),0.30327953020160076,0.8615870478025549,0.6662087912087912,0.9707738106000307,1.0,16/49,26.00%,RNASEH2B;PABPC4;SIDT2;DFFB;MANBA;HTRA2;OGA;RNASE3;MTREX;HNRNPD;PRKN;EXOSC7;RNASEH1;DNASE1L1;PNPT1;UBE2G1
prerank,base-excision repair (GO:0006284),0.3035537662444435,0.8614368450753316,0.6542699724517906,0.9704614817943149,1.0,11/48,17.88%,TDG;NTHL1;RFC3;USP47;APEX2;ERCC6;ADPRS;POLB;PRMT6;POLE;RFC1
prerank,Golgi to plasma membrane transport (GO:0006893),0.30035609337905655,0.8611077949696575,0.6414835164835165,0.9705289973935514,1.0,1/47,0.06%,STXBP6
prerank,protein polyglutamylation (GO:0018095),0.3931518099486315,0.8607772020418043,0.6086956521739131,0.9705976042472938,1.0,3/11,16.93%,TTLL1;CFAP20;TTLL9
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.31743877637938644,-0.8602500840480525,0.6567164179104478,0.9039315824497038,1.0,3/14,5.81%,ENPP1;ENPP3;CMPK1
prerank,aerobic respiration (GO:0009060),-0.2981334490332017,-0.8601726890205513,0.6465753424657534,0.9032501825113395,1.0,8/20,29.17%,SDHB;UQCRC2;MTFR1;ME3;OXA1L;NDUFS8;MTFR2;UQCR10
prerank,aerobic electron transport chain (GO:0019646),0.2903286276909834,0.8599054148419399,0.6615581098339719,0.9717378384761183,1.0,14/68,15.68%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;SDHD;SDHAF2;COX7C;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3847901579440688,0.8598989455543792,0.6424870466321243,0.9711432476785646,1.0,3/13,13.50%,SPRED1;HIC1;SPRED2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.33529485250873986,0.8594422291662535,0.65,0.9715229469114245,1.0,9/27,23.67%,CSTF3;POP7;ERN1;DICER1;TOE1;PCF11;RPP30;RNASE1;RNASEH1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.2979589931177336,0.8592505680037084,0.6515353805073432,0.971315124625422,1.0,7/51,13.88%,USP50;WNT5A;NLRC4;ISL1;HMGB1;EGR1;GSDMD
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.33498833893046864,-0.8592389684877548,0.6903553299492385,0.9042786711418098,1.0,2/13,7.84%,SLC4A10;GRIK2
prerank,negative regulation of histone modification (GO:0031057),-0.3242901981983308,-0.8588743312073832,0.6580188679245284,0.9042067783285564,1.0,8/14,39.99%,JARID2;NOC2L;BRCA1;AASS;THAP7;CTBP1;SNCA;SPHK2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.31936164887726276,0.8588256138683049,0.6530612244897959,0.971562957090576,1.0,7/35,17.88%,TDG;NTHL1;RFC3;ADPRS;POLB;POLE;RFC1
prerank,neurotransmitter secretion (GO:0007269),-0.24631430664290443,-0.8587841107897638,0.7433962264150943,0.9035227324260775,1.0,20/44,29.33%,STXBP3;LIN7A;HSPA8;SYN1;GAD1;NRXN1;SYN3;NRXN2;DNAJC5;CPLX2;UNC13A;SYN2;RIMS1;SNAP25;SLC32A1;PPFIA3;PIP5K1C;PTPRN2;GRM4;SYT1
prerank,negative regulation of protein polymerization (GO:0032272),0.32872557845123784,0.8585077769801542,0.6281481481481481,0.971590832049137,1.0,4/27,8.36%,KANK4;CDH5;KANK1;DYRK1A
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.24896059935844406,-0.8581214700994071,0.7188612099644128,0.9040318992231239,1.0,8/39,13.20%,TEK;ANGPT1;NDNF;KDR;GATA2;RAMP2;SCG2;THBS1
prerank,negative regulation of hydrolase activity (GO:0051346),0.29736059322720687,0.8580180085996483,0.6721311475409836,0.9719698899566025,1.0,4/49,7.45%,F11R;SH3RF2;RDX;MAPK7
prerank,nucleosome organization (GO:0034728),0.2893468311568633,0.8579123643730671,0.6578249336870027,0.971582127922491,1.0,17/55,21.52%,SOX9;KAT6B;CTCF;PAF1;LIN54;SMARCD2;INO80;MCM3AP;SETD2;NAP1L1;ACTR6;SPTY2D1;NAA60;ZNHIT1;DAXX;RSF1;ARID1A
prerank,renal filtration (GO:0097205),0.40432167804338914,0.8578025527749514,0.6155202821869489,0.9711989415151294,1.0,2/10,11.52%,SULF1;XPNPEP3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.36760432481593275,0.857687696394018,0.6213592233009708,0.9708191536484214,1.0,1/16,0.78%,ACKR3
prerank,snRNA processing (GO:0016180),0.3619240652455588,0.8576424797060146,0.6452145214521452,0.9703008688572073,1.0,5/16,18.95%,INTS10;TUT1;INTS6L;INTS3;TOE1
prerank,DNA double-strand break processing (GO:0000729),0.3569628112077927,0.8563417320354796,0.6356209150326797,0.972340896444009,1.0,3/18,6.89%,SMARCAD1;NBN;UBE2V2
prerank,reverse cholesterol transport (GO:0043691),-0.3372780233411444,-0.8562564149244456,0.6790123456790124,0.9070833202456635,1.0,5/13,26.09%,APOE;ABCG1;CLU;SCARB1;LCAT
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.2989865921921314,-0.8561479076023332,0.6692913385826772,0.9064245084295576,1.0,4/20,10.59%,TGFBR1;HIF1A;DNAJB2;EPAS1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3400663066961213,0.8560150104246264,0.6759689922480621,0.9723827461404893,1.0,8/26,16.65%,SOCS5;TSG101;NCK2;CBLB;ADRA2A;SOCS4;HBEGF;FBXW7
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3986655778981878,0.8559461462411547,0.6406779661016949,0.9718970937199602,1.0,1/11,1.73%,EGFR
prerank,positive regulation of organelle organization (GO:0010638),0.3215607232683702,0.855917184336793,0.6287769784172662,0.9713555459831209,1.0,7/32,15.90%,PPARGC1A;RAB3GAP2;IRGM;GSK3B;LNPK;HTRA2;SHCBP1L
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.293957920900478,-0.8556620344077986,0.6852367688022284,0.9066520800093449,1.0,4/20,5.19%,SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,steroid hormone biosynthetic process (GO:0120178),0.32760506441427406,0.8550834067577731,0.6289855072463768,0.9724049529275872,1.0,5/29,19.79%,HSD17B3;HSD17B2;STARD3;STAR;HSD17B11
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2828605860453425,-0.855027793837843,0.6997167138810199,0.9071249059662623,1.0,3/22,5.38%,SLC7A5;LACC1;TNFRSF1B
prerank,tRNA aminoacylation (GO:0043039),0.30917171015536504,0.8550140048779541,0.6458923512747875,0.9719516036267144,1.0,13/37,22.22%,RARS2;VARS1;DARS1;KARS1;AIMP1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;GATB;MARS2
prerank,snRNA 3'-end processing (GO:0034472),0.3543755139991155,0.854919123039928,0.6506410256410257,0.9715441632234953,1.0,5/19,21.48%,EXOSC5;TUT1;INTS6L;TOE1;EXOSC7
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3262881812933598,0.8544996584679528,0.6328725038402457,0.9718106219598014,1.0,3/24,3.58%,CAMK2D;PDE4D;FKBP1B
prerank,cellular response to reactive oxygen species (GO:0034614),0.29115069344160194,0.8536594686453596,0.6772554002541296,0.9728919889896307,1.0,10/59,12.99%,PXN;EGFR;MPV17;FER;TNFAIP3;MAPK7;MAP3K5;HDAC6;NFE2L2;AQP1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3137512258135594,-0.853028693559717,0.6692111959287532,0.9104049658875848,1.0,6/17,15.96%,ADCY1;ADCY7;ADCY4;ADCY2;PRKAR2B;CYSLTR2
prerank,determination of left/right symmetry (GO:0007368),0.3123074579883956,0.8527003582512238,0.6572237960339944,0.974213421159267,1.0,8/36,15.14%,ENKUR;STIL;CCDC39;FOXJ1;LEFTY1;SMO;DNAH5;CCDC40
prerank,calcium ion transmembrane transport (GO:0070588),0.2733778188921374,0.8526250393035307,0.6986634264884569,0.9737510761174499,1.0,7/86,4.74%,NALCN;TRPM3;SLC8B1;ANO6;SLC24A1;TRPV4;ATP2B4
prerank,regulation of actin nucleation (GO:0051125),0.3908977133781363,0.8525130524860749,0.6291161178509532,0.9733750797605906,1.0,1/12,3.44%,ARPIN
prerank,anterograde trans-synaptic signaling (GO:0098916),0.24859777716062043,0.8523505416511628,0.759871931696905,0.9730991734680876,1.0,31/224,14.69%,HRH1;CHRNB3;CEL;MINK1;GRIA3;SLC12A4;NPTX2;SLC1A6;CPLX1;GABBR2;PAFAH1B1;PRKAR2A;GABRR2;GABRG2;HCRTR2;MYCBPAP;DOC2A;MPZ;RPS6KA3;GRIA1;SCN2B;GABRG1;GABRB3;SNCG;GRM1;KIF5A;CHRM2;PRKACB;HCRT;UNC13B;CHRM3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.28848810217615517,0.8523371259928094,0.6794380587484036,0.9725243354922161,1.0,7/68,9.49%,LBP;IL1A;WNT5A;IL17RA;TLR7;ISL1;HMGB1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3581260479589764,0.8522032555504303,0.6251944012441679,0.972185079744538,1.0,1/18,0.80%,TSHZ3
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.36544855825292777,0.8519868085743056,0.6116352201257862,0.9720347188052836,1.0,2/16,7.25%,RBFOX2;DDX17
prerank,regulation of cilium movement (GO:0003352),0.3962794868056174,0.8518972767450617,0.6334586466165414,0.9716216469828057,1.0,3/10,15.69%,CCDC39;CCDC40;CFAP298
prerank,cellular response to hypoxia (GO:0071456),0.26543600587121224,0.8513324711269836,0.7190751445086705,0.9721306745504166,1.0,28/126,18.76%,RORA;PSME3;EGLN3;SUV39H1;PSMB5;HILPDA;AQP1;CREBBP;PSMB2;P4HB;PSMA2;PSMA6;BAD;PSMD13;PSMA7;PGK1;UBQLN1;RGCC;BNIP3;HP1BP3;SUV39H2;PSME4;BACH1;PINK1;PSMC4;PSMB6;PSMD12;PSMD14
prerank,sensory perception of taste (GO:0050909),-0.3581244461689873,-0.8512981350128542,0.6390134529147982,0.9131396951131294,1.0,8/10,49.94%,PKD2L1;PKD1L3;CD36;ASIC1;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,filopodium assembly (GO:0046847),-0.3133621022371328,-0.8510979077656147,0.662269129287599,0.9126487614178294,1.0,3/16,5.88%,DNM3;FGD5;ARHGEF4
prerank,response to molecule of bacterial origin (GO:0002237),0.28196179515107656,0.8510209373622946,0.6964285714285714,0.9721329743586999,1.0,10/69,11.08%,LBP;PTPN22;HNRNPA0;IRAK3;FER;TNFAIP3;ACOD1;RPS6KA3;S100A9;TAB2
prerank,nuclear pore organization (GO:0006999),-0.32133001938609307,-0.8509089155865963,0.65,0.9121576873106084,1.0,3/14,6.17%,NUP107;SEH1L;NUP133
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.35213457696459416,-0.8507880817857716,0.6884875846501128,0.9115285948823453,1.0,3/10,13.13%,PCGF5;IGF2;PRMT7
prerank,positive regulation of defense response (GO:0031349),0.27657813571915435,0.8505049651343138,0.7035670356703567,0.9725683941782571,1.0,18/89,17.74%,NPAS2;MGST2;LRSAM1;WNT5A;ABCC1;IL17RA;TLR7;TRADD;POLR3G;PTGER4;TNIP1;PLSCR1;S100A9;POLR3D;IL15;NFKBIZ;MDK;LPL
prerank,respiratory chain complex IV assembly (GO:0008535),0.3454504044163561,0.8500456647723535,0.6395705521472392,0.9728730185845997,1.0,7/21,19.28%,COA5;COX15;COX19;COX16;BCS1L;SURF1;COA8
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.32206971822202124,0.8498331857960131,0.6452599388379205,0.9727199090531539,1.0,10/27,25.12%,SPRED1;HIC1;DYRK1A;SPRED2;YJU2;ATR;KMT5A;TWIST1;PTTG1IP;MDM2
prerank,tRNA export from nucleus (GO:0006409),0.3189404943953875,0.8496494135096012,0.6771771771771772,0.9718723077036169,1.0,10/32,15.46%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3189404943953875,0.8496494135096012,0.6771771771771772,0.9718723077036169,1.0,10/32,15.46%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,stabilization of membrane potential (GO:0030322),-0.3051354648544633,-0.8491086325142877,0.6553524804177546,0.9140667276565531,1.0,1/16,0.21%,KCNK2
prerank,vesicle coating (GO:0006901),-0.22317192428182192,-0.8490294099080601,0.7699115044247787,0.9116199621994556,1.0,19/61,21.26%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.22317192428182192,-0.8490294099080601,0.7699115044247787,0.9116199621994556,1.0,19/61,21.26%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,COPII vesicle coating (GO:0048208),-0.22317192428182192,-0.8490294099080601,0.7699115044247787,0.9116199621994556,1.0,19/61,21.26%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.30541159337412327,0.848435506049064,0.6452476572958501,0.9737209578156388,1.0,4/42,5.75%,UBE2L6;USP43;POLI;RFC3
prerank,histone H2B ubiquitination (GO:0033523),0.40109609243102534,0.8482250994698217,0.6349206349206349,0.9735234591680745,1.0,5/10,23.22%,LEO1;PAF1;CDC73;RNF20;DTX3L
prerank,oligosaccharide metabolic process (GO:0009311),0.30183644930712056,0.8482153507759478,0.6707988980716253,0.9729391527266622,1.0,7/46,11.50%,ST3GAL4;B3GALT1;NAGA;NEU1;ST8SIA5;MANBA;ST8SIA3
prerank,COPII-coated vesicle budding (GO:0090114),-0.21958914174536398,-0.8480382469865855,0.7981651376146789,0.9128715437898383,1.0,20/68,21.26%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;SCAP;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,membrane lipid catabolic process (GO:0046466),0.39932071649932355,0.8476626033423494,0.6296296296296297,0.9734597566302642,1.0,2/10,4.80%,NAGA;MGST2
prerank,histone H4 acetylation (GO:0043967),0.3062692490097633,0.8475723245715132,0.6666666666666666,0.9730551527342471,1.0,13/47,19.22%,OGT;KMT2A;BEND3;HAT1;KANSL2;MSL3;TRRAP;KAT8;BRD8;MORF4L2;RUVBL2;NAA40;NAA60
prerank,regulation of T cell cytokine production (GO:0002724),-0.32267885073876235,-0.8471430766052465,0.7146666666666667,0.9138840500959169,1.0,3/15,6.74%,B2M;TNFRSF1B;TRAF6
prerank,phosphatidylserine metabolic process (GO:0006658),0.31549386989669703,0.8467679103947914,0.6666666666666666,0.9740553955765241,1.0,4/32,9.00%,MBOAT2;SLC27A1;ABHD12;PLSCR1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.2773754391051696,-0.8466846060578004,0.713527851458886,0.9139262623634914,1.0,4/24,7.87%,CDC42;MEF2A;MAPK12;CDON
prerank,negative regulation by host of viral process (GO:0044793),-0.3423569200276565,-0.8466286685492103,0.651270207852194,0.9131773244021906,1.0,2/10,10.27%,ZC3H12A;EIF2AK4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.37285046674454747,0.8465742609314034,0.6177474402730375,0.9738628784607283,1.0,3/14,16.84%,ANO6;GPER1;RGCC
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2969270276678451,-0.8461330783855131,0.6811224489795918,0.9133077016198587,1.0,4/18,12.90%,PIK3R1;BCL2L11;RNFT1;BOK
prerank,response to ionizing radiation (GO:0010212),-0.2183564150812923,-0.845891500720886,0.8113207547169812,0.9129566185015796,1.0,30/70,27.50%,USP28;PAXIP1;BLM;ANXA1;NHEJ1;EEF1D;RHOB;BABAM2;NET1;TOPBP1;RAD1;CLK2;RNF8;EYA3;ABRAXAS1;RAD9B;KDM4D;TRIM13;XRCC4;FANCD2;GRB2;RAD51;NABP1;LIG4;BRCA1;DCUN1D3;PRKAA1;ATM;SMPD1;BRAT1
prerank,negative regulation of viral process (GO:0048525),-0.22555938154937633,-0.8458720215322382,0.7829787234042553,0.9121307688852818,1.0,18/57,21.48%,MID2;BST2;TRIM14;ZC3HAV1;TRIM35;TRIM28;PROX1;UBP1;PARP10;CHMP3;ISG15;IFIT1;ZFP36;RSAD2;TRIM8;TRIM13;TRIM11;SHFL
prerank,positive regulation of cell killing (GO:0031343),0.38607528207163566,0.8456511114606098,0.6538461538461539,0.975103577807326,1.0,6/13,23.34%,WNT5A;NOXO1;FZD7;SYK;MAPK8;RAC1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3955648663798334,0.8455576377292165,0.6360294117647058,0.9746903760722734,1.0,2/10,12.34%,NPTX2;DLGAP2
prerank,neuronal action potential (GO:0019228),0.3382600747050656,0.8455525649267982,0.6415711947626841,0.9741021329222904,1.0,2/22,4.79%,SCN10A;CACNA1H
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.28894612584147117,-0.8455515132790798,0.6873315363881402,0.9119294907050742,1.0,2/20,6.91%,PLCB1;AGRN
prerank,multivesicular body organization (GO:0036257),0.3234233118337998,0.8455207488747761,0.6511299435028248,0.9735728951494034,1.0,7/31,11.97%,TSG101;CHMP5;PDCD6IP;IST1;CHMP4A;CHMP4B;CHMP4C
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.260974306944721,-0.8441928072509877,0.7134670487106017,0.9137905776731933,1.0,16/30,34.40%,ARHGEF2;NOS3;FAS;CFLAR;TNFSF10;CASP8;ICAM1;RIPK1;BRCA1;RNF34;DDX3X;TRAF2;RFFL;HMOX1;FAIM2;SERPINE1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3469098109538305,0.8440960892078533,0.6494345718901454,0.9757490871167197,1.0,2/19,2.82%,CXCL17;MPP1
prerank,receptor-mediated endocytosis (GO:0006898),0.25987484206366807,0.8440901139291449,0.7193181818181819,0.9751658395336259,1.0,24/132,16.60%,CAV1;ACKR3;FOLR1;HSPH1;COLEC11;CAV2;CD9;TFR2;DNM1;SGIP1;INPP5F;CUBN;M6PR;NEDD4;CD81;AMN;CTTN;HSPG2;CLEC9A;CLTB;AP2A2;SNX1;SYK;SCARB2
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.29301453133336114,-0.8436305120095478,0.6819407008086253,0.9139994866809069,1.0,6/20,27.37%,AKR1B1;FDXR;TSPO;STARD3NL;HSD17B10;TSPOAP1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.38545266893370533,0.8434506677822542,0.6465364120781527,0.9758205365016938,1.0,3/13,18.77%,RIC3;STX4;TM9SF4
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.35419270185748064,-0.843295040125749,0.6906976744186046,0.9138405595282535,1.0,4/10,15.44%,CACNB2;CALM1;CALM3;SRI
prerank,negative regulation of nervous system development (GO:0051961),-0.29519950480905455,-0.8432665774051037,0.6881720430107527,0.913038979536478,1.0,2/17,4.54%,APPL2;B2M
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.3736142034546674,0.8432540353757386,0.654300168634064,0.975630162972035,1.0,2/13,4.79%,STX1A;CACNA1H
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2965843500311965,0.843008195104361,0.6747967479674797,0.9749437830845971,1.0,12/50,15.46%,IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;PUM2;NUP93
prerank,regulation of gene silencing by RNA (GO:0060966),0.2965843500311965,0.843008195104361,0.6747967479674797,0.9749437830845971,1.0,12/50,15.46%,IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;PUM2;NUP93
prerank,negative regulation of transposition (GO:0010529),0.359340324371322,0.842805913435074,0.6385542168674698,0.9747474591811757,1.0,3/16,12.29%,PIWIL2;SIRT7;TEX15
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.23267961958378805,-0.8424302179209106,0.7547169811320755,0.9138225149397292,1.0,17/48,22.66%,EP300;ATAD2B;ACTB;TAF1D;DEK;SMARCD1;H1-0;SMARCA5;SERTAD1;POLR2F;KAT2B;KAT2A;TAF1C;POLR2K;POLR1C;ZMIZ2;POLR1F
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.30351711957357314,-0.8423178316609741,0.7061855670103093,0.9131887165202333,1.0,6/17,16.52%,BMP4;RFX3;VEZF1;BTG1;NKX6-1;AHI1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2815099479393704,0.8421350642246194,0.7064676616915423,0.9754123682499148,1.0,6/76,8.41%,CAV1;PRICKLE1;AXIN1;HDAC4;CUL3;TNIP1
prerank,regulation of actin filament-based movement (GO:1903115),-0.3446675035455802,-0.8421276204722135,0.6768149882903981,0.912721153030114,1.0,7/10,31.45%,ANK2;SRI;PLN;PDE4B;SCN5A;PDPN;STC1
prerank,cGMP metabolic process (GO:0046068),-0.3344818101001908,-0.8420756696848998,0.661498708010336,0.9119828154841136,1.0,2/12,9.40%,NPR1;PDE2A
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2860324889243071,-0.8419294741040892,0.695054945054945,0.9114179895364304,1.0,11/21,28.16%,RPS7;UBE2S;RPL23;GOLGA2;CDC14B;SKP1;MAD2L2;RPL5;MAD2L1;RPL11;GORASP1
prerank,regulation of mitotic nuclear division (GO:0007088),0.29224568185809785,0.8417987728187704,0.6797385620915033,0.9754620915006939,1.0,9/55,9.47%,FBXO43;KIF20B;CAV2;IL1A;NUP62;TOM1L1;CDK13;FBXO5;TOM1L2
prerank,double-strand break repair (GO:0006302),0.25217595981483776,0.8414183094456454,0.7525083612040134,0.9756236506367131,1.0,37/158,19.61%,SMC5;BRCC3;EYA1;PAXX;SMARCAD1;KPNA2;NBN;UBE2V2;PALB2;SWI5;UIMC1;ACTR8;HMGB1;ZSWIM7;ERCC1;TDP1;ZFYVE26;INO80;MDC1;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;POLB;EME2;REV3L;RECQL5;KDM4B;TNKS1BP1;TDP2;BRIP1;SFR1;PSMD14;MRE11;XRCC6;SUMO1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2841775914155411,0.8413862412793056,0.6849489795918368,0.9750799845498135,1.0,14/69,15.68%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;SDHD;SDHAF2;COX7C;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,peptidyl-serine phosphorylation (GO:0018105),0.25386423623406945,0.8413843590928333,0.7519640852974186,0.9744938600247955,1.0,21/153,13.35%,PLK2;PRKCE;CAMK2D;STK38;EIF2AK3;PRKCA;MORC3;HIPK1;BRSK1;STK38L;DYRK1A;CSNK1G3;GSK3B;RPS6KA3;MASTL;CSNK1A1;SRPK2;TOP1;SGK1;PKD1;ERN1
prerank,positive regulation of myelination (GO:0031643),-0.345736021364217,-0.8410721371162991,0.6674757281553398,0.9122922208612753,1.0,2/11,5.38%,PARD3;TNFRSF1B
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2661501969649588,-0.8403207930848957,0.717948717948718,0.9129434708754434,1.0,7/26,18.59%,PDE8A;AKT1;GPR37;LRRK2;HSPB1;GPR37L1;ATF4
prerank,myoblast fusion (GO:0007520),0.3764802927657894,0.8400303772746999,0.6323024054982818,0.9765851130141177,1.0,3/12,12.38%,CD9;CACNA1H;CD81
prerank,positive regulation of protein ubiquitination (GO:0031398),0.27759718339457984,0.8399955745993904,0.6984126984126984,0.9760633831170088,1.0,4/80,4.37%,CAV1;PRICKLE1;AXIN1;SPSB4
prerank,peptidyl-lysine modification (GO:0018205),0.26701245810951496,0.8396628838690715,0.7221542227662179,0.9761334860318457,1.0,32/99,23.44%,STX1A;EYA1;SENP6;UBE2I;HDAC4;NUP62;SIRT3;PIAS2;NUP160;SIRT7;NUP37;TPR;NUP50;HDAC6;RANBP2;NUP210;NUP153;ATPSCKMT;NUP93;SENP3;SUMO1;SENP2;TRPM4;LOXL2;ETFBKMT;NUP43;VIPAS39;VCPKMT;IFIH1;SIRT2;SAE1;BCL11A
prerank,regulation of mitotic spindle organization (GO:0060236),0.31711957613779446,0.8396002878280185,0.6604850213980028,0.9756658566993379,1.0,7/35,12.02%,NUP62;CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C;MAP9
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.2948970493109103,0.8395239942641499,0.6744186046511628,0.9752423426074458,1.0,11/49,13.64%,SRC;DACT1;PPM1A;LDLRAD4;PTGER4;ISL1;GSK3B;HMGB1;NLRP2B;HDAC6;LCMT1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.1907492914201321,-0.8390561034998489,0.8861788617886179,0.9147371273612377,1.0,55/148,27.75%,PRKAG2;CHD4;WRN;EP300;RPL37;RPS15;TOP3A;RPS20;JMY;BLM;ATRIP;HDAC1;AKT1;BRD7;SMYD2;PRKAB2;PIP4K2A;RPL23;RICTOR;CSNK2A1;NOC2L;TOPBP1;RAD1;CDK5R1;BARD1;CSNK2B;BANP;TP53RK;NUAK1;RAD17;RFC2;CDK5RAP3;RAD9B;TAF6;EHMT2;MAP2K6;RPL5;PIP4P1;RMI2;PRDM1;CDK2;BRCA1;PAK1IP1;RNF34;MLST8;L3MBTL1;PRKAA1;RFC4;RPF2;RMI1;ATM;ING5;TPX2;RPL11;TAF11
prerank,DNA repair (GO:0006281),0.24215614903194096,0.8389763408788846,0.8110647181628392,0.9757062365292092,1.0,64/284,19.61%,FAAP24;TDG;MSH6;BRCC3;EYA1;POLI;SLC30A9;KMT5C;FANCC;PDS5B;RFC3;KPNA2;FANCF;NBN;UBE2V2;MSH2;UIMC1;ACTR8;USP47;TRRAP;APEX2;ERCC6;ERCC1;TDP1;MEN1;INO80;CETN2;MDC1;MGMT;RFWD3;ADPRS;GTF2H1;NUCKS1;ALKBH1;RAD51AP2;POLB;EME2;REXO4;RECQL5;FAM111A;PRMT6;POLE;DDB2;FANCL;INTS3;CHD1L;KDM4B;USP45;TNKS1BP1;RHNO1;CUL4B;SETD2;PSME4;TDP2;BRIP1;BACH1;GTF2H3;ERCC6L2;ASCC2;MRE11;ASCC1;MLH3;RPAIN;SUMO1
prerank,regulation of mitotic cell cycle (GO:0007346),0.2534634895421196,0.8387257333131953,0.7840531561461794,0.9755973051289392,1.0,37/171,18.76%,SMOC2;FBXO43;KIF20B;CAV2;PRKCA;PSME3;NEK7;CDK13;FBXO5;BRINP1;CDC20;PSMB5;ANAPC5;ANAPC7;EIF4E;ANAPC11;BUB3;CDKN1C;ANAPC2;PSMB2;UBE2D1;PSMA2;TTC28;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;NEK11;SCRIB;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,peptide cross-linking (GO:0018149),0.32764363917659217,0.8386885766932616,0.6621621621621622,0.9750803114135683,1.0,3/25,6.66%,CD3G;FN1;COL3A1
prerank,mRNA 3'-end processing (GO:0031124),0.27478156585675434,0.8383750683657046,0.7130214917825537,0.9750819148560189,1.0,26/78,25.25%,CSTF1;RBM8A;SRSF4;LEO1;RPRD1B;TUT1;PAF1;CSTF3;RPRD1A;UPF3B;THOC3;THOC5;SLU7;SYMPK;PAPOLG;SRSF3;DHX38;CDC73;NUDT21;SRSF11;PCF11;CPSF2;WDR33;SARNP;PABPN1;TENT4B
prerank,regulation of microtubule-based process (GO:0032886),0.3070329654276766,0.838257139387533,0.675561797752809,0.9747350235362063,1.0,5/36,11.27%,EFNA5;GSK3B;PHLDB1;APC;HDAC6
prerank,ureteric bud development (GO:0001657),0.350789517336744,0.8377210867782281,0.6288492706645057,0.9752113546532508,1.0,1/17,0.41%,GPC3
prerank,negative regulation of cell death (GO:0060548),0.26909381839706276,0.8376913440027222,0.7120481927710843,0.9746749944718661,1.0,14/88,10.71%,PPARGC1A;SPEF1;WNT16;NPAS2;NUP62;KANK2;AMIGO2;ATG5;CD200R1;GSK3B;POU4F1;FERMT2;CHMP4A;CHMP4B
prerank,zinc ion transport (GO:0006829),0.34015706709828925,0.8376458571618786,0.6377708978328174,0.9741792429441763,1.0,3/21,6.05%,SLC39A13;SLC30A9;SLC30A6
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.29024908044264375,0.8371969631111957,0.6702269692923899,0.9744632203287504,1.0,4/50,5.90%,NR3C2;EGFR;TLR7;TRADD
prerank,cardiac muscle contraction (GO:0060048),0.31378487049668025,0.8371029609101341,0.6829971181556196,0.9740519597805432,1.0,7/34,15.19%,CAMK2D;CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1;TNNI3
prerank,aminoglycan metabolic process (GO:0006022),0.394583141742577,0.8369809348222286,0.6305506216696269,0.9736985033425083,1.0,1/10,2.21%,XYLT2
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2595270680329235,-0.8366690176087629,0.7215568862275449,0.9185758346029398,1.0,14/28,32.99%,CLIP1;RPS3;MAPT;CDK5R1;ARL2;FES;MET;GIT1;HSPA1A;CDK5RAP2;DCTN1;HSPA1B;NAV3;TOGARAM1
prerank,regulation of primary metabolic process (GO:0080090),-0.19562526073948666,-0.8366561000971336,0.8992805755395683,0.9177489294721544,1.0,24/126,15.44%,ROCK2;PPARD;PSMA1;TGS1;LDLR;PLPP1;APOE;TBL1XR1;PSMD11;HMGCS1;C1QTNF2;TNFAIP8L3;PSMD7;PSMD4;PRKAB2;NFYB;FGFR4;SP1;PSMB4;PMVK;ID2;CERS2;MVK;NFYC
prerank,methylguanosine-cap decapping (GO:0110156),-0.35082576929978915,-0.8360088200618284,0.680089485458613,0.918109147904869,1.0,3/10,10.58%,EDC3;EDC4;PNRC2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.2861213552827587,-0.8359186851233493,0.7074468085106383,0.9174384376269825,1.0,2/19,1.31%,AFDN;BMP6
prerank,chloride transport (GO:0006821),0.2777683002136178,0.8357352809683657,0.7034659820282413,0.9755461530808075,1.0,13/74,12.51%,SLC12A2;SLC26A9;ANO6;SLC12A4;SLC12A3;CLCN2;CLCN1;GABRR2;GABRG2;BEST1;GABRG1;GABRB3;ANO10
prerank,regulation of dendritic spine development (GO:0060998),0.35121636567040043,0.8355748237025341,0.6687898089171974,0.9752736006740848,1.0,3/19,7.65%,PPFIA2;LLPH;ARF6
prerank,cellular protein metabolic process (GO:0044267),0.2374795036383558,0.8353985415007359,0.8375634517766497,0.9750507307144478,1.0,44/396,11.24%,FAM20C;IGFBP6;GPC3;STC2;RPSA;SLC35A1;UBE2L6;LAMB2;LAMC1;PCSK5;DUSP12;STK38;MMP15;APH1B;ERO1A;SCG3;MRPL37;MRPL43;UBE2I;CDKL3;NUCB1;CPE;FN1;BMP15;PABPC4;NCSTN;ADAM10;ABL2;GOLM1;RCN1;CDH2;IGFALS;DARS1;TNIP1;CSNK1G3;RPL35;MRPL41;RPS13;MRPS15;MRPS33;MANBA;PROC;MRPL3;PRKCSH
prerank,regulation of gene silencing by miRNA (GO:0060964),0.28487556189004054,0.8352742139478323,0.6905071521456437,0.9746986432896798,1.0,20/62,22.90%,DND1;IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;FXR1;PUM2;NUP93;PPARG;DHX9;NUP43;PUM1;ELAVL1;SEC13
prerank,cellular response to light stimulus (GO:0071482),-0.21248392570079444,-0.8352716435906824,0.8472222222222222,0.9179156704201659,1.0,16/66,19.92%,USP28;PTPRK;EP300;RPL26;NPM1;CDC25A;EIF2AK4;KDM1A;NOC2L;POLK;ZBTB1;NSMCE3;DHX36;ATF4;PARP1;ERCC4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.393013830963471,0.8352597892656206,0.6419753086419753,0.9735646314887023,1.0,2/10,18.84%,CNGB1;CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.393013830963471,0.8352597892656206,0.6419753086419753,0.9735646314887023,1.0,2/10,18.84%,CNGB1;CEP250
prerank,positive regulation of transport (GO:0051050),0.27095204108709803,0.835039530470509,0.7148194271481942,0.9734132537985355,1.0,7/85,5.49%,GPC3;NEDD4L;GPLD1;KMT2A;LMAN2;TFR2;DOCK2
prerank,error-prone translesion synthesis (GO:0042276),0.34710340144354446,0.8350096146486649,0.6481481481481481,0.9728890704944255,1.0,10/21,27.69%,POLI;RFC3;REV3L;RFC1;RPA3;POLE2;PRIMPOL;REV1;RPA2;RPA1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.25534923395640075,-0.8349516828491849,0.7408637873754153,0.9177155283640068,1.0,10/33,17.53%,CYP1B1;SIRPA;ANXA1;OSER1;RHOB;RPS3;NET1;FXN;ANKZF1;TRPM2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.32345993037811804,-0.8348945736347431,0.6690647482014388,0.9169895052255306,1.0,5/12,25.09%,NAE1;CLSPN;TOPBP1;RAD17;STK33
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3236092574149423,0.8347731474809118,0.6833073322932918,0.9727779549970647,1.0,4/26,6.01%,USP50;APH1B;PSME3;NCSTN
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3733292181978499,0.8347630630079322,0.6432078559738135,0.9722173521136948,1.0,3/12,17.26%,UPP2;CAD;DCK
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.35130073849762644,-0.8344372382797589,0.6666666666666666,0.9170445890643371,1.0,6/10,35.89%,ENPP2;PLA2G15;PLA2G7;PLA2G6;LIPC;PLA2G5
prerank,neural crest cell development (GO:0014032),-0.22967791814069952,-0.8343948570777291,0.7923076923076923,0.9162892011020142,1.0,21/44,32.91%,SEMA6D;SEMA7A;SEMA3C;SEMA6A;TBX1;RADIL;TCOF1;ANXA6;SEMA3G;SOX10;HTR2B;TAPT1;SEMA4G;SEMA3F;SEMA3D;SEMA5A;SNAI2;NRTN;SEMA4F;NRG1;SEMA5B
prerank,regulation of cell size (GO:0008361),0.33532642449887456,0.8343328592537853,0.6718266253869969,0.9724070808110368,1.0,12/23,23.75%,VAV2;RDX;PLEK;RARG;PTEN;EZR;RAP1GAP2;RHOA;LAMTOR5;RPTOR;RAC1;MTOR
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.32230863412430577,-0.8338411735017575,0.6882494004796164,0.9164950692894249,1.0,5/14,19.72%,ACTR2;ARID2;MMS19;PARP1;TIMELESS
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.28372406741097916,0.8337585900929931,0.6874205844980941,0.9729000649808492,1.0,12/59,16.08%,BCL3;REL;TLR7;TRADD;AZI2;IRAK1BP1;TICAM1;SHARPIN;TAB2;TICAM2;TBK1;RELB
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.32493569636692593,0.833430519614991,0.6686567164179105,0.9729246888087365,1.0,6/26,10.99%,HEYL;KANK2;NCOR1;PIAS2;ISL1;NCOR2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.29781275461448914,0.833356807127454,0.6767537826685007,0.972492930807125,1.0,12/43,19.02%,BRCC3;BRSK1;NBN;CHFR;RINT1;UIMC1;DONSON;CDC6;FZR1;INTS3;ORC1;MRE11
prerank,histone H2A acetylation (GO:0043968),0.37044984257427316,0.8333512317859856,0.6585760517799353,0.9719252505655868,1.0,6/16,18.84%,MSL3;TRRAP;BRD8;MORF4L2;RUVBL2;NAA40
prerank,Golgi localization (GO:0051645),-0.34265460033871753,-0.8328547395028039,0.7142857142857143,0.9176418107033282,1.0,3/11,6.04%,CDC42;UVRAG;PDCD10
prerank,chemical synaptic transmission (GO:0007268),0.24080064594373476,0.8328359522488835,0.8146596858638744,0.9723004762464387,1.0,37/284,13.52%,HRH1;CHRNB3;CEL;PDLIM4;MINK1;STX1A;RIC3;GRIA3;SLC12A4;NPTX2;BRSK1;SLC1A6;RAB3A;CPLX1;GABBR2;PAFAH1B1;PRKAR2A;GABRR2;GRID1;GABRG2;HCRTR2;MYCBPAP;DOC2A;MPZ;RPS6KA3;GRIA1;SCN2B;GABRG1;GABRB3;DLGAP2;SNCG;GRM1;KIF5A;PTEN;CHRM2;PRKACB;HCRT
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.30574667195148514,0.8325009129280284,0.6750700280112045,0.9723760127789314,1.0,1/37,0.26%,EFNA5
prerank,steroid biosynthetic process (GO:0006694),0.285193263279188,0.8324001160682668,0.6965428937259923,0.9719906297656685,1.0,8/56,11.64%,HSD17B3;CYP7B1;OSBPL6;SC5D;HSD17B4;ACOT8;PRLR;MSMO1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.37923277220081364,0.8322037215502787,0.6490939044481054,0.9717523702891208,1.0,4/12,10.99%,HEYL;NCOR1;PIAS2;NCOR2
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.22261579011697646,-0.8321327786041512,0.7817460317460317,0.9181605543639102,1.0,12/56,13.57%,LACC1;IRAK4;ALPK1;CTSL;TRAF6;PLCG2;NOD1;BCL10;LGMN;S100A1;MAPKAPK2;MAPKAPK3
prerank,regulation of interleukin-10 production (GO:0032653),0.2977820736536399,0.832042677948533,0.6885714285714286,0.9714749715306833,1.0,1/44,0.38%,TRIB2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.35341700552554656,0.8312715381916626,0.6615646258503401,0.97238705256819,1.0,5/15,24.20%,SOX9;SMO;PAX2;LHX1;SIX1
prerank,stem cell development (GO:0048864),0.3538497863477352,0.8310054517799669,0.6535303776683087,0.9723236715872439,1.0,2/16,7.86%,PTPRC;CDH2
prerank,negative regulation of immune effector process (GO:0002698),0.37506187457658136,0.8303170571340117,0.6593220338983051,0.9730734428174932,1.0,2/13,5.71%,CD55;FER
prerank,regulation of translation (GO:0006417),0.24876102907330377,0.8299969867419899,0.7727771679473107,0.9730983583199682,1.0,47/173,22.10%,BCL3;FXR2;PIWIL2;GIGYF2;FOXO3;EIF2AK3;CNOT10;SAMD4B;PUS7;EIF5B;IGF2BP2;RPS6KA3;EIF4E;CNOT7;EIF1;METTL5;ATXN2;ILF3;PLD1;EIF2B4;UPF3B;ETF1;CSDE1;NSUN5;DDX6;SOX4;ALKBH1;MIF4GD;FXR1;PYM1;MTG2;CPEB3;ERBB2;LTN1;SYNCRIP;CNOT8;CNOT1;DHX9;HNRNPD;LARP4;EIF4G2;IL6;MALSU1;TSFM;ELAVL1;IMPACT;DDX25
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.21794778441616808,-0.829724519923427,0.7808764940239044,0.9221919116534898,1.0,18/55,19.53%,NUPR1;TGFBR1;BCL2L11;GSDME;FAS;BECN1;TNFSF12;BCL10;RPS3;BID;BOK;TNFSF10;WWOX;TPD52L1;STYXL1;AGT;RACK1;BBC3
prerank,tRNA transport (GO:0051031),0.3077499300761146,0.829675777977204,0.6875912408759124,0.9731226908326497,1.0,10/35,15.46%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,receptor catabolic process (GO:0032801),0.3298643104370578,0.8294330819946746,0.6676923076923077,0.9729887609869582,1.0,6/24,11.37%,KIF16B;PIK3R4;GPRASP1;ZNRF3;SNX25;NEDD4
prerank,regulation of receptor binding (GO:1900120),0.39417500908116043,0.8291073489777009,0.6462093862815884,0.9730418822093911,1.0,1/10,1.78%,PTPRF
prerank,mitochondrial gene expression (GO:0140053),0.2946409128061427,0.8290860045509991,0.6897506925207756,0.9725080659686003,1.0,13/42,21.18%,FOXO3;FASTKD2;MRPS28;RARS2;PTCD3;TFB2M;MRPS15;TEFM;MRPL16;NDUFA7;MRPL2;GATB;MRPS7
prerank,positive regulation of protein maturation (GO:1903319),0.38591846515409306,0.82896050125933,0.6696113074204947,0.9721869565691093,1.0,4/11,16.91%,TFR2;NLRC4;SOX4;BAG2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.299157361026529,0.8288854434447355,0.6896551724137931,0.9717486568771242,1.0,3/40,4.10%,PKDCC;ANO6;BMPR1B
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.2874369219566397,0.8288408655103348,0.7002688172043011,0.9712507439574064,1.0,16/51,21.67%,LPAR1;PXN;RAPGEF3;ARHGEF5;PLEK;FERMT2;FHOD1;NF2;ARHGEF10L;ARHGEF10;RGCC;RHOA;PFN2;PPM1E;S100A10;CX3CL1
prerank,negative regulation of transferase activity (GO:0051348),0.3233234131743753,0.8287850505938847,0.6756756756756757,0.9707881489211352,1.0,6/28,17.63%,SRC;FBXO5;GSK3B;MEN1;CDKN1C;IRS2
prerank,defense response to virus (GO:0051607),-0.20184013788429817,-0.8283439478970824,0.8646616541353384,0.9240287722210455,1.0,25/100,21.48%,SERINC3;IFNAR2;ABCC9;SAMHD1;IRF2;IFIT2;IFIT3;AGBL5;BST2;FLNA;IRF1;NDUFAF4;AKAP1;ABCE1;MOV10;ISG15;IFIT1;CD40;RSAD2;PDE12;OPRK1;CGAS;TLR3;BNIP3L;SHFL
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3194795096167688,0.8280981610927227,0.6862170087976539,0.9714771161549557,1.0,3/29,9.49%,CXCL17;ANO6;HMGB1
prerank,protein tetramerization (GO:0051262),0.2775929841274572,0.8276826065483373,0.7151898734177216,0.9716795863820425,1.0,4/67,7.02%,ALDH1A3;ALDH9A1;ACOT13;ACACA
prerank,fatty acid metabolic process (GO:0006631),-0.1893858887453495,-0.8275238980974425,0.8865248226950354,0.9247354514821845,1.0,28/115,20.98%,ACSL1;ACSL3;ADIPOR2;PPARD;ACADSB;LPIN2;ACOT7;GPX4;ACSL6;CPT2;ECHDC3;LPIN3;ACBD5;MLYCD;ACLY;ABCD2;CPT1A;ACOT6;HACL1;ACOT11;PER2;PNPLA3;ACOX1;OXSM;PLA2G15;XBP1;SLC27A2;ADIPOR1
prerank,cellular protein-containing complex assembly (GO:0034622),0.2498587992858753,0.8273794032053705,0.7803203661327232,0.9716589297458236,1.0,30/159,15.46%,STXBP6;PXN;AXIN1;SRC;NCK2;CCDC39;SGIP1;PSMG2;CASQ2;IMMP2L;CALY;PFDN6;PSMG1;TPR;CHMP4A;CHMP4B;LONP1;VAMP8;PRLR;CCT2;AHCTF1;VAMP1;HOPX;NUP153;RTN4;CLTB;POMP;CCDC40;PSMD13;NUP93
prerank,bile acid metabolic process (GO:0008206),0.321446527147115,0.8264934501523559,0.7002967359050445,0.9728125932486064,1.0,4/27,10.29%,CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.36954714560485136,0.826327066552568,0.65625,0.9725472305865043,1.0,5/13,22.61%,PRPF3;USP4;SRSF12;SRSF10;LSM2
prerank,lysosome organization (GO:0007040),0.3028074433736768,0.8262683789237937,0.692090395480226,0.9720915446762479,1.0,6/36,11.69%,HOOK2;HPS1;ABCA1;ATP10B;TFEB;HOOK3
prerank,positive regulation of protein binding (GO:0032092),0.2801188743893194,0.8261152450555771,0.7042801556420234,0.9718071484581926,1.0,21/56,24.27%,CAV1;ADD1;DACT1;TRIM21;AMFR;STK3;GSK3B;MEN1;PKD1;CAPRIN2;RAN;PPP2CA;PIN1;PRKN;AKTIP;TCF7L2;DERL1;NMD3;DTX3L;RIPK2;HIPK2
prerank,kinetochore organization (GO:0051383),-0.3250291599858514,-0.8260029139842258,0.6853658536585366,0.9267927884187622,1.0,9/13,40.08%,CENPT;CENPC;CENPE;NDC80;CENPF;CENPA;DLGAP5;NUF2;CENPW
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.23751575629027902,-0.8259884629171805,0.7927631578947368,0.9259655812755422,1.0,18/40,27.93%,COMMD1;RPS7;SGTA;RPL23;CSNK2A1;PTK2;UBQLN4;RAD23A;HFE;LAPTM5;FOXF2;CDK5RAP3;CLU;RPL5;UBE3A;RPL11;CCDC22;SMURF1
prerank,peptide metabolic process (GO:0006518),0.27416803311876653,0.8258337158179757,0.7208706786171575,0.971766723167052,1.0,17/75,16.37%,PCSK5;MGAT3;CPE;LVRN;LNPEP;BACE2;GSTZ1;GSTA4;MME;GSTA3;GSTK1;LTA4H;MIPEP;ABCB9;GGT1;NLN;BACE1
prerank,defense response to bacterium (GO:0042742),-0.1936355560552637,-0.8258170767565577,0.8897058823529411,0.9254112370922368,1.0,23/105,22.04%,ANXA3;IL6R;GBP4;RPS19;NOD1;PPP1R11;RPL30;STAB1;PGLYRP1;GBP6;GBP7;CFP;CEBPB;GBP2;ISG15;MR1;RARRES2;ADGRB1;COLEC12;ROMO1;TLR3;OPTN;RPL39
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.30870313622523277,-0.8258134518710148,0.6888888888888889,0.9245681877395944,1.0,4/15,16.13%,TGFB3;CUEDC2;TGFB2;HFE
prerank,sphingolipid catabolic process (GO:0030149),-0.3082021436167088,-0.825708551467135,0.7,0.9239117275636584,1.0,4/15,13.41%,ACER2;ENPP2;PDXDC1;SPHK1
prerank,UV-damage excision repair (GO:0070914),0.37625430831138545,0.8248208825085493,0.6695804195804196,0.9731193171955662,1.0,4/12,17.29%,ERCC1;INO80;DDB2;CUL4B
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.31392947353865774,-0.8242743778129886,0.7051597051597052,0.9257879247939592,1.0,3/13,9.36%,ENPP1;BPNT2;TPST1
prerank,response to cAMP (GO:0051591),0.30347375222258643,0.8240206208237133,0.6797671033478894,0.9741085891406873,1.0,2/37,1.89%,RAPGEF3;RAP1A
prerank,keratinocyte differentiation (GO:0030216),0.3100107292966758,0.8237250159246374,0.6690962099125365,0.9741161907834304,1.0,3/29,4.96%,JAG1;WNT16;WNT5A
prerank,pyruvate metabolic process (GO:0006090),0.28771259917906983,0.8237221981312159,0.7186666666666667,0.9735527887061094,1.0,12/52,17.85%,HK2;HOGA1;ALDOB;DLAT;PGM1;SLC16A1;ENO3;GCK;ME2;PGK1;LDHB;ENO2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.23738203159081353,0.8233533644764391,0.8477366255144033,0.9736783396121632,1.0,82/341,20.54%,NEDD4L;UBE2L6;RNF130;WDR81;UBE3C;RNF122;PCBP2;UBE2I;SPSB4;PSME3;KEAP1;TOM1L1;TSG101;TNFAIP3;CHFR;SIAH1;ZNRF3;CUL3;UBL7;CDC20;AMFR;PSMB5;ANAPC5;ANAPC7;SIAH3;NPLOC4;UBE3D;SHARPIN;RCHY1;TRPC4AP;ANAPC11;OTUD7B;FBXL19;NEDD4;SPOPL;BUB3;FBXL17;TTC3;FAF1;FBXO11;NFE2L2;RNF185;FBXO21;FBXO8;ANAPC2;PSMB2;UBA1;UBE2D3;UBE2D1;PSMA2;KLHL22;KLHL15;FEM1C;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;PSMA7;PLAA;UBE2R2;FBXW7;UBQLN1;ITCH;RNF7;PSME4;WDR91;ANAPC16;PINK1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;USP9X;KBTBD7;GID4;UBE2W;DDIT3;PRKN;RNF146;RNF14
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2709826337800107,0.8229118923223674,0.7298701298701299,0.973948103680031,1.0,8/73,9.49%,LBP;IL1A;WNT5A;PTPRC;EPHB2;ISL1;PTPRJ;HMGB1
prerank,protein alkylation (GO:0008213),0.3304110734038792,0.8225433144571379,0.6686478454680534,0.9740962310126456,1.0,9/22,25.76%,ETF1;LCMT1;METTL22;CAMKMT;ETFBKMT;VCPKMT;EEF2KMT;PRMT8;PRMT3
prerank,positive regulation of telomerase activity (GO:0051973),0.30426270306107367,0.8220556996743013,0.7098674521354934,0.9743993009335722,1.0,4/33,12.08%,NEK7;NAF1;WRAP53;CCT2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.30387311497276304,0.8217224675426483,0.7025495750708215,0.9744405503677299,1.0,4/34,6.39%,PTPN22;WNT5A;PTPRC;EPHB2
prerank,synaptic vesicle cycle (GO:0099504),0.3053208959725812,0.8215621323199619,0.6911764705882353,0.9741636993413854,1.0,4/30,7.29%,STX1A;BRSK1;RAB3A;CPLX1
prerank,determination of bilateral symmetry (GO:0009855),-0.26963163271804114,-0.8214735314033743,0.7249283667621776,0.9302001531183395,1.0,6/24,14.89%,NPHP3;TBX1;GALNT11;CITED2;ZIC3;MKKS
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.36646121585583336,0.8214587715638884,0.6736474694589878,0.9737726722523438,1.0,2/14,8.64%,AK5;NMNAT3
prerank,neuron projection fasciculation (GO:0106030),-0.34653010045634436,-0.8214392532792698,0.717948717948718,0.929420759142601,1.0,7/10,31.99%,EPHA4;ARHGAP35;CDK5R1;EPHB3;AMIGO1;SEMA5A;NRCAM
prerank,carbohydrate derivative catabolic process (GO:1901136),0.33960414042956066,0.8213645739925258,0.6618357487922706,0.9733973568251132,1.0,5/18,15.81%,NAGA;BPGM;MANBA;DERA;OGA
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.31674684505710354,0.8213313399011725,0.7087227414330218,0.9728895959406978,1.0,1/27,0.73%,LPAR1
prerank,maturation of SSU-rRNA (GO:0030490),-0.24684747934590184,-0.8212770358359957,0.7554179566563467,0.928854967169006,1.0,18/34,30.26%,RPS19;RPS16;RPS8;RIOK1;HEATR1;TSR1;DHX37;MRPS11;RIOK3;UTP4;PWP2;WDR3;RPS14;NOB1;NAT10;RRP36;WDR46;UTP6
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2961125093791531,0.8211204408634534,0.691771269177127,0.9727411038519816,1.0,6/37,15.32%,CAV1;FIS1;SIAH1;S100A9;SFPQ;BAD
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.32705880049963043,0.8206889320357288,0.6784,0.9729762780555353,1.0,4/20,9.04%,CAMK2D;FKBP1B;ATP1A2;CASQ2
prerank,proteoglycan metabolic process (GO:0006029),0.31904354959144154,0.8205295237053617,0.6848,0.9726974322560766,1.0,5/26,11.13%,ADAMTS12;SULF1;BMPR1B;CANT1;CHST12
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2677494365347327,0.8203794201270433,0.7599502487562189,0.9724123893814927,1.0,21/80,18.40%,KIF2A;LMAN2;RACGAP1;PLPP3;TAPBP;KIF3C;RINT1;ATP9B;ATP9A;COPE;KIF26A;KIF5A;COPG1;HTT;ZW10;COPA;TMED2;ERGIC1;ARCN1;KLC2;COG3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2602954936178354,0.8202605801218157,0.7580452920143027,0.9720679443363629,1.0,7/104,5.18%,CAV1;DLX1;SPRED1;SPRY1;BMPR1B;NBL1;PPM1A
prerank,regulation of lamellipodium organization (GO:1902743),0.36014426989345416,0.820174756839454,0.676818950930626,0.9716793959257611,1.0,2/14,5.71%,CAPZB;FER
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.285238544573679,0.8201557787254863,0.7103448275862069,0.9711443087015591,1.0,7/48,12.28%,OTOP1;ARG1;IRAK3;PTPRC;NLRP2B;CNOT7;STAT2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.32271689718311225,0.8200614465239637,0.6558139534883721,0.9707502378716135,1.0,1/24,0.78%,ACKR3
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2618115580366991,-0.8200147722327302,0.716374269005848,0.93040389568392,1.0,10/24,26.51%,KCNB1;C2CD5;ANK3;MTCL1;MIEF2;TCAF2;HRAS;ITGB2;CIB1;ITGAM
prerank,neutrophil migration (GO:1990266),0.284186271549921,0.8199583206897809,0.7189973614775725,0.970378292682234,1.0,1/58,0.29%,CXADR
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3364528951079816,0.8196764222750021,0.6544,0.9703116143420607,1.0,1/19,0.52%,F11R
prerank,cellular amide metabolic process (GO:0043603),0.2577517623079863,0.8193881676319856,0.7783075089392133,0.9702877629658936,1.0,22/102,16.70%,FOLR2;PCCB;PLPP2;PLPP3;CPE;PLAAT5;MTHFD1;ACOT13;CLN8;CERK;NIT1;ST6GAL1;ACSF2;ACOT8;MME;ACOT2;MIPEP;ABCB9;SLC46A1;PANK2;NLN;ALDH1L2
prerank,prostanoid metabolic process (GO:0006692),0.36505911070670083,0.8192924576492585,0.6672158154859967,0.9699015842796918,1.0,6/13,25.98%,CYP2S1;PLAA;HPGD;PTGR1;PTGR2;GSTM1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.2821402074003722,-0.81927225051904,0.7398373983739838,0.9309496394950776,1.0,11/22,27.96%,RPL37;RPS15;RPS7;RPS20;RPL23;EEF1E1;CDK5RAP3;PLA2R1;UBB;ATM;MSX1
prerank,nuclear envelope organization (GO:0006998),0.3302640065196376,0.8190056194020259,0.6692307692307692,0.9698585379794431,1.0,7/20,20.84%,NEMP1;SUN1;REEP3;EMD;NUP93;LEMD2;REEP4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.27228716757375654,0.8188978889501721,0.7414698162729659,0.9695006015234111,1.0,15/62,18.15%,MLLT3;LEO1;CDK13;CDK7;PAF1;ELL;NELFB;SUPT4H1;GTF2F2;GTF2H1;ELOA;RTF1;TCEA1;SETD2;GTF2H3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.33717830856194453,0.8188087632501798,0.670926517571885,0.9691063641339216,1.0,9/21,22.92%,AATF;HDAC6;ABCD1;ABCB7;PINK1;COA8;PRKN;PAX2;SIRT2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.31210317878474875,0.8188032664015199,0.7161572052401747,0.9685587986919298,1.0,11/29,21.06%,TRAPPC3L;GOSR1;COG6;COPE;COPG1;COPA;RAB33B;TRAPPC3;COG3;NSF;COG5
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.312484358847559,0.8187147538128781,0.7147058823529412,0.9681633986190095,1.0,12/31,22.21%,PPP1R13B;SFN;GSK3B;BAD;NMT1;YWHAG;YWHAE;E2F1;BAX;MAPK8;TFDP1;YWHAB
prerank,organophosphate catabolic process (GO:0046434),-0.3392471588724816,-0.8187040383703109,0.7223529411764706,0.9311954786828266,1.0,1/11,2.72%,ENPP2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.31890898682203206,0.8186675258217347,0.6666666666666666,0.9676892250285579,1.0,5/24,16.93%,TTLL1;AGBL4;CFAP20;NAA10;TTLL9
prerank,amide transport (GO:0042886),0.32001884398165126,0.8184149237353958,0.7104851330203443,0.9676028886544664,1.0,6/26,14.92%,FOLR1;FOLR2;SLC27A1;CERT1;ABCB9;SLC46A1
prerank,histone mRNA catabolic process (GO:0071044),-0.30160462068056815,-0.8180762416634959,0.7066326530612245,0.9314901310504599,1.0,4/15,15.02%,SSB;TENT2;TUT7;MTPAP
prerank,termination of RNA polymerase II transcription (GO:0006369),0.31025148313958206,0.8173932708469885,0.6939078751857355,0.9689174270670567,1.0,4/33,7.27%,CSTF1;SNRPF;MED18;CSTF3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.353814083661696,0.8173678982341486,0.6613418530351438,0.9684000557816665,1.0,4/14,18.26%,RMND1;FASTKD2;MPV17L2;RPUSD4
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.2682720355918299,-0.8173515205999361,0.7467018469656992,0.9319503502120093,1.0,12/23,36.29%,TGM2;SLC9A1;LRRK2;ATF4;PDE4B;ADCY6;NR4A3;APLP1;KCNQ1;RYR2;GNG2;SNCA
prerank,protein autoubiquitination (GO:0051865),0.27918441832890706,0.8171267587678029,0.7390745501285347,0.968290875875872,1.0,14/61,17.27%,SH3RF2;RNF122;LRSAM1;TRIM21;CUL3;AMFR;RNF220;UBE3D;OBI1;RNF185;UBE2D3;WWP2;DDB2;ITCH
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.37455579990508214,0.817004152674589,0.6800699300699301,0.9679609410892981,1.0,2/11,6.82%,LEO1;PAF1
prerank,DNA duplex unwinding (GO:0032508),-0.2277097542523058,-0.8169807098324063,0.7790262172284644,0.9318196850239225,1.0,21/50,32.05%,WRN;RBX1;BLM;MCM6;ANXA1;SSBP1;ERCC2;XPA;GTF2H4;DDX1;PARP1;MCMDC2;TWNK;RAD51;UBB;GTF2H5;DDB1;ASCC3;MCM9;MCM7;MCM2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.264829501276915,0.8165065409707476,0.7434944237918215,0.9683226486587986,1.0,14/83,17.83%,PLK2;CDK15;CDK7;FBXO5;CUL3;EIF4E;CDC6;CRLF3;POLE;E2F1;USP37;CUL4B;BACH1;ORC1
prerank,organic acid transport (GO:0015849),0.2590072729321164,0.8163984402933253,0.745742092457421,0.9679651592890721,1.0,13/94,11.57%,LRRC8D;CEACAM1;FOLR1;FOLR2;ATP8B1;SLC38A2;SLC27A1;SLC6A13;SLC7A14;SLC7A2;SLC27A4;SLC16A1;SLC3A1
prerank,presynapse organization (GO:0099172),0.37158941546618773,0.8163658488200222,0.6666666666666666,0.967474490469191,1.0,3/10,22.12%,WNT5A;NLGN3;NLGN2
prerank,positive regulation of vascular permeability (GO:0043117),0.37039487730962667,0.8163538811411812,0.671118530884808,0.9669409508295062,1.0,3/12,8.23%,TRPV4;TJP2;OCLN
prerank,chromosome organization (GO:0051276),0.2604975720309568,0.8160515588004659,0.7649208282582217,0.966962126907656,1.0,23/99,20.27%,MSH6;CDAN1;SATB1;MSH2;SUV39H1;GATAD1;SUPT4H1;HDAC2;AXIN2;CETN2;RFWD3;NUCKS1;COPS5;DDB2;CENPH;BRWD1;GEM;CUL4B;MTF2;HMGN2;TCF7L1;HDAC3;HMG20A
prerank,nucleus organization (GO:0006997),-0.2289992350826495,-0.8154041892086916,0.7798507462686567,0.9339500844926418,1.0,9/47,11.18%,PITPNB;SYNE1;SEH1L;NUP133;RPS19;CTDNEP1;LEMD3;VPS4A;USP36
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.35377889071888907,0.8150918572655276,0.6672240802675585,0.9681390611112018,1.0,4/15,13.35%,TSEN54;RTRAF;TSEN34;ERN1
prerank,RNA methylation (GO:0001510),0.2751938371090046,0.8149765384249332,0.7474489795918368,0.9677816255697731,1.0,18/60,23.23%,MRM2;BUD23;RBM15B;TARBP1;TFB2M;METTL5;THADA;FTSJ1;TRMT5;NSUN5;CMTR1;THUMPD3;METTL2A;METTL2B;ZC3H13;TRMO;TFB1M;MEPCE
prerank,regulation of phosphatase activity (GO:0010921),0.31776812482089445,0.814657465086231,0.7088607594936709,0.9678022861388154,1.0,8/24,24.04%,SH3RF2;PTPA;HTT;CHP1;PPP6R3;PPP6R1;PPP6R2;URI1
prerank,Golgi to lysosome transport (GO:0090160),-0.3291137428780471,-0.8146542291345586,0.7172413793103448,0.9344906727123106,1.0,3/11,16.29%,RBSN;SORT1;LAPTM5
prerank,regulation of response to biotic stimulus (GO:0002831),-0.2531626165599108,-0.8139486285898967,0.7597597597597597,0.9349179054294081,1.0,8/28,17.39%,FOXP1;APPL2;SAMHD1;LRP8;IRF1;GATA6;ERAP1;CASP8
prerank,response to unfolded protein (GO:0006986),0.2839368066538906,0.8138114008677139,0.7168021680216802,0.9688083103590149,1.0,14/48,21.89%,HSPH1;DNAJC4;SERPINH1;BAG3;ERN1;HSPA4;ERP44;DNAJB4;BAX;DDIT3;PRKN;DAXX;HSPA9;DERL1
prerank,androgen receptor signaling pathway (GO:0030521),0.37740574878000954,0.8132127729245863,0.6809605488850772,0.9693686009922579,1.0,5/11,21.52%,DDX17;TMF1;RNF14;DAXX;ARID1A
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.1992932795390411,-0.8131890174108238,0.9032258064516129,0.935446434169787,1.0,24/80,21.76%,DENND5A;TRAPPC10;RAB6B;TMED9;RHOBTB3;GOSR2;RBSN;SURF4;UBE2O;RGP1;VPS26B;BET1L;PREPL;CLN5;STX6;HEATR5A;STX16;YKT6;PLEKHJ1;TBC1D17;RAB7B;RAB7A;RNF126;VTI1B
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.29054496822007814,0.8129650544804231,0.7401574803149606,0.9692350489326149,1.0,4/46,4.96%,HK2;TOMM34;MFN2;FIS1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.2453315792391519,-0.8129528229136523,0.7637540453074434,0.9350817145855631,1.0,7/35,14.82%,LGR4;ADCY1;ADCY7;ADCY4;ADCY2;EDNRA;LGR5
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.34849658499470304,0.8129495925464094,0.6832,0.9687066720435098,1.0,7/17,25.21%,ALG9;DHDDS;DPAGT1;DOLK;DOLPP1;ALG12;ALG14
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.25351080938365367,-0.8128746916132866,0.7228915662650602,0.9343926422421815,1.0,10/30,22.09%,VAMP5;SEC16A;ANK3;MACF1;BBS2;PREPL;GGA3;SYS1;OPTN;RAB10
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3225513058712424,0.8126954346531121,0.7021943573667712,0.9686093892229994,1.0,4/24,9.49%,CXCL17;ANO6;NBL1;HMGB1
prerank,protein localization to nucleus (GO:0034504),0.25657122475680894,0.812589982549181,0.7565320665083135,0.9682419120054814,1.0,18/102,16.76%,PRICKLE1;BCL3;IPO8;NOL8;MORC3;NUP62;PAF1;FAM53B;TPR;MMP12;NUP50;COL1A1;CSE1L;NUP153;RAN;NUP93;SYK;YWHAE
prerank,synaptonemal complex assembly (GO:0007130),0.3548029352912676,0.8117048248995146,0.6756756756756757,0.968717608817717,1.0,3/15,17.97%,TEX11;REC8;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.3548029352912676,0.8117048248995146,0.6756756756756757,0.968717608817717,1.0,3/15,17.97%,TEX11;REC8;SYCP2
prerank,cellular senescence (GO:0090398),0.3071428602329949,0.8116567311542615,0.7056213017751479,0.9682666018294926,1.0,3/27,7.23%,SMC5;SPI1;TBX2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3124779256568666,-0.811570736645256,0.7132352941176471,0.9359096378409812,1.0,2/13,2.60%,DDO;MTHFS
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.374048898906106,0.811428817465756,0.6845878136200717,0.9681485667507713,1.0,1/10,4.96%,WNT5A
prerank,positive regulation of axon extension (GO:0045773),0.3182910958412447,0.8109757581535145,0.680952380952381,0.9683889877641747,1.0,2/22,4.59%,NTN1;DSCAM
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.2852023875487335,-0.8109664303927473,0.7525773195876289,0.9361455212941118,1.0,11/19,37.82%,TEK;KDR;NRP1;LIMS1;TSC1;SFRP1;PPM1F;MYOC;HRG;THY1;MAP4K4
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.24385365759549946,-0.8102995428969385,0.7916666666666666,0.9365039272966442,1.0,9/32,15.95%,ARHGEF2;STMN2;EML2;CAMSAP1;CLIP3;STMN1;APC2;MID1IP1;TUBB4A
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.30220988537569876,0.8099797134932623,0.6942028985507246,0.9696232633157166,1.0,2/30,1.84%,NEDD4L;KCNA5
prerank,peroxisomal membrane transport (GO:0015919),0.32073948863552254,0.8096094917165002,0.7025796661608498,0.9697606191429086,1.0,5/27,12.75%,RAB8B;FIS1;PEX2;PXMP2;ABCD1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.24147753534491856,-0.8095609187970866,0.8013029315960912,0.93693579672637,1.0,5/38,8.41%,SASH1;BMP6;POLR3B;CYBA;SLC15A4
prerank,response to UV-A (GO:0070141),0.3580970634797317,0.8094511397416395,0.6734006734006734,0.9695082612564139,1.0,2/14,10.88%,EGFR;MME
prerank,apical protein localization (GO:0045176),0.38019006869662664,0.809249024588736,0.6866791744840526,0.9693065798548258,1.0,2/10,6.15%,ATP8B1;SHROOM2
prerank,striated muscle cell development (GO:0055002),0.35224804409294286,0.8091870449532232,0.6855670103092784,0.9688533128219774,1.0,4/14,13.58%,TMOD2;SDC1;TMOD1;FLII
prerank,liver development (GO:0001889),0.3010303545909845,0.8091653962724779,0.7069486404833837,0.9683406863806191,1.0,5/32,7.30%,COBL;NF1;LSR;GFER;CCDC39
prerank,histone acetylation (GO:0016573),0.2759684722997289,0.8091209611287785,0.7280593325092707,0.9678752376379313,1.0,19/69,19.22%,SPI1;BEND3;HAT1;KAT6B;TAF10;MSL3;TRRAP;PHF20L1;CREBBP;KAT8;BRD8;TADA2A;BRPF3;MORF4L2;TAF5;BRD1;RUVBL2;NAA40;NAA60
prerank,positive regulation of cytokine production (GO:0001819),0.23483861888092064,0.8085800437699203,0.8751311647429171,0.9683031362736877,1.0,44/292,17.74%,RORA;LBP;IL18R1;SULF1;GLMN;ITK;CXCL17;PDE4D;TXK;IL1A;EIF2AK3;PTPN22;WNT5A;PTPRC;IL17RA;TLR7;CRTAM;RARA;POLR3G;PTGER4;ISL1;HMGB1;TICAM1;HILPDA;ADRA2A;IL6ST;EGR1;CD276;POLR3D;CREBBP;IL7;CLEC9A;TNFRSF14;IL15;PIBF1;TBK1;BATF;SYK;CRCP;RGCC;MDK;SCRIB;SPTBN1;LPL
prerank,photoreceptor cell development (GO:0042461),-0.30315875556401645,-0.8085322940149953,0.713903743315508,0.9379429935116594,1.0,7/14,32.17%,DCX;RP1;MFSD2A;AHI1;TULP1;MYO7A;CDHR1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.26146132652381415,0.8081764638909669,0.7645631067961165,0.9684946459786382,1.0,22/87,19.28%,SDHAF4;LYRM7;NDUFA6;NDUFB10;COA5;NDUFS3;NDUFS6;IMMP2L;SDHAF2;COX19;NDUFA3;NDUFV2;COX16;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2;SURF1;COA8
prerank,detection of visible light (GO:0009584),0.3473151322725807,0.8080095289250481,0.6895424836601307,0.9682392387671377,1.0,2/16,5.04%,GNAQ;CNGB1
prerank,visual system development (GO:0150063),0.29302667107899977,0.8078979023942054,0.7144886363636364,0.9679059244517861,1.0,6/37,8.69%,PBX1;BMPR1B;HIPK1;SH3PXD2B;FREM2;ABCB5
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3627544320438511,0.8078590108201464,0.7078260869565217,0.9674182679737952,1.0,4/12,20.28%,GPLD1;ADCY8;STX4;TRPM4
prerank,cellular response to fatty acid (GO:0071398),-0.32506836188038324,-0.8078587645209463,0.7222222222222222,0.9382785536760754,1.0,4/12,21.16%,PID1;ZC3H12A;NR1H4;DGAT2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.29103000086594394,0.8078515326987128,0.7254901960784313,0.9668863014248703,1.0,6/42,15.16%,LBP;DEFA6;IRGM;AQP1;GSDMD;TNFRSF14
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.27161584138999184,0.807438040325979,0.7360931435963778,0.9671086615034212,1.0,15/58,19.61%,SMC5;BRCC3;PAXX;NBN;UBE2V2;UIMC1;HMGB1;ERCC6;ERCC1;MDC1;POLB;PSMD14;MRE11;XRCC6;SUMO1
prerank,organophosphate biosynthetic process (GO:0090407),0.29545146022804747,0.8073972061797325,0.7238493723849372,0.9666423067258757,1.0,10/37,20.22%,AGPAT4;PPIP5K2;TPK1;AGPAT5;GK;PPIP5K1;MOCS2;FADS1;ITPKA;TKT
prerank,inositol phosphate metabolic process (GO:0043647),0.28534474714524916,0.8073739478176841,0.7142857142857143,0.9661316925943039,1.0,3/46,1.51%,PLCD3;PLCE1;PLCB3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.36564520363102737,0.8072031784973259,0.6772486772486772,0.9659012569213838,1.0,5/12,22.15%,RBM15B;LRIF1;PCGF3;CDYL;YTHDC1
prerank,regulation of vacuole organization (GO:0044088),0.33225772356822386,0.8071955235070049,0.6921824104234527,0.9653700541602954,1.0,10/20,27.29%,MTMR3;ENO3;LAPTM4B;SCARB2;ENO2;RAB5A;ENO1;NPRL2;TBC1D14;IFT20
prerank,renal water homeostasis (GO:0003091),0.32099995731418346,0.807041673297502,0.6886326194398682,0.9651134791030332,1.0,9/23,18.74%,ADCY5;PRKAR2A;ADCY9;AQP1;PRKACB;ADCY8;ADCY3;WFS1;RAB11FIP2
prerank,positive regulation of protein import (GO:1904591),0.3010794785249179,0.8060365311527455,0.7209985315712188,0.9663432855510554,1.0,8/30,15.39%,ARHGEF5;UBR5;BAG3;RBM22;PIK3R2;TPR;RAN;CDH1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2936891223937523,0.8055720500912501,0.6845238095238095,0.966625497373868,1.0,6/32,17.83%,CDK15;FBXO5;CDC6;E2F1;BACH1;ORC1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2851053525147906,0.8045135567181851,0.7115117891816921,0.9679428717814207,1.0,6/45,13.88%,USP50;WNT5A;NLRC4;ISL1;EGR1;GSDMD
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3040106524683038,-0.8037932314326607,0.7577937649880095,0.9446760460078574,1.0,6/15,27.69%,RPS7;RPL23;MAD2L2;RPL5;MAD2L1;RPL11
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.3415423290354518,-0.8037781072951299,0.7429193899782135,0.9438629429166052,1.0,1/10,0.68%,TGFA
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.20184726192159927,-0.8036306453268314,0.8181818181818182,0.9432978904986834,1.0,26/72,26.23%,IFNAR2;MADD;LIFR;JAK2;CFLAR;USP18;RNF31;CLIP3;ABCE1;SPHK1;IKBKB;CASP8;CD24;IRAK2;RACK1;CDC37;VRK2;IKBKG;SOCS3;SIGIRR;RIPK1;SPPL2B;BIRC3;SPATA2;PYCARD;ZBP1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.24927758688357238,0.8026376212783086,0.7988304093567251,0.9707917040957599,1.0,13/112,9.49%,LBP;IL1A;PTPN22;IRAK3;WNT5A;PTPRC;TNFAIP3;EPHB2;SELENOS;RARA;ISL1;PTPRJ;HMGB1
prerank,glycogen biosynthetic process (GO:0005978),0.35618159072384514,0.8023777047301252,0.708185053380783,0.9701777616063383,1.0,2/12,7.99%,GYS1;PGM1
prerank,glucan biosynthetic process (GO:0009250),0.35618159072384514,0.8023777047301252,0.708185053380783,0.9701777616063383,1.0,2/12,7.99%,GYS1;PGM1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3264064106645974,-0.8022132570725158,0.7099056603773585,0.9450118008611672,1.0,6/11,24.51%,WIPI1;STX17;ATG13;WIPI2;WDR45B;WDR45
prerank,glycolytic process (GO:0006096),0.3100899382578556,0.8021999000342316,0.7125567322239031,0.9699383660236578,1.0,9/28,22.50%,HK2;ALDOB;PGM1;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,protein stabilization (GO:0050821),0.24145094308261122,0.8021441184715062,0.8161434977578476,0.9695054962300446,1.0,46/168,21.01%,PPARGC1A;PARVA;GTSE1;WDR81;FLOT2;PLPP3;GNAQ;MORC3;CDK7;BAG3;IRGM;STK3;ATP1B3;LAMP1;RASSF2;ZSWIM7;HYPK;USP13;DVL3;CCT2;PTEN;SOX4;RTN4;PER3;TESC;FBXW7;PRKRA;BAG2;RAB21;CHP1;WFS1;PINK1;COG3;RABL3;USP9X;AAK1;COA8;LAMP2;SUMO1;SEL1L;PFN2;PIN1;PRKN;MUL1;CCT3;PDCL3
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.33198888997461284,0.8019343165191632,0.7198067632850241,0.9693337292884708,1.0,4/18,12.96%,NF1;MORC3;PEX2;EMD
prerank,activation of protein kinase A activity (GO:0034199),0.3349551315059535,0.8016412540035436,0.701048951048951,0.9693232506612495,1.0,6/16,15.58%,ADCY5;PRKAR2A;ADCY9;PRKACB;ADCY8;ADCY3
prerank,cilium-dependent cell motility (GO:0060285),-0.2678382604239881,-0.8012327697828051,0.7595628415300546,0.9458944000437577,1.0,10/22,36.67%,RFX3;EFHC2;DNAH3;CFAP44;DRC1;CFAP54;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2699139473142239,-0.8007268280394675,0.773936170212766,0.945902558040479,1.0,10/21,31.38%,ARHGEF2;STMN2;CAMSAP1;APC2;MID1IP1;KATNB1;CIB1;TPX2;CAMSAP3;NAV3
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.31875561273375236,0.8006278477600696,0.710077519379845,0.9706186138286863,1.0,2/26,7.46%,CEACAM1;RARA
prerank,positive regulation of neuron death (GO:1901216),0.27879741454727486,0.8004779625013345,0.7233201581027668,0.9703435895676846,1.0,9/46,11.42%,NF1;FOXO3;WNT5A;EFNB2;MAP3K5;GSK3B;SARM1;SRPK2;EGR1
prerank,endoplasmic reticulum organization (GO:0007029),0.26424202619282444,0.8002960903968395,0.7745222929936306,0.9701184774015903,1.0,26/72,25.93%,STX1A;CAV2;LMAN2;EIF2AK3;ATL2;TRAM1;REEP3;LNPK;EMD;OTOF;UBE2J2;RTN4;SEC61G;STX5;RAB18;REEP4;VAMP2;PRNP;VAPA;VCPIP1;VAPB;DNM1L;SERP1;LMAN1;REEP5;SEC61A1
prerank,negative regulation of ATPase activity (GO:0032780),-0.29221931248542016,-0.7999452446277526,0.7455012853470437,0.9463598360832701,1.0,6/16,27.54%,PAM16;PXK;IFIT1;PLN;OXA1L;TSC1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.36252187509979295,0.7999205115617761,0.68561872909699,0.9702385770151063,1.0,3/14,6.74%,ATIC;PFAS;PPAT
prerank,macroautophagy (GO:0016236),0.2483879138771801,0.7990051380707524,0.7949886104783599,0.9712426346602119,1.0,38/118,22.27%,DYNLL1;PRKAG1;SRC;MFN2;PIP4K2B;PIK3R4;TSG101;ATG5;MTMR3;DYNLL2;CHMP4A;CHMP4B;VAMP8;CHMP4C;ARL8B;TOMM40;LIX1;ATG7;PIK3C3;PLAA;EI24;UBQLN1;MTERF3;CSNK2A2;PINK1;TBC1D5;SNAP29;MAP1LC3B;ATG3;LAMP2;RB1CC1;PRKN;VPS16;CHMP2A;ATG14;TCIRG1;VIPAS39;VPS36
prerank,positive regulation of transmembrane transport (GO:0034764),-0.31149798208287804,-0.7983362437838306,0.7381489841986456,0.9483073847460011,1.0,7/13,23.59%,ACSL1;C2CD5;CLIP3;P2RX7;CA2;NR4A3;C3
prerank,cellular response to pH (GO:0071467),0.33764644208396233,0.7982628540831117,0.6830870279146142,0.9720146415991043,1.0,4/17,17.14%,GPLD1;RAB11FIP5;KCNK4;CHP1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2695047669684785,0.7975958426897386,0.7506493506493507,0.9726742953638646,1.0,8/68,7.37%,CSTF1;CAVIN1;SNRPF;MED18;CDK7;POLR1E;CSTF3;SMN1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.30812864639641435,0.7975466812268509,0.7042042042042042,0.9722157527606788,1.0,3/29,9.55%,SPI1;CRTAM;LAMP1
prerank,protein deubiquitination (GO:0016579),0.23286175931725644,0.7974919167256493,0.8574423480083857,0.9717702091402366,1.0,55/242,18.83%,USP50;TNIP3;OGT;BRCC3;TFPT;FOXK1;PSME3;TAF10;KEAP1;TNFAIP3;USP8;OTUB2;USP48;CCP110;FOXK2;TNIP1;CDC20;UIMC1;PSMB5;ACTR8;MINDY2;USP47;TRRAP;USP13;OTUD7B;APC;INO80;PTEN;USP15;USP4;PSMB2;POLB;UBE2D1;PSMA2;PSMA6;USP35;COPS5;PSMD13;PSMA7;DDB2;INO80B;STAMBPL1;STAMBP;USP45;USP37;PSME4;NFRKB;PSMC4;FOXO4;PSMB6;PSMD12;RHOA;PSMD14;USP9X;KDM1B
prerank,negative regulation of signaling receptor activity (GO:2000272),0.31134570116618154,0.7973440892601461,0.6915204678362573,0.9714957661424148,1.0,5/25,11.67%,SOCS5;TSG101;EPHB2;CBLB;SOCS4
prerank,mRNA modification (GO:0016556),0.3177299860238323,0.7972604388634381,0.6967840735068913,0.9711114181621283,1.0,3/22,6.98%,RPUSD2;PUS7;PUS3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.30516463870094446,0.7970095215725167,0.7286356821589205,0.97098831808708,1.0,1/29,1.14%,MBOAT2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.36711961378539587,0.7966168769776644,0.698019801980198,0.9711307056995273,1.0,3/12,10.99%,NCOR1;LIN28B;NCOR2
prerank,protein mannosylation (GO:0035268),-0.2637105051252355,-0.7965519190677578,0.8,0.9505650981890409,1.0,3/22,4.35%,TMTC2;TMTC1;DPM1
prerank,polyamine metabolic process (GO:0006595),0.35220217075871263,0.7961934442622042,0.685,0.971343518652294,1.0,4/13,14.34%,SAT2;HDAC6;SMOX;SMS
prerank,regulation of programmed necrotic cell death (GO:0062098),0.32617783688569546,0.795847203919505,0.7131901840490797,0.9714030784536312,1.0,3/20,9.03%,OGT;FLOT2;PDCD6IP
prerank,cellular response to cytokine stimulus (GO:0071345),0.22814885679831,0.795834263340149,0.9106598984771573,0.9708824626299252,1.0,44/416,12.28%,RORA;TEC;LBP;IL19;IL18R1;RIPOR2;PTPN13;ADAMTS12;LEPR;SLC12A2;SOCS5;STX1A;ITGAX;IL1A;PTPN14;FOXO3;SOX9;IRAK3;WNT5A;FN1;FER;TRADD;SOCS6;LAMA5;ABL2;MCL1;SDC1;PTPRJ;ACOD1;IRGM;GSK3B;PTPRT;GAB2;POU4F1;AXL;TYK2;TPR;MME;IL6ST;EGR1;PRLR;PTPN18;NFE2L2;STAT2
prerank,cell differentiation in spinal cord (GO:0021515),0.37104561986965134,0.7958183630583759,0.7243243243243244,0.9703686393363061,1.0,3/10,13.45%,ZC4H2;ISL1;SOX4
prerank,polyol metabolic process (GO:0019751),0.28106757391537096,0.7957783463892479,0.7175368139223561,0.9699102748375319,1.0,3/46,1.51%,PLCD3;PLCE1;PLCB3
prerank,RNA stabilization (GO:0043489),0.29719288516336373,0.7956416915303333,0.7017291066282421,0.9696076840494602,1.0,8/33,16.96%,DND1;NAF1;TENT5C;AXIN2;TENT5D;TAF15;ZCCHC17;E2F1
prerank,meiosis I (GO:0007127),-0.260038925244972,-0.7955241918126872,0.7843137254901961,0.9513795744758315,1.0,3/23,8.93%,BCL2L11;FOXJ3;MYBL1
prerank,response to leucine (GO:0043201),-0.3358095024300182,-0.7952777147436405,0.7152941176470589,0.9500987781606952,1.0,1/10,0.83%,UBR1
prerank,cellular response to leucine (GO:0071233),-0.3358095024300182,-0.7952777147436405,0.7152941176470589,0.9500987781606952,1.0,1/10,0.83%,UBR1
prerank,acyl-CoA metabolic process (GO:0006637),0.2968620227519335,0.7951439283337256,0.7471590909090909,0.9699494341472067,1.0,10/35,17.60%,ACOT13;ACACA;OGDH;ACSF2;DLST;ACOT8;ACOT2;ACACB;SUCLG2;SUCLA2
prerank,negative regulation of protein catabolic process (GO:0042177),-0.22946996990474922,-0.7949207086552184,0.8213058419243986,0.9498787814931885,1.0,14/40,26.51%,TIMP3;PTPN3;FLNA;RGP1;CTSA;BANP;TIMP4;CDK5RAP3;ADGRB1;MAD2L2;NELL1;MAD2L1;AGAP2;CST3
prerank,cellular response to starvation (GO:0009267),0.24106521792740687,0.7948227068456282,0.8070776255707762,0.9699790627423129,1.0,18/147,9.21%,INHBB;MYBBP1A;PRKAG1;FOXO3;EIF2AK3;ATP6V0D2;KLF10;WDR24;PDK4;PIK3R4;MIOS;BRSK1;ATG5;RIPOR1;MAP3K5;SESN1;MTMR3;STK24
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.33388674908943894,-0.7946217440461452,0.7184035476718403,0.9495480884256476,1.0,1/10,1.02%,ACTN2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.2736969571717173,-0.7944361537964515,0.7715877437325905,0.9490250019147687,1.0,7/20,19.84%,ADGRV1;AKAP6;LRRK2;PRKAR2B;PJA2;TCIM;MIF
prerank,adipose tissue development (GO:0060612),-0.32249628282673537,-0.7943849563893141,0.7252475247524752,0.9482830595324014,1.0,5/11,25.47%,ARID5B;LRP5;XBP1;DGAT2;NAMPT
prerank,regulation of innate immune response (GO:0045088),0.2662461613986539,0.7940727091282895,0.7237715803452855,0.9707175782803572,1.0,9/57,9.33%,PTPN22;IRAK3;TNFAIP3;TRIM21;N4BP1;POLR3G;ACOD1;PLSCR1;TRAFD1
prerank,response to glucocorticoid (GO:0051384),-0.25620614807524444,-0.7938132406162849,0.7784090909090909,0.9484217767385845,1.0,3/26,7.39%,SLIT2;BCL2L11;ANXA1
prerank,cellular response to ketone (GO:1901655),0.29762393546603777,0.7935753194696524,0.7293233082706767,0.971051956234535,1.0,8/35,15.58%,PTGFR;SRC;ADCY5;PTGER4;ACOD1;AQP1;ADCY8;ADCY3
prerank,negative regulation of histone acetylation (GO:0035067),0.36427800518944603,0.7933500581388051,0.7135593220338983,0.9709281529981791,1.0,1/11,3.65%,SPI1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.27066693423106913,0.7933460753681166,0.7656050955414013,0.9703995412411434,1.0,7/62,7.45%,ACKR3;SRC;CREB3L1;SELENOS;NDUFS3;MCL1;MAPK7
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.27657788644288506,-0.7932593483304213,0.7841530054644809,0.948517367427717,1.0,5/20,12.84%,SLC8A3;SMDT1;SLC25A23;MICU1;MICU2
prerank,eye photoreceptor cell development (GO:0042462),0.34085588072240536,0.7928248162154233,0.6973058637083994,0.970738182895009,1.0,3/15,12.78%,RORB;CEP290;RPGRIP1L
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.22817135718898623,-0.7927986400385487,0.8540145985401459,0.9484942222445402,1.0,12/44,18.15%,ROCK2;ZC3HAV1;PABPC1;ZC3H12A;YTHDF1;MOV10;ZFP36;TNRC6C;DHX36;RC3H1;METTL16;YTHDF2
prerank,proteasome assembly (GO:0043248),0.36908961673507507,0.7927796140307762,0.7052810902896082,0.9702839420006888,1.0,4/11,15.40%,PSMG2;PSMG1;POMP;PSMD13
prerank,response to endoplasmic reticulum stress (GO:0034976),0.24591416612103914,0.7927657762058757,0.8028335301062574,0.9697776693494511,1.0,27/107,21.89%,THBS4;ERO1A;EIF2AK3;CREB3L1;SELENOS;MAP3K5;PIK3R2;DDRGK1;GSK3B;ERN1;RNF185;P4HB;MBTPS1;UBQLN1;QRICH1;WFS1;ERP44;TMEM259;TMTC3;BAX;SEL1L;CREB3L2;DDIT3;PRKN;NCK1;JUN;DERL1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3148854466803812,-0.7925020912129774,0.7454128440366973,0.9481714772466758,1.0,7/12,29.21%,SERINC3;PSPH;SEPHS1;CBS;SEPHS2;CTH;PHGDH
prerank,cell part morphogenesis (GO:0032990),0.35930838646075,0.7923879467130281,0.7181663837011885,0.9698875586469492,1.0,2/13,6.56%,FIS1;PACSIN2
prerank,regulation of autophagosome maturation (GO:1901096),-0.3039863258181944,-0.792200673302926,0.7368421052631579,0.9478164789394065,1.0,3/13,14.57%,UVRAG;RUBCN;UBQLN4
prerank,positive regulation of exocytosis (GO:0045921),0.2877153642239475,0.7918238666024704,0.7149059334298119,0.9703039330824054,1.0,14/35,26.16%,TSG101;RAB3A;SDC1;PDCD6IP;SDC4;RAB2B;RAB27B;RAB5A;CHMP2A;RAB9A;SNF8;STAM;ATP6AP1;CLASP2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.34053059562916893,0.7917347305177077,0.7035175879396985,0.9699223935656178,1.0,6/14,24.09%,SRSF4;SFSWAP;SAP18;SRSF12;SRSF10;RBMX
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.2992409668331967,-0.7907392978237135,0.7614457831325301,0.94945553046692,1.0,7/14,28.89%,PAXIP1;SNW1;DNMT3B;SMAD4;BRCA1;KMT2E;WDR5
prerank,carbohydrate derivative transport (GO:1901264),0.3323629352965098,0.7907221347603275,0.7208931419457735,0.9711897846055957,1.0,1/18,0.73%,LBP
prerank,response to growth factor (GO:0070848),-0.22581923559347994,-0.7905382326649072,0.8503401360544217,0.9489550701168241,1.0,9/41,13.99%,TGFBR1;ACVRL1;BMPR2;KLF4;RPS6KB1;AKT1;GATA6;SPHK1;PLK5
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.30747513569987045,-0.7901977914355649,0.7592137592137592,0.9487134053514182,1.0,5/12,21.75%,SGTA;SEC61B;SEC62;SGTB;GET3
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.23988121678436905,-0.7899762779560664,0.8213058419243986,0.9482323153805223,1.0,14/32,30.58%,PICALM;PGAM1;EIF2A;TCOF1;NR1H4;RBM4B;TIGAR;GEMIN5;TSC1;MTPN;NANOS3;RBM3;GRM5;TMED10
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.2804757659073663,-0.7888681192222827,0.7584415584415585,0.9492295141449932,1.0,5/16,21.89%,CEBPG;VAMP7;TUBB4B;PLEKHM2;RAET1E
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.29831787170468904,0.7888328213885234,0.7346041055718475,0.9739570242375052,1.0,7/32,15.38%,BRCC3;BRSK1;NBN;RINT1;UIMC1;DONSON;FZR1
prerank,positive regulation of cell population proliferation (GO:0008284),0.2243290378234701,0.7886329624990193,0.9196337741607324,0.9737881641130691,1.0,48/423,10.49%,FGF7;NTRK3;CDH13;GLI1;FGFR1;LAMC1;PTGFR;FOLR2;EGFR;FGF1;ACER3;KIF20B;ITGAX;PTHLH;SAPCD2;SOX9;S100A6;HDAC4;BMP5;WNT5A;PTPRC;FN1;RPRD1B;FER;CDK13;CEP131;ADAM10;KRAS;EFNB2;HOXC10;TBX2;RARA;FBXO5;CUL3;DPP4;S100B;GCNT2;FGF18;TSHR;DDRGK1;TET1;MECP2;GAB2;HDAC2;CNOT7;HILPDA;ADRA2A;TBC1D8
prerank,peptidyl-lysine dimethylation (GO:0018027),0.3201140780256535,0.7886065599465127,0.7124802527646129,0.973296791106775,1.0,5/18,17.48%,KMT2A;SUV39H1;KMT2D;SETD2;SUV39H2
prerank,positive regulation of protein deacetylation (GO:0090312),0.35557483454807115,0.7877908937253312,0.698051948051948,0.9741662869517909,1.0,3/14,15.59%,DYRK1A;FNTA;SAP30BP
prerank,pre-replicative complex assembly (GO:0036388),0.2642979279054669,0.7876220990629738,0.7807692307692308,0.973929942869909,1.0,18/64,18.76%,PSME3;ORC5;PSMB5;ORC3;CDC6;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;GMNN;PSME4;ORC1;ORC6;PSMC4;PSMB6;PSMD12;PSMD14
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.3263459472880955,-0.7876046768482647,0.7648401826484018,0.9504762666212232,1.0,2/10,6.34%,FGFR2;TBX1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3212967751272947,0.7869662415350951,0.7152103559870551,0.97455229146762,1.0,9/22,21.62%,PSMB5;NFE2L2;PSMB2;PSMA2;PSMA6;PSMA7;PSME4;PSMB6;PSMB3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3076631101911548,-0.7866763205314571,0.7425287356321839,0.9511909941648299,1.0,9/13,51.86%,CYRIB;MR1;IL12A;IL12RB1;IL23A;IL23R;IL12B;PVR;XCL1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.2628257180680352,0.7866571660548461,0.800771208226221,0.9745780941786989,1.0,5/65,7.40%,CAV1;SPRED1;SPRY1;PPM1A;LDLRAD4
prerank,establishment of apical/basal cell polarity (GO:0035089),0.34271959801473006,0.7866317817865587,0.7096219931271478,0.9740835370074136,1.0,6/14,18.52%,OPHN1;FOXJ1;PATJ;EZR;SCRIB;RHOA
prerank,organic cation transport (GO:0015695),0.324696020937174,0.7859477909779577,0.7420886075949367,0.9747129661213044,1.0,6/20,17.34%,SLC29A4;SLC22A3;SEC14L1;SLC25A26;SLC25A19;RALBP1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.30610166879930045,0.7857538349034557,0.7349042709867453,0.9745204094361088,1.0,4/27,11.08%,MAP3K1;IRAK3;TNIP1;TAB2
prerank,peptidyl-threonine modification (GO:0018210),0.26663467187717543,0.7857442838632713,0.7655860349127181,0.9740057485913127,1.0,23/66,25.71%,CAMK2D;GALNTL6;PRKCA;HIPK1;DYRK1A;CAD;GSK3B;CIT;TBK1;GALNT4;LMTK2;DYRK2;CSNK2A2;PDPK1;CDC42BPG;ACVR1;MAPK8;MAPK1;PRKCD;HIPK2;ROCK1;TNKS;TAF1
prerank,protein homooligomerization (GO:0051260),0.2471617381018377,0.7855521248559264,0.813441483198146,0.9737969390334104,1.0,10/114,9.03%,ALDH1A3;ALDH9A1;BEND3;ACOT13;SPAST;NLRC4;ACACA;CLYBL;ATL2;PDCD6IP
prerank,negative regulation of double-strand break repair (GO:2000780),-0.24732334146472099,-0.7854106620950203,0.7854785478547854,0.952422984917208,1.0,13/30,25.40%,SHLD2;POLQ;UBQLN4;HSF1;TRIP12;CYREN;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;SMCHD1;PARPBP
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.33334882853455733,0.7849380194573867,0.71875,0.9742756537535425,1.0,4/17,11.99%,AKAP13;GPR101;ADRA2A;ADCY9
prerank,axoneme assembly (GO:0035082),0.30215463937241993,0.784622194422804,0.7496382054992764,0.9742923292680052,1.0,4/30,9.41%,SPEF1;SPAG17;CCDC39;FOXJ1
prerank,cellular response to amino acid starvation (GO:0034198),-0.20048458102367894,-0.7835406337442374,0.9186602870813397,0.954631709638952,1.0,22/71,23.21%,FAS;LAMTOR3;SEH1L;DEPDC5;SH3GLB1;ATP6V0C;RNF152;RRAGC;EIF2AK4;ATP6V1C1;ATF2;RRAGD;CEBPB;ATP6V1D;ATF4;CASTOR2;ATP6V1F;CASTOR1;LAMTOR2;ATP6V1E1;PRKD1;SLC38A9
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.24500238400704527,-0.783441443613732,0.8206686930091185,0.9539626188341985,1.0,7/29,16.10%,SMAD3;ADAR;AGO3;PUS10;AGO4;TUT7;ZC3H7A
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.34340704614472395,0.7834219262022999,0.7304492512479202,0.9758237811575718,1.0,4/14,13.09%,KEAP1;FAF1;NFKBIB;PKD1
prerank,mucosal immune response (GO:0002385),0.3414542247526753,0.783359172072686,0.7098865478119936,0.9754157674165034,1.0,3/15,18.92%,DEFA6;OTUD7B;RNASE3
prerank,photoperiodism (GO:0009648),0.30528472989012306,0.783130078438869,0.7207207207207207,0.9752648007301129,1.0,7/28,17.06%,CRTC1;BHLHE40;FBXL17;PER3;FBXL12;FBXL3;PPP1CA
prerank,apoptotic process (GO:0006915),0.2338167123619232,0.7830528917200595,0.864951768488746,0.9748616035299716,1.0,16/203,7.41%,EFNA5;DLC1;PRKCE;FAP;HK2;CYFIP2;OGT;MAGI3;IL1A;CIDEB;EGLN3;TRADD;FASTKD2;MAGEH1;PAX3;SIAH1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.23483336677452837,-0.7830461731021073,0.819047619047619,0.9537340324528724,1.0,19/34,37.19%,SYT9;SYT7;SYN1;LRRK2;PREPL;DTNBP1;SYT13;SYT6;RIMS1;RAB27A;RIMS3;RAB15;SYT15;SYT1;SYT5;SYT17;UNC13D;SYT4;SYT3
prerank,Golgi ribbon formation (GO:0090161),-0.3003180470863566,-0.7828788073025472,0.775175644028103,0.9531731846780698,1.0,5/13,21.37%,GOLGA2;MYO18A;STX6;STX16;OPTN
prerank,protein targeting (GO:0006605),-0.17592876036755453,-0.7824800429961848,0.9724137931034482,0.9529732178174143,1.0,27/118,20.47%,PARD3;KIF13B;ZFAND6;AKAP6;RASSF9;AQP11;RABGEF1;TIMM44;GABARAP;AP4E1;ZFAND2A;TIMM17B;TAOK2;SPCS1;MICALL1;ZDHHC2;HACL1;PEX6;AIP;VPS37C;PEX1;ZDHHC14;TIMM10B;TIMM8B;CDC37;KATNB1;ZDHHC24
prerank,positive regulation of response to stimulus (GO:0048584),-0.2295527450552458,-0.7815881128736486,0.872852233676976,0.953588081550903,1.0,11/40,19.73%,B2M;SELENON;YPEL3;ECHDC3;CD80;TGFB2;CDKN2AIP;ILK;EEF1E1;RSAD2;CGAS
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3215684607697712,0.7813533740915305,0.7026143790849673,0.9771843427759034,1.0,5/19,17.89%,FOLR2;MTHFD1;SLC46A1;ALDH1L2;SLC19A1
prerank,protein modification by small protein removal (GO:0070646),0.2274058361927611,0.7811470855226212,0.8903966597077244,0.9769986067320553,1.0,58/252,19.65%,USP50;TNIP3;OGT;BRCC3;SENP6;TFPT;FOXK1;PSME3;TAF10;KEAP1;TNFAIP3;USP8;OTUB2;USP48;CCP110;FOXK2;TNIP1;CDC20;UIMC1;PSMB5;ACTR8;USP47;TRRAP;USP13;OTUD7B;APC;INO80;PTEN;USP15;USP4;PSMB2;POLB;UBE2D1;PSMA2;PSMA6;USP35;COPS5;PSMD13;PSMA7;DDB2;INO80B;STAMBPL1;STAMBP;USP45;USP37;PSME4;NFRKB;PSMC4;FOXO4;PSMB6;PSMD12;RHOA;PSMD14;USP9X;KDM1B;SENP3;SENP2;ADRB2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.24736462637841417,0.7811201778502519,0.8107476635514018,0.9765173966847353,1.0,14/101,10.37%,FGFR1;EGFR;CCND3;FGF1;SRC;SLC27A1;ATP2B4;WNT5A;SYAP1;FGF18;IRGM;DIPK2A;FERMT2;ADRA2A
prerank,synaptic vesicle transport (GO:0048489),0.36217869435966715,0.7810280500433853,0.7253521126760564,0.9761372435019758,1.0,4/11,19.71%,KIF5A;KIF5B;TMEM230;SPG11
prerank,negative regulation of protein modification process (GO:0031400),0.2562367709189902,0.7808025709212376,0.8027465667915106,0.9759741969039317,1.0,12/79,12.92%,NTRK3;PTPN13;PLPP3;ATP2B4;IBTK;EPHB2;OCLN;GSK3B;MEN1;ENSA;PTEN;PTPA
prerank,response to interferon-beta (GO:0035456),-0.2606012609129704,-0.7807196831260813,0.7587209302325582,0.9541724269473291,1.0,4/22,10.10%,IFNAR2;UBE2K;BST2;IRF1
prerank,hyaluronan catabolic process (GO:0030214),0.3315866331106743,0.7806856506992174,0.7251655629139073,0.9756556134020093,1.0,7/18,24.71%,HEXA;CEMIP2;HEXB;CHP1;CEMIP;GUSB;FGF2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3128979510254827,0.7806501774958319,0.7262830482115086,0.9751868144320067,1.0,3/22,8.28%,FLOT2;MAPK7;GCNT2
prerank,purine nucleotide catabolic process (GO:0006195),-0.29837835264729207,-0.7804713419217568,0.7740384615384616,0.9537249563794715,1.0,5/13,24.18%,XDH;NT5C;HINT1;NT5C1A;GDA
prerank,tRNA metabolic process (GO:0006399),0.3313212753003417,0.7803591174085314,0.7281553398058253,0.9751542504272611,1.0,8/17,23.14%,KARS1;POP7;ADAT1;DARS2;DTD1;RPP21;THG1L;RPP30
prerank,negative regulation of autophagy (GO:0010507),0.2732266561954286,0.7799541707750238,0.8012903225806451,0.9752943998283496,1.0,10/54,14.39%,LEPR;FOXK1;PTPN22;MCL1;FOXK2;NRBP2;EIF4E;TAB2;ATG7;KLHL22
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2080449285929319,-0.7797484103141153,0.8969957081545065,0.9540269287338512,1.0,14/52,20.88%,DNAJC3;PREB;GOSR2;SSR1;WIPI1;TPP1;SYVN1;LMNA;GSK3A;TLN1;DNAJB11;SEC31A;XBP1;TATDN2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.30681858306568033,0.7791878456664169,0.7351598173515982,0.9760159238593057,1.0,7/27,17.06%,CRTC1;BHLHE40;FBXL17;PER3;FBXL12;FBXL3;PPP1CA
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3243784547895493,-0.778835264271514,0.7410926365795725,0.9546514735227462,1.0,4/10,26.37%,GALNT3;MGAT5B;GALNT2;GALNT13
prerank,regulation of actin filament depolymerization (GO:0030834),-0.31293847298944016,-0.7781724785086037,0.7494033412887828,0.9549090774859533,1.0,1/12,1.04%,PLEKHH2
prerank,dendrite morphogenesis (GO:0048813),0.2885888189614769,0.7780868449126415,0.7605633802816901,0.9773047304026303,1.0,4/35,6.39%,LRP4;MINK1;DIP2A;EPHB2
prerank,ncRNA catabolic process (GO:0034661),0.3041943195319905,0.7780524486604663,0.7433234421364985,0.9768428782294405,1.0,4/28,9.57%,EXOSC5;DIS3L2;LIN28B;EXOSC10
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.31241509574013593,-0.7775117934135951,0.7577197149643705,0.9551085697179358,1.0,6/11,36.51%,AKAP6;LRRC38;ALG10B;LRRC55;TREM2;RNF207
prerank,regulation of dendrite morphogenesis (GO:0048814),0.28829825162552386,0.7773469884291946,0.7581792318634424,0.9774532586003976,1.0,8/32,15.44%,NEDD4L;CDKL3;GSK3B;SARM1;NEDD4;SEMA4D;CAPRIN2;FBXW8
prerank,response to amino acid starvation (GO:1990928),-0.19854557983676882,-0.7770660211009026,0.9375,0.9549737405915867,1.0,22/72,23.21%,FAS;LAMTOR3;SEH1L;DEPDC5;SH3GLB1;ATP6V0C;RNF152;RRAGC;EIF2AK4;ATP6V1C1;ATF2;RRAGD;CEBPB;ATP6V1D;ATF4;CASTOR2;ATP6V1F;CASTOR1;LAMTOR2;ATP6V1E1;PRKD1;SLC38A9
prerank,lytic vacuole organization (GO:0080171),0.29179208842043114,0.7770080670367457,0.7363896848137536,0.9774710924873377,1.0,5/32,11.69%,HOOK2;HPS1;ABCA1;TFEB;HOOK3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3310063883195943,0.7765739197397145,0.7208588957055214,0.9776993893834488,1.0,3/18,10.99%,EGFR;NCOR1;NCOR2
prerank,regulation of multicellular organismal development (GO:2000026),-0.2564505158068946,-0.7764963718149621,0.8109756097560976,0.9550586758208259,1.0,8/25,19.75%,INSR;SOX17;SPAAR;TRIP12;DHX36;KAT2A;CD24;PTN
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.30357232356463004,-0.7759040196099914,0.7697841726618705,0.9551424895050472,1.0,4/13,12.40%,BMP4;ZC3H8;CAMK4;TOX
prerank,protein insertion into ER membrane (GO:0045048),0.2817837731285161,0.775236854560663,0.759018759018759,0.9794323108857146,1.0,8/37,15.12%,STX1A;EMC9;EMC7;TRAM1;EMD;OTOF;UBE2J2;SEC61G
prerank,transport along microtubule (GO:0010970),-0.29939087463222913,-0.77489051673484,0.7749419953596288,0.9558777718726927,1.0,3/13,11.25%,CDC42;BORCS5;CLIP3
prerank,regulation of defense response to virus by host (GO:0050691),0.2945747693606786,0.7746912712073882,0.7518910741301059,0.9797969581878168,1.0,3/30,6.13%,PTPN22;TNFAIP3;ZDHHC1
prerank,peptidyl-serine modification (GO:0018209),0.23216517795438324,0.7745985030827905,0.8668146503884573,0.9794093350046493,1.0,19/166,11.96%,PLK2;PRKCE;CAMK2D;STK38;EIF2AK3;PRKCA;MORC3;HIPK1;BRSK1;STK38L;DYRK1A;CSNK1G3;GSK3B;RPS6KA3;MASTL;CSNK1A1;SRPK2;TOP1;SGK1
prerank,regulation of presynapse organization (GO:0099174),-0.27473529235311506,-0.774016786906583,0.7984084880636605,0.9555865585434862,1.0,12/18,37.47%,LRRC4B;MDGA1;PTPRD;EIF4G1;IL1RAPL2;SLITRK2;SLITRK3;VPS35;LRFN4;LRFN5;SNCA;WNT7A
prerank,regulation of presynapse assembly (GO:1905606),-0.27473529235311506,-0.774016786906583,0.7984084880636605,0.9555865585434862,1.0,12/18,37.47%,LRRC4B;MDGA1;PTPRD;EIF4G1;IL1RAPL2;SLITRK2;SLITRK3;VPS35;LRFN4;LRFN5;SNCA;WNT7A
prerank,DNA recombination (GO:0006310),-0.22699802749263398,-0.7739257459815557,0.8848684210526315,0.9549118623296955,1.0,4/37,5.83%,RAD51B;TSN;WRN;BLM
prerank,peroxisome organization (GO:0007031),0.3031515374688033,0.7735440418165602,0.7473841554559043,0.9806253086795658,1.0,5/25,12.75%,FIS1;TMEM135;PEX2;ACOT8;ABCD1
prerank,protein localization to organelle (GO:0033365),0.23543649579284814,0.7734567071791119,0.8333333333333334,0.9802371536075464,1.0,45/133,25.31%,ZNF423;STX1A;SCG3;CSRP3;PACSIN2;PAF1;SNX10;RIPOR1;ARF6;OBSCN;DDRGK1;TRAM1;LAMP1;GCC2;COL1A1;TTC21B;EMD;OTOF;TMEM30A;UBE2J2;SEC61G;YWHAE;RAB33B;STX5;EHD1;COG3;BBS1;CEP250;DHX9;LAMP2;TIA1;TULP2;VAMP2;IFT140;ZBTB7A;PRNP;ARL3;VAPA;SIX1;BMP7;SERP1;MDM2;CD68;CSNK1D;CNTLN
prerank,inositol phosphate biosynthetic process (GO:0032958),0.36212512420043563,0.7723267443983909,0.7277580071174378,0.9815444583937905,1.0,6/11,29.24%,PPIP5K2;PPIP5K1;ITPKA;FGF2;IP6K2;ITPKB
prerank,phospholipid metabolic process (GO:0006644),0.2539399883952487,0.7722926774191511,0.8027295285359801,0.9810813006384225,1.0,7/71,8.31%,PLPP2;ACP6;PLPP3;PIP4K2B;AGPAT4;CLN8;ABHD12
prerank,nitrogen compound transport (GO:0071705),0.23503914938178497,0.7720567166540987,0.8586326767091541,0.9809272296780476,1.0,21/141,13.98%,LRRC8D;SLC12A2;CD3G;SLC38A2;SLC29A4;SLC22A3;ABCC1;SLC6A13;SEC14L1;SLC52A1;SLC7A14;CERT1;CD320;SLC7A2;CUBN;SLC3A1;CEP290;AMN;AQP1;TMEM30A;SLC6A4
prerank,sarcomere organization (GO:0045214),-0.24131510114981453,-0.7718482600771684,0.8305084745762712,0.9572046662135423,1.0,2/27,1.91%,ACTN2;TPM1
prerank,protein depolymerization (GO:0051261),0.3033791920779697,0.7718337320782254,0.7442572741194488,0.9807773422484443,1.0,4/27,8.51%,KIF2A;NCKAP5L;CKAP5;MICAL3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.35485715167936865,0.771312804146103,0.7225130890052356,0.9811602932395332,1.0,2/11,9.65%,SCARA3;TICAM1
prerank,male gonad development (GO:0008584),0.28484261244569575,0.7711630773262416,0.7713068181818182,0.9808824864805543,1.0,7/34,15.36%,WNT2B;SOX9;WNT5A;MSH2;CSDE1;NR5A1;KITLG
prerank,regulation of fibroblast migration (GO:0010762),0.32900254408982255,0.7711123908482358,0.7397708674304418,0.9804429869695855,1.0,1/20,1.22%,PRKCE
prerank,negative regulation of glycolytic process (GO:0045820),-0.3240078751348715,-0.7710825465328152,0.7632183908045977,0.956737755805971,1.0,2/10,3.46%,NUPR1;CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.3240078751348715,-0.7710825465328152,0.7632183908045977,0.956737755805971,1.0,2/10,3.46%,NUPR1;CBFA2T3
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.2242556180045589,-0.7710279182394217,0.8581818181818182,0.9560062970426799,1.0,10/43,16.59%,ENG;TBX3;NPHP3;SOX17;ZIC3;MEGF8;VANGL2;MKKS;AHI1;SOX18
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.26038301712844986,0.7709846948849647,0.8021108179419525,0.9801177403586122,1.0,21/59,23.88%,RUNX2;SOX9;MED7;AGO1;MED13;MECP2;MED23;PTEN;CBFB;MED8;MED12;MED31;BAX;MED15;IL6;MED16;TWIST1;TCF7L2;JUN;MED27;MED20
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3477237897586692,0.7709531093144747,0.7280701754385965,0.9796495605914438,1.0,8/11,31.21%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.2817010245422667,0.7709469556841743,0.7761627906976745,0.9791398205666193,1.0,4/37,8.91%,OGT;FHIT;N4BP1;DDRGK1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.32153235674661673,-0.7708710796522986,0.7637231503579952,0.9554347346116147,1.0,3/10,35.75%,ABCA2;APOC1;SHH
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.23460328781812112,-0.7700541452615383,0.8275862068965517,0.9558702833297287,1.0,8/30,26.38%,CD34;PLCG2;PRKCZ;LGALS9;ISG15;NOD2;PYCARD;STAT3
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.30437400677674786,-0.7698273403408186,0.7579462102689487,0.955423422018056,1.0,5/13,21.26%,NUPR1;LRRK2;FEZ2;SCFD1;SEC22B
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.29526407136959004,0.7696777544992043,0.7720364741641338,0.9806354118912851,1.0,7/27,18.23%,PISD;SLC27A1;PLAAT5;ETNK2;PNPLA8;SELENOI;LPIN1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.24900488713206154,0.7696515663617075,0.8276283618581907,0.9801552003812558,1.0,22/87,18.76%,WEE1;PSME3;DACT1;KANK2;FBXO5;PSMB5;USP47;APC;PTEN;FHL1;ZFP36L2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RGCC;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,cardiac muscle tissue development (GO:0048738),0.272924074871158,0.7691813344721065,0.784656796769852,0.9804008743094216,1.0,9/50,12.86%,SGCD;AKAP13;SGCG;CSRP3;BMP5;TBX2;TBX18;NDUFV2;KDM6B
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.2843552262800212,-0.768666363555452,0.8209718670076727,0.9564014484348021,1.0,8/17,27.31%,PODXL;RET;TGFB2;SKAP1;NCKAP1L;CIB1;RAC3;P2RY12
prerank,protein localization to lysosome (GO:0061462),0.2938289293304701,0.7684506437183245,0.7485119047619048,0.9810395086375466,1.0,9/28,19.60%,ZFYVE16;M6PR;GCC2;NEDD4;CD81;RTN4;AP3M1;SCARB2;LAMTOR5
prerank,regulation of DNA recombination (GO:0000018),0.2853489285234828,0.7681343777395626,0.7521613832853026,0.9810357587603736,1.0,4/32,7.45%,MSH6;SMARCAD1;KPNA2;MSH2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.29500661664332395,0.7677299279182899,0.768361581920904,0.9811547952272053,1.0,5/31,19.01%,HSD17B3;PRLR;LSS;STAR;MOCS2
prerank,establishment of protein localization to membrane (GO:0090150),-0.20517043634825025,-0.7675335037750812,0.875,0.9573151425146545,1.0,16/66,18.51%,PARD3;AFDN;RFTN1;GORASP2;SYNE3;AQP11;RABGEF1;BID;RAB11A;TAOK2;MICALL1;ZDHHC2;VPS37C;ZDHHC14;RAB11B;COX18
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.36421135007331157,0.7674981551474206,0.7234782608695652,0.9810108112202418,1.0,1/10,2.66%,ANO6
prerank,positive regulation of double-strand break repair (GO:2000781),-0.22154712052349804,-0.7671903199362148,0.886435331230284,0.9569962987696233,1.0,13/39,26.75%,SHLD2;SLF2;SLF1;ACTR2;ARID2;MMS19;PARP1;TIMELESS;KDM4D;MAD2L2;SMCHD1;ZCWPW1;PARP3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.25522377390068374,-0.7667462360299768,0.8080229226361032,0.9568473785827618,1.0,4/21,12.40%,NES;PROX1;KDM1A;TOX
prerank,negative regulation of secretion (GO:0051048),-0.3178267268620013,-0.7665092581800204,0.7743467933491687,0.9563996650172234,1.0,8/10,42.87%,NR1H3;EGF;ERBB3;SPX;NRG1;VAMP3;TIFAB;CD74
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3173135917378089,-0.7664695372898302,0.7598152424942263,0.954838410272028,1.0,5/11,21.13%,FKBP1A;CALM1;CALM3;SRI;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3173135917378089,-0.7664695372898302,0.7598152424942263,0.954838410272028,1.0,5/11,21.13%,FKBP1A;CALM1;CALM3;SRI;GSTO1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3548894364388496,0.765692100997497,0.7348993288590604,0.9833250035546469,1.0,5/11,18.69%,BMP5;EGR1;NR5A1;ASAH1;STAR
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3302320398326044,-0.7655996121528209,0.7654028436018957,0.9553277229897296,1.0,2/10,16.44%,BMP4;SALL1
prerank,synaptic vesicle exocytosis (GO:0016079),0.274980735827935,0.7655850089498331,0.7878359264497878,0.9829742137615145,1.0,13/40,21.99%,STX1A;RIMS2;RAB3A;CPLX1;STX2;STX19;OTOF;UNC13B;STX4;SNAP23;SNAP29;VAMP2;SNPH
prerank,protein acylation (GO:0043543),0.27811061066629517,0.7653162433931764,0.7759336099585062,0.9828763105309939,1.0,10/38,14.96%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;CREBBP;ZDHHC20;GLUL;NAT9;ZDHHC8;NAA10
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3196941118875435,0.7649788933805672,0.7570532915360502,0.982887029690911,1.0,6/18,19.28%,COA5;COX19;COX16;BCS1L;SURF1;COA8
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.27344316792043893,-0.7643282716957259,0.7766233766233767,0.9563969354100594,1.0,11/18,43.41%,GPR137B;TLR3;FSTL3;TCTA;LILRB1;LILRB3;CARTPT;TMEM178A;LRRC17;TLR4;IL4
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3163966253324101,-0.7641681100220331,0.784037558685446,0.9558021344299276,1.0,5/11,19.72%,BLM;ZRANB3;LIG3;TIPIN;TIMELESS
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.2749318253277354,0.7633877853134118,0.8041958041958042,0.9848734188283462,1.0,8/39,16.84%,ASS1;JAG1;RDX;MAPK7;NF2;PLG;CDH1;RGCC
prerank,regulation of macroautophagy (GO:0016241),0.23757144985167644,0.7632748862552878,0.8319526627218935,0.9845185739479531,1.0,25/105,22.04%,DCN;PRKAG1;ATP6V0D2;SCOC;SESN1;NRBP2;ATP6V0A1;PAFAH1B2;HDAC6;NEDD4;ERN1;RRAGB;SNX5;TBK1;UBQLN1;BNIP3;PINK1;ATP6V1G1;LAMTOR5;RB1CC1;RPTOR;CAPN1;MAPK8;TSC2;GNAI3
prerank,regulation of chromosome segregation (GO:0051983),0.32325820950460954,0.7621266701343742,0.755868544600939,0.9858409842046113,1.0,5/16,21.52%,SMC5;CDC6;PUM2;CSNK2A2;PUM1
prerank,mRNA polyadenylation (GO:0006378),0.3009496324856703,0.7618890079838021,0.7577160493827161,0.9851731009099154,1.0,12/26,25.76%,LEO1;TUT1;PAF1;CSTF3;SYMPK;PAPOLG;CDC73;PCF11;CPSF2;WDR33;TENT4B;PNPT1
prerank,RNA polyadenylation (GO:0043631),0.3009496324856703,0.7618890079838021,0.7577160493827161,0.9851731009099154,1.0,12/26,25.76%,LEO1;TUT1;PAF1;CSTF3;SYMPK;PAPOLG;CDC73;PCF11;CPSF2;WDR33;TENT4B;PNPT1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.29987439267660154,-0.7614607970512505,0.7712895377128953,0.9589996519060993,1.0,2/12,3.65%,NKD1;PROM1
prerank,regulation of rRNA processing (GO:2000232),0.3293673395341604,0.7612280003455637,0.7495908346972177,0.9857418022749871,1.0,3/16,9.58%,BUD23;UTP15;SIRT7
prerank,apoptotic DNA fragmentation (GO:0006309),0.32644512163462813,0.7607192605123388,0.7439613526570048,0.9860644074102681,1.0,4/16,14.63%,DFFB;HMGB1;EXOG;DICER1
prerank,vacuolar acidification (GO:0007035),0.3045307165817296,0.7603638595403025,0.7584,0.9861244529460059,1.0,4/21,11.51%,ATP6V0D2;DMXL1;ATP6V0A1;DMXL2
prerank,mitotic spindle assembly (GO:0090307),0.2761025975585566,0.7602853305231467,0.7896995708154506,0.9857425151538514,1.0,8/42,18.52%,KIF2A;RACGAP1;SMC3;MAP9;ARHGEF10;PIBF1;OFD1;RHOA
prerank,protein ubiquitination (GO:0016567),0.2182612549541933,0.7597068948338955,0.9513677811550152,0.9861477968255324,1.0,112/471,22.14%,NEDD4L;PDZRN3;UBE2L6;ZNRF2;FBXL15;DTX1;PELI2;UBE2E2;SH3RF2;IRF2BP1;UBE3C;LZTR1;RNF122;LMO7;SPSB4;PSME3;LRSAM1;LEO1;TMEM129;KEAP1;TRIM21;SELENOS;UBR5;CHFR;PEX2;PAF1;UBE2V2;SIAH1;FBXO31;ZNRF3;CUL3;AMFR;PSMB5;BLMH;RNF220;LNPEP;ANAPC7;DTX4;UBE3D;OBI1;RCHY1;KLHL7;TRPC4AP;ANAPC11;FBXL19;LONRF1;NEDD4;KLHL21;FBXL5;FBXL17;FBXO11;NFE2L2;RFWD3;RNF185;FBXO21;PSMB2;CBFB;UBE2J2;UBA1;UBE2D3;UBE2D1;PSMA2;KLHL22;PSMA6;WWP2;PSMD13;FBXW8;PSMA7;TRIM5;FBXO41;DDB2;FANCL;UBE2R2;FBXL12;FBXW7;FBXL3;RTF1;ITCH;CUL4B;RNF7;VPS11;PSME4;ANAPC16;PINK1;KLHL18;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;USP9X;ATG3;DDA1;PEX13;HECTD2;UBE2W;CDC73;PRKN;MKRN1;RNF146;RNF14;MUL1;CUL7;TRAF7;ZNRF1;PSMB3;AKTIP;DERL1;RNF157;CUL5;MIB2;FBXW11
prerank,positive regulation of mRNA processing (GO:0050685),0.3110532023851396,0.7583389953656908,0.7488789237668162,0.9878022818682994,1.0,7/21,20.09%,LEO1;PAF1;CELF4;RBMXL1;TRA2B;PRDX6;CDC73
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.32402763905916726,0.7575023198908891,0.7408026755852842,0.9886205608095471,1.0,2/16,9.55%,CRTAM;LAMP1
prerank,ribosomal large subunit assembly (GO:0000027),-0.2423212232598345,-0.757217805849535,0.8268156424581006,0.9642602501704983,1.0,11/24,33.54%,RPLP0;RPL3;MRPL20;NLE1;PPAN;RPL5;RPF2;RPL11;RPL24;DDX28;NOP53
prerank,membrane depolarization during action potential (GO:0086010),0.29215297099362375,0.7563850966037051,0.7884914463452566,0.9898305166622606,1.0,3/26,5.19%,SCN10A;CACNA1H;ATP1A2
prerank,glycoprotein metabolic process (GO:0009100),-0.20665726660324082,-0.7562709703929701,0.923728813559322,0.9648187917598372,1.0,14/53,19.87%,ST8SIA4;MGAT4A;ST6GALNAC3;HIF1A;GANC;STT3B;B4GALT7;FBXO17;ST8SIA2;GCNT1;FUT8;FBXO44;GAL3ST2;ST8SIA1
prerank,positive regulation of protein depolymerization (GO:1901881),0.3527184749094494,0.7562679228553794,0.7580071174377224,0.9895098922186142,1.0,3/11,14.21%,TRPV4;PLEK;CFL2
prerank,mitochondrial translation (GO:0032543),0.23719217602149056,0.7560160527926764,0.8261904761904761,0.9893664076621803,1.0,28/104,21.18%,MRPL37;MRPL43;MRPL33;FASTKD2;MRPS28;MRPS35;RARS2;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;NDUFA7;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2;MRPL34;GFM1;GATB;TSFM;MRPS7
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.35069989328981244,0.7556254765487943,0.7303754266211604,0.9894688876734643,1.0,11/11,64.95%,NFKBIZ;MALT1;NFKBID;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;PRKCQ
prerank,interstrand cross-link repair (GO:0036297),0.2619809314746745,0.7556182974848833,0.8007915567282322,0.9889614890753556,1.0,13/53,21.53%,FAAP24;MSH6;FANCC;FANCF;ERCC1;RFWD3;NUCKS1;RAD51AP2;FANCL;ERCC6L2;ATR;SLX4;RPA3
prerank,erythrocyte development (GO:0048821),-0.3209525682070642,-0.7556041759823848,0.8028846153846154,0.9650032770145472,1.0,4/10,28.47%,ABCB10;ALAS1;NCKAP1L;ALAS2
prerank,endochondral bone morphogenesis (GO:0060350),0.3524355620006021,0.7550814908374694,0.7601296596434359,0.9892553903142969,1.0,2/11,4.10%,TRPV4;BMPR1B
prerank,dendritic spine morphogenesis (GO:0060997),-0.2799434060552993,-0.7539551334312283,0.8082901554404145,0.9664669735928147,1.0,5/15,18.50%,SHANK3;CDC42;EPHB3;CTNND2;EPHB1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3484140018457392,0.7536439562849693,0.7572463768115942,0.9909308610334663,1.0,4/11,17.93%,PRKCA;RDX;SYK;JAK1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.311296346020536,-0.7535572492421656,0.7899761336515513,0.9661734364945636,1.0,4/11,25.92%,FAS;LGALS9;PLAUR;CAAP1
prerank,negative regulation of viral genome replication (GO:0045071),0.2697581776620526,0.7534206040975749,0.8005464480874317,0.9907535127283216,1.0,7/40,11.01%,N4BP1;SRPK1;TNIP1;PLSCR1;RESF1;SRPK2;ILF3
prerank,positive regulation of locomotion (GO:0040017),0.2882204746976815,0.7531699306912616,0.7849624060150376,0.9906433042380419,1.0,2/27,4.97%,NTN1;CAVIN1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.2993819253067512,0.7531323805347144,0.7769110764430577,0.9901823806735267,1.0,8/24,20.35%,NF1;FOXO3;MCL1;SRPK2;BACE1;FBXW7;BAX;DDIT3
prerank,selective autophagy (GO:0061912),0.2585592918393156,0.7530172077164039,0.7935222672064778,0.9898498058447731,1.0,15/56,21.47%,DYNLL1;WDR81;ATG5;DDRGK1;DYNLL2;HDAC6;LGALS8;UBQLN1;ATG2B;MAP1LC3B;DYNC1LI2;RB1CC1;PRKN;DYNC1I1;ATG14
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3580531632190326,0.7529698957428005,0.765089722675367,0.9894099336946204,1.0,1/10,2.99%,PDE4D
prerank,establishment of spindle orientation (GO:0051294),0.29105644889145865,0.7527284641939417,0.775,0.9892726567338584,1.0,9/28,22.14%,SAPCD2;PAFAH1B1;MAP4;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,neuron cell-cell adhesion (GO:0007158),0.32629890753919133,0.752626395564507,0.7858347386172007,0.9889135830006074,1.0,1/14,1.67%,CEL
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.30351665656422777,-0.7524226946636442,0.7805486284289277,0.9669512110152075,1.0,5/12,15.95%,STMN2;EML2;CLIP3;STMN1;TUBB4A
prerank,regulation of stem cell population maintenance (GO:2000036),0.31431799776907804,0.7523751589929539,0.7837398373983739,0.9887786722801151,1.0,8/18,27.17%,NCOA3;CNOT1;ZC3H13;LOXL2;ELAVL1;CNOT2;REST;TAF6L
prerank,T cell differentiation (GO:0030217),0.27147917006989175,0.7516969910353305,0.781292984869326,0.9892717494274037,1.0,4/40,4.99%,LEPR;SPI1;PTPN22;PTPRC
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.28570843999954704,0.751657410261336,0.7735562310030395,0.9888112671758362,1.0,3/30,8.36%,ACKR3;FBXO5;DYRK1A
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.21787730836292957,-0.7514475967470814,0.8996282527881041,0.9674708955691821,1.0,6/44,12.71%,PRKAG2;INSIG2;OSBPL1A;OSBPL9;SCP2;PMVK
prerank,positive regulation of histone deacetylation (GO:0031065),-0.2967925271223602,-0.751348895344576,0.8062015503875969,0.9667962106105881,1.0,4/12,29.95%,AKAP8L;APLNR;PRKD1;CTBP1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.3040179238481403,-0.7512691506170603,0.7834821428571429,0.966098924645368,1.0,6/11,42.87%,KDM1A;MIF;TAF9;TRIAP1;MUC1;CD74
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.30313604217663737,0.7512628279475453,0.7885802469135802,0.9888966281128111,1.0,3/23,5.26%,SPI1;PPM1A;UACA
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.23229333772229124,-0.7511449030241917,0.8395061728395061,0.9654568829290763,1.0,10/29,22.19%,EDC3;NT5C3B;HBS1L;EDC4;EXOSC3;LSM7;DIS3;EXOSC1;DCP2;LSM5
prerank,positive regulation of macrophage migration (GO:1905523),-0.26157894055270964,-0.7510885062014531,0.806615776081425,0.9647306136753938,1.0,7/19,18.75%,CMKLR1;IL34;THBS1;PTK2;CSF1;P2RX4;RARRES2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.32126390132385113,0.7509867088629734,0.7706708268330733,0.9888080431997831,1.0,5/18,12.29%,NCOR1;RPS13;PTBP3;NCOR2;PTBP2
prerank,T cell migration (GO:0072678),0.33949372155045654,0.7508590854520814,0.7567084078711985,0.9884831309764432,1.0,2/13,11.78%,SLC12A2;GPR183
prerank,regulation of TOR signaling (GO:0032006),-0.1950802715598896,-0.7508562245901809,0.9395348837209302,0.9642252776351113,1.0,12/67,14.68%,UBR1;FNIP1;LAMTOR3;SEH1L;FBXO9;DEPDC5;RRAGC;RICTOR;TMEM127;GSK3A;DEPTOR;RRAGD
prerank,protein targeting to peroxisome (GO:0006625),0.2941658306486512,0.7502882452402725,0.7912254160363086,0.9888327118658157,1.0,5/29,12.75%,RAB8B;FIS1;PEX2;PXMP2;ABCD1
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.20470439749975816,-0.7501609324056145,0.9045801526717557,0.9643888426965852,1.0,17/49,28.89%,EP300;SETD1A;HDAC1;MYL9;AGO3;THBS1;MOV10;AGO4;TNRC6C;KAT2B;RAB7B;NR4A3;KMT2B;CIB1;L3MBTL1;KMT2E;WDR5
prerank,neutrophil activation (GO:0042119),0.3481679466838743,0.7499730590215413,0.7588028169014085,0.9888210673030242,1.0,4/12,24.11%,IL15;SYK;PREX1;PRKCD
prerank,mitotic cytokinesis (GO:0000281),0.26444763963313217,0.7499327964497782,0.8013605442176871,0.9883568829014507,1.0,12/47,17.60%,RACGAP1;SON;USP8;SPAST;PDCD6IP;CNTROB;CHMP4B;APC;CIT;STAMBP;RTKN;SPTBN1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.2651433942063685,-0.7498729416573217,0.8140845070422535,0.9639924217414354,1.0,4/19,17.04%,SLCO1C1;KLF4;KLF2;EGF
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2705155857759292,0.749604570608599,0.7796143250688705,0.9883415904597057,1.0,1/42,0.78%,ACKR3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3372207953546541,0.7491974872151184,0.7671957671957672,0.9884830288524996,1.0,3/12,7.69%,GLI2;EPHB2;PAFAH1B1
prerank,chromatin assembly or disassembly (GO:0006333),0.3387653372312306,0.7487672208271913,0.7560975609756098,0.9886091935508938,1.0,3/11,20.24%,CDAN1;SUV39H2;RBBP4
prerank,negative regulation of reproductive process (GO:2000242),0.30975917201610875,0.7485084994351772,0.731023102310231,0.9884830856917404,1.0,2/17,5.04%,SULF1;ACVR1C
prerank,DNA catabolic process (GO:0006308),0.34893256645837023,0.7484982846559284,0.7592920353982301,0.9879807992804645,1.0,4/11,25.93%,DFFB;REXO4;DNASE1L1;FBH1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.24205762792323177,-0.7471526919788856,0.8429752066115702,0.9667953112672398,1.0,6/22,18.59%,PHF8;DHX33;NCL;HEATR1;PWP1;ATF4
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.28827059155688894,-0.746683796310644,0.805352798053528,0.9666335107479582,1.0,6/14,18.75%,CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2
prerank,mitochondrial translational termination (GO:0070126),0.23906328945101563,0.7464992206463072,0.8423645320197044,0.9905590783721634,1.0,20/88,18.18%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.3265045334435806,0.7460766414478387,0.7774140752864157,0.9906926687852421,1.0,6/15,26.21%,CNTNAP4;ZDHHC3;ZDHHC12;NLGN2;USP46;ADRA1A
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.33023576891295164,0.7460565495071297,0.7669565217391304,0.9902119189027089,1.0,2/13,9.18%,NRARP;COL4A1
prerank,DNA metabolic process (GO:0006259),0.21559755712810963,0.7452976117147765,0.9213602550478215,0.9908232317694688,1.0,59/270,19.61%,TDG;MSH6;POLI;KMT5C;NTHL1;SMARCAD1;FANCC;PDS5B;RFC3;STN1;KPNA2;ORC5;NBN;UBE2V2;TOP3B;MSH2;NT5E;DFFB;HMGB1;SIRT7;ORC3;TRRAP;AXIN2;LONP1;SRPK2;ERCC1;TDP1;TOP1;MEN1;INO80;MGMT;CDC6;GEN1;ADPRS;GTF2H1;ALKBH1;POLB;REXO4;RECQL5;RAN;POLE;DDB2;FANCL;INTS3;CHD1L;USP45;GMNN;PSME4;TERF2;BACH1;NOC3L;ORC1;RFC1;ORC6;GTF2H3;MRE11;XRCC6;RPAIN;SUMO1
prerank,CENP-A containing chromatin organization (GO:0061641),-0.22952651245874126,-0.7451394851396993,0.8789808917197452,0.9670834083020654,1.0,14/29,31.97%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.22952651245874126,-0.7451394851396993,0.8789808917197452,0.9670834083020654,1.0,14/29,31.97%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2993966835251216,-0.7446842433353058,0.7839805825242718,0.9668878777346911,1.0,4/12,26.36%,IL18;CD80;PAEP;IL17D
prerank,negative regulation of telomere maintenance (GO:0032205),0.330821526252506,0.7445644029175414,0.7811447811447811,0.9914664855340698,1.0,8/15,28.07%,NBN;ERCC1;TERF2;SLX4;SMG6;TNKS;RAD50;TERF2IP
prerank,polyol biosynthetic process (GO:0046173),0.32222706197296025,0.7441887958880624,0.7732656514382402,0.9915405314060239,1.0,2/16,6.93%,ACER3;PPIP5K2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3494807479832365,0.7440164792657163,0.7485928705440901,0.991304150135193,1.0,2/10,10.68%,PTPN22;MAPK8IP1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3270778242651293,0.7435069754947561,0.7670549084858569,0.9915752880618974,1.0,3/14,11.03%,TSEN54;RTRAF;TSEN34
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.28392576443878237,-0.7433984058954922,0.8004926108374384,0.9678074407400317,1.0,6/14,35.01%,IL18;CD80;PAEP;IL17D;CD84;RASGRP1
prerank,piRNA metabolic process (GO:0034587),0.30643262723297915,0.7430960486964866,0.7745571658615137,0.9916777883934494,1.0,2/19,12.29%,PIWIL2;TEX15
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.296697695787402,0.743009652017168,0.7857142857142857,0.9912884652576052,1.0,6/24,18.76%,PSME3;TMF1;PKD1;RHBDF1;PINK1;PSMD14
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.294219711593359,0.7425348883082992,0.7781109445277361,0.9914709797300761,1.0,10/25,21.89%,CUL3;LONP1;HDAC6;ZYG11B;FBXL17;RNF185;KLHL15;UBE2W;YME1L1;DERL1
prerank,positive regulation of protein kinase activity (GO:0045860),0.22585059786011275,0.7424312772009232,0.8782412626832018,0.9911315769854694,1.0,21/148,11.42%,RAP1A;AXIN1;MINK1;PRKAG1;MMD2;SRC;SLC27A1;PTPRC;TOM1L1;LCP2;SRCIN1;SYAP1;IRGM;STK3;RASSF2;DLG3;LAT;ADRA2A;RELN;TAB2;EGR1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.26873944299848784,0.7418350045646317,0.7994389901823282,0.9914921615111366,1.0,12/39,22.12%,TFR2;ISL1;RASL10B;GCK;SOX4;AIMP1;GPER1;BAD;IRS2;GLUD1;TCF7L2;NLGN2
prerank,response to prostaglandin E (GO:0034695),-0.3163446382388596,-0.7416878039883927,0.8244444444444444,0.9692734626460124,1.0,4/10,28.88%,TGFBR3;CCL19;ADCY6;SFRP1
prerank,protein deacylation (GO:0035601),0.300212654529918,0.7413251772448729,0.7698056801195815,0.9917541366927397,1.0,10/23,23.98%,HDAC4;SIRT3;SIRT7;HDAC6;ABHD10;HDAC3;LYPLA2;ABHD17C;SIRT2;SIN3A
prerank,myelination in peripheral nervous system (GO:0022011),0.3349071877855616,0.7412842027643537,0.7706576728499157,0.9913159587052423,1.0,8/13,24.00%,NF1;CNTNAP1;NCMAP;DICER1;ARHGEF10;PRX;SIRT2;SKI
prerank,necroptotic process (GO:0070266),-0.2656199471422826,-0.7412052773235088,0.8501291989664083,0.9690878680864752,1.0,6/16,25.91%,PGAM5;IPMK;TRPM7;TLR3;RIPK1;LY96
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.21151274527452169,-0.7409964557039835,0.903448275862069,0.9685394265968625,1.0,7/40,14.31%,PID1;ARL6IP5;AKT1;VCP;LRRK2;SLC25A33;MAPT
prerank,UV protection (GO:0009650),0.3501920513086511,0.7407749668529715,0.7633451957295374,0.9915637352718466,1.0,1/10,2.10%,SCARA3
prerank,GTP metabolic process (GO:0046039),-0.278321124510869,-0.7407236239266788,0.8045325779036827,0.9681100346052817,1.0,3/15,15.54%,LRRK2;IMPDH1;OPA1
prerank,protein modification by small protein conjugation (GO:0032446),0.21434176618608178,0.7405470148819896,0.947584789311408,0.9913986204426326,1.0,87/361,22.14%,NEDD4L;PDZRN3;FBXL15;DTX1;STX1A;EYA1;LZTR1;LMO7;UBE2I;SPSB4;LEO1;TMEM129;NUP62;KEAP1;TRIM21;SELENOS;CHFR;PEX2;PAF1;UBE2V2;PIAS2;ZNRF3;CUL3;AMFR;NUP160;RNF220;DDRGK1;ANAPC7;DTX4;NUP37;TPR;RCHY1;KLHL7;TRPC4AP;ANAPC11;NUP50;NEDD4;RANBP2;KLHL21;FBXL5;FBXL17;FBXO11;NFE2L2;NUP210;NUP153;RFWD3;ATG7;UBE2J2;UBA1;UBE2D3;UBE2D1;WWP2;FBXW8;NUP93;TRIM5;UBE2R2;FBXW7;FBXL3;RTF1;URM1;ITCH;CUL4B;RNF7;VPS11;ANAPC16;PINK1;KLHL18;CDC23;USP9X;ATG3;SUMO1;PEX13;UBE2W;CDC73;TRPM4;PRKN;MKRN1;RNF14;MUL1;CUL7;NUP43;TRAF7;DERL1;RNF157;CUL5;MIB2;FBXW11
prerank,cellular response to interferon-beta (GO:0035458),0.3216003917919163,0.7403500724534318,0.7642140468227425,0.9911858653132907,1.0,3/14,13.79%,ACOD1;IRGM;HTRA2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.21315968593900916,0.7402489581263748,0.9402061855670103,0.9908208010865378,1.0,61/336,17.71%,NFATC2;BCL3;UBE2E2;SMC5;MSH6;POLI;CIDEB;WDR76;PAXX;KMT5C;FANCC;PDS5B;BRSK1;RFC3;FANCF;NBN;UBR5;HIC1;MCL1;MSH2;SUV39H1;FBXO31;AATF;BOD1L1;SFN;MASTL;SIRT7;USP47;TRRAP;APC;ERCC1;TDP1;MEN1;INO80;OARD1;MGMT;RFWD3;ADPRS;GTF2H1;CHCHD6;ETAA1;HTRA2;ALKBH1;POLB;UBA1;REXO4;NEK4;RECQL5;FAM111A;YAP1;DDB2;FANCL;INTS3;BATF;CHD1L;USP45;E2F1;CUL4B;DYRK2;PSME4;BACH1
prerank,V(D)J recombination (GO:0033151),-0.29728090146908404,-0.7397296326821694,0.781021897810219,0.9685591638580924,1.0,4/11,24.88%,DCAF1;LIG3;XRCC4;LIG4
prerank,protein localization to condensed chromosome (GO:1903083),0.3400392067947436,0.7395886849905844,0.7684391080617495,0.9913172592911791,1.0,4/12,22.27%,BUB3;ZWILCH;ZW10;MIS12
prerank,epithelial cell differentiation (GO:0030855),0.2428396908833513,0.738733824490693,0.8536585365853658,0.9920899828331949,1.0,16/88,17.72%,GLI1;CDHR2;JAG1;ANXA4;ZDHHC7;HDAC2;GSTK1;KDM6B;FZD7;ERBB4;UPK1A;PGK1;PPARG;SCRIB;CTSB;FSTL1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.2997158252313742,0.7385821116624465,0.7897897897897898,0.9918059826228384,1.0,4/20,7.98%,SCD5;ACACA;GCDH;HSD17B4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.28330656502589113,0.7385458974658463,0.8046647230320699,0.991359461979989,1.0,5/29,17.97%,TEX11;SIRT7;MEI4;REC8;SYCP2
prerank,regulation of apoptotic process (GO:0042981),0.20921585551129512,0.7385454841779188,0.9718875502008032,0.9908512931111922,1.0,101/676,15.35%,NGF;ITGA6;PLK2;DKKL1;TIAM2;EGFR;PPP1R13B;BCL3;SH3RF2;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;STIL;FOXO3;CIDEB;SOX9;VAV2;SRC;NUP62;WNT5A;ACVR1C;TRIO;EGLN3;DDAH2;SON;ANXA4;TRADD;ARHGEF5;NCSTN;ADAM10;PHLDA1;MCL1;NLRC4;ARHGEF1;PERP;SIAH1;BAG3;MAP3K5;PHLPP1;NAA35;RBM5;KALRN;AATF;OBSCN;DDRGK1;STK3;GSK3B;RPS6KA3;HMGB1;NLRP2B;RASSF2;SLC27A4;USP47;AXL;HDAC2;TAX1BP1;HYPK;RARG;PROC;APC;IL6ST;PRLR;HTATIP2;SGK1;ARHGEF6;SEMA4D;FAF1;LANCL1;FBXO11;TMBIM4;NF2;DHCR24;MGMT;PTPA;AQP1;ADAMTSL4;DIABLO;CREBBP;IL7;ATG7;SOX4;LCMT1;HTRA2;HTT;DNAJA3;DDX42;RTN4;UNC13B;CHM;COPS5;FZD9;GPER1;PTPN6;BAD;PDCD2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.2919792065725004,0.7383977395956222,0.7762345679012346,0.9905674026531242,1.0,5/23,19.24%,ALOXE3;LTA4H;ELOVL6;HPGD;FADS1
prerank,maintenance of protein location in nucleus (GO:0051457),0.308074173304472,0.7382196687740149,0.8050314465408805,0.9903208364935865,1.0,3/20,9.77%,BCL3;MORC3;SUN1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.30383711625033905,-0.7376690310802815,0.8075,0.9695150474337056,1.0,2/11,11.04%,CCT7;CCT8
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.30383711625033905,-0.7376690310802815,0.8075,0.9695150474337056,1.0,2/11,11.04%,CCT7;CCT8
prerank,transcription by RNA polymerase I (GO:0006360),-0.22391405877576273,-0.737423264891897,0.8503184713375797,0.9690077714509786,1.0,12/34,23.85%,MNAT1;TAF1D;ERCC2;TCOF1;CCNH;POLR2F;TAF1C;GTF2H4;POLR2K;POLR1C;POLR1F;RRN3
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.23368795502018258,-0.7372815757003972,0.8543689320388349,0.9683808835603104,1.0,12/28,36.22%,SIRPA;SH3KBP1;CYRIB;NCKAP1L;NOD2;PYCARD;TNIP2;CCR2;HSPD1;CCL2;PRKCQ;THY1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.30174689058327864,0.7370026594067476,0.7996794871794872,0.9916098956087458,1.0,5/20,23.89%,ANO6;GPER1;RGCC;IL6;PDCD4
prerank,sister chromatid segregation (GO:0000819),0.2783442040850163,0.7368978603544113,0.8055964653902798,0.9912559057709562,1.0,8/31,17.28%,TUBG1;DSN1;INO80;TUBG2;KLHL22;ZW10;RAN;CENPK
prerank,dendritic cell chemotaxis (GO:0002407),0.32242451432688907,0.7368269025065642,0.7962003454231433,0.9908585788504795,1.0,4/14,20.28%,HMGB1;GPR183;CCR5;TRPM4
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3135943558841008,0.736679437827428,0.7858347386172007,0.9905581318939616,1.0,2/17,9.55%,CRTAM;LAMP1
prerank,neuron remodeling (GO:0016322),-0.30415170201691266,-0.7362350615665788,0.8119266055045872,0.9689249606533289,1.0,5/10,31.40%,EPHA8;C1QA;C3;SCARF1;RND1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.28518174818752423,-0.7361911268839829,0.8036175710594315,0.9681882461934043,1.0,1/13,1.43%,GLI3
prerank,proteasomal protein catabolic process (GO:0010498),0.21751382673717123,0.7357584174619112,0.9121475054229935,0.9914625746793173,1.0,49/201,22.14%,NEDD4L;RNF122;PCBP2;SPSB4;PSME3;SOCS6;SIAH1;CUL3;PSMB5;SIAH3;UBE3D;SHARPIN;FBXL19;NEDD4;SPOPL;FBXL17;FAF1;NFE2L2;RNF185;PSMB2;UBE2D3;PSMA2;KLHL22;FEM1C;PSMA6;WWP2;PSMD13;PSMA7;PLAA;FBXW7;ITCH;CUL4B;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;KBTBD7;GID4;SEL1L;UBE2W;DDIT3;PRKN;PPP2R5C;ZNRF1;PSMB3;DERL1;GID8;FBXW11
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3031616201403722,0.7355535231596065,0.7897271268057785,0.9912517883564491,1.0,6/19,24.19%,TLR7;TBK1;SETD2;DHX9;IFIH1;RIPK2
prerank,cellular response to oxygen levels (GO:0071453),-0.3073966556046537,-0.7354257458319331,0.8094170403587444,0.9683962739145753,1.0,3/10,22.77%,CPEB4;PICK1;CCDC115
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3183342897108127,0.7354145000852104,0.7986348122866894,0.9909750832944254,1.0,6/15,24.71%,FGF1;ITGA5;JAK1;PDPK1;PKM;FGF2
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3353814106127371,0.7344190501549807,0.7758318739054291,0.9919435494832833,1.0,2/11,8.11%,PCBP2;IGF2BP2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.24800916942656928,0.7342749204402798,0.8446475195822454,0.9916471453623316,1.0,12/57,16.00%,BRCC3;BRSK1;NBN;RINT1;FBXO31;UIMC1;MDC1;DONSON;RFWD3;EME2;FZR1;NEK11
prerank,glutathione biosynthetic process (GO:0006750),-0.30165820833138896,-0.7342469303531406,0.783410138248848,0.9691130242887147,1.0,4/11,18.03%,GCLM;CNDP2;GGCT;GCLC
prerank,regulation of trophoblast cell migration (GO:1901163),-0.2774505944506264,-0.7342218984396426,0.7909319899244333,0.9683491490717206,1.0,7/14,31.98%,GJA1;SMURF2;C1QBP;YTHDF3;ACVR1B;CALR;TIMP1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3414289727580574,0.7341886465214948,0.7926186291739895,0.9912682631995665,1.0,4/12,14.78%,DPYS;DPYSL2;CTPS2;DPYSL5
prerank,protein K63-linked ubiquitination (GO:0070534),-0.21362786561609406,-0.7341727151257783,0.8896551724137931,0.9676181212829374,1.0,7/41,9.85%,RNF115;TRAF3IP2;TRAF6;UBE2N;UBE2S;RNF152;UBE2O
prerank,positive regulation of hormone secretion (GO:0046887),0.3174957613257069,0.7340715952338674,0.7977346278317152,0.9909318537144197,1.0,3/17,11.35%,TFR2;RASL10B;VAMP8
prerank,ether lipid biosynthetic process (GO:0008611),-0.3162217457369797,-0.7340584886556286,0.8149882903981265,0.9669477105094297,1.0,1/10,3.61%,CHPT1
prerank,atrioventricular valve development (GO:0003171),-0.27728548948257636,-0.7339871335762969,0.8303341902313625,0.9662431530079165,1.0,5/14,25.08%,BMPR2;BMP2;TGFB2;APLNR;NOTCH1
prerank,cell proliferation in forebrain (GO:0021846),-0.3071654753188242,-0.7338339825319327,0.8,0.9656352158825956,1.0,1/10,0.77%,NUMB
prerank,receptor recycling (GO:0001881),-0.3058036919951458,-0.7332603310415916,0.7963386727688787,0.9655366883266652,1.0,4/10,18.44%,ARFGEF2;NSG1;PLEKHJ1;RAB11B
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.27291789376518194,0.7331772114445503,0.8287373004354136,0.9917023837442696,1.0,7/34,16.89%,DOCK5;DOCK1;RREB1;FERMT2;P4HB;MDK;ARHGEF7
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3323489030857357,0.7330000614780903,0.7803571428571429,0.9914530496037861,1.0,2/12,4.99%,PTPN22;PTPRC
prerank,response to UV-B (GO:0010224),0.33459767536523544,0.7327282963290791,0.7929824561403509,0.9913897264773706,1.0,2/12,10.88%,MSH2;MME
prerank,mitotic sister chromatid segregation (GO:0000070),0.23705561859197988,0.7327122844311547,0.8779904306220095,0.9909059822003656,1.0,28/98,22.27%,NUP62;PDS5B;TUBG1;DSN1;CUL3;DIS3L2;TEX14;CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C;INO80;TUBG2;KLHL22;ZW10;RAN;REC8;PIBF1;CENPK;CSNK2A2;CDC23;DCTN2;RRS1;KMT5A;CHMP2A;PRC1;MIS12
prerank,neurotransmitter biosynthetic process (GO:0042136),0.312608473701626,0.7324672851623839,0.7538994800693241,0.9907485477613129,1.0,1/14,1.67%,ALDH9A1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.26854316775970427,-0.7319089697332128,0.8242894056847545,0.9663719604715484,1.0,5/17,15.32%,NR1H3;HDAC9;NR1H2;FURIN;SORT1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2277096762468278,0.73190176563005,0.8731082654249127,0.9910928638669947,1.0,22/117,17.74%,ALDH1A3;PCCB;CYP2S1;HOGA1;CKMT2;DLAT;SCPEP1;ABAT;SLC27A4;ACSF2;GAMT;SLC16A1;ACOT2;MSMO1;PNPLA8;AASDH;GGT1;PANK2;ME2;LDHB;PPARG;LPL
prerank,DNA strand elongation (GO:0022616),0.3073479086445986,0.7315221414199852,0.8095238095238095,0.9911442254968243,1.0,3/18,8.18%,RFC3;NBN;GINS4
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.279551261134709,0.7314741888013421,0.799405646359584,0.990702074670157,1.0,6/31,13.19%,WEE1;DACT1;KANK2;APC;PTEN;FHL1
prerank,positive regulation of protein polymerization (GO:0032273),0.2490766783660864,0.7311285236839745,0.8451612903225807,0.9907212095981479,1.0,15/65,21.99%,PRKCE;CDC42EP4;FER;NCK2;ARF6;OCLN;CTTN;CDC42EP3;SLAIN2;PINK1;BAIAP2;PFN2;NCK1;TENM1;HCK
prerank,mitochondrial fission (GO:0000266),0.3130699630613582,0.7307931265099928,0.785483870967742,0.990717961111067,1.0,3/16,8.64%,DNM1;FIS1;MIEF1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.33681758128967504,0.7303919635687304,0.7720848056537103,0.9907960416010881,1.0,4/11,22.08%,PARP11;PARP6;PARP8;TIPARP
prerank,natural killer cell mediated immunity (GO:0002228),-0.261386741377567,-0.7300434523016657,0.8363171355498721,0.9679002034094353,1.0,4/15,21.89%,CEBPG;TUBB4B;PLEKHM2;RAET1E
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3122590593729772,0.7297365256540004,0.8009708737864077,0.9912162934484716,1.0,3/16,17.29%,PDS5B;REC8;DSCC1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.343725076261688,0.7296067704108857,0.7586805555555556,0.9909077804061547,1.0,2/10,7.87%,CHFR;DIS3L2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.28045107034647726,-0.7295458618893617,0.8350253807106599,0.9677086084284882,1.0,4/14,23.24%,ENTPD1;ENTPD5;ENTPD3;NUDT16
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.30032902136172773,0.729400399486101,0.8051529790660226,0.9906988267744367,1.0,7/21,16.76%,FKBP1B;BOD1L1;GSK3B;MASTL;ENSA;PTPA;YWHAE
prerank,cellular lipid catabolic process (GO:0044242),0.2773248468861498,0.7291814252375932,0.8315132605304212,0.9905318516639252,1.0,4/27,10.29%,CEL;MGST2;ABHD12;ACOT8
prerank,phagosome acidification (GO:0090383),-0.2310076394281596,-0.7290232610432328,0.8808864265927978,0.9675616327167235,1.0,8/26,24.02%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D;ATP6V1F;RAB7A;ATP6V1E1;RAB38
prerank,negative regulation of cilium assembly (GO:1902018),0.3298359712387911,0.7289428959434716,0.7674825174825175,0.9903721611846805,1.0,4/12,15.73%,LIMK2;CCP110;MAP4;YAP1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.24872070216211306,-0.7288007335520288,0.870026525198939,0.967043215703222,1.0,7/21,19.84%,CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2;MIF
prerank,cellular response to drug (GO:0035690),-0.24088847697211796,-0.7287915488095918,0.8773006134969326,0.9662685372077495,1.0,2/25,3.02%,ACER2;TFRC
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.28828810187350723,-0.7286571858605944,0.8191489361702128,0.9656516553935189,1.0,5/11,32.17%,SMARCD1;SERTAD1;ZMIZ2;CDCA4;ZMIZ1
prerank,histone mRNA metabolic process (GO:0008334),-0.22942181058734523,-0.7280878908063971,0.8771929824561403,0.9655850379074982,1.0,10/27,27.27%,SSB;TENT2;SNRPE;TUT7;MTPAP;NCBP1;LSM11;DCP2;SLBP;ATM
prerank,regulation of protein binding (GO:0043393),0.2273188025923639,0.7280118503572763,0.8976744186046511,0.9911595034294941,1.0,35/114,24.54%,CAV1;EFHB;ADD1;HDAC4;DACT1;STYX;TRIM21;AMFR;STK3;GSK3B;MEN1;PKD1;CTNNBIP1;CAPRIN2;RAN;GNL3L;BAG2;PPP1CA;SYMPK;PPP2CA;BAX;PIN1;PRKN;MAPK8;DDX11;AKTIP;TCF7L2;DERL1;NMD3;DTX3L;PRMT8;PRKCD;RIPK2;HIPK2;ROCK1
prerank,protein oxidation (GO:0018158),-0.2864687374198384,-0.7277475540990154,0.8329411764705882,0.9652206814518501,1.0,2/11,12.25%,LOXL1;LOXL3
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.21622523221219492,-0.7270693402653091,0.8912280701754386,0.9653290445651477,1.0,6/34,11.97%,GRIN2B;GABRA2;AKT1;GRIN1;LRRK2;GSK3A
prerank,neuron fate commitment (GO:0048663),-0.2820813249432866,-0.7268396309890683,0.82,0.9648076292271406,1.0,6/14,28.18%,TGFBR1;MYT1L;ID2;POU3F2;DLL4;DLL1
prerank,inflammatory response (GO:0006954),0.21634573148348796,0.72662290990585,0.924487594390507,0.9927592755147934,1.0,8/195,4.50%,HRH1;F11R;PTGFR;FOLR2;IL1A;HDAC4;HNRNPA0;REL
prerank,recombinational repair (GO:0000725),0.23575218399771897,0.7264579559936825,0.8702101359703337,0.9924954428084276,1.0,18/77,19.02%,SMC5;NBN;PALB2;SWI5;ZSWIM7;ZFYVE26;INO80;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;REV3L;RECQL5;RHNO1;SFR1;PSMD14;MRE11
prerank,tRNA processing (GO:0008033),0.24305171385072327,0.7262795539907956,0.8460543337645536,0.9922470260655601,1.0,18/61,23.14%,TSEN54;PUS3;WDR4;CDKAL1;KARS1;POP7;RTRAF;TSEN34;FTSJ1;ADAT1;ANKRD16;URM1;TYW5;PTCD1;RPP21;THG1L;TRMT1;RPP30
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2376056127319413,0.7259984180937954,0.8822085889570552,0.9921625837704798,1.0,13/86,15.10%,PRKCE;CDC42EP4;TRPV4;FER;NCK2;ARF6;OCLN;PLEK;EFEMP2;CTTN;CFL2;CDC42EP3;SLAIN2
prerank,regulation of transport (GO:0051049),0.2718794007928773,0.7254503706626866,0.8200836820083682,0.9924083470690048,1.0,10/36,21.40%,CLDN19;LEPR;CLDN10;WWC1;MBTPS1;PINK1;ICA1L;PRKN;MUL1;VAMP2
prerank,gas transport (GO:0015669),0.34788936000677173,0.725088014008349,0.7881508078994613,0.9924288510257537,1.0,2/10,12.99%,IPCEF1;AQP1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.29837075654605255,0.7247853336096249,0.800658978583196,0.9923822427878368,1.0,7/19,20.41%,HDAC6;HTRA2;HTT;FBXW7;CSNK2A2;PINK1;PRKN
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2685876865547546,0.7246950055768326,0.8189655172413793,0.9920140874574028,1.0,14/38,25.91%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2;NDUFA11;NDUFA12;NDUFS4;NDUFS1;NDUFA9
prerank,regulation of histone methylation (GO:0031060),0.32680016208240653,0.7242273729238364,0.8027210884353742,0.9921612548859857,1.0,2/13,9.16%,PAF1;TET1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3053069916525064,-0.7242103467010146,0.8235294117647058,0.9656169972504999,1.0,2/10,5.83%,WRN;BLM
prerank,t-circle formation (GO:0090656),-0.3053069916525064,-0.7242103467010146,0.8235294117647058,0.9656169972504999,1.0,2/10,5.83%,WRN;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3053069916525064,-0.7242103467010146,0.8235294117647058,0.9656169972504999,1.0,2/10,5.83%,WRN;BLM
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3040671018367195,-0.7238612548952295,0.8253588516746412,0.9652571309207891,1.0,2/10,4.89%,HOXB4;ACE
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.2861913843617733,-0.7238224012251956,0.8387909319899244,0.9645221638611476,1.0,3/13,20.59%,TMSB4X;PER2;MAD2L2
prerank,positive regulation of insulin secretion (GO:0032024),0.26372314100247773,0.7238131939129978,0.8201438848920863,0.992248832189667,1.0,13/36,22.12%,GPLD1;ISL1;GCK;SOX4;GPER1;BAD;ADCY8;STX4;IRS2;GLUD1;TRPM4;TCF7L2;NLGN2
prerank,leukocyte tethering or rolling (GO:0050901),0.30966273209038225,0.7237329195405996,0.8032258064516129,0.9918520642971717,1.0,6/17,24.54%,ITGB7;PODXL2;ITGB1;CX3CR1;GOLPH3;ROCK1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2773198437844175,0.7229845658237413,0.826783114992722,0.9924218377208858,1.0,6/30,15.93%,TNIP3;TICAM1;UBE2D3;UBE2D1;TICAM2;TBK1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.23507772588584921,-0.7226574573481125,0.883289124668435,0.9651200245018728,1.0,11/24,31.65%,NOX4;MTHFR;MTR;MTRR;CBS;GCLC;ADI1;CTH;MSRA;MPST;CDO1
prerank,microtubule-based transport (GO:0099111),0.33176870678048065,0.7223757445874462,0.7711442786069652,0.9927875443779858,1.0,5/12,24.34%,SPAG17;HTT;CCDC40;DYNC1I1;DYNC1I2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.25914003931111135,-0.7217015233089467,0.8263157894736842,0.9654349269931412,1.0,7/16,28.57%,SLC39A14;GSK3A;MRAP2;PDE6H;C3;ACP3;GRP
prerank,negative regulation of myotube differentiation (GO:0010832),-0.2797449371703744,-0.7216923168571806,0.8403141361256544,0.9646669467796845,1.0,5/12,25.08%,CCN3;HDAC1;BDNF;XBP1;NOTCH1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.315354427484572,0.7215083675472471,0.7818499127399651,0.9934852802841418,1.0,2/14,7.46%,SOCS5;RARA
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.33453939905166763,0.7212825112636575,0.7799642218246869,0.9933070373916286,1.0,3/11,21.16%,HMGB1;CBFB;RUNX1
prerank,O-glycan processing (GO:0016266),0.249091259316568,0.7205240216077528,0.8442953020134228,0.9938537736133051,1.0,5/54,9.51%,ST3GAL4;C1GALT1C1;GCNT4;POFUT1;ST6GAL1
prerank,cGMP biosynthetic process (GO:0006182),-0.29899808044980075,-0.7201009900120027,0.8257756563245824,0.9658263156160131,1.0,1/10,4.51%,NPR1
prerank,regulation of neurogenesis (GO:0050767),0.24775594290657046,0.7200512949910188,0.8614379084967321,0.9940111822201401,1.0,13/55,21.67%,RGS14;HEYL;BHLHE40;MME;DOCK7;HOOK3;PCM1;GPER1;YAP1;NAP1L1;IL6;CX3CR1;CX3CL1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.33728343865643506,0.719817843279819,0.7689594356261023,0.9938254257771115,1.0,2/10,8.00%,DPP4;PIEZO1
prerank,regulation of mRNA stability (GO:0043488),0.2196618502323427,0.7194902238052764,0.9182530795072789,0.9937863823279428,1.0,35/145,22.21%,FXR2;DND1;GIGYF2;CELF1;PRKCA;PSME3;SAMD4B;EXOSC5;IGF2BP2;PSMB5;TENT5C;AXIN2;TENT5D;TAF15;ZFP36L2;PSMB2;FXR1;PSMA2;PUM2;FASTKD1;PSMA6;PSMD13;PSMA7;E2F1;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;HNRNPD;EXOSC7;PUM1;PSMB3;ELAVL1;YWHAB
prerank,urogenital system development (GO:0001655),0.32977529514900955,0.7194567176266334,0.7946902654867256,0.9933399360951937,1.0,2/11,6.39%,SOX9;EPHB2
prerank,establishment of mitotic spindle orientation (GO:0000132),0.2914614681052493,0.719351543745868,0.803030303030303,0.9930046600386891,1.0,8/23,22.14%,SAPCD2;PAFAH1B1;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,RNA interference (GO:0016246),0.3109287596512433,0.7193156791165237,0.8090614886731392,0.9925520166866643,1.0,6/17,19.33%,CELF1;AGO1;DICER1;TSNAX;PRKRA;DHX9
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.286950722962969,0.7192651588035494,0.8043143297380585,0.9921270101053761,1.0,3/21,6.60%,EIF2AK3;CREB3L1;SELENOS
prerank,neutrophil activation involved in immune response (GO:0002283),0.2034106365974283,0.7185276330567092,0.9734693877551021,0.9926014134746137,1.0,79/428,19.50%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;SYK;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.269853607851005,-0.7183475363828243,0.8629441624365483,0.9670375272781205,1.0,6/15,22.11%,SPHK1;SMPD3;ORMDL1;ORMDL2;RACK1;ORMDL3
prerank,cardiac muscle cell action potential (GO:0086001),0.2729464760226692,0.7181442393841713,0.8139183055975794,0.9926202219963981,1.0,3/30,5.19%,SCN10A;SLC4A3;ATP1A2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.3065968234404675,0.7180204774924995,0.7990654205607477,0.9922814610159191,1.0,6/17,17.11%,APLN;TAFA5;EFEMP2;PTEN;GPER1;PPARG
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.28680032450622983,-0.7178854293053365,0.8351893095768375,0.9667440411246001,1.0,6/12,30.04%,WAC;PLK5;RPS27L;CDK2;CCND1;PLK3
prerank,ncRNA export from nucleus (GO:0097064),0.26350142333079307,0.7178189244883101,0.8468335787923417,0.9920660599919462,1.0,10/36,15.46%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.23017640487950208,0.7175548481879331,0.8778173190984578,0.9919467176747628,1.0,14/88,14.11%,FXR2;GIGYF2;EIF2AK3;CNOT10;SAMD4B;CLN8;PUS7;IGF2BP2;CNOT7;RIC1;ILF3;HDAC6;DDX6;FXR1
prerank,response to UV (GO:0009411),0.22990322837599741,0.7171792611569412,0.902122641509434,0.9919746934569644,1.0,14/95,13.12%,EGFR;SCARA3;BCL3;MSH6;BRSK1;N4BP1;MSH2;USP47;ERCC6;NEDD4;MEN1;INO80;AQP1;CREBBP
prerank,DNA replication initiation (GO:0006270),-0.2101420531417091,-0.7168137156534607,0.9033232628398792,0.9671427157130867,1.0,17/37,32.05%,PRIM2;POLE4;MCM6;ORC2;POLA1;LRWD1;CDC7;TOPBP1;CDC45;POLA2;CDK2;MCM3;MCM7;POLE3;MCM5;MCM10;MCM2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3366102681799507,0.7167955378500025,0.7992957746478874,0.99201478511896,1.0,5/10,22.92%,BAG3;NCK1;JUN;IMPACT;SIRT2
prerank,coenzyme A metabolic process (GO:0015936),-0.2684170678159502,-0.7167688727601487,0.8446601941747572,0.9664145947245412,1.0,6/14,24.11%,ACOT7;PANK1;ACLY;PPCDC;PANK3;DCAKD
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3083359776371902,0.7164887622619751,0.8067092651757188,0.9919465313597775,1.0,1/15,1.39%,AK5
prerank,TOR signaling (GO:0031929),0.2774081154719873,0.7163570070716707,0.8256172839506173,0.9916361790241671,1.0,3/26,10.01%,PRR5;SYAP1;MAPKAP1
prerank,tRNA modification (GO:0006400),0.2411323844375885,0.7163513068220778,0.8797385620915033,0.9911484481715931,1.0,19/62,22.37%,TARBP1;PUS7;PUS3;WDR4;CDKAL1;THADA;FTSJ1;TRMT5;ALKBH1;ANKRD16;URM1;TYW5;THUMPD3;METTL2A;METTL2B;OSGEP;TRMO;THG1L;TRMT1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.31149201888516853,0.7162165410582446,0.8012718600953895,0.9908257487720974,1.0,3/15,9.57%,TMEM129;SELENOS;NPLOC4
prerank,mesenchymal cell development (GO:0014031),0.3040074166452532,0.7156119346092981,0.7904761904761904,0.9911253556718315,1.0,2/18,7.86%,HEYL;CDH2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2518349660841493,-0.7154745795960682,0.8624078624078624,0.9671413932490622,1.0,4/17,22.83%,WASF3;FCHSD2;PICK1;CORO1B
prerank,pre-miRNA processing (GO:0031054),-0.27943349478314927,-0.7144156248036521,0.8567708333333334,0.9675478553161261,1.0,4/14,14.65%,ADAR;AGO3;AGO4;TUT7
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2612082046684754,-0.7137793400686021,0.8405797101449275,0.9675070058989615,1.0,6/15,21.80%,ATF2;TIPIN;MUS81;RAD17;RAD9B;FANCD2
prerank,axon extension (GO:0048675),0.2808496417927574,0.713170014617024,0.7996820349761526,0.9939695833281299,1.0,7/23,21.72%,NRP2;SEMA3A;SLC9A6;AUTS2;USP9X;SPG11;NLGN3
prerank,negative regulation of cellular component organization (GO:0051129),0.24013979228407475,0.713133346760753,0.8662420382165605,0.9935198292256042,1.0,11/74,13.64%,FAP;RAPGEF3;SRC;LRSAM1;IRAK3;RDX;ISL1;GSK3B;HDAC6;SACS;LCMT1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.18465014632243162,-0.7129974137413554,0.9478672985781991,0.9675929605819502,1.0,19/72,22.71%,ENPP1;EDC3;RBX1;EDC4;ZC3H12A;PNRC2;ERCC2;XPA;POLK;SPO11;MUS81;RFC2;PDE12;GTF2H4;DDX1;PARP1;ERCC4;ERCC5;POLD2
prerank,neutrophil degranulation (GO:0043312),0.20192556488645144,0.7129969338288068,0.9755102040816327,0.9932082244388599,1.0,78/425,19.50%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.29762150289695527,0.7128032549063521,0.8220472440944881,0.9929652810513927,1.0,7/18,18.46%,SRC;RDX;EZR;RAB21;VPS11;SNX12;DENND10
prerank,peptidyl-arginine modification (GO:0018195),-0.2629786377639789,-0.712426658705309,0.8493506493506493,0.9674472126612889,1.0,11/15,50.67%,ART3;PRMT7;KRTCAP2;PRMT1;PADI2;PARK7;ART1;PADI1;PADI4;ART4;ART5
prerank,histone H3 acetylation (GO:0043966),-0.20435141080620095,-0.7121898853474333,0.9018181818181819,0.9669383600727043,1.0,10/40,18.35%,LEF1;JADE1;TRIM16;KAT14;PHF14;SGF29;DR1;KAT2B;KAT2A;JADE2
prerank,regulation of cytokine production (GO:0001817),0.221763258471929,0.7114949894538918,0.9193548387096774,0.9941884098892168,1.0,15/126,10.37%,GLMN;ITK;TXK;IL1A;PTPRC;TRIM21;N4BP1;PLD3;CRTAM;PTGER4;IGF2BP2;DTX4;NLRP4;HILPDA;ADRA2A
prerank,serine family amino acid metabolic process (GO:0009069),-0.25992430855341403,-0.711367571878957,0.8519417475728155,0.9670164354546776,1.0,9/16,34.20%,PSPH;CBS;GCLC;SEPHS2;CTH;THNSL2;SHMT2;CDO1;SHMT1
prerank,regulation of autophagosome assembly (GO:2000785),0.2669001792396072,0.7113068663821878,0.8372093023255814,0.9939684479552523,1.0,6/33,10.71%,LRSAM1;PIP4K2B;RAB3GAP2;MTMR3;CHMP4A;CHMP4B
prerank,nuclear export (GO:0051168),0.22914343110061566,0.7108382225358449,0.901863354037267,0.9941071381006655,1.0,21/80,21.77%,RBM8A;SRSF4;NUP62;EIF4E;TPR;UPF3B;CSE1L;NUP153;PKD1;THOC3;LSG1;RAN;THOC5;CHP1;XPO5;SLU7;SRSF3;DHX38;SRSF11;STRADB;XPO4
prerank,positive regulation of translation (GO:0045727),0.22546418936790932,0.7107559999222179,0.8992805755395683,0.9937245475889092,1.0,26/94,23.75%,BCL3;FXR2;PIWIL2;RMND1;FASTKD2;METTL5;PLD1;UPF3B;NSUN5;MPV17L2;SOX4;FXR1;PYM1;CPEB3;ERBB2;RPUSD4;DHX9;YBX3;HNRNPD;LARP4;IL6;HABP4;ELAVL1;PKM;NIBAN1;MTOR
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.2898906648224215,-0.7105293068599586,0.8258823529411765,0.9671070193503536,1.0,2/11,12.14%,SLC30A10;ABCD2
prerank,regulation of mast cell activation (GO:0033003),-0.29722672900453984,-0.7105079291924096,0.8534883720930233,0.9663598161422552,1.0,7/10,42.20%,LYN;CRLF2;MILR1;CD300LF;CD84;TSLP;CD226
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2131690380223435,0.7101114945664753,0.9344262295081968,0.9940844701236448,1.0,35/175,22.11%,EDA;TNFSF8;ADAMTS12;FOXO3;PSME3;TRADD;ACOD1;PSMB5;NFE2L2;CDIP1;TNFRSF11B;ZFP36L2;TXNDC17;PSMB2;PSMA2;PSMA6;GPER1;TNFRSF14;PSMD13;PSMA7;PSME4;ASAH1;PSMC4;PSMB6;PSMD12;PSMD14;DHX9;YBX3;CCL14;ST18;TRAF3;TRAF5;PSMB3;CX3CL1;LTBR
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.2676106115342987,-0.7100419595964449,0.8504901960784313,0.9661012145046904,1.0,1/14,1.35%,PPP2R2B
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.23602036402892798,-0.7100329496844368,0.8801089918256131,0.9653407013076294,1.0,4/22,14.99%,B2M;TRAF6;CYRIB;ZBTB1
prerank,regulation of cell growth (GO:0001558),0.21153436507338044,0.7097096392006199,0.9407407407407408,0.994113022971961,1.0,47/204,21.74%,PTCH2;VGLL4;PLCE1;CEACAM1;CAMK2D;EGFR;DCBLD2;ADAM10;NDUFS3;LTBP4;PTPRJ;EBAG9;RPS6KA3;USP47;S100A9;SGK1;INO80;KIF26A;CRLF3;FHL1;NAIF1;RTN4;CAPRIN2;KLHL22;SIPA1;NDRG3;EI24;ERBB2;ARHGEF11;RAB33B;MMP14;MINAR1;ITCH;SOCS2;PPP2CA;EIF4G2;RPTOR;MUL1;CISH;CEP43;FRZB;CCAR2;SERTAD2;OSGIN1;ENO1;TAF9B;RBBP7
prerank,regulation of necroptotic process (GO:0060544),0.28637051292163085,0.7092959978713775,0.8288288288288288,0.9941980795097073,1.0,3/23,9.03%,OGT;FLOT2;PDCD6IP
prerank,protein import into peroxisome matrix (GO:0016558),-0.2843557812614206,-0.7089665359990935,0.8507853403141361,0.9658146213260891,1.0,4/12,19.50%,PEX26;PEX6;PEX1;PEX10
prerank,fluid transport (GO:0042044),0.32303388861562493,0.7084439982317852,0.7961335676625659,0.9948207662497442,1.0,3/12,21.70%,SLC4A11;AQP1;SLC26A6
prerank,translational termination (GO:0006415),0.22601893741211582,0.7082129314083585,0.9010989010989011,0.9946540247205204,1.0,21/95,18.18%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;ETF1;CHCHD1;MRPL16;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2
prerank,positive regulation of JNK cascade (GO:0046330),0.23286134553053822,0.7075747049357388,0.8687898089171975,0.9949959446858152,1.0,10/70,12.05%,AXIN1;SH3RF2;MINK1;WNT16;SEMA3A;MAP3K5;HMGB1;RASSF2;MAPK8IP1;MTURN
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.23731465396149742,0.7073821392761563,0.8791773778920309,0.9947696234971359,1.0,17/65,18.76%,PSME3;CHFR;PSMB5;USP47;CHMP4C;FHL1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;INTS3;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,positive regulation of histone modification (GO:0031058),0.26663387047306714,0.7073684535554271,0.8417366946778712,0.9942966918883765,1.0,3/33,9.16%,PPARGC1A;PAF1;TET1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.2559869021635634,-0.7072308128463134,0.8564102564102564,0.966885481214559,1.0,5/15,25.78%,FKBP1A;LEMD3;CSNK2B;FSTL3;ACVR1B
prerank,sodium ion import across plasma membrane (GO:0098719),0.3001179546525664,0.7063944978060014,0.806930693069307,0.9950758035932671,1.0,3/17,11.18%,SLC12A2;SLC9A7;SLC9A6
prerank,regulation of secretion (GO:0051046),-0.27218994166652244,-0.7062437729343901,0.8661417322834646,0.9671634343172987,1.0,2/13,2.67%,ACSL3;MYO6
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3166431771037621,0.705879994970364,0.802065404475043,0.995273229379977,1.0,2/13,7.60%,BMS1;NOP14
prerank,autophagy of peroxisome (GO:0030242),-0.28616535584568775,-0.7056625374688306,0.8607888631090487,0.9670003418444614,1.0,4/12,15.58%,SQSTM1;NBR1;ACBD5;USP30
prerank,dendritic cell migration (GO:0036336),-0.2609747145957912,-0.7055701769109183,0.8684863523573201,0.966356905620109,1.0,1/16,0.58%,EPS8
prerank,histone modification (GO:0016570),0.22260761889981512,0.7054497754075079,0.910394265232975,0.9953583036327649,1.0,19/109,16.00%,EYA1;KAT6B;HDAC4;TAF10;RCOR3;SIN3B;MSL3;SIRT7;HDAC2;TRRAP;HDAC6;PHF20L1;CREBBP;BAZ2A;KAT8;BRD8;PRMT6;MORF4L2;NEK11
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.3071006865476038,0.705423072396073,0.8338815789473685,0.9949049270145637,1.0,2/15,7.89%,FAP;DPP4
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2978596157272418,0.7054139436334126,0.8295081967213115,0.9944266355241317,1.0,9/18,29.29%,NAIF1;BAD;BNIP3;MUL1;BCL2L1;SLC25A5;SPG7;PPIF;BCL2
prerank,mitochondrial translational elongation (GO:0070125),0.22760253421731994,0.7052246145660208,0.9067164179104478,0.9941824762966444,1.0,34/88,27.92%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;MRPL40;MRPL22;GADD45GIP1;MRPL4;MRPL2;MRPL34;GFM1;TSFM;MRPS7;MRPL11;MRPL19;MRPL39;MRPS18A;MRPL1;MRPL13;MRPL47;MRPL21;DAP3;MRPL57;MRPL46;GFM2
prerank,metal ion transport (GO:0030001),0.2326671366156131,0.7050924825656232,0.9073170731707317,0.9938777514700958,1.0,4/86,4.37%,CAV1;SLC24A1;TRPV4;SLC30A9
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2671512926350519,-0.7050669060981573,0.8235294117647058,0.9661131820000541,1.0,5/13,22.43%,FLNA;SUFU;DBN1;GOPC;GET4
prerank,protein localization to mitochondrion (GO:0070585),0.32863444235881595,0.7044568557419754,0.8149466192170819,0.9942556686610502,1.0,1/11,1.86%,HK2
prerank,neurogenesis (GO:0022008),0.25176274232256435,0.70431620095691,0.8407460545193687,0.9939452243054451,1.0,6/43,13.55%,LPAR1;NTN5;BTBD2;ERCC6;WDR62;CIT
prerank,osteoclast differentiation (GO:0030316),0.2824056541223475,0.7039139134920626,0.82398753894081,0.9939612023054669,1.0,4/22,11.78%,SRC;SNX10;GAB2;GPR183
prerank,spindle assembly (GO:0051225),0.2376656714652298,0.7037703924084037,0.8861578266494179,0.993666377972401,1.0,21/67,26.16%,KIF2A;SMC3;NEK7;NCOR1;TUBGCP5;MAP9;INO80;MAPRE2;ARHGEF10;PIBF1;OFD1;RHOA;HDAC3;TUBGCP6;HAUS8;HAUS3;HAUS7;NEK6;CSNK1D;TNKS;CLASP2
prerank,regulation of telomere maintenance (GO:0032204),0.27426407657752105,0.7035319002156407,0.8300751879699249,0.9934959123838605,1.0,12/26,28.07%,NBN;ERCC1;TERF2;MRE11;HNRNPD;SMG6;ATRX;PML;YLPM1;RAD50;SMG5;TERF2IP
prerank,histone exchange (GO:0043486),-0.20689476321864012,-0.7032915184058477,0.9187279151943463,0.967274452894946,1.0,16/37,31.97%,NPM1;RUVBL1;SMARCA5;ANP32E;CENPT;RNF8;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,negative regulation of binding (GO:0051100),0.23293929238255792,0.7032653938358162,0.9038701622971286,0.9933559270464449,1.0,20/81,21.85%,CAV1;EFHB;DACT1;STYX;GSK3B;SMO;CTNNBIP1;GNL3L;BAG2;E2F1;PPP1CA;SYMPK;SUMO1;BAX;PIN1;HABP4;MAPK8;RSF1;DDX11;JUN
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2502639085916198,0.7030819790475805,0.8755129958960328,0.9930843259258615,1.0,14/45,23.65%,FOXO3;GCNT2;EIF4E;ATXN2;EIF2B4;PUM2;SPOUT1;LARP4;NUDT21;ATG14;PUM1;DDX25;YTHDC1;ZC3H7B
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.30357084375925486,0.7029394049299874,0.8166666666666667,0.9927877539906155,1.0,1/15,1.84%,KCNA5
prerank,regulation of intracellular transport (GO:0032386),0.25700943612637106,0.7028003602345313,0.8573466476462197,0.9924767961167721,1.0,10/38,21.27%,RINT1;INPP5F;ATP9A;LAMP1;WWC1;TTC21B;ATPSCKMT;LCP1;DNAJC30;GRIPAP1
prerank,JNK cascade (GO:0007254),0.2533507994969363,0.7027932285600444,0.8571428571428571,0.9920020362785569,1.0,6/40,12.01%,MINK1;MAPK10;MAP3K5;PTGER4;TAB2;ARHGEF6
prerank,I-kappaB phosphorylation (GO:0007252),0.32718148137794495,0.7027070839165076,0.8049645390070922,0.9916285379601565,1.0,1/10,5.70%,TLR7
prerank,telomere capping (GO:0016233),0.30400341299693034,0.7024706729800863,0.8204697986577181,0.9914550698006945,1.0,4/16,19.02%,STN1;NBN;TERF2;MRE11
prerank,oligodendrocyte differentiation (GO:0048709),0.2901056482135892,0.7015531004724802,0.8330658105939005,0.9921308511561487,1.0,4/19,13.10%,EIF2B3;SOX9;EIF2B4;NSUN5
prerank,membrane repolarization (GO:0086009),-0.2602579604358165,-0.7015361690855129,0.8461538461538461,0.9682836048051643,1.0,7/15,30.79%,KCNJ2;ATP1B1;ATP1B2;KCNE4;KCNH2;ATP1A1;KCNQ1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.2836899351729118,0.701213231015935,0.8382126348228043,0.9920735127595622,1.0,5/21,12.50%,PDE4D;ACAT1;NT5E;NT5C2;NUDT18
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2791937947877903,0.7009074236742642,0.8656488549618321,0.9919705023392387,1.0,5/23,14.66%,DFFB;HMGB1;EXOG;DICER1;REXO4
prerank,negative regulation of cellular catabolic process (GO:0031330),0.23934002507510127,0.7007224316324768,0.8789407313997478,0.9917181348422319,1.0,9/63,11.08%,LEPR;GPLD1;FOXK1;PTPN22;MCL1;FOXK2;EIF4E;RIC1;TAB2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.2304044001311043,0.7005382528241387,0.9001218026796589,0.9914792612591247,1.0,5/77,6.98%,ITGA6;SRC;PSME3;NDUFS3;MCL1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.20867198760595448,-0.700347307888978,0.9353846153846154,0.9687226972228198,1.0,5/32,12.85%,RPS19;RPL30;PGLYRP1;GAPDH;CCL13
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.24009615871650866,0.7002693835345918,0.8754764930114358,0.9913273763471705,1.0,21/59,25.71%,CAMK2D;PRKCA;HIPK1;DYRK1A;CAD;GSK3B;CIT;TBK1;LMTK2;DYRK2;CSNK2A2;PDPK1;CDC42BPG;ACVR1;MAPK8;MAPK1;PRKCD;HIPK2;ROCK1;TNKS;TAF1
prerank,negative regulation of cell cycle process (GO:0010948),0.23520980595385532,0.7000882746991074,0.893048128342246,0.9910971401989717,1.0,18/61,24.76%,FBXO43;TOM1L1;FBXO5;CCP110;TOM1L2;CHMP4C;GPER1;E2F1;TERF2;FOXO4;RBBP4;CHMP2A;RBBP7;TFDP1;NME6;BMP7;APAF1;CBX3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.29671083457949005,0.6999542389063875,0.8398744113029827,0.9907836492413941,1.0,6/17,21.89%,TMEM129;SELENOS;NPLOC4;HM13;SEL1L;DERL1
prerank,cellular response to glucose stimulus (GO:0071333),0.2649682729474204,0.6997471541076224,0.8201754385964912,0.9905662115821008,1.0,8/30,15.58%,ZBTB20;RAB11FIP5;ERN1;SOX4;UNC13B;TRA2B;GPER1;ADCY8
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.28795767838042596,0.6993602505310417,0.84688995215311,0.9905823160613058,1.0,4/18,14.35%,SEC14L1;NPLOC4;USP15;PUM2
prerank,protein targeting to lysosome (GO:0006622),0.2803360767617091,0.6993294295120174,0.8188854489164087,0.990136524609585,1.0,7/20,19.50%,ZFYVE16;M6PR;GCC2;NEDD4;AP3M1;SCARB2;LAMP2
prerank,positive regulation of T cell migration (GO:2000406),0.2829138816984467,0.6991994504592385,0.8135860979462876,0.9898350349426915,1.0,5/20,18.90%,WNT5A;ADAM10;TNFRSF14;RHOA;DOCK8
prerank,neural crest cell migration (GO:0001755),0.2617924153066776,0.698950625116442,0.863448275862069,0.9896567042898569,1.0,9/36,18.71%,FOLR1;SEMA4B;FN1;SEMA3A;SEMA4D;SEMA6C;ERBB4;SEMA4C;SEMA4A
prerank,centromere complex assembly (GO:0034508),-0.20789674055816731,-0.697393156335973,0.906896551724138,0.9710303536241092,1.0,16/36,31.97%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPE;CENPX;CENPI;MIS18A;CENPN;CENPF;CENPA
prerank,innate immune response in mucosa (GO:0002227),0.33227158502029924,0.6969102035668981,0.8135593220338984,0.9917686702539508,1.0,2/10,18.92%,DEFA6;RNASE3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3351345640859413,0.6962857879020058,0.8256880733944955,0.9920837480378792,1.0,2/10,11.15%,RACGAP1;APC
prerank,vitamin D metabolic process (GO:0042359),0.3149682820425682,0.6961434947329408,0.8275290215588723,0.9917873522090389,1.0,2/13,10.15%,CUBN;GC
prerank,amino sugar biosynthetic process (GO:0046349),0.3071666626502246,0.69586895579532,0.8221830985915493,0.9916497522651062,1.0,8/12,31.21%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,inositol phosphate catabolic process (GO:0071545),-0.27440071280093326,-0.6956946209843959,0.8564231738035264,0.9719234863155392,1.0,6/12,29.36%,NUDT3;IMPA1;INPP5A;INPP5B;SYNJ1;INPP5J
prerank,positive regulation of type I interferon production (GO:0032481),-0.17656819298032794,-0.695479650332147,0.975609756097561,0.9713635378512593,1.0,17/73,21.44%,EP300;POLR3E;POLR3B;IRF1;GAPDH;POLR3A;DHX33;POLR3H;ISG15;DHX36;POLR2F;FLOT1;POLR2K;CGAS;TLR3;POLR1C;RIOK3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.26125500860232587,0.6951639751488299,0.8542274052478134,0.9920352481472737,1.0,10/31,22.61%,DCP1B;EXOSC5;DIS3L2;CNOT7;DDX6;CNOT8;LSM3;EXOSC7;DCPS;LSM2
prerank,mitochondrial transport (GO:0006839),0.2430048063455988,0.6935826545495273,0.8918558077436582,0.9934998214016293,1.0,9/53,16.94%,TOMM34;MFN2;FIS1;SLC25A13;TOMM40;STARD3;BAD;BCS1L;BNIP3
prerank,negative regulation of immune system process (GO:0002683),0.2950637734590588,0.6932748199207102,0.8216123499142367,0.9933915257363385,1.0,2/16,6.66%,SOX9;COL3A1
prerank,"transcription, DNA-templated (GO:0006351)",0.20438589658677356,0.6932095590468759,0.9633620689655172,0.9929977539712744,1.0,38/207,18.15%,DTX1;BCL3;MLLT3;FOXO3;TAF10;LEO1;GTF3C6;TAF4B;CDK7;PAF1;RREB1;SMN1;POLR3G;ELL;NELFB;SUPT4H1;TFB2M;ERCC6;NAT14;NFKBIB;GTF2F2;TAF15;BRF2;GTF2H1;TRIP11;GTF3C5;MBD1;BAZ2A;CBFB;TEFM;TAF5;CRCP;ELOA;E2F1;RTF1;TCEA1;TSC22D1;GTF2H3
prerank,entry into host (GO:0044409),0.31259939008502435,0.6927470709589065,0.8133561643835616,0.9930791943742013,1.0,3/13,15.39%,SRC;CCR5;CDH1
prerank,glutathione metabolic process (GO:0006749),-0.20435320491708914,-0.6925056021862561,0.9480968858131488,0.9735611825263505,1.0,12/38,25.82%,GCLM;CTNS;ETHE1;GLRX2;CNDP2;GGCT;GSTT2;HPGDS;GCLC;GSTT1;GSR;GGT5
prerank,cardiac muscle cell contraction (GO:0086003),0.28360191825655895,0.6924626351109053,0.8279742765273312,0.9929671827261732,1.0,1/19,1.42%,CAMK2D
prerank,positive regulation of protein transport (GO:0051222),0.22967434870240191,0.6920409938268237,0.8908629441624365,0.9929856414068773,1.0,12/67,14.28%,RAB29;KIF20B;IL1A;FRMD4A;CEP131;ARHGEF5;RIPOR1;ARF6;TPR;CEP290;PCM1;UNC13B
prerank,negative regulation of mRNA processing (GO:0050686),0.29409813914148497,0.6918935810384772,0.8289036544850499,0.9926928114841412,1.0,6/15,24.09%,SRSF4;SFSWAP;SAP18;SRSF12;SRSF10;RBMX
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.314709119274901,0.6917615360816393,0.8038528896672504,0.9923790099157087,1.0,3/10,23.12%,CRTAM;SCRIB;PRNP
prerank,neutrophil mediated immunity (GO:0002446),0.19556629758405128,0.6915357663641755,0.9817073170731707,0.9921916166040428,1.0,78/432,19.50%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.302624086146118,0.6914974701596432,0.8330683624801272,0.9917676736334617,1.0,2/14,12.38%,RAB29;CD81
prerank,release of cytochrome c from mitochondria (GO:0001836),0.30218268313783364,0.6914771873048242,0.8401305057096248,0.9913183999094278,1.0,8/17,27.21%,FIS1;SFN;FZD9;BAD;BAX;DNM1L;MFF;BCL2L1
prerank,pentose-phosphate shunt (GO:0006098),-0.28454632833257576,-0.6912731337058077,0.8627906976744186,0.9739534283677332,1.0,4/11,19.24%,RPIA;PGLS;PGD;RBKS
prerank,lysosome localization (GO:0032418),0.25227869438161354,0.6907692668637664,0.8668596237337193,0.9917203350442484,1.0,8/37,14.20%,RAB3A;TFEB;BORCS6;HDAC6;SPAG9;ARL8B;KIF5B;RAB34
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.21884425163339938,0.6906667518559668,0.9180522565320665,0.9908934698854384,1.0,23/104,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,cellular response to lectin (GO:1990858),0.21884425163339938,0.6906667518559668,0.9180522565320665,0.9908934698854384,1.0,23/104,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.23863550015019006,0.6903046844288028,0.8901960784313725,0.9908623675070033,1.0,17/53,24.50%,PSME3;BCKDK;PSMB5;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;PSMB3;OAZ2;AZIN1;PSMD2
prerank,positive regulation of lipid storage (GO:0010884),-0.23357867402330124,-0.6902274349596149,0.8911174785100286,0.9741982750975829,1.0,6/21,25.19%,OSBPL11;ZC3H12A;PLIN3;FITM2;C3;SCARB1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.24959917216146874,-0.6894599769928161,0.8605263157894737,0.9741485166826793,1.0,1/18,0.68%,SMAD3
prerank,chromatin remodeling at centromere (GO:0031055),-0.20981994669870102,-0.6888539702863443,0.9210526315789473,0.9739416284423746,1.0,14/31,31.97%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,cellular response to UV-A (GO:0071492),-0.28216293411424853,-0.688804186179437,0.8620689655172413,0.9732238751560827,1.0,2/11,11.42%,MMP2;MMP1
prerank,pinocytosis (GO:0006907),0.3264289376405135,0.6887037629649106,0.8141592920353983,0.9923065963244119,1.0,3/10,15.49%,DOCK2;RAB34;SNX5
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21775628985444007,0.6880191562548806,0.9180522565320665,0.9926611666727732,1.0,23/105,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,translational elongation (GO:0006414),0.21798434016429774,0.6879662772084962,0.9201474201474201,0.9922516763438475,1.0,28/101,22.51%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;EEFSEC;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;LTN1;MRPL40;MRPL22;GADD45GIP1;MRPL4;GTPBP1;MRPL2;MRPL34;EEF1G;GFM1;TSFM;MRPS7;MRPL11;GTPBP2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.274352559036356,-0.6870740730297967,0.8940886699507389,0.9740706533741239,1.0,4/13,17.74%,ZC3HAV1;ZC3H12A;MOV10;RC3H1
prerank,positive regulation of RNA splicing (GO:0033120),0.26771555574173594,0.6869888584286649,0.8661764705882353,0.992979288512031,1.0,7/29,14.85%,SLC38A2;RBM22;DYRK1A;CELF4;RBMXL1;ERN1;TRA2B
prerank,protein catabolic process (GO:0030163),0.22889801966216375,0.6868878541911287,0.90234375,0.9926230921882949,1.0,5/59,7.41%,CEACAM1;LRSAM1;CLN8;SOCS6;SIAH1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2911217982831651,0.6865633484427721,0.8481421647819063,0.9925341776602908,1.0,3/18,9.58%,EIF2AK3;UTP15;SIRT7
prerank,negative regulation of lipid catabolic process (GO:0050995),0.29300240272083555,0.6861377304661994,0.82398753894081,0.9925634825577756,1.0,2/17,10.37%,GPLD1;ADRA2A
prerank,lipid biosynthetic process (GO:0008610),0.2261327296887158,0.6860834290614704,0.9076549210206561,0.9921599572237805,1.0,15/77,20.41%,HSD17B3;AGPAT4;CLN8;SCD5;ACACA;AGPAT5;PRLR;LSS;SCD;LPL;STAR;AGPS;FADS1;GGPS1;DOLPP1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.22006596907519807,0.6860228736701046,0.9303178484107579,0.9917491891001406,1.0,22/88,18.76%,FBXL15;PSME3;FBXO31;PSMB5;FBXL5;FBXL17;FBXO38;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;FBXL12;DMAC2;FBXW7;FBXL3;CUL4B;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3192734793803538,0.6850376847331759,0.8511796733212341,0.9924435571218534,1.0,2/10,9.57%,SEC14L1;NPLOC4
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2866703828442425,-0.6850181951707097,0.836405529953917,0.9752173728731597,1.0,6/10,34.14%,COMT;SARDH;CHDH;SLC44A1;DMGDH;HNMT
prerank,negative regulation by host of viral transcription (GO:0043922),-0.26767065326165485,-0.6849531272382747,0.875609756097561,0.9745268696853643,1.0,7/12,44.42%,HDAC1;POU2F3;HMGA2;TFAP4;CCL5;CCL4;TARDBP
prerank,positive regulation of chromosome organization (GO:2001252),0.2974497814653472,0.6846637250075708,0.8218487394957983,0.9924078427074272,1.0,7/15,26.70%,NBN;SHCBP1L;MRE11;DDX11;ATRX;PML;RAD50
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.22830946531947183,-0.6843878320755094,0.914364640883978,0.974285107574625,1.0,10/24,27.21%,RBPJ;HIF1A;KLF2;HSF1;CEBPB;ATF4;ATF6;NOTCH1;ATF3;ATF6B
prerank,retrograde axonal transport (GO:0008090),0.2956592933577888,0.6839117800897018,0.8313659359190556,0.992805034060058,1.0,6/16,22.14%,ACTR10;PAFAH1B1;KIF5A;KIF5B;DLG2;FBXW11
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2176714997877363,0.6836894592489096,0.9339735894357744,0.9925967422348007,1.0,10/104,8.84%,TRIB2;CCND3;SRC;SLC27A1;TSG101;CCNG1;CDK7;SYAP1;CCNJ;IRGM
prerank,DNA-dependent DNA replication (GO:0006261),0.20964124070087042,0.682885660103024,0.9527104959630911,0.993082552728689,1.0,32/128,18.76%,PSME3;RFC3;ORC5;GINS4;PSMB5;SIRT7;ORC3;SRPK2;CDK2AP1;CDC6;PSMB2;TEFM;POLG2;POLB;PSMA2;PSMA6;REV3L;RECQL5;PSMD13;POLE;PSMA7;GMNN;PSME4;GINS3;NOC3L;ORC1;RFC1;ORC6;PSMC4;PSMB6;PSMD12;PSMD14
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.1975972746650558,-0.6816059928533664,0.946969696969697,0.9760044546403535,1.0,16/38,29.95%,NPM1;HIRA;RUVBL1;SMARCA5;CENPT;CENPP;UBN1;CENPC;CENPQ;MIS18BP1;CENPO;IPO4;CENPX;CENPI;MIS18A;CENPN
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2694061705250068,0.6814057458853346,0.8496932515337423,0.9942793711978237,1.0,8/25,20.46%,MTHFD1;PPAT;PRPSAP2;PRPS1;PRPS1L1;DCK;GART;ADSL
prerank,regulation of immunoglobulin production (GO:0002637),0.2728337093761889,0.6807362964503675,0.8736349453978159,0.9945908296655335,1.0,2/23,6.39%,PTPRC;EPHB2
prerank,carbohydrate transport (GO:0008643),0.3090723589612635,0.6803135927120164,0.8186528497409327,0.9946060509683846,1.0,2/11,12.99%,SLC2A2;AQP1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.3030708594081901,0.6796506464038882,0.8275862068965517,0.9948857793573528,1.0,4/13,18.11%,TYK2;IL6ST;JAK1;OAS2
prerank,transcription by RNA polymerase III (GO:0006383),-0.21402432627351808,-0.6788999474451345,0.911042944785276,0.9776645787568419,1.0,8/27,19.34%,BRF1;SNAPC1;ZC3H8;GTF3C4;IVNS1ABP;POLR3H;SNAPC5;POLR2K
prerank,telomere organization (GO:0032200),-0.18975019735088716,-0.6782300487961007,0.9505703422053232,0.9775162540767662,1.0,13/43,29.83%,SP100;WRN;BLM;DCLRE1B;PARP1;ERCC4;POLD2;ACD;PARP3;ATM;CTC1;PTGES3;TINF2
prerank,long-term memory (GO:0007616),0.2868080445482918,0.6773502723340066,0.8390804597701149,0.9970972950313624,1.0,4/19,15.60%,RGS14;SGK1;NFATC4;CPEB3
prerank,polarized epithelial cell differentiation (GO:0030859),0.2974394451059814,0.676831996373453,0.831858407079646,0.9972139746170774,1.0,5/13,18.52%,OPHN1;ZDHHC7;EZR;SCRIB;RHOA
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.21483962659526618,-0.6761942205230376,0.9329446064139941,0.9785014495081491,1.0,10/28,29.85%,ITPR1;TMEM117;CEBPB;CASP4;ATF4;BBC3;AIFM1;TRIB3;TRAF2;PPP1R15A
prerank,positive regulation of TOR signaling (GO:0032008),-0.19549678241284976,-0.6759538974237052,0.96875,0.9779649539951318,1.0,15/40,28.17%,FNIP1;LAMTOR3;SEH1L;RRAGC;GPR137B;RICTOR;RRAGD;LAMTOR2;NCKAP1L;PIP4P1;SLC38A9;FLCN;MLST8;RHEB;LAMTOR4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2265254430171718,-0.675858406378527,0.9438502673796791,0.9765258045977644,1.0,9/21,27.84%,RBX1;ERCC2;XPA;GTF2H4;PARP1;ERCC4;ERCC5;GTF2H5;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2265254430171718,-0.675858406378527,0.9438502673796791,0.9765258045977644,1.0,9/21,27.84%,RBX1;ERCC2;XPA;GTF2H4;PARP1;ERCC4;ERCC5;GTF2H5;DDB1
prerank,axonemal dynein complex assembly (GO:0070286),0.25741535284030376,0.6753012284883806,0.8805309734513275,0.9984379857852294,1.0,7/27,22.53%,CFAP73;CCDC39;DNAH5;CCDC40;ODAD1;DNAI4;CFAP100
prerank,nucleosome assembly (GO:0006334),0.2524032044882091,0.6747819461449684,0.8474820143884892,0.9985574850684896,1.0,3/31,4.43%,SOX9;HAT1;KAT6B
prerank,central nervous system myelination (GO:0022010),0.3062300717796228,0.6746156603367145,0.8671209540034072,0.9982783563213874,1.0,2/11,12.80%,CNTNAP1;PTEN
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29128510180958656,0.6742434567070363,0.8204697986577181,0.9982155863371427,1.0,8/15,28.94%,RAB3GAP2;SEC61G;RAB3GAP1;SRPRA;SEC61A1;ZFAND2B;SRPRB;SPCS3
prerank,ruffle organization (GO:0031529),-0.2449698963294249,-0.6741186695958536,0.8903061224489796,0.9772282409726353,1.0,5/16,22.83%,TPM1;AIF1L;PIP5K1A;CARMIL1;CORO1B
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.2569204554911039,-0.6738290897992414,0.9046454767726161,0.9759647698141828,1.0,1/14,2.64%,ABCG2
prerank,heme catabolic process (GO:0042167),-0.2569204554911039,-0.6738290897992414,0.9046454767726161,0.9759647698141828,1.0,1/14,2.64%,ABCG2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.3050960904022313,0.6731265346411754,0.8298969072164949,0.9989950186453748,1.0,1/12,2.29%,JAG1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2967059034536778,0.6730515452456945,0.8404605263157895,0.9986007905854901,1.0,1/12,4.05%,SOX9
prerank,tRNA 5'-leader removal (GO:0001682),0.3013737938690194,0.6729196275796685,0.8412698412698413,0.9982727845677971,1.0,6/13,24.93%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2222076771798718,0.6728982435569796,0.9070631970260223,0.9978263520640689,1.0,16/72,18.76%,REL;PSME3;CARD10;PSMB5;PSMB2;PSMA2;PSMA6;DICER1;PSMD13;PSMA7;RELB;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,cellular response to misfolded protein (GO:0071218),0.2800404499882699,0.672535698809283,0.865414710485133,0.9977443869304152,1.0,10/20,30.01%,CUL3;RNF185;KLHL15;UBE2W;DERL1;STUB1;UGGT1;UGGT2;DNAJB12;DNAJC18
prerank,positive regulation of transporter activity (GO:0032411),0.30081788794086756,0.6723000309447473,0.8413793103448276,0.9975301015293144,1.0,2/13,11.96%,KMT2A;SGK1
prerank,N-terminal protein amino acid modification (GO:0031365),0.2981418431195552,0.6720133125647246,0.845514950166113,0.9973559859688924,1.0,4/14,19.22%,NAA35;NAA10;NAA40;NAA60
prerank,phosphate ion transmembrane transport (GO:0035435),-0.26819934470318785,-0.6716390920492952,0.895,0.9770282633896179,1.0,5/12,29.54%,SLC25A30;SLC25A11;SLC37A1;SLC37A2;SLC37A3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.26374824530251223,0.6715265552363147,0.8796875,0.9974479119938238,1.0,2/24,6.13%,PTPN22;ZDHHC1
prerank,organelle fission (GO:0048285),0.26664790382023507,0.6710735187679765,0.8492935635792779,0.9974674348351437,1.0,4/24,10.29%,DNM1;FIS1;MIEF1;ACOT8
prerank,positive regulation of viral life cycle (GO:1903902),0.2758779567567337,0.6707709423792271,0.8466165413533835,0.9973264109234959,1.0,4/22,14.09%,TSG101;KPNA2;AXL;P4HB
prerank,cellular biogenic amine metabolic process (GO:0006576),0.30454392447032025,0.6704227596973882,0.8423817863397548,0.9972422548176045,1.0,2/12,4.89%,SLC29A4;SLC22A3
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.28181847484757483,0.669938154342226,0.873581847649919,0.9972981755331662,1.0,3/17,8.59%,SRC;ATP1A2;ACOD1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19336738351506677,0.6694010894240743,0.9823284823284824,0.9974142670600026,1.0,77/314,22.14%,NEDD4L;FBXL15;RNF122;PCBP2;SPSB4;PSME3;TMEM129;SELENOS;SIAH1;FBXO31;FBXO5;CUL3;CDC20;AMFR;PSMB5;ANAPC5;ANAPC7;SIAH3;NPLOC4;UBE3D;SHARPIN;ANAPC11;FBXL19;NEDD4;SPOPL;BUB3;FBXL5;FBXL17;FAF1;NFE2L2;RNF185;FBXO38;ANAPC2;PSMB2;UBE2J2;UBE2D3;UBE2D1;PSMA2;KLHL22;KLHL15;FEM1C;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;PSMA7;PLAA;FBXL12;LTN1;DMAC2;FBXW7;UBQLN1;FBXL3;ITCH;CUL4B;PSME4;ANAPC16;WFS1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;KBTBD7;GID4;SEL1L;UBE2W;DDIT3;PRKN;PPP2R5C;ZNRF1;PSMB3;DERL1;GID8;CUL5;FBXW11
prerank,regulation of cytoplasmic transport (GO:1903649),0.3131076335993662,0.6693047481806034,0.8379310344827586,0.9970504580394551,1.0,2/11,9.27%,SRC;ATP9A
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.24567846312616448,0.6689644372641278,0.8710144927536232,0.9969502218390761,1.0,6/34,9.65%,IRAK3;TNFAIP3;ACOD1;SARM1;NLRP2B;TICAM1
prerank,glycerophospholipid metabolic process (GO:0006650),0.21855861587974693,0.6684795682487085,0.9264705882352942,0.9970136920710995,1.0,8/75,9.37%,PLCB3;GPLD1;ACP6;PAFAH1B1;PIGB;ABHD12;PLEK;PIGA
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.25023728401267387,-0.6681589314069325,0.8933002481389578,0.9791322148483291,1.0,5/14,29.83%,TPP1;PINX1;ACD;TNKS2;TINF2
prerank,tRNA methylation (GO:0030488),0.24318166712371989,0.6680684350236,0.9069111424541608,0.9969842854089078,1.0,13/34,25.34%,TARBP1;THADA;FTSJ1;TRMT5;THUMPD3;METTL2A;METTL2B;TRMT1L;TRMO;TRMT1;THUMPD2;PRORP;MTO1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.2739829246505411,-0.6679988460214691,0.8914027149321267,0.9777550714657468,1.0,1/10,4.40%,AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.2739829246505411,-0.6679988460214691,0.8914027149321267,0.9777550714657468,1.0,1/10,4.40%,AP2A1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.27733151017636537,0.667038156665702,0.8330464716006885,0.9975937175764344,1.0,2/16,8.76%,KMT5C;WRAP53
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.20706909509639426,-0.6669937616866685,0.9519230769230769,0.9778013026260486,1.0,11/32,23.85%,MNAT1;TAF1D;ERCC2;CCNH;POLR2F;TAF1C;GTF2H4;POLR2K;POLR1C;POLR1F;RRN3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.24987335250553305,0.6658882666049543,0.892128279883382,0.9983747885424186,1.0,6/33,13.19%,WEE1;DACT1;KANK2;APC;PTEN;FHL1
prerank,cellular response to virus (GO:0098586),-0.20675658467220934,-0.6658713179898722,0.9470404984423676,0.9779453216725151,1.0,10/30,32.37%,GSDME;HIF1A;ZC3H12A;LGALS9;RIOK3;CCL19;DDX3X;VWCE;EIF5A;CXCL10
prerank,regulation of protein targeting to membrane (GO:0090313),-0.20541165424891983,-0.6655289060357358,0.9415384615384615,0.977486700098983,1.0,10/28,26.51%,KCNB1;C2CD5;ANK3;MTCL1;MIEF2;TCAF2;HRAS;ITGB2;CIB1;ITGAM
prerank,anterograde axonal transport (GO:0008089),0.24350706095274607,0.6653773429535529,0.9002932551319648,0.9984383520132746,1.0,12/37,24.60%,SPAST;KIF5A;KIF5B;AP3M1;AP3B1;RAB21;AP3S2;RAB27B;DLG2;BLOC1S2;MAPK8IP3;BLOC1S4
prerank,protein localization to chromosome (GO:0034502),-0.20074586541212963,-0.66518569958876,0.9609120521172638,0.9770322769472701,1.0,13/34,31.97%,SLF2;TPP1;SLF1;ESR1;PINX1;XRCC4;ACD;TNKS2;PARP3;CHMP7;MCM9;TINF2;CENPA
prerank,heterochromatin assembly (GO:0031507),0.27547502620881303,0.6650547691923825,0.8602150537634409,0.9982998067237826,1.0,7/20,24.46%,BEND3;SUV39H1;BAZ2A;ZNFX1;SIRT2;EZH1;CENPV
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.22312706006922367,-0.6649734168031148,0.9146005509641874,0.9764547712279151,1.0,7/22,21.74%,RNF115;VPS4A;MVB12A;VPS37C;UBAP1;VPS28;RNF126
prerank,regulation of sensory perception of pain (GO:0051930),-0.27140641113710673,-0.6643250182397433,0.8851674641148325,0.9762074130003747,1.0,4/11,31.41%,CCN3;ACP3;SPX;F2R
prerank,negative regulation of translation (GO:0017148),0.21286952504250822,0.6638764770591012,0.9441747572815534,0.9991050197133878,1.0,11/87,11.01%,FXR2;GIGYF2;EIF2AK3;CNOT10;CELF1;SAMD4B;PUS7;IGF2BP2;CNOT7;TPR;ILF3
prerank,microtubule bundle formation (GO:0001578),0.24534475436672695,0.6637886059010808,0.8888888888888888,0.9987326989304808,1.0,5/42,9.41%,NCKAP5L;SPEF1;CAPN6;SPAST;FOXJ1
prerank,heart looping (GO:0001947),0.2416511531012213,0.6636810434515847,0.8893617021276595,0.9983699789514051,1.0,4/39,7.30%,FOLR1;STIL;TBX2;CCDC39
prerank,protein localization to vacuole (GO:0072665),-0.2546130508927224,-0.6630471834036153,0.8923076923076924,0.9764356619210813,1.0,3/13,13.94%,SH3GLB1;GLMP;LMBRD1
prerank,magnesium ion transport (GO:0015693),0.3042356773892792,0.6626383043776608,0.8507718696397941,0.9990419273611407,1.0,3/12,12.90%,NIPA2;MRS2;TUSC3
prerank,pyroptosis (GO:0070269),-0.24503944636742148,-0.66242309461836,0.9030612244897959,0.9761869601407044,1.0,6/15,32.88%,GSDME;CASP8;CASP4;ZBP1;CASP1;TREM2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2239966666902308,0.6622359463272646,0.9344692005242464,0.9990024509775958,1.0,17/60,21.69%,RUNX2;SOX9;MED7;AGO1;MED13;MECP2;MED23;PTEN;CBFB;MED8;MED12;MED31;BAX;MED15;IL6;MED16;TCF7L2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.25826610673398,0.6621357925824136,0.8738738738738738,0.9986348357184215,1.0,7/25,21.38%,ZNF326;ELL;SUPT4H1;ERCC6;THOC5;TSFM;CCAR2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2809474193698419,0.6618325615553351,0.8870431893687708,0.9984896174890051,1.0,5/18,20.41%,MAPK7;NFE2L2;HTRA2;PINK1;PRKN
prerank,regulation of synapse maturation (GO:0090128),0.3160944868211721,0.6617645494924563,0.8353552859618717,0.9980905031597002,1.0,3/10,13.85%,CDC20;RELN;ANAPC2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.20572025479871783,-0.6616960291003303,0.9283489096573209,0.9760464018236594,1.0,16/29,37.90%,IKBKB;CASP8;CD40;TLR3;IKBKG;RIPK1;BIRC3;LY96;UBB;TANK;CD300LF;IKBKE;TLR6;RPS27A;UBC;CD14
prerank,positive regulation of telomere capping (GO:1904355),0.27556831408788296,0.6615105961185629,0.8656,0.9979039426002232,1.0,4/17,25.70%,NEK7;HNRNPD;MAPK1;TNKS
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.25087456372115596,0.660908997676021,0.8873668188736682,0.9980569737049334,1.0,7/28,20.41%,AXIN1;DDRGK1;PTEN;FBXW7;BAG2;TMTC3;PRKN
prerank,programmed necrotic cell death (GO:0097300),-0.2298948924196649,-0.6602061260385265,0.9342105263157895,0.9765139174965514,1.0,6/18,25.91%,PGAM5;IPMK;TRPM7;TLR3;RIPK1;LY96
prerank,global genome nucleotide-excision repair (GO:0070911),0.2613991565936633,0.6594706444805462,0.8924242424242425,0.99909377657838,1.0,8/26,18.15%,ERCC1;CETN2;GTF2H1;DDB2;CHD1L;USP45;CUL4B;GTF2H3
prerank,regulation of microtubule nucleation (GO:0010968),0.31743640760742875,0.6592333433443085,0.8218181818181818,0.998853050986071,1.0,3/10,16.89%,CKAP5;MECP2;ARHGEF7
prerank,protein-DNA complex assembly (GO:0065004),0.20446365211588685,0.659153586748743,0.9541176470588235,0.9984612764645112,1.0,34/116,21.62%,SOX9;KAT6B;PSME3;ORC5;CDK7;PSMB5;ORC3;CETN2;CDC6;GTF2H1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;DDB2;CHD1L;GMNN;CUL4B;PSME4;ORC1;ORC6;NAP1L1;GTF2H3;PSMC4;PSMB6;PSMD12;PSMD14;SPTY2D1;NAA60;DAXX;RSF1;RPA3;PSMB3
prerank,integrated stress response signaling (GO:0140467),0.2881921770841356,0.658037313675874,0.8624595469255664,0.9991427535909891,1.0,6/14,24.33%,EIF2AK3;NFE2L2;QRICH1;DDIT3;IMPACT;HSPA5
prerank,aromatic amino acid family metabolic process (GO:0009072),0.302606987410787,0.65658901267016,0.8614564831261101,1.0,1.0,1/10,3.05%,IL4I1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2283749192402047,0.6562933999305753,0.9205298013245033,0.9995491593432226,1.0,13/56,18.17%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2283749192402047,0.6562933999305753,0.9205298013245033,0.9995491593432226,1.0,13/56,18.17%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.24548211889471144,0.6558672841784817,0.9097859327217125,0.9995223718758359,1.0,4/28,10.74%,KMT5C;WRAP53;SIRT7;ERCC6
prerank,negative regulation of leukocyte migration (GO:0002686),0.31425496913459805,0.6557415270677985,0.864406779661017,0.9991759802383076,1.0,2/10,9.01%,BMP5;CD200R1
prerank,positive regulation of T cell differentiation (GO:0045582),-0.196403851085784,-0.6551105106295826,0.9658703071672355,0.9797061625137051,1.0,3/36,5.06%,LEF1;GLI3;DUSP10
prerank,mitochondrial protein processing (GO:0034982),-0.26597500727965917,-0.653928803276008,0.9101382488479263,0.9797955903384649,1.0,1/11,1.45%,OMA1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.24419343900769333,-0.653289168604256,0.8983516483516484,0.9795288032823547,1.0,3/15,11.04%,CCT7;RUVBL1;CCT8
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.26237743302567507,0.6531647167219771,0.8740279937791602,1.0,1.0,2/21,8.37%,KCNA5;NOS1AP
prerank,pancreas development (GO:0031016),0.2915889206762882,0.6531530232985221,0.8741379310344828,1.0,1.0,4/12,15.14%,CCDC39;ISL1;FOXF1;CCDC40
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.2748406885261245,-0.6531376012966509,0.8952164009111617,0.9788832468365581,1.0,2/10,17.74%,ZC3H12A;RC3H1
prerank,positive regulation of bone resorption (GO:0045780),0.29947858085309376,0.6517776976081282,0.8654173764906303,1.0,1.0,1/11,4.28%,PRKCA
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2336255319626697,0.6512376999284557,0.9193548387096774,1.0,1.0,9/40,15.67%,BOD1L1;DONSON;GEN1;RFWD3;NUCKS1;ETAA1;EME2;FAM111A;POLE
prerank,positive regulation of protein sumoylation (GO:0033235),-0.2722625855147459,-0.6509660370720084,0.888095238095238,0.979780183039114,1.0,4/10,18.90%,UBA2;PIAS3;RWDD3;GNL3
prerank,positive regulation of heart contraction (GO:0045823),0.2720540987470153,0.6506774653933677,0.9056603773584906,1.0,1.0,2/19,5.62%,ATP1A2;APLN
prerank,protein localization to cell junction (GO:1902414),0.26260332170028616,0.6505957748630898,0.8790199081163859,1.0,1.0,6/22,22.12%,TJP2;CGNL1;FERMT2;JAK1;ARHGEF18;NLGN2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.21092395981142043,0.6500906844903774,0.9566831683168316,1.0,1.0,24/86,21.94%,PSME3;EGLN3;ANKRD2;MAPK7;BAG3;PSMB5;INO80;NFE2L2;CREBBP;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;BACH1;PSMC4;PSMB6;PSMD12;PSMD14;GCN1;DDIT3;PSMB3;IMPACT
prerank,nuclear migration (GO:0007097),0.29099253382759316,0.6497294339603362,0.8631756756756757,1.0,1.0,5/13,14.24%,PAFAH1B1;DOCK7;HOOK3;PCM1;CLMN
prerank,B cell proliferation (GO:0042100),-0.2320992806651287,-0.6496565953302254,0.9074550128534704,0.9800291903604011,1.0,1/17,1.74%,CTPS1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.21991876293964718,-0.6495803418219841,0.936,0.9793406832413039,1.0,7/22,20.52%,WDR12;NOP9;RPS21;EXOSC3;NOL9;KRI1;ERI3
prerank,autophagy of nucleus (GO:0044804),-0.23277783175543193,-0.6492800327723716,0.9069148936170213,0.9788172097322116,1.0,7/16,24.51%,WIPI1;ULK2;ATG13;WIPI2;ATG12;WDR45B;WDR45
prerank,macrophage activation (GO:0042116),0.24036010449866266,0.6492002225088284,0.9022662889518414,1.0,1.0,1/34,0.73%,LBP
prerank,glycosphingolipid metabolic process (GO:0006687),0.22907384632178215,0.6489038491466899,0.9272976680384087,1.0,1.0,8/42,14.23%,A4GALT;SUMF1;CERK;NEU1;HEXA;ST8SIA5;ST8SIA3;HEXB
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2237019172308498,0.6480116516849549,0.9348404255319149,1.0,1.0,6/55,8.67%,COQ7;MPV17;RAC2;DHRS4;ACOD1;AATF
prerank,defense response to Gram-positive bacterium (GO:0050830),0.23387365707508034,0.6479205205756118,0.90633608815427,1.0,1.0,1/40,0.73%,LBP
prerank,DNA geometric change (GO:0032392),-0.21214400100233732,-0.6476677165684902,0.9258241758241759,0.9791802185325095,1.0,6/24,18.89%,WRN;BLM;ANXA1;ZRANB3;DHX36;DDX1
prerank,peptidyl-methionine modification (GO:0018206),-0.25792738978502605,-0.6475813740766926,0.8814814814814815,0.9784844570834847,1.0,1/12,5.92%,NAA15
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24381147565051967,-0.6474828847113462,0.9177377892030848,0.9778121451908031,1.0,8/14,32.62%,WDR12;NOL9;RPF2;RPL7;ZNHIT3;RPL7L1;DDX18;FTSJ3
prerank,lipoxygenase pathway (GO:0019372),0.28607825585794583,0.6471174604550548,0.8712374581939799,1.0,1.0,3/14,21.55%,ALOXE3;HPGD;PON3
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.24703957295311182,-0.6466625969198495,0.9147869674185464,0.9776218361954845,1.0,3/13,17.04%,RBPJ;GSK3A;SMAD4
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.30312005274367704,0.6465247279406873,0.8679245283018868,1.0,1.0,2/11,9.89%,SELENOS;AXL
prerank,mitotic metaphase plate congression (GO:0007080),0.22848348387760292,0.6465150716925584,0.9278215223097113,1.0,1.0,15/51,22.27%,NUP62;CUL3;CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C;ZW10;PIBF1;MAD1L1;CDC23;DCTN2;RRS1;CHMP2A;MIS12
prerank,sphingoid biosynthetic process (GO:0046520),0.29609191119976935,0.6464752850035255,0.8489583333333334,1.0,1.0,1/11,2.60%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.29609191119976935,0.6464752850035255,0.8489583333333334,1.0,1.0,1/11,2.60%,ACER3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2745764203198787,0.6460182739705421,0.8624595469255664,1.0,1.0,2/17,7.80%,EMC9;EMC7
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.29634854742982625,0.646001747883776,0.839572192513369,0.9998096673686562,1.0,4/11,24.22%,ATL2;RTN4;VCPIP1;VAPB
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2210789390241283,0.6453002616443279,0.9415670650730412,1.0,1.0,13/56,18.52%,RACGAP1;SON;USP8;SPAST;PDCD6IP;IST1;CHMP4B;APC;CIT;STAMBP;RTKN;SPTBN1;RHOA
prerank,lipid homeostasis (GO:0055088),0.22263197658106593,0.645238576194323,0.9368279569892473,0.9996381836728186,1.0,11/57,17.63%,ZBTB20;CLN8;USF2;TLCD3A;ABCA1;THADA;ABCD1;PNPLA8;FBXW7;PPARG;IRS2
prerank,snRNA metabolic process (GO:0016073),0.27360924643958784,0.6447409879495649,0.8650927487352446,0.999647129921489,1.0,2/17,5.85%,INTS10;TUT1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.29617944296630666,0.6441098287468888,0.8581196581196581,0.9997880147591327,1.0,3/10,20.75%,HDAC6;PRKN;ETFBKMT
prerank,negative regulation of interferon-gamma production (GO:0032689),0.2544730365138109,0.6423011493149325,0.890625,1.0,1.0,3/23,9.89%,RARA;HMGB1;AXL
prerank,regulation of endocytic recycling (GO:2001135),0.3014970202959594,0.642171918062386,0.8831615120274914,1.0,1.0,3/11,9.27%,EHD2;INPP5F;ATP9A
prerank,telomere maintenance (GO:0000723),-0.17557218450622303,-0.6416866060614577,0.972,0.980261321813263,1.0,18/50,30.41%,SP100;WRN;BLM;DCLRE1B;SMC6;TPRKB;PARP1;ERCC4;POLD2;ACD;RAD51;PARP3;ATM;CTC1;PTGES3;TINF2;XRCC3;TEN1
prerank,B cell mediated immunity (GO:0019724),0.29680919421781027,0.6412383039215812,0.8479427549194991,1.0,1.0,1/10,7.45%,MSH2
prerank,regulation of microtubule depolymerization (GO:0031114),0.25069953400330863,0.6404331070226763,0.9085271317829458,1.0,1.0,2/25,3.32%,SPEF1;TRPV4
prerank,regulation of cellular amine metabolic process (GO:0033238),0.22316437206452888,0.6397851443178979,0.9242021276595744,1.0,1.0,16/50,24.50%,PSME3;PSMB5;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;PSMB3;OAZ2;AZIN1;PSMD2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.2540212581104201,-0.638552940085274,0.9127358490566038,0.9816545079403964,1.0,7/12,28.40%,PARP2;PARP10;PARP1;TNKS2;PARP3;PARP12;PARP16
prerank,mitochondrial membrane organization (GO:0007006),0.23857487488016954,0.6384542896731171,0.9205882352941176,1.0,1.0,15/32,29.89%,MFN2;MICOS10;MTX1;CHCHD6;BAD;BNIP3;CHCHD3;HSPA9;APOOL;BCL2L1;SLC25A5;SPG7;PPIF;BCL2;APOO
prerank,endoderm formation (GO:0001706),0.23682593764295487,0.6377013816313281,0.9078947368421053,1.0,1.0,3/35,5.16%,MMP15;ITGA7;FN1
prerank,positive regulation of chemokine production (GO:0032722),0.2279846155448315,0.6376662410872725,0.9342465753424658,1.0,1.0,10/44,21.62%,WNT5A;IL17RA;TLR7;HMGB1;EGR1;IL7;SYK;LPL;IL6;TWIST1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.28003732647256097,0.6371390733221767,0.8731942215088283,1.0,1.0,2/14,6.60%,CREB3L1;SELENOS
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.29284448201552,0.6369736459332138,0.8615107913669064,1.0,1.0,1/11,4.96%,WNT5A
prerank,negative regulation of dephosphorylation (GO:0035305),0.26123899710244003,0.6363989441153965,0.8816855753646677,1.0,1.0,4/18,17.14%,SH3RF2;ENSA;PTPA;CHP1
prerank,water transport (GO:0006833),-0.24933977581323105,-0.6359812118713732,0.9093023255813953,0.9825914482959295,1.0,3/12,31.14%,AQP11;AQP4;PDPN
prerank,phosphate ion transport (GO:0006817),-0.2292001338869236,-0.6355565178438205,0.91005291005291,0.9820772649158163,1.0,5/16,29.54%,SLC25A30;SLC25A11;SLC37A1;SLC37A2;SLC37A3
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.20043846336180937,-0.6339907739444463,0.9534883720930233,0.9823558774806803,1.0,11/29,27.84%,RBX1;MNAT1;ERCC2;XPA;CCNH;GTF2H4;PARP1;ERCC5;UBB;GTF2H5;DDB1
prerank,regulation of cell cycle (GO:0051726),0.1846271159962026,0.6338624603373862,0.9989561586638831,1.0,1.0,50/271,18.32%,FAP;MYBBP1A;PPP1R13B;KIF20B;SOX9;MFN2;PTPRC;SON;RPRD1B;NEK7;NBN;ADAM10;TRIM21;CDK7;LIN54;RARA;FBXO5;BRINP1;E4F1;PES1;NLRP2B;MASTL;POU4F1;TRNP1;SRPK2;APC;ZBTB49;FBXL17;MEN1;NF2;DHCR24;CRLF3;PKD1;ERN1;HTRA2;TTC28;SIPA1;FZD9;GPER1;FBXL12;HPGD;CDC14A;FBXL3;RGCC;GMNN;LIN37;GADD45GIP1;CSNK2A2;FGF10;FOXO4
prerank,regulation of myelination (GO:0031641),0.24868367470543007,0.6333094202238828,0.8970149253731343,1.0,1.0,5/25,14.63%,ITGAX;EIF2AK3;NCMAP;NSUN5;DICER1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.25923354167431,-0.6332987066418567,0.9168591224018475,0.982025945977159,1.0,4/10,29.78%,TNFRSF1B;ZBTB1;AGER;CCR2
prerank,regulation of microglial cell activation (GO:1903978),-0.23696291944642653,-0.6330720213073887,0.9190600522193212,0.9814337658843684,1.0,3/15,13.41%,LDLR;TTBK1;SPHK1
prerank,negative regulation of calcium ion transport (GO:0051926),0.27627708929526207,0.6321124518822084,0.8941368078175895,1.0,1.0,4/15,21.05%,ATP1A2;ADRA2A;PACSIN3;CBARP
prerank,rRNA catabolic process (GO:0016075),0.26878804620253793,0.6320851252830143,0.9040650406504065,1.0,1.0,2/16,9.57%,EXOSC5;EXOSC10
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.2640859960150333,0.6317377141728364,0.889937106918239,1.0,1.0,9/20,25.77%,AGO1;PUM2;DICER1;SPOUT1;TSNAX;PRKRA;PUM1;ZC3H7B;AGO2
prerank,phagosome maturation (GO:0090382),-0.1836373683701476,-0.6315671352580202,0.9617834394904459,0.9816138834598958,1.0,9/35,24.02%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D;RAB32;ATP6V1F;RAB7A;ATP6V1E1;RAB38
prerank,synaptic vesicle localization (GO:0097479),0.27903118842396335,0.6312632303100492,0.8868552412645591,1.0,1.0,4/13,19.71%,KIF5A;KIF5B;TMEM230;SPG11
prerank,cell cycle G1/S phase transition (GO:0044843),0.21577733459244736,0.631134555391676,0.9450980392156862,1.0,1.0,9/61,17.29%,PLK2;CDK7;CUL3;EIF4E;CRLF3;POLE;E2F1;USP37;CUL4B
prerank,establishment of mitotic spindle localization (GO:0040001),0.2462394991159693,0.6311343244123829,0.9113737075332349,1.0,1.0,8/28,22.14%,SAPCD2;PAFAH1B1;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2514819754467621,0.6305793576652566,0.908695652173913,1.0,1.0,8/25,22.32%,B3GALT1;B4GAT1;NDST1;EXT1;EXT2;B3GNT8;NDST4;HS2ST1
prerank,mRNA destabilization (GO:0061157),0.2291426493452812,0.6305278253338431,0.921875,1.0,1.0,4/38,7.87%,DND1;GIGYF2;CELF1;DIS3L2
prerank,regulation of response to oxidative stress (GO:1902882),0.28477663675569637,0.6301857218594645,0.8853615520282186,1.0,1.0,4/11,20.41%,ABCD1;AIFM2;PINK1;PRKN
prerank,regulation of interleukin-1 beta production (GO:0032651),0.21093251200552324,0.6296527797383819,0.959079283887468,1.0,1.0,7/66,11.42%,USP50;WNT5A;TNFAIP3;NLRC4;ISL1;NLRP2B;EGR1
prerank,outer dynein arm assembly (GO:0036158),-0.24147320211581508,-0.6292976273408901,0.9073170731707317,0.9822047734850835,1.0,8/14,40.56%,LRRC49;DNAL1;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,DNA methylation (GO:0006306),0.25094583124136277,0.6291346414290292,0.8984126984126984,1.0,1.0,4/23,13.94%,BEND3;TEX15;ZFP57;BAZ2A
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.2508376189915746,0.6289766120844779,0.9183055975794251,1.0,1.0,7/24,18.71%,SEMA4B;DSCAM;SEMA3A;SEMA4D;SEMA6C;SEMA4C;SEMA4A
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2362144284731655,0.6288885750396828,0.9121037463976945,1.0,1.0,9/37,18.15%,NTHL1;RFC3;ERCC1;GTF2H1;DDB2;CHD1L;CUL4B;RFC1;GTF2H3
prerank,sensory perception (GO:0007600),0.22279597437248655,0.6285006400407797,0.9409340659340659,1.0,1.0,7/45,13.89%,SCN10A;ALOXE3;GNAL;MME;TMEM150C;TRPV2;KCNK4
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.23883200829936568,-0.6284357106997988,0.8939393939393939,0.9819920873139216,1.0,3/14,18.16%,SCAP;SEC23A;SEC31A
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.23434975131621838,-0.6277224958197941,0.9334975369458128,0.9816594113314321,1.0,5/15,29.81%,ARMC10;KDM1A;MIF;TAF9;TRIAP1
prerank,ESCRT III complex disassembly (GO:1904903),0.303789351850971,0.6269994743340821,0.8492647058823529,1.0,1.0,2/10,9.92%,CHMP5;IST1
prerank,ESCRT complex disassembly (GO:1904896),0.303789351850971,0.6269994743340821,0.8492647058823529,1.0,1.0,2/10,9.92%,CHMP5;IST1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.2734038486622665,0.6269378619735232,0.8686514886164624,1.0,1.0,4/13,18.77%,GCC2;CD81;TMEM30A;TM9SF4
prerank,regulation of lipid catabolic process (GO:0050994),0.26197811525643055,0.6265073767880386,0.892018779342723,1.0,1.0,4/19,20.89%,ADRA2A;ABCD1;TYSND1;ALK
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.24784179291692193,0.6253700953228764,0.9239940387481371,1.0,1.0,4/23,13.61%,HOOK2;HOOK3;KIF5A;KIF5B
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.24434767216690664,-0.6251995626843776,0.9044117647058824,0.9823862011060293,1.0,2/12,13.12%,ACSL3;MFSD2A
prerank,regulation of neuroblast proliferation (GO:1902692),0.26774573472337376,0.6251881090237319,0.8858520900321544,1.0,1.0,4/15,21.67%,NF1;FZD3;CX3CR1;CX3CL1
prerank,regulation of mRNA catabolic process (GO:0061013),0.19553639252542238,0.6250961281635388,0.9827586206896551,1.0,1.0,30/121,22.21%,FXR2;PRKCA;PSME3;SAMD4B;EXOSC5;IGF2BP2;PSMB5;CNOT7;ZFP36L2;PSMB2;FXR1;PSMA2;PUM2;PSMA6;PSMD13;PSMA7;PSME4;CNOT8;GTPBP1;PSMC4;PSMB6;PSMD12;PSMD14;CNOT1;HNRNPD;EXOSC7;PUM1;PSMB3;ELAVL1;YWHAB
prerank,negative regulation of translational initiation (GO:0045947),-0.23904471183146547,-0.6237432135052419,0.9164619164619164,0.9824720539281008,1.0,2/13,10.27%,PAIP2;EIF2AK4
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.2815354360044471,0.6235218934685399,0.8883071553228621,1.0,1.0,3/12,18.69%,CACNA1H;STARD3;STAR
prerank,regulation of oxidoreductase activity (GO:0051341),0.2743526703375035,0.6227379131864627,0.8784246575342466,1.0,1.0,2/13,11.27%,ABL2;HDAC6
prerank,regulation of protein modification process (GO:0031399),0.21627286352972477,0.622220272949187,0.948,1.0,1.0,14/50,21.47%,CDH5;SPRED1;FN1;FER;STAT2;ATG7;SPRED2;SOCS1;WARS1;RABL3;PPP2CA;PIN1;CCAR2;ATG14
prerank,regulation of viral genome replication (GO:0045069),0.21096956306873504,0.621657476292695,0.9500640204865557,1.0,1.0,8/56,11.01%,PPIE;N4BP1;SRPK1;TNIP1;PLSCR1;CNOT7;SRPK2;ILF3
prerank,cholesterol efflux (GO:0033344),-0.21363332263764584,-0.6216349722897754,0.9562982005141388,0.982999623435721,1.0,8/20,32.71%,APOE;STX12;ABCG1;TSKU;ABCG4;SCARB1;SOAT2;APOC1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.28871184750759177,0.6215352808517379,0.8771929824561403,1.0,1.0,6/11,24.99%,FXR1;PUM2;XPO5;DHX9;PUM1;FMR1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.26718307703286953,0.6204264541175979,0.89,1.0,1.0,3/16,15.60%,DND1;ZFP36L2;CPEB3
prerank,positive regulation of interleukin-8 production (GO:0032757),0.21666805256725696,0.6203779151662087,0.9440745672436751,1.0,1.0,3/49,9.49%,LBP;TLR7;HMGB1
prerank,regulation of cellular pH (GO:0030641),0.2390720414948759,0.6200021671069282,0.9211678832116789,1.0,1.0,4/29,11.18%,SLC4A3;SLC4A4;SLC9A7;SLC9A6
prerank,B cell activation (GO:0042113),0.20702991165160667,0.6193839331442094,0.9597402597402598,1.0,1.0,7/68,8.21%,TPD52;HDAC4;PTPRC;BANK1;EPHB2;MSH2;PTPRJ
prerank,protein export from nucleus (GO:0006611),0.23716410361363144,0.6192495942347107,0.9166666666666666,1.0,1.0,9/27,21.77%,STYX;TPR;CSE1L;PKD1;RAN;CHP1;XPO5;STRADB;XPO4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2852996380168981,0.619211112500429,0.8964941569282137,1.0,1.0,4/12,20.64%,WRAP53;CCT2;GNL3L;CCT3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.24558089948970002,0.6188941436255139,0.9174174174174174,1.0,1.0,3/24,12.77%,SLC27A1;CDS2;PNPLA8
prerank,anterograde synaptic vesicle transport (GO:0048490),0.2650169506396607,0.6188493876569692,0.9013157894736842,0.9996189270476232,1.0,5/15,24.60%,AP3M1;AP3B1;AP3S2;BLOC1S2;BLOC1S4
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.2650169506396607,0.6188493876569692,0.9013157894736842,0.9996189270476232,1.0,5/15,24.60%,AP3M1;AP3B1;AP3S2;BLOC1S2;BLOC1S4
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.2732905490429085,0.6180728498168621,0.9074733096085409,0.9997884413252831,1.0,6/13,27.68%,DYRK1A;YJU2;TWIST1;PTTG1IP;MDM2;SNAI1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2696968626206,0.6176680394490545,0.8948275862068965,0.9996465744239935,1.0,5/14,23.43%,USP15;PUM2;PUM1;ZDHHC5;DHX58
prerank,negative regulation of cation channel activity (GO:2001258),0.24193544443552353,0.6167715680137548,0.943076923076923,0.9998734072217392,1.0,4/26,10.76%,FKBP1B;EPHB2;CASQ2;KCNAB1
prerank,regulation of response to stress (GO:0080134),0.2893993280724572,0.6162176540713914,0.8916518650088809,0.9998444330108937,1.0,1/10,3.16%,SLC38A2
prerank,regulation of interferon-beta production (GO:0032648),0.21691883712132423,0.6157087430211269,0.9498644986449865,0.9997884580799491,1.0,14/46,24.66%,REL;TLR7;POLR3G;POLR3D;TBK1;RELB;OAS2;DHX9;TRAF3;IFIH1;DHX58;POLR3C;RIPK2;YY1
prerank,T cell differentiation in thymus (GO:0033077),-0.23087900803117203,-0.6154476307066914,0.9375,0.9857816030563908,1.0,1/14,1.43%,GLI3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19604903377501526,0.6152322945044604,0.9722557297949337,0.9997143830464298,1.0,17/84,18.94%,FXR2;GIGYF2;EIF2AK3;CNOT10;SAMD4B;PUS7;IGF2BP2;CNOT7;ILF3;DDX6;FXR1;RTN4;CPEB3;SYNCRIP;CNOT8;CHRNA7;CNOT1
prerank,male meiosis I (GO:0007141),-0.22858752866251741,-0.6144179224038363,0.9558441558441558,0.9856054370868013,1.0,2/16,8.93%,FOXJ3;MYBL1
prerank,positive regulation of response to external stimulus (GO:0032103),0.19073352287310114,0.6139434719027331,0.9798099762470309,1.0,1.0,23/128,17.74%,PRKCA;MGST2;LRSAM1;WNT5A;ABCC1;IL17RA;TLR7;TRADD;POLR3G;PTGER4;TNIP1;ACOD1;PLSCR1;S100A9;POLR3D;USP15;PUM2;PLG;IL15;NFKBIZ;MDK;STX4;LPL
prerank,protein acetylation (GO:0006473),0.23354710125931288,0.6132310085970569,0.950509461426492,1.0,1.0,8/30,19.22%,HAT1;NAA35;CREBBP;NAT9;NAA10;DSCC1;NAA40;NAA60
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.2678166893607966,0.6132288500703054,0.8824476650563607,0.9999166213850412,1.0,2/15,10.37%,GPLD1;ADRA2A
prerank,histone ubiquitination (GO:0016574),0.25235157424105187,0.6129486790241023,0.9023622047244094,0.9996698701467044,1.0,2/21,6.82%,LEO1;PAF1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2676692919146612,0.6120763440799863,0.9158249158249159,0.9998293352802143,1.0,4/14,22.73%,TUT1;ERN1;NUDT21;CPSF2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.28148715334615526,0.6108564533296738,0.9011345218800648,1.0,1.0,1/11,4.21%,HAT1
prerank,negative regulation of ion transport (GO:0043271),-0.20361866959030062,-0.6108533298723794,0.9650145772594753,0.9868089936868112,1.0,14/24,43.09%,ACTN2;PXK;NOS1;GPM6B;PLN;WNK1;WNK2;STC1;LILRB1;SNCA;HTR1B;CD33;HRH3;VIP
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.29049336215177013,0.6103918251626169,0.8982142857142857,1.0,1.0,3/10,18.34%,FN1;LAPTM4B;CDH3
prerank,AMP metabolic process (GO:0046033),-0.23800587648642135,-0.6102960356147231,0.9439024390243902,0.9863708956197658,1.0,3/13,18.92%,XDH;NUDT2;NT5C1A
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.21469536473214568,-0.6096472005021992,0.9463806970509383,0.9859784074443367,1.0,3/18,9.06%,NPHP3;RFX3;SPEF2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.22276177106505834,-0.6095462365217278,0.935064935064935,0.9852958138574301,1.0,4/16,16.56%,TRA2A;SNW1;NCL;NCBP1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.2608666375055869,0.6094762454479088,0.9032786885245901,1.0,1.0,7/16,24.89%,SIK3;RRAGB;KLHL22;GPR137C;LAMTOR5;RRAGA;CLEC16A
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.25285484210851455,-0.6083765963861696,0.9099099099099099,0.9851884227661554,1.0,5/10,35.92%,SMYD2;SETD6;EHMT1;SETD7;METTL18
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2259346836876489,0.6081970298157215,0.9357142857142857,1.0,1.0,9/39,18.15%,NTHL1;RFC3;ERCC1;GTF2H1;DDB2;CHD1L;CUL4B;RFC1;GTF2H3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.18583499878695317,0.6074148674849235,0.989749430523918,1.0,1.0,13/132,11.36%,RPSA;SF3B1;CELF1;ZRSR2;SNRPF;SMN1;SRPK1;RBM5;NAF1;CELF2;CELF4;SRPK2;LUC7L2
prerank,microtubule anchoring at centrosome (GO:0034454),0.2794813417742418,0.6073399408057906,0.8926654740608229,1.0,1.0,3/10,15.04%,HOOK3;PCM1;CCDC120
prerank,rRNA 3'-end processing (GO:0031125),-0.254832237907877,-0.6066437240791231,0.9409190371991247,0.9853816064205206,1.0,3/10,20.52%,RPS21;EXOSC3;ERI3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.20892929177803538,0.6062799998015347,0.9550858652575958,1.0,1.0,14/55,18.76%,PSME3;PSMB5;USP47;FHL1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.28539354076893336,0.605217920847357,0.8745583038869258,1.0,1.0,2/10,18.27%,HMGB1;PSMC4
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.26632326144534396,0.6048072243004305,0.9060869565217391,1.0,1.0,8/13,31.21%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2240469711626996,0.6040115381371909,0.9536903039073806,1.0,1.0,6/36,15.63%,TXK;WNT5A;IRGM;AXL;IL7;TICAM2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.19786052569155432,-0.6028785477394937,0.9637462235649547,0.9864564635486041,1.0,3/24,12.17%,RAPGEF2;PDE2A;PRKAR2B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.19996153975512637,0.602048887912163,0.98375,1.0,1.0,17/70,18.76%,PSME3;TAPBP;PSMB5;LNPEP;VAMP8;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;CYBB;PSMC4;PSMB6;PSMD12;SNAP23;PSMD14
prerank,establishment of vesicle localization (GO:0051650),0.25191433749812825,0.6016208645288698,0.9133858267716536,1.0,1.0,5/18,19.71%,LIMK2;KIF5A;KIF5B;TMEM230;SPG11
prerank,nucleoside salvage (GO:0043174),0.28872292715631415,0.6013746061100791,0.9097472924187726,1.0,1.0,1/10,4.03%,UPP2
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.24467216192228303,0.6013744638589748,0.9202453987730062,1.0,1.0,5/20,18.94%,CELF1;AGO1;CNOT7;CNOT8;CNOT1
prerank,regulation of hemopoiesis (GO:1903706),0.28459617053274033,0.6012468084911322,0.898972602739726,1.0,1.0,4/10,26.73%,CREBBP;CBFB;RUNX1;MYSM1
prerank,gene silencing by miRNA (GO:0035195),0.22618395926343426,0.6011057697060793,0.95,1.0,1.0,10/32,18.94%,AGO1;CNOT7;PUM2;DICER1;RAN;SPOUT1;PRKRA;XPO5;CNOT8;CNOT1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.2581057696741409,0.6004408343814254,0.9258064516129032,1.0,1.0,2/16,9.37%,PIGB;PIGA
prerank,positive regulation of interferon-beta production (GO:0032728),0.22081464217520508,0.5975235531129592,0.9546099290780142,1.0,1.0,10/33,24.19%,TLR7;POLR3G;POLR3D;TBK1;OAS2;DHX9;IFIH1;DHX58;POLR3C;RIPK2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.24740522784839264,0.5974614855973359,0.9226973684210527,1.0,1.0,1/18,2.89%,GPLD1
prerank,DNA methylation or demethylation (GO:0044728),0.25209809371780456,0.5974391411821879,0.9210526315789473,1.0,1.0,3/19,13.94%,BEND3;TEX15;BAZ2A
prerank,DNA alkylation (GO:0006305),0.25209809371780456,0.5974391411821879,0.9210526315789473,1.0,1.0,3/19,13.94%,BEND3;TEX15;BAZ2A
prerank,double-strand break repair via homologous recombination (GO:0000724),0.19077676534969404,0.597008832647611,0.9864029666254636,1.0,1.0,19/95,19.02%,SMC5;NBN;PALB2;SWI5;GINS4;ZSWIM7;ZFYVE26;INO80;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;REV3L;RECQL5;REC8;SFR1;PSMD14;MRE11
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.28458930248238123,0.5969168106275616,0.8967391304347826,1.0,1.0,3/10,14.46%,ST6GAL1;NAGK;GNPDA2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.19556788369282951,-0.5957782172880792,0.9697885196374623,0.9891664166894767,1.0,11/25,32.46%,HSPA8;DNAJB5;SDF2;BAG1;HSPA1A;HSPA14;DNAJB1;PTGES3;HSPA1B;HSPA2;SDF2L1
prerank,stress granule assembly (GO:0034063),0.24297980980212827,0.5950322040475527,0.9354330708661417,1.0,1.0,5/20,19.08%,ATXN2;CSDE1;UBAP2L;DDX6;G3BP1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.26416137257468325,0.5944972983961117,0.9194395796847635,1.0,1.0,4/13,21.52%,SPI1;ARID1B;SERTAD2;ARID1A
prerank,exit from mitosis (GO:0010458),0.27723314047941694,0.5921668107252172,0.9184782608695652,1.0,1.0,3/12,10.71%,SPAST;SIRT7;CHMP4B
prerank,protein ADP-ribosylation (GO:0006471),-0.185592722081368,-0.5914598681807522,0.9940828402366864,0.9903972591751693,1.0,10/28,29.27%,ART3;ZC3HAV1;PARP2;PARP10;PARP1;TNKS2;PARP3;PARP12;PARP16;SIRT6
prerank,P-body assembly (GO:0033962),-0.23574233299738778,-0.5913569039856096,0.941747572815534,0.9897068306119877,1.0,7/12,36.14%,EDC3;RC3H1;LIMD1;LSM4;DYNC1H1;EIF4ENIF1;PATL2
prerank,regulation of chromatin binding (GO:0035561),-0.24971439486702685,-0.5910397177295356,0.9217391304347826,0.9890966824463258,1.0,3/10,26.41%,MED25;KDM4D;BTAF1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.22319746004564103,-0.5903095393398216,0.9430051813471503,0.9886887897276038,1.0,2/14,15.73%,TRAF6;CSF1
prerank,protein methylation (GO:0006479),0.21520356663360032,0.5901584601535262,0.96105702364395,1.0,1.0,12/40,25.76%,ETF1;ATPSCKMT;LCMT1;METTL22;PRMT6;CAMKMT;ICMT;ETFBKMT;VCPKMT;EEF2KMT;PRMT8;PRMT3
prerank,cellular response to nutrient levels (GO:0031669),0.20041859988819483,0.5901221410048654,0.9796178343949045,1.0,1.0,8/62,13.76%,INHBB;KLF10;PDK4;RIPOR1;STK24;TFEB;ATG7;RRAGB
prerank,regulation of interferon-alpha production (GO:0032647),0.23627677734980915,0.5883346417984809,0.9554531490015361,1.0,1.0,8/23,28.83%,TLR7;TBK1;SETD2;DHX9;IFIH1;RIPK2;HAVCR2;MAVS
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.19367295542593466,-0.5878803801533703,0.9739130434782609,0.9890180965788239,1.0,10/23,36.82%,RBX1;XPA;COPS6;PARP1;GPS1;UBB;DDB1;COPS8;RPS27A;UBC
prerank,cranial nerve development (GO:0021545),-0.23885642189578912,-0.5866521164732272,0.9536585365853658,0.9887892028539422,1.0,3/11,16.64%,CHD7;SALL1;TMEM126A
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.27948672427567844,0.5861244408949813,0.9153713298791019,1.0,1.0,3/10,20.64%,WRAP53;CCT2;CCT3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.2576417016823954,0.5851680073979769,0.9200652528548124,1.0,1.0,2/15,9.65%,IL17RA;TICAM1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.2427419357690418,0.5849330154343481,0.9203980099502488,1.0,1.0,4/18,17.65%,RFC3;GINS4;POLE;GINS3
prerank,positive regulation of chromatin organization (GO:1905269),-0.23156866737977416,-0.5827925648416112,0.9414519906323185,0.9895836174917351,1.0,4/12,29.83%,UBE2N;TAL1;ACD;TINF2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.24594002747682747,-0.5826027714294798,0.9444444444444444,0.9889271144086492,1.0,4/10,29.08%,SSBP1;CDC7;WIZ;E2F7
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.21527325029989663,-0.5823116071341067,0.9683377308707124,0.9883311789031591,1.0,5/15,24.84%,HECW2;ANAPC1;PTTG1;CENPE;TACC3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.27086517518296926,0.5820745941863709,0.9279588336192109,1.0,1.0,1/10,4.33%,DIP2A
prerank,histone lysine methylation (GO:0034968),0.21304273628329884,0.5812681022960013,0.9644886363636364,1.0,1.0,8/33,21.35%,KMT2A;SUV39H1;MEN1;DYDC2;KMT2D;SUV39H2;ASH2L;SETDB1
prerank,coenzyme A biosynthetic process (GO:0015937),0.2724243722341222,0.5812657599803683,0.9259259259259259,1.0,1.0,3/11,15.34%,COASY;ACAT1;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2724243722341222,0.5812657599803683,0.9259259259259259,1.0,1.0,3/11,15.34%,COASY;ACAT1;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2724243722341222,0.5812657599803683,0.9259259259259259,1.0,1.0,3/11,15.34%,COASY;ACAT1;PANK2
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.21923770697866124,-0.5793297448352398,0.9555555555555556,0.988810492617305,1.0,2/15,7.39%,BCL2L11;ANXA1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2712750082314057,0.5784652798806629,0.9204737732656514,1.0,1.0,3/11,20.64%,WRAP53;CCT2;CCT3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.22696190488579523,-0.5780642655950241,0.9633867276887872,0.9886069066534251,1.0,3/13,12.42%,SEC16A;SEC16B;SAR1B
prerank,hyaluronan metabolic process (GO:0030212),0.23068846494514098,0.5775986226304145,0.9264264264264265,1.0,1.0,7/23,24.71%,HEXA;CEMIP2;HEXB;CHP1;CEMIP;GUSB;FGF2
prerank,tRNA 5'-end processing (GO:0099116),0.25109572749592896,0.5766306648411594,0.9285714285714286,1.0,1.0,6/15,24.93%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,peptidyl-lysine methylation (GO:0018022),0.2227122136032774,0.5761455581090255,0.9444444444444444,1.0,1.0,8/26,22.64%,SUV39H1;ATPSCKMT;SETD2;SUV39H2;ETFBKMT;KMT5A;VCPKMT;EEF2KMT
prerank,renal absorption (GO:0070293),0.2718279248269243,0.5760969066466655,0.929553264604811,1.0,1.0,2/10,11.96%,MAGED2;SGK1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.21780083607419506,0.5760339756982493,0.9583333333333334,1.0,1.0,13/31,30.01%,BAG3;HDAC6;ERN1;BAX;UBE2W;PRKN;DAXX;HSPA9;HSPA5;STUB1;RHBDD1;DNAJB12;DNAJC18
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.22085654736947755,0.5749374133023091,0.9505247376311844,1.0,1.0,1/27,1.39%,AK5
prerank,homologous chromosome segregation (GO:0045143),-0.19892229829398983,-0.5745151185542067,0.9767441860465116,0.989272055373981,1.0,15/20,50.59%,TERB1;PTTG1;CENPC;FANCD2;ZCWPW1;SGO1;MAJIN;MEIOB;IHO1;PRDM9;FMN2;RNF212B;MEIKIN;ANKRD31;TERB2
prerank,protein targeting to mitochondrion (GO:0006626),0.1994018197721857,0.5730691751971796,0.9806201550387597,1.0,1.0,9/52,19.36%,TOMM34;MFN2;FIS1;IMMP2L;TOMM40;MIPEP;HSPA4;DNAJC19;GRPEL2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.23586426501980162,0.5720814705866961,0.9495268138801262,1.0,1.0,6/19,22.89%,WNT5A;MAPK7;CBFB;DHX9;RUNX1;IFIH1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.22054009872986138,0.571919924438964,0.9572901325478645,1.0,1.0,7/27,21.52%,EGFR;DDX6;FXR1;PUM2;DHX9;IL6;PUM1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.25907315461481095,0.5717601288310501,0.9317803660565723,1.0,1.0,1/12,4.28%,PRKCA
prerank,insulin secretion (GO:0030073),0.23786496288424716,0.5714085594538714,0.9255663430420712,1.0,1.0,4/19,18.74%,RIMS2;RAB11FIP5;CAMK2G;RAB11FIP2
prerank,replication fork processing (GO:0031297),0.20942262420796826,0.570948745711262,0.9700427960057061,1.0,1.0,15/38,27.59%,BOD1L1;GEN1;RFWD3;NUCKS1;ETAA1;EME2;FAM111A;MRE11;ATR;DDX11;PRIMPOL;ATRX;FBH1;FANCM;BRCA2
prerank,nucleotide-excision repair (GO:0006289),0.1822392613573003,0.570148138422491,0.9891696750902527,1.0,1.0,20/101,18.15%,SLC30A9;FANCC;RFC3;PPIE;CDK7;ERCC6;ERCC1;CETN2;GTF2H1;POLB;COPS5;POLE;DDB2;CHD1L;USP45;TCEA1;CUL4B;BRIP1;RFC1;GTF2H3
prerank,DNA replication (GO:0006260),0.17919880555765488,0.5678444148961366,0.98698224852071,1.0,1.0,29/105,22.78%,RFC3;ORC5;NBN;PTMS;ORC3;TOP1;CDK2AP1;DONSON;CDC6;POLG2;POLB;REV3L;RECQL5;FAM111A;POLE;RHNO1;BRIP1;ORC1;RFC1;ORC6;NAP1L1;MRE11;RPAIN;ATR;RAD9A;RPA3;HELB;POLE2;MCM4
prerank,regulation of leukocyte migration (GO:0002685),0.2417080132395722,0.5673969107935087,0.9466666666666667,1.0,1.0,2/16,12.38%,RAC2;CD81
prerank,ATP transport (GO:0015867),-0.23826099798355244,-0.5670569519759769,0.9393939393939394,0.9913261864343997,1.0,3/10,27.27%,ABCC6;SLC25A24;SLC25A42
prerank,modulation by symbiont of host process (GO:0044003),-0.2422333496453429,-0.5663320433326572,0.9452054794520548,0.9908343706035831,1.0,1/10,4.54%,B2M
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.18869093509375734,0.5655660793899759,0.983729662077597,1.0,1.0,16/67,18.76%,PSME3;TAPBP;PSMB5;VAMP8;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;CYBB;PSMC4;PSMB6;PSMD12;SNAP23;PSMD14
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.21283615339621637,0.5654578506984743,0.967741935483871,1.0,1.0,7/31,19.95%,AXIN1;CDC20;PTEN;FZR1;FBXW7;PINK1;PIN1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.24323349999920985,0.5652751452891315,0.9356913183279743,1.0,1.0,5/16,19.22%,NAA35;CREBBP;NAA10;NAA40;NAA60
prerank,DNA biosynthetic process (GO:0071897),-0.2025616678245274,-0.5646159383047887,0.9669211195928753,0.9906867092996245,1.0,6/16,35.08%,WRN;POLA1;POLD2;CDKN2D;POLL;TYMS
prerank,intracellular sterol transport (GO:0032366),0.2598568903145151,0.5642827602925113,0.9363166953528399,1.0,1.0,7/13,26.12%,ABCA1;OSBPL2;STAR;NPC1;RELCH;STARD4;NPC2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.24912845068101458,0.5633709701509707,0.931899641577061,1.0,1.0,4/13,24.33%,DDRGK1;WFS1;NCK1;HSPA5
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2523786203697635,0.5620657965176605,0.9444444444444444,1.0,1.0,3/13,13.64%,TPR;GEN1;LCMT1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21428241722437394,0.5614113853571832,0.9431137724550899,1.0,1.0,3/30,6.71%,CAVIN1;CDK7;POLR1E
prerank,cellular response to unfolded protein (GO:0034620),-0.18172720801872938,-0.5607178029580447,0.9807692307692307,0.9912924088570583,1.0,12/26,36.75%,HSPA8;HSF1;OPTN;ABCB10;TMBIM6;HSPA1A;HSPA14;HSPA1B;HSPD1;HSPA2;PACRG;DAB2IP
prerank,lipid droplet formation (GO:0140042),-0.23002918904058478,-0.5597410566710908,0.95662100456621,0.9908909841888106,1.0,5/10,35.91%,FITM2;AUP1;BSCL2;SQLE;CDS1
prerank,sulfur amino acid catabolic process (GO:0000098),0.2619294611312462,0.5596474324696254,0.9378330373001776,1.0,1.0,2/10,15.15%,BLMH;TXN2
prerank,regulation of protein sumoylation (GO:0033233),0.2376819249635736,0.5582064074732981,0.9406919275123559,1.0,1.0,6/17,25.06%,HDAC4;EGR1;GNL3L;MUL1;SAE1;PIAS1
prerank,protein localization to kinetochore (GO:0034501),0.24943760671020257,0.5580355416995028,0.9444444444444444,1.0,1.0,3/14,14.75%,BUB3;ZWILCH;ZW10
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2075509374975173,0.5567898936501832,0.9631811487481591,1.0,1.0,7/33,19.02%,STN1;WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11
prerank,histone monoubiquitination (GO:0010390),0.22214989117675804,0.5565445855173603,0.9596273291925466,1.0,1.0,8/24,23.22%,LEO1;PAF1;DDB2;CUL4B;CDC73;PCGF1;RNF20;DTX3L
prerank,regulation of intracellular pH (GO:0051453),0.2061695287126311,0.5553980739517487,0.9657631954350927,1.0,1.0,4/34,11.18%,SLC4A3;SLC4A4;SLC9A7;SLC9A6
prerank,central nervous system neuron axonogenesis (GO:0021955),0.2513171636117708,0.5547572376399421,0.9547038327526133,1.0,1.0,2/12,12.80%,EPHB2;PTEN
prerank,positive regulation of lipid catabolic process (GO:0050996),0.23151335122354677,0.5543318914699479,0.965964343598055,1.0,1.0,6/19,24.58%,ABCD1;IRS2;AKT2;TWIST1;PRKCD;DAGLB
prerank,skeletal muscle contraction (GO:0003009),0.226961880722018,0.5542095136964683,0.9563106796116505,1.0,1.0,3/19,16.69%,TNNI1;TNNI3;RCSD1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.2194364937842464,0.5540327776429003,0.9622047244094488,1.0,1.0,5/22,21.08%,PPM1A;DUSP8;PPP1CA;PPP2CA;PPM1E
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2330591675141317,0.5539292372558418,0.9696969696969697,1.0,1.0,5/18,20.64%,NAF1;EXOSC10;CCT2;RUVBL2;CCT3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.24806980101688533,0.5530778485231483,0.9432989690721649,1.0,1.0,11/11,75.21%,RTP3;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;LPO;RTP4;PKD1L3;PKD2L1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.2602675478456393,0.5518124269611913,0.9511343804537522,1.0,1.0,4/10,27.78%,FZD3;CX3CR1;CX3CL1;SMARCD3
prerank,detection of calcium ion (GO:0005513),-0.21282454691156932,-0.5516896428182058,0.9656862745098039,0.9927345700330545,1.0,8/13,46.96%,CALM1;CALM3;SYT1;RYR2;KCNMB2;KCNMB1;CASR;KCNIP2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.24410674116183767,0.5514078189286281,0.9331046312178388,1.0,1.0,4/13,25.21%,ALG9;DPAGT1;ALG12;ALG14
prerank,organelle transport along microtubule (GO:0072384),0.20676685596204492,0.5510379547775306,0.9609022556390977,1.0,1.0,8/31,22.77%,PAFAH1B1;NDE1;COPG1;KIF5B;HTT;DYNC1I1;FBXW11;RHOT2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.2604917857390777,0.5508371839036784,0.9395509499136442,1.0,1.0,2/10,11.18%,GABRG2;GABRG1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.24446243345773636,0.550834140091695,0.9381443298969072,1.0,1.0,3/12,15.04%,HOOK3;PCM1;CCDC120
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.18003225182185348,-0.5496558564988577,0.9848942598187311,0.992588441630795,1.0,7/24,21.22%,JARID2;BMI1;SUZ12;DNMT3B;EED;TASOR;DNMT3A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.25097506675077,0.5496463859131101,0.9354838709677419,1.0,1.0,4/11,24.33%,CREB3L1;DDIT3;MBTPS2;HSPA5
prerank,production of siRNA involved in RNA interference (GO:0030422),0.26387133119499473,0.5495718961859929,0.9318568994889267,1.0,1.0,3/10,16.65%,DICER1;TSNAX;PRKRA
prerank,RNA biosynthetic process (GO:0032774),0.20493269163339006,0.5481836157393271,0.9794721407624634,1.0,1.0,5/31,15.64%,TAF10;SMN1;NAT14;BRF2;TAF5
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.2039199997525843,-0.5479158043323532,0.9751243781094527,0.9923792582711201,1.0,6/16,26.75%,MUS81;ERCC4;TOP2B;TOP2A;CENPX;RMI1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.20528276554762656,-0.546691878859826,0.9691211401425178,0.9920173149196264,1.0,4/14,23.42%,IL18;PRKCZ;RSAD2;NOD2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.23447829682960797,0.5460073876060237,0.9560067681895094,1.0,1.0,8/15,30.78%,CNOT7;CPEB3;CNOT1;TENT4B;AGO2;TENT4A;POLR2G;TOB1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.24770358987389463,0.5419596689061489,0.9578414839797639,1.0,1.0,3/12,15.38%,CDC20;PTEN;FZR1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2057058468582405,0.5407680489765252,0.9743975903614458,1.0,1.0,2/29,7.63%,AXIN1;FBXO5
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.19447101155842106,-0.5407043785085899,0.9791666666666666,0.9929909408123658,1.0,7/16,29.83%,PINX1;DHX36;PARP1;ERCC4;TNKS2;ATM;TINF2
prerank,protein deneddylation (GO:0000338),-0.22403030573155067,-0.5404493619517617,0.95,0.9923217326305435,1.0,4/10,32.50%,COPS6;GPS1;COPS8;TOR1A
prerank,protein localization to chromatin (GO:0071168),0.22892586048513758,0.5396747039265107,0.9647435897435898,1.0,1.0,4/18,18.67%,MSH2;PPHLN1;LEMD2;RUVBL2
prerank,telomere maintenance via telomerase (GO:0007004),0.2055368656747409,0.5395777045266018,0.9790732436472347,1.0,1.0,11/28,28.07%,WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;SHQ1;TERF2IP
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2047824604068055,0.53945312979431,0.9718518518518519,1.0,1.0,11/29,28.07%,WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;SHQ1;TERF2IP
prerank,cytoplasmic translational initiation (GO:0002183),0.22801791737808697,0.5384033914094513,0.9509803921568627,1.0,1.0,1/17,3.60%,EIF2B3
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.16645785161660842,-0.5376379131030735,0.990228013029316,0.9923698485003065,1.0,12/30,32.46%,HSPA8;ENTPD5;DNAJB5;SDF2;BAG1;HSPA1A;HSPA14;DNAJB1;PTGES3;HSPA1B;HSPA2;SDF2L1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.2293213264703538,0.5372749042658036,0.9678456591639871,1.0,1.0,4/15,18.94%,CNOT7;ZFP36L2;CPEB3;CNOT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.2293213264703538,0.5372749042658036,0.9678456591639871,1.0,1.0,4/15,18.94%,CNOT7;ZFP36L2;CPEB3;CNOT1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2085094310966736,-0.536156396259515,0.9776674937965261,0.992012293611608,1.0,4/13,22.44%,NCBP1;CPSF1;CPSF7;CPSF6
prerank,regulation of RNA export from nucleus (GO:0046831),0.25023866582947746,0.535618004728064,0.9618181818181818,1.0,1.0,5/11,24.03%,TPR;NUP153;SETD2;DHX9;IWS1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.19761888217718737,-0.5352006917463414,0.9879227053140096,0.991528451404985,1.0,9/16,34.30%,CACTIN;SRSF1;WBP4;WBP11;DDX23;SNRPC;SART1;NCBP2;CWC15
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.22529816435588815,0.5348968066756804,0.9697452229299363,1.0,1.0,6/18,24.54%,ITGB7;PODXL2;ITGB1;CX3CR1;GOLPH3;ROCK1
prerank,sensory perception of pain (GO:0019233),0.2183558011950431,0.5347214643119914,0.9737654320987654,1.0,1.0,3/21,13.89%,ALOXE3;MME;KCNK4
prerank,intracellular pH reduction (GO:0051452),0.19655910504194668,0.5334574539926683,0.9741379310344828,1.0,1.0,4/33,11.51%,ATP6V0D2;DMXL1;ATP6V0A1;DMXL2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.24521744713858484,0.533114979322055,0.9497307001795332,1.0,1.0,1/10,11.42%,EGR1
prerank,regulation of nervous system development (GO:0051960),0.19450596506967652,0.5314881504335038,0.9829545454545454,1.0,1.0,9/37,22.92%,HEYL;BHLHE40;DOCK7;NSUN5;YAP1;GBX1;CX3CR1;CX3CL1;SIRT2
prerank,positive regulation of viral genome replication (GO:0045070),0.20275872219349686,0.5307823795739284,0.9737226277372263,1.0,1.0,4/29,10.90%,PPIE;SRPK1;CNOT7;SRPK2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.20247993142899012,-0.5283860382386588,0.9668367346938775,0.9924698762562987,1.0,2/13,15.54%,LRRK2;OPA1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.21339126868265657,0.5279462305089526,0.9751552795031055,1.0,1.0,6/22,18.15%,CETN2;GTF2H1;DDB2;CHD1L;CUL4B;GTF2H3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.23457014075086413,0.5273694301982317,0.9645868465430016,1.0,1.0,5/14,21.62%,ABCD1;TYSND1;IRS2;AKT2;TWIST1
prerank,antibacterial humoral response (GO:0019731),0.22716178320976513,0.5268739168174947,0.9562289562289562,1.0,1.0,15/16,65.36%,DEFA6;RNASE3;ANG;DMBT1;PLA2G1B;WFDC2;LTF;DEFB1;RNASE7;WFDC3;RNASE6;CAMP;JCHAIN;SLPI;PLA2G6
prerank,inorganic ion transmembrane transport (GO:0098660),0.2405532552449438,0.5265708741239261,0.967128027681661,1.0,1.0,1/12,4.79%,CACNA1H
prerank,cell differentiation in hindbrain (GO:0021533),0.24078532812992254,0.5249153257678185,0.9488536155202821,1.0,1.0,1/11,3.66%,OPHN1
prerank,regulation of macrophage migration (GO:1905521),0.2544499973598159,0.524576903550555,0.9591836734693877,1.0,1.0,2/10,12.38%,CD200R1;CD81
prerank,response to peptide (GO:1901652),0.19167937629543608,0.5217457700872792,0.9854227405247813,1.0,1.0,4/33,12.28%,EIF2B3;MMP12;EIF2B4;STAT2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.24720579018996022,0.5179334109409464,0.9529616724738676,1.0,1.0,1/10,6.35%,SIRT3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.24720579018996022,0.5179334109409464,0.9529616724738676,1.0,1.0,1/10,6.35%,SIRT3
prerank,acylglycerol catabolic process (GO:0046464),0.19770391670444878,0.5164597273496566,0.9824046920821115,1.0,1.0,5/30,20.02%,ABHD12;LIPE;LPL;FAAH;LYPLA2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.2359489759272713,0.5158230396531079,0.9454855195911414,1.0,1.0,2/11,12.80%,OCRL;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.2359489759272713,0.5158230396531079,0.9454855195911414,1.0,1.0,2/11,12.80%,OCRL;PTEN
prerank,peptide hormone secretion (GO:0030072),0.2022410784199837,0.5152225900302172,0.974739970282318,1.0,1.0,2/26,6.97%,RIMS2;LTBP4
prerank,histone methylation (GO:0016571),0.20120518939231838,0.514916088956718,0.9760119940029985,1.0,1.0,5/26,17.48%,SUV39H1;SIRT7;CREBBP;PRMT6;SUV39H2
prerank,regulation of double-strand break repair (GO:2000779),0.18286275552099257,0.5142647943744304,0.9958333333333333,1.0,1.0,10/39,22.69%,OTUB2;UBR5;WRAP53;SIRT7;MGMT;PPP4C;SETD2;DDX11;TWIST1;SPIDR
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.20450331926926033,-0.5136113099042153,0.9908466819221968,0.99504282219986,1.0,3/11,28.12%,JAK2;XBP1;CIITA
prerank,steroid catabolic process (GO:0006706),0.24491589254330903,0.5125100389468293,0.9508771929824561,1.0,1.0,10/10,75.52%,HSD17B11;HSD11B1;SPP1;HSD17B6;CYP19A1;FGF23;CYP24A1;CYP27B1;HSD17B14;YWHAH
prerank,immunoglobulin mediated immune response (GO:0016064),0.2387647501883003,0.5110012200323251,0.9551971326164874,1.0,1.0,10/10,76.14%,CD81;ZP3;GAPT;CD19;CARD9;CD74;TLR8;FCER1G;FCGR2B;CD27
prerank,phagosome-lysosome fusion (GO:0090385),0.24056595144168658,0.5094969354583084,0.9675675675675676,1.0,1.0,3/10,18.86%,ARL8B;RAB34;RAB39A
prerank,error-free translesion synthesis (GO:0070987),0.21134644116350104,0.5087910681366699,0.9792993630573248,1.0,1.0,3/22,10.64%,RFC3;NPLOC4;RCHY1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.1908560261841585,0.5053491965977789,0.9914040114613181,1.0,1.0,6/32,23.05%,NEK7;NAF1;CCT2;ATR;CCT3;MAPK1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.18200917833766078,0.5026425159226013,0.9916083916083916,1.0,1.0,8/37,22.92%,NCOR1;AATF;ATXN2;ANKRD13B;PINK1;PRKN;PAX2;SIRT2
prerank,T cell activation involved in immune response (GO:0002286),-0.19532400365317823,-0.5024608354457369,0.9845758354755784,0.996502140986287,1.0,10/12,52.70%,EIF2AK4;ICAM1;SLC11A1;LILRB1;FCER1G;CD74;ITGAL;F2RL1;IFNK;TNFSF18
prerank,negative regulation of interleukin-12 production (GO:0032695),0.2218044915135698,0.502416288988007,0.9714765100671141,1.0,1.0,2/14,15.87%,IRAK3;PIBF1
prerank,positive regulation of immune response (GO:0050778),0.16741967281028255,0.5013177252466788,0.9974358974358974,1.0,1.0,9/64,17.17%,PTPRC;POLR3G;PLSCR1;KARS1;IL6ST;CD81;POLR3D;IL15;STX4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.20406620291213484,-0.4996642841141112,0.971764705882353,0.9962883182558611,1.0,5/10,35.96%,AKT1;MYD88;TREM2;CD36;TLR6
prerank,negative regulation of interferon-beta production (GO:0032688),0.23909543243874215,0.49932121263920753,0.9771528998242531,1.0,1.0,1/10,4.50%,REL
prerank,striated muscle contraction (GO:0006941),0.1716705010871771,0.4992603908871594,0.9946666666666667,1.0,1.0,8/53,16.69%,CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1;TNNI3;ARHGEF11;RCSD1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.20932705948287894,0.4983118164152563,0.981042654028436,0.9998788048610372,1.0,8/18,28.37%,AMFR;RNF185;EDEM2;SEL1L;RNF103;MAN1B1;UGGT1;UGGT2
prerank,cellular response to radiation (GO:0071478),0.17740664006922371,0.4975345632900477,0.9874651810584958,0.9996482772142095,1.0,9/40,22.69%,OPN1MW;OPN1MW3;SWI5;INO80;TNKS1BP1;RHNO1;GPR52;RAD9A;SPIDR
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.23230659779614077,0.49299565187344174,0.9737302977232924,1.0,1.0,2/11,15.10%,EFNB2;GPER1
prerank,sensory perception of smell (GO:0007608),0.224061119460966,0.48943349994889596,0.9636048526863085,1.0,1.0,10/11,48.40%,ADCY3;UBR3;SLC24A4;OBP2B;GFY;DRD2;OMP;BEST2;SYT10;BBS4
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.21755019873784834,0.48863841012948805,0.9779661016949153,1.0,1.0,1/14,5.17%,CARD10
prerank,nuclear membrane disassembly (GO:0051081),0.21354076582546164,0.48630207980362256,0.9692058346839546,1.0,1.0,1/14,4.28%,PRKCA
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.2100916967209385,0.48183913802303474,0.986159169550173,1.0,1.0,3/13,18.94%,CNOT7;CPEB3;CNOT1
prerank,regulation of mast cell degranulation (GO:0043304),0.21345077949209168,0.47923822539618405,0.9750445632798574,1.0,1.0,3/14,16.49%,FER;GAB2;SYK
prerank,glycine metabolic process (GO:0006544),0.21569365976145644,0.47851797877350594,0.9798319327731092,1.0,1.0,12/12,78.45%,GLDC;DLD;SDSL;SDS;BAAT;AMT;GLYAT;SHMT1;GCAT;SHMT2;GCSH;RIDA
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.18703365237009906,0.47656684213119505,0.9897209985315712,1.0,1.0,6/25,19.72%,CIDEB;GPER1;BAD;BNIP3;PINK1;BAX
prerank,lipid droplet organization (GO:0034389),0.19170854271356794,0.4747019556328816,0.9907120743034056,1.0,1.0,22/22,80.86%,HILPDA;CDS2;RAB18;RAB3GAP1;PLA2G4C;FAF2;ZFYVE1;PPIA;FITM1;CIDEC;TSPO2;HSD17B13;SMIM22;CIDEA;PLIN5;CDS1;SQLE;BSCL2;PPID;AUP1;FITM2;PNPLA3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.18906489820962247,0.4739092435232328,0.9877112135176651,1.0,1.0,5/24,21.53%,RFC3;POLB;POLE;RFC1;RPA3
prerank,positive regulation of T cell activation (GO:0050870),0.16190378734875316,0.4735969005512806,0.9986876640419947,1.0,1.0,13/62,21.79%,FLOT2;PTPRC;NCK2;IL6ST;CD276;CD81;IL7;IL15;MDK;DOCK8;IL6;NCK1;CCDC88B
prerank,negative regulation of interleukin-17 production (GO:0032700),0.2217549585739392,0.47357693720221256,0.9725776965265083,0.9996633317114408,1.0,10/10,77.84%,DDIT3;PRNP;VSIR;IFNG;TNFSF4;IL12B;FOXP3;TLR4;IL12A;NCKAP1L
prerank,serine family amino acid catabolic process (GO:0009071),-0.19984036740296923,-0.47307513320966976,0.9907192575406032,0.9994011604380965,1.0,5/10,34.20%,CBS;GCSH;THNSL2;SHMT2;SHMT1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.2106867679345155,0.47223748735136445,0.9741824440619621,0.999479015730897,1.0,4/14,24.33%,DDRGK1;COPS5;BAX;HSPA5
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.1975618654286058,0.4714834056023326,0.9786535303776683,0.9991893175393961,1.0,3/18,13.32%,ISL1;AQP1;ZFP36L2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.20530448468943918,0.4709110529950253,0.9781879194630873,0.9988772584876953,1.0,4/15,23.67%,POP7;DICER1;RPP30;RNASEH1
prerank,phospholipid homeostasis (GO:0055091),-0.19363291277901937,-0.46780173415161985,0.9840546697038725,0.9992812547778034,1.0,4/11,34.58%,ABCG1;RCN3;FABP3;TLCD2
prerank,regulation of response to interferon-gamma (GO:0060330),0.2048071968366028,0.4675145142183766,0.9774696707105719,0.9990387939150631,1.0,5/14,26.57%,SOCS1;JAK1;SUMO1;PIAS1;PTPN2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.18847141790242483,0.4672264717312262,0.9844479004665629,0.9986632646073781,1.0,2/23,9.55%,CRTAM;LAMP1
prerank,protein homotrimerization (GO:0070207),-0.17449049583493695,-0.46534159895678673,0.9951573849878934,0.9980853057170438,1.0,1/14,3.29%,SCARA5
prerank,protein trimerization (GO:0070206),-0.17449049583493695,-0.46534159895678673,0.9951573849878934,0.9980853057170438,1.0,1/14,3.29%,SCARA5
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.18605576074559388,0.4619455992923472,0.9869918699186991,0.999086569337588,1.0,7/19,26.09%,NAGK;GNPDA2;PMM1;GFPT1;GFPT2;PMM2;AMDHD2
prerank,neural crest cell differentiation (GO:0014033),0.19340343078808886,0.459059798795388,0.9903225806451613,0.9991048838940556,1.0,2/18,11.87%,CDH2;FBXL17
prerank,negative regulation of receptor internalization (GO:0002091),0.20089477444885268,0.4571768152345192,0.9829351535836177,0.9989617146881105,1.0,2/12,15.17%,ATXN2;ANKRD13B
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.2073379885701926,0.45474050670895527,0.9830220713073005,0.9988914545421548,1.0,1/12,8.28%,GCNT2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.18656941401482885,0.45223633974587485,0.9903069466882067,0.9988169039691646,1.0,7/17,27.68%,DYRK1A;YJU2;PRKN;TWIST1;PTTG1IP;MDM2;SNAI1
prerank,regulation of AMPA receptor activity (GO:2000311),0.17806125295630118,0.44717271208751697,0.9909774436090225,0.9990669210152797,1.0,2/25,10.52%,MINK1;RELN
prerank,spermatid development (GO:0007286),0.16810408775083202,0.4456113312773438,0.9956521739130435,0.9988370893111443,1.0,6/32,23.55%,TDRD5;IQCG;CEP57;CDYL;DDX25;SYCP3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.1810792069642631,-0.44469066598599366,0.9948186528497409,0.9992280679611646,1.0,5/11,37.96%,VCP;AUP1;TOR1A;POMT2;UFD1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.195534730243403,0.44219706173969353,0.9931740614334471,0.9988195246392622,1.0,2/13,21.30%,NEDD4;EPN2
prerank,spliceosomal snRNP assembly (GO:0000387),0.16249694062377618,0.43780271576294155,0.9971139971139971,0.9988994796531239,1.0,3/38,7.37%,SNRPF;PRPF3;SMN1
prerank,phagolysosome assembly (GO:0001845),0.19680625509258004,0.43636302680472094,0.9759862778730704,0.9986443599133698,1.0,3/12,18.86%,ARL8B;RAB34;RAB39A
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.17593874119793898,0.4352827068170011,0.9922239502332815,0.9983385738456719,1.0,9/22,28.37%,AMFR;RNF185;EDEM2;SEL1L;RNF103;MAN1B1;UGGT1;MAN1C1;UGGT2
prerank,regulation of superoxide anion generation (GO:0032928),0.18896436584845794,0.42997939583883527,0.9982638888888888,0.9984706723593213,1.0,2/14,16.49%,AATF;SYK
prerank,cell-cell junction maintenance (GO:0045217),-0.17148005097723223,-0.4298694617980452,0.9977827050997783,0.9994879478568729,1.0,1/11,6.24%,MYADM
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.16498210810471467,-0.42798265097251154,0.9954022988505747,0.9988709854918624,1.0,13/13,83.52%,MAPT;ITGB2;ITGAM;TGFB1;CRP;GSTP1;F2RL1;CD177;FPR2;TYROBP;SOD1;PRKCD;SYK
prerank,regulation of lipid storage (GO:0010883),0.1693010310606266,0.422856563494401,0.9923076923076923,0.9987130061008487,1.0,4/22,20.67%,HILPDA;FBXW7;LPL;IL6
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.15869667586384853,0.4224508973125683,0.9985714285714286,0.9983276089344636,1.0,3/35,12.08%,NEK7;NAF1;CCT2
prerank,regulation of chromosome organization (GO:0033044),0.1638670290260706,0.4156912999977905,0.9951845906902087,0.9984674210038286,1.0,10/22,31.16%,SHCBP1L;TERF2;HNRNPD;SMG6;CENPV;YLPM1;SMG5;TERF2IP;XRCC5;WAPL
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.18731352945079194,0.40422887487885606,0.9947460595446584,0.9988330408075904,1.0,3/11,23.75%,SIRT7;DDX11;MTOR
prerank,positive regulation of lymphocyte migration (GO:2000403),0.18374428960182881,0.40119602269053917,0.9965397923875432,0.9986003364956141,1.0,3/12,18.90%,TNFRSF14;RHOA;DOCK8
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.17278736816392581,0.3931656615692289,0.9983050847457627,0.998623057968923,1.0,2/14,19.89%,NLRP2B;CCDC3
prerank,secretory granule organization (GO:0033363),0.17267141920155593,0.37441447744159684,1.0,0.9989975875273157,1.0,1/10,9.72%,ABCA1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.15547886703588487,-0.3727110395041231,0.9976851851851852,0.9997444823384714,1.0,6/11,42.67%,JAK2;STAT3;IL12RB2;STAT4;IL27RA;IL12A
